The search: sars in the database(s) BIOSIS Previews 2005: 47 2005/10/30
  -2005/11/05, BIOSIS Previews 2005: 46 2005/10/23-2005/10/29, BIOSIS Previews
  2005: 45 2005/10/16-2005/10/22, BIOSIS Previews 2005: 44 2005/10/09-2005/10/15,
  BIOSIS Previews 2005: 35-43 2005/09-2005/10, BIOSIS Previews 27-34 2005/07
  -2005/08, BIOSIS Previews 18-26 2005/05-2005/06, BIOSIS Previews 9-17 2005/03
  -2005/04, BIOSIS Previews 1-8 2005/01-2005/02, BIOSIS Previews 2003, BIOSIS
  Previews 2002, BIOSIS Previews 2001, BIOSIS Previews 2000, BIOSIS Previews 
  1999, BIOSIS Previews  1998, BIOSIS Previews 1997, BIOSIS Previews 1996, BIOSIS
  Previews 1995, BIOSIS Previews 1994, BIOSIS Previews  1993, BIOSIS Previews
  1992, BIOSIS Previews  1991, BIOSIS Previews 1990, BIOSIS Previews 1989, BIOSIS
  Previews 1988, BIOSIS Previews 1987, BIOSIS Previews 1986, BIOSIS Previews
  1985, BIOSIS Previews 1984, BIOSIS Previews 1983, BIOSIS Previews 1982, BIOSIS
  Previews 1981, BIOSIS Previews 1980, BIOSIS Previews 1979, BIOSIS Previews
  1978, BIOSIS Previews 1977, BIOSIS Previews 1975-1976, BIOSIS Previews  1972
  -1974, BIOSIS Previews  1969-1971 returned 2547 records


Record 1 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein
  results in specific humoral immune responses against SARS-CoV in rats
AU: Liu,-Ran-Yi [Author]; Wu,-Li-Zhi [Author]; Huang,-Bi-Jun [Author]; Huang,
  -Jia-Ling [Author]; Zhang,-Yan-Ling [Author]; Ke,-Miao-La [Author]; Wang,-Jun
  -Mei [Author]; Tan,-Wei-Ping [Author]; Zhang,-Ru-Hua [Author]; Chen,-Han-Kui
  [Author]; Zeng,-Yi-Xin [Author]; Huang,-Wenlin [Author,-Reprint-Author]
AD: Natl Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, 651 Dong Feng
  Rd E, Guangzhou 510060, Peoples R China
EMA: wl_huang@hotmail.com
SO: Virus-Research. 2005; 112(1-2): 24-31
PY: 2005
DT: Article
IS: 0168-1702
LA: English
AB: The causative agent of severe acute respiratory syndrome (SARS) has been
  identified as SARS-associated coronavirus (SARS-CoV), but the prophylactic
  treatment of SARS-CoV is still under investigation. We constructed a
  recombinant adenovirus containing a truncated N-terminal fragment of the SARS
  -CoV Spike (S) gene (from -45 to 1469, designated Ad-S-N), which encoded a
  truncated S protein (490 amino-acid residues, a part of 672 amino-acid S 1
  subunit), and investigated whether this construct could induce effective
  immunity against SARS-CoV in Wistar rats. Rats were immunized either
  subcutaneously or intranasally with Ad-SN once a week for three consecutive
  weeks. Our results showed that all of the immunized animals generated humoral
  immunity against the SARS-CoV spike protein, and the sera of immunized rats
  showed strong capable of protecting from SARS-CoV infection in vitro.
  Histopathological examination did not find evident side effects in the
  immunized animals. These results indicate that an adenoviral-based vaccine
  carrying an N-terminal fragment of the Spike gene is able to elicit strong SARS
  -CoV-specific humoral immune responses in rats, and may be useful for the
  development of a protective vaccine against SARS-CoV infection. (c) 2005
  Elsevier B.V. All rights reserved.
AI: Y
MC: Pharmacology-; Infection-; Immune-System: Chemical-Coordination-and
  -Homeostasis; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Respiratory-System: Respiration-
ST: -[03116-] Adenoviridae-, -dsDNA-Viruses, Viruses-, Microorganisms-; -[03613
  -] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-, Microorganisms-; 
  -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: Adenovirus- (Adenoviridae-): species-; Severe-Acute-Respiratory-Syndrome
  -associated-coronavirus (Coronaviridae-): common-, SARS-CoV, common-; Wistar
  -rat (Muridae-): common-
TN: Adenoviridae-: Double-Stranded-DNA-Viruses, Microorganisms-, Viruses-;
  Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-
CB: S-protein; recombinant-adenovius-N-terminal-Spike-gene-fragment: immunologic
  -drug, immunostimulant-drug, vaccine-, intranasal-administration, subcutaneous
  -administration
GN: Severe-Acute-Respiratory-Syndrome-associated-coronavirus-Spike-gene
  [Coronaviridae-]
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, etiology-, prevention-and
  -control
MQ: histopathological-examination: laboratory-techniques, histology-and-cytology
  -techniques
MI: humoral-immune-response
CC: 03502- (Genetics-General)
03506- (Genetics-Animal)
12512- (Pathology
  -Therapy)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
22002- (Pharmacology-General)
22018-
  (Pharmacology-Immunological-processes-and-allergy)
31500- (Genetics-of
  -bacteria-and-viruses)
33502- (Virology-General-and-methods)
34502-
  (Immunology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510243289
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0168
  -1702&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0168
  -1702&isbn=&volume=112&issue=1-2&spage=24&pages=24
  -31&date=2005&title=Virus%20Research&atitle=Adenoviral%20expression%20of%20a%20t
  runcated%20S1%20subunit%20of%20SARS
  -CoV%20spike%20protein%20results%20in%20specific%20humoral%20immune%20responses%
  20against%20SARS
  -CoV%20in%20rats&aulast=Liu&pid=%3Cauthor%3ELiu%2c%20Ran%20Yi%3bWu%2c%20Li%20Zhi
  %3bHuang%2c%20Bi%20Jun%3bHuang%2c%20Jia%20Ling%3bZhang%2c%20Yan%20Ling%3bKe%2c%2
  0Miao%20La%3bWang%2c%20Jun%20Mei%3bTan%2c%20Wei%20Ping%3bZhang%2c%20Ru%20Hua%3bC
  hen%2c%20Han%20Kui%3bZeng%2c%20Yi%20Xin%3bHuang%2c%20Wenlin%3C%2Fauthor%3E%3CAN%
  3E200510243289%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 2 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Vaccine design for severe acute respiratory syndrome coronavirus
AU: He,-Yuxian [Author]; Jiang,-Shibo [Author,-Reprint-Author]
AD: New York Blood Ctr, Lindsley F Kimball Res Inst, Viral Immunol Lab, New
  York, NY 10021 USA
EMA: sjiang@nybloodcenter.org
SO: Viral-Immunology. 2005; 18(2): 327-332
PY: 2005
DT: Literature-Review; Article
IS: 0882-8245
LA: English
AB: Severe acute respiratory syndrome (SARS) is an emerging infectious disease
  caused by a new coronavirus (SARS-CoV). Recent studies suggest that SARS-CoV is
  zoonotic and may have a broad host range besides humans. Although the global
  outbreak of SARS has been contained, there are serious concerns over its re
  -emergence and bioterrorism potential. As a part of preparedness, development
  of a safe and effective vaccine is one of the highest priorities in fighting
  SARS. A number of candidate vaccines, using a variety of approaches, are under
  development. The first vaccine tested in clinical trial is made from the
  inactivated form of SARS-CoV. Several live attenuated, genetically engineered
  or vector vaccines encoding the SARS-CoV spike (S) protein have been in pre
  -clinical studies. These vaccine candidates are effective in terms of eliciting
  protective immunity in the vaccinated animals. However, caution should be taken
  with the safety of whole virus or full-length S protein-based immunogens in
  humans because they may induce harmful immune or inflammatory responses. We
  propose to use the receptor-binding domain (RBD) of SARS-CoV S protein
  (residues 318-510) for developing a safe and effective subunit SARS vaccine, as
  it is not only a functional domain that mediates virus-receptor binding but
  also a major neutralization determinant of SARS-CoV. It has been demonstrated
  that the RBD of SARS-CoV S protein contains multiple conformational epitopes
  capable of inducing highly potent neutralizing antibody responses and
  protective immunity.
AI: Y
MC: Pharmacology-; Immune-System: Chemical-Coordination-and-Homeostasis
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-Coronavirus (Coronaviridae-): species-,
  SARS-virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: immunogens-; vaccine-: immunologic-drug, immunostimulant-drug, vaccine-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, immunology-
CC: 12512- (Pathology-Therapy)
16006- (Respiratory-system-Pathology)
22002-
  (Pharmacology-General)
22005- (Pharmacology-Clinical-pharmacology)
22018-
  (Pharmacology-Immunological-processes-and-allergy)
33502- (Virology-General
  -and-methods)
34502- (Immunology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510243267
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0882
  -8245&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0882
  -8245&isbn=&volume=18&issue=2&spage=327&pages=327
  -332&date=2005&title=Viral%20Immunology&atitle=Vaccine%20design%20for%20severe%2
  0acute%20respiratory%20syndrome%20coronavirus&aulast=He&pid=%3Cauthor%3EHe%2c%20
  Yuxian%3bJiang%2c%20Shibo%3C%2Fauthor%3E%3CAN%3E200510243267%3C%2FAN%3E%3CDT%3EL
  iterature%20Review%3bArticle%3C%2FDT%3E

Record 3 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Augmentation of immune responses to SARS coronavirus by a combination of DNA
  and whole killed virus vaccines
AU: Zakhartchouk,-Alexander-N [Author,-Reprint-Author]; Liu,-Qiang [Author];
  Petric,-Martin [Author]; Babiuk,-Lorne-A [Author]
AD: Univ Saskatchewan, Vaccine and Infect Dis Org, 120 Vet Rd, Saskatoon, SK S7N
  5E3, Canada
EMA: zakhartchouk@sask.usask.ca
SO: Vaccine-. 2005; 23(35): 4385-4391,4392-4453
PY: 2005
DT: Article
IS: 0264-410X
LA: English
AB: We studied the immunogenicity of a DNA SARS-vaccine, a whole killed virus,
  or a whole killed and DNA vaccine combination. The DNA vaccine contained a
  plasmid encoding the SARS coronavirus (SARS-CoV) S protein under the control of
  the human CMV promoter and intron A. The whole killed virus vaccine was
  comprised of SARS-CoV, propagated in Vero-E6 cells, with subsequent beta
  -propilactone inactivation and formulated with aluminum hydroxide adjuvant.
  Mice immunized twice with the DNA vaccine and once with the whole killed virus
  elicited higher antibody responses than mice immunized three times with the DNA
  vaccine or once with the whole killed virus vaccine. Mice immunized twice with
  the whole killed virus vaccine elicited higher antibody responses than mice
  immunized three times with the DNA vaccine or once with the whole killed virus
  vaccine. However, a combination of the vaccines induced T-helper type I (Th1)
  immune responses while the whole killed virus vaccine induced T helper type 2
  (Th2) immune response. These results demonstrate that combination of the DNA
  vaccine and the whole killed virus vaccine can be used to enhance the magnitude
  and change the bias of the immune responses to SARS-CoV. (c) 2005 Elsevier Ltd.
  All rights reserved.
AI: Y
MC: Pharmacology-; Infection-; Immune-System: Chemical-Coordination-and
  -Homeostasis; Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-, host-; SARS-virus
  (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome-virus, common-,
  pathogen-, strain-Tor-2; mouse- (Muridae-): common-, host-, female-, strain
  -BALB-c
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-; Muridae
  -: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman-Mammals,
  Rodents-, Vertebrates-
PS: T-helper-cell: immune-system
CB: intron-A: 98530-12-2; CMV-promoter; beta-propiolactone: 57-57-8; S-protein;
  DNA-vaccine: antiinfective-drug, antiviral-drug, vaccine-
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease
RN: 98530-12-2; 57-57-8
MI: immune-response
CC: 02506- (Cytology-Animal)
12512- (Pathology-Therapy)
16004- (Respiratory
  -system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
22002- (Pharmacology-General)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510243169
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0264
  -410X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0264
  -410X&isbn=&volume=23&issue=35&spage=&pages=&date=2005&title=Vaccine%20&atitle=A
  ugmentation%20of%20immune%20responses%20to%20SARS%20coronavirus%20by%20a%20combi
  nation%20of%20DNA%20and%20whole%20killed%20virus%20vaccines&aulast=Zakhartchouk&
  pid=%3Cauthor%3EZakhartchouk%2c%20Alexander%20N%3bLiu%2c%20Qiang%3bPetric%2c%20M
  artin%3bBabiuk%2c%20Lorne%20A%3C%2Fauthor%3E%3CAN%3E200510243169%3C%2FAN%3E%3CDT
  %3EArticle%3C%2FDT%3E

Record 4 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Angiotensin-converting enzyme 2 protects from severe acute lung
AU: Imai,-Yumiko [Author]; Kuba,-Keiji [Author]; Rao,-Shuan [Author]; Huan,-Yi
  [Author]; Guo,-Feng [Author]; Guan,-Bin [Author]; Yang,-Peng [Author]; Sarao,
  -Renu [Author]; Wada,-Teiji [Author]; Leong-Poi,-Howard [Author]; Crackower,
  -Michael-A [Author]; Fukamizu,-Akiyoshi [Author]; Hui,-Chi-Chung [Author];
  Hein,-Lutz [Author]; Uhlig,-Stefan [Author]; Slutsky,-Arthur-S [Author]; Jiang,
  -Chengyu [Author]; Penninger,-Josef-M [Author,-Reprint-Author]
AD: Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria
EMA: Josef.penninger@imba.oeaw.ac.at
SO: Nature-(London). 2005; 436(7047): 112-116
PY: 2005
DT: Article
IS: 0028-0836
LA: English
AB: Acute respiratory distress syndrome (ARDS), the most severe form of acute
  lung injury, is a devastating clinical syndrome with a high mortality rate (30
  -60%) (refs 1-3). Predisposing factors for ARDS are diverse(1,3) and include
  sepsis, aspiration, pneumonias and infections with the severe acute respiratory
  syndrome (SARS) corona-virus(4,5). At present, there are no effective drugs for
  improving the clinical outcome of ARDS(1-3). Angiotensin-converting enzyme
  (ACE) and ACE2 are homologues with different key functions in the renin
  -angiotensin system(6-8). ACE cleaves angiotensin I to generate angiotensin II,
  whereas ACE2 inactivates angiotensin II and is a negative regulator of the
  system. ACE2 has also recently been identified as a potential SARS virus
  receptor and is expressed in lungs(9,10). Here we report that ACE2 and the
  angiotensin II type 2 receptor (AT(2)) protect mice from severe acute lung
  injury induced by acid aspiration or sepsis. However, other components of the
  renin-angiotensin system, including ACE, angiotensin II and the angiotensin II
  type 1a receptor (AT(1)a), promote disease pathogenesis, induce lung oedemas
  and impair lung function. We show that mice deficient for Ace show markedly
  improved disease, and also that recombinant ACE2 can protect mice from severe
  acute lung injury. Our data identify a critical function for ACE2 in acute lung
  injury, pointing to a possible therapy for a syndrome affecting millions of
  people worldwide every year.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Respiratory-System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; mouse- (Muridae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-
PS: lung-: respiratory-system
CB: angiotensin-I: 9041-90-1; angiotensin-II: 11128-99-7; renin-angiotensin
  -system; acetylcholinesterase-: 9000-81-1, EC-3.1.1.7; angiotensin-converting
  -enzyme-2; angiotensin-II-type-2-receptor: AT-2-receptor; angiotensin-II-type
  -1a-receptor: AT-1a-receptor
DS: acute-respiratory-distress-syndrome: (Respiratory-Distress-Syndrome-(MeSH)),
  respiratory-system-disease, pathology-, prevention-and-control, etiology-
RN: 9041-90-1; 11128-99-7; 9000-81-1
CC: 10060- (Biochemistry-studies-General)
10064- (Biochemistry-studies-Proteins
  -peptides-and-amino-acids)
10802- (Enzymes-General-and-comparative-studies
  -coenzymes)
12502- (Pathology-General)
16004- (Respiratory-system-Physiology
  -and-biochemistry)
16006- (Respiratory-system-Pathology)
17002- (Endocrine
  -General)
33502- (Virology-General-and-methods)
AN: 200510240426
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0028
  -0836&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0028
  -0836&isbn=&volume=436&issue=7047&spage=112&pages=112
  -116&date=2005&title=Nature%20%28London%29&atitle=Angiotensin
  -converting%20enzyme%202%20protects%20from%20severe%20acute%20lung&aulast=Imai&p
  id=%3Cauthor%3EImai%2c%20Yumiko%3bKuba%2c%20Keiji%3bRao%2c%20Shuan%3bHuan%2c%20Y
  i%3bGuo%2c%20Feng%3bGuan%2c%20Bin%3bYang%2c%20Peng%3bSarao%2c%20Renu%3bWada%2c%2
  0Teiji%3bLeong%20Poi%2c%20Howard%3bCrackower%2c%20Michael%20A%3bFukamizu%2c%20Ak
  iyoshi%3bHui%2c%20Chi%20Chung%3bHein%2c%20Lutz%3bUhlig%2c%20Stefan%3bSlutsky%2c%
  20Arthur%20S%3bJiang%2c%20Chengyu%3bPenninger%2c%20Josef%20M%3C%2Fauthor%3E%3CAN
  %3E200510240426%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 5 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Concentration and detection of SARS coronavirus in sewage from Hiao Tang
  Shan Hospital and the 309th Hospital
AU: Wang,-Xin-Wei [Author]; Li,-Jin-Song [Author]; Guo,-Ting-Kai [Author]; Zhen,
  -Bei [Author]; Kong,-Qing-Xin [Author]; Yi,-Bin [Author]; Li,-Zhong [Author];
  Song,-Nong [Author]; Jin,-Min [Author]; Xiao,-Wen-Jun [Author]; Zhu,-Xiu-Mei
  [Author]; Gu,-Chang-Qing [Author]; Yin,-Jing [Author]; Wei,-Wei [Author]; Yao,
  -Wei [Author]; Liu,-Chao [Author]; Li,-Jian-Feng [Author]; Ou,-Guo-Rong
  [Author]; Wang,-Min-Nian [Author]; Fang,-Tong-Yu [Author]; Wang,-Gui-Jie
  [Author]; Qiu,-Yao-Hui [Author]; Wu,-Huai-Huan [Author]; Chao,-Fu-Huan
  [Author]; Li,-Jun-Wen [Author,-Reprint-Author]
AD: Tianjin Inst Environm and Hlth, 1 Da Li Rd, Tianjin 300050, Peoples R China
EMA: junwenli@eyou.com
SO: Journal-of-Virological-Methods. 2005; 128(1-2): 156-161
PY: 2005
DT: Article
IS: 0166-0934
LA: English
AB: The transmission of severe acute respiratory syndrome-associated coronavirus
  (SARS-CoV) is associated with close contact to SARS patients and droplet
  secretions of those patients. The finding of positive RT-PCR results from
  stools of SARS patients suggests that stools of SARS patients or sewage
  containing stools of patients could transmit SARS-CoV. We used a novel style of
  electropositive filter media particle to concentrate the SARS-CoV from the
  sewage of two hospitals receiving SARS patients in Beijing. We also used cell
  culture, RT-PCR and gene sequencing to detect and identify the viruses from
  sewage. No infectious SARS-CoV contamination was found in any of the samples
  collected, but the nucleic acid of SARS-CoV could be detected in the sewage
  from the two hospitals before disinfection. While the RNA was only detected in
  three samples from the 309th Hospital, the others were negative after
  disinfection. These findings provide strong evidence that SARS-CoV can be
  excreted through the stool/urine of patients into sewage system, thus making
  the sewage system a possible route of transmission. (c) 2005 Elsevier B.V. All
  rights reserved.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Respiratory-System: Respiration-; Waste-Management: Sanitation-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Coronavirus- (Coronaviridae-): genus-, pathogen-; SARS-virus (Coronaviridae
  -): common-, Severe-Acute-Respiratory-Syndrome-virus, common-, pathogen-; human
  - (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: stool-: digestive-system
CB: nucleic-acids
GE: Beijing-: China-, Asia-, Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, transmission-; coronavirus
  -infection: viral-disease, transmission-
MQ: reverse-transcriptase-polymerase-chain-reaction: RT-PCR, laboratory
  -techniques, genetic-techniques
MI: virus-transmission; hospital-sewage
CC: 03502- (Genetics-General)
03508- (Genetics-Human)
10062- (Biochemistry
  -studies-Nucleic-acids-purines-and-pyrimidines)
14004- (Digestive-system
  -Physiology-and-biochemistry)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
31500- (Genetics-of
  -bacteria-and-viruses)
33502- (Virology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
37014- (Public-health-Sewage-disposal-and
  -sanitary-measures)
AN: 200510239847
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0166
  -0934&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0166
  -0934&isbn=&volume=128&issue=1-2&spage=156&pages=156
  -161&date=2005&title=Journal%20of%20Virological%20Methods&atitle=Concentration%2
  0and%20detection%20of%20SARS%20coronavirus%20in%20sewage%20from%20Hiao%20Tang%20
  Shan%20Hospital%20and%20the%20309th%20Hospital&aulast=Wang&pid=%3Cauthor%3EWang%
  2c%20Xin%20Wei%3bLi%2c%20Jin%20Song%3bGuo%2c%20Ting%20Kai%3bZhen%2c%20Bei%3bKong
  %2c%20Qing%20Xin%3bYi%2c%20Bin%3bLi%2c%20Zhong%3bSong%2c%20Nong%3bJin%2c%20Min%3
  bXiao%2c%20Wen%20Jun%3bZhu%2c%20Xiu%20Mei%3bGu%2c%20Chang%20Qing%3bYin%2c%20Jing
  %3bWei%2c%20Wei%3bYao%2c%20Wei%3bLiu%2c%20Chao%3bLi%2c%20Jian%20Feng%3bOu%2c%20G
  uo%20Rong%3bWang%2c%20Min%20Nian%3bFang%2c%20Tong%20Yu%3bWang%2c%20Gui%20Jie%3bQ
  iu%2c%20Yao%20Hui%3bWu%2c%20Huai%20Huan%3bChao%2c%20Fu%20Huan%3bLi%2c%20Jun%20We
  n%3C%2Fauthor%3E%3CAN%3E200510239847%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 6 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV):
  Identification of neutralizing and antibodies reactive to S, N, M and E viral
  proteins
AU: Tripp,-Ralph-A [Author]; Haynes,-Lia-M [Author,-Reprint-Author]; Moore,
  -Deborah [Author]; Anderson,-Barbara [Author]; Tamin,-Azaibi [Author];
  Harcourt,-Brian-H [Author]; Jones,-Les-P [Author]; Yilla,-Mamadi [Author];
  Babcock,-Gregory-J [Author]; Greenough,-Thomas [Author]; Ambrosino,-Donna-M
  [Author]; Alvarez,-Rene [Author]; Callaway,-Justin [Author]; Cavitt,-Sheana
  [Author]; Kamrud,-Kurt [Author]; Alterson,-Harold [Author]; Smith,-Jonathan
  [Author]; Harcourt,-Jennifer-L [Author]; Miao,-Congrong [Author]; Razdan,-Raj
  [Author]; Comer,-James-A [Author]; Rollin,-Pierre-E [Author]; Ksiazek,-Thomas-G
  [Author]; Sanchez,-Anthony [Author]; Rota,-Paul-A [Author]; Bellini,-William-J
  [Author]; Anderson,-Larry-J [Author]
AD: Ctr Dis Control and Prevent, Natl Ctr Infect Dis, Div Viral and Rickettsial
  Dis, Resp and Enter Virus Branch, 1600 Clifton Rd,NE,Mailstop G-09, Atlanta, GA
  30333 USA
EMA: loh5@cdc.gov
SO: Journal-of-Virological-Methods. 2005; 128(1-2): 21-28
PY: 2005
DT: Article
IS: 0166-0934
LA: English
AB: Monoclonal antibodies (Mabs) against the Urbam strain of the SARS-associated
  coronavirus (SARS-CoV) were developed and characterized for reactivity to SARS
  -Cov and SARS-CoV S, N, M, and E proteins using enzyme-linked immunoabsorbent
  (ELISA), radioimmunoprecipitation, immunofluorescence, Western Blot and
  microneutralization assays. Twenty-six mAbs were reactive to SARS-CoV by ELISA,
  and nine were chosen for detailed characterization. Five mAbs reacted against
  the S protein, two against the M protein, and one each against the N and E
  proteins. Two of five S protein mAbs neutralized SARS-CoV infection of Vero E6
  cells and reacted to an epitope within amino acids 490-510 in the S protein.
  While two of the three non-neutralizing antibodies recognized at second epitope
  within amino acids 270-350. The mAbs characterized should prove useful for
  developing SARS-CoV diagnostic assays and for studying the biology of infection
  and pathogenesis of disease. (c) 2005 Elsevier B.V. All rights reserved.
AI: Y
MC: Infection-; Immune-System: Chemical-Coordination-and-Homeostasis;
  Biochemistry-and-Molecular-Biophysics
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-, African-green-monkey
  -kidney-cells; SARS-associated-coronavirus (Coronaviridae-): common-, SARS-CoV,
  common-, pathogen-, strain-Urbani; human- (Hominidae-): common-, host-; mouse-
  (Muridae-): common-, infant-, female-, strain-BALB-c; SP2-0-cell-line (Muridae
  -): cell_line-, non-secretor-myeloma-cells; B-cell-hybridoma (Muridae-): common-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-;
  Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-
PS: splenocyte-: blood-and-lymphatics
CB: monoclonal-antibodies; immunoglobulin-M: IgM-; immunoglobulin-G2a: IgG2a-;
  immunoglobulin-G1: IgG1-; S-protein: spike-protein; M-protein: membrane
  -protein; N-proteins: nucleocapsid-proteins; E-proteins: small-envelope-proteins
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10060- (Biochemistry
  -studies-General)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16006- (Respiratory-system-Pathology)
25000- (Pediatrics-)
33502-
  (Virology-General-and-methods)
34502- (Immunology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510239830
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0166
  -0934&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0166
  -0934&isbn=&volume=128&issue=1-2&spage=21&pages=21
  -28&date=2005&title=Journal%20of%20Virological%20Methods&atitle=Monoclonal%20ant
  ibodies%20to%20SARS-associated%20coronavirus%20%28SARS
  -CoV%29%3a%20Identification%20of%20neutralizing%20and%20antibodies%20reactive%20
  to%20S%2c%20N%2c%20M%20and%20E%20viral%20proteins&aulast=Tripp&pid=%3Cauthor%3ET
  ripp%2c%20Ralph%20A%3bHaynes%2c%20Lia%20M%3bMoore%2c%20Deborah%3bAnderson%2c%20B
  arbara%3bTamin%2c%20Azaibi%3bHarcourt%2c%20Brian%20H%3bJones%2c%20Les%20P%3bYill
  a%2c%20Mamadi%3bBabcock%2c%20Gregory%20J%3bGreenough%2c%20Thomas%3bAmbrosino%2c%
  20Donna%20M%3bAlvarez%2c%20Rene%3bCallaway%2c%20Justin%3bCavitt%2c%20Sheana%3bKa
  mrud%2c%20Kurt%3bAlterson%2c%20Harold%3bSmith%2c%20Jonathan%3bHarcourt%2c%20Jenn
  ifer%20L%3bMiao%2c%20Congrong%3bRazdan%2c%20Raj%3bComer%2c%20James%20A%3bRollin%
  2c%20Pierre%20E%3bKsiazek%2c%20Thomas%20G%3bSanchez%2c%20Anthony%3bRota%2c%20Pau
  l%20A%3bBellini%2c%20William%20J%3bAnderson%2c%20Larry%20J%3C%2Fauthor%3E%3CAN%3
  E200510239830%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 7 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Vesicular stomatitis virus pseudotyped with severe acute respiratory
  syndrome coronavirus spike protein
AU: Fukushi,-Shuetsu [Author,-Reprint-Author]; Mizutani,-Tetsuya [Author];
  Saijo,-Masayuki [Author]; Matsuyama,-Shutoku [Author]; Miyajima,-Naoko
  [Author]; Taguchi,-Fumihiro [Author]; Itamura,-Shigeyuki [Author]; Kurane,
  -Ichiro [Author]; Morikawa,-Shigeru [Author]
AD: Natl Inst Infect Dis, Special Pathogens Lab, Dept Virol 1, Lab Resp Viral
  Dis, Gakuen 4-7-1, Tokyo 2080011, Japan
EMA: fukushi@nih.go.jp
SO: Journal-of-General-Virology. 2005; 86(Part 8): 2269-2274
PY: 2005
DT: Article
IS: 0022-1317
LA: English
AB: Severe acute respiratory syndrome coronavirus (SARS-CoV) contains a single
  spike (S) protein, which binds to its receptor, angiotensin-converting enzyme 2
  (ACE2), induces membrane fusion and serves as a neutralizing antigen. A SARS
  -CoV-S protein-bearing vesicular stomatitis virus (VSV) pseudotype using the
  VSV Delta G* system was generated. Partial deletion of the SARS-CoV-S protein
  cytoplasmic domain allowed efficient incorporation into VSV particles and led
  to the generation of a pseudotype (VSV-SARS-St19) at high titre. Green
  fluorescent protein expression was demonstrated as early as 7 In after
  infection of Vero E6 cells with VSV-SARS-St19. VSV-SARS-St19 was neutralized by
  anti-SARS-CoV antibody and soluble ACE2, and its infection was blocked by
  treatment of Vero E6 cells with anti-ACE2 antibody. These results indicated
  that VSV-SARS-St19 infection is mediated by SARS-CoV-S protein in an ACE2
  -dependent manner. VSV-SARS-St19 will be useful for analysing the function of
  SARS-CoV-S protein and for developing rapid methods of detecting neutralizing
  antibodies specific for SARS-CoV infection.
AI: Y
MC: Infection-; Biochemistry-and-Molecular-Biophysics
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03504-] Rhabdoviridae-, -Negative-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-, African-green-monkey
  -kidney-cells; Severe-acute-respiratory-syndrome-coronavinus (Coronaviridae-):
  species-, SARS-CoV, common-, pathogen-; Vesicular-stomatitis-virus
  (Rhabdoviridae-): species-, pathogen-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Rhabdoviridae-: Microorganisms-, Negative-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: antibody-; spike-protein; green-fluorescent-protein: expression-;
  angiotensin-converting-enzyme-2: ACE2-enzyme
CC: 02506- (Cytology-Animal)
10060- (Biochemistry-studies-General)
10064-
  (Biochemistry-studies-Proteins-peptides-and-amino-acids)
33502- (Virology
  -General-and-methods)
34502- (Immunology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
AN: 200510238777
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -1317&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -1317&isbn=&volume=86&issue=Part%208&spage=2269&pages=2269
  -2274&date=2005&title=Journal%20of%20General%20Virology&atitle=Vesicular%20stoma
  titis%20virus%20pseudotyped%20with%20severe%20acute%20respiratory%20syndrome%20c
  oronavirus%20spike%20protein&aulast=Fukushi&pid=%3Cauthor%3EFukushi%2c%20Shuetsu
  %3bMizutani%2c%20Tetsuya%3bSaijo%2c%20Masayuki%3bMatsuyama%2c%20Shutoku%3bMiyaji
  ma%2c%20Naoko%3bTaguchi%2c%20Fumihiro%3bItamura%2c%20Shigeyuki%3bKurane%2c%20Ich
  iro%3bMorikawa%2c%20Shigeru%3C%2Fauthor%3E%3CAN%3E200510238777%3C%2FAN%3E%3CDT%3
  EArticle%3C%2FDT%3E

Record 8 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Development of putative GABAergic neurons in the appendicularian urochordate
  Oikopleura dioica
AU: Soviknes,-Anne-Mette [Author]; Chourrout,-Daniel [Author]; Glover,-Joel-C
  [Author,-Reprint-Author]
AD: Bergen High Technol Ctr, Sars Int Ctr Marine Mol Biol, Thormohlensgt 55, N
  -5008 Bergen, Norway
EMA: joel.glover@basalmed.uio.no
SO: Journal-of-Comparative-Neurology. 2005; 490(1): 12-28
PY: 2005
DT: Article
IS: 0021-9967
LA: English
AB: Studying the developing brain of urochordates can increase our understanding
  of brain evolution in the chordate lineage. To begin addressing regional
  patterns of neuronal differentiation in appendicularian urochordates, we
  examined the development of putative GABAergic neurons in Oikopleura dioica
  using GABA immunohistochemistry and in situ hybridization for the GABA
  -synthesizing enzyme GAD. First, we assessed the developmental dynamics of
  neuron number and organization in the cerebral and caudal ganglia. We then
  identified and mapped the positions of putative GABAergie neurons using
  confocal microscopy. We found GAD mRNA-positive and GABA-immunopositive neurons
  in the first brain nerves and the cerebral and caudal ganglia, but not in the
  caudal nerve cord. In both ganglia GAD mRNA-positive and GABA-immunopositive
  neurons are found in the same characteristic intraganglionic locations. The
  differentiation of these GABAergic markers occurs first in the first brain
  nerves and the cerebral ganglion and then with a several-hour delay in the
  caudal ganglion. In all three structures GAD mRNA expression appears 2-3 hours
  prior to GABA expression. In general, GABA is expressed by the same number of
  neurons as express GAD. Several discrepancies suggest differential regulation
  of the GABAergic phenotype in different neurons, however. Our results show that
  the GABAergic phenotype has a stereotyped pattern of expression along the
  anteroposterior axis of the CNS. Given recent genome sequencing and
  developmental patterning gene studies in this species, the GABAergic neurons in
  O. dioica provide a good model for assessing, at the invertebrate-vertebrate
  transition, the molecular mechanisms that specify the GABAergic phenotype.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Nervous-System: Neural-Coordination
ST: -[85104-] Urochordata-, -Protochordata, Chordata-, Animalia-
OR: Oikopleura-dioica (Urochordata-): species-
TN: Urochordata-: Animals-, Chordates-, Invertebrates-, Protochordates-
PS: neuron-: nervous-system; brain-: nervous-system; central-nervous-system: CNS
  -, nervous-system; nerve-: nervous-system; cerebral-ganglion: nervous-system;
  caudal-ganglion: nervous-system
CB: messenger-RNA: mRNA-; gamma-aminobutyric-acid: GABA-, 56-12-2; GABAergic-;
  GAD-
RN: 56-12-2
MQ: immunohistochemistry-: laboratory-techniques, histology-and-cytology
  -techniques, immunologic-techniques; in-situ-hybridization: laboratory
  -techniques, histology-and-cytology-techniques, genetic-techniques
CC: 02506- (Cytology-Animal)
10060- (Biochemistry-studies-General)
10062-
  (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
10064-
  (Biochemistry-studies-Proteins-peptides-and-amino-acids)
20504- (Nervous
  -system-Physiology-and-biochemistry)
AN: 200510238476
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0021
  -9967&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0021
  -9967&isbn=&volume=490&issue=1&spage=12&pages=12
  -28&date=2005&title=Journal%20of%20Comparative%20Neurology&atitle=Development%20
  of%20putative%20GABAergic%20neurons%20in%20the%20appendicularian%20urochordate%2
  0Oikopleura%20dioica&aulast=Soviknes&pid=%3Cauthor%3ESoviknes%2c%20Anne%20Mette%
  3bChourrout%2c%20Daniel%3bGlover%2c%20Joel%20C%3C%2Fauthor%3E%3CAN%3E20051023847
  6%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 9 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Histone H4 post-translational modifications in chordate mitotic and
  endoreduplicative cell cycles
AU: Spada,-Fabio [Author,-Reprint-Author]; Chioda,-Mariacristina [Author];
  Thompson,-Eric-M [Author]
AD: Bergen High Technol Ctr, Sars Int Ctr Marine Mol Biol, Thormolensgt 55, N
  -5008 Bergen, Norway
EMA: f.spada@lmu.edu; Eric.Thompson@sars.uib.no
SO: Journal-of-Cellular-Biochemistry. 2005; 95(5): 885-901
PY: 2005
DT: Article
IS: 0730-2312
LA: English
AB: Histone post-translational modifications mark distinct structural and
  functional chromatin states but little is known of their involvement in the
  progression of different cell cycle types across phylogeny. We compared
  temporal and spatial dynamics of histone H4 post-translational modifications
  during both mitotic and endoreduplicative cycles of the urochordate, Oikopleura
  dioica, and proliferating mammalian cells. Enclocycling cells showed no signs
  of chromosome condensation or entry into mitosis. They exhibited an evolution
  of replication patterns indicative of reduced chromatin compartmentalization
  relative to proliferating mammalian cells. in the latter cells, published cell
  cycle profiles of histone H4 acetylated at lysine 16 (H4AcK16) or dimethylated
  at lysine 20 (H4Me(2)K20) are disputed. Our results, using different, widely
  used H4AcK16 antibodies, revealed significant anti body-specific discrepancies
  in spatial and temporal cell cycle regulation of this modification, with
  repercussions for interpretation of previous immunofluorescence and
  immunoprecipitation data based on these reagents. On the other hand, three
  different antibodies to H4Me2K20 revealed similar cell cycle profiles of this
  modification that were conserved throughout the mitotic cell cycle in
  urochordate and mammalian cells, with accumulation at mitosis and a decrease
  during S-phase. H4Me2K20 also cycled in enclocycles, indicating that dynamics
  of this modification are not strictly constrained by the mitotic phase of the
  cell cycle and suggesting additional roles during G- and S-phase progression.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Cell-Biology
ST: -[85104-] Urochordata-, -Protochordata, Chordata-, Animalia-
OR: Oikopleura-dioica (Urochordata-): species-
TN: Urochordata-: Animals-, Chordates-, Invertebrates-, Protochordates-
PS: chromatin-
CB: antibodies-; lysine-: 70-54-2; histone-H4
RN: 70-54-2
MQ: immunofluorescence-: laboratory-techniques, immunologic-techniques;
  immunoprecipitation-: laboratory-techniques, immunologic-techniques
MI: mitosis-; eEndocycling-
CC: 02502- (Cytology-General)
02506- (Cytology-Animal)
10060- (Biochemistry
  -studies-General)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
34502- (Immunology-General-and-methods)
AN: 200510238327
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0730
  -2312&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0730
  -2312&isbn=&volume=95&issue=5&spage=885&pages=885
  -901&date=2005&title=Journal%20of%20Cellular%20Biochemistry&atitle=Histone%20H4%
  20post-translational%20modifications%20in%20chordate%20mitotic%20and%20endoredup
  licative%20cell%20cycles&aulast=Spada&pid=%3Cauthor%3ESpada%2c%20Fabio%3bChioda%
  2c%20Mariacristina%3bThompson%2c%20Eric%20M%3C%2Fauthor%3E%3CAN%3E200510238327%3
  C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 10 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Peptide domain involved in the interaction between membrane protein and
  nucleocapsid protein of SARS-associated coronavirus
AU: Fang,-Xiaonan [Author]; Ye,-Linbai [Author,-Reprint-Author]; Timani,-Khalid
  -Amine [Author]; Li,-Shanshan [Author]; Zen,-Yingchun [Author]; Zhao,-Meng
  [Author]; Zheng,-Hong [Author]; Wu,-Zhenghui [Author]
AD: Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples
  R China
EMA: linbaiye@whu.edu.cn
SO: Journal-of-Biochemistry-and-Molecular-Biology. 2005; 38(4): 381-385
PY: 2005
DT: Article
IS: 1225-8687
LA: English
AB: Severe acute respiratory syndrome (SARS) is an emerging infectious disease
  associated with a novel coronavirus (CoV) that was identified and molecularly
  characterized in 2003. Previous studies on various coronaviruses indicate that
  protein-protein interactions amongst various coronavirus proteins are critical
  for viral assembly and morphogenesis. It is necessary to elucidate the
  molecular mechanism of SARS-CoV replication and rationalize the anti-SARS
  therapeutic intervention. In this study, we employed an in vitro GST pull-down
  assay to investigate the interaction between the membrane (M) and the
  nucleocapsid (N) proteins. Our results show that the interaction between the M
  and N proteins does take place in vitro. Moreover, we provide an evidence that
  12 amino acids domain (194-205) in the M protein is responsible for binding to
  N protein. Our work will help shed light on the molecular mechanism of the
  virus assembly and provide valuable information pertaining to rationalization
  of future anti-viral strategies.
AI: Y
MC: Infection-; Biochemistry-and-Molecular-Biophysics
ST: -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram-Negative-Rods,
  Eubacteria-, Bacteria-, Microorganisms-
OR: Escherichia-coli (Enterobacteriaceae-): species-, expression-system, strain
  -BL21
TN: Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-
CB: membrane-proteins; nucleocapsid-proteins
DS: coronavirus-infection: viral-disease; severe-acute-respiratory-syndrome:
  SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)), respiratory-system-disease,
  viral-disease, genetics-
MQ: GST-pull-down-assay: glutathione-S-transferase-pull-down-assay, laboratory
  -techniques, genetic-techniques
MI: molecular-mechanism; interaction-; virus-assembly; peptide-domain
CC: 10060- (Biochemistry-studies-General)
10064- (Biochemistry-studies-Proteins
  -peptides-and-amino-acids)
10508- (Biophysics-Membrane-phenomena)
16006-
  (Respiratory-system-Pathology)
31000- (Physiology-and-biochemistry-of-bacteria)
AN: 200510238180
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1225
  -8687&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1225
  -8687&isbn=&volume=38&issue=4&spage=381&pages=381
  -385&date=2005&title=Journal%20of%20Biochemistry%20and%20Molecular%20Biology&ati
  tle=Peptide%20domain%20involved%20in%20the%20interaction%20between%20membrane%20
  protein%20and%20nucleocapsid%20protein%20of%20SARS
  -associated%20coronavirus&aulast=Fang&pid=%3Cauthor%3EFang%2c%20Xiaonan%3bYe%2c%
  20Linbai%3bTimani%2c%20Khalid%20Amine%3bLi%2c%20Shanshan%3bZen%2c%20Yingchun%3bZ
  hao%2c%20Meng%3bZheng%2c%20Hong%3bWu%2c%20Zhenghui%3C%2Fauthor%3E%3CAN%3E2005102
  38180%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 11 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human
  dendritic cells
AU: Law,-Helen-K-W [Author]; Cheung,-Chung-Yan [Author]; Ng,-Hoi-Yee [Author];
  Sia,-Sin-Fun [Author]; Chan,-Yuk-On [Author]; Luk,-Winsie [Author]; Nicholls,
  -John-M [Author]; Malik-Peiris,-J-S [Author]; Lau,-Yu-Lung [Author,-Reprint
  -Author]
AD: Univ Hong Kong, Queen Mary Hosp, Fac Med, Dept Paediat and Adolescent Med,
  Pokfulam, Hong Kong, Peoples R China
EMA: lauylung@hkucc.hku.hk
SO: Blood-. 2005; 106(7): 2366-2374
PY: 2005
DT: Article
IS: 0006-4971
LA: English
AB: Lymphopenia and increasing viral load in the first 10 days of severe acute
  respiratory syndrome (SARS) suggested immune evasion by SARS-coronavirus (CoV).
  In this study, we focused on dendritic cells (DCs) which play important roles
  in linking the innate and adaptive immunity. SARS-CoV was shown to infect both
  immature and mature human monocyte-derived DCs by electron microscopy and
  immunofluorescence. The detection of negative strands of SARS-CoV RNA in DCs
  suggested viral replication. However, no increase in viral RNA was observed.
  Using cytopathic assays, no increase in virus titer was detected in infected
  DCs and cell-culture supernatant, confirming that virus replication was
  incomplete. No induction of apoptosis or maturation was detected in SARS-CoV
  -infected DCs. The SARS-CoV-Infected DCs showed low expression of antiviral
  cytokines (interferon alpha [IFN-alpha], IFN-beta, IFN-gamma, and interleukin
  12p40 [IL-12p40]), moderate up-regulation of proinflammatory cytokines (tumor
  necrosis factor alpha [TNF-alpha] and IL-6) but significant upregulation of
  inflammatory chemokines (macrophage inflammatory protein 1 alpha [MIP-1 alpha],
  regulated on activation normal T cell expressed and secreted [RANTES]),
  interferon-inducible protein of 10 kDa [IP-10], and monocyte chemoattractant
  protein 1 (MCIP-1]]). The lack of antiviral cytokine response against a
  background of intense chemokine upregulation could represent a mechanism of
  immune evasion by SARS-CoV.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Immune-System: Chemical
  -Coordination-and-Homeostasis
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
PS: monocyte-: immune-system, blood-and-lymphatics; dendritic-cell: immune-system
CB: RNA-; interferon-gamma: expression-; interferon-beta: 74899-71-1, expression
  -; interferon-alpha: expression-; tumor-necrosis-factor-alpha: up-regulation;
  interleukin-12p40: expression-; interleukin-6: up-regulation; macrophage
  -inflammatory-protein-1-alpha: up-regulation; regulated-on-activation-normal-T
  -cell-expressed-and-secreted: RANTES-, up-regulation; interferon-inducible
  -protein-10: up-regulation; monocyte-chemoattractant-protein-1: up-regulation
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; lymphopenia-: (Lymphopenia
  -(MeSH)), blood-and-lymphatic-disease, immune-system-disease
RN: 74899-71-1
MI: apoptosis-; viral-replication; viral-load; maturation-
CC: 02506- (Cytology-Animal)
10060- (Biochemistry-studies-General)
10062-
  (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
10064-
  (Biochemistry-studies-Proteins-peptides-and-amino-acids)
15002- (Blood-Blood
  -and-lymph-studies)
15004- (Blood-Blood-cell-studies)
15006- (Blood-Blood
  -lymphatic-and-reticuloendothelial-pathologies)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
34508- (Immunology-Immunopathology-tissue-immunology)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510233703
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0006
  -4971&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0006
  -4971&isbn=&volume=106&issue=7&spage=2366&pages=2366
  -2374&date=2005&title=Blood%20&atitle=Chemokine%20up-regulation%20in%20SARS
  -coronavirus-infected%2c%20monocyte
  -derived%20human%20dendritic%20cells&aulast=Law&pid=%3Cauthor%3ELaw%2c%20Helen%2
  0K%20W%3bCheung%2c%20Chung%20Yan%3bNg%2c%20Hoi%20Yee%3bSia%2c%20Sin%20Fun%3bChan
  %2c%20Yuk%20On%3bLuk%2c%20Winsie%3bNicholls%2c%20John%20M%3bMalik%20Peiris%2c%20
  J%20S%3bLau%2c%20Yu%20Lung%3C%2Fauthor%3E%3CAN%3E200510233703%3C%2FAN%3E%3CDT%3E
  Article%3C%2FDT%3E

Record 12 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Expression and purification of N and E proteins from Severe Acute
  Respiratory Syndrome (SARS)-associated coronavirus: A comparative study
AU: Lai,-Chia-Wei [Author]; Chung,-Yao-Chi [Author]; Lai,-Yiu-Kay [Author];
  Chang,-Margaret-Dah-Tsyr [Author]; Hu,-Yu-Chen [Author,-Reprint-Author]
AD: Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 300, Taiwan
EMA: ychu@mx.nthu.edu.tw
SO: Biotechnology-Letters. 2005; 27(13): 883-891
PY: 2005
DT: Article
IS: 0141-5492
LA: English
AB: Histidine-tagged N (rNH) and E (rEH) proteins of Severe Acute Respiratory
  Syndrome (SARS)-coronovirus were expressed in the baculovirus/insect cell
  system and purified by immobilized metal affinity chromatography. rNH and rEH
  proteins differed markedly with respect to expression levels, cell death
  kinetics and subcellular localizations that led to different extraction and
  purification schemes. The features of both proteins are compared and the
  potential applications of purified rNH and rEH are discussed.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Respiratory-System:
  Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[75330-] Lepidoptera-, -Insecta, Arthropoda-, Invertebrata-,
  Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; Sf-9-cell-line (Lepidoptera-): cell_line-, host-, insect-cells
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Lepidoptera-: Animals-, Arthropods-, Insects-, Invertebrates-
CB: N-protein: expression-, purification-; E-protein: expression-, purification-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: immobilized-metal-affinity-chromatography: laboratory-techniques,
  chromatographic-techniques
CC: 02506- (Cytology-Animal)
10060- (Biochemistry-studies-General)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
64076- (Invertebrata-comparative-experimental
  -morphology-physiology-and-pathology-Insecta-physiology)
AN: 200510233553
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0141
  -5492&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0141
  -5492&isbn=&volume=27&issue=13&spage=883&pages=883
  -891&date=2005&title=Biotechnology%20Letters&atitle=Expression%20and%20purificat
  ion%20of%20N%20and%20E%20proteins%20from%20Severe%20Acute%20Respiratory%20Syndro
  me%20%28SARS%29
  -associated%20coronavirus%3a%20A%20comparative%20study&aulast=Lai&pid=%3Cauthor%
  3ELai%2c%20Chia%20Wei%3bChung%2c%20Yao%20Chi%3bLai%2c%20Yiu%20Kay%3bChang%2c%20M
  argaret%20Dah%20Tsyr%3bHu%2c%20Yu%20Chen%3C%2Fauthor%3E%3CAN%3E200510233553%3C%2
  FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 13 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Propylene glycol-induced lactic acidosis in a patient with normal renal
  function: A proposed mechanism and monitoring recommendations
AU: Neale,-Bruce-W [Author]; Mesler,-Eleanor-L [Author,-Reprint-Author]; Young,
  -Michael [Author]; Rebuck,-Jill-A [Author]; Weise,-Wolfgang-J [Author]
AD: Fletcher Allen Hlth Care, Dept Pharm, 111 Colchester Ave, Burlington, VT
  05401 USA
EMA: eleanor.mesier@vtmednet.org
SO: Annals-of-Pharmacotherapy. 2005; 39(10): 1732-1736
PY: 2005
DT: Article
IS: 1060-0280
LA: English
AB: OBJECTIVE: To report a case of severe propylene glycol-induced lactic
  acidosis not attributable to renal dysfunction that was secondary to
  administration of high-dose intravenous lorazepam.CASE SUMMARY: A 24-year-old
  female with community-acquired pneumonia presented with severe acute
  respiratory distress syndrome. To maintain adequate sedation and ventilation
  and reduce airway pressure, several relaxation strategies were used including
  high-dose intravenous lorazepam, fentanyl, and cisatracurium. After 18 days of
  high-dose continuous infusion of lorazepam (maximum dose 50 mg/h), the patient
  developed severe lactic acidosis secondary to propylene glycol toxicity, the
  main diluent of lorazepam. The acidosis temporarily resolved with bicarbonate
  administration and discontinuation of lorazepam. Her renal function remained
  stable for a time (serum creatinine 0.5 mg/dL, blood urea nitrogen 10 mg/dL,
  urine output 100-200 mL/h). However, after several more days, the patient's
  condition deteriorated, and she ultimately died.DISCUSSION: Previous cases of
  propylene glycol toxicity secondary to high-dose lorazepam infusion have
  occurred in patients with compromised renal function. Our patient's renal
  function remained stable throughout the hospital course, which caused us to
  look further for an explanation for the propylene glycol-induced lactic
  acidosis. Based on the Naranjo probability scale, propylene glycol was
  determined to be the probable cause of lactic acidosis. Since this case
  occurred, our intensive care unit has instituted recommendations for the
  prevention of lorazepam-associated propylene glycol toxicity.CONCLUSIONS: Our
  case highlights the development of propylene glycol-induced lactic acidosis
  secondary to high-dose lorazepam infusion not associated with renal dysfunction.
AI: Y
MC: Pharmacology-; Metabolism-; Pulmonary-Medicine: Human-Medicine, Medical
  -Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, adult-, female-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
CB: propylene-glycol: 57-55-6; fentanyl-: 437-38-7, analgesic-drug; lorazepam-:
  846-49-1, gastrointestinal-drug, autonomic-drug, intravenous-administration;
  cisatracurium-: 96946-41-7, analgesic-drug
DS: lactic-acidosis: (Acidosis-, Lactic-(MeSH)), metabolic-disease; severe-acute
  -respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)),
  respiratory-system-disease, viral-disease; renal-dysfunction: (Kidney-Diseases
  -(MeSH)), urologic-disease; community-acquired-pneumonia: (Community-Acquired
  -Infections-(MeSH)), respiratory-system-disease, infectious-disease
RN: 57-55-6; 437-38-7; 846-49-1; 96946-41-7
CC: 10060- (Biochemistry-studies-General)
12512- (Pathology-Therapy)
13002-
  (Metabolism-General-metabolism-and-metabolic-pathways)
13020- (Metabolism
  -Metabolic-disorders)
15506- (Urinary-system-Pathology)
16006- (Respiratory
  -system-Pathology)
22002- (Pharmacology-General)
22005- (Pharmacology
  -Clinical-pharmacology)
22014- (Pharmacology-Digestive-system)
22024-
  (Pharmacology-Neuropharmacology)
36001- (Medical-and-clinical-microbiology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510232885
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1060
  -0280&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1060
  -0280&isbn=&volume=39&issue=10&spage=1732&pages=1732
  -1736&date=2005&title=Annals%20of%20Pharmacotherapy&atitle=Propylene%20glycol
  -induced%20lactic%20acidosis%20in%20a%20patient%20with%20normal%20renal%20functi
  on%3a%20A%20proposed%20mechanism%20and%20monitoring%20recommendations&aulast=Nea
  le&pid=%3Cauthor%3ENeale%2c%20Bruce%20W%3bMesler%2c%20Eleanor%20L%3bYoung%2c%20M
  ichael%3bRebuck%2c%20Jill%20A%3bWeise%2c%20Wolfgang%20J%3C%2Fauthor%3E%3CAN%3E20
  0510232885%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 14 of 2547 in BIOSIS Previews 2005: 47 2005/10/30-2005/11/05

TI: Pneumonitis and multi-organ system disease in common marmosets (Callithrix
  jacchus) infected with the severe acute respiratory syndrome-associated
  coronavirus
AU: Greenough,-Thomas-C [Author,-Reprint-Author]; Carville,-Angela [Author];
  Coderre,-James [Author]; Somasundaran,-Mohan [Author]; Sullivan,-John-L
  [Author]; Luzuriaga,-Katherine [Author]; Mansfield,-Keith [Author]
AD: Univ Massachusetts, Sch Med, Dept Pediat, 373 Plantat St,Biotech 2,Suite
  318, Worcester, MA 01605 USA
EMA: thomas.greenough@umassmed.edu
SO: American-Journal-of-Pathology. 2005; 167(2): 455-463
PY: 2005
DT: Article
IS: 0002-9440
LA: English
AB: Severe acute respiratory syndrome (SARS) is a significant emerging
  infectious disease. Humans infected with the etiological agent, SARS-associated
  coronavirus (SARS-CoV), primarily present with pneumonitis but may also develop
  hepatic, gastrointestinal, and renal pathology. We inoculated common marmosets
  (Callithilx jacchus) with the objective of developing a small nonhuman primate
  model of SARS. Two groups of C jacchus were inoculated intratracheally with
  cell culture supernatant containing SARS-CoV. In a time course pathogenesis
  study, animals were evaluated at 2, 4, and 7 days after infection for
  morphological changes and evidence of viral replication. All animals developed
  a multifocal mononuclear cell interstitial pneumonitis, accompanied by
  multinucleated syncytial cells, edema, and bronchiolitis in most animals. Viral
  antigen localized primarily to infected alveolar macrophages and type-1
  pneumocytes; by immunohistochemistry. Viral RNA was detected in all animals
  from pulmonary tissue extracts obtained at necropsy. Viral RNA was also
  detected in tracheobronchial lymph node and myocardium, together with
  inflammatory changes, in some animals. Hepatic inflammation was observed in
  most animals, predominantly as a multifocal lymphocytic hepatitis accompanied
  by necrosis of individual hepatocytes. These findings identify the common
  marmoset as a promising nonhuman primate to study SARS-CoV pathogenesis.
AI: Y
MC: Infection-; Respiratory-System: Respiration-
ST: -[86195-] Callithricidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Callithrix-jacchus (Callithricidae-): species-, common-marmoset, common-,
  immature-, host-; Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-):
  common-, SARS-virus, common-, pathogen-, strain-Urbani
TN: Callithricidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
PS: myocardium-: muscular-system, circulatory-system; alveolar-macrophage:
  immune-system; tracheobronchial-lymph-node: immune-system, blood-and-lymphatics
DS: pneumonitis-: respiratory-system-disease, etiology-; severe-acute
  -respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)),
  respiratory-system-disease, viral-disease, pathology-; multi-organ-system
  -disease: disease-miscellaneous, etiology-
CC: 02506- (Cytology-Animal)
12502- (Pathology-General)
14504- (Cardiovascular
  -system-Physiology-and-biochemistry)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
17504-
  (Muscle-Physiology-and-biochemistry)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510232594
UD: 20051102
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0002
  -9440&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0002
  -9440&isbn=&volume=167&issue=2&spage=455&pages=455
  -463&date=2005&title=American%20Journal%20of%20Pathology&atitle=Pneumonitis%20an
  d%20multi-organ%20system%20disease%20in%20common%20marmosets%20%28Callithrix%20j
  acchus%29%20infected%20with%20the%20severe%20acute%20respiratory%20syndrome
  -associated%20coronavirus&aulast=Greenough&pid=%3Cauthor%3EGreenough%2c%20Thomas
  %20C%3bCarville%2c%20Angela%3bCoderre%2c%20James%3bSomasundaran%2c%20Mohan%3bSul
  livan%2c%20John%20L%3bLuzuriaga%2c%20Katherine%3bMansfield%2c%20Keith%3C%2Fautho
  r%3E%3CAN%3E200510232594%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 15 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Risk of respiratory infections in health care workers: Lessons on infection
  control emerge from the sars outbreak
AU: Wilder-Smith,-Annelies [Author,-Reprint-Author]; Low,-Jenny-Guek-Hong
  [Author]
AD: Tan Tock Seng Hosp, Dept Infect Dis, Travellers Hlth and Vaccinat Ctr, 11
  Jalan Tan Tock Seng, Singapore 308433, Singapore
EMA: epvws@pacific.net.sg
SO: Southeast-Asian-Journal-of-Tropical-Medicine-and-Public-Health. 2005; 36(2):
  481-488
PY: 2005
DT: Article
IS: 0125-1562
LA: English
AB: Close proximity of persons together with handling of human secretions (eg
  respiratory secretions) make health care workers (HCW) particularly vulnerable
  to transmission of droplet-transmitted respiratory infections. This was
  tragically highlighted during the international outbreak of severe acute
  respiratory syndrome (SARS) in 2003 with attack rates of more than 50% in HCW.
  The purpose of this article is to review common airborne and droplet
  -transmitted bacterial and viral respiratory tract infections with regard to
  their impact on health care workers. Lessons need to be learned from the SARS
  epidemic. The three main strategies to prevent or control occupationally
  acquired infections are relatively simple and cost-effective-droplet and
  contact precautions and for some pathogens also vaccination. Enforced
  implementation of stringent droplet precautions during the SARS crisis should
  be maintained; and this will most likely have a major additional impact on
  other nosocomial infections. Employee health services should proactively and
  creatively devise delivery systems that enhance compliance with vaccination
  programs for all health care workers. Hospital surveillance should be expanded
  to all respiratory diseases to facilitate early detection of nosocomial
  outbreaks, and this should also include surveillance of all HCW. Integrated
  syndromic and virological surveillance systems set up during the SARS epidemic
  will also further our understanding of other respiratory infections in the
  hospital setting. Even if pursuing early diagnosis for unspecific respiratory
  illnesses is expensive, identification of the causative organism may reduce
  unnecessary isolation, contact tracing and anxiety, in particular during an
  outbreak situation. We have a duty to protect our health care workers.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies; Occupational-Health: Allied
  -Medical-Sciences; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: respiratory-tract: respiratory-system
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, transmission-, prevention
  -and-control, epidemiology-
MQ: vaccination-: therapeutic-and-prophylactic-techniques, clinical-techniques;
  droplet-precaution: therapeutic-and-prophylactic-techniques, clinical-techniques
MI: health-care-worker; hospital-setting
CC: 16004- (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory
  -system-Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
37013- (Public-health-Occupational
  -health)
37052- (Public-health-epidemiology-Communicable-diseases)
37054-
  (Public-health-epidemiology-Organic-diseases-and-neoplasms)
37056- (Public
  -health-epidemiology-Miscellaneous)
AN: 200510230675
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0125
  -1562&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0125
  -1562&isbn=&volume=36&issue=2&spage=481&pages=481
  -488&date=2005&title=Southeast%20Asian%20Journal%20of%20Tropical%20Medicine%20an
  d%20Public%20Health&atitle=Risk%20of%20respiratory%20infections%20in%20health%20
  care%20workers%3a%20Lessons%20on%20infection%20control%20emerge%20from%20the%20s
  ars%20outbreak&aulast=Wilder
  -Smith&pid=%3Cauthor%3EWilder%20Smith%2c%20Annelies%3bLow%2c%20Jenny%20Guek%20Ho
  ng%3C%2Fauthor%3E%3CAN%3E200510230675%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 16 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Effects of 1-week and 6-week exposure to GSM/DCS radiofrequency radiation on
  micronucleus formation in B6C3F1 mice
AU: Goerlitz,-Bernd-D [Author,-Reprint-Author]; Mueller,-Meike [Author]; Ebert,
  -Sven [Author]; Hecker,-Hartmut [Author]; Kuster,-Niels [Author]; Dasenbrock,
  -Clemens [Author]
AD: Fraunhofer Inst Toxicol and Expt Med, Nikolai Fuchs Str 1, D-30625 Hannover,
  Germany
EMA: goerlitz-eicklingen@t-online.de
SO: Radiation-Research. 2005; 164(4, Part 1): 431-439
PY: 2005
DT: Article
IS: 0033-7587
LA: English
AB: The aim of this study was to examine the possible induction of micronuclei
  in erythrocytes of the peripheral blood and bone marrow and in keratinocytes
  and spleen lymphocytes of mice exposed to radiofrequency (RF) radiation for 2
  It per day over periods of 1 and 6 weeks, respectively. The applied signal
  simulated the exposure from GSM900 and DCS1800 handsets, including the low
  -frequency amplitude modulation components as they occur during speaking (GSM
  Basic), listening (DTX) and moving within the environment (handovers, power
  control). The carrier frequency was set to the center of the system's uplink
  band, i.e., 902 MHz for GSM and 1747 MHz for DCS. Uniform whole-body exposure
  was achieved by restraining the mice in tubes at fixed positions in the
  exposure setup. Mice were exposed to slot-averaged whole-body SARs of 33.2,
  11.0, 3.7 and 0 mW/g during the I-week study and 24.9, 8.3, 2.8 and 0 mW/g
  during the 6-week study. Exposure levels for the 1- and 6-week studies were
  determined in a pretest to confirm that no thermal effect was present that
  could influence the genotoxic end points. During both experiments and for both
  frequencies, no clinical abnormalities were detected in the animals. Cells of
  the bone marrow from the femur (1-week study), erythrocytes of the peripheral
  blood (6-week study), keratinocytes from the tail root, and lymphocytes from
  the spleen (both studies) were isolated on slides and stained for micronucleus
  analysis. Two thousand cells per animal were scored in erythrocyte and
  keratinocyte samples. In spleen lymphocytes, 1000 binucleated lymphocytes were
  scored for each animal. The RF-field exposure had no influence on the formation
  of red blood cells. After 1 week of exposure, the ratio of polychromatic to
  normochromatic erythrocytes was unchanged in the treated groups compared to the
  sham-exposed groups. Furthermore, the RF-field exposure of mice did not induce
  an increase in the number of micronuclei in erythrocytes of the bone marrow or
  peripheral blood, in keratinocytes, or in spleen lymphocytes compared to the
  sham-treated control. (c) 2005 by Radiation Research Society.
AI: Y
MC: Immune-System: Chemical-Coordination-and-Homeostasis; Blood-and-Lymphatics:
  Transport-and-Circulation; Methods-and-Techniques; Integumentary-System:
  Chemical-Coordination-and-Homeostasis; Radiation-Biology
ST: -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: B6C3F1-mouse (Muridae-): common-
TN: Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-
PS: femur-: skeletal-system; erythrocyte-: blood-and-lymphatics; bone-marrow:
  immune-system, blood-and-lymphatics; peripheral-blood: blood-and-lymphatics;
  keratinocyte-: integumentary-system; spleen-lymphocyte: immune-system, blood
  -and-lymphatics; micronucleus-: micronucleus-formation
MQ: radiofrequency-radiation-exposure: laboratory-techniques
MI: GSM900-handset; DCS1800-handset
CC: 02506- (Cytology-Animal)
06502- (Radiation-biology-General)
15002- (Blood
  -Blood-and-lymph-studies)
15004- (Blood-Blood-cell-studies)
18004- (Bones
  -joints-fasciae-connective-and-adipose-tissue-Physiology-and
  -biochemistry)
18504- (Integumentary-system-Physiology-and
  -biochemistry)
34502- (Immunology-General-and-methods)
AN: 200510229842
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0033
  -7587&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0033
  -7587&isbn=&volume=164&issue=4%2c%20Part%201&spage=431&pages=431
  -439&date=2005&title=Radiation%20Research&atitle=Effects%20of%201
  -week%20and%206
  -week%20exposure%20to%20GSM%2fDCS%20radiofrequency%20radiation%20on%20micronucle
  us%20formation%20in%20B6C3F1%20mice&aulast=Goerlitz&pid=%3Cauthor%3EGoerlitz%2c%
  20Bernd%20D%3bMueller%2c%20Meike%3bEbert%2c%20Sven%3bHecker%2c%20Hartmut%3bKuste
  r%2c%20Niels%3bDasenbrock%2c%20Clemens%3C%2Fauthor%3E%3CAN%3E200510229842%3C%2FA
  N%3E%3CDT%3EArticle%3C%2FDT%3E

Record 17 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Expression of the proto-oncogene Fos after exposure to radiofrequency
  radiation relevant to wireless communications
AU: Whitehead,-Timothy-D [Author]; Brownstein,-Bernard-H [Author]; Parry,-Jesse
  -J [Author]; Thompson,-Dominic [Author]; Cha,-Bibianna-A [Author]; Moros,
  -Eduardo-G [Author]; Rogers,-Buck-E [Author]; Roti-Roti,-Joseph-L [Author,
  -Reprint-Author]
AD: Washington Univ, Sch Med, Dept Radiat Oncol, Radiat and Canc Biol Div, 4511
  Forest Pk Blvd,Suite 411, St Louis, MO 63108 USA
EMA: rotiroti@radonc.wustl.edu
SO: Radiation-Research. 2005; 164(4, Part 1): 420-430
PY: 2005
DT: Article
IS: 0033-7587
LA: English
AB: In this study the expression levels of the proto-oncogene Fos were measured
  after exposure to radiofrequency (RF) radiation at two relatively high specific
  absorption rates (SARs) of 5 and 10 W/kg for three types of modulated signals:
  847.74 MHz code division multiple access (CDMA),. 835.62 MHz frequency division
  multiple access (FDMA), and 836.55 MHz time division multiple access (TDMA).
  This work was undertaken to confirm a previous report by Goswami et al.
  (Radiat. Res. 151, 300-309, 1999) that CDMA and FDMA radiation caused small but
  statistically significant increases in Fos levels as cells entered plateau
  phase during exposure. No effects on Myc or Jun levels were observed in that
  study. Therefore, in the present study, analyses were restricted to Fos
  expression during the transition from exponential growth to plateau phase. Fos
  expression was measured using the real-time polymerase chain reaction (RT-PCR)
  technique. Serum-stimulated C3H 10T1/2 cells were used as a positive control
  for Fos expression. Possible influences of final cell number or pH variability
  on Fos expression were evaluated. Expression of Fos mRNA in C3H 10T1/2 cells
  was not significantly different from that found after sham exposure at either
  SAR level for any signal modulation. Therefore, the results of Goswami et al.
  could not be confirmed. (c) 2005 by Radiation Research Society.
AI: Y
MC: Methods-and-Techniques; Molecular-Genetics: Biochemistry-and-Molecular
  -Biophysics; Radiation-Biology
ST: -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: murine- (Muridae-): common-; C3H-10-T1-2-cell-line (Muridae-): cell_line-
TN: Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-
CB: mRNA-: messenger-RNA
GN: murine-Fos-gene [Muridae-]: expression-; murine-Myc-gene [Muridae-]; murine
  -Jun-gene [Muridae-]
MQ: real-time-polymerase-chain-reaction: RT-PCR, laboratory-techniques, genetic
  -techniques; radiofrequency-radiation-exposure: laboratory-techniques
MI: time-division-multiple-access; specific-absorption-rate; pH-variability;
  final-cell-number; code-division-multiple-access; frequency-division-multiple
  -access
CC: 02506- (Cytology-Animal)
03502- (Genetics-General)
03506- (Genetics
  -Animal)
06502- (Radiation-biology-General)
10062- (Biochemistry-studies
  -Nucleic-acids-purines-and-pyrimidines)
AN: 200510229841
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0033
  -7587&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0033
  -7587&isbn=&volume=164&issue=4%2c%20Part%201&spage=420&pages=420
  -430&date=2005&title=Radiation%20Research&atitle=Expression%20of%20the%20proto
  -oncogene%20Fos%20after%20exposure%20to%20radiofrequency%20radiation%20relevant%
  20to%20wireless%20communications&aulast=Whitehead&pid=%3Cauthor%3EWhitehead%2c%2
  0Timothy%20D%3bBrownstein%2c%20Bernard%20H%3bParry%2c%20Jesse%20J%3bThompson%2c%
  20Dominic%3bCha%2c%20Bibianna%20A%3bMoros%2c%20Eduardo%20G%3bRogers%2c%20Buck%20
  E%3bRoti%20Roti%2c%20Joseph%20L%3C%2Fauthor%3E%3CAN%3E200510229841%3C%2FAN%3E%3C
  DT%3EArticle%3C%2FDT%3E

Record 18 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Quantitative analysis of severe acute respiratory syndrome (SARS)-associated
  coronavirus-infected cells using proteomic approaches - Implications for
  cellular responses to virus infection
AU: Jiang,-Xiao-Sheng [Author]; Tang,-Liu-Ya [Author]; Dai,-Jie [Author]; Zhou,
  -Hu [Author]; Li,-Su-Jun [Author]; Xia,-Qi-Chang [Author]; Wu,-Jia-Rui [Author,
  -Reprint-Author]; Zeng,-Rong [Author]
AD: Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem and Cell Biol, Res
  Ctr Proteome Anal,Key Lab Proteom, 320 YueYang Rd, Shanghai 200031, Peoples R
  China
EMA: wujr@sibs.ac.cn; zr@sibs.ac.cn
SO: Molecular-and-Cellular-Proteomics. 2005; 4(7): 902-913
PY: 2005
DT: Article
IS: 1535-9476
LA: English
AB: We present the first proteomic analysis on the cellular response to severe
  acute respiratory syndrome-associated coronavirus (SARS-CoV) infection. The
  differential proteomes of Vero E6 cells with and without infection of the SARS
  -CoV were resolved and quantitated with two-dimensional differential gel
  electrophoresis followed by ESI-MS/MS identification. Moreover isotope-coded
  affinity tag technology coupled with two-dimensional LCMS/ MS were also applied
  to the differential proteins of infected cells. By combining these two
  complementary strategies, 355 unique proteins were identified and quantitated
  with 186 of them differentially expressed ( at least 1.5-fold quantitative
  alteration) between infected and uninfected Vero E6 cells. The implication for
  cellular responses to virus infection was analyzed in depth according to the
  proteomic results. Thus, the present work provides large scale protein-related
  information to investigate the mechanism of SARS-CoV infection and pathogenesis.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-, African-green-monkey
  -kidney-cells; Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common
  -, SARS-virus, common-; Coronavirus- (Coronaviridae-): genus-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
CB: proteome-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; coronavirus-infection:
  viral-disease
MQ: ESI-MS: electrospray-ionization-mass-spectrometry, laboratory-techniques,
  spectrum-analysis-techniques; two-dimensional-differential-gel-electrophoresis:
  electrophoretic-techniques, laboratory-techniques; two-dimensional-LC-MS/MS:
  laboratory-techniques, spectrum-analysis-techniques, chromatographic
  -techniques; isotope-coded-affinity-tag-technology: laboratory-techniques
CC: 02506- (Cytology-Animal)
03502- (Genetics-General)
03506- (Genetics
  -Animal)
16006- (Respiratory-system-Pathology)
31500- (Genetics-of-bacteria
  -and-viruses)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510226780
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1535
  -9476&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1535
  -9476&isbn=&volume=4&issue=7&spage=902&pages=902
  -913&date=2005&title=Molecular%20and%20Cellular%20Proteomics&atitle=Quantitative
  %20analysis%20of%20severe%20acute%20respiratory%20syndrome%20%28SARS%29
  -associated%20coronavirus-infected%20cells%20using%20proteomic%20approaches%20
  -%20Implications%20for%20cellular%20responses%20to%20virus%20infection&aulast=Ji
  ang&pid=%3Cauthor%3EJiang%2c%20Xiao%20Sheng%3bTang%2c%20Liu%20Ya%3bDai%2c%20Jie%
  3bZhou%2c%20Hu%3bLi%2c%20Su%20Jun%3bXia%2c%20Qi%20Chang%3bWu%2c%20Jia%20Rui%3bZe
  ng%2c%20Rong%3C%2Fauthor%3E%3CAN%3E200510226780%3C%2FAN%3E%3CDT%3EArticle%3C%2FD
  T%3E

Record 19 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: A flow-through shear-type microfilter chip for separating plasma and virus
  particles from whole blood
AU: Yobas,-Levent [Author,-Reprint-Author]; Gui,-Ee-Ling [Author]; Ji,-Hongmiao
  [Author]; Li,-Jing [Author]; Chen,-Yu [Author]; Hui,-Wing-Cheong [Author];
  Mohamed-Rafe,-Siti-Rafeah-Binte [Author]; Swarup,-Sanjay [Author]; Wong,-Sek
  -Man [Author]; Lim,-Tit-Meng [Author]; Heng,-Chew-Kiat [Author]
AD: Inst Microelect, 11 Sci Pk Rd,Singapore Sci Pk 2, Singapore 117685, Singapore
BK: Royal Society of Chemistry Special Publication. 2005; 7-9
AUB: Kutter--JP; Laurell-T; Nilsson-J; Jensen-K; Harrison-DJ
PB: ROYAL SOC CHEMISTRY, THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF,
  CAMBS, UK
PY: 2005
DT: Book-Chapter; Meeting
IS: 0260-6291
IB: 0854048960
MT: 8th International Conference on Miniaturized Systems for Chemistry and Life
  Sciences, Malmo, SWEDEN; September 26 -30, 2004 
SP: VINNIVACrafoord FdnSwedish Fdn Strateg ResMCPTMicralyneSAMSUNGMicro
  PlastabGYROSLung UnivErysave ABATS MedSilex MicrosystJohnson &JohnsonCaliper
  Life SciMicroFluid Syst IncAnalyt ChemSci AAASLab ChipJournal Separat Sci
SE: ROYAL SOCIETY OF CHEMISTRY SPECIAL PUBLICATIONS.
LA: English
AB: A flow-through shear-type microfilter chip has been proposed for the purpose
  of separating plasma and virus particles from whole blood. The Microfilter
  chips have been fabricated in three different design configurations by silicon
  micromachining and tested for their percent efficiency of separating plasma
  from diluted blood samples. One of the designs has been further demonstrated to
  be capable of isolating virus particles from a spiked sample of whole blood.
AI: Y
MC: Clinical-Immunology: Human-Medicine, Medical-Sciences; Infection-; Equipment
  -Apparatus-Devices-and-Instrumentation; Hematology-: Human-Medicine, Medical
  -Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[03600-] Positive-Sense-ssRNA-Viruses, -Viruses,
  Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-; Cymbidium-mosaic-virus (Positive-Sense
  -ssRNA-Viruses): species-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Positive-Sense-ssRNA-Viruses: Microorganisms-, Positive-Sense
  -Single-Stranded-RNA-Viruses, Viruses-
PS: serum-: blood-and-lymphatics; plasma-: blood-and-lymphatics; red-blood-cell:
  blood-and-lymphatics; whole-blood: blood-and-lymphatics; white-blood-cell:
  immune-system, blood-and-lymphatics
CB: hemoglobin-; nucleic-acids
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-, diagnosis-
MQ: flow-through-shear-type-microfilter-chip: medical-equipment; silicon
  -micromachining: laboratory-techniques
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10062- (Biochemistry
  -studies-Nucleic-acids-purines-and-pyrimidines)
10064- (Biochemistry-studies
  -Proteins-peptides-and-amino-acids)
10065- (Biochemistry-studies-Porphyrins
  -and-bile-pigments)
12504- (Pathology-Diagnostic)
15002- (Blood-Blood-and
  -lymph-studies)
15004- (Blood-Blood-cell-studies)
15006- (Blood-Blood
  -lymphatic-and-reticuloendothelial-pathologies)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
34508- (Immunology-Immunopathology-tissue-immunology)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510226362
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0260
  -6291&lpa.holdlink.isbn=0854048960
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0260
  -6291&isbn=0854048960&volume=&issue=&spage=&pages=&date=2005&title=&atitle=A%20f
  low-through%20shear
  -type%20microfilter%20chip%20for%20separating%20plasma%20and%20virus%20particles
  %20from%20whole%20blood&aulast=Yobas&pid=%3Cauthor%3EYobas%2c%20Levent%3bGui%2c%
  20Ee%20Ling%3bJi%2c%20Hongmiao%3bLi%2c%20Jing%3bChen%2c%20Yu%3bHui%2c%20Wing%20C
  heong%3bMohamed%20Rafe%2c%20Siti%20Rafeah%20Binte%3bSwarup%2c%20Sanjay%3bWong%2c
  %20Sek%20Man%3bLim%2c%20Tit%20Meng%3bHeng%2c%20Chew%20Kiat%3C%2Fauthor%3E%3CAN%3
  E200510226362%3C%2FAN%3E%3CDT%3EBook%20Chapter%3bMeeting%3C%2FDT%3E

Record 20 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Aspects of the general biology of Sars' eelpout, Lycenchelys sarsi (Collett,
  1871) (Pisces, Zoarcidae), in Oslofjorden, Norway
AU: Nash,-Richard-D-M [Author,-Reprint-Author]; Geffen,-Audrey-J [Author]
AD: Inst Marine Res, POB 1870, N-5817 Bergen, Norway
EMA: richard.nash@imr.no
SO: Marine-Biology-Research. 2005; 1(1): 33-38
PY: 2005
DT: Article
IS: 1745-10001745-1019
LA: English
AB: Biological data on the sizes, age, growth and aspects of the reproduction of
  Sars' eelpout Lycenchelys sarsi were obtained during a study of the Oslojord
  fish fauna in 1981. Lycenchelys sarsi is a relatively small zoarcid that occurs
  on soft sediment. Spawning in the Oslofjord occurs between April and possibly
  as late as August. This species is typical for zoarcids in that it has a
  relatively low fecundity ( 20 - 40 eggs per female) and the eggs are relatively
  large (yolked oocytes up to 5.4 mm diameter). Sexual maturity is reached when
  the fish are approximately 11 cm in total length, corresponding to an age of 3 
  - 5 years. The maximum ages of L. sarsi found in the Oslofjord were 6 + years.
  In general, males reach a larger size than females.
AI: Y
MC: Development-; Marine-Ecology: Ecology-, Environmental-Sciences; Biogeography
  -: Population-Studies
ST: -[85206-] Osteichthyes-, -Pisces, Vertebrata-, Chordata-, Animalia-; -[85200
  -] Pisces-, -Vertebrata, Chordata-, Animalia-
OR: Lycenchelys-sarsii (Osteichthyes-): species-, Sars'-eelpout, common-, egg-,
  adult-, female-, male-, biological-data; Pisces- (Pisces-): higher_taxa-;
  Zoarcidae- (Pisces-): higher_taxa-
TN: Osteichthyes-: Animals-, Chordates-, Fish-, Nonhuman-Vertebrates,
  Vertebrates-; Pisces-: Animals-, Chordates-, Fish-, Nonhuman-Vertebrates,
  Vertebrates-
GE: Oslofjorden-: Norway-, Europe-, Palearctic-region
MI: soft-sediment; sexual-maturity; low-fecundity
CC: 07502- (Ecology-environmental-biology-General-and-methods)
07508- (Ecology
  -environmental-biology-Animal)
07512- (Ecology-environmental-biology
  -Oceanography)
25502- (Development-and-Embryology-General-and
  -descriptive)
62800- (Animal-distribution)
AN: 200510226017
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1745
  -10001745-1019&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1745
  -10001745-1019&isbn=&volume=1&issue=1&spage=33&pages=33
  -38&date=2005&title=Marine%20Biology%20Research&atitle=Aspects%20of%20the%20gene
  ral%20biology%20of%20Sars%27%20eelpout%2c%20Lycenchelys%20sarsi%20%28Collett%2c%
  201871%29%20%28Pisces%2c%20Zoarcidae%29%2c%20in%20Oslofjorden%2c%20Norway&aulast
  =Nash&pid=%3Cauthor%3ENash%2c%20Richard%20D%20M%3bGeffen%2c%20Audrey%20J%3C%2Fau
  thor%3E%3CAN%3E200510226017%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 21 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Autoantibodies against human epithelial cells and endothelial cells after
  severe acute respiratory syndrome (SARS)-associated coronavirus infection
AU: Yang,-Yao-Hsu [Author]; Huang,-Yu-Hui [Author]; Chuang,-Ya-Hui [Author];
  Peng,-Chung-Min [Author]; Wang,-Li-Chieh [Author]; Lin,-Yu-Tsan [Author];
  Chiang,-Bor-Luen [Author,-Reprint-Author]
AD: Natl Taiwan Univ Hosp, Dept Pediat, Coll Med, 7 ChungShan S Rd, Taipei,
  Taiwan
EMA: gicmbor@ha.mc.ntu.edu.tw
SO: Journal-of-Medical-Virology. 2005; 77(1): 1-7
PY: 2005
DT: Article
IS: 0146-6615
LA: English
AB: The severe acute respiratory syndrome (SARS) is caused by infection with the
  SARS-associated coronavirus (SARS-CoV) and characterized by severe pulmonary
  inflammation and fibrosis. In this study, the development of autoantibodies
  against human epithelial cells and endothelial cells in patients with SARS at
  different time periods (the first week: phase I, 1 month after the disease
  onset: phase II/phase III) were investigated. Antibodies in sera of patients
  and healthy controls against: (1) A549 human pulmonary epithelial cell-line,
  (2) human umbilical venous endothelial cells (HUVEC), (3) primary human
  pulmonary endothelial cells (HPEC) were detected by cell-based ELISA and
  indirect immunofluorescence staining. The results revealed that serum levels of
  IgG anti-A549 cells antibodies, IgG anti-HUVEC antibodies, and IgM anti-HPEC
  antibodies were significantly higher in SARS patients at phase II/phase III
  than those in healthy controls. Sera from SARS patients at phase II/ phase III
  could mediate complement dependent cytotoxicity against some A549 cells and
  HPEC. It is concluded that some autoantibodies against human epithelial cells
  and endothelial cells would be developed after SARS-CoV infection and this
  phenomenon may indicate post-infectious cellular injury and also induce SARS
  -induced immunopathology. (c) 2005 Wiley-Liss, Inc.
AI: Y
MC: Infection-; Immune-System: Chemical-Coordination-and-Homeostasis;
  Respiratory-System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-associated-coronavirus (Coronaviridae-): species-, pathogen-; human-
  (Hominidae-): common-, host-; HUVEC-cell-line (Hominidae-): cell_line-; A549
  -cell-line (Hominidae-): cell_line-; HPEC-cell-line (Hominidae-): cell_line-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: serum-: blood-and-lymphatics
CB: IgG-: immunoglobulin-G; IgM-: immunoglobulin-M
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, pathology-, etiology-
MQ: ELISA-: laboratory-techniques, immunologic-techniques; indirect
  -immunofluorescence-staining: laboratory-techniques, histology-and-cytology
  -techniques, immunologic-techniques
CC: 02508- (Cytology-Human)
10064- (Biochemistry-studies-Proteins-peptides-and
  -amino-acids)
12502- (Pathology-General)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
33502-
  (Virology-General-and-methods)
34502- (Immunology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510224244
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0146
  -6615&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0146
  -6615&isbn=&volume=77&issue=1&spage=1&pages=1
  -7&date=2005&title=Journal%20of%20Medical%20Virology&atitle=Autoantibodies%20aga
  inst%20human%20epithelial%20cells%20and%20endothelial%20cells%20after%20severe%2
  0acute%20respiratory%20syndrome%20%28SARS%29
  -associated%20coronavirus%20infection&aulast=Yang&pid=%3Cauthor%3EYang%2c%20Yao%
  20Hsu%3bHuang%2c%20Yu%20Hui%3bChuang%2c%20Ya%20Hui%3bPeng%2c%20Chung%20Min%3bWan
  g%2c%20Li%20Chieh%3bLin%2c%20Yu%20Tsan%3bChiang%2c%20Bor%20Luen%3C%2Fauthor%3E%3
  CAN%3E200510224244%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 22 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Assays for the assessment of neutralizing antibody activities against Severe
  Acute Respiratory Syndrome (SARS) associated coronavirus (SCV)
AU: Wang,-Shixia [Author]; Sakhatskyy,-Pavlo [Author]; Chou,-Te-Hui-W [Author];
  Lu,-Shan [Author,-Reprint-Author]
AD: Univ Massachusetts, Sch Med, Dept Med, Lab Nucl Acid Vaccines, Lazare Res
  Bldg,364 Plantat St, Worcester, MA 01605 USA
EMA: shan.lu@umassmed.edu
SO: Journal-of-Immunological-Methods. 2005; 301(1-2): 21-30
PY: 2005
DT: Article
IS: 0022-1759
LA: English
AB: Accurate assessment of neutralizing antibody activities is important either
  for patients infected with Severe Acute Respiraton, Syndrome (SARS) or for
  animals and volunteers immunized with the experimental vaccines against the
  SARS associated coronavirus (SCV). However, the current assay based on the
  cytopathic effect (CPE) which has been frequently cited in literature has
  several limitations. The CPE assay relies on the visual observation oil the
  damage of SCV infected target cells under a microscope. It is subjected to
  observer variations and it is difficult to generate a quantitative
  determination of neutralizing activities based on the level of CPE. In the
  current study, we established the utility of two additional assays to measure
  the neutralizing activities against SCV: the plaque reduction (PR) and the
  neutral red staining (NRS) assays. The PR assay described in this study was
  modified from the traditional viral plaque reduction assay by using an improved
  crystal staining method to achieve better plague formation in SCV infected Vero
  E6 cells. The NRS neutralization assay was adopted from a similar system used
  for detecting neutralizing antibody responses against human immunodeficiency
  virus type I (HIV-1). In this assay, the protective effect of neutralizing
  antibodies was determined by the cell viability which is measured by the uptake
  of neutral red dye at A(540). The neutralizing antibody titers can be easily
  determined with either of the two new assays. In this report, we described the
  utility of these two new neutralization assays in measuring the neutralizing
  activities against SCV infection from rabbit sera immunized with various forms
  of spike protein of SCV (c) 2005 Elsevier B.V. All rights reserved.
AI: Y
MC: Infection-; Methods-and-Techniques; Immune-System: Chemical-Coordination-and
  -Homeostasis
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: African-green-monkey (Cercopithecidae-): common-, host-; Vero-E6-cell-line
  (Cercopithecidae-): cell_line-, African-green-monkey-kidney-cells; Severe-acute
  -respiratory-syndrome-associated-coronavirus (Coronaviridae-): common-,
  pathogen-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
CB: neutralizing-antibody
DS: severe-acute-respiratory-syndrome-associated-coronavirus-infection:
  respiratory-system-disease, infectious-disease, viral-disease, pathology-,
  immunology-
MQ: plaque-reduction-assay: laboratory-techniques, bioassay-techniques; neutral
  -red-staining-assay: laboratory-techniques, bioassay-techniques
CC: 02506- (Cytology-Animal)
12502- (Pathology-General)
16006- (Respiratory
  -system-Pathology)
33502- (Virology-General-and-methods)
34502- (Immunology
  -General-and-methods)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510224003
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -1759&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -1759&isbn=&volume=301&issue=1-2&spage=21&pages=21
  -30&date=2005&title=Journal%20of%20Immunological%20Methods&atitle=Assays%20for%2
  0the%20assessment%20of%20neutralizing%20antibody%20activities%20against%20Severe
  %20Acute%20Respiratory%20Syndrome%20%28SARS%29%20associated%20coronavirus%20%28S
  CV%29&aulast=Wang&pid=%3Cauthor%3EWang%2c%20Shixia%3bSakhatskyy%2c%20Pavlo%3bCho
  u%2c%20Te%20Hui%20W%3bLu%2c%20Shan%3C%2Fauthor%3E%3CAN%3E200510224003%3C%2FAN%3E
  %3CDT%3EArticle%3C%2FDT%3E

Record 23 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Donor infection: An opinion on lung donor utilization
AU: Garrity,-Edward-R-Jr [Author,-Reprint-Author]; Boettcher,-Heidi [Author];
  Gabbay,-Eli [Author]
AD: Loyola Univ, Med Ctr, Dept Pulm and Crit Care Med, 2160 S 1st Ave, Maywood,
  IL 60153 USA
EMA: egarrit@lumc.edu
SO: Journal-of-Heart-and-Lung-Transplantation. 2005; 24(7): 791-797
PY: 2005
DT: Editorial; Article
IS: 1053-2498
LA: English
MC: Surgery-: Medical-Sciences; Pharmacology-; Infection-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03615-] Flaviviridae-, -Positive-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-; -[07700-] Gram-Positive-Cocci, -Eubacteria, Bacteria
  -, Microorganisms-; -[03115-] Herpesviridae-, -dsDNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[07702-] Micrococcaceae-, -Gram-Positive-Cocci,
  Eubacteria-, Bacteria-, Microorganisms-; -[06508-] Pseudomonadaceae-, -Gram
  -Negative-Aerobic-Rods-and-Cocci, Eubacteria-, Bacteria-, Microorganisms-; 
  -[03305-] Retroviridae-, -DNA-and-RNA-Reverse-Transcribing-Viruses, Viruses-,
  Microorganisms-; -[03000-] Viruses-, -Microorganisms
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; West-Nile-virus (Flaviviridae-): species-, pathogen-; Enterococcus- (Gram
  -Positive-Cocci): genus-, pathogen-; Varicella-Zoster-virus (Herpesviridae-):
  common-, Human-herpesvirus-3, species-, pathogen-; Herpesvirus- (Herpesviridae
  -): common-, pathogen-; Epstein-Barr-virus (Herpesviridae-): common-, EBV-,
  common-, pathogen-; human- (Hominidae-): common-, host-; Staphylococcus-aureus
  (Micrococcaceae-): species-, pathogen-; Burkholderia-cepacia (Pseudomonadaceae
  -): species-, pathogen-; Human-immunodeficiency-virus (Retroviridae-): species
  -, HIV-, common-, pathogen-; Hepatitis-virus (Viruses-): common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Flaviviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA
  -Viruses, Viruses-; Gram-Positive-Cocci: Bacteria-, Eubacteria-, Microorganisms
  -; Herpesviridae-: Double-Stranded-DNA-Viruses, Microorganisms-, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-;
  Micrococcaceae-: Bacteria-, Eubacteria-, Microorganisms-; Pseudomonadaceae-:
  Bacteria-, Eubacteria-, Microorganisms-; Retroviridae-: DNA-and-RNA-Reverse
  -Transcribing-Viruses, Microorganisms-, Viruses-; Viruses-: Microorganisms-,
  Viruses-
CB: infectious-agents; methicillin-: 61-32-5, antibacterial-drug, antiinfective
  -drug, resistance-; vancomycin-: 1404-90-6, antibacterial-drug, antiinfective
  -drug, resistance-
DS: Epstein-Barr-virus-infection: neoplastic-disease, viral-disease; fungal
  -infection: (Mycoses-(MeSH)), fungal-disease; hepatitis-: (Hepatitis-(MeSH)),
  digestive-system-disease; cancer-: (Neoplasms-(MeSH)), neoplastic-disease;
  Creutzfeldt-Jakob-disease: nervous-system-disease, prion-disease, behavioral
  -and-mental-disorders; severe-acute-respiratory-syndrome: SARS-, (Severe-Acute
  -Respiratory-Syndrome-(MeSH)), respiratory-system-disease, viral-disease; human
  -immunodeficiency-virus-infection: HIV-infection, (HIV-Infections-(MeSH)),
  viral-disease, immune-system-disease; herpesvirus-infection: (Herpesviridae
  -Infections-(MeSH)), viral-disease; Burkholderia-cepacia-infection: bacterial
  -disease; Staphylococcus-aureus-infection: bacterial-disease, drug-therapy;
  West-Nile-fever: nervous-system-disease, viral-disease; enterococcus-infection:
  bacterial-disease, drug-therapy; Varicella-Zoster-infection: viral-disease
RN: 61-32-5; 1404-90-6
MQ: lung-transplantation: therapeutic-and-prophylactic-techniques, clinical
  -techniques
CC: 07004- (Behavioral-biology-Human-behavior)
10060- (Biochemistry-studies
  -General)
11105- (Anatomy-and-Histology-Surgery)
12512- (Pathology
  -Therapy)
14006- (Digestive-system-Pathology)
16006- (Respiratory-system
  -Pathology)
20506- (Nervous-system-Pathology)
21002- (Psychiatry
  -Psychopathology-psychodynamics-and-therapy)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
24004- (Neoplasms
  -Pathology-clinical-aspects-and-systemic-effects)
31000- (Physiology-and
  -biochemistry-of-bacteria)
33502- (Virology-General-and-methods)
34508-
  (Immunology-Immunopathology-tissue-immunology)
36002- (Medical-and-clinical
  -microbiology-Bacteriology)
36006- (Medical-and-clinical-microbiology
  -Virology)
36008- (Medical-and-clinical-microbiology-Mycology)
38502-
  (Chemotherapy-General-methods-and-metabolism)
38504- (Chemotherapy
  -Antibacterial-agents)
AN: 200510223922
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1053
  -2498&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1053
  -2498&isbn=&volume=24&issue=7&spage=791&pages=791
  -797&date=2005&title=Journal%20of%20Heart%20and%20Lung%20Transplantation&atitle=
  Donor%20infection%3a%20An%20opinion%20on%20lung%20donor%20utilization&aulast=Gar
  rity&pid=%3Cauthor%3EGarrity%2c%20Edward%20R%20Jr%3bBoettcher%2c%20Heidi%3bGabba
  y%2c%20Eli%3C%2Fauthor%3E%3CAN%3E200510223922%3C%2FAN%3E%3CDT%3EEditorial%3bArti
  cle%3C%2FDT%3E

Record 24 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Multiple organ infection and the pathogenesis of SARS
AU: Gu,-Jiang [Author,-Reprint-Author]; Gong,-Encong [Author]; Zhang,-Bo
  [Author]; Zheng,-Jie [Author]; Gao,-Zifen [Author]; Zhong,-Yanfeng [Author];
  Zou,-Wanzhong [Author]; Zhan,-Jun [Author]; Wang,-Shenglan [Author]; Xie,
  -Zhigang [Author]; Zhuang,-Hui [Author]; Wu,-Bingquan [Author]; Zhong,-Haohao
  [Author]; Shao,-Hongquan [Author]; Fang,-Weigang [Author]; Gao,-Dongshia
  [Author]; Pei,-Fei [Author]; Li,-Xingwang [Author]; He,-Zhongpin [Author]; Xu,
  -Danzhen [Author]; Shi,-Xeying [Author]; Anderson,-Virginia-M [Author]; Leong,
  -Anthony-S-Y [Author]
AD: Peking Univ, Dept Pathol, Beijing 100083, Peoples R China
EMA: jgu@privatedoctor.org
SO: Journal-of-Experimental-Medicine. 2005; 202(3): 415-424
PY: 2005
DT: Article
IS: 0022-1007
LA: English
AB: After > 8,000 infections and > 700 deaths worldwide, the pathogenesis of the
  new infectious disease, severe acute respiratory syndrome (SARS), remains
  poorly understood. We investigated 18 autopsies of patients who had suspected
  SARS; 8 cases were confirmed as SARS. We evaluated white blood cells from 22
  confirmed SARS patients at various stages of the disease. T lymphocyte counts
  in 65 confirmed and 35 misdiagnosed SARS cases also were analyzed
  retrospectively. SARS viral particles and genomic sequence were detected in a
  large number of circulating lymphocytes, monocytes, and lymphoid tissues, as
  well as in the epithelial cells of the respiratory tract, the mucosa of the
  intestine, the epithelium of the renal distal tubules, the neurons of the
  brain, and macrophages in different organs. SARS virus seemed to be capable of
  infecting multiple cell types in several organs; immune cells and pulmonary
  epithelium were identified as the main sites of injury. A comprehensive theory
  of pathogenesis is proposed for SARS with immune and lung damage as key
  features.
AI: Y
MC: Infection-; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, adult-, aged-80-and-over, middle-age, female-,
  male-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: intestine-: digestive-system; neuron-: nervous-system; brain-: nervous
  -system; macrophage-: immune-system, blood-and-lymphatics; monocyte-: immune
  -system, blood-and-lymphatics; lung-: respiratory-system; T-lymphocyte: immune
  -system, blood-and-lymphatics; white-blood-cell: immune-system, blood-and
  -lymphatics; lymphoid-tissue: blood-and-lymphatics; renal-distal-tubule:
  excretory-system; respiratory-tract-epithelial-cell: respiratory-system
SD: AY274119-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, etiology-
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
03506- (Genetics
  -Animal)
10062- (Biochemistry-studies-Nucleic-acids-purines-and
  -pyrimidines)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
14004- (Digestive-system-Physiology-and-biochemistry)
15002- (Blood
  -Blood-and-lymph-studies)
15004- (Blood-Blood-cell-studies)
15504- (Urinary
  -system-Physiology-and-biochemistry)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
20504- (Nervous-system
  -Physiology-and-biochemistry)
24500- (Gerontology-)
34502- (Immunology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510223753
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -1007&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -1007&isbn=&volume=202&issue=3&spage=415&pages=415
  -424&date=2005&title=Journal%20of%20Experimental%20Medicine&atitle=Multiple%20or
  gan%20infection%20and%20the%20pathogenesis%20of%20SARS&aulast=Gu&pid=%3Cauthor%3
  EGu%2c%20Jiang%3bGong%2c%20Encong%3bZhang%2c%20Bo%3bZheng%2c%20Jie%3bGao%2c%20Zi
  fen%3bZhong%2c%20Yanfeng%3bZou%2c%20Wanzhong%3bZhan%2c%20Jun%3bWang%2c%20Shengla
  n%3bXie%2c%20Zhigang%3bZhuang%2c%20Hui%3bWu%2c%20Bingquan%3bZhong%2c%20Haohao%3b
  Shao%2c%20Hongquan%3bFang%2c%20Weigang%3bGao%2c%20Dongshia%3bPei%2c%20Fei%3bLi%2
  c%20Xingwang%3bHe%2c%20Zhongpin%3bXu%2c%20Danzhen%3bShi%2c%20Xeying%3bAnderson%2
  c%20Virginia%20M%3bLeong%2c%20Anthony%20S%20Y%3C%2Fauthor%3E%3CAN%3E200510223753
  %3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 25 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Researches on the eukaryotic expression and immunogenecity of SARS-Cov M
  protein
AU: Tong-De-yan [Author,-Reprint-Author]; Wang-Xiao-hua [Author]; Zheng-Xiu-juan
  [Author]; Guan-Qing-dong [Author]; Xiong-Si-dong [Author]
AD: Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200032, Peoples R China
EMA: sdxiong@shmu.edu.cn
SO: Fudan-Xuebao-(Yixuekexueban). 2005; 32(1): 21-24
PY: 2005
DT: Article
IS: 0257-8131
LA: Chinese
AB: Purpose To investigate the eukaryotic expression and immunogenecity of SARS
  -Cov M protein. Methods RT-PCR based gene cloning strategy was applied to get
  the whole SARS-Cov M gene from the genome of SARS-Cov virus. The M gene
  fragment was then cloned into pcDNA4-his/myc and pVAON33 vectors. Western Blot
  was employed for the detection of the M-his/myc fusion protein and ELISA was
  used to trace specific humoral immune response elicited by the pVAON33-M gene
  immunization. Results After transfection, M protein was proved to express well.
  Subsequent immunization test proved that specific anti-M antibody was elicited
  in the BALB/c mice. Conclusions our results suggested that M protein was a
  candidate target for vaccine development.
AI: Y
MC: Infection-; Methods-and-Techniques; Immune-System: Chemical-Coordination-and
  -Homeostasis; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[00500-] Organisms-, -Organisms
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; mouse- (Muridae-): common-, host-, breed-BALB-c; eukaryote- (Organisms-):
  common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-; Organisms-: Organisms-
CB: gene-vector; M-protein: expression-; anti-M-antibody
GN: eukaryote-M-gene [Organisms-]: eukaryote-M-protein-gene
MQ: ELISA-: laboratory-techniques, immunologic-techniques; gene-therapy: genetic
  -techniques, clinical-techniques, therapeutic-and-prophylactic-techniques;
  vaccination-: clinical-techniques; Western-blot: electrophoretic-techniques,
  immunologic-techniques, laboratory-techniques; RT-PCR: reverse-transcriptase
  -polymerase-chain-reaction, laboratory-techniques, genetic-techniques
CC: 03502- (Genetics-General)
03506- (Genetics-Animal)
10062- (Biochemistry
  -studies-Nucleic-acids-purines-and-pyrimidines)
10064- (Biochemistry-studies
  -Proteins-peptides-and-amino-acids)
31500- (Genetics-of-bacteria-and
  -viruses)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510221238
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0257
  -8131&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0257
  -8131&isbn=&volume=32&issue=1&spage=21&pages=21
  -24&date=2005&title=Fudan%20Xuebao%20%28Yixuekexueban%29&atitle=Researches%20on%
  20the%20eukaryotic%20expression%20and%20immunogenecity%20of%20SARS
  -Cov%20M%20protein&aulast=&pid=%3Cauthor%3ETong%20De%20yan%3bWang%20Xiao%20hua%3
  bZheng%20Xiu%20juan%3bGuan%20Qing%20dong%3bXiong%20Si%20dong%3C%2Fauthor%3E%3CAN
  %3E200510221238%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 26 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Factorial analysis of dependent variable with interval data fitted to gamma
  distribution
AU: Cai-Quan-cai [Author,-Reprint-Author]; Xu-Qin-feng [Author]; Jiang-Qing-wu
  [Author]; Cheng-Xiang [Author]; Guo-Qiang [Author]; Sun-Qing-wen [Author]; Zhao
  -Gen-ming [Author]
AD: Fudan Univ, Sch Management, Sch Publ Hlth, Dept Epidemiol, Shanghai 200032,
  Peoples R China
EMA: qwjiang@shmu.edu.cn
SO: Fudan-Xuebao-(Yixuekexueban). 2005; 32(3): 275-279
PY: 2005
DT: Article
IS: 0257-8131
LA: Chinese
AB: Purpose To develop a method to make factorial analysis of dependent variable
  with interval data fitted to Gamma distribution and conduct it to explore
  factors that influencing the incubation period of severe acute respiratory
  syndrome (SARS). Methods EM algorithm was employed to solve the maximum
  likelihood estimation (MLE) of parameters of general linear model (GLM) based
  on Gamma distribution with interval data, then univariate and multivariate
  analyses were applied to explore factors that influencing SARS incubation
  period. Results We obtained MLE, the approximate standard error of each
  parameter of GLM, and the results of significant test of GLM. The results from
  factorial analysis of SARS incubation period showed that both contact pattern
  and epidemic area had significant impacts on the incubation period; older
  patients had a longer incubation period; and the incubation period of the
  medical personnel was obviously shorter than that of the non-medical personnel.
  Conclusions MLE based on EM algorithm is robust for parameter estimation of GLM
  based on Gamma distribution with interval data. GLM method can be used to
  explore factors that influencing SARS incubation period with interval data.
AI: Y
MC: Infection-; Mathematical-Biology: Computational-Biology
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: general-linear-model: mathematical-and-computer-techniques; maximum
  -likelihood-method: mathematical-and-computer-techniques; EM-algorithm:
  mathematical-and-computer-techniques
MI: Gamma-distribution
CC: 04500- (Mathematical-biology-and-statistical-methods)
16006- (Respiratory
  -system-Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510221205
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0257
  -8131&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0257
  -8131&isbn=&volume=32&issue=3&spage=275&pages=275
  -279&date=2005&title=Fudan%20Xuebao%20%28Yixuekexueban%29&atitle=Factorial%20ana
  lysis%20of%20dependent%20variable%20with%20interval%20data%20fitted%20to%20gamma
  %20distribution&aulast=&pid=%3Cauthor%3ECai%20Quan%20cai%3bXu%20Qin%20feng%3bJia
  ng%20Qing%20wu%3bCheng%20Xiang%3bGuo%20Qiang%3bSun%20Qing%20wen%3bZhao%20Gen%20m
  ing%3C%2Fauthor%3E%3CAN%3E200510221205%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 27 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: SARS vaccine protective in mice
AU: Stadler,-Konrad [Author]; Roberts,-Anjeanette [Author]; Becker,-Stephan
  [Author]; Vogel,-Leatrice [Author]; Eickmann,-Markus [Author]; Kolesnikova,
  -Larissa [Author]; Klenk,-Hans-Dieter [Author]; Murphy,-Brian [Author];
  Rappuoli,-Rino [Author]; Abrignani,-Sergio [Author,-Reprint-Author]; Subbarao,
  -Kanta [Author]
AD: Chiron Vaccines, Via Fiorentina 1, I-53100 Siena, Italy
EMA: sergio_abrignani@chiron.com
SO: Emerging-Infectious-Diseases. 2005; 11(8): 1312-1314
PY: 2005
DT: Letter
IS: 1080-6040
LA: English
MC: Pharmacology-; Infection-; Immune-System: Chemical-Coordination-and
  -Homeostasis; Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Vero-cell-line (Cercopithecidae-): cell_line-; Severe-acute-respiratory
  -syndrome-coronavirus (Coronaviridae-): species-, SARS-virus, common-, pathogen
  -, strain-Urbani, strain-FRA; mouse- (Muridae-): common-, host-, strain-BALB-c
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-; Muridae
  -: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman-Mammals,
  Rodents-, Vertebrates-
CB: immunoglobulin-G: IgG-; DNA-vaccine: immunologic-drug, immunostimulant-drug,
  vaccine-; PBS-; MF59-: 172889-84-8; parainfluenza-virus-vaccine: immunologic
  -drug, immunostimulant-drug, vaccine-; vaccinia-Ankara-vaccine: immunologic
  -drug, immunostimulant-drug, vaccine-
SD: AY278741-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence;
  AY310120-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, prevention-and-control
RN: 172889-84-8
CC: 02506- (Cytology-Animal)
03506- (Genetics-Animal)
10062- (Biochemistry
  -studies-Nucleic-acids-purines-and-pyrimidines)
10064- (Biochemistry-studies
  -Proteins-peptides-and-amino-acids)
12512- (Pathology-Therapy)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
22002- (Pharmacology-General)
22018- (Pharmacology-Immunological
  -processes-and-allergy)
31500- (Genetics-of-bacteria-and-viruses)
33502-
  (Virology-General-and-methods)
34502- (Immunology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510220129
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1080
  -6040&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1080
  -6040&isbn=&volume=11&issue=8&spage=1312&pages=1312
  -1314&date=2005&title=Emerging%20Infectious%20Diseases&atitle=SARS%20vaccine%20p
  rotective%20in%20mice&aulast=Stadler&pid=%3Cauthor%3EStadler%2c%20Konrad%3bRober
  ts%2c%20Anjeanette%3bBecker%2c%20Stephan%3bVogel%2c%20Leatrice%3bEickmann%2c%20M
  arkus%3bKolesnikova%2c%20Larissa%3bKlenk%2c%20Hans%20Dieter%3bMurphy%2c%20Brian%
  3bRappuoli%2c%20Rino%3bAbrignani%2c%20Sergio%3bSubbarao%2c%20Kanta%3C%2Fauthor%3
  E%3CAN%3E200510220129%3C%2FAN%3E%3CDT%3ELetter%3C%2FDT%3E

Record 28 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Posttraumatic stress after SARS
AU: Wu,-Kitty-K [Author,-Reprint-Author]; Chan,-Sumee-K [Author]; Ma,-Tracy-M
  [Author]
AD: Caritas Med Ctr, Dept Clin Psychol, 111 Wing Hong St, Kowloon, Hong Kong,
  Peoples R China
EMA: wukyk@ha.org.hk
SO: Emerging-Infectious-Diseases. 2005; 11(8): 1297-1300
PY: 2005
DT: Article
IS: 1080-6040
LA: English
AB: Posttraumatic stress disorder (PTSD) can arise in patients with medical
  illness. We used 2 Chinese self-report measures to examine features of PTSD,
  anxiety, and depression in 131 survivors of severe acute respiratory syndrome
  at 1 month and 3 months after discharge from the hospital. Risk factors
  associated with psychological distress were identified.
AI: Y
MC: Methods-and-Techniques; Infection-; Psychiatry-: Human-Medicine, Medical
  -Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, adolescent-, aged-, aged-80-and-over, middle
  -age, adult-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; posttraumatic-stress
  -disorder: (Stress-Disorders, Post-Traumatic-(MeSH)), behavioral-and-mental
  -disorders, symptom-
MQ: Hospital-Anxiety-and-Depression-Scale: clinical-techniques, diagnostic
  -techniques; Diagnostic-and-Statistical-Manual-of-Mental-Disorders, Fourth
  -Edition: clinical-techniques, diagnostic-techniques; Impact-of-Event-Scale--
  -Revised: clinical-techniques, diagnostic-techniques
MI: psychological-effect
CC: 07004- (Behavioral-biology-Human-behavior)
16006- (Respiratory-system
  -Pathology)
21002- (Psychiatry-Psychopathology-psychodynamics-and
  -therapy)
24500- (Gerontology-)
25000- (Pediatrics-)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510220123
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1080
  -6040&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1080
  -6040&isbn=&volume=11&issue=8&spage=1297&pages=1297
  -1300&date=2005&title=Emerging%20Infectious%20Diseases&atitle=Posttraumatic%20st
  ress%20after%20SARS&aulast=Wu&pid=%3Cauthor%3EWu%2c%20Kitty%20K%3bChan%2c%20Sume
  e%20K%3bMa%2c%20Tracy%20M%3C%2Fauthor%3E%3CAN%3E200510220123%3C%2FAN%3E%3CDT%3EA
  rticle%3C%2FDT%3E

Record 29 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Modeling control strategies of respiratory pathogens
AU: Pourbohloul,-Babak [Author,-Reprint-Author]; Meyers,-Lauren-Ancel [Author];
  Skowronski,-Danuta-M [Author]; Krajden,-Mel [Author]; Patrick,-David-M
  [Author]; Brunham,-Robert-C [Author]
AD: Univ British Columbia, Ctr Dis Control, Div Math Modeling, 655 W 12th Ave,
  Vancouver, BC V5Z 4R4, Canada
EMA: babak.pourbohloul@bccdc.ca
SO: Emerging-Infectious-Diseases. 2005; 11(8): 1249-1256
PY: 2005
DT: Article
IS: 1080-6040
LA: English
AB: Effectively controlling infectious diseases requires quantitative
  comparisons of quarantine, infection control precautions, case identification
  and isolation, and immunization interventions. We used contact network
  epidemiology to predict the effect of various control policies for a mildly
  contagious disease, such as severe acute respiratory syndrome, and a moderately
  contagious disease, such as smallpox. The success of an intervention depends on
  the transmissibility of the disease and the contact pattern between persons
  within a community. The model predicts that use of face masks and general
  vaccination will only moderately affect the spread of mildly contagious
  diseases. In contrast, quarantine and ring vaccination can prevent the spread
  of a wide spectrum of diseases. Contact network epidemiology can provide
  valuable quantitative input to public health decision-making, even before a
  pathogen is well characterized.
AI: Y
MC: Methods-and-Techniques; Infection-; Pulmonary-Medicine: Human-Medicine,
  Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[03110-] Poxviridae-, -dsDNA-Viruses, Viruses-,
  Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-; Smallpox-virus (Poxviridae-): common-,
  Variola-virus, species-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Poxviridae-: Double-Stranded-DNA-Viruses, Microorganisms-,
  Viruses-
DS: smallpox-: (Smallpox-(MeSH)), viral-disease, etiology-, prevention-and
  -control; severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory
  -Syndrome-(MeSH)), respiratory-system-disease, viral-disease, etiology-,
  prevention-and-control
MQ: vaccination-: clinical-techniques; immunization-: clinical-techniques;
  quarantine-: clinical-techniques; face-mask: protective-clothing
CC: 16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510220114
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1080
  -6040&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1080
  -6040&isbn=&volume=11&issue=8&spage=1249&pages=1249
  -1256&date=2005&title=Emerging%20Infectious%20Diseases&atitle=Modeling%20control
  %20strategies%20of%20respiratory%20pathogens&aulast=Pourbohloul&pid=%3Cauthor%3E
  Pourbohloul%2c%20Babak%3bMeyers%2c%20Lauren%20Ancel%3bSkowronski%2c%20Danuta%20M
  %3bKrajden%2c%20Mel%3bPatrick%2c%20David%20M%3bBrunham%2c%20Robert%20C%3C%2Fauth
  or%3E%3CAN%3E200510220114%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 30 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Emerging infections and pregnancy: West Nile virus, monkeypox, severe acute
  respiratory syndrome, and bioterrorism
AU: Jamieson,-Denise-J [Author,-Reprint-Author]; Jernigan,-Daniel-B [Author];
  Ellis,-Jane-E [Author]; Treadwell,-Tracee-A [Author]
AD: Natl Ctr Chron Dis Prevent and Hlth Promot, Ctr Dis Control and Prevent, Div
  Reprod Hlth, 4770 Buford Highway, Atlanta, GA 30341 USA
EMA: djamieson@cdc.gov
SO: Clinics-in-Perinatology. 2005; 32(3): 765-776,XI,XII-764
PY: 2005
DT: Article
IS: 0095-5108
LA: English
AB: As new infectious diseases, such as West Nile virus, monkeypox, and severe
  acute respiratory syndrome (SARS) are recognized in the United States, there
  are critical questions about how these infectious diseases will affect pregnant
  women and their infants. In addition, the implications of bioterrorist attacks
  for exposed pregnant women need to be considered. In this article, the authors
  address the following questions for a number of infectious disease threats: (1)
  does pregnancy affect the clinical course of these novel infectious diseases?,
  (2) what are the implications for prophylaxis and treatment of exposed or
  infected pregnant women?, and (3) are these novel infectious diseases
  transmitted during pregnancy, labor and delivery, or breastfeeding?
AI: Y
MC: Infection-; Obstetrics-: Human-Medicine, Medical-Sciences
ST: -[75314-] Diptera-, -Insecta, Arthropoda-, Invertebrata-, Animalia-; -[86215
  -] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: Anthrax- (Diptera-): genus-; human- (Hominidae-): common-, adult-, infant-
TN: Diptera-: Animals-, Arthropods-, Insects-, Invertebrates-; Hominidae-:
  Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; smallpox-: (Smallpox
  -(MeSH)), viral-disease; monkeypox-: viral-disease; West-Nile-fever: nervous
  -system-disease, viral-disease
MI: pregnancy-; bioterrorism-
CC: 16006- (Respiratory-system-Pathology)
16506- (Reproductive-system
  -Pathology)
20506- (Nervous-system-Pathology)
25000- (Pediatrics-)
36006-
  (Medical-and-clinical-microbiology-Virology)
64076- (Invertebrata-comparative
  -experimental-morphology-physiology-and-pathology-Insecta-physiology)
AN: 200510219105
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0095
  -5108&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0095
  -5108&isbn=&volume=32&issue=3&spage=&pages=&date=2005&title=Clinics%20in%20Perin
  atology&atitle=Emerging%20infections%20and%20pregnancy%3a%20West%20Nile%20virus%
  2c%20monkeypox%2c%20severe%20acute%20respiratory%20syndrome%2c%20and%20bioterror
  ism&aulast=Jamieson&pid=%3Cauthor%3EJamieson%2c%20Denise%20J%3bJernigan%2c%20Dan
  iel%20B%3bEllis%2c%20Jane%20E%3bTreadwell%2c%20Tracee%20A%3C%2Fauthor%3E%3CAN%3E
  200510219105%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 31 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Detection of severe acute respiratory syndrome coronavirus in the brain:
  Potential role of the chemokine mig in pathogenesis
AU: Xu,-Jun [Author]; Zhong,-Shuqing [Author]; Liu,-Jinghua [Author]; Li,-Li
  [Author]; Li,-Yong [Author]; Wu,-Xinwei [Author]; Li,-Zhijie [Author]; Deng,
  -Peng [Author]; Zhang,-Jingqiang [Author]; Zhong,-Nanshan [Author]; Ding,
  -Yanqing [Author]; Jiang,-Yong [Author,-Reprint-Author]
AD: So Med Univ, Dept Pathophysiol, Key Lab Funct Prote Guangdong Province,
  Guangzhou 510515, Peoples R China
EMA: yjiang@fimmu.com
SO: Clinical-Infectious-Diseases. 2005; 41(8): 1089-1096
PY: 2005
DT: Article
IS: 1058-4838
LA: English
AB: Background. Previous studies have shown that common human coronavirus might
  be neurotropic, although it was first isolated as a pathogen of the respiratory
  tract. We noticed that a few patients with severe acute respiratory syndrome
  (SARS) experienced central nervous symptoms during the course of illness. In
  the present study, we isolated a SARS coronavirus strain from a brain tissue
  specimen obtained from a patient with SARS with significant central nervous
  symptoms.Methods. Using transmission electronic microscopy and nested reverse
  transcription - polymerase chain reaction, the causative pathogen was
  identified in cultures of a brain tissue specimen obtained from the patient
  with SARS. Histopathologic examination of the brain tissue was performed using
  the methods of immunohistochemistry analysis and double immunofluorescence
  staining. Fifteen cytokines and chemokines were detected in the blood of the
  patient with SARS by means of a bead-based multiassay system.Results. A
  fragment specific for SARS human coronavirus was amplified from cultures of the
  brain suspension, and transmission electronic microscopy revealed the presence
  of an enveloped virus morphologically compatible with a coronavirus isolated in
  the cultures. Pathologic examination of the brain tissue revealed necrosis of
  neuron cells and broad hyperplasia of gliocytes. Immunostaining demonstrated
  that monokine induced by interferon-gamma (Mig) was expressed in gliocytes with
  the infiltration of CD68(+) monocytes/macrophages and CD3(+) T lymphocytes in
  the brain mesenchyme. Cytokine/chemokine assay revealed that levels of
  interferon-gamma-inducible protein 10 and Mig in the blood were highly
  elevated, although the levels of other cytokines and chemokines were close to
  normal.Conclusions. This study provides direct evidence that SARS human
  coronavirus is capable of infecting the central nervous system, and that Mig
  might be involved in the brain immunopathology of SARS.
AI: Y
MC: Clinical-Immunology: Human-Medicine, Medical-Sciences; Clinical-Chemistry:
  Allied-Medical-Sciences; Infection-; Neurology-: Human-Medicine, Medical
  -Sciences; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Human-coronavirus (Coronaviridae-): common-, pathogen-; human- (Hominidae-):
  common-, adult-, host-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: brain-: nervous-system; respiratory-tract: respiratory-system; CD68-positive
  -cell: immune-system; monocyte-: macrophage-, immune-system, blood-and
  -lymphatics; CD3-positive-T-lymphocytes: immune-system, blood-and-lymphatics;
  gliocyte-: nervous-system
CB: interferon-gamma; interferon-gamma-inducible-protein-10; Mig-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, nervous-system-disease,
  pathology-, immunology-, symptom-, diagnosis-
MQ: immunohistochemistry-staining: laboratory-techniques, histology-and-cytology
  -techniques, immunologic-techniques; double-immunofluorescence-staining:
  laboratory-techniques, histology-and-cytology-techniques, immunologic
  -techniques; transmission-electronic-microscopy: imaging-and-microscopy
  -techniques, diagnostic-techniques, clinical-techniques; nested-reverse
  -transcription-polymerase-chain-reaction: genetic-techniques, diagnostic
  -techniques, clinical-techniques
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10006- (Clinical
  -biochemistry-General-methods-and-applications)
10064- (Biochemistry-studies
  -Proteins-peptides-and-amino-acids)
12502- (Pathology-General)
12504-
  (Pathology-Diagnostic)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood
  -Blood-cell-studies)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
20504- (Nervous-system
  -Physiology-and-biochemistry)
20506- (Nervous-system-Pathology)
33502-
  (Virology-General-and-methods)
34502- (Immunology-General-and-methods)
34508-
  (Immunology-Immunopathology-tissue-immunology)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510218970
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1058
  -4838&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1058
  -4838&isbn=&volume=41&issue=8&spage=1089&pages=1089
  -1096&date=2005&title=Clinical%20Infectious%20Diseases&atitle=Detection%20of%20s
  evere%20acute%20respiratory%20syndrome%20coronavirus%20in%20the%20brain%3a%20Pot
  ential%20role%20of%20the%20chemokine%20mig%20in%20pathogenesis&aulast=Xu&pid=%3C
  author%3EXu%2c%20Jun%3bZhong%2c%20Shuqing%3bLiu%2c%20Jinghua%3bLi%2c%20Li%3bLi%2
  c%20Yong%3bWu%2c%20Xinwei%3bLi%2c%20Zhijie%3bDeng%2c%20Peng%3bZhang%2c%20Jingqia
  ng%3bZhong%2c%20Nanshan%3bDing%2c%20Yanqing%3bJiang%2c%20Yong%3C%2Fauthor%3E%3CA
  N%3E200510218970%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 32 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: JNK and PI3k/Akt signaling pathways are required for establishing persistent
  SARS-CoV infection in Vero E6 cells
AU: Mizutani,-Tetsuya [Author,-Reprint-Author]; Fukushi,-Shuetsu [Author];
  Saijo,-Masayuki [Author]; Kurane,-Ichiro [Author]; Morikawa,-Shigeru [Author]
AD: Natl Inst Infect Dis, Dep Virol 1, Special Pathogens Lab, Gakuen 4-7-1,
  Tokyo 2080011, Japan
EMA: tmizutan@nih.go.jp
SO: Biochimica-et-Biophysica-Acta. 2005; 1741(1-2): 4-10
PY: 2005
DT: Article
IS: 0925-4439
LA: English
AB: Persistence was established after most of the SARS-CoV-infected Vero E6
  cells died. RNA of the defective interfering virus was not observed in the
  persistently infected cells by Northern blot analysis. SARS-CoV diluted to 2
  PFU failed to establish persistence, suggesting that some particular viruses in
  the seed virus did not induce persistent infection. Interestingly, a viral
  receptor, angiotensin converting enzyme (ACE)-2, was down-regulated in
  persistently infected cells. G418-selected clones established from parent Vero
  E6 cells, which were transfected with a plasmid containing the neomycin
  resistance gene, were infected with SARS-CoV, resulting in a potential cell
  population capable of persistence in Vero E6 cells. Our previous studies
  demonstrated that signaling pathways of extracellular signal-related kinase
  (ERK 1 /2), c-Jun N-terminal protein kinase (JNK), p38 mitogen-activated
  protein kinase (MAPK), and phosphatidylinositol Y-kinase (P13K)/Akt were
  activated in SARS-CoV-infected Vero E6 cells. Previous studies also showed that
  the activation of p38 MAPK by viral infection-induced apoptosis, and a weak
  activation of Akt was not sufficient to protect from apoptosis. In the present
  study, we showed that the inhibitors of INK and P13K/Akt inhibited the
  establishment of persistence, but those of MAPK/ERK kinase (MEK; as an
  inhibitor for ERK1/ 2) and p38 MAPK did not. These results indicated that two
  signaling pathways of JNK and P13K/Akt were important for the establishment of
  persistence in Vero E6 cells. (c) 2005 Elsevier B.V. All rights reserved.
AI: Y
MC: Infection-; Biochemistry-and-Molecular-Biophysics; Respiratory-System:
  Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-, monkey-kidney-cells;
  Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-; LoVo-cell
  -line (Hominidae-): cell_line-, human-intestinal-cells
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
CB: plasmid-; RNA-; Akt-; phosphatidylinositol-3'-kinase: 115926-52-8, EC
  -2.7.1.137; viral-receptor; p38-mitogen-activated-protein-kinase: MAPK-, 165245
  -96-5, EC-2.7.1.37; c-Jun-N-terminal-protein-kinase: JNK-, 155215-87-5;
  extracellular-signal-related-kinase-1/2; angiotensin-converting-enzyme-2;
  neomycin-resistance-gene; MAPK/ERK-kinase: EC-2.7.1.37
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
RN: 115926-52-8; 165245-96-5; 155215-87-5
MQ: Northern-blot: electrophoretic-techniques, genetic-techniques, laboratory
  -techniques
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10060- (Biochemistry
  -studies-General)
10062- (Biochemistry-studies-Nucleic-acids-purines-and
  -pyrimidines)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510216732
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0925
  -4439&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0925
  -4439&isbn=&volume=1741&issue=1-2&spage=4&pages=4
  -10&date=2005&title=Biochimica%20et%20Biophysica%20Acta&atitle=JNK%20and%20PI3k%
  2fAkt%20signaling%20pathways%20are%20required%20for%20establishing%20persistent%
  20SARS-CoV%20infection%20in%20Vero%20E6%20cells&aulast=Mizutani&pid=%3Cauthor%3E
  Mizutani%2c%20Tetsuya%3bFukushi%2c%20Shuetsu%3bSaijo%2c%20Masayuki%3bKurane%2c%2
  0Ichiro%3bMorikawa%2c%20Shigeru%3C%2Fauthor%3E%3CAN%3E200510216732%3C%2FAN%3E%3C
  DT%3EArticle%3C%2FDT%3E

Record 33 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Papain-like protease 2 (PLP2) from severe acute respiratory syndrome
  coronavirus (SARS-CoV): Expression, purification, characterization, and
  inhibition
AU: Han,-Yu-San [Author]; Chang,-Gu-Gang [Author]; Juo,-Chiun-Gung [Author];
  Lee,-Hong-Jen [Author]; Yeh,-Shiou-Hwei [Author]; Hsu,-John-Tsu-An [Author];
  Chen,-Xin [Author,-Reprint-Author]
AD: Natl Hlth Res Inst, Div Biotechnol and Pharmaceut Res, Miaoli County 350,
  Taiwan
EMA: xchen@nhri.org.tw
SO: Biochemistry-. 2005; 44(30): 10349-10359
PY: 2005
DT: Article
IS: 0006-2960
LA: English
AB: Viral proteases are essential for pathogenesis and virulence of severe acute
  respiratory syndrome coronavirus (SARS-CoV). Little information is available on
  SARS-CoV papain-like protease 2 (PLP2), and development of inhibitors against
  PLP2 is attractive for antiviral therapy. Here, we report the characterization
  of SARS-CoV PLP2 (from residues 1414 to 1858) purified from baculovirus
  -infected insect cells. We demonstrate that SARS-CoV PLP2 by itself
  differentially cleaves between the amino acids Gly180 and Ala181, Gly818 and
  Ala819, and Gly2740 and Lys2741 of the viral polypeptide pp1a, as determined by
  reversed-phase high-performance liquid chromatography analysis coupled with
  mass spectrometry. This protease is especially selective for the P1, P4, and P6
  sites of the substrate. The study demonstrates, for the first time among
  coronaviral PLPs, that the reaction mechanism of SARS-CoV PLP2 is
  characteristic of papain and compatible with the involvement of the catalytic
  dyad (Cys)-S-/ (His)-Im(+)H ion pair. With a fluorogenic inhibitor-screening
  platform, we show that zinc ion and its conjugates potently inhibit the
  enzymatic activity of SARS-CoV PLP2. In addition, we provided evidence for
  evolutionary reclassification of SARS-CoV. The results provide important
  insights into the biochemical properties of the coronaviral PLP family and a
  promising therapeutic way to fight SARS-CoV.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Respiratory-System:
  Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[75330-] Lepidoptera-, -Insecta, Arthropoda-, Invertebrata-,
  Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; Sf9-cell-line (Lepidoptera-): cell_line-, host-, baculovirus-infected-insect
  -cells
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Lepidoptera-: Animals-, Arthropods-, Insects-, Invertebrates-
CB: papain-: 9001-73-4, EC-3.4.22.2; papain-like-proteinase-2; viral-polypeptide
  -ppla; catalytic-dyad; zinc-ion: 23713-49-7, antiinfective-drug, antiviral-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; coronavirus-infection:
  viral-disease
RN: 9001-73-4; 23713-49-7
MQ: reversed-phase-high-performance-liquid-chromatography: laboratory
  -techniques, chromatographic-techniques
MI: antiviral-therapy; biochemical-property; evolutionary-reclassification
CC: 02506- (Cytology-Animal)
10060- (Biochemistry-studies-General)
10069-
  (Biochemistry-studies-Minerals)
12512- (Pathology-Therapy)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38506- (Chemotherapy-Antiviral-agents)
64076- (Invertebrata
  -comparative-experimental-morphology-physiology-and-pathology-Insecta
  -physiology)
AN: 200510216721
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0006
  -2960&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0006
  -2960&isbn=&volume=44&issue=30&spage=10349&pages=10349
  -10359&date=2005&title=Biochemistry%20&atitle=Papain
  -like%20protease%202%20%28PLP2%29%20from%20severe%20acute%20respiratory%20syndro
  me%20coronavirus%20%28SARS
  -CoV%29%3a%20Expression%2c%20purification%2c%20characterization%2c%20and%20inhib
  ition&aulast=Han&pid=%3Cauthor%3EHan%2c%20Yu%20San%3bChang%2c%20Gu%20Gang%3bJuo%
  2c%20Chiun%20Gung%3bLee%2c%20Hong%20Jen%3bYeh%2c%20Shiou%20Hwei%3bHsu%2c%20John%
  20Tsu%20An%3bChen%2c%20Xin%3C%2Fauthor%3E%3CAN%3E200510216721%3C%2FAN%3E%3CDT%3E
  Article%3C%2FDT%3E

Record 34 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and
  Lactococcus lactis for serodiagnosis and mucosal vaccination
AU: Pei,-Huadong [Author]; Liu,-Jingfang [Author]; Cheng,-Yun [Author]; Sun,
  -Chaomin [Author]; Wang,-Chen [Author]; Lu,-Yueping [Author]; Ding,-Jie
  [Author]; Zhou,-Jian [Author]; Xiang,-Hua [Author,-Reprint-Author]
AD: Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing
  100080, Peoples R China
EMA: xiangh@sun.im.ac.cn
SO: Applied-Microbiology-and-Biotechnology. 2005; 68(2): 220-227
PY: 2005
DT: Article
IS: 0175-7598
LA: English
AB: The nucleocapsid (N) protein of the severe acute respiratory syndrome (SARS)
  -associated coronavirus (SARS-CoV) is an important antigen for the early
  diagnosis of SARS and the development of vaccines. It was expressed in
  Escherichia coli as a fusion with human glutathione S-transferase (hGST) and
  was confirmed by Western blotting analysis. This recombinant N protein (hGST-N)
  was purified and used to measure the SARS-CoV N-specific antibody in the sera
  of eight SARS patients by enzyme-linked immunosorbent assay. Specific antibody
  response to this purified recombinant N protein was 100% positive in the SARS
  patients' sera, while none of the control sera from 30 healthy people gave a
  positive reaction in the same assay. The SARS-CoV N protein was also expressed
  in Lactococcus lactis in the cytoplasm or secreted into the medium. The N
  -producing strain MG1363/pSECN and the purified hGST-N protein were
  respectively administered to mice, either orally or intranasally. Results
  indicated that orally delivered MG1363/pSECN induced significant N-specific IgG
  in the sera. In conclusion, our work provides a novel strategy to produce the
  SARS-CoV N protein for serodiagnosis and for L. lactis-based mucosal vaccines.
AI: Y
MC: Immune-System: Chemical-Coordination-and-Homeostasis; Respiratory-System:
  Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-; -[07700-] Gram
  -Positive-Cocci, -Eubacteria, Bacteria-, Microorganisms-; -[86215-] Hominidae-,
  -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: Severe-Acute-Rspiratory-Sydrome-associated-Cronavirus (Coronaviridae-):
  species-, SARS-coronavirus, common-, pathogen-; Escherichia-coli
  (Enterobacteriaceae-): species-; Lactococcus-lactis (Gram-Positive-Cocci):
  species-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-; Gram
  -Positive-Cocci: Bacteria-, Eubacteria-, Microorganisms-; Hominidae-: Animals-,
  Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: serum-: blood-and-lymphatics
CB: immunoglobulin-G: IgG-; antibody-; glutathione-S-transferase: GST-, 50812-37
  -8, EC-2.5.1.18; N-protein; nucleocapsid-protein: expression-, antigen-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, diagnosis-
RN: 50812-37-8
MQ: ELISA-: laboratory-techniques, immunologic-techniques; Western-blotting:
  electrophoretic-techniques, immunologic-techniques, laboratory-techniques;
  vaccination-: clinical-techniques; serodiagnosis-: laboratory-techniques,
  immunologic-techniques, diagnostic-techniques, clinical-techniques
CC: 10064- (Biochemistry-studies-Proteins-peptides-and-amino-acids)
10802-
  (Enzymes-General-and-comparative-studies-coenzymes)
12504- (Pathology
  -Diagnostic)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
31000- (Physiology-and-biochemistry-of
  -bacteria)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510215858
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0175
  -7598&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0175
  -7598&isbn=&volume=68&issue=2&spage=220&pages=220
  -227&date=2005&title=Applied%20Microbiology%20and%20Biotechnology&atitle=Express
  ion%20of%20SARS
  -coronavirus%20nucleocapsid%20protein%20in%20Escherichia%20coli%20and%20Lactococ
  cus%20lactis%20for%20serodiagnosis%20and%20mucosal%20vaccination&aulast=Pei&pid=
  %3Cauthor%3EPei%2c%20Huadong%3bLiu%2c%20Jingfang%3bCheng%2c%20Yun%3bSun%2c%20Cha
  omin%3bWang%2c%20Chen%3bLu%2c%20Yueping%3bDing%2c%20Jie%3bZhou%2c%20Jian%3bXiang
  %2c%20Hua%3C%2Fauthor%3E%3CAN%3E200510215858%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3
  E

Record 35 of 2547 in BIOSIS Previews 2005: 46 2005/10/23-2005/10/29

TI: The interaction between severe acute respiratory syndrome coronavirus 3C
  -like proteinase and a dimeric inhibitor by capillary electrophoresis
AU: Ding,-Li [Author]; Zhang,-Xin-Xiang [Author,-Reprint-Author]; Wei,-Ping
  [Author]; Fan,-Keqiang [Author]; Lai,-Luhua [Author]
AD: Peking Univ, Coll Chem and Mol Engn, Beijing 100871, Peoples R China
EMA: zxx@pku.edu.cn; lblai@pku.edu.cn
SO: Analytical-Biochemistry. 2005; 343(1): 159-165
PY: 2005
DT: Article
IS: 0003-2697
LA: English
AB: 3C-like proteinase of severe acute respiratory syndrome (SARS) coronavirus
  has been demonstrated to be a key target for drug design against SARS. The
  interaction between SARS coronavirus 3C-like (3CL) proteinase and an
  octapeptide interface inhibitor was studied by affinity capillary
  electrophoresis (ACE). The binding constants were estimated by the change of
  migration time of the analytes in the buffer solution containing different
  concentrations of SARS 3CL proteinase. The results showed that SARS 3CL
  proteinase was able to complex with the octapeptide competitively, with binding
  constants of 2.44 x 10(4) m-(1) at 20 degrees C and 2.11 x 10(4) M-1 at 37
  degrees C. In addition, the thermodynamic parameters deduced reveal that
  hydrophobic interaction might play major roles, along with electrostatic force,
  in the binding process. The ACE method used here could be developed to be an
  effective and simple way of applying large-scale drug screening and evaluation.
  (c) 2005 Elsevier Inc. All rights reserved.
AI: Y
MC: Pharmacology-; Infection-; Parasitology-; Enzymology-: Biochemistry-and
  -Molecular-Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: buffer-solution; analytes-; 3C-like-proteinase: 218925-73-6; octapeptide
  -interface-inhibitor: enzyme-inhibitor-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy, etiology-
RN: 218925-73-6
MQ: affinity-capillary-electrophoresis: electrophoretic-techniques, laboratory
  -techniques
CC: 10802- (Enzymes-General-and-comparative-studies-coenzymes)
12512-
  (Pathology-Therapy)
16006- (Respiratory-system-Pathology)
22002-
  (Pharmacology-General)
33502- (Virology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
60502- (Parasitology-General)
AN: 200510215048
UD: 20051025
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0003
  -2697&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0003
  -2697&isbn=&volume=343&issue=1&spage=159&pages=159
  -165&date=2005&title=Analytical%20Biochemistry&atitle=The%20interaction%20betwee
  n%20severe%20acute%20respiratory%20syndrome%20coronavirus%203C
  -like%20proteinase%20and%20a%20dimeric%20inhibitor%20by%20capillary%20electropho
  resis&aulast=Ding&pid=%3Cauthor%3EDing%2c%20Li%3bZhang%2c%20Xin%20Xiang%3bWei%2c
  %20Ping%3bFan%2c%20Keqiang%3bLai%2c%20Luhua%3C%2Fauthor%3E%3CAN%3E200510215048%3
  C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 36 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: The probability of failing in detecting an infectious disease at entry
  points into a country
AU: Dell'Olmodarme,-M [Author]; Prati,-M-C [Author,-Reprint-Author]
AD: Scuola Normale Super Pisa, Classe Sci, Piazza Cavalieri 7, I-56100 Pisa,
  Italy
EMA: mc.prati@sns.it
SO: Statistics-in-Medicine. 2005; 24(17): 2669-2679
PY: 2005
DT: Article
IS: 0277-6715
LA: English
AB: In a group of N individuals, carrying an infection with prevalence pi, the
  exact probability P of failing in detecting the infection is evaluated when a
  diagnostic test of sensitivity s and specificity s' is carried out on a sample
  of n individuals extracted without replacement from the group. Furthermore, the
  minimal number of individuals that must be tested if the probability P has to
  be lower than a fixed value is determined as a function of it. If all n tests
  result negative, confidence intervals for pi are given both in the
  frequentistic and Bayesian approach. These results are applied to recent data
  for severe acute respiratory syndrome (SARS). The conclusion is that entry
  screening with a diagnostic test is rarely an efficacious tool for preventing
  importation of a disease into a country. Copyright (C) 2005 John Wiley & Sons,
  Ltd.
AI: Y
MC: Infection-; Mathematical-Biology: Computational-Biology
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease; infectious-disease: (Infection-(MeSH)), infectious-disease,
  transmission-, diagnosis-, epidemiology-
MQ: Bayesian-method: mathematical-and-computer-techniques
MI: failure-probablitiy; country-entry-point; disease-importation
CC: 04500- (Mathematical-biology-and-statistical-methods)
12504- (Pathology
  -Diagnostic)
16006- (Respiratory-system-Pathology)
36001- (Medical-and
  -clinical-microbiology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510212109
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0277
  -6715&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0277
  -6715&isbn=&volume=24&issue=17&spage=2669&pages=2669
  -2679&date=2005&title=Statistics%20in%20Medicine&atitle=The%20probability%20of%2
  0failing%20in%20detecting%20an%20infectious%20disease%20at%20entry%20points%20in
  to%20a%20country&aulast=Dell%27Olmodarme&pid=%3Cauthor%3EDell%27Olmodarme%2c%20M
  %3bPrati%2c%20M%20C%3C%2Fauthor%3E%3CAN%3E200510212109%3C%2FAN%3E%3CDT%3EArticle
  %3C%2FDT%3E

Record 37 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Study designs in healthcare research
AU: Arabi,-Yaseen [Author,-Reprint-Author]
AD: Dept Intens Care, MC 1425,POB 22490,King Abdul Aziz Med City, Riyadh 11426,
  Saudi Arabia
EMA: arabi@ngha.med.sa
SO: Saudi-Medical-Journal. 2005; 26(8): 1175-1179
PY: 2005
DT: Literature-Review; Article
IS: 0379-5284
LA: English
MC: Pharmacology-; Infection-; Epidemiology-: Population-Studies; Pulmonary
  -Medicine: Human-Medicine, Medical-Sciences; Neurology-: Human-Medicine,
  Medical-Sciences; Ophthalmology-: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-; Influenza-virus (Orthomyxoviridae-):
  common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Orthomyxoviridae-: Microorganisms-, Negative-Sense-Single
  -Stranded-RNA-Viruses, Viruses-
CB: influenza-vaccine: antiinfective-drug, antiviral-drug, vaccine-, intranasal
  -administration; beclomethasone-: 4419-39-0, hormone-drug, inhalation
  -administration; budesonide-: 51333-22-3, hormone-drug, autonomic-drug,
  inhalation-administration
GE: Australia-: Australasian-region; Hong-Kong: Asia-, Palearctic-region;
  Framingham-: Massachusetts-, USA-, North-America, Nearctic-region
DS: hypertension-: (Hypertension-(MeSH)), vascular-disease; diabetes-: (Diabetes
  -Mellitus-(MeSH)), endocrine-disease/pancreas, metabolic-disease; cataract-:
  (Cataract-(MeSH)), eye-disease; cardiovascular-disease: (Cardiovascular
  -Diseases-(MeSH)), heart-disease, vascular-disease; severe-acute-respiratory
  -syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)), respiratory
  -system-disease, viral-disease, diagnosis-; influenza-: (Influenza-(MeSH)),
  respiratory-system-disease, viral-disease, drug-therapy; Bell's-palsy: nervous
  -system-disease
RN: 4419-39-0; 51333-22-3
MQ: dialysis-therapy: therapeutic-and-prophylactic-techniques, clinical
  -techniques
MI: WHO-
CC: 10067- (Biochemistry-studies-Sterols-and-steroids)
12504- (Pathology
  -Diagnostic)
12512- (Pathology-Therapy)
13020- (Metabolism-Metabolic
  -disorders)
14506- (Cardiovascular-system-Heart-pathology)
14508-
  (Cardiovascular-system-Blood-vessel-pathology)
16006- (Respiratory-system
  -Pathology)
17008- (Endocrine-Pancreas)
20006- (Sense-organs
  -Pathology)
20506- (Nervous-system-Pathology)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
22016- (Pharmacology
  -Endocrine)
22024- (Pharmacology-Neuropharmacology)
33502- (Virology-General
  -and-methods)
35500- (Allergy-)
36006- (Medical-and-clinical-microbiology
  -Virology)
37052- (Public-health-epidemiology-Communicable-diseases)
37054-
  (Public-health-epidemiology-Organic-diseases-and-neoplasms)
37056- (Public
  -health-epidemiology-Miscellaneous)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510212011
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0379
  -5284&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0379
  -5284&isbn=&volume=26&issue=8&spage=1175&pages=1175
  -1179&date=2005&title=Saudi%20Medical%20Journal&atitle=Study%20designs%20in%20he
  althcare%20research&aulast=Arabi&pid=%3Cauthor%3EArabi%2c%20Yaseen%3C%2Fauthor%3
  E%3CAN%3E200510212011%3C%2FAN%3E%3CDT%3ELiterature%20Review%3bArticle%3C%2FDT%3E

Record 38 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Disease contact tracing in random and clustered networks
AU: Kiss,-Istvan-Z [Author,-Reprint-Author]; Green,-Darren-M [Author]; Kao,
  -Rowland-R [Author]
AD: Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, UK
EMA: istvan.kiss@zoo.ox.ac.uk
SO: Proceedings-of-the-Royal-Society-Biological-Sciences-Series-B. 2005;
  272(1570): 1407-1414
PY: 2005
DT: Article
IS: 0962-8452
LA: English
AB: The efficacy of contact tracing, be it between individuals (e.g. sexually
  transmitted diseases or severe acute respiratory syndrome) or between groups of
  individuals (e.g. foot-and-mouth disease; FMD), is difficult to evaluate
  without precise knowledge of the underlying contact structure; i.e. who is
  connected to whom? Motivated by the 2001 FMD epidemic in the UK, we determine,
  using stochastic simulations and deterministic 'moment closure' models of
  disease transmission on networks of premises (nodes), network and disease
  properties that are important for contact tracing efficiency. For random
  networks with a high average number of connections per node, little clustering
  of connections and short latency periods, contact tracing is typically
  ineffective. In this case, isolation of infected nodes is the dominant factor
  in determining disease epidemic size and duration. If the latency period is
  longer and the average number of connections per node small, or if the network
  is spatially clustered, then the contact tracing performs better and an overall
  reduction in the proportion of nodes that are removed during an epidemic is
  observed.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies; Models-and-Simulations:
  Computational-Biology
GE: UK-: Europe-, Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, transmission-; sexually
  -transmitted-disease: (Sexually-Transmitted-Diseases-(MeSH)), infectious
  -disease, reproductive-system-disease, transmission-; foot-and-mouth-disease:
  (Foot-and-Mouth-Disease-(MeSH)), viral-disease, transmission-
MQ: stochastic-simulation: mathematical-and-computer-techniques; moment-closure
  -model: mathematical-and-computer-techniques; disease-contact-tracing: clinical
  -techniques
MI: epidemic-; disease-transmission; latency-period; random-network; clustered
  -network
CC: 04500- (Mathematical-biology-and-statistical-methods)
10515- (Biophysics
  -Biocybernetics)
16006- (Respiratory-system-Pathology)
16506- (Reproductive
  -system-Pathology)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
37052- (Public-health-epidemiology-Communicable-diseases)
37056-
  (Public-health-epidemiology-Miscellaneous)
AN: 200510211899
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0962
  -8452&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0962
  -8452&isbn=&volume=272&issue=1570&spage=1407&pages=1407
  -1414&date=2005&title=Proceedings%20of%20the%20Royal%20Society%20Biological%20Sc
  iences%20Series%20B&atitle=Disease%20contact%20tracing%20in%20random%20and%20clu
  stered%20networks&aulast=Kiss&pid=%3Cauthor%3EKiss%2c%20Istvan%20Z%3bGreen%2c%20
  Darren%20M%3bKao%2c%20Rowland%20R%3C%2Fauthor%3E%3CAN%3E200510211899%3C%2FAN%3E%
  3CDT%3EArticle%3C%2FDT%3E

Record 39 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Regulatory use of (Q)SARs in toxicological hazard assessment strategies
AU: Spielmann,-H [Author,-Reprint-Author]; Gerner,-I [Author]; Hoefer,-T
  [Author]; Liebsch,-M [Author]; Herzler,-M [Author]
AD: BfR Fed Inst Risk Assessment, ZEBET, Natl Ctr Documentat and Evaluat
  Alternat Methods An, D-12277 Berlin, Germany
SO: Naunyn-Schmiedeberg's-Archives-of-Pharmacology. 2005; 371(Suppl. 1): R134
PY: 2005
DT: Meeting-Abstract; Meeting
IS: 0028-1298
MT: 46th Spring Meeting of the Deutsche-Gesellschaft-fur-Experimentelle-und
  -Klinische-Pharmakologie-und-Toxikologie, Mainz, GERMANY; March 15 -17, 2005 
SP: Deutsche Gesellsch Experimentelle Klinische Pharmakolog Toxikolog
LA: English
MC: Toxicology-; Government-and-Law
GE: Germany-: Europe-, Palearctic-region
MQ: toxicological-hazard-assessment: laboratory-techniques
MI: Q(SAR)-; European-Commission-policy; Registration-Evaluation-and
  -Authorization-of-Chemicals-system
CC: 00508- (General-biology-Institutions-administration-and-legislation)
00520-
  (General-biology-Symposia-transactions-and-proceedings)
22501- (Toxicology
  -General-and-methods)
AN: 200510211074
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0028
  -1298&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0028
  -1298&isbn=&volume=371&issue=Suppl.%201&spage=&pages=R134&date=2005&title=Naunyn
  %20Schmiedeberg%27s%20Archives%20of%20Pharmacology&atitle=Regulatory%20use%20of%
  20%28Q%29SARs%20in%20toxicological%20hazard%20assessment%20strategies&aulast=Spi
  elmann&pid=%3Cauthor%3ESpielmann%2c%20H%3bGerner%2c%20I%3bHoefer%2c%20T%3bLiebsc
  h%2c%20M%3bHerzler%2c%20M%3C%2Fauthor%3E%3CAN%3E200510211074%3C%2FAN%3E%3CDT%3EM
  eeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 40 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: The severe acute respiratory syndrome coronavirus 3a protein up-regulates
  expression of fibrinogen in lung epithelial cells
AU: Tan,-Yee-Joo [Author,-Reprint-Author]; Tham,-Puay-Yoke [Author]; Chan,
  -Daphne-Z-L [Author]; Chou,-Chih-Fong [Author]; Shen,-Shuo [Author]; Fielding,
  -Burtram-C [Author]; Tan,-Timothy-H-P [Author]; Lim,-Seng-Gee [Author]; Hong,
  -Wanjin [Author]
AD: Natl Univ Singapore, Inst Mol and Cell Biol, 61 Biopolis Dr, Singapore
  138673, Singapore
EMA: mcbtanyj@imcb.a-star.edu.sg
SO: Journal-of-Virology. 2005; 79(15): 10083-10087
PY: 2005
DT: Article
IS: 0022-538X
LA: English
AB: Here we analyzed the gene expression profile of cells that stably express
  the severe acute respiratory syndrome coronavirus (SARS-CoV) 3a protein to
  determine its effects on host functions. A lung epithelial cell-line, A549, was
  chosen for this study because the lung is the primary organ infected by SARS
  -CoV and fatalities resulted mainly from pulmonary complications. Our results
  showed that the expression of 3a up-regulates the mRNA levels of all three
  subunits, A alpha, B beta, and gamma, of fibrinogen. Consequently, the
  intracellular levels as well as the secretion of fibrinogen were increased. We
  also observed increased fibrinogen levels in SARS-CoV-infected Vero E6 cells.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics; Cell
  -Biology; Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-; Severe-acute-respiratory
  -syndrome-coronavirus (Coronaviridae-): common-, SARS-CoV, common-; A549-cell
  -line (Hominidae-): cell_line-, lung-epithelial-cells
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: lung-: respiratory-system; lung-epithelial-cell
CB: mRNA-: messenger-RNA; fibrinogen-: expression-; 3a-protein; fibrinogen-A
  -alpha; fibrinogen-B-beta; fibrinogen-gamma
DS: severe-acute-respiratory-syndrome-coronavirus-infection: SARS-CoV,
  respiratory-system-disease, viral-disease
MQ: gene-expression-profile: genetic-techniques
MI: host-functions; sequence-data: nucleotide-sequences, genbank-database
CC: 02502- (Cytology-General)
02506- (Cytology-Animal)
02508- (Cytology
  -Human)
03502- (Genetics-General)
03506- (Genetics-Animal)
03508- (Genetics
  -Human)
10062- (Biochemistry-studies-Nucleic-acids-purines-and
  -pyrimidines)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
31500- (Genetics-of-bacteria-and
  -viruses)
33502- (Virology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510208416
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -538X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -538X&isbn=&volume=79&issue=15&spage=10083&pages=10083
  -10087&date=2005&title=Journal%20of%20Virology&atitle=The%20severe%20acute%20res
  piratory%20syndrome%20coronavirus%203a%20protein%20up
  -regulates%20expression%20of%20fibrinogen%20in%20lung%20epithelial%20cells&aulas
  t=Tan&pid=%3Cauthor%3ETan%2c%20Yee%20Joo%3bTham%2c%20Puay%20Yoke%3bChan%2c%20Dap
  hne%20Z%20L%3bChou%2c%20Chih%20Fong%3bShen%2c%20Shuo%3bFielding%2c%20Burtram%20C
  %3bTan%2c%20Timothy%20H%20P%3bLim%2c%20Seng%20Gee%3bHong%2c%20Wanjin%3C%2Fauthor
  %3E%3CAN%3E200510208416%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 41 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Inhibition, escape, and attenuated growth of severe acute respiratory
  syndrome coronavirus treated with antisense morpholino oligomers
AU: Neuman,-Benjamin-W [Author,-Reprint-Author]; Stein,-David-A [Author];
  Kroeker,-Andrew-D [Author]; Churchill,-Michael-J [Author]; Kim,-Alice-M
  [Author]; Kuhn,-Peter [Author]; Dawson,-Philip [Author]; Moulton,-Hong-M
  [Author]; Bestwick,-Richard-K [Author]; Iversen,-Patrick-L [Author]; Buchmeier,
  -Michael-J [Author]
AD: Scripps Res Inst, Div Virol, Dept Neuropharmacol, 10550 N Torrey Pines Rd,
  La Jolla, CA 92037 USA
EMA: bneuman@scripps.edu
SO: Journal-of-Virology. 2005; 79(15): 9665-9676
PY: 2005
DT: Article
IS: 0022-538X
LA: English
AB: The recently emerged severe acute respiratory syndrome coronavirus (SARS
  -CoV) is a potent pathogen of humans and is capable of rapid global spread.
  Peptide-conjugated antisense morpholino oligomers (P-PMO) were designed to bind
  by base pairing to specific sequences in the SARS-CoV (Tor2 strain) genome. The
  P-PMO were tested for their capacity to inhibit production of infectious virus
  as well as to probe the function of conserved viral RNA motifs and secondary
  structures. Several virus-targeted P-PMO and a random-sequence control P-PMO
  showed low inhibitory activity against SARS coronavirus. Certain other virus
  -targeted P-PMO reduced virus-induced cytopathology and cell-to-cell spread as
  a consequence of decreasing viral amplification. Active P-PMO were effective
  when administered at any time prior to peak viral synthesis and exerted
  sustained antiviral effects while present in culture medium. P-PMO showed low
  nonspecific inhibitory activity against translation of nontargeted RNA or
  growth of the arenavirus lymphocytic choriomeningitis virus. Two P-PMO
  targeting the viral transcription-regulatory sequence (TRS) region in the 5'
  untranslated region were the most effective inhibitors tested. After several
  viral passages in the presence of a TRS-targeted P-PMO, partially drug
  -resistant SARS-CoV mutants arose which contained three contiguous base point
  mutations at the binding site of a TRS-targeted P-PMO. Those partially
  resistant viruses grew more slowly and formed smaller plaques than wild-type
  SARS-CoV. These results suggest PMO compounds have powerful therapeutic and
  investigative potential toward coronavirus infection.
AI: Y
MC: Pharmacology-; Infection-; Molecular-Genetics: Biochemistry-and-Molecular
  -Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -, strain-Tor2; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: RNA-; Peptide-conjugated-antisense-morpholino-oligomers: P-PMO,
  antiinfective-drug, antiviral-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy
CC: 03502- (Genetics-General)
03508- (Genetics-Human)
10062- (Biochemistry
  -studies-Nucleic-acids-purines-and-pyrimidines)
12512- (Pathology
  -Therapy)
16006- (Respiratory-system-Pathology)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
31500- (Genetics-of
  -bacteria-and-viruses)
33502- (Virology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510208373
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -538X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -538X&isbn=&volume=79&issue=15&spage=9665&pages=9665
  -9676&date=2005&title=Journal%20of%20Virology&atitle=Inhibition%2c%20escape%2c%2
  0and%20attenuated%20growth%20of%20severe%20acute%20respiratory%20syndrome%20coro
  navirus%20treated%20with%20antisense%20morpholino%20oligomers&aulast=Neuman&pid=
  %3Cauthor%3ENeuman%2c%20Benjamin%20W%3bStein%2c%20David%20A%3bKroeker%2c%20Andre
  w%20D%3bChurchill%2c%20Michael%20J%3bKim%2c%20Alice%20M%3bKuhn%2c%20Peter%3bDaws
  on%2c%20Philip%3bMoulton%2c%20Hong%20M%3bBestwick%2c%20Richard%20K%3bIversen%2c%
  20Patrick%20L%3bBuchmeier%2c%20Michael%20J%3C%2Fauthor%3E%3CAN%3E200510208373%3C
  %2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 42 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Apical entry and release of severe acute respiratory syndrome-associated
  coronavirus in polarized Calu-3 lung epithelial cells
AU: Tseng,-Chien-Te-K [Author,-Reprint-Author]; Tseng,-Jennifer [Author];
  Perrone,-Lucy [Author]; Worthy,-Melissa [Author]; Popov,-Vsevolod [Author];
  Peters,-Clarence-J [Author]
AD: Univ Texas, Med Branch, Dept Microbiol and Immunol, 301 Univ Blvd,G-150,
  Galveston, TX 77555 USA
EMA: sktseng@utmb.edu
SO: Journal-of-Virology. 2005; 79(15): 9470-9479
PY: 2005
DT: Article
IS: 0022-538X
LA: English
AB: Severe acute respiratory syndrome (SARS), caused by a novel coronavirus
  (CoV) known as SARS-CoV, is a contagious and life-threatening respiratory
  illness with pneumocytes as its main target. A full understanding of how SARS
  -CoV would interact with lung epithelial cells will be vital for advancing our
  knowledge of SARS pathogenesis. However, an in vitro model of SARS-CoV
  infection using relevant lung epithelial cells is not yet available, making it
  difficult to dissect the pathogenesis of SARS-CoV in the lungs. Here, we report
  that SARS-CoV can productively infect human bronchial epithelial Calu-3 cells,
  causing cytopathic effects, a process reflective of its natural course of
  infection in the lungs. Indirect immunofluorescence studies revealed a
  preferential expression of angiotensin-converting enzyme 2 (ACE-2), the
  functional receptor of SARS-CoV, on the apical surface. Importantly, both ACE-2
  and viral antigen appeared to preferentially colocalize at the apical domain of
  infected cells. In highly polarized Calu-3 cells grown on the membrane inserts,
  we found that cells exposed to virus through the apical rather than the
  basolateral surface showed high levels of viral replication. Progeny virus was
  released into the apical chamber at titers up to 5 logs higher than those
  recovered from the basolateral chambers of polarized cultures. Taken together,
  these results indicate that SARS-CoV almost exclusively entered and was
  released from the apical domain of polarized Calu-3 cells, which might provide
  important insight into the mechanism of transmission and pathogenesis of SARS
  -CoV.
AI: Y
MC: Infection-; Respiratory-System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Coronavirus- (Coronaviridae-): genus-; Calu-3-cell-line (Hominidae-):
  cell_line-, human-lung-epithelial-cells
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: lungs-: respiratory-system
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; Severe-acute-respiratory
  -syndrome-coronavirus: SARS-CoV, respiratory-system-disease, viral-disease
CC: 02508- (Cytology-Human)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
33502- (Virology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510208355
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -538X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -538X&isbn=&volume=79&issue=15&spage=9470&pages=9470
  -9479&date=2005&title=Journal%20of%20Virology&atitle=Apical%20entry%20and%20rele
  ase%20of%20severe%20acute%20respiratory%20syndrome
  -associated%20coronavirus%20in%20polarized%20Calu
  -3%20lung%20epithelial%20cells&aulast=Tseng&pid=%3Cauthor%3ETseng%2c%20Chien%20T
  e%20K%3bTseng%2c%20Jennifer%3bPerrone%2c%20Lucy%3bWorthy%2c%20Melissa%3bPopov%2c
  %20Vsevolod%3bPeters%2c%20Clarence%20J%3C%2Fauthor%3E%3CAN%3E200510208355%3C%2FA
  N%3E%3CDT%3EArticle%3C%2FDT%3E

Record 43 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Screening and identification of linear B-cell epitopes and entry-blocking
  peptide of severe acute respiratory syndrome (SARS)-associated coronavirus
  using synthetic overlapping peptide library
AU: Hu,-Hongbo [Author]; Li,-Li [Author]; Kao,-Richard-Y [Author]; Kou,-Binbin
  [Author]; Wang,-Zhanguo [Author]; Zhang,-Liang [Author]; Zhang,-Huiyuan
  [Author]; Hao,-Zhiyong [Author]; Tsui,-Wayne-H [Author]; Ni,-Anping [Author];
  Cui,-Lianxian [Author]; Fan,-Baoxing [Author]; Guo,-Feng [Author]; Rao,-Shuan
  [Author]; Jiang,-Chengyu [Author]; Li,-Qian [Author]; Sun,-Manji [Author]; He,
  -Wei [Author,-Reprint-Author]; Liu,-Gang [Author]
AD: Chinese Acad Med Sci, Inst Mat Med, 1 Xian Nong Tan St, Beijing 100050,
  Peoples R China
EMA: hewei@pumc.edu.cn; gangliu27@yahoo.com
SO: Journal-of-Combinatorial-Chemistry. 2005; 7(5): 648-656
PY: 2005
DT: Article
IS: 1520-4766
LA: English
AB: A 10-mer overlapping peptide library has been synthesized for screening and
  identification of linear B-cell epitopes of severe acute respiratory syndrome
  associated coronavirus (SARS-CoV), which spanned the major structural proteins
  of SARS-CoV. One hundred and eleven candidate peptides were positive according
  to the result of PEPscan, which were assembled into 22 longer peptides. Five of
  these peptides showed high cross-immunoreactivities (similar to 66.7 to 90.5%)
  to SARS convalescent patients' sera from the severest epidemic regions of the
  China mainland. Most interestingly, S471-503, a peptide located at the receptor
  binding domain (RBD) of SARS-CoV, could specifically block the binding between
  the RBD and angiotensin-converting enzyme 2, resulting in the inhibition of
  SARS-CoV entrance into host cells in vitro. The study demonstrated that S471
  -503 peptide was a potential immunoantigen for the development of peptide-based
  vaccine or a candidate for further drug, evaluation against the SARS-CoV virus
  -cell fusion.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies; Methods-and-Techniques;
  Clinical-Immunology: Human-Medicine, Medical-Sciences; Pulmonary-Medicine:
  Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: serum-: blood-and-lymphatics; B-cell: immune-system, blood-and-lymphatics
CB: epitope-; angiotensin-converting-enzyme-2; receptor-binding-domain; entry
  -blocking-peptide
GE: China-: Asia-, Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-
MQ: PEPscan-: clinical-techniques, diagnostic-techniques
MI: synthetic-overlapping-peptide-library
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
15002- (Blood-Blood-and
  -lymph-studies)
15004- (Blood-Blood-cell-studies)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
34508- (Immunology-Immunopathology-tissue-immunology)
36006-
  (Medical-and-clinical-microbiology-Virology)
37052- (Public-health
  -epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510206497
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1520
  -4766&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1520
  -4766&isbn=&volume=7&issue=5&spage=648&pages=648
  -656&date=2005&title=Journal%20of%20Combinatorial%20Chemistry&atitle=Screening%2
  0and%20identification%20of%20linear%20B-cell%20epitopes%20and%20entry
  -blocking%20peptide%20of%20severe%20acute%20respiratory%20syndrome%20%28SARS%29
  -associated%20coronavirus%20using%20synthetic%20overlapping%20peptide%20library&
  aulast=Hu&pid=%3Cauthor%3EHu%2c%20Hongbo%3bLi%2c%20Li%3bKao%2c%20Richard%20Y%3bK
  ou%2c%20Binbin%3bWang%2c%20Zhanguo%3bZhang%2c%20Liang%3bZhang%2c%20Huiyuan%3bHao
  %2c%20Zhiyong%3bTsui%2c%20Wayne%20H%3bNi%2c%20Anping%3bCui%2c%20Lianxian%3bFan%2
  c%20Baoxing%3bGuo%2c%20Feng%3bRao%2c%20Shuan%3bJiang%2c%20Chengyu%3bLi%2c%20Qian
  %3bSun%2c%20Manji%3bHe%2c%20Wei%3bLiu%2c%20Gang%3C%2Fauthor%3E%3CAN%3E2005102064
  97%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 44 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Primates and the ecology of their infectious diseases: How will
  anthropogenic change affect host-parasite interactions?
AU: Chapman,-Colin-A [Author,-Reprint-Author]; Gillespie,-Thomas-R [Author];
  Goldberg,-Tony-L [Author]
AD: McGill Univ, Dept Anthropol, 855 Sherbrooke St W, Montreal, PQ H3A 2T7,
  Canada
EMA: Colin.Chapman@McGill.ca
SO: Evolutionary-Anthropology. 2005; 14(4): 134-144
PY: 2005
DT: Article
IS: 1060-1538
LA: English
AB: The sudden appearance of diseases like SARS (severe acute respiratory
  syndrome(1)), the devastating impacts of diseases like Ebola on both human and
  wildlife communities,(2,3) and the immense social and economic costs created by
  viruses like HIV4 underscore our need to understand the ecology of infectious
  diseases. Given that monkeys and apes often share parasites with humans,
  understanding the ecology of infectious diseases in nonhuman primates is of
  paramount importance. This is well illustrated by the HIV viruses, the
  causative agents of human AIDS, which evolved recently from related viruses of
  chimpanzees (Pan troglodytes) and sooty mangabeys (Cercocebus atys(5)), as well
  as by the outbreaks of Ebola virus, which trace their origins to zoonotic
  transmissions from local apes.(6) A consideration of how environmental change
  may promote contact between humans and nonhuman primates and thus increase the
  possibility of sharing infectious diseases detrimental to humans or nonhuman
  primates is now paramount in conservation and human health planning.
AI: Y
MC: Infection-; Parasitology-; Human-Medicine: Medical-Sciences; Wildlife
  -Management: Conservation-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[86235-] Pongidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[86190-] Primates-, -Mammalia, Vertebrata-, Chordata-, Animalia-
OR: Cercocebus-atys (Cercopithecidae-): species-, sooty-mangabey, common-; human
  - (Hominidae-): common-; ape- (Pongidae-): common-; Pan-troglodytes (Pongidae
  -): species-, chimpanzee-, common-; nonhuman-primate (Primates-): common-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Hominidae-: Animals-,
  Chordates-, Humans-, Mammals-, Primates-, Vertebrates-; Pongidae-: Animals-,
  Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman-Vertebrates, Nonhuman
  -Primates, Primates-, Vertebrates-; Primates-: Animals-, Chordates-, Mammals-,
  Nonhuman-Mammals, Nonhuman-Vertebrates, Nonhuman-Primates, Primates-,
  Vertebrates-
DS: HIV-infection: human-immunodeficiency-virus-infection, blood-and-lymphatic
  -disease, immune-system-disease, viral-disease, transmission-; severe-acute
  -respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)),
  respiratory-system-disease, viral-disease, transmission-; AIDS-: acquired
  -immunodeficiency-syndrome, viral-disease, immune-system-disease, transmission
  -; Ebola-virus-disease: viral-disease, transmission-; parasitic-disease:
  (Parasitic-Diseases-(MeSH)), parasitic-disease, transmission-
MI: host-parasite-interaction; anthropogenic-change; zoonotic-transmission;
  human-health-planning; disease-resevoir
CC: 00512- (General-biology-Conservation-and-resource-management)
07502-
  (Ecology-environmental-biology-General-and-methods)
07518- (Ecology
  -environmental-biology-Wildlife-management-terrestrial)
12502- (Pathology
  -General)
15006- (Blood-Blood-lymphatic-and-reticuloendothelial
  -pathologies)
16006- (Respiratory-system-Pathology)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36006- (Medical-and-clinical-microbiology
  -Virology)
60502- (Parasitology-General)
60504- (Parasitology-Medical)
AN: 200510205122
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1060
  -1538&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1060
  -1538&isbn=&volume=14&issue=4&spage=134&pages=134
  -144&date=2005&title=Evolutionary%20Anthropology&atitle=Primates%20and%20the%20e
  cology%20of%20their%20infectious%20diseases%3a%20How%20will%20anthropogenic%20ch
  ange%20affect%20host
  -parasite%20interactions%3f&aulast=Chapman&pid=%3Cauthor%3EChapman%2c%20Colin%20
  A%3bGillespie%2c%20Thomas%20R%3bGoldberg%2c%20Tony%20L%3C%2Fauthor%3E%3CAN%3E200
  510205122%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 45 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: A prediction rule for clinical diagnosis of severe acute respiratory syndrome
AU: Ho,-P-L [Author]; Chau,-P-H [Author]; Yip,-P-S-F [Author]; Ooi,-G-C
  [Author]; Khong,-P-L [Author]; Wong,-P-C [Author]; Ko,-C [Author]; Yan,-C
  [Author]; Ho,-J-C [Author]; Tsang,-K-W [Author,-Reprint-Author]
AD: Univ Hong Kong, Univ Dept Med, Div Resp and Crit Care Med, Queen Mary Hosp,
  Pokfulam, Hong Kong, Peoples R China
EMA: kwttsang@hku.hk
SO: European-Respiratory-Journal. 2005; 26(3): 474-479
PY: 2005
DT: Article
IS: 0903-1936
LA: English
AB: A prospective study was undertaken to identify clinical, radiographical,
  haematological and biochemical profiles of severe acute respiratory syndrome
  (SARS) patients.A prediction rule, which demarcates low from high risk patients
  for SARS in an outbreak situation was developed. A total of 295 patients with
  unexplained respiratory illnesses, admitted to Queen Mary Hospital, Hong Kong
  SAR, China, in March to July 2003, were evaluated for clinical, radiological,
  haematological and alanine transaminase (ALT) data daily for 3 days after
  hospitalisation.In total, 44 cases were subsequently confirmed to have SARS by
  RT-PCR (68.2%) and serology (100%). The scoring system of attributing 11, 10,
  3, 3 and 3 points to the presence of independent risk factors, namely:
  epidemiological link, radiographical deterioration, myalgia, lymphopenia and
  elevated ALT respectively, generated high and low-risk (total score 11-30 and 0
  -10, respectively) groups for SARS. The sensitivity and specificity of this
  prediction rule in positively identifying a SARS patient were 97.7 and 81.3%,
  respectively. The positive and negative predictive values were 47.8 and 99.5%,
  respectively.The prediction rule appears to be helpful in assessing suspected
  patients with severe acute respiratory syndrome at the bedside, and should be
  further validated in other severe acute respiratory syndrome cohorts.
AI: Y
MC: Infection-; Clinical-Chemistry: Allied-Medical-Sciences; Radiology-: Medical
  -Sciences; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, adult-, middle-age,
  host-, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: alanine-transaminase: 9000-86-6, EC-2.6.1.2
DS: lymphopenia-: (Lymphopenia-(MeSH)), blood-and-lymphatic-disease, immune
  -system-disease; myalgia-: muscle-disease; severe-acute-respiratory-syndrome:
  SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)), respiratory-system-disease,
  viral-disease, diagnosis-
RN: 9000-86-6
MQ: radiologic-imaging: laboratory-techniques, diagnostic-techniques, clinical
  -techniques, imaging-and-microscopy-techniques
CC: 06504- (Radiation-biology-Radiation-and-isotope-techniques)
10006-
  (Clinical-biochemistry-General-methods-and-applications)
12504- (Pathology
  -Diagnostic)
15006- (Blood-Blood-lymphatic-and-reticuloendothelial
  -pathologies)
16006- (Respiratory-system-Pathology)
17506- (Muscle
  -Pathology)
33502- (Virology-General-and-methods)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510205113
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0903
  -1936&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0903
  -1936&isbn=&volume=26&issue=3&spage=474&pages=474
  -479&date=2005&title=European%20Respiratory%20Journal&atitle=A%20prediction%20ru
  le%20for%20clinical%20diagnosis%20of%20severe%20acute%20respiratory%20syndrome&a
  ulast=Ho&pid=%3Cauthor%3EHo%2c%20P%20L%3bChau%2c%20P%20H%3bYip%2c%20P%20S%20F%3b
  Ooi%2c%20G%20C%3bKhong%2c%20P%20L%3bWong%2c%20P%20C%3bKo%2c%20C%3bYan%2c%20C%3bH
  o%2c%20J%20C%3bTsang%2c%20K%20W%3C%2Fauthor%3E%3CAN%3E200510205113%3C%2FAN%3E%3C
  DT%3EArticle%3C%2FDT%3E

Record 46 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus
  spike protein domain 2 cross-reacts with lung epithelial cells and causes
  cytotoxicity
AU: Lin,-Y-S [Author]; Lin,-C-F [Author]; Fang,-Y-T [Author]; Kuo,-Y-M [Author];
  Liao,-P-C [Author]; Yeh,-T-M [Author]; Hwa,-K-Y [Author]; Shieh,-C-C-K
  [Author]; Yen,-J-H [Author]; Wang,-H-J [Author]; Su,-I-J [Author]; Lei,-H-Y
  [Author,-Reprint-Author]
AD: Natl Cheng Kung Univ, Coll Med, Dept Microbiol and Immunol, 1 Univ Rd,
  Tainan 701, Taiwan
EMA: hylei@mail.ncku.edu.tw
SO: Clinical-and-Experimental-Immunology. 2005; 141(3): 500-508
PY: 2005
DT: Article
IS: 0009-9104
LA: English
AB: Both viral effect and immune-mediated mechanism are involved in the
  pathogenesis of severe acute respiratory syndrome-associated coronavirus (SARS
  -CoV) infection. In this study, we showed that in SARS patient sera there were
  autoantibodies (autoAbs) that reacted with A549 cells, the type-2 pneumocytes,
  and that these autoAbs were mainly IgG. The autoAbs were detectable 20 days
  after fever onset. Tests of non-SARS-pneumonia patients did not show the same
  autoAb production as in SARS patients. After sera IgG bound to A549 cells,
  cytotoxicity was induced. Cell cytotoxicity and the anti-epithelial cell IgG
  level were positively correlated. Preabsorption and binding assays indicated
  the existence of cross-reactive epitopes on SARS-CoV spike protein domain 2
  (S2). Furthermore, treatment of A549 cells with anti-S2 Abs and IFN-gamma
  resulted in an increase in the adherence of human peripheral blood mononuclear
  cells to these epithelial cells. Taken together, we have demonstrated that the
  anti-S2 Abs in SARS patient sera cause cytotoxic injury as well as enhance
  immune cell adhesion to epithelial cells. The onset of autoimmune responses in
  SARS-CoV infection may be implicated in SARS pathogenesis.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Toxicology-; Infection-; Respiratory
  -System: Respiration-
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: Hep3B-cell-line (Hominidae-): cell_line-, human-hepatoma-cells; A549-cell
  -line (Hominidae-): cell_line-, human-lung-adenocarcinoma-cells; MRC5-cell-line
  (Hominidae-): cell_line-, human-lung-fibroblast-cells
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: peripheral-blood-mononuclear-cell: immune-system, blood-and-lymphatics; lung
  -epithelial-cell: respiratory-system
CB: autoantibodies-; IgG-: immunoglobulin-G; IFN-gamma: interferon-gamma; spike
  -protein: toxin-, cytotoxin-, domain-2
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10060- (Biochemistry
  -studies-General)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
17002- (Endocrine-General)
22501- (Toxicology
  -General-and-methods)
34502- (Immunology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
AN: 200510204317
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0009
  -9104&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0009
  -9104&isbn=&volume=141&issue=3&spage=500&pages=500
  -508&date=2005&title=Clinical%20and%20Experimental%20Immunology&atitle=Antibody%
  20to%20severe%20acute%20respiratory%20syndrome%20%28SARS%29
  -associated%20coronavirus%20spike%20protein%20domain%202%20cross
  -reacts%20with%20lung%20epithelial%20cells%20and%20causes%20cytotoxicity&aulast=
  Lin&pid=%3Cauthor%3ELin%2c%20Y%20S%3bLin%2c%20C%20F%3bFang%2c%20Y%20T%3bKuo%2c%2
  0Y%20M%3bLiao%2c%20P%20C%3bYeh%2c%20T%20M%3bHwa%2c%20K%20Y%3bShieh%2c%20C%20C%20
  K%3bYen%2c%20J%20H%3bWang%2c%20H%20J%3bSu%2c%20I%20J%3bLei%2c%20H%20Y%3C%2Fautho
  r%3E%3CAN%3E200510204317%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 47 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: 1-year pulmonary function and health status in survivors of severe acute
  respiratory syndrome
AU: Ong,-Kian-Chung [Author,-Reprint-Author]; Wei-Keong,-Alan [Author]; Lee,
  -Lawrence-Soon-U [Author]; Kaw,-Gregony [Author]; Kwek,-Seow-Khee [Author];
  Leow,-Melvin-Khee-Shing [Author]; Earnest,-Arul [Author]
AD: Mt Elizabeth Med Ctr, KCOng Chest and Med Clin, 3 Mt Elizabeth 12-03,
  Singapore 228510, Singapore
EMA: ongkianchung@yahoo.com.sg
SO: Chest-. 2005; 128(3): 1393-1400
PY: 2005
DT: Article
IS: 0012-3692
LA: English
AB: Study objectives: To characterize the long-term pulmonary, function and
  health status in a prospectively identified cohort of patients who survived the
  severe acute respiratory syndrome (SARS).Design: Prospective follow-up cohort
  study.Setting: University-affiliated hospital.Patients: Ninety-four patients
  who recovered from SARS were assessed at a uniform time point of I year after
  hospital discharge.Measurements: The study, included the measurement of static
  and dynamic lung volumes, the determination of the diffusing capacity, of the
  lung for carbon monoxide (DLCO), and a health status evaluation using the St.
  George Respiratory, Questionnaire (SGRQ).Results: Eleven patients (12%) had
  mild impairment of FVC, 20 (21%) had mild impairment of FEV1, 5 (5%) had mild
  impairment of the FEV1/FVC ratio, and 17 (18%) had mild impairment of the DLCO.
  There was one patient (1%) who had moderate impairment of FVC, one patient (1%)
  who had moderate impairment of the FEV1/FVC ratio, and three patients (3%) who
  had moderate impairment of the DLCO. No pulmonary, function abnormalities were
  detected in 59 patients (63%). Mean scores were significantly higher (ie,
  worse) than the population norms in the activity (p < 0.001), impacts (p <
  0.001), and total (p < 0.001) domains of the SGRQ.Conclusions: One year after
  recovery, from SARS, persistent pulmonary, function impairment was found in
  about one third of patients. The health status of SARS survivors was also
  significantly worse compared with the healthy, population. The main
  determinants of morbidity, in recovered SARS patients need to be further
  defined.
AI: Y
MC: Infection-; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, adult-, middle-age, host-, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: lung-: respiratory-system
CB: carbon-monoxide: 630-08-0
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
RN: 630-08-0
MQ: St.George-Respiratory-Questionnaire: clinical-techniques, diagnostic
  -techniques
MI: health-status; pulmonary-, function-
CC: 10060- (Biochemistry-studies-General)
16004- (Respiratory-system-Physiology
  -and-biochemistry)
16006- (Respiratory-system-Pathology)
33502- (Virology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510204161
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0012
  -3692&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0012
  -3692&isbn=&volume=128&issue=3&spage=1393&pages=1393
  -1400&date=2005&title=Chest%20&atitle=1
  -year%20pulmonary%20function%20and%20health%20status%20in%20survivors%20of%20sev
  ere%20acute%20respiratory%20syndrome&aulast=Ong&pid=%3Cauthor%3EOng%2c%20Kian%20
  Chung%3bWei%20Keong%2c%20Alan%3bLee%2c%20Lawrence%20Soon%20U%3bKaw%2c%20Gregony%
  3bKwek%2c%20Seow%20Khee%3bLeow%2c%20Melvin%20Khee%20Shing%3bEarnest%2c%20Arul%3C
  %2Fauthor%3E%3CAN%3E200510204161%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 48 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Susceptibility of human and rat neural cell lines to infection by SARS
  -coronavirus
AU: Yamashita,-Makiko [Author]; Yamate,-Masanobu [Author]; Li,-Gui-Mei [Author];
  Ikuta,-Kazuyoshi [Author,-Reprint-Author]
AD: Osaka Univ, Dept Virol, Microbial Dis Res Inst, 2-2 Yamadaoka, Suita, Osaka
  5650871, Japan
EMA: ikuta@biken.osaka-u.ac.jp
SO: Biochemical-and-Biophysical-Research-Communications. 2005; 334(1): 79-85
PY: 2005
DT: Article
IS: 0006-291X
LA: English
AB: Pathological characterization of autopsied tissues from patients with SARS
  revealed severe damage in restricted tissues, such as lung, with no apparent
  cell damage in other tissues, such as intestine and brain. Here, we examined
  the susceptibility of neural cell lines of human (OL) and rat (C6) origins to
  SARS-associated coronavirus. Both of the neural cell lines showed no apparent
  cytopathic effects (CPE) by infection but produced virus with infectivity of
  10(2-5) per ml, in sharp contrast to the production by infected Vero E6 cells
  of > 10(9) per ml that showed a lytic infection with characteristic rounding
  CPE. Interestingly, the infection of intestinal cell line CaCo-2 also induced
  no apparent CPE, with production of the virus at a slightly lower level as that
  of the Vero E6 cell culture. Notably, the cellular receptor for the virus,
  angiotensin-converting enzyme 2 was expressed at similar levels on Vero E6 and
  CaCo-2 cells, but at undetectable levels on OL and C6 cells. (c) 2005 Elsevier
  Inc. All rights reserved.
AI: Y
MC: Nervous-System: Neural-Coordination; Infection-; Enzymology-: Biochemistry
  -and-Molecular-Biophysics; Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-; Severe-Acute-Respiratory
  -Syndrome-virus (Coronaviridae-): common-, SARS-virus, common-, pathogen-; OL
  -cell-line (Hominidae-): cell_line-, human-oligodendroglioma-derived-cell; CaCo
  -2-cell-line (Hominidae-): cell_line-, human-intestine-derived-cell; C6-cell
  -line (Muridae-): cell_line-, rat-glioma-derived-cell
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-;
  Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-
PS: intestine-: digestive-system; brain-: nervous-system; neural-cell: nervous
  -system
CB: angiotensin-converting-enzyme-2: expression-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, etiology-
MQ: autopsy-: clinical-techniques, diagnostic-techniques
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10802- (Enzymes-General
  -and-comparative-studies-coenzymes)
14004- (Digestive-system-Physiology-and
  -biochemistry)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
20504- (Nervous-system-Physiology-and
  -biochemistry)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510203438
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0006
  -291X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0006
  -291X&isbn=&volume=334&issue=1&spage=79&pages=79
  -85&date=2005&title=Biochemical%20and%20Biophysical%20Research%20Communications&
  atitle=Susceptibility%20of%20human%20and%20rat%20neural%20cell%20lines%20to%20in
  fection%20by%20SARS
  -coronavirus&aulast=Yamashita&pid=%3Cauthor%3EYamashita%2c%20Makiko%3bYamate%2c%
  20Masanobu%3bLi%2c%20Gui%20Mei%3bIkuta%2c%20Kazuyoshi%3C%2Fauthor%3E%3CAN%3E2005
  10203438%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 49 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid
  peptide
AU: Blicher,-Thomas [Author]; Sandholm-Kastrup,-Jette [Author]; Buus,-Soren
  [Author]; Gajhede,-Michael [Author,-Reprint-Author]
AD: Danish Univ Pharmaceut Sci, Dept Med Chem, Univ Pk 2, DK-2100 Copenhagen,
  Denmark
EMA: mig@dfuni.dk
SO: Acta-Crystallographica-Section-D-Biological-Crystallography. 2005; 61(Part
  8): 1031-1040
PY: 2005
DT: Article
IS: 0907-4449
LA: English
AB: The structure of the human MHC-I molecule HLA-A* 1101 in complex with a
  nonameric peptide (KTFPPTEPK) has been determined by X-ray crystallography to
  1.45 angstrom resolution. The peptide is derived from the SARS-CoV nucleocapsid
  protein positions 362 - 370 (SNP362-370). It is conserved in all known isolates
  of SARS-CoV and has been verified by in vitro peptide-binding studies to be a
  good to intermediate binder to HLA-A* 0301 and HLA-A* 1101, with IC50 values of
  70 and 186 nM, respectively [Sylvester-Hvid et al. (2004), Tissue Antigens, 63,
  395 - 400]. In terms of the residues lining the peptide-binding groove, the HLA
  -A* 1101 - SNP362 - 370 complex is very similar to other known structures of
  HLA-A*1101 and HLA-A* 6801. The SNP362-370 peptide is held in place by 17
  hydrogen bonds to the alpha-chain residues and by nine water molecules which
  are also tightly bound in the peptide-binding groove. Thr6 of the peptide
  (Thr6p) does not make efficient use of the middle ( E) pocket. For vaccine
  development, there seems to be a potential for optimization targeted at this
  position. All residues except Thr2p and Lys9p are accessible for T-cell
  recognition.
AI: Y
MC: Molecular-Genetics: Biochemistry-and-Molecular-Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): species-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: T-cell: immune-system, blood-and-lymphatics
CB: hydrogen-: 1333-74-0; nucleocapsid-; alpha-chain; MHC-I
GN: human-HLA-A-gene [Hominidae-]: A-1101-allele, A-6801, A-0301-allele
RN: 1333-74-0
MQ: X-ray-crystallography: laboratory-techniques, crystallographic-techniques
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
03502- (Genetics
  -General)
03508- (Genetics-Human)
10060- (Biochemistry-studies
  -General)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
31500- (Genetics-of-bacteria-and-viruses)
33502- (Virology-General
  -and-methods)
34502- (Immunology-General-and-methods)
AN: 200510202702
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0907
  -4449&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0907
  -4449&isbn=&volume=61&issue=Part%208&spage=1031&pages=1031
  -1040&date=2005&title=Acta%20Crystallographica%20Section%20D%20Biological%20Crys
  tallography&atitle=High-resolution%20structure%20of%20HLA
  -A%2a1101%20in%20complex%20with%20SARS%20nucleocapsid%20peptide&aulast=Blicher&p
  id=%3Cauthor%3EBlicher%2c%20Thomas%3bSandholm%20Kastrup%2c%20Jette%3bBuus%2c%20S
  oren%3bGajhede%2c%20Michael%3C%2Fauthor%3E%3CAN%3E200510202702%3C%2FAN%3E%3CDT%3
  EArticle%3C%2FDT%3E

Record 50 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Sequence analysis and structural prediction of the severe acute respiratory
  syndrome coronavirus nsp5
AU: Lu,-Jia-Hai [Author,-Reprint-Author]; Zhang,-Ding-Mei [Author]; Wang,-Guo
  -Ling [Author]; Guo,-Zhong-Min [Author]; Li,-Juan [Author]; Tan,-Bing-Yan
  [Author]; Ou-Yang,-Li-Ping [Author]; Ling,-Wen-Hua [Author]; Yu,-Xin-Bing
  [Author]; Zhong,-Nan-Shan [Author]
AD: Natl Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510080, Peoples R China
EMA: jiahailu@yahoo.com.cn
SO: Acta-Biochimica-et-Biophysica-Sinica. 2005; 37(7): 473-479
PY: 2005
DT: Article
IS: 1672-9145
LA: English
AB: The non-structural proteins (nsp or replicase proteins) of coronaviruses are
  relatively conserved and can be effective targets for drugs. Few studies have
  been conducted into the function of the severe acute respiratory syndrome
  coronavirus (SARS-CoV) nsp5. In this study, bioinformatics methods were
  employed to predict the secondary structure and construct 3-D models of the
  SARS-CoV GD strain nsp5. Sequencing and sequential comparison was performed to
  analyze the mutation trend of the polymerase nsp5 gene during the epidemic
  process using a nucleotide-nucleotide basic local alignment search tool
  (BLASTN) and a protein-protein basic local alignment search tool (BLASTP). The
  results indicated that the nsp5 gene was steady during the epidemic process and
  the protein was homologous with other coronavirus nsp5 proteins. The protein
  encoded by the nsp5 gene was expressed in COS-7 cells and analyzed by sodium
  dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE). This study
  provided the foundation for further exploration of the protein's biological
  function, and contributed to the search for anti-SARS-CoV drugs.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: COS-7-cell-line (Cercopithecidae-): cell_line-; Vero-E6-cell-line
  (Cercopithecidae-): cell_line-; Severe-Acute-Respiratory-Syndrome-virus
  (Coronaviridae-): common-, pathogen-; Coronavirus- (Coronaviridae-): genus-,
  pathogen-, strain-GD; human- (Hominidae-): common-, middle-age, host-, female-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
GN: Coronavirus-nsp5-gene [Coronaviridae-]: Coronavirus-non-structural-protein-5
  -gene
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; coronavirus-infection:
  viral-disease
MQ: sequence-analysis: laboratory-techniques, genetic-techniques; sodium
  -dodecylsulfate-polyacrylamide-gel-electrophoresis: SDS-PAGE, electrophoretic
  -techniques, laboratory-techniques
MI: structural-prediction
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
03506- (Genetics
  -Animal)
03508- (Genetics-Human)
10060- (Biochemistry-studies-General)
16006
  - (Respiratory-system-Pathology)
31500- (Genetics-of-bacteria-and
  -viruses)
33502- (Virology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510202695
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1672
  -9145&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1672
  -9145&isbn=&volume=37&issue=7&spage=473&pages=473
  -479&date=2005&title=Acta%20Biochimica%20et%20Biophysica%20Sinica&atitle=Sequenc
  e%20analysis%20and%20structural%20prediction%20of%20the%20severe%20acute%20respi
  ratory%20syndrome%20coronavirus%20nsp5&aulast=Lu&pid=%3Cauthor%3ELu%2c%20Jia%20H
  ai%3bZhang%2c%20Ding%20Mei%3bWang%2c%20Guo%20Ling%3bGuo%2c%20Zhong%20Min%3bLi%2c
  %20Juan%3bTan%2c%20Bing%20Yan%3bOu%20Yang%2c%20Li%20Ping%3bLing%2c%20Wen%20Hua%3
  bYu%2c%20Xin%20Bing%3bZhong%2c%20Nan%20Shan%3C%2Fauthor%3E%3CAN%3E200510202695%3
  C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 51 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Preparation and characterization of monoclonal antibodies against SARS
  -associated coronavirus nucleocapsid protein
AU: Jiang-Yi [Author]; Chen-Shi-ping [Author,-Reprint-Author]; Dong-Hong-yan
  [Author]; Feng-Chang-fang [Author]; Wang-Bao-jun [Author]
AD: Chinese Acad Med Sci, Inst Basic Med Sci, Dept Cell Biol, Peking Union Med
  Coll, Beijing 100005, Peoples R China
EMA: chenshiping@btamail.net.cn
SO: Jiepou-Xuebao. 2005; 36(2): 221-223
PY: 2005
DT: Article
IS: 0529-1356
LA: Chinese
AB: Objective To prepare monoclonal antibodies against recombinant severe acute
  respiratory syndrome (SARS)-associated coronavirus (CoV) nucleocapsid (N)
  protein in order to offer a tool for either further research or early diagnosis
  of SARS. Method BALB/c mice were immunized by injection of recombinant N
  protein of SARS-CoV. The hybridomas which can produce McAbs were plated in a
  semi-solid medium containing methycellulose. The identifications of the mAb
  against the N protein of SARS-CoV, including spcificity, affinity, isotypes and
  results of pairing test, were performed using indirect enzyme-linked
  immunosorbent assay (ELISA), indirect fluorescent antibody assay (IFA), and
  double diffusion assay. Results Fifteen strains of hybridomas were obtained, 10
  of them were specific to SARS-CoV. Affinity constants (Ka) was between 10(8)
  mol/L-1 and 10(9) mol/L-1. Among the 10 strains, 1 strain was identified as the
  immunoglobulin G(2b)(IgG(2b)) isotype, another one was IgG(3), and the others
  were IgG(1). Eight out of the 10 strains were specific to the N protein without
  detectable cross-reactivity with twelve related pathogens. Two strains had
  cross reactions. One reacted with influenza A, B, and parainfluenza serotypes 1
  2, 3, another one reacted with influenza A and B. Five out of 10 formed six
  pair ways, the sensityvity of two pairs reached 1 mu g/L. Conclusion We
  obtained McAbs of high-specificity and high-affinity to SARS-CoV and
  established the double-antibody sandwich ELISA-based test for detecting N
  antigen. The results of our work have provided a foundation for further
  research on either protein group or early diagnosis of SARS.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Respiratory-System:
  Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-; -[03503-] Paramyxoviridae-, -Negative
  -Sense-ssRNA-Viruses, Viruses-, Microorganisms-
OR: Coronavirus- (Coronaviridae-): genus-; mouse- (Muridae-): common-; Influenza
  -A-virus (Orthomyxoviridae-): species-; Influenza-B-virus (Orthomyxoviridae-):
  species-; Parainfluenza-virus (Paramyxoviridae-): common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-; Orthomyxoviridae-: Microorganisms-,
  Negative-Sense-Single-Stranded-RNA-Viruses, Viruses-; Paramyxoviridae-:
  Microorganisms-, Negative-Sense-Single-Stranded-RNA-Viruses, Viruses-
CB: monoclonal-antibodies; nucleocapsid-protein; IgG-1: immunoglobulin-G1; N
  -protein; methycellulose-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, diagnosis-
MQ: ELISA-: laboratory-techniques, immunologic-techniques; indirect-fluorescent
  -antibody-test: laboratory-techniques, immunologic-techniques; double-antibody
  -sandwich-ELISA: laboratory-techniques, immunologic-techniques
CC: 10060- (Biochemistry-studies-General)
12504- (Pathology-Diagnostic)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510202689
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0529
  -1356&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0529
  -1356&isbn=&volume=36&issue=2&spage=221&pages=221
  -223&date=2005&title=Jiepou%20Xuebao&atitle=Preparation%20and%20characterization
  %20of%20monoclonal%20antibodies%20against%20SARS
  -associated%20coronavirus%20nucleocapsid%20protein&aulast=&pid=%3Cauthor%3EJiang
  %20Yi%3bChen%20Shi%20ping%3bDong%20Hong%20yan%3bFeng%20Chang%20fang%3bWang%20Bao
  %20jun%3C%2Fauthor%3E%3CAN%3E200510202689%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 52 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Animal models for SARS pathogenesis and vaccine studies.
AU: Subbarao,-Kanta [Author,-Reprint-Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 509
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Pharmacology-; Respiratory-System: Respiration-
ST: -[86310-] Cricetidae-, -Rodentia, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[86190-] Primates-, -Mammalia, Vertebrata-, Chordata-, Animalia-
OR: hamster- (Cricetidae-): common-; mouse- (Muridae-): common-; non-human
  -primate (Primates-): common-
TN: Cricetidae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-; Muridae-: Animals-, Chordates-, Mammals-,
  Nonhuman-Vertebrates, Nonhuman-Mammals, Rodents-, Vertebrates-; Primates-:
  Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman-Vertebrates,
  Nonhuman-Primates, Primates-, Vertebrates-
PS: serum-: blood-and-lymphatics; respiratory-tract: respiratory-system
CB: severe-acute-respiratory-syndrome-vaccine: immunologic-drug, immunostimulant
  -drug, vaccine-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy, prevention
  -and-control, pathology-
MI: viral-replication
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
12502-
  (Pathology-General)
12512- (Pathology-Therapy)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
22002-
  (Pharmacology-General)
22018- (Pharmacology-Immunological-processes-and
  -allergy)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510202653
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=509&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Animal%20models%20for%20SARS%20pathogenesis%20and%20vaccine%20studies.&
  aulast=Subbarao&pid=%3Cauthor%3ESubbarao%2c%20Kanta%3C%2Fauthor%3E%3CAN%3E200510
  202653%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 53 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: The re-emergence of SARS.
AU: Peiris,-Malik [Author,-Reprint-Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 509
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Infection-; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
GE: Guangdong-: China-, Asia-, Palearctic-region
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease, pathology-, transmission-
MI: inter-species-transmission
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
12502-
  (Pathology-General)
16006- (Respiratory-system-Pathology)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510202652
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=509&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=The%20re
  -emergence%20of%20SARS.&aulast=Peiris&pid=%3Cauthor%3EPeiris%2c%20Malik%3C%2Faut
  hor%3E%3CAN%3E200510202652%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FD
  T%3E

Record 54 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Advances in SAR-CoV biology
AU: Denison,-Mark-R [Author,-Reprint-Author]; Sperry,-S-M [Author]; Kazni,-L
  [Author]; Graham,-R-L [Author]; Lu,-X [Author]; Yount,-B [Author]; Weiss,-S-R
  [Author]; Baric,-R-S [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 509
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Clinical-Immunology: Human-Medicine, Medical-Sciences; Infection-; Pulmonary
  -Medicine: Human-Medicine, Medical-Sciences
ST: -[33000-] Animalia-, -Animalia; -[03613-] Coronaviridae-, -Positive-Sense
  -ssRNA-Viruses, Viruses-, Microorganisms-; -[86215-] Hominidae-, -Primates,
  Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: animal- (Animalia-): common-; Coronavirus- (Coronaviridae-): genus-; human-
  (Hominidae-): common-
TN: Animalia-: Animals-; Coronaviridae-: Microorganisms-, Positive-Sense-Single
  -Stranded-RNA-Viruses, Viruses-; Hominidae-: Animals-, Chordates-, Humans-,
  Mammals-, Primates-, Vertebrates-
PS: immune-system: immune-system
CB: SAR-CoV
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease, pathology-, etiology-
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
12502-
  (Pathology-General)
16006- (Respiratory-system-Pathology)
33502- (Virology
  -General-and-methods)
34502- (Immunology-General-and-methods)
34508-
  (Immunology-Immunopathology-tissue-immunology)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510202651
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=509&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Advances%20in%20SAR
  -CoV%20biology&aulast=Denison&pid=%3Cauthor%3EDenison%2c%20Mark%20R%3bSperry%2c%
  20S%20M%3bKazni%2c%20L%3bGraham%2c%20R%20L%3bLu%2c%20X%3bYount%2c%20B%3bWeiss%2c
  %20S%20R%3bBaric%2c%20R%20S%3C%2Fauthor%3E%3CAN%3E200510202651%3C%2FAN%3E%3CDT%3
  EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 55 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: IVIG: from antitoxin in erysipelas to immune modulator in SARS.
AU: Low,-Donald-E [Author,-Reprint-Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 480
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Pharmacology-; Clinical-Immunology: Human-Medicine, Medical-Sciences;
  Infection-; Dermatology-: Human-Medicine, Medical-Sciences; Neurology-: Human
  -Medicine, Medical-Sciences; Pulmonary-Medicine: Human-Medicine, Medical
  -Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03615-] Flaviviridae-, -Positive-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-; -[07700-] Gram-Positive-Cocci, -Eubacteria, Bacteria
  -, Microorganisms-; -[03115-] Herpesviridae-, -dsDNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[03503-] Paramyxoviridae-, -Negative-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-; -[03205-] Parvoviridae-, -ssDNA-Viruses,
  Viruses-, Microorganisms-
OR: Severe-acute-respiratory-syndrome (Coronaviridae-): species-, pathogen-;
  West-Nile-virus (Flaviviridae-): species-, pathogen-; streptococci- (Gram
  -Positive-Cocci): common-, pathogen-, group-A; Cytomegalovirus- (Herpesviridae
  -): genus-, pathogen-; human- (Hominidae-): common-, host-; Metapneumovirus-
  (Paramyxoviridae-): genus-, pathogen-; Parvovirus-B19 (Parvoviridae-): species
  -, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Flaviviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA
  -Viruses, Viruses-; Gram-Positive-Cocci: Bacteria-, Eubacteria-, Microorganisms
  -; Herpesviridae-: Double-Stranded-DNA-Viruses, Microorganisms-, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-;
  Paramyxoviridae-: Microorganisms-, Negative-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Parvoviridae-: Single-Stranded-DNA-Viruses, Microorganisms-, Viruses-
PS: plasma-: blood-and-lymphatics
CB: intravenous-immunoglobulin: IVIG-, immunologic-drug, intravenous
  -administration
DS: sepsis-: (Sepsis-(MeSH)), bacterial-disease, drug-therapy; cytomegalovirus
  -infection: (Cytomegalovirus-Infections-(MeSH)), viral-disease, drug-therapy;
  severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy; erysipelas-:
  (Erysipelas-(MeSH)), bacterial-disease, integumentary-system-disease, drug
  -therapy; group-A-streptococcal-toxic-shock-syndrome: bacterial-disease, drug
  -therapy; West-Nile-virus-encephalitis: nervous-system-disease, viral-disease,
  drug-therapy; parvovirus-B19-infection: viral-disease, drug-therapy;
  metapneumovirus-infection: viral-disease, drug-therapy
MI: polyclonality-
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
12512-
  (Pathology-Therapy)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood
  -Blood-cell-studies)
16006- (Respiratory-system-Pathology)
18506-
  (Integumentary-system-Pathology)
20506- (Nervous-system-Pathology)
22002-
  (Pharmacology-General)
22005- (Pharmacology-Clinical-pharmacology)
22018-
  (Pharmacology-Immunological-processes-and-allergy)
31000- (Physiology-and
  -biochemistry-of-bacteria)
33502- (Virology-General-and-methods)
34508-
  (Immunology-Immunopathology-tissue-immunology)
36002- (Medical-and-clinical
  -microbiology-Bacteriology)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510202528
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=480&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=IVIG%3a%20from%20antitoxin%20in%20erysipelas%20to%20immune%20modulator%
  20in%20SARS.&aulast=Low&pid=%3Cauthor%3ELow%2c%20Donald%20E%3C%2Fauthor%3E%3CAN%
  3E200510202528%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 56 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Individual and cluster sensitivity of respiratory virus testing in
  institutional outbreaks.
AU: Smieja,-M [Author,-Reprint-Author]; McNally,-C [Author]; Loeb,-M [Author];
  Fearon,-M [Author]; Burton,-L [Author]; Haley,-A [Author]; Suggett,-B [Author];
  Taha,-M [Author]; Richardson,-S [Author]; Ontario-Lab-Working-Grp-Rapid
  -Diagnosis-Emerging-Infect [Reprint-Author,-Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 469
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Epidemiology-: Population-Studies; Methods-and-Techniques; Infection-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-; -[03503-] Paramyxoviridae-, -Negative
  -Sense-ssRNA-Viruses, Viruses-, Microorganisms-; -[03603-] Picornaviridae-, 
  -Positive-Sense-ssRNA-Viruses, Viruses-, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): species-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-; Influenza-A
  -virus (Orthomyxoviridae-): species-, pathogen-; Influenza-B-virus
  (Orthomyxoviridae-): species-, pathogen-; Parainfluenza-virus (Paramyxoviridae
  -): species-, pathogen-; Rhinovirus- (Picornaviridae-): genus-, pathogen-;
  Enterovirus- (Picornaviridae-): species-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Orthomyxoviridae-: Microorganisms-, Negative-Sense-Single
  -Stranded-RNA-Viruses, Viruses-; Paramyxoviridae-: Microorganisms-, Negative
  -Sense-Single-Stranded-RNA-Viruses, Viruses-; Picornaviridae-: Microorganisms-,
  Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
GE: Toronto-: Ontario-, Canada-, North-America, Nearctic-region; Hamilton-:
  Ontario-, Canada-, North-America, Nearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, diagnosis-; influenza
  -virus-infection: (Influenza-(MeSH)), respiratory-system-disease, viral
  -disease, diagnosis-
MQ: enzyme-immunoassay: laboratory-techniques, immunologic-techniques
MI: institutional-outbreak
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
12504-
  (Pathology-Diagnostic)
16006- (Respiratory-system-Pathology)
33502- (Virology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
37052- (Public-health-epidemiology-Communicable-diseases)
37054-
  (Public-health-epidemiology-Organic-diseases-and-neoplasms)
37056- (Public
  -health-epidemiology-Miscellaneous)
AN: 200510202496
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=469&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Individual%20and%20cluster%20sensitivity%20of%20respiratory%20virus%20t
  esting%20in%20institutional%20outbreaks.&aulast=Smieja&pid=%3Cauthor%3ESmieja%2c
  %20M%3bMcNally%2c%20C%3bLoeb%2c%20M%3bFearon%2c%20M%3bBurton%2c%20L%3bHaley%2c%2
  0A%3bSuggett%2c%20B%3bTaha%2c%20M%3bRichardson%2c%20S%3bOntario%20Lab%20Working%
  20Grp%20Rapid%20Diagnosis%20Emerging%20Infect%3C%2Fauthor%3E%3CAN%3E200510202496
  %3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 57 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Inhibitors of SARS coronaviruses (SARSCoV) in vitro and in vivo.
AU: Barnard,-D-L [Author,-Reprint-Author]; Day,-C [Author]; Jung,-K [Author];
  Hubbard,-V-D [Author]; Smee,-D-F [Author]; Morrey,-J-D [Author]; Sidwell,-R-W
  [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 468-469
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Pharmacology-; Toxicology-; Infection-; Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: African-green-monkey (Cercopithecidae-): common-, host-; Severe-Acute
  -Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS-virus, common-,
  pathogen-; Balb-C-mouse (Muridae-): common-, host-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-; Muridae
  -: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman-Mammals,
  Rodents-, Vertebrates-
PS: kidney-: excretory-system
CB: monoamine-oxidase: 9001-66-5; cysteine-protease: 37353-41-6; sodium
  -ion/potassium-ion-ATPase: EC-3.6.3.9; calpain-II-inhibitor: enzyme-inhibitor
  -drug, antiviral-drug, antiinfective-drug, intraperitoneal-administration,
  cysteine-protease-inhibitor, efficacy-; calpain-V-inhibitor: enzyme-inhibitor
  -drug, antiviral-drug, antiinfective-drug, intraperitoneal-administration,
  cysteine-protease-inhibitor, efficacy-; ouabain-: 630-60-4, enzyme-inhibitor
  -drug, antiviral-drug, antiinfective-drug, toxin-, cytotoxin-, intraperitoneal
  -administration, sodium-ion/potassium-ion-ATPase-inhibitor, efficacy-;
  bifemelane-: 90293-01-9, enzyme-inhibitor-drug, antiviral-drug, antiinfective
  -drug, toxin-, cytotoxin-, intraperitoneal-administration, monoamine-oxidase
  -inhibitor, efficacy-; calpain-VI-inhibitor: enzyme-inhibitor-drug, antiviral
  -drug, antiinfective-drug, cysteine-protease-inhibitor
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy, therapy-,
  transmission-
RN: 9001-66-5; 37353-41-6; 630-60-4; 90293-01-9
MQ: spectrophotometry-: laboratory-techniques, spectrum-analysis-techniques;
  neutral-red-uptake-assay: laboratory-techniques; cytopathic-effect-reduction
  -assay: laboratory-techniques; virus-yield-reduction-assay: laboratory
  -techniques
MI: drug-development
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10060-
  (Biochemistry-studies-General)
10802- (Enzymes-General-and-comparative-studies
  -coenzymes)
12512- (Pathology-Therapy)
15504- (Urinary-system-Physiology-and
  -biochemistry)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
22002- (Pharmacology-General)
22501-
  (Toxicology-General-and-methods)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
38502- (Chemotherapy-General
  -methods-and-metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510202492
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=468&pages=468
  -469&date=2004&title=Abstracts%20of%20the%20Interscience%20Conference%20on%20Ant
  imicrobial%20Agents%20and%20Chemotherapy&atitle=Inhibitors%20of%20SARS%20coronav
  iruses%20%28SARSCoV%29%20in%20vitro%20and%20in%20vivo.&aulast=Barnard&pid=%3Caut
  hor%3EBarnard%2c%20D%20L%3bDay%2c%20C%3bJung%2c%20K%3bHubbard%2c%20V%20D%3bSmee%
  2c%20D%20F%3bMorrey%2c%20J%20D%3bSidwell%2c%20R%20W%3C%2Fauthor%3E%3CAN%3E200510
  202492%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 58 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Evaluation of the Adaltis ELISA assay and the euroimmune IFA assay for the
  detection of IgG antibodies against SARS-CoV in serum.
AU: Mazzulli,-T [Author,-Reprint-Author]; Chua,-R [Author]; Kreiswirth,-N
  [Author]; Pong-Porter,-S [Author]; Rzayev,-Y [Author]; Akhavan,-P [Author];
  Akhavan,-P [Author]; McGreer,-A [Author]; Petric,-M [Author]; Mahony,-J
  [Author]; Willey,-B [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 468
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Clinical-Immunology: Human-Medicine, Medical-Sciences; Methods-and
  -Techniques; Infection-; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: serum-: blood-and-lymphatics
CB: IgG-antibodies: immunoglobulin-G-antibodies; anti-nuclear-factor
GE: Toronto-: USA-, North-America, Nearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; respiratory-illness:
  respiratory-system-disease
MQ: Adaltis-Elisa-Assay: laboratory-techniques, immunologic-techniques;
  Euroimmune-IFA-Assay: Euroimmune-indirect-fluorescent-antibody-assay,
  laboratory-techniques, immunologic-techniques
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10064-
  (Biochemistry-studies-Proteins-peptides-and-amino-acids)
15002- (Blood-Blood
  -and-lymph-studies)
15004- (Blood-Blood-cell-studies)
16006- (Respiratory
  -system-Pathology)
33502- (Virology-General-and-methods)
34502- (Immunology
  -General-and-methods)
34508- (Immunology-Immunopathology-tissue
  -immunology)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510202491
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=468&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Evaluation%20of%20the%20Adaltis%20ELISA%20assay%20and%20the%20euroimmun
  e%20IFA%20assay%20for%20the%20detection%20of%20IgG%20antibodies%20against%20SARS
  -CoV%20in%20serum.&aulast=Mazzulli&pid=%3Cauthor%3EMazzulli%2c%20T%3bChua%2c%20R
  %3bKreiswirth%2c%20N%3bPong%20Porter%2c%20S%3bRzayev%2c%20Y%3bAkhavan%2c%20P%3bA
  khavan%2c%20P%3bMcGreer%2c%20A%3bPetric%2c%20M%3bMahony%2c%20J%3bWilley%2c%20B%3
  C%2Fauthor%3E%3CAN%3E200510202491%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting
  %3C%2FDT%3E

Record 59 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Evaluation of Bayer's research-based coronavirus assay (BCA) and the artus
  RealArt HPA-coronavirus LC RT PCR assay (ARA) for the detection and
  quantification of SARS-CoV SARS) RNA in clinical samples.
AU: Mazzulli,-T [Author,-Reprint-Author]; Kreiswirth,-N [Author]; Ahkavan,-P
  [Author]; Poutanen,-S [Author]; Detmer,-J [Author]; Sangha,-S [Author]; Bush,-C
  [Author]; Willey,-B [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 468
PY: 2004
DT: Meeting-Poster; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Methods-and-Techniques; Infection-; Equipment-Apparatus-Devices-and
  -Instrumentation; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; Coronavirus- (Coronaviridae-): genus-; human-
  (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: lung-: respiratory-system
CB: RNA-
GE: Toronto-: Ontario-, Canada-, North-America, Nearctic-region
DS: coronavirus-infection: viral-disease; severe-acute-respiratory-syndrome:
  SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)), respiratory-system-disease,
  viral-disease, diagnosis-
MQ: Qiagen-RNA-Mini-Kit: medical-equipment; Stratagene-thermocycler: medical
  -equipment; Roche-LightCycler: medical-equipment; Bayer's-coronavirus-assay:
  clinical-techniques, diagnostic-techniques; RealArt-HPA-coronavirus-RT-PCR
  -assay: RealArt-HPA-Coronavirus-reverse-transcriptase-polymerase-chain-reaction
  -assay, clinical-techniques, diagnostic-techniques
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10062-
  (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
12504- (Pathology
  -Diagnostic)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510202490
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=468&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Evaluation%20of%20Bayer%27s%20research
  -based%20coronavirus%20assay%20%28BCA%29%20and%20the%20artus%20RealArt%20HPA
  -coronavirus%20LC%20RT%20PCR%20assay%20%28ARA%29%20for%20the%20detection%20and%2
  0quantification%20of%20SARS
  -CoV%20SARS%29%20RNA%20in%20clinical%20samples.&aulast=Mazzulli&pid=%3Cauthor%3E
  Mazzulli%2c%20T%3bKreiswirth%2c%20N%3bAhkavan%2c%20P%3bPoutanen%2c%20S%3bDetmer%
  2c%20J%3bSangha%2c%20S%3bBush%2c%20C%3bWilley%2c%20B%3C%2Fauthor%3E%3CAN%3E20051
  0202490%3C%2FAN%3E%3CDT%3EMeeting%20Poster%3bMeeting%3C%2FDT%3E

Record 60 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Infection control (IC) resource availability and application in community
  hospitals.
AU: Iversen,-N [Author,-Reprint-Author]; Christenson,-M [Author]; Abbott,-G
  [Author]; Hitt,-J [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 375
PY: 2004
DT: Meeting-Poster; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Pharmacology-; Infection-; Hematology-: Human-Medicine, Medical-Sciences;
  Urology-: Human-Medicine, Medical-Sciences; Pulmonary-Medicine: Human-Medicine,
  Medical-Sciences; Hospital-Administration: Allied-Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy; catheter
  -related-urinary-tract-infection: urologic-disease, infectious-disease, drug
  -therapy, prevention-and-control, transmission-; ventilator-associated
  -pneumonia: respiratory-system-disease, infectious-disease, drug-therapy;
  surgical-infection: infectious-disease, drug-therapy, prevention-and-control;
  catheter-related-blood-stream-infection: blood-and-lymphatic-disease,
  infectious-disease
MQ: electronic-survey: clinical-techniques, diagnostic-techniques
MI: antimicrobial-resistance; patient-safety; education-; hand-hygiene; training
  -; infection-control-resources: availability-, application-; community
  -hospitals: bed-size
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
12512-
  (Pathology-Therapy)
15006- (Blood-Blood-lymphatic-and-reticuloendothelial
  -pathologies)
15506- (Urinary-system-Pathology)
16006- (Respiratory-system
  -Pathology)
22002- (Pharmacology-General)
22005- (Pharmacology-Clinical
  -pharmacology)
33502- (Virology-General-and-methods)
36001- (Medical-and
  -clinical-microbiology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
37010- (Public-health-Public-health-administration-and
  -statistics)
AN: 200510202127
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=375&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Infection%20control%20%28IC%29%20resource%20availability%20and%20applic
  ation%20in%20community%20hospitals.&aulast=Iversen&pid=%3Cauthor%3EIversen%2c%20
  N%3bChristenson%2c%20M%3bAbbott%2c%20G%3bHitt%2c%20J%3C%2Fauthor%3E%3CAN%3E20051
  0202127%3C%2FAN%3E%3CDT%3EMeeting%20Poster%3bMeeting%3C%2FDT%3E

Record 61 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Diving suit: Sterile, ambulatory, personal device for protective and
  preventive isolation of nosocomial invasive fungal infections (IFI) in
  neutropenic patients hospitalised in Laminar air flow room who need a
  disruption of isolation.
AU: Thiebaut,-A [Author,-Reprint-Author]; Perraud,-M [Author]; Ozil,-S [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 362
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Infection-; Epidemiology-: Population-Studies; Equipment-Apparatus-Devices
  -and-Instrumentation
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, female-, male-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
DS: neutropenia-: (Neutropenia-(MeSH)), blood-and-lymphatic-disease; dyspnea-:
  (Dyspnea-(MeSH)), respiratory-system-disease; SARS-: severe-acute-respiratory
  -syndrome, respiratory-system-disease, viral-disease; claustrophobia-:
  behavioral-and-mental-disorders; pulmonary-aspergillosis: (Aspergillosis
  -(MeSH)), fungal-disease, pathology-, prevention-and-control, therapy-,
  diagnosis-, etiology-; nosocomial-invasive-fungal-infection: infectious-disease
MQ: Doppler-imaging: laboratory-techniques, diagnostic-techniques, clinical
  -techniques, imaging-and-microscopy-techniques; pulmonary-CT-scan: pulmonary
  -computed-tornographic-scan, laboratory-techniques, diagnostic-techniques,
  clinical-techniques, imaging-and-microscopy-techniques; diving-suit: protective
  -clothing; laminar-air-flow-room: medical-equipment; HEPA-filter: medical
  -equipment
MI: immunocompromization-; air-contamination; isolation-disruption; medical
  -staff-protection
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
07004-
  (Behavioral-biology-Human-behavior)
12502- (Pathology-General)
12504-
  (Pathology-Diagnostic)
12512- (Pathology-Therapy)
15006- (Blood-Blood
  -lymphatic-and-reticuloendothelial-pathologies)
16006- (Respiratory-system
  -Pathology)
21002- (Psychiatry-Psychopathology-psychodynamics-and
  -therapy)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
36008- (Medical
  -and-clinical-microbiology-Mycology)
37052- (Public-health-epidemiology
  -Communicable-diseases)
37054- (Public-health-epidemiology-Organic-diseases
  -and-neoplasms)
37056- (Public-health-epidemiology-Miscellaneous)
AN: 200510202077
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=362&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Diving%20suit%3a%20Sterile%2c%20ambulatory%2c%20personal%20device%20for
  %20protective%20and%20preventive%20isolation%20of%20nosocomial%20invasive%20fung
  al%20infections%20%28IFI%29%20in%20neutropenic%20patients%20hospitalised%20in%20
  Laminar%20air%20flow%20room%20who%20need%20a%20disruption%20of%20isolation.&aula
  st=Thiebaut&pid=%3Cauthor%3EThiebaut%2c%20A%3bPerraud%2c%20M%3bOzil%2c%20S%3C%2F
  author%3E%3CAN%3E200510202077%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%
  2FDT%3E

Record 62 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Psychological distress in healthcare workers (HCW) on home and work
  quarantine for SARS.
AU: Styra,-R-G [Author,-Reprint-Author]; Reynolds,-D [Author]; Garay,-J
  [Author]; Deamond,-S [Author]; Moran,-K [Author]; Deveareaux,-S [Author];
  McGeer,-A [Author]; Gold,-W-L [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 342
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Infection-; Psychiatry-: Human-Medicine, Medical-Sciences; Pulmonary
  -Medicine: Human-Medicine, Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, child-, adult-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease; post-traumatic-stress-disorder: (Stress-Disorders, Post-Traumatic
  -(MeSH)), behavioral-and-mental-disorders; psychological-distress: (Stress-,
  Psychological-(MeSH)), behavioral-and-mental-disorders, etiology-
MQ: multivariate-logistic-regression-analysis: mathematical-and-computer
  -techniques; general-health-questionnaire: clinical-techniques, diagnostic
  -techniques
MI: healthcare-worker; quarantine-
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
07004-
  (Behavioral-biology-Human-behavior)
16006- (Respiratory-system
  -Pathology)
21002- (Psychiatry-Psychopathology-psychodynamics-and
  -therapy)
25000- (Pediatrics-)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510201995
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=342&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Psychological%20distress%20in%20healthcare%20workers%20%28HCW%29%20on%2
  0home%20and%20work%20quarantine%20for%20SARS.&aulast=Styra&pid=%3Cauthor%3EStyra
  %2c%20R%20G%3bReynolds%2c%20D%3bGaray%2c%20J%3bDeamond%2c%20S%3bMoran%2c%20K%3bD
  eveareaux%2c%20S%3bMcGeer%2c%20A%3bGold%2c%20W%20L%3C%2Fauthor%3E%3CAN%3E2005102
  01995%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 63 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Lack of compliance with quarantine measures for SARS.
AU: Gold,-W-L [Author,-Reprint-Author]; Styra,-R-G [Author]; Reynolds,-D
  [Author]; Garay,-J [Author]; Deamond,-S [Author]; Moran,-K [Author];
  Deveareaux,-S [Author]; McGeer,-A [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 341
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Infection-; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
GE: Toronto-: Ontario-, Canada-, North-America, Nearctic-region; Durham-Region:
  Ontario-, Canada-, North-America, Nearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, transmission-, prevention
  -and-control
MI: quarantine-
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
16006-
  (Respiratory-system-Pathology)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510201993
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=341&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Lack%20of%20compliance%20with%20quarantine%20measures%20for%20SARS.&aul
  ast=Gold&pid=%3Cauthor%3EGold%2c%20W%20L%3bStyra%2c%20R%20G%3bReynolds%2c%20D%3b
  Garay%2c%20J%3bDeamond%2c%20S%3bMoran%2c%20K%3bDeveareaux%2c%20S%3bMcGeer%2c%20A
  %3C%2Fauthor%3E%3CAN%3E200510201993%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeti
  ng%3C%2FDT%3E

Record 64 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: SARS transmission from patients requiring intubation: a multi-center
  investigation in Toronto, Canada.
AU: Shigayeva,-A [Author,-Reprint-Author]; McGeer,-A [Author]; Scales,-D
  [Author]; Raboud,-J [Author]; Henry,-B [Author]; Paton,-S [Author]; Simor,-A
  [Author]; Vearncombe,-M [Author]; Stewart,-T [Author]; Chapman,-M [Author];
  Ofner,-M [Author]; Loeb,-M [Author]; MacDonald,-C [Author]; Zoutman,-D
  [Author]; Reynolds,-D [Author]; Kassan,-H [Author]; Bontovics,-E [Author];
  Green,-K [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 341
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Infection-; Serology-: Allied-Medical-Sciences; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
GE: Toronto-: Ontario-, Canada-, North-America, Nearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, transmission-, prevention
  -and-control, therapy-, diagnosis-
MQ: serology-: laboratory-techniques, immunologic-techniques, diagnostic
  -techniques, clinical-techniques; intubation-: therapeutic-and-prophylactic
  -techniques, clinical-techniques
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
12504-
  (Pathology-Diagnostic)
12512- (Pathology-Therapy)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
36504- (Medical-and-clinical-microbiology
  -Serodiagnosis)
AN: 200510201992
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=341&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=SARS%20transmission%20from%20patients%20requiring%20intubation%3a%20a%2
  0multi-center%20investigation%20in%20Toronto%2c%20Canada.&aulast=Shigayeva&pid=%
  3Cauthor%3EShigayeva%2c%20A%3bMcGeer%2c%20A%3bScales%2c%20D%3bRaboud%2c%20J%3bHe
  nry%2c%20B%3bPaton%2c%20S%3bSimor%2c%20A%3bVearncombe%2c%20M%3bStewart%2c%20T%3b
  Chapman%2c%20M%3bOfner%2c%20M%3bLoeb%2c%20M%3bMacDonald%2c%20C%3bZoutman%2c%20D%
  3bReynolds%2c%20D%3bKassan%2c%20H%3bBontovics%2c%20E%3bGreen%2c%20K%3C%2Fauthor%
  3E%3CAN%3E200510201992%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 65 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: SARS-CoV seroprevalence study among patients and visitors to a Toronto
  emergency room.
AU: Shigayeva,-A [Author,-Reprint-Author]; Vasa,-P [Author]; Qazi,-S [Author];
  Green,-K [Author]; Tong,-A [Author]; Dimoulos,-P [Author]; Davies,-L [Author];
  Henry,-B [Author]; Varia,-M [Author]; Sarwal,-S [Author]; Wilson,-S [Author];
  McGeer,-A [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 341
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Clinical-Immunology: Human-Medicine, Medical-Sciences; Infection-; Serology
  -: Allied-Medical-Sciences; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: serum-: blood-and-lymphatics
GE: Toronto-: USA-, North-America, Nearctic-region
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease, transmission-
MQ: serology-: laboratory-techniques, immunologic-techniques, diagnostic
  -techniques, clinical-techniques; SARS-antibody-testing: severe-acute
  -respiratory-syndrome-antibiotic-testing, clinical-techniques, diagnostic
  -techniques
MI: emergency-department
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
15002-
  (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell-studies)
16006-
  (Respiratory-system-Pathology)
34508- (Immunology-Immunopathology-tissue
  -immunology)
36006- (Medical-and-clinical-microbiology-Virology)
36504-
  (Medical-and-clinical-microbiology-Serodiagnosis)
AN: 200510201991
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=341&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=SARS-CoV%20seroprevalence%20study%20among%20patients%20and%20visitors%2
  0to%20a%20Toronto%20emergency%20room.&aulast=Shigayeva&pid=%3Cauthor%3EShigayeva
  %2c%20A%3bVasa%2c%20P%3bQazi%2c%20S%3bGreen%2c%20K%3bTong%2c%20A%3bDimoulos%2c%2
  0P%3bDavies%2c%20L%3bHenry%2c%20B%3bVaria%2c%20M%3bSarwal%2c%20S%3bWilson%2c%20S
  %3bMcGeer%2c%20A%3C%2Fauthor%3E%3CAN%3E200510201991%3C%2FAN%3E%3CDT%3EMeeting%20
  Abstract%3bMeeting%3C%2FDT%3E

Record 66 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Nosocomial transmission of methicillin-resistant Staphylococcus aureus
  (MRSA) during an outbreak of severe acute respiratory syndrome (SARS).
AU: Poutanen,-S-M [Author,-Reprint-Author]; Vearncombe,-M [Author]; McGeer,-A-J
  [Author]; Large,-G [Author]; Simor,-A-E [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 311
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Epidemiology-: Population-Studies; Infection-; Equipment-Apparatus-Devices
  -and-Instrumentation; Pulmonary-Medicine: Human-Medicine, Medical-Sciences;
  Hospital-Administration: Allied-Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[07702-] Micrococcaceae-, -Gram-Positive-Cocci,
  Eubacteria-, Bacteria-, Microorganisms-
OR: Severe-acute-respiratory-syndrome (Coronaviridae-): species-, pathogen-;
  human- (Hominidae-): common-, host-; Staphylococcus-aureus (Micrococcaceae-):
  species-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Micrococcaceae-: Bacteria-, Eubacteria-, Microorganisms-
GE: Toronto-: Ontario-, Canada-, North-America, Nearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-; methicillin
  -resistant-Staphylococcus-aureus-infection: MRSA-, bacterial-disease,
  transmission-, epidemiology-
MQ: gown-: protective-clothing; N95-respirator-mask: protective-clothing; eye
  -goggles: protective-clothing; gloves-: protective-clothing
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
16006-
  (Respiratory-system-Pathology)
31000- (Physiology-and-biochemistry-of
  -bacteria)
33502- (Virology-General-and-methods)
36002- (Medical-and-clinical
  -microbiology-Bacteriology)
36006- (Medical-and-clinical-microbiology
  -Virology)
37010- (Public-health-Public-health-administration-and
  -statistics)
37052- (Public-health-epidemiology-Communicable-diseases)
37054-
  (Public-health-epidemiology-Organic-diseases-and-neoplasms)
37056- (Public
  -health-epidemiology-Miscellaneous)
AN: 200510201871
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=311&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Nosocomial%20transmission%20of%20methicillin
  -resistant%20Staphylococcus%20aureus%20%28MRSA%29%20during%20an%20outbreak%20of%
  20severe%20acute%20respiratory%20syndrome%20%28SARS%29.&aulast=Poutanen&pid=%3Ca
  uthor%3EPoutanen%2c%20S%20M%3bVearncombe%2c%20M%3bMcGeer%2c%20A%20J%3bLarge%2c%2
  0G%3bSimor%2c%20A%20E%3C%2Fauthor%3E%3CAN%3E200510201871%3C%2FAN%3E%3CDT%3EMeeti
  ng%20Abstract%3bMeeting%3C%2FDT%3E

Record 67 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Paradoxical increase in MRSA rates following enhanced infection control
  measures for SARS.
AU: Chai,-L [Author,-Reprint-Author]; Kumarasinghe,-G [Author]; Goh,-H [Author];
  Ng,-T [Author]; Earnest,-A [Author]; Tambyah,-P-A [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 311
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Infection-; Pulmonary-Medicine: Human-Medicine, Medical-Sciences; Hospital
  -Administration: Allied-Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[07702-] Micrococcaceae-, -Gram-Positive-Cocci,
  Eubacteria-, Bacteria-, Microorganisms-
OR: Severe-acute-respiratory-virus-syndrome (Coronaviridae-): species-, pathogen
  -; human- (Hominidae-): common-, host-; Staphylococcus-aureus (Micrococcaceae
  -): species-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Micrococcaceae-: Bacteria-, Eubacteria-, Microorganisms-
CB: methicillin-: 61-32-5, antibacterial-drug, antiinfective-drug
DS: nosocomial-infection: (Cross-Infection-(MeSH)), infectious-disease; severe
  -acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)),
  respiratory-system-disease, viral-disease, prevention-and-control; methicillin
  -resistant-Staphylococcus-aureus-infection: MRSA-, bacterial-disease
RN: 61-32-5
MQ: glove-: protective-clothing; N95-mask: protective-clothing; gown-:
  protective-clothing; goggle-: protective-clothing
MI: health-care-worker; hand-washing
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10060-
  (Biochemistry-studies-General)
12512- (Pathology-Therapy)
16006- (Respiratory
  -system-Pathology)
31000- (Physiology-and-biochemistry-of-bacteria)
33502-
  (Virology-General-and-methods)
36001- (Medical-and-clinical-microbiology
  -General-and-methods)
36002- (Medical-and-clinical-microbiology
  -Bacteriology)
36006- (Medical-and-clinical-microbiology-Virology)
37010-
  (Public-health-Public-health-administration-and-statistics)
38502-
  (Chemotherapy-General-methods-and-metabolism)
38504- (Chemotherapy
  -Antibacterial-agents)
AN: 200510201870
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=311&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Paradoxical%20increase%20in%20MRSA%20rates%20following%20enhanced%20inf
  ection%20control%20measures%20for%20SARS.&aulast=Chai&pid=%3Cauthor%3EChai%2c%20
  L%3bKumarasinghe%2c%20G%3bGoh%2c%20H%3bNg%2c%20T%3bEarnest%2c%20A%3bTambyah%2c%2
  0P%20A%3C%2Fauthor%3E%3CAN%3E200510201870%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3
  bMeeting%3C%2FDT%3E

Record 68 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Correlation between emergency medical workers' (EMSW) experience with SARS
  and knowledge of influenza vaccine (FluV) and vaccine receipt.
AU: Yazdanian,-S [Author,-Reprint-Author]; Styra,-R-G [Author]; Tomlinson,-G
  [Author]; McGeer,-A [Author]; Gold,-W-L [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 262
PY: 2004
DT: Meeting-Poster; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Pharmacology-; Clinical-Immunology: Human-Medicine, Medical-Sciences;
  Infection-; Occupational-Health: Allied-Medical-Sciences; Education-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, adult-, host-, female
  -, male-; Influenza-virus (Orthomyxoviridae-): species-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Orthomyxoviridae-: Microorganisms-, Negative-Sense-Single
  -Stranded-RNA-Viruses, Viruses-
CB: FluV-: immunologic-drug, immunostimulant-drug, vaccine-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; influenza-virus-infection:
  (Influenza-(MeSH)), respiratory-system-disease, viral-disease, prevention-and
  -control, immunology-
MQ: vaccination-: clinical-techniques
MI: occupational-exposure; emergency-medical-worker; vaccine-knowledge; vaccine
  -receipt
CC: 00514- (General-biology-General-textbooks-and-audio-visual-aids)
00520-
  (General-biology-Symposia-transactions-and-proceedings)
12512- (Pathology
  -Therapy)
16006- (Respiratory-system-Pathology)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
22018- (Pharmacology
  -Immunological-processes-and-allergy)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36006- (Medical-and-clinical-microbiology
  -Virology)
37013- (Public-health-Occupational-health)
AN: 200510201692
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=&pages=262&date=2004&title=Abstracts%20of%20t
  he%20Interscience%20Conference%20on%20Antimicrobial%20Agents%20and%20Chemotherap
  y&atitle=Correlation%20between%20emergency%20medical%20workers%27%20%28EMSW%29%2
  0experience%20with%20SARS%20and%20knowledge%20of%20influenza%20vaccine%20%28FluV
  %29%20and%20vaccine%20receipt.&aulast=Yazdanian&pid=%3Cauthor%3EYazdanian%2c%20S
  %3bStyra%2c%20R%20G%3bTomlinson%2c%20G%3bMcGeer%2c%20A%3bGold%2c%20W%20L%3C%2Fau
  thor%3E%3CAN%3E200510201692%3C%2FAN%3E%3CDT%3EMeeting%20Poster%3bMeeting%3C%2FDT
  %3E

Record 69 of 2547 in BIOSIS Previews 2005: 45 2005/10/16-2005/10/22

TI: Development of a SARS recombinant CoV-spike protein vaccine.
AU: Andersen,-K-M [Author,-Reprint-Author]; Kuchar,-T [Author]; Chubet,-R-G
  [Author]; Holtz,-K-M [Author]; Duarte,-J-C [Author]; Zhou,-Z [Author]; Wang,-M
  [Author]
SO: Abstracts-of-the-Interscience-Conference-on-Antimicrobial-Agents-and
  -Chemotherapy. 2004; 44: 258-259
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0733-6373
MT: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy,
  Washington, DC, USA; October 30 -November 02, 2004
LA: English
MC: Biochemistry-and-Molecular-Biophysics; Pharmacology-; Immune-System:
  Chemical-Coordination-and-Homeostasis
ST: -[03114-] Baculoviridae-, -dsDNA-Viruses, Viruses-, Microorganisms-; -[03613
  -] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-, Microorganisms-; 
  -[75300-] Insecta-, -Arthropoda, Invertebrata-, Animalia-
OR: Baculovirus- (Baculoviridae-): species-, expression-system; Severe-Acute
  -Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen-; eypresSF
  -positive-cell-line (Insecta-): cell_line-
TN: Baculoviridae-: Double-Stranded-DNA-Viruses, Microorganisms-, Viruses-;
  Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Insecta-: Animals-, Arthropods-, Insects-, Invertebrates-
CB: S-protein: transmembrane-domain, full-length-his-tagged, hydrophobic-C
  -terminus, capsid-glycoprotein, isoelectric-point, glycosylation-site; ACE2
  -protein; SARS-recombinant-CoV-spike-protein-vaccine: Severe-Acute-Respiratory
  -Syndrome--recombinant-CoV-spike-protein-vaccine, immunologic-drug,
  immunostimulant-drug, vaccine-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, pathology-, immunology-,
  etiology-
MQ: immobilized-metal-ion-affinity-chromatography: laboratory-techniques,
  chromatographic-techniques; ion-exchange-chromatography: laboratory-techniques,
  chromatographic-techniques
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
02506-
  (Cytology-Animal)
10060- (Biochemistry-studies-General)
12502- (Pathology
  -General)
12512- (Pathology-Therapy)
16006- (Respiratory-system
  -Pathology)
22002- (Pharmacology-General)
22018- (Pharmacology-Immunological
  -processes-and-allergy)
33502- (Virology-General-and-methods)
34502-
  (Immunology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
64076- (Invertebrata-comparative-experimental-morphology-physiology
  -and-pathology-Insecta-physiology)
AN: 200510201678
UD: 20051018
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0733
  -6373&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0733
  -6373&isbn=&volume=44&issue=&spage=258&pages=258
  -259&date=2004&title=Abstracts%20of%20the%20Interscience%20Conference%20on%20Ant
  imicrobial%20Agents%20and%20Chemotherapy&atitle=Development%20of%20a%20SARS%20re
  combinant%20CoV
  -spike%20protein%20vaccine.&aulast=Andersen&pid=%3Cauthor%3EAndersen%2c%20K%20M%
  3bKuchar%2c%20T%3bChubet%2c%20R%20G%3bHoltz%2c%20K%20M%3bDuarte%2c%20J%20C%3bZho
  u%2c%20Z%3bWang%2c%20M%3C%2Fauthor%3E%3CAN%3E200510201678%3C%2FAN%3E%3CDT%3EMeet
  ing%20Abstract%3bMeeting%3C%2FDT%3E

Record 70 of 2547 in BIOSIS Previews 2005: 44 2005/10/09-2005/10/15

TI: Deciphering dengue: The Cuban experience
AU: Guzman,-Maria-G [Author,-Reprint-Author]
AD: Inst Med Trop Pedro Kouri, Dept Virol, PAHO WHO Collaborating Ctr Viral Dis,
  Autopista Novia del Mediodia,Km 6-1 2,POB Mariano, Habana, Cuba
EMA: lupe@ipk.sld.cu
SO: Science-(Washington-D-C). 2005; 309(5740): 1495-1497
PY: 2005
DT: Article
IS: 0036-8075
LA: English
MC: Pharmacology-; Epidemiology-: Population-Studies; Infection-
ST: -[03615-] Flaviviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Dengue-virus (Flaviviridae-): species-, pathogen-; human- (Hominidae-):
  common-, child-, adult-, adolescent-, host-
TN: Flaviviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: dengue-vaccination: immunologic-drug, immunostimulant-drug, vaccine-
GE: Cuba-: West-Indies, Neotropical-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; HIV-infection: human
  -immunodeficiency-virus-infection, blood-and-lymphatic-disease, immune-system
  -disease, viral-disease; AIDS-: acquired-immunodeficiency-syndrome, viral
  -disease, immune-system-disease; dengue-: (Dengue-(MeSH)), viral-disease,
  epidemiology-, immunology-, therapy-
CC: 12512- (Pathology-Therapy)
15006- (Blood-Blood-lymphatic-and
  -reticuloendothelial-pathologies)
16006- (Respiratory-system-Pathology)
22002
  - (Pharmacology-General)
22005- (Pharmacology-Clinical-pharmacology)
22018-
  (Pharmacology-Immunological-processes-and-allergy)
25000- (Pediatrics-)
33502
  - (Virology-General-and-methods)
34502- (Immunology-General-and
  -methods)
34508- (Immunology-Immunopathology-tissue-immunology)
36006-
  (Medical-and-clinical-microbiology-Virology)
37052- (Public-health
  -epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510199942
UD: 20051011
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0036
  -8075&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0036
  -8075&isbn=&volume=309&issue=5740&spage=1495&pages=1495
  -1497&date=2005&title=Science%20%28Washington%20D%20C%29&atitle=Deciphering%20de
  ngue%3a%20The%20Cuban%20experience&aulast=Guzman&pid=%3Cauthor%3EGuzman%2c%20Mar
  ia%20G%3C%2Fauthor%3E%3CAN%3E200510199942%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 71 of 2547 in BIOSIS Previews 2005: 44 2005/10/09-2005/10/15

TI: Low prevalence of subclinical severe acute respiratory syndrome-associated
  coronavirus infection among hospital healthcare workers in Hong Kong
AU: Lai,-Thomas-Sik-To [Author,-Reprint-Author]; Ng,-Tak-Keung [Author]; Seto,
  -Wing-Hong [Author]; Yam,-Loretta [Author]; Law,-Kin-Ip [Author]; Chan,-Jane
  [Author]
AD: Princess Margaret Hosp, Dept Med, Kowloon, Hong Kong, Peoples R China
EMA: laist@ha.org.hk
SO: Scandinavian-Journal-of-Infectious-Diseases. 2005; 37(6-7): 500-503
PY: 2005
DT: Article
IS: 0036-5548
LA: English
AB: We recruited 688 hospital healthcare workers who cared for patients with
  severe acute respiratory syndrome (SARS) and did not develop the disease in the
  Hong Kong outbreak in 2003. A questionnaire survey was conducted and serum
  samples were collected for SARS-associated coronavirus (SARS-CoV) antibody. The
  high-risk procedures performed and the types of unprotected exposures were
  recorded for analysis. Only 1 asymptomatic nurse had positive serological test.
  The result demonstrates the low rate of subclinical SARS-CoV infection in
  hospital healthcare workers and that the infection control practice against
  SARS in Hong Kong's hospitals during the outbreak was highly effective.
AI: Y
MC: Infection-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Coronavirus- (Coronaviridae-): genus-; human- (Hominidae-): common-, adult-,
  middle-age, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: serum-: blood-and-lymphatics
GE: Hong-Kong: Asia-, Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
CC: 15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510199891
UD: 20051011
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0036
  -5548&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0036
  -5548&isbn=&volume=37&issue=6-7&spage=500&pages=500
  -503&date=2005&title=Scandinavian%20Journal%20of%20Infectious%20Diseases&atitle=
  Low%20prevalence%20of%20subclinical%20severe%20acute%20respiratory%20syndrome
  -associated%20coronavirus%20infection%20among%20hospital%20healthcare%20workers%
  20in%20Hong%20Kong&aulast=Lai&pid=%3Cauthor%3ELai%2c%20Thomas%20Sik%20To%3bNg%2c
  %20Tak%20Keung%3bSeto%2c%20Wing%20Hong%3bYam%2c%20Loretta%3bLaw%2c%20Kin%20Ip%3b
  Chan%2c%20Jane%3C%2Fauthor%3E%3CAN%3E200510199891%3C%2FAN%3E%3CDT%3EArticle%3C%2
  FDT%3E

Record 72 of 2547 in BIOSIS Previews 2005: 44 2005/10/09-2005/10/15

TI: Using siRNA in prophylactic and therapeutic regimens against SARS
  coronavirus in rhesus macaque
AU: Li,-Bao-jian [Author]; Tang,-Qingquan [Author]; Cheng,-Du [Author]; Qin,
  -Chuan [Author]; Xie,-Frank-Y [Author]; Wei,-Qiang [Author]; Xu,-Jun [Author];
  Liu,-Yijia [Author]; Zheng,-Bo-jian [Author]; Woodle,-Martin-C [Author]; Zhong,
  -Nanshan [Author]; Lu,-Patrick-Y [Author,-Reprint-Author]
AD: Intradigm Corp, 12115 K Parklawn Dr, Rockville, MD 20852 USA
EMA: nanshan@vip.163.com; patricklu@intradigm.com
SO: Nature-Medicine. 2005; 11(9): 944-951
PY: 2005
DT: Article
IS: 1078-8956
LA: English
AB: Development of therapeutic agents for severe acute respiratory syndrome (
  SARS) viral infection using short interfering RNA ( siRNA) inhibitors
  exemplifies a powerful new means to combat emerging infectious diseases. Potent
  siRNA inhibitors of SARS coronavirus ( SCV) in vitro were further evaluated for
  efficacy and safety in a rhesus macaque ( Macaca mulatta) SARS model using
  clinically viable delivery while comparing three dosing regimens. Observations
  of SARS- like symptoms, measurements of SCV RNA presence and lung
  histopathology and immunohistochemistry consistently showed siRNA- mediated
  anti- SARS efficacy by either prophylactic or therapeutic regimens. The siRNAs
  used provided relief from SCV infection - induced fever, diminished SCV viral
  levels and reduced acute diffuse alveoli damage. The 10 - 40 mg/ kg accumulated
  dosages of siRNA did not show any sign of siRNA- induced toxicity. These
  results suggest that a clinical investigation is warranted and illustrate the
  prospects for siRNA to enable a massive reduction in development time for new
  targeted therapeutic agents.
AI: Y
MC: Pharmacology-; Infection-; Immune-System: Chemical-Coordination-and
  -Homeostasis; Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Macaca-mulatta (Cercopithecidae-): species-, rhesus-macaque, common-, host-;
  Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen-,
  strain-PUMC-01
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
CB: short-interfering-RNA-inhibitors: siRNA-inhibitors, antiinfective-drug,
  antiviral-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy
CC: 12512- (Pathology-Therapy)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
22002- (Pharmacology
  -General)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
38502-
  (Chemotherapy-General-methods-and-metabolism)
38506- (Chemotherapy-Antiviral
  -agents)
AN: 200510199151
UD: 20051011
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1078
  -8956&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1078
  -8956&isbn=&volume=11&issue=9&spage=944&pages=944
  -951&date=2005&title=Nature%20Medicine&atitle=Using%20siRNA%20in%20prophylactic%
  20and%20therapeutic%20regimens%20against%20SARS%20coronavirus%20in%20rhesus%20ma
  caque&aulast=Li&pid=%3Cauthor%3ELi%2c%20Bao%20jian%3bTang%2c%20Qingquan%3bCheng%
  2c%20Du%3bQin%2c%20Chuan%3bXie%2c%20Frank%20Y%3bWei%2c%20Qiang%3bXu%2c%20Jun%3bL
  iu%2c%20Yijia%3bZheng%2c%20Bo%20jian%3bWoodle%2c%20Martin%20C%3bZhong%2c%20Nansh
  an%3bLu%2c%20Patrick%20Y%3C%2Fauthor%3E%3CAN%3E200510199151%3C%2FAN%3E%3CDT%3EAr
  ticle%3C%2FDT%3E

Record 73 of 2547 in BIOSIS Previews 2005: 44 2005/10/09-2005/10/15

TI: Survival of severe acute respiratory syndrome coronavirus
AU: Lai,-Mary-Y-Y [Author]; Cheng,-Peter-K-C [Author]; Lim,-Wilina-W-L [Author,
  -Reprint-Author]
AD: Publ Hlth Lab Ctr, Div Virol, Rm 901,382 Nam Cheong St, Kowloon, Hong Kong,
  Peoples R China
EMA: Wllim@pacific.net.hk
SO: Clinical-Infectious-Diseases. 2005; 41(7): E67-E71
PY: 2005
DT: Article
IS: 1058-4838
LA: English
AB: Background. The primary modes of transmission of severe acute respiratory
  syndrome (SARS) coronavirus (SARS-CoV) appear to be direct mucus membrane
  contact with infectious droplets and through exposure to formites. Knowledge of
  the survival characteristics of the virus is essential for formulating
  appropriate infection-control measures.Methods. Survival of SARS-CoV strain
  GVU6109 was studied in stool and respiratory specimens. Survival of the virus
  on different environmental surfaces, including a laboratory request form, an
  impervious disposable gown, and a cotton nondisposable gown, was investigated.
  The virucidal effects of sodium hypochlorite, house detergent, and a peroxygen
  compound on the virus were also studied.Results. SARS-CoV GVU6109 can survive
  for 4 days in diarrheal stool samples with an alkaline pH, and it can remain
  infectious in respiratory specimens for 17 days at room temperature. Even at a
  relatively high concentration ( 104 tissue culture infective doses/mL), the
  virus could not be recovered after drying of a paper request form, and its
  infectivity was shown to last longer on the disposable gown than on the cotton
  gown. All disinfectants tested were shown to be able to reduce the virus load
  by 13 log within 5 min.Conclusions. Fecal and respiratory samples can remain
  infectious for a long period of time at room temperature. The risk of infection
  via contact with droplet-contaminated paper is small. Absorbent material, such
  as cotton, is preferred to nonabsorptive material for personal protective
  clothing for routine patient care where risk of large spillage is unlikely. The
  virus is easily inactivated by commonly used disinfectants.
AI: Y
MC: Infection-; Respiratory-System: Respiration-; Pesticides-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-, host-; Severe-Acute
  -Respiratory-Syndrome-coronavirus (Coronaviridae-): common-, pathogen-, strain
  -GVU6109
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
PS: stool-: digestive-system; respiratory-system: respiratory-system; mucus
  -membrane
CB: sodium-hypochlorite: 7681-52-9, pesticide-, disinfectant-; peroxygen
  -compound: pesticide-, disinfectant-; house-detergent: pesticide-, disinfectant-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, transmission-
RN: 7681-52-9
MI: room-temperature
CC: 02506- (Cytology-Animal)
14004- (Digestive-system-Physiology-and
  -biochemistry)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
54600- (Pest-control-general
  -pesticides-and-herbicides)
AN: 200510195198
UD: 20051011
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1058
  -4838&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1058
  -4838&isbn=&volume=41&issue=7&spage=E67&pages=E67
  -E71&date=2005&title=Clinical%20Infectious%20Diseases&atitle=Survival%20of%20sev
  ere%20acute%20respiratory%20syndrome%20coronavirus&aulast=Lai&pid=%3Cauthor%3ELa
  i%2c%20Mary%20Y%20Y%3bCheng%2c%20Peter%20K%20C%3bLim%2c%20Wilina%20W%20L%3C%2Fau
  thor%3E%3CAN%3E200510195198%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 74 of 2547 in BIOSIS Previews 2005: 44 2005/10/09-2005/10/15

TI: Managing severe acute respiratory syndrome (SARS) intellectual property
  rights: the possible role of patent pooling
AU: Simon,-James-H-M [Author,-Reprint-Author]; Claassen,-Eric [Author]; Correa,
  -Carmen-E [Author]; Osterhaus,-Albert-D-M-E [Author]
AD: CoroNovat BV, Molewaterpl 50,Room Ee1985, NL-3015 GE Rotterdam, Netherlands
EMA: simon@vironovative.com
SO: Bulletin-of-the-World-Health-Organization. 2005; 83(9): 707-710
PY: 2005
DT: Article
IS: 0042-9686
LA: English
AB: Patent applications that incorporate the genomic sequence of the severe
  acute respiratory syndrome (SARS) coronavirus, have been filed by a number of
  organizations. This is likely to result in a fragmentation of intellectual
  property (IP) rights which in turn may adversely affect the development of
  products, such as vaccines, to combat SARS. Placing these patent rights into a
  patent pool to be licensed on a non-exclusive basis may circumvent these
  difficulties and set a key precedent for the use of this form of mechanism in
  other areas of health care, leading to benefits to public health.
AI: Y
MC: Pharmacology-; Infection-; Public-Health: Allied-Medical-Sciences;
  Respiratory-System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: vaccine-: immunologic-drug, immunostimulant-drug, vaccine-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, prevention-and-control
MI: genomic-sequence; intellectual-property-rights; patent-pooling
CC: 12512- (Pathology-Therapy)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
22018- (Pharmacology
  -Immunological-processes-and-allergy)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37001- (Public
  -health-General-and-miscellaneous)
AN: 200510194619
UD: 20051011
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0042
  -9686&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0042
  -9686&isbn=&volume=83&issue=9&spage=707&pages=707
  -710&date=2005&title=Bulletin%20of%20the%20World%20Health%20Organization&atitle=
  Managing%20severe%20acute%20respiratory%20syndrome%20%28SARS%29%20intellectual%2
  0property%20rights%3a%20the%20possible%20role%20of%20patent%20pooling&aulast=Sim
  on&pid=%3Cauthor%3ESimon%2c%20James%20H%20M%3bClaassen%2c%20Eric%3bCorrea%2c%20C
  armen%20E%3bOsterhaus%2c%20Albert%20D%20M%20E%3C%2Fauthor%3E%3CAN%3E200510194619
  %3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 75 of 2547 in BIOSIS Previews 2005: 44 2005/10/09-2005/10/15

TI: Lessons in case management for the physician
AU: Lim,-T-K [Author,-Reprint-Author]
AD: Natl Univ Singapore Hosp, Dept Med, 5 Lower Kent Ridge Rd, Singapore 119074,
  Singapore
EMA: mdclimtk@nus.edu.sg
SO: Annals-Academy-of-Medicine-Singapore. 2005; 34(5): 339-340
PY: 2005
DT: Editorial; Article
IS: 0304-4602
LA: English
MC: Respiratory-System: Respiration-; Hospital-Administration: Allied-Medical
  -Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; chronic-obstructive
  -pulmonary-disease: (Lung-Diseases, Obstructive-(MeSH)), respiratory-system
  -disease; community-acquired-pneumonia: (Community-Acquired-Infections-(MeSH)),
  respiratory-system-disease, infectious-disease
MI: physician-; patient-care; case-management
CC: 16004- (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory
  -system-Pathology)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37010- (Public
  -health-Public-health-administration-and-statistics)
AN: 200510193255
UD: 20051011
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0304
  -4602&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0304
  -4602&isbn=&volume=34&issue=5&spage=339&pages=339
  -340&date=2005&title=Annals%20Academy%20of%20Medicine%20Singapore&atitle=Lessons
  %20in%20case%20management%20for%20the%20physician&aulast=Lim&pid=%3Cauthor%3ELim
  %2c%20T%20K%3C%2Fauthor%3E%3CAN%3E200510193255%3C%2FAN%3E%3CDT%3EEditorial%3bArt
  icle%3C%2FDT%3E

Record 76 of 2547 in BIOSIS Previews 2005: 44 2005/10/09-2005/10/15

TI: Rapid awareness and transmission of severe acute respiratory syndrome in
  Hanoi French Hospital, Vietnam
AU: Nishiura,-Hiroshi [Author]; Kuratsuji,-Tadatoshi [Author,-Reprint-Author];
  Quy,-Tran [Author]; Phi,-Nguyen-Chi [Author]; Van-Ban,-Vo [Author]; Ha,-Le-Dang
  [Author]; Long,-Hoang-Thuy [Author]; Yanai,-Hiedki [Author]; Keicho,-Naoto
  [Author]; Kirikae,-Teruo [Author]; Sasazuki,-Takehiko [Author]; Anderson,-Roy-M
  [Author]
AD: Int Med Ctr Japan, Res Inst, Shinjuku Ku, Toyama 1-21-1, Tokyo 1628655, Japan
EMA: kuratsuji@ri.imcj.go.jp
SO: American-Journal-of-Tropical-Medicine-and-Hygiene. 2005; 73(1): 17-25
PY: 2005
DT: Article
IS: 0002-9637
LA: English
AB: A case-control study was conducted to examine the relationship between
  severe acute respiratory syndrome (SARS) and the time-dependent precautionary
  behaviors taken during an outbreak of SARS in Hanoi French Hospital (HFH),
  Vietnam. Masks (odds ratio [OR] = 0.3; 95% confidence interval [Cl]: 0.1, 0.7)
  and gowns (OR = 0.2; 95% CI: 0.0, 0.8) appeared to prevent SARS transmission.
  The proportion of doctors and nurses who undertook each measure significantly
  improved (chi(2) = 9.8551, P = 0.043) after the onset of secondary cases. The
  impact of individual behaviors on an outbreak was investigated through
  mathematical approaches. The reproduction number decreased from 4.1 to 0.7
  after notification. The basic reproduction number was estimated, and the use of
  masks alone was shown to be insufficient in containing an epidemic. Intuitive
  results obtained by means of stochastic individual-based simulations showed
  that rapid improvements in behavior and isolation would increase the
  probability of extinction.
AI: Y
MC: Epidemiology-: Population-Studies; Infection-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
GE: Hanoi-: Vietnam-, Asia-, Oriental-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, transmission-, prevention
  -and-control, etiology-, epidemiology-
MQ: mask-: protective-clothing; gown-: protective-clothing
CC: 16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37052- (Public
  -health-epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510193120
UD: 20051011
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0002
  -9637&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0002
  -9637&isbn=&volume=73&issue=1&spage=17&pages=17
  -25&date=2005&title=American%20Journal%20of%20Tropical%20Medicine%20and%20Hygien
  e&atitle=Rapid%20awareness%20and%20transmission%20of%20severe%20acute%20respirat
  ory%20syndrome%20in%20Hanoi%20French%20Hospital%2c%20Vietnam&aulast=Nishiura&pid
  =%3Cauthor%3ENishiura%2c%20Hiroshi%3bKuratsuji%2c%20Tadatoshi%3bQuy%2c%20Tran%3b
  Phi%2c%20Nguyen%20Chi%3bVan%20Ban%2c%20Vo%3bHa%2c%20Le%20Dang%3bLong%2c%20Hoang%
  20Thuy%3bYanai%2c%20Hiedki%3bKeicho%2c%20Naoto%3bKirikae%2c%20Teruo%3bSasazuki%2
  c%20Takehiko%3bAnderson%2c%20Roy%20M%3C%2Fauthor%3E%3CAN%3E200510193120%3C%2FAN%
  3E%3CDT%3EArticle%3C%2FDT%3E

Record 77 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Pulmonary sequelae in convalescent patients after severe acute respiratory
  syndrome: Evaluation with thin-section CT
AU: Chang,-Yeun-Chung [Author]; Yu,-Chong-jen [Author]; Chang,-Shan-Chwen
  [Author]; Galvin,-Jeffrey-R [Author]; Liu,-Hon-Man [Author]; Hsiao,-Cheng
  -Hsiang [Author]; Kuo,-Ping-Hong [Author]; Chen,-Kuan-Yu [Author]; Franks,-Teri
  -J [Author]; Huang,-Kou-Mou [Author]; Yang,-Pan-Chyr [Author,-Reprint-Author]
AD: Natl Taiwan Univ, Coll Med, 7 Chung Shan S Rd, Taipei 10764, Taiwan
EMA: pcyang@ha.mc.ntu.edu.tw
SO: Radiology-. 2005; 236(3): 1067-1075,1059
PY: 2005
DT: Article
IS: 0033-8419
LA: English
AB: PURPOSE: To prospectively evaluate lung parenchyma on paired inspiration
  -expiration thin-section computed tomographic (CT) scans in patients recovering
  from severe acute respiratory syndrome (SARS).MATERIALS AND METHODS: After the
  institutional review board approved the study and written consent was obtained
  from patients, 40 patients (25 female, 15 male; mean age, 42.8 years +/- 12.3
  [standard deviation]) underwent thin-section CT at 51.8 days +/- 20.2 after
  onset of SARS symptoms. Twenty of the 40 patients underwent follow-up thin
  -section CT at 140.7 days +/- 26.7 after symptom onset. Lung findings were
  scored according to extent and then grouped in three categories (ground-glass
  opacity, interstitial opacity, and air trapping) for analysis. Mean CT scores
  for each finding in the various patient subgroups were compared by using the
  Mann-Whitney test. Clinical parameters and scores were evaluated for
  correlation by using Spearman rank correlation analysis. Mean scores for each
  finding were compared between the two serial examinations by using the Wilcoxon
  matched-pairs signed rank test.RESULTS: Air trapping, ground-glass opacity, and
  reticulation were found in 37 (92%), 36 (90%), and 28 (70%) of 40 patients,
  respectively, at initial thin-section CT examination and in 16 (80%), 14 (70%),
  and 10 (50%) of 20 patients, respectively, at follow-up examination. Scans from
  patients with adult respiratory distress syndrome (ARDS) had a significantly
  higher score for ground-glass opacity than did those from patients without ARDS
  (P = .009). A comparison of scores for the serial thin-section CT examinations
  indicated a significant reduction in the extent of ground-glass opacity (P <
  .001) and interstitial opacity (P < .001) but not in that of air trapping (P =
  .38) at follow-up examination. At initial thin-section CT, scores for ground
  -glass opacity, interstitial opacity, and air trapping correlated with age;
  those for ground-glass opacity and air trapping, with peak C-reactive protein
  level. At the second examination, scores for ground-glass opacity and
  interstitial opacity correlated with peak lactate dehydrogenase level; that for
  air trapping, with age and peak C-reactive protein level.CONCLUSION: Thin
  -section CT scores correlated with clinical and laboratory parameters in
  patients after SARS. Although ground-glass opacity and interstitial opacity
  resolve over time, air trapping persists. (c) RSNA, 2005.
AI: Y
MC: Infection-; Methods-and-Techniques; Pulmonary-Medicine: Human-Medicine,
  Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, adult-, middle-age, female-, male-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: lung-parenchyma: respiratory-system
CB: lactate-dehydrogenase: 9001-60-9, EC-1.1.1.27; C-reactive-protein
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, diagnosis-; adult
  -respiratory-distress-syndrome: (Respiratory-Distress-Syndrome, Adult-(MeSH)),
  respiratory-system-disease, diagnosis-
RN: 9001-60-9
MQ: thin-section-computed-tomography: clinical-techniques, diagnostic-techniques
MI: pulmonary-sequelae; convalescent-patient
CC: 10064- (Biochemistry-studies-Proteins-peptides-and-amino-acids)
10802-
  (Enzymes-General-and-comparative-studies-coenzymes)
12504- (Pathology
  -Diagnostic)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510191994
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0033
  -8419&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0033
  -8419&isbn=&volume=236&issue=3&spage=&pages=&date=2005&title=Radiology%20&atitle
  =Pulmonary%20sequelae%20in%20convalescent%20patients%20after%20severe%20acute%20
  respiratory%20syndrome%3a%20Evaluation%20with%20thin
  -section%20CT&aulast=Chang&pid=%3Cauthor%3EChang%2c%20Yeun%20Chung%3bYu%2c%20Cho
  ng%20jen%3bChang%2c%20Shan%20Chwen%3bGalvin%2c%20Jeffrey%20R%3bLiu%2c%20Hon%20Ma
  n%3bHsiao%2c%20Cheng%20Hsiang%3bKuo%2c%20Ping%20Hong%3bChen%2c%20Kuan%20Yu%3bFra
  nks%2c%20Teri%20J%3bHuang%2c%20Kou%20Mou%3bYang%2c%20Pan%20Chyr%3C%2Fauthor%3E%3
  CAN%3E200510191994%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 78 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Severe acute respiratory syndrome (SARS) S protein production in plants:
  Development of recombinant vaccine
AU: Pogrebnyak,-Natalia [Author]; Golovkin,-Maxim [Author]; Andrianov,
  -Vyacheslav [Author]; Spitsin,-Sergei [Author]; Smirnov,-Yuriy [Author]; Egolf,
  -Richard [Author]; Koprowski,-Hilary [Author,-Reprint-Author]
AD: Thomas Jefferson Univ, Biotechnol Fdn Labs, Philadelphia, PA 19107 USA
EMA: hilary.koprowski@jefferson.edu
SO: Proceedings-of-the-National-Academy-of-Sciences-of-the-United-States-of
  -America. 2005; 102(25): 9062-9067
PY: 2005
DT: Article
IS: 0027-8424
LA: English
AB: In view of a recent spread of severe acute respiratory syndrome (SARS),
  there is a high demand for production of a vaccine to prevent this disease.
  Recent studies indicate that SARS-coronavirus (CoV) spike protein (S protein)
  and its truncated fragments are considered the best candidates for generation
  of the recombinant vaccine. Toward the development of a safe, effective, and
  inexpensive vaccine candidate, we have expressed the N-terminal fragment of
  SARS-CoV S protein (S1) in tomato and low-nicotine tobacco plants.
  Incorporation of the S1 fragment into plant genomes as well as its
  transcription was confirmed by PCR and RT-PCR analyses. High levels of
  expression of recombinant S1 protein were observed in several transgenic lines
  by Western blot analysis using specific antibodies. Plant-derived antigen was
  evaluated to induce the systemic and mucosal immune responses in mice. Mice
  showed significantly increased levels of SARS-CoV-specific IgA after oral
  ingestion of tomato fruits expressing S1 protein. Sera of mice parenterally
  primed with tobacco-derived S1 protein revealed the presence of SARS-CoV
  -specific IgG as detected by Western blot and ELISA analysis.
AI: Y
MC: Pharmacology-; Infection-; Immune-System: Chemical-Coordination-and
  -Homeostasis; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Respiratory-System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-; -[86375-] Muridae-, 
  -Rodentia, Mammalia-, Vertebrata-, Chordata-, Animalia-; -[06509-] Rhizobiaceae
  -, -Gram-Negative-Aerobic-Rods-and-Cocci, Eubacteria-, Bacteria-,
  Microorganisms-; -[26775-] Solanaceae-, -Dicotyledones, Angiospermae-,
  Spermatophyta-, Plantae-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; Escherichia-coli (Enterobacteriaceae-): species-,
  expression-system, strain-Rosetta-2; mouse- (Muridae-): common-, female-,
  strain-BALB-c; Agrobacterium- (Rhizobiaceae-): genus-, gene-vector;
  Lycopersicon-esculentum (Solanaceae-): species-, tomato-, common-, cultivar
  -Money-Maker; Nicotiana-tabacum (Solanaceae-): species-, tobacco-, common-,
  cultivar-LAMD-609
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-; Muridae
  -: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman-Mammals,
  Rodents-, Vertebrates-; Rhizobiaceae-: Bacteria-, Eubacteria-, Microorganisms-;
  Solanaceae-: Angiosperms-, Dicots-, Plants-, Spermatophytes-, Vascular-Plants
CB: antibodies-; antigens-; IgA-: immunoglobulin-A; recombinant-vaccine:
  immunologic-drug, immunostimulant-drug; spike-protein: S-protein, N-terminal
  -fragment
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, etiology-, immunology-,
  genetics-, prevention-and-control
MQ: PCR-: polymerase-chain-reaction, laboratory-techniques, genetic-techniques;
  ELISA-: laboratory-techniques, immunologic-techniques; Western-blot:
  electrophoretic-techniques, immunologic-techniques, laboratory-techniques; RT
  -PCR: reverse-transcriptase-polymerase-chain-reaction, laboratory-techniques,
  genetic-techniques
MI: immune-response
CC: 03502- (Genetics-General)
03504- (Genetics-Plant)
03506- (Genetics
  -Animal)
10062- (Biochemistry-studies-Nucleic-acids-purines-and
  -pyrimidines)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
12512- (Pathology-Therapy)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
22002- (Pharmacology
  -General)
22018- (Pharmacology-Immunological-processes-and-allergy)
31000-
  (Physiology-and-biochemistry-of-bacteria)
31500- (Genetics-of-bacteria-and
  -viruses)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
51508-
  (Plant-physiology-Respiration-fermentation)
AN: 200510191824
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0027
  -8424&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0027
  -8424&isbn=&volume=102&issue=25&spage=9062&pages=9062
  -9067&date=2005&title=Proceedings%20of%20the%20National%20Academy%20of%20Science
  s%20of%20the%20United%20States%20of%20America&atitle=Severe%20acute%20respirator
  y%20syndrome%20%28SARS%29%20S%20protein%20production%20in%20plants%3a%20Developm
  ent%20of%20recombinant%20vaccine&aulast=Pogrebnyak&pid=%3Cauthor%3EPogrebnyak%2c
  %20Natalia%3bGolovkin%2c%20Maxim%3bAndrianov%2c%20Vyacheslav%3bSpitsin%2c%20Serg
  ei%3bSmirnov%2c%20Yuriy%3bEgolf%2c%20Richard%3bKoprowski%2c%20Hilary%3C%2Fauthor
  %3E%3CAN%3E200510191824%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 79 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Two new diastylidae (Crustacea : Cumacea) from California, collected by the
  RN Velero IV
AU: Gerken,-Sarah [Author,-Reprint-Author]
AD: Univ Alaska, Dept Biol Sci, 3211 Providence Dr, Anchorage, AK 99508 USA
EMA: sarah.gerken@uaa.alaska.edu
SO: Proceedings-of-the-Biological-Society-of-Washington. 2005; 118(2): 270-284
PY: 2005
DT: Article
IS: 0006-324X
LA: English
AB: Two new species, Diastylis newberryi and Diastyloides pacifica, are
  described, based on specimens collected off the coast of California. Diastylis
  newberryi is a problematical species, falling between the definitions of the
  genera Diastylis Say, 1818 and Leptostylis Sars, 1869, but can be identified by
  the unique combination of a single pair of lateral setae on the telson, male
  first antenna not greatly expanded, and male second antenna extending past the
  pleon. Diastyloides pacifica is the first species of the genus to be collected
  outside the North Atlantic basin.
AI: Y
MC: Biogeography-: Population-Studies; Marine-Ecology: Ecology-, Environmental
  -Sciences; Systematics-and-Taxonomy
ST: -[75000-] Arthropoda-, -Invertebrata, Animalia-; -[75100-] Crustacea-, 
  -Arthropoda, Invertebrata-, Animalia-; -[75112-] Malacostraca-[new-taxon],
  Crustacea-, Arthropoda-, Invertebrata-, Animalia-
OR: Cumacea- (Arthropoda-): higher_taxa-; Crustacea- (Crustacea-): higher_taxa-;
  Diastylis-newberryi (Malacostraca-): species-, new-species, adult-, immature-,
  female-, male-, description-; Diastyloides-pacifica (Malacostraca-): species-,
  new-species, adult-, immature-, female-, male-, description-
TN: Arthropoda-: Animals-, Arthropods-, Invertebrates-; Crustacea-: Animals-,
  Arthropods-, Crustaceans-, Invertebrates-; Malacostraca-: Animals-, Arthropods
  -, Crustaceans-, Invertebrates-
GE: California-: USA-, North-America, Nearctic-region; Pacific-Ocean: Pacific
  -Ocean
MI: R/V-Velero-IV
CC: 00504- (General-biology-Taxonomy-nomenclature-and-terminology)
07502-
  (Ecology-environmental-biology-General-and-methods)
07508- (Ecology
  -environmental-biology-Animal)
07512- (Ecology-environmental-biology
  -Oceanography)
11102- (Anatomy-and-Histology-Gross-anatomy)
62800- (Animal
  -distribution)
63552- (Invertebrata-general-and-systematic-Arthropoda
  -general)
63554- (Invertebrata-general-and-systematic-Arthropoda
  -Crustacea)
64052- (Invertebrata-comparative-experimental-morphology
  -physiology-and-pathology-Arthropoda-general)
64054- (Invertebratacomparative
  -experimental-morphology-physiology-and-pathology-Arthropoda-crustacea)
AN: 200510191730
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0006
  -324X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0006
  -324X&isbn=&volume=118&issue=2&spage=270&pages=270
  -284&date=2005&title=Proceedings%20of%20the%20Biological%20Society%20of%20Washin
  gton&atitle=Two%20new%20diastylidae%20%28Crustacea%20%3a%20Cumacea%29%20from%20C
  alifornia%2c%20collected%20by%20the%20RN%20Velero%20IV&aulast=Gerken&pid=%3Cauth
  or%3EGerken%2c%20Sarah%3C%2Fauthor%3E%3CAN%3E200510191730%3C%2FAN%3E%3CDT%3EArti
  cle%3C%2FDT%3E

Record 80 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Coronavirus phylogeny based on a geometric approach
AU: Zheng,-Wen-Xin [Author]; Chen,-Ling-Ling [Author]; Ou,-Hong-Yu [Author];
  Gao,-Feng [Author]; Zhang,-Chun-Ting [Author,-Reprint-Author]
AD: Tianjin Univ, Dept Phys, Tianjin 300072, Peoples R China
EMA: ctzhang@tju.edu.cn
SO: Molecular-Phylogenetics-and-Evolution. 2005; 36(2): 224-232
PY: 2005
DT: Article
IS: 1055-7903
LA: English
AB: A novel coronavirus has been identified as the cause of the outbreak of
  severe acute respiratory syndrome (SARS). Previous phylogenetic analyses based
  on sequence alignments show that SARS-CoVs form a new group distantly related
  to the other three groups of previously characterized coronaviruses. In this
  paper, a geometric approach based on the Z-curve representation of the whole
  genome sequence is proposed to analyze the phylogenetic relationships of
  coronaviruses. The evolutionary distances are obtained through measuring the
  differences among the three-dimensional Z-curves. The Z-curve is approximately
  described by its geometric center and the associated three eigenvectors, which
  indicate the center position and the trend of the Z-curve, respectively.
  Although some information is lost due to the approximate description of the Z
  -curve, the phylogenetic tree constructed based on these parameters is
  consistent with those of previous analyses. The present method has the merits
  of simplicity and intuitiveness, but it is still in its premature stage.
  Because the phylogenetic relationships are inferred from the whole genome,
  instead of some individual genes, the present method represents a new direction
  of phylogeny study in the post-genome era. (c) 2005 Elsevier Inc. All rights
  reserved.
AI: Y
MC: Infection-; Population-Genetics: Population-Studies; Respiratory-System:
  Respiration-; Evolution-and-Adaptation
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; Coronavirus- (Coronaviridae-): genus-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; coronavirus-infection:
  viral-disease
MQ: phylogenetic-analysis: laboratory-techniques, genetic-techniques; Z-curve:
  mathematical-and-computer-techniques
MI: Genbank-sequence-data; phylogenetic-relationship; sequence-alignment;
  evolutionary-distance; geometric-approach; post-genome-era
CC: 01500- (Evolution-)
03509- (Genetics-Population-genetics)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510190835
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1055
  -7903&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1055
  -7903&isbn=&volume=36&issue=2&spage=224&pages=224
  -232&date=2005&title=Molecular%20Phylogenetics%20and%20Evolution&atitle=Coronavi
  rus%20phylogeny%20based%20on%20a%20geometric%20approach&aulast=Zheng&pid=%3Cauth
  or%3EZheng%2c%20Wen%20Xin%3bChen%2c%20Ling%20Ling%3bOu%2c%20Hong%20Yu%3bGao%2c%2
  0Feng%3bZhang%2c%20Chun%20Ting%3C%2Fauthor%3E%3CAN%3E200510190835%3C%2FAN%3E%3CD
  T%3EArticle%3C%2FDT%3E

Record 81 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Correlation between photosensitivity and downwelling irradiance in
  mesopelagic crustaceans
AU: Myslinski,-Trevor-J [Author]; Frank,-Tamara-M [Author,-Reprint-Author];
  Widder,-Edith-A [Author]
AD: Harbor Branch Oceanog Inst, Ft Pierce, FL 34946 USA
EMA: frank@hboi.edu
SO: Marine-Biology-(Berlin). 2005; 147(3): 619-629
PY: 2005
DT: Article
IS: 0025-3162
LA: English
AB: The current study determined behavioral and electrophysiological
  photosensitivities for three species of mesopelagic crustaceans: Pasiphaea
  multidentata Esmark, 1866 (Decapoda: Pasiphaeidae), Sergestes arcticus Kroyer,
  1855 (Decapoda: Sergestidae), and Meganyctiphanes norvegica M. Sars, 1857
  (Euphausiacea: Euphausiidae). In addition, in situ quanti. cations of the
  species' vertical distributions in relation to downwelling irradiances were
  also determined in two locations in the northwest Atlantic Ocean, Wilkinson
  Basin (WB) and Oceanographer Canyon (OC). Data are from six 2-week cruises
  between June and September from 1995 to 2001. P. multidentata and M. norvegica
  were the most abundant large crustaceans in WB, and S. arcticus and M.
  norvegica were the most abundant large crustaceans in OC. The behavioral light
  sensitivity thresholds of P. multidentata and M. norvegica from WB were both 10
  7 photons cm(-2) s(-1) and those of S. arcticus and M. norvegica from OC were
  both 10 8 photons cm(-2) s(-1). Electrophysiologically, P. multidentata was
  significantly more sensitive than M. norvegica from either location, S.
  arcticus was significantly more sensitive than M. norvegica from OC, and M.
  norvegica from WB was significantly more sensitive than M. norvegica from OC. A
  correlation was found between electrophysiologically measured photosensitivity
  and downwelling irradiance, with the most sensitive species, P. multidentata
  and S. arcticus, associated with the lowest irradiance at daytime depths. The
  photosensitivities of M. norvegica collected from the clearer waters of OC were
  significantly lower than those of individuals collected from the more turbid WB
  waters. These results indicate that downwelling irradiance has a significant
  impact on interspecies and intraspecies vertical distribution patterns in the
  mesopelagic realm.
AI: Y
MC: Behavior-; Biogeography-: Population-Studies; Marine-Ecology: Ecology-,
  Environmental-Sciences
ST: -[75112-] Malacostraca-, -Crustacea, Arthropoda-, Invertebrata-, Animalia-
OR: Meganyctiphanes-norvegica (Malacostraca-): species-; Pasiphaea-multidentata
  (Malacostraca-): species-; Sergestes-arcticus (Malacostraca-): species-
TN: Malacostraca-: Animals-, Arthropods-, Crustaceans-, Invertebrates-
GE: Wilkinson-Basin: Atlantic-Ocean; Oceanographer-Canyon: Atlantic-Ocean
MI: behavior-; species-abundance; vertical-distribution; photosensitivity-;
  downwelling-irradiance
CC: 07002- (Behavioral-biology-General-and-comparative-behavior)
07003-
  (Behavioral-biology-Animal-behavior)
07502- (Ecology-environmental-biology
  -General-and-methods)
07508- (Ecology-environmental-biology-Animal)
07512-
  (Ecology-environmental-biology-Oceanography)
62800- (Animal
  -distribution)
64054- (Invertebratacomparative-experimental-morphology
  -physiology-and-pathology-Arthropoda-crustacea)
AN: 200510190650
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0025
  -3162&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0025
  -3162&isbn=&volume=147&issue=3&spage=619&pages=619
  -629&date=2005&title=Marine%20Biology%20%28Berlin%29&atitle=Correlation%20betwee
  n%20photosensitivity%20and%20downwelling%20irradiance%20in%20mesopelagic%20crust
  aceans&aulast=Myslinski&pid=%3Cauthor%3EMyslinski%2c%20Trevor%20J%3bFrank%2c%20T
  amara%20M%3bWidder%2c%20Edith%20A%3C%2Fauthor%3E%3CAN%3E200510190650%3C%2FAN%3E%
  3CDT%3EArticle%3C%2FDT%3E

Record 82 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Response of memory CD8(+) T cells to severe acute respiratory syndrome
  (SARS) coronavirus in recovered SARS patients and healthy individuals
AU: Chen,-Huabiao [Author]; Hou,-Jinlin [Author]; Jiang,-Xiaodong [Author]; Ma,
  -Shiwu [Author]; Meng,-Minjile [Author]; Wang,-Baomei [Author]; Zhang,-Minghui
  [Author]; Zhang,-Mingxia [Author]; Tang,-Xiaoping [Author]; Zhang,-Fuchun
  [Author]; Wan,-Tao [Author]; Li,-Nan [Author]; Yu,-Yizhi [Author]; Hu,-Hongbo
  [Author]; Yang,-Ruifu [Author]; He,-Wei [Author]; Wang,-Xiaoning [Author]; Cao,
  -Xuetao [Author,-Reprint-Author]
AD: Second Mil Med Univ, Inst Immunol, 800 Xiangyin Rd, Shanghai 200433, Peoples
  R China
EMA: caoxt@public3.sta.net.cn
SO: Journal-of-Immunology. 2005; 175(1): 591-598
PY: 2005
DT: Article
IS: 0022-1767
LA: English
AB: To date, the pathogenesis of severe acute respiratory syndrome (SARS) in
  humans is still not well understood. SARS coronavirus (SARS-CoV)-specific CTL
  responses, in particular their magnitude and duration of postinfection
  immunity, have not been extensively studied. In this study, we found that heat
  -inactivated SARS-CoV elicited recall CTL responses to newly identified spike
  protein-derived epitopes (SSp-1, S978, and S1202) in peripheral blood of all
  HLA-A*0201(+) recovered SARS patients over 1 year postinfection. Intriguingly,
  heat-inactivated SARS-CoV elicited recall-like CTL responses to SSp-1 but not
  to S978, S1202, or dominant epitopes from several other human viruses in 5 of
  36 (13.8%) HLA-A*0201(+) healthy donors without any contact history with SARS
  -CoV. SSp-1-specific CTLs expanded from memory T cells of both recovered SARS
  patients, and the five exceptional healthy donors shared a differentiated
  effector CTL phenotype, CD45RA(+)CCR7(-)CD62L(-), and expressed CCR5 and CD44.
  However, compared with the high avidity of SSp-1-specific CTLs derived from
  memory T cells of recovered SARS patients, SSp-l-specific CTLs from the five
  exceptional healthy donors were of low avidity, as determined by their rapid
  tetramer dissociation kinetics and reduced cytotoxic reactivity, IFN-gamma
  secretion, and intracellular production of IFN-gamma, TNF-alpha, perforin, and
  granzyme A. These results indicate that SARS-CoV infection induces strong and
  long-lasting CTL-mediated immunity in surviving SARS patients, and that cross
  -reactive memory T cells to SARS-CoV may exist in the T cell repertoire of a
  small subset of healthy individuals and can be reactivated by SARS-CoV
  infection.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Clinical-Immunology: Human-Medicine, Medical-Sciences; Pulmonary-Medicine:
  Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, female-, male-; 293
  -cell-line (Hominidae-): cell_line-, human-embryonic-kidney-cells; SW480-cell
  -line (Hominidae-): cell_line-, human-colorectal-carcinoma-cells
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: CTL-: cytotoxic-T-lymphocyte, immune-system, blood-and-lymphatics; memory
  -CD8-positive-T-cell: immune-system, blood-and-lymphatics
CB: IFN-gamma: interferon-gamma; TNF-alpha: tumor-necrosis-factor-alpha; CCR5-;
  perforin-; CD44-; CD62L-; CCR7-; CD45RA-; granzyme-A: 143180-73-8, EC-3.4.21.78
GN: human-HLA-gene [Hominidae-]: A-0201-allele
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, pathology-, etiology-
RN: 143180-73-8
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
03502- (Genetics
  -General)
03508- (Genetics-Human)
10064- (Biochemistry-studies-Proteins
  -peptides-and-amino-acids)
10508- (Biophysics-Membrane-phenomena)
12502-
  (Pathology-General)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood
  -Blood-cell-studies)
16006- (Respiratory-system-Pathology)
17002- (Endocrine
  -General)
31500- (Genetics-of-bacteria-and-viruses)
33502- (Virology-General
  -and-methods)
34502- (Immunology-General-and-methods)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510189809
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -1767&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -1767&isbn=&volume=175&issue=1&spage=591&pages=591
  -598&date=2005&title=Journal%20of%20Immunology&atitle=Response%20of%20memory%20C
  D8%28%2b%29%20T%20cells%20to%20severe%20acute%20respiratory%20syndrome%20%28SARS
  %29%20coronavirus%20in%20recovered%20SARS%20patients%20and%20healthy%20individua
  ls&aulast=Chen&pid=%3Cauthor%3EChen%2c%20Huabiao%3bHou%2c%20Jinlin%3bJiang%2c%20
  Xiaodong%3bMa%2c%20Shiwu%3bMeng%2c%20Minjile%3bWang%2c%20Baomei%3bZhang%2c%20Min
  ghui%3bZhang%2c%20Mingxia%3bTang%2c%20Xiaoping%3bZhang%2c%20Fuchun%3bWan%2c%20Ta
  o%3bLi%2c%20Nan%3bYu%2c%20Yizhi%3bHu%2c%20Hongbo%3bYang%2c%20Ruifu%3bHe%2c%20Wei
  %3bWang%2c%20Xiaoning%3bCao%2c%20Xuetao%3C%2Fauthor%3E%3CAN%3E200510189809%3C%2F
  AN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 83 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: The 3a protein of severe acute respiratory syndrome-associated coronavirus
  induces apoptosis in Vero E6 cells
AU: Law,-Patrick-T-W [Author]; Wong,-Chi-Hang [Author]; Au,-Thomas-C-C [Author];
  Chuck,-Chi-Pang [Author]; Kong,-Siu-Kai [Author]; Chan,-K-S [Author]; To,-Ka
  -Fai [Author]; Lo,-Anthony-W-I [Author]; Chan,-Judy-Y-W [Author]; Suen,-Yick
  -Keung [Author]; Chan,-H-Y-Edwin [Author]; Fung,-Kwok-Pui [Author]; Waye,-Mary
  -M-Y [Author]; Sung,-Joseph-J-Y [Author]; Lo,-Y-M-Dennis [Author]; Tsui,
  -Stephen-K-W [Author,-Reprint-Author]
AD: Chinese Univ Hong Kong, Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples
  R China
EMA: kwtsui@cuhk.edu.hk
SO: Journal-of-General-Virology. 2005; 86(Part 7): 1921-1930
PY: 2005
DT: Article
IS: 0022-1317
LA: English
AB: An outbreak of severe acute respiratory syndrome (SARS) occurred in China
  and the first case emerged in mid-November 2002. The aetiological agent of this
  disease was found to be a previously unknown coronavirus, SARS-associated
  coronavirus (SARS-CoV). The detailed pathology of SAIRS-CoV infection and the
  host response to the viral infection are still not known. The 3a gene encodes a
  non-structural viral protein, which is predicted to be a transmembrane protein.
  In this study, it was shown that the 3a protein was expressed in the lungs and
  intestinal tissues of SARS patients and that the protein localized to the
  endoplasmic reticulum in 3a-transfected monkey kidney Vero E6 cells. In vitro
  experiments of chromatin condensation and DNA fragmentation suggested that the
  3a protein may trigger apoptosis. These data showed that overexpression of a
  single SARS-CoV protein can induce apoptosis in vitro.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Respiratory-System:
  Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-, monkey-kidney-cells; SARS
  -virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome-virus,
  common-, pathogen-; human- (Hominidae-): common-, host-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: lung-: respiratory-system; intestinal-tissue
CB: chromatin-; DNA-: fragmentation-; 3a-protein
GE: China-: Asia-, Palearctic-region
GN: SARS-virus-3a-gene [Coronaviridae-]
DS: coronavirus-infection: viral-disease, etiology-; severe-acute-respiratory
  -syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)), respiratory
  -system-disease, viral-disease, etiology-, genetics-
MI: apoptosis-
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
03506- (Genetics
  -Animal)
03508- (Genetics-Human)
10060- (Biochemistry-studies-General)
10062
  - (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
31500- (Genetics-of-bacteria-and-viruses)
33502- (Virology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510189644
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -1317&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -1317&isbn=&volume=86&issue=Part%207&spage=1921&pages=1921
  -1930&date=2005&title=Journal%20of%20General%20Virology&atitle=The%203a%20protei
  n%20of%20severe%20acute%20respiratory%20syndrome
  -associated%20coronavirus%20induces%20apoptosis%20in%20Vero%20E6%20cells&aulast=
  Law&pid=%3Cauthor%3ELaw%2c%20Patrick%20T%20W%3bWong%2c%20Chi%20Hang%3bAu%2c%20Th
  omas%20C%20C%3bChuck%2c%20Chi%20Pang%3bKong%2c%20Siu%20Kai%3bChan%2c%20K%20S%3bT
  o%2c%20Ka%20Fai%3bLo%2c%20Anthony%20W%20I%3bChan%2c%20Judy%20Y%20W%3bSuen%2c%20Y
  ick%20Keung%3bChan%2c%20H%20Y%20Edwin%3bFung%2c%20Kwok%20Pui%3bWaye%2c%20Mary%20
  M%20Y%3bSung%2c%20Joseph%20J%20Y%3bLo%2c%20Y%20M%20Dennis%3bTsui%2c%20Stephen%20
  K%20W%3C%2Fauthor%3E%3CAN%3E200510189644%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 84 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Identification of critical active-site residues in angiotensin-converting
  enzyme-2 (ACE2) by site-directed mutagenesis
AU: Guy,-Jodie-L [Author,-Reprint-Author]; Jackson,-Richard-M [Author]; Jensen,
  -Hanne-A [Author]; Hooper,-Nigel-M [Author]; Turner,-Anthony-J [Author]
AD: Univ Leeds, Sch Biochem and Microbiol, Leeds LS2 9JT, W Yorkshire, UK
EMA: bmbjlg@bmb.leeds.ac.uk
SO: FEBS-Journal. 2005; 272(14): 3512-3520
PY: 2005
DT: Article
IS: 1742-464X1742-4658
LA: English
AB: Angiotensin-converting enzyme-2 (ACE2) may play an important role in
  cardiorenal disease and it has also been implicated as a cellular receptor for
  the severe acute respiratory syndrome (SARS) virus. The ACE2 active-site model
  and its crystal structure, which was solved recently, highlighted key
  differences between ACE2 and its counterpart angiotensin-converting enzyme
  (ACE), which are responsible for their differing substrate and inhibitor
  sensitivities. In this study the role of ACE2 active-site residues was explored
  by site-directed mutagenesis. Arg273 was found to be critical for substrate
  binding such that its replacement causes enzyme activity to be abolished.
  Although both His505 and His345 are involved in catalysis, it is His345 and not
  His505 that acts as the hydrogen bond donor/acceptor in the formation of the
  tetrahedral peptide intermediate. The difference in chloride sensitivity
  between ACE2 and ACE was investigated, and the absence of a second chloride
  -binding site (CL2) in ACE2 confirmed. Thus ACE2 has only one chloride-binding
  site (CL1) whereas ACE has two sites. This is the first study to address the
  differences that exist between ACE2 and ACE at the molecular level. The results
  can be applied to future studies aimed at unravelling the role of ACE2,
  relative to ACE, in vivo.
AI: Y
MC: Enzymology-: Biochemistry-and-Molecular-Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): species-, SARS
  -virus, common-, pathogen-; HEK293-cell-line (Hominidae-): cell_line-, human
  -embryonic-kedney-cells
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: chloride-: 16887-00-6; angiotensin-converting-enzyme: ACE-, 9015-82-1;
  angiotensin-converting-enzyme-2: ACE2-enzyme
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; cardiorenal-disease:
  vascular-disease, urologic-disease
RN: 16887-00-6; 9015-82-1
MQ: site-directed-mutagenesis: laboratory-techniques, genetic-techniques
MI: critical-active-site-residue
CC: 02508- (Cytology-Human)
10060- (Biochemistry-studies-General)
10802-
  (Enzymes-General-and-comparative-studies-coenzymes)
14508- (Cardiovascular
  -system-Blood-vessel-pathology)
15506- (Urinary-system-Pathology)
16006-
  (Respiratory-system-Pathology)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510186560
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1742
  -464X1742-4658&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1742
  -464X1742-4658&isbn=&volume=272&issue=14&spage=3512&pages=3512
  -3520&date=2005&title=FEBS%20Journal&atitle=Identification%20of%20critical%20act
  ive-site%20residues%20in%20angiotensin-converting%20enzyme
  -2%20%28ACE2%29%20by%20site
  -directed%20mutagenesis&aulast=Guy&pid=%3Cauthor%3EGuy%2c%20Jodie%20L%3bJackson%
  2c%20Richard%20M%3bJensen%2c%20Hanne%20A%3bHooper%2c%20Nigel%20M%3bTurner%2c%20A
  nthony%20J%3C%2Fauthor%3E%3CAN%3E200510186560%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%
  3E

Record 85 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Biogenesis and subcellular localization of the SARS coronavirus surface
  proteins
AU: Nal-Rogier,-Beatrice [Author,-Reprint-Author]; Chan,-Che-Man [Author]; Siu,
  -Lewis [Author]; Chu,-Kid [Author]; Altmeyer,-Ralf [Author]
AD: HKU Pasteur Res Ctr, Pokfulam, Hong Kong, Peoples R China
SO: FASEB-Journal. 2004; 18(8, Suppl. S): C71
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0892-6638
MT: Annual Meeting of the American-Society-for-Biochemistry-and-Molecular
  -Biology/8th Congress of the International-Union-for-Biochemistry-and-Molecular
  -Biology, Boston, MA, USA; June 12 -16, 2004 
SP: Amer Soc BioChem & Mol BiolInt Union Biochem & Mol Biol
LA: English
AB: SARS-CoV is a recently identified coronavirus responsible for an acute
  respiratory disease in human. The viral particles are composed of four
  structural proteins: three surface proteins Spike (S), Membrane (M), Envelope
  (E) and the Nucleocapsid (N) protein. Virus assembly is a well coordinated
  process requiringtrafficking of viral structural proteins to specific cellular
  compartments for budding.Our objective is to understand the fundamental steps
  of SARS-CoV morphogenesisincluding viral protein biogenesis, processing,
  subcellular trafficking and assembly. Combining biochemical techniques and
  confocal microscopy we attempt to elucidate the dynamic interactions of viral
  proteins with each other and with the proteins of the secretory pathway. Viral
  proteins were expressed in the Semliki Forest Virus expression vector as fusion
  proteins with several reporters (flag peptide and fluorescent proteins). Using
  pulse-chase labeling we studied kinetic events of co/post-translational
  modifications of S, M and E proteins. Our results indicate that both S and M
  proteins acquire complex EndoH resistant N-glycans in Golgi compartments with
  similar kinetics. Confocal laser microscopy analysis corroborated these
  findings showing a predominant ER location for E, Golgi for M and S.
  Furthermore S protein can be detected at the cell surface by immunofluorescence
  staining and FACS analysis.Altogether our results suggest that subcellular
  localization of SARS CoV surface proteins is similar to what has been described
  for other coronaviruses. They indicate that the Golgi or ER-Golgi intermediate
  compartments are the site of viral particle formation. More detailed
  colocalization studies are underway to delineate the dynamic processes leading
  to assembly and budding of infectious SARS CoV.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03616-] Togaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses
  -, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): species-, SARS
  -coronavirus, common-, pathogen-; Semliki-Forest-virus (Togaviridae-): species
  -, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Togaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA
  -Viruses, Viruses-
PS: Golgi-apparatus
CB: membrane-protein; nucleocapsid-protein; N-glycans; envelope-glycoproteins;
  spike-protein; surface-proteins
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: confocal-microscopy: laboratory-techniques, imaging-and-microscopy
  -techniques; confocal-laser-microscopy: laboratory-techniques, imaging-and
  -microscopy-techniques; pulse-chase-labeling: laboratory-techniques
MI: morphogenesis-; biogenesis-; subcellular-localization; virus-assembly
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10060-
  (Biochemistry-studies-General)
16006- (Respiratory-system-Pathology)
33502-
  (Virology-General-and-methods)
AN: 200510185433
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0892
  -6638&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0892
  -6638&isbn=&volume=18&issue=8%2c%20Suppl.%20S&spage=&pages=C71&date=2004&title=F
  ASEB%20Journal&atitle=Biogenesis%20and%20subcellular%20localization%20of%20the%2
  0SARS%20coronavirus%20surface%20proteins&aulast=Nal
  -Rogier&pid=%3Cauthor%3ENal%20Rogier%2c%20Beatrice%3bChan%2c%20Che%20Man%3bSiu%2
  c%20Lewis%3bChu%2c%20Kid%3bAltmeyer%2c%20Ralf%3C%2Fauthor%3E%3CAN%3E200510185433
  %3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 86 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: SARS 3CLpro; Efficient expression and purification for assay development and
  crystallography
AU: Martin,-John [Author,-Reprint-Author]; Zhao,-Huizhen [Author]; Sweitzer,
  -Sharon [Author]; Lewis,-Tia [Author]; Kerrigan,-John [Author]; Scott,-Gilbert
  [Author]; Tomaszek,-Thaddeus [Author]; McQueney,-Michael [Author]; Hassell,
  -Annie [Author]; Shewchuk,-Lisa [Author]; Johanson,-Kyung [Author]
AD: GlaxoSmithKline Pharma, GEPB Upper Merion, King Of Prussia, PA USA
SO: FASEB-Journal. 2004; 18(8, Suppl. S): C17
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0892-6638
MT: Annual Meeting of the American-Society-for-Biochemistry-and-Molecular
  -Biology/8th Congress of the International-Union-for-Biochemistry-and-Molecular
  -Biology, Boston, MA, USA; June 12 -16, 2004 
SP: Amer Soc BioChem & Mol BiolInt Union Biochem & Mol Biol
LA: English
AB: A novel coronavirus has been identified as the causative agent of severe
  acuterespiratory syndrome (SARS). The viral main protemase, 3CLpro (3C-like
  protease), which controls the activities of the coronavirus replication
  complex, could be an attractive target for therapy. 3CLpro is encoded from
  amino acid 3241to 3544 of polyprotein and contains catalytic His and Cys, but
  lacks the conserved catalytic acidic residue that is chararacteristic of other
  3C-like protease. To develop assay for high throughput screening and to
  determine crystal structure, the 3CLpro coding region was synthesized and
  expressed in E coli as an GST fusion protein with a thrombin cleavage site as a
  soluble protein at high level. The GST fusion protein in E coli cell lysate
  supernatant was captured on glutathione agarose and by on-column thrombin
  cleavage reaction, highly pure 3CLpro was released from the resin. Molecular
  weight by LC/MS analysis was33,845Da consistent with the predicted mass based
  on cDNA sequence. The purified 3CLpro was active toward a small peptide
  fluorogenic substrate, however enzyme rapidly loses activity upon storage at
  4oC. Inclusion of 5-10% glycerol in the storage buffer stabilized the enzyme
  activity. To obtain high resolutioncrystals, 3CLpro was further purified to >
  99% purity using Phenyl, MonoQ, and Superdex 75. A 2.3 angstrom structure of
  3CLpro has been solved.
AI: Y
MC: Methods-and-Techniques; Infection-; Enzymology-: Biochemistry-and-Molecular
  -Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-
OR: Coronavirus- (Coronaviridae-): genus-, pathogen-; Escherichia-coli
  (Enterobacteriaceae-): species-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-
CB: glycerol-: 56-81-5; lysate-; thrombin-: 9002-04-4, EC-3.4.21.5; polyprotein
  -; complementary-DNA-sequence: cDNA-sequence; GST-fusion-protein; 3C-like
  -protease; replication-complex; glutathione-agarose: 148374-14-5
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
RN: 56-81-5; 9002-04-4; 148374-14-5
MQ: high-throughput-screening: laboratory-techniques, genetic-techniques;
  crystallography-: laboratory-techniques, crystallographic-techniques; liquid
  -chromatography/mass-spectrometry: LC/MS-, laboratory-techniques, spectrum
  -analysis-techniques, chromatographic-techniques
MI: crystal-structure; assay-development
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10060-
  (Biochemistry-studies-General)
10802- (Enzymes-General-and-comparative-studies
  -coenzymes)
15002- (Blood-Blood-and-lymph-studies)
16006- (Respiratory-system
  -Pathology)
31000- (Physiology-and-biochemistry-of-bacteria)
33502- (Virology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510185182
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0892
  -6638&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0892
  -6638&isbn=&volume=18&issue=8%2c%20Suppl.%20S&spage=&pages=C17&date=2004&title=F
  ASEB%20Journal&atitle=SARS%203CLpro%3b%20Efficient%20expression%20and%20purifica
  tion%20for%20assay%20development%20and%20crystallography&aulast=Martin&pid=%3Cau
  thor%3EMartin%2c%20John%3bZhao%2c%20Huizhen%3bSweitzer%2c%20Sharon%3bLewis%2c%20
  Tia%3bKerrigan%2c%20John%3bScott%2c%20Gilbert%3bTomaszek%2c%20Thaddeus%3bMcQuene
  y%2c%20Michael%3bHassell%2c%20Annie%3bShewchuk%2c%20Lisa%3bJohanson%2c%20Kyung%3
  C%2Fauthor%3E%3CAN%3E200510185182%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting
  %3C%2FDT%3E

Record 87 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Predictive, non-GLP models of secondary pharmacodynamics: putting the best
  compounds forward
AU: Reinhart,-Glenn-A [Author,-Reprint-Author]; Fryer,-Ryan-M [Author]; Osinski,
  -Mark-A [Author]; Polakowski,-James-S [Author]; Cox,-Bryan-F [Author]; Gintant,
  -Gary-A [Author]
AD: Abbott Labs, Dept R46R, Bldg AP9,100 Abbott Pk Rd, Abbott Pk, IL 60064 USA
EMA: glenn.reinhart@abbott.com
SO: Current-Opinion-in-Chemical-Biology. 2005; 9(4): 392-399
PY: 2005
DT: Article
IS: 1367-5931
LA: English
AB: Secondary pharmacodynamic studies of new chemical entities (NCEs) play a
  critical role in support of efficient drug discovery. In an era in which speed
  and efficiency are the norm for pharmaceutical discovery, the need to identify
  NCEs with greater patient tolerability continues to increase. Early use of
  secondary pharmacodynamic models (in vivo and in vitro) provides the foundation
  for critical, early decisions regarding lead molecules. Scientifically robust,
  non-GLP (good laboratory practices) secondary pharmacodynamic studies can
  eliminate compounds or structural series with undesirable profiles early, and
  may prove useful in defining structure-activity relationships (SARs) with
  regards to off-target effects.
AI: Y
MC: Pharmacology-
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia
  -; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-; rat- (Muridae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates
  -; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-
PS: respiratory-system: respiratory-system; cardiovascular-system: circulatory
  -system; gastrointestinal-system: digestive-system; CNS-: central-nervous
  -system, nervous-system
MI: drug-discovery; hemodynamics-; structure-activity-relationships; new
  -chemical-entities; secondary-pharmacodynamics; good-laboratory-practices
CC: 12512- (Pathology-Therapy)
14004- (Digestive-system-Physiology-and
  -biochemistry)
14504- (Cardiovascular-system-Physiology-and
  -biochemistry)
16004- (Respiratory-system-Physiology-and-biochemistry)
20504-
  (Nervous-system-Physiology-and-biochemistry)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
AN: 200510184609
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1367
  -5931&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1367
  -5931&isbn=&volume=9&issue=4&spage=392&pages=392
  -399&date=2005&title=Current%20Opinion%20in%20Chemical%20Biology&atitle=Predicti
  ve%2c%20non-GLP%20models%20of%20secondary%20pharmacodynamics%3a%20putting%20the%
  20best%20compounds%20forward&aulast=Reinhart&pid=%3Cauthor%3EReinhart%2c%20Glenn
  %20A%3bFryer%2c%20Ryan%20M%3bOsinski%2c%20Mark%20A%3bPolakowski%2c%20James%20S%3
  bCox%2c%20Bryan%20F%3bGintant%2c%20Gary%20A%3C%2Fauthor%3E%3CAN%3E200510184609%3
  C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 88 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: A numerical evaluation of SAR distribution and temperature changes around a
  metallic plate in the head of a RF exposed worker
AU: McIntosh,-Robert-L [Author,-Reprint-Author]; Anderson,-Vitas [Author];
  McKenzie,-Raymond-J [Author]
AD: Telstra Res Labs, 770 Blackburn Rd, Clayton, Vic 3168, Australia
EMA: robert.l.mcintosh@team.telstra.com
SO: Bioelectromagnetics-. 2005; 26(5): 377-388
PY: 2005
DT: Article
IS: 0197-8462
LA: English
AB: The 1998 International Commission for Non-Ionising Radiation (ICNIRP)
  Guidelines for human exposure to radiofrequency (RF) fields contain a
  recommendation to assess the potential impact of metallic implants in workers
  exposed up to the allowable occupational field limits. This study provides an
  example of how numerical electromagnetic (EM) and thermal modelling can be used
  to determine whether scattered RF fields around metallic implants in workers
  exposed to allowable occupational ambient field limits will comply with the
  recommendations of relevant standards and guidelines. A case study is performed
  for plane wave exposures of a 50 mm diameter titanium cranioplasty plate,
  implanted around 5-6 mm under the surface of the forehead. The level of
  exposures was set to the ambient power flux density limits for occupational
  exposures specified in the 1998 ICNIRP guidelines and the cur-rent 1999 IEEE
  C95.1 standard over the frequency range 100-3000 MHz. Two distinct peak
  responses were observed. There was a resonant response for the whole implant at
  200-300 MHz where the maximum dimension of the implant is around a third of the
  wavelength of the RF exposure. This, however, resulted in relatively low peak
  specific energy absorption rate (SAR) levels around the implant at the exposure
  limits. Between 2100-2800 MHz, a second SAR concentrating mechanism of
  constructive interference of the wave reflected back and forth between the air
  -scalp interface and the scalp-plate interface resulted in higher peak SARs
  that were within the allowable limits for the ICNIRP exposures, but not for the
  IEEE C95.1 exposures. Moreover, the IEEE peak SAR limits were also exceeded, to
  a lesser degree, even when the implant was not present. However, thermal
  modelling indicated that the peak SAR concentrations around the implant did not
  result in any peak temperature rise above 1 degrees C for occupational
  exposures recommended in the ICNIRP guidelines, and hence would not pose any
  significant health risk. (c) 2005 Wiley-Liss, Inc.
AI: Y
MC: Occupational-Health: Allied-Medical-Sciences; Radiation-Biology
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
CB: titanium-: 7440-32-6
RN: 7440-32-6
MQ: metallic-implant: clinical-techniques; thermal-modelling: mathematical-and
  -computer-techniques; numerical-electromagnetic-modelling: mathematical-and
  -computer-techniques; cranioplasty-: clinical-techniques
MI: radiofrequency-field; International-Commission-for-Non-lonising-Radiation;
  specific-energy-absorption-rate
CC: 06502- (Radiation-biology-General)
10069- (Biochemistry-studies
  -Minerals)
37013- (Public-health-Occupational-health)
AN: 200510183532
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0197
  -8462&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0197
  -8462&isbn=&volume=26&issue=5&spage=377&pages=377
  -388&date=2005&title=Bioelectromagnetics%20&atitle=A%20numerical%20evaluation%20
  of%20SAR%20distribution%20and%20temperature%20changes%20around%20a%20metallic%20
  plate%20in%20the%20head%20of%20a%20RF%20exposed%20worker&aulast=McIntosh&pid=%3C
  author%3EMcIntosh%2c%20Robert%20L%3bAnderson%2c%20Vitas%3bMcKenzie%2c%20Raymond%
  20J%3C%2Fauthor%3E%3CAN%3E200510183532%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 89 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Identification of natural compounds with antiviral activities against SARS
  -associated coronavirus
AU: Li,-Shi-you [Author]; Chen,-Cong [Author]; Zhang,-Hai-qing [Author]; Guo,
  -Hai-yan [Author]; Wang,-Hui [Author]; Wang,-Lin [Author]; Zhang,-Xiang
  [Author]; Hua,-Shi-neng [Author]; Yu,-Jun [Author]; Xiao,-Pei-gen [Author]; Li,
  -Rong-song [Author]; Tan,-Xuehai [Author,-Reprint-Author]
AD: Chinese Acad Sci, Beijing Genom Inst, Beijing 101300, Peoples R China
EMA: tanxh@genomics.org.cn
SO: Antiviral-Research. 2005; 67(1): 18-23
PY: 2005
DT: Article
IS: 0166-3542
LA: English
AB: More than 200 Chinese medicinal herb extracts were screened for antiviral
  activities against Severe Acute Respiratory Syndrome-associated coronavirus
  (SARS-CoV) using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4
  -sulfophenyl)-2H-tetrazolium inner salt (NITS) assay for virus-induced
  cytopathic effect (CPE). Four of these extracts showed moderate to potent
  antiviral activities against SARS-CoV with 50% effective concentration (EC50)
  ranging from 2.4 +/- 0.2 to 88.2 +/- 7.7 mu g/ml. Out of the four, Lycoris
  radiata was most potent. To identify the active component, L. radiata extract
  was subjected to further fractionation, purification, and CPE/MTS assays. This
  process led to the identification of a single substance lycorine as an anti
  -SARS-CoV component with an EC50 value of 15.7 +/- 1.2 nM. This compound has a
  CC50 value of 14980.0 +/- 912.0 nM in cytotoxicity assay and a selective index
  (SI) greater than 900. The results suggested that four herbal extracts and the
  compound lycorine are candidates for the development of new anti-SARS-CoV drugs
  in the treatment of SARS. (c) 2005 Elsevier B.V. All rights reserved.
AI: Y
MC: Infection-; Pharmacognosy-: Pharmacology-; Respiratory-System: Respiration-
ST: -[25220-] Amaryllidaceae-, -Monocotyledones, Angiospermae-, Spermatophyta-,
  Plantae-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Lycoris-radiata (Amaryllidaceae-): species-, medicinal-plant; Severe-Acute
  -Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS-virus, common-,
  pathogen-
TN: Amaryllidaceae-: Angiosperms-, Monocots-, Plants-, Spermatophytes-, Vascular
  -Plants; Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA
  -Viruses, Viruses-
CB: natural-products; Chinese-medicinal-herb-extracts; Lycoris-radiata-extract:
  antiinfective-drug, antiviral-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy, etiology-
CC: 12512- (Pathology-Therapy)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
33502- (Virology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
38502-
  (Chemotherapy-General-methods-and-metabolism)
38506- (Chemotherapy-Antiviral
  -agents)
51508- (Plant-physiology-Respiration-fermentation)
54000-
  (Pharmacognosy-and-pharmaceutical-botany)
AN: 200510183151
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0166
  -3542&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0166
  -3542&isbn=&volume=67&issue=1&spage=18&pages=18
  -23&date=2005&title=Antiviral%20Research&atitle=Identification%20of%20natural%20
  compounds%20with%20antiviral%20activities%20against%20SARS
  -associated%20coronavirus&aulast=Li&pid=%3Cauthor%3ELi%2c%20Shi%20you%3bChen%2c%
  20Cong%3bZhang%2c%20Hai%20qing%3bGuo%2c%20Hai%20yan%3bWang%2c%20Hui%3bWang%2c%20
  Lin%3bZhang%2c%20Xiang%3bHua%2c%20Shi%20neng%3bYu%2c%20Jun%3bXiao%2c%20Pei%20gen
  %3bLi%2c%20Rong%20song%3bTan%2c%20Xuehai%3C%2Fauthor%3E%3CAN%3E200510183151%3C%2
  FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 90 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Methods for estimating the case fatality ratio for a novel, emerging
  infectious disease
AU: Ghani,-A-C [Author,-Reprint-Author]; Donnelly,-C-A [Author]; Cox,-D-R
  [Author]; Griffin,-J-T [Author]; Fraser,-C [Author]; Lam,-T-H [Author]; Ho,-L-M
  [Author]; Chan,-W-S [Author]; Anderson,-R-M [Author]; Hedley,-A-J [Author];
  Leung,-G-M [Author]
AD: Univ London London Sch Hyg and Trop Med, Infect Dis Epidemiol Unit, Dept
  Infect and Trop Dis, Keppel St, London WC1E 7HT, UK
EMA: azra.ghani@lshtm.ac.uk
SO: American-Journal-of-Epidemiology. 2005; 162(5): 479-486
PY: 2005
DT: Article
IS: 0002-9262
LA: English
AB: During the course of an epidemic of a potentially fatal disease, it is
  important that the case fatality ratio be well estimated. The authors propose a
  novel method for doing so based on the Kaplan-Meier survival procedure, jointly
  considering two outcomes (death and recovery), and evaluate its performance by
  using data from the 2003 epidemic of severe acute respiratory syndrome in Hong
  Kong, People's Republic of China. They compare this estimate obtained at
  various points in the epidemic with the case fatality ratio eventually
  observed; with two commonly quoted, naive estimates derived from cumulative
  incidence and mortality statistics at single time points; and with estimates in
  which a parametric mixture model is used. They demonstrate the importance of
  patient characteristics regarding outcome by analyzing subgroups defined by age
  at admission to the hospital.
AI: Y
MC: Epidemiology-: Population-Studies; Infection-; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences; Mathematical-Biology: Computational-Biology
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, adult-, aged-, middle
  -age, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: respiratory-system: respiratory-system
GE: Hong-Kong: Asia-, Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-, mortality-
MQ: Kaplan-Meier-survival-procedure: mathematical-and-computer-techniques
MI: hospital-admission
CC: 04500- (Mathematical-biology-and-statistical-methods)
16004- (Respiratory
  -system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
24500- (Gerontology-)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37052- (Public
  -health-epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510182768
UD: 20051004
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0002
  -9262&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0002
  -9262&isbn=&volume=162&issue=5&spage=479&pages=479
  -486&date=2005&title=American%20Journal%20of%20Epidemiology&atitle=Methods%20for
  %20estimating%20the%20case%20fatality%20ratio%20for%20a%20novel%2c%20emerging%20
  infectious%20disease&aulast=Ghani&pid=%3Cauthor%3EGhani%2c%20A%20C%3bDonnelly%2c
  %20C%20A%3bCox%2c%20D%20R%3bGriffin%2c%20J%20T%3bFraser%2c%20C%3bLam%2c%20T%20H%
  3bHo%2c%20L%20M%3bChan%2c%20W%20S%3bAnderson%2c%20R%20M%3bHedley%2c%20A%20J%3bLe
  ung%2c%20G%20M%3C%2Fauthor%3E%3CAN%3E200510182768%3C%2FAN%3E%3CDT%3EArticle%3C%2
  FDT%3E

Record 91 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Nederlandse Vereniging voor Veterinaire Epidemiologie en Economie
  (VEEC)
Netherlands Society for Veterinary Epidemiology and Economy (VEEC)
AU: Overgaauw,-Paul [Author]
SO: Tijdschrift-voor-Diergeneeskunde. 2005; 130(8): 249-251
PY: 2005
DT: Article
IS: 0040-7453
LA: Dutch
MC: Infection-; Epidemiology-: Population-Studies
ST: -[75000-] Arthropoda-, -Invertebrata, Animalia-; -[06702-]
  Enterobacteriaceae-, -Facultatively-Anaerobic-Gram-Negative-Rods, Eubacteria-,
  Bacteria-, Microorganisms-; -[03615-] Flaviviridae-, -Positive-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-; -[07700-] Gram-Positive-Cocci, 
  -Eubacteria, Bacteria-, Microorganisms-; -[86215-] Hominidae-, -Primates,
  Mammalia-, Vertebrata-, Chordata-, Animalia-; -[03000-] Viruses-, 
  -Microorganisms
OR: arthropod- (Arthropoda-): common-, disease-vector; Salmonella-typhimurium
  (Enterobacteriaceae-): species-, pathogen-; Salmonella-dublin
  (Enterobacteriaceae-): species-, pathogen-; West-Nile-virus (Flaviviridae-):
  species-, pathogen-, distribution-; Streptococcus-suis (Gram-Positive-Cocci):
  species-; human- (Hominidae-): common-, host-; influenza-virus (Viruses-):
  common-, pathogen-; rabies-virus (Viruses-): common-, pathogen-
TN: Arthropoda-: Animals-, Arthropods-, Invertebrates-; Enterobacteriaceae-:
  Bacteria-, Eubacteria-, Microorganisms-; Flaviviridae-: Microorganisms-,
  Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-; Gram-Positive-Cocci:
  Bacteria-, Eubacteria-, Microorganisms-; Hominidae-: Animals-, Chordates-,
  Humans-, Mammals-, Primates-, Vertebrates-; Viruses-: Microorganisms-, Viruses-
PS: respiratory-system: respiratory-system; tonsil-: immune-system, dental-and
  -oral-system, blood-and-lymphatics
CB: antiinfluenza-agents: antiinfective-drug, antiviral-drug
GE: USA-: North-America, Nearctic-region; Europe-: Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; cholera-: (Cholera
  -(MeSH)), bacterial-disease, epidemiology-; salmonellosis-: bacterial-disease,
  epidemiology-; rabies-: (Rabies-(MeSH)), viral-disease, epidemiology-; West
  -Nile-fever: nervous-system-disease, viral-disease, epidemiology-; avian
  -influenza: (Influenza-(MeSH)), viral-disease, infectious-disease, pathology-,
  mortality-, prevention-and-control, symptom-, epidemiology-, transmission-;
  meningitis-: (Meningitis-(MeSH)), nervous-system-disease, viral-disease,
  epidemiology-
MQ: polymerase-chain-reaction: laboratory-techniques, genetic-techniques;
  bacterial-culture: laboratory-techniques, culturing-techniques; Bayesian
  -method: mathematical-and-computer-techniques; serotyping-: laboratory
  -techniques, immunologic-techniques, diagnostic-techniques, clinical-techniques
MI: risk-assessment; ecosystem-; infection-control; sensitivity-; specificity-;
  seroconversion-; pandemic-; viral-spread; Nederlandse-Vereniging-voor
  -Veterinaire-Epidemiologie-en-Economie; emerging-zoonosis: epidemiology-
CC: 10062- (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
12502-
  (Pathology-General)
12512- (Pathology-Therapy)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
19004-
  (Dental-Physiology-and-biochemistry)
20506- (Nervous-system-Pathology)
31000-
  (Physiology-and-biochemistry-of-bacteria)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
36001- (Medical-and
  -clinical-microbiology-General-and-methods)
36002- (Medical-and-clinical
  -microbiology-Bacteriology)
36006- (Medical-and-clinical-microbiology
  -Virology)
37052- (Public-health-epidemiology-Communicable-diseases)
37054-
  (Public-health-epidemiology-Organic-diseases-and-neoplasms)
37056- (Public
  -health-epidemiology-Miscellaneous)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38506- (Chemotherapy-Antiviral-agents)
64052- (Invertebrata
  -comparative-experimental-morphology-physiology-and-pathology-Arthropoda
  -general)
AN: 200510181939
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0040
  -7453&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0040
  -7453&isbn=&volume=130&issue=8&spage=249&pages=249
  -251&date=2005&title=Tijdschrift%20voor%20Diergeneeskunde&atitle=Nederlandse%20V
  ereniging%20voor%20Veterinaire%20Epidemiologie%20en%20Economie%20%28VEEC%29&aula
  st=Overgaauw&pid=%3Cauthor%3EOvergaauw%2c%20Paul%3C%2Fauthor%3E%3CAN%3E200510181
  939%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 92 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: The estimation of SARS incubation distribution from serial interval data
  using a convolution likelihood
AU: Kuk,-Anthony-Y-C [Author,-Reprint-Author]; Ma,-Stefan [Author]
AD: Natl Univ Singapore, Dept Stat and Appl Probabil, 6 Sci Dr 2, Singapore
  117546, Singapore
EMA: stakuka@nus.edu.sg
SO: Statistics-in-Medicine. 2005; 24(16): 2525-2537
PY: 2005
DT: Article
IS: 0277-6715
LA: English
AB: The incubation period of SARS is the time between infection of disease and
  onset of symptoms. Knowledge about the distribution of incubation times is
  crucial in determining the length of quarantine period and is an important
  parameter in modelling the spread and control of SARS. As the exact time of
  infection is unknown for most patients, the incubation time cannot be
  determined. What is observable is the serial interval which is the time from
  the onset of symptoms in an index case to the onset of symptoms in a subsequent
  case infected by the index case. By constructing a convolution likelihood based
  on the serial interval data, we are able to estimate the incubation
  distribution which is assumed to be Weibull, and justifications are given to
  support this choice over other distributions. The method is applied to data
  provided by the Ministry of Health of Singapore and the results justify the
  choice of a ten-day quarantine period. The indirect estimate obtained using the
  method of convolution likelihood is validated by means of comparison with a
  direct estimate obtained directly from a subset of patients for whom the
  incubation time can be ascertained. Despite its name, the proposed indirect
  estimate is actually more precise than the direct estimate because serial
  interval data are recorded for almost all patients, whereas exact incubation
  times can be determined for only a small subset. It is possible to obtain an
  even more efficient estimate by using the combined data but the improvement is
  not substantial. Copyright (C) 2005 John Wiley & Sons, Ltd.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies; Mathematical-Biology:
  Computational-Biology
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
GE: Singapore-: Asia-, Oriental-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, infectious-disease, viral-disease,
  transmission-
MQ: Weibull-distribution: mathematical-and-computer-techniques; convolution
  -likelihood: mathematical-and-computer-techniques
MI: Ministry-of-Health; quarantine-period; disease-incubation-period
CC: 04500- (Mathematical-biology-and-statistical-methods)
16006- (Respiratory
  -system-Pathology)
33502- (Virology-General-and-methods)
36001- (Medical-and
  -clinical-microbiology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
37052- (Public-health-epidemiology-Communicable
  -diseases)
37054- (Public-health-epidemiology-Organic-diseases-and
  -neoplasms)
37056- (Public-health-epidemiology-Miscellaneous)
AN: 200510181768
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0277
  -6715&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0277
  -6715&isbn=&volume=24&issue=16&spage=2525&pages=2525
  -2537&date=2005&title=Statistics%20in%20Medicine&atitle=The%20estimation%20of%20
  SARS%20incubation%20distribution%20from%20serial%20interval%20data%20using%20a%2
  0convolution%20likelihood&aulast=Kuk&pid=%3Cauthor%3EKuk%2c%20Anthony%20Y%20C%3b
  Ma%2c%20Stefan%3C%2Fauthor%3E%3CAN%3E200510181768%3C%2FAN%3E%3CDT%3EArticle%3C%2
  FDT%3E

Record 93 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Toward inherently secure and resilient societies
AU: Allenby,-Brad [Author,-Reprint-Author]; Fink,-Jonathan [Author]
AD: Arizona State Univ, Dept Civil and Environm Engn, Tempe, AZ 85287 USA
EMA: brad.allenby@asu.edu
SO: Science-(Washington-D-C). 2005; 309(5737): 1034-1036,1030
PY: 2005
DT: Article
IS: 0036-8075
LA: English
AB: Recent years have seen a number of challenges to social stability and order,
  ranging from terrorist attacks and natural disasters to epidemics such as AIDS
  and SARS. Such challenges have generated specific policy responses, such as
  enhanced security at transportation hubs and planned deployment of a global
  tsunami detection network. However, the range of challenges and the practical
  impossibility of adequately addressing each in turn argue for adoption of a
  more comprehensive systems perspective. This should be based on the principle
  of enhancing social and economic resiliency as well as meeting security and
  emergency response needs and, to the extent possible, developing and
  implementing dual-use technologies that offer societal benefits even if
  anticipated disasters never occur.
AI: Y
MC: Sociology-: Population-Studies
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
DS: acquired-immunodeficiency-syndrome: AIDS-, (Acquired-Immunodeficiency
  -Syndrome-(MeSH)), viral-disease, immune-system-disease, epidemiology-; severe
  -acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)),
  respiratory-system-disease, viral-disease, epidemiology-
MI: terrorist-attack; natural-disaster; social-resiliency; economic-resiliency
CC: 05500- (Social-biology-and-human-ecology)
16006- (Respiratory-system
  -Pathology)
34508- (Immunology-Immunopathology-tissue-immunology)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510181616
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0036
  -8075&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0036
  -8075&isbn=&volume=309&issue=5737&spage=&pages=&date=2005&title=Science%20%28Was
  hington%20D%20C%29&atitle=Toward%20inherently%20secure%20and%20resilient%20socie
  ties&aulast=Allenby&pid=%3Cauthor%3EAllenby%2c%20Brad%3bFink%2c%20Jonathan%3C%2F
  author%3E%3CAN%3E200510181616%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 94 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Gammarus species from River Jumahe, China (Crustacea, Amphipoda, Gammaridae)
AU: Hou,-Zhong-E [Author]; Li,-Shuqiang [Author,-Reprint-Author]
AD: Chinese Acad Sci, Inst Zool, Beijing 100080, Peoples R China
EMA: lisq@ioz.ac.cn
SO: Revue-Suisse-de-Zoologie. 2005; 112(2): 313-327
PY: 2005
DT: Article
IS: 0035-418X
LA: English
AB: Gammarus species from River Jumahe, China (Crustacea, Amphipoda,
  Gammaridae). - Three Gammarus species are reported from River Jumahe. Gammarus
  madidus,sp. n. is characterized by antenna 2 with groups of long setae along
  the anterior and posterior margins, inner ramus of uropod 3 reaching about 40%
  of length of outer ramus and both rami fringed with long simple setae. G.
  lacustris Sars, 1863 is distinguished by epimeral plates 2 and 3 with sharp
  posterodistal corners, inner ramus of uropod 3 reaching about 75% of length of
  outer ramus and both rami armed with plumose setae. G. nekkensis Uchida, 1935
  differs from congeneric species by pereopod 3 with long curled setae on the
  posterior margin and inner ramus of uropod 3 reaching 50% of outer ramus.
  Distribution data of these gammarids are presented.
AI: Y
MC: Biogeography-: Population-Studies; Systematics-and-Taxonomy
ST: -[75100-] Crustacea-, -Arthropoda, Invertebrata-, Animalia-; -[75112-]
  Malacostraca-[new-taxon], Crustacea-, Arthropoda-, Invertebrata-, Animalia-
OR: Crustacea- (Crustacea-): higher_taxa-; Amphipoda- (Crustacea-): higher_taxa
  -; Gammarus- (Malacostraca-): genus-; Gammaridae- (Malacostraca-): family-;
  Gammarus-madidus (Malacostraca-): species-, new-species, description-; Gammarus
  -lacustris (Malacostraca-): species-, description-; Gammarus-nekkensis
  (Malacostraca-): species-, description-
TN: Crustacea-: Animals-, Arthropods-, Crustaceans-, Invertebrates-;
  Malacostraca-: Animals-, Arthropods-, Crustaceans-, Invertebrates-
GE: River-Jumahe: China-, Asia-, Palearctic-region
MI: distribution-data
CC: 00504- (General-biology-Taxonomy-nomenclature-and-terminology)
07502-
  (Ecology-environmental-biology-General-and-methods)
07508- (Ecology
  -environmental-biology-Animal)
11102- (Anatomy-and-Histology-Gross
  -anatomy)
62800- (Animal-distribution)
63554- (Invertebrata-general-and
  -systematic-Arthropoda-Crustacea)
64054- (Invertebratacomparative-experimental
  -morphology-physiology-and-pathology-Arthropoda-crustacea)
AN: 200510181471
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0035
  -418X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0035
  -418X&isbn=&volume=112&issue=2&spage=313&pages=313
  -327&date=2005&title=Revue%20Suisse%20de%20Zoologie&atitle=Gammarus%20species%20
  from%20River%20Jumahe%2c%20China%20%28Crustacea%2c%20Amphipoda%2c%20Gammaridae%2
  9&aulast=Hou&pid=%3Cauthor%3EHou%2c%20Zhong%20E%3bLi%2c%20Shuqiang%3C%2Fauthor%3
  E%3CAN%3E200510181471%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 95 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Studies on the genus Onisimus Boeck, 1871 (Crustacea, Amphipoda,
  Lysianassoidea, Uristidae) Part I. The brevicaudatus and sextonae species groups
AU: Vader,-Wim [Author]; Johnsen,-Jan-Roger [Author]; Berge,-Jorgen [Author,
  -Reprint-Author]
AD: UNIS, Dept Biol, N-9171 Longyearbyen, Norway
EMA: jorgen.berge@unis.no
SO: Organisms-Diversity-and-Evolution. 2005; 5(2): 161-164
PY: 2005
DT: Article
IS: 1439-6092
LA: English
AB: The genus Onisimus Boeck is divided into five species groups to be treated
  in this and forthcoming publications; a key to these groups includes the genera
  Menigrates Boeck and Paralibrotus Stephensen. Further keys and redescriptions
  are presented to all species within two Onisimus species groups. The O.
  brevicaudatus-group comprises the species O. affinis Hansen, 1886 ( = O. dubius
  Schellenberg, 1935, syn. n.), O. botkini Birula, 1897, O. brevicaudatus Hansen,
  1887, O. caricus Hansen, 1887, and O. detjugini Gurjanova, 1929. The O.
  sextonae-group consists of the species O. abyssi Oldevig, 1959, O. leucopis
  (G.O. Sars, 1879), and O. sextonae Chevreux, 1926. The full redescriptions of
  these species are provided in an accompanying Organisms Diversity and Evolution
  Electronic Supplement. (c) 2005 Gesellschaft fur Biologische Systematik.
  Published by Elsevier GmbH. All rights reserved.
AI: Y
MC: Systematics-and-Taxonomy
ST: -[75112-] Malacostraca-, -Crustacea, Arthropoda-, Invertebrata-, Animalia-
OR: Onisimus- (Malacostraca-): genus-; Onisimus-caricus (Malacostraca-): species
  -; Menigrates- (Malacostraca-): genus-; Paralibrotus- (Malacostraca-): genus-;
  Onisimus-brevicaudatus (Malacostraca-): species-; Onisimus-affinis
  (Malacostraca-): species-; Onisimus-botkini (Malacostraca-): species-; Onisimus
  -derjugini (Malacostraca-): species-; Onisimus-sextonae (Malacostraca-):
  species-; Onisimus-abyssi (Malacostraca-): species-; Onisimus-leucopis
  (Malacostraca-): species-
TN: Malacostraca-: Animals-, Arthropods-, Crustaceans-, Invertebrates-
CC: 00504- (General-biology-Taxonomy-nomenclature-and-terminology)
63554-
  (Invertebrata-general-and-systematic-Arthropoda-Crustacea)
64054-
  (Invertebratacomparative-experimental-morphology-physiology-and-pathology
  -Arthropoda-crustacea)
AN: 200510180734
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1439
  -6092&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1439
  -6092&isbn=&volume=5&issue=2&spage=161&pages=161
  -164&date=2005&title=Organisms%20Diversity%20and%20Evolution&atitle=Studies%20on
  %20the%20genus%20Onisimus%20Boeck%2c%201871%20%28Crustacea%2c%20Amphipoda%2c%20L
  ysianassoidea%2c%20Uristidae%29%20Part%20I.%20The%20brevicaudatus%20and%20sexton
  ae%20species%20groups&aulast=Vader&pid=%3Cauthor%3EVader%2c%20Wim%3bJohnsen%2c%2
  0Jan%20Roger%3bBerge%2c%20Jorgen%3C%2Fauthor%3E%3CAN%3E200510180734%3C%2FAN%3E%3
  CDT%3EArticle%3C%2FDT%3E

Record 96 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Antibody responses to individual proteins of SARS coronavirus and their
  neutralization activities
AU: Qiu,-Maofeng [Author]; Shi,-Yuling [Author]; Guo,-Zhaobiao [Author]; Chen,
  -Zeliang [Author]; He,-Rongqiao [Author]; Chen,-Runsheng [Author]; Zhou,
  -Dongsheng [Author]; Dai,-Erhei [Author]; Wang,-Xiaoyi [Author]; Si,-Bingyin
  [Author]; Song,-Yajun [Author]; Li,-Jingxiang [Author]; Yang,-Ling [Author];
  Wang,-Jin [Author]; Wang,-Hongxia [Author]; Pang,-Xin [Author]; Zhai,-Junhui
  [Author]; Du,-Zongmin [Author]; Liu,-Ying [Author]; Zhang,-Yong [Author]; Li,
  -Linhai [Author]; Wang,-Jian [Author]; Sun,-Bing [Author]; Yang,-Ruifu [Author,
  -Reprint-Author]
AD: Acad Mil Med Sci, Inst Microbiol and Epidemiol, 20 Dongdajie, Beijing
  100071, Peoples R China
EMA: yangrf@nic.bmi.ac.cn
SO: Microbes-and-Infection. 2005; 7(5-6): 882-889
PY: 2005
DT: Article
IS: 1286-4579
LA: English
AB: A novel coronavirus, the severe acute respiratory syndrome (SARS)
  coronavirus (SARS-CoV), was identified as the causative agent of SARS. The
  profile of specific antibodies to individual proteins of the virus is critical
  to the development of vaccine and diagnostic tools. In this study, 13
  recombinant proteins associated with four structural proteins (S, E, M and N)
  and five putative uncharacterized proteins (3a, 3b, 6, 7a and 9b) of the SARS
  -CoV were prepared and used for screening and monitoring their specific IgG
  antibodies in SARS patient sera by protein microarray. Antibodies to proteins
  S, 3a, N and 9b were detected in the sera from convalescent-phase SARS
  patients, whereas those to proteins E, M, 3b, 6 and 7a were undetected. In the
  detectable specific antibodies, anti-S and anti-N were dominant and could
  persist in the sera of SARS patients until week 30. Among the rabbit antisera
  to recombinant proteins S3, N, 3a and 9b, only anti-S3 serum showed significant
  neutralizing activity to the SARS-CoV infection in Vero E6 cells. The results
  suggest (1) that anti-S and anti-N antibodies are diagnostic markers and in
  particular that S3 is immunogenic and therefore is a good candidate as a
  subunit vaccine antigen; and (2) that, from a virus structure viewpoint, the
  presence in some human sera of antibodies reacting with two recombinant
  polypeptides, 3a and 9b, supports the hypothesis that they are synthesized
  during the virus cycle. (c) 2005 Elsevier SAS. All rights reserved.
AI: Y
MC: Infection-; Biochemistry-and-Molecular-Biophysics
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-; SARS-virus (Coronaviridae
  -): common-, Severe-Acute-Respiratory-Syndrome-virus, common-; human-
  (Hominidae-): common-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: serum-: blood-and-lymphatics
CB: IgG-: immunoglobulin-G; protein-S; protein-N; protein-3a; protein-9b
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease
MI: antibody-response
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10060- (Biochemistry
  -studies-General)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510180280
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1286
  -4579&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1286
  -4579&isbn=&volume=7&issue=5-6&spage=882&pages=882
  -889&date=2005&title=Microbes%20and%20Infection&atitle=Antibody%20responses%20to
  %20individual%20proteins%20of%20SARS%20coronavirus%20and%20their%20neutralizatio
  n%20activities&aulast=Qiu&pid=%3Cauthor%3EQiu%2c%20Maofeng%3bShi%2c%20Yuling%3bG
  uo%2c%20Zhaobiao%3bChen%2c%20Zeliang%3bHe%2c%20Rongqiao%3bChen%2c%20Runsheng%3bZ
  hou%2c%20Dongsheng%3bDai%2c%20Erhei%3bWang%2c%20Xiaoyi%3bSi%2c%20Bingyin%3bSong%
  2c%20Yajun%3bLi%2c%20Jingxiang%3bYang%2c%20Ling%3bWang%2c%20Jin%3bWang%2c%20Hong
  xia%3bPang%2c%20Xin%3bZhai%2c%20Junhui%3bDu%2c%20Zongmin%3bLiu%2c%20Ying%3bZhang
  %2c%20Yong%3bLi%2c%20Linhai%3bWang%2c%20Jian%3bSun%2c%20Bing%3bYang%2c%20Ruifu%3
  C%2Fauthor%3E%3CAN%3E200510180280%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 97 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: An animal model of SARS produced by infection of Macaca mulatta with SARS
  coronavirus
AU: Qin,-Chuan [Author]; Wang,-Jianwel [Author]; Wei,-Qiang [Author]; She,
  -Mingpeng [Author]; Marasco,-Wayne-A [Author]; Jiang,-Hong [Author]; Tu,
  -Xinming [Author]; Zhu,-Hua [Author]; Ren,-Lili [Author]; Gao,-Hong [Author];
  Guo,-Li [Author]; Huang,-Lan [Author]; Yang,-Renquan [Author]; Cong,-Zhe
  [Author]; Guo,-Lan [Author]; Wang,-Yanbin [Author]; Liu,-Yali [Author]; Sun,
  -Yili [Author]; Duan,-Shumin [Author]; Qu,-Jianguo [Author]; Chen,-Liangbiao
  [Author]; Tong,-Wei [Author]; Ruan,-Li [Author]; Liu,-Peimao [Author]; Zhang,
  -Hua [Author]; Zhang,-Jianmin [Author]; Zhang,-Hyuan [Author]; Liu,-Depei
  [Author]; Liu,-Qian [Author]; Hong,-Tao [Author]; He,-Wei [Author,-Reprint
  -Author]
AD: Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, 5 Dong Dan San Tiao,
  Beijing 100005, Peoples R China
EMA: heweiimu@public.bta.net.cn
SO: Journal-of-Pathology. 2005; 206(3): 251-259
PY: 2005
DT: Article
IS: 0022-3417
LA: English
AB: A new SARS animal model was established by inoculating SARS coronavirus
  (SARS-CoV) into rhesus macaques (Macaca mulatta) through the nasal cavity.
  Pathological pulmonary changes were successively detected on days 5-60 after
  virus inoculation. All eight animals showed a transient fever 2-3 days after
  inoculation. Immunological, molecular biological, and pathological studies
  support the establishment of this SARS animal model. Firstly, SARS-CoV-specific
  IgGs were detected in the sera of macaques from 11 to 60 days after
  inoculation. Secondly, SARS-CoV RNA could be detected in pharyngeal swab
  samples using nested RT-PCR in all infected animals from 5 days after virus
  inoculation. Finally, histopathological changes of interstitial pneumonia were
  found in the lungs during the 60 days after viral inoculation: these changes
  were less marked at later time points, indicating that an active healing
  process together with resolution of an acute inflammatory response was taking
  place in these animals. This animal model should provide insight into the
  mechanisms of SARS-CoV-related pulmonary disease and greatly facilitate the
  development of vaccines and therapeutics against SARS. (c) Pathological Society
  of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
AI: Y
MC: Virology-; Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Macaca-mulatta (Cercopithecidae-): species-, rhesus-macaque, common-,
  newborn-, infant-, host-, female-, male-; SARS-coronavirus (Coronaviridae-):
  common-, pathogen-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
PS: lung-: respiratory-system; nasal-cavity: respiratory-system; sera-: blood
  -and-lymphatics
CB: RNA-; immunoglobulins-; vaccine-: immunologic-drug, immunostimulant-drug,
  vaccine-
DS: interstitial-pneumonia: respiratory-system-disease, infectious-disease;
  severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy
MI: histopathological-change; acute-inflammatory-response; pathological
  -pulmonary-change; pharyngeal-swab-sample; active-healing-process
CC: 10062- (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
10064-
  (Biochemistry-studies-Proteins-peptides-and-amino-acids)
12512- (Pathology
  -Therapy)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
22018- (Pharmacology-Immunological-processes
  -and-allergy)
33502- (Virology-General-and-methods)
34502- (Immunology
  -General-and-methods)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510179687
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -3417&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -3417&isbn=&volume=206&issue=3&spage=251&pages=251
  -259&date=2005&title=Journal%20of%20Pathology&atitle=An%20animal%20model%20of%20
  SARS%20produced%20by%20infection%20of%20Macaca%20mulatta%20with%20SARS%20coronav
  irus&aulast=Qin&pid=%3Cauthor%3EQin%2c%20Chuan%3bWang%2c%20Jianwel%3bWei%2c%20Qi
  ang%3bShe%2c%20Mingpeng%3bMarasco%2c%20Wayne%20A%3bJiang%2c%20Hong%3bTu%2c%20Xin
  ming%3bZhu%2c%20Hua%3bRen%2c%20Lili%3bGao%2c%20Hong%3bGuo%2c%20Li%3bHuang%2c%20L
  an%3bYang%2c%20Renquan%3bCong%2c%20Zhe%3bGuo%2c%20Lan%3bWang%2c%20Yanbin%3bLiu%2
  c%20Yali%3bSun%2c%20Yili%3bDuan%2c%20Shumin%3bQu%2c%20Jianguo%3bChen%2c%20Liangb
  iao%3bTong%2c%20Wei%3bRuan%2c%20Li%3bLiu%2c%20Peimao%3bZhang%2c%20Hua%3bZhang%2c
  %20Jianmin%3bZhang%2c%20Hyuan%3bLiu%2c%20Depei%3bLiu%2c%20Qian%3bHong%2c%20Tao%3
  bHe%2c%20Wei%3C%2Fauthor%3E%3CAN%3E200510179687%3C%2FAN%3E%3CDT%3EArticle%3C%2FD
  T%3E

Record 98 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Discovery of potent anilide inhibitors against the severe acute respiratory
  syndrome 3CL protease
AU: Shie,-Jiun-Jie [Author]; Fang,-Jim-Min [Author,-Reprint-Author]; Kuo,-Chih
  -Jung [Author]; Kuo,-Tun-Hsun [Author]; Liang,-Po-Huang [Author]; Huang,-Hung
  -Jyun [Author]; Yang,-Wen-Bin [Author]; Lin,-Chun-Hung [Author]; Chen,-Jiun
  -Ling [Author]; Wu,-Yin-Ta [Author]; Wong,-Chi-Huey [Author]
AD: Natl Taiwan Univ, Dept Chem, Taipei 106, Taiwan
EMA: jmfang@ntu.edu.tw
SO: Journal-of-Medicinal-Chemistry. 2005; 48(13): 4469-4473
PY: 2005
DT: Article
IS: 0022-2623
LA: English
AB: A diversified library of peptide anilides was prepared, and their inhibition
  activities against the SARS-CoV 3CL protease were examined by a fluorogenic
  tetradecapeptide substrate. The most potent inhibitor is an anilide derived
  from 2-chloro-4-nitroaniline, L-phenylalanine and 4-(dimethylamino)benzoic
  acid. This anilide is a competitive inhibitor of the SARS-CoV 3CL protease with
  K-i = 0.03 mu M. The molecular docking experiment indicates that the P1 residue
  of this anilide inhibitor is distant from the nucleophilic SH of Cys145 in the
  active site.
AI: Y
MC: Infection-; Biochemistry-and-Molecular-Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: L-phenylalanine: 63-91-2; anilides-: inhibitor-, P1-residue; 3CL-protease:
  inhibition-; 2-chloro-4-nitroaniline: 121-87-9; 4-(dimethylamino)benzoic-acid
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
RN: 63-91-2; 121-87-9
MI: molecular-docking-experiment
CC: 10060- (Biochemistry-studies-General)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510179521
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -2623&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -2623&isbn=&volume=48&issue=13&spage=4469&pages=4469
  -4473&date=2005&title=Journal%20of%20Medicinal%20Chemistry&atitle=Discovery%20of
  %20potent%20anilide%20inhibitors%20against%20the%20severe%20acute%20respiratory%
  20syndrome%203CL%20protease&aulast=Shie&pid=%3Cauthor%3EShie%2c%20Jiun%20Jie%3bF
  ang%2c%20Jim%20Min%3bKuo%2c%20Chih%20Jung%3bKuo%2c%20Tun%20Hsun%3bLiang%2c%20Po%
  20Huang%3bHuang%2c%20Hung%20Jyun%3bYang%2c%20Wen%20Bin%3bLin%2c%20Chun%20Hung%3b
  Chen%2c%20Jiun%20Ling%3bWu%2c%20Yin%20Ta%3bWong%2c%20Chi%20Huey%3C%2Fauthor%3E%3
  CAN%3E200510179521%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 99 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Pyrrolo[1,5]benzoxa(thia)zepines as a new class of potent apoptotic agents.
  Biological studies and identification of an intracellular location of their
  drug target
AU: Mc-Gee,-Margaret-M [Author]; Gemma,-Sandra [Author]; Butini,-Stefania
  [Author]; Ramunno,-Anna [Author]; Zisterer,-Daniela-M [Author]; Fattorusso,
  -Caterina [Author]; Catalanotti,-Bruno [Author]; Kukreja,-Gagan [Author];
  Fiorini,-Isabella [Author]; Pisano,-Claudio [Author]; Cucco,-Carla [Author];
  Novellino,-Ettore [Author]; Nacci,-Vito [Author]; Williams,-D-Clive [Author];
  Campiani,-Giuseppe [Author,-Reprint-Author]
AD: Univ Siena, Dipartimento Farmacochim Tecnol, Via Aldo Moro, I-53100 Siena,
  Italy
EMA: campiani@unisi.it
SO: Journal-of-Medicinal-Chemistry. 2005; 48(13): 4367-4377
PY: 2005
DT: Article
IS: 0022-2623
LA: English
AB: We have recently developed five novel pyrrolo-1,5-benzoxazepines as
  proapoptotic agents. Their JNK-dependent induction of apoptosis in tumor cells
  suggested their potential as novel anticancer agents. The core structure of the
  apoptotic agent 6 was investigated, and the SARs were expanded with the design
  and synthesis of several analogues. To define the apoptotic mechanism of the
  new compounds and the localization of their drug target, two analogues of 6
  were designed and synthesized to delineate events leading to JNK activation.
  The cell-penetrating compound 16 induced apoptosis in tumor cells, while its
  nonpenetrating analogue, 17, was incapable of inducing apoptosis or activating
  JNK. Plasma membrane permeabilization of tumor cells resulted in 17-induced JNK
  activation, suggesting that the pyrrolo-1,5-benzoxazepine molecular target is
  intracellular. Interestingly, compound 6 displayed cytotoxic activity against a
  panel of human tumor cell lines but demonstrated negligible toxicity in vivo
  with no effect on the animals' hematology parameters.
AI: Y
MC: Pharmacology-; Tumor-Biology; Biochemistry-and-Molecular-Biophysics
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia
  -; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: MCF-7-cell-line (Hominidae-): cell_line-, human-breast-carcinoma-cells;
  1321N1-cell-line (Hominidae-): cell_line-, astrocytoma-cells; HL-60-cell-line
  (Hominidae-): cell_line-, human-acute-myelocytic-leukemia-cells; Hut-78-cell
  -line (Hominidae-): cell_line-, T-cell-lymphoma-cells; CML-cell-line (Hominidae
  -): cell_line-, chronic-myelogenous-leukemia-cells; C6-cell-line (Muridae-):
  cell_line-, rat-glioma-cells
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates
  -; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-
PS: plasma-membrane
CB: c-Jun-N-terminal-kinase: JNK-, 155215-87-5; pyrrolo[1,5]benzoxa(thia)zepine
  -: antineoplastic-drug, proapoptotic-agent
DS: tumor-: (Neoplasms-(MeSH)), neoplastic-disease
RN: 155215-87-5
MI: specific-absorption-rate; apoptotic-mechanism; intracellular-location; drug
  -target-localization; cell-penetrating-compound; hematology-parameter
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10060- (Biochemistry
  -studies-General)
12512- (Pathology-Therapy)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
24004- (Neoplasms
  -Pathology-clinical-aspects-and-systemic-effects)
24008- (Neoplasms
  -Therapeutic-agents-and-therapy)
AN: 200510179512
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -2623&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -2623&isbn=&volume=48&issue=13&spage=4367&pages=4367
  -4377&date=2005&title=Journal%20of%20Medicinal%20Chemistry&atitle=Pyrrolo%5b1%2c
  5%5dbenzoxa%28thia%29zepines%20as%20a%20new%20class%20of%20potent%20apoptotic%20
  agents.%20Biological%20studies%20and%20identification%20of%20an%20intracellular%
  20location%20of%20their%20drug%20target&aulast=Mc
  -Gee&pid=%3Cauthor%3EMc%20Gee%2c%20Margaret%20M%3bGemma%2c%20Sandra%3bButini%2c%
  20Stefania%3bRamunno%2c%20Anna%3bZisterer%2c%20Daniela%20M%3bFattorusso%2c%20Cat
  erina%3bCatalanotti%2c%20Bruno%3bKukreja%2c%20Gagan%3bFiorini%2c%20Isabella%3bPi
  sano%2c%20Claudio%3bCucco%2c%20Carla%3bNovellino%2c%20Ettore%3bNacci%2c%20Vito%3
  bWilliams%2c%20D%20Clive%3bCampiani%2c%20Giuseppe%3C%2Fauthor%3E%3CAN%3E20051017
  9512%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 100 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Recurrent mutations associated with isolation and passage of SARS
  coronavirus in cells from non-human primates
AU: Poon,-Leo-L-M [Author]; Leung,-Cynthia-S-W [Author]; Chan,-Kwok-H [Author];
  Yuen,-Kwok-Y [Author]; Guan,-Yi [Author]; Peiris,-Joseph-S-M [Author,-Reprint
  -Author]
AD: Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Pokfulam, Hong Kong, Hong
  Kong, Peoples R China
EMA: malik@hkucc.hku.hk
SO: Journal-of-Medical-Virology. 2005; 76(4): 435-440
PY: 2005
DT: Article
IS: 0146-6615
LA: English
AB: Four clinical isolates of SARS coronavirus were serially passaged in two
  primate cell lines (FRhK4 and Vero E6). Viral genetic sequences encoding for
  structural proteins and open reading frames 6-8 were determined in the original
  clinical specimen, the initial virus isolate (passage 0) and at passages 5, 10,
  and 15. After 15 passages, a total of 15 different mutations were identified
  and 12 of them were non-synonymous mutations. Seven of these mutations were
  recurrent mutation and all located at the spike, membrane, and Orf 8a protein
  encoding sequences. Mutations in the membrane protein and a deletion in ORF 6-8
  were already observed in passage 0, suggesting these amino acid substitutions
  are important in the adaptation of the virus isolate in primate cell culture. A
  mutation in the spike gene (residue 24079) appeared to be unique to adaptation
  in FRhK4 cells. It is important to be aware of cell culture associated
  mutations when interpreting data on molecular evolution of SARS coronavirus.
  (c) 2005 Wiley-Liss, Inc.
AI: Y
MC: Infection-; Methods-and-Techniques; Molecular-Genetics: Biochemistry-and
  -Molecular-Biophysics; Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[86190-] Primates-, -Mammalia, Vertebrata-, Chordata-,
  Animalia-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-; Severe-acute-respiratory
  -syndrome-virus (Coronaviridae-): species-, SARS-virus, common-, pathogen-;
  human- (Hominidae-): common-, host-; FRhK4-cell-line (Primates-): cell_line-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-;
  Primates-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-
CB: membrane-protein; spike-protein; open-reading-frames-6-8
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: cell-culture: laboratory-techniques, culturing-techniques
MI: recurrent-mutation; viral-isolation; viral-passage
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
03502- (Genetics
  -General)
03506- (Genetics-Animal)
03508- (Genetics-Human)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
31500- (Genetics-of-bacteria-and-viruses)
32500- (Tissue-culture
  -apparatus-methods-and-media)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510179464
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0146
  -6615&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0146
  -6615&isbn=&volume=76&issue=4&spage=435&pages=435
  -440&date=2005&title=Journal%20of%20Medical%20Virology&atitle=Recurrent%20mutati
  ons%20associated%20with%20isolation%20and%20passage%20of%20SARS%20coronavirus%20
  in%20cells%20from%20non
  -human%20primates&aulast=Poon&pid=%3Cauthor%3EPoon%2c%20Leo%20L%20M%3bLeung%2c%2
  0Cynthia%20S%20W%3bChan%2c%20Kwok%20H%3bYuen%2c%20Kwok%20Y%3bGuan%2c%20Yi%3bPeir
  is%2c%20Joseph%20S%20M%3C%2Fauthor%3E%3CAN%3E200510179464%3C%2FAN%3E%3CDT%3EArti
  cle%3C%2FDT%3E

Record 101 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: SARS, emerging diseases, healthcare workers and respirators
AU: Lange,-J-H [Author,-Reprint-Author]
AD: Envirosafe Training and Consultants, POB 114022, Pittsburgh, PA 15239 USA
EMA: johnhlange@worldnet.att.net
SO: Journal-of-Hospital-Infection. 2005; 60(3): 293
PY: 2005
DT: Letter
IS: 0195-6701
LA: English
MC: Methods-and-Techniques; Infection-; Pulmonary-Medicine: Human-Medicine,
  Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, female-, male-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, transmission-; avian
  -influenza: (Influenza-(MeSH)), respiratory-system-disease, viral-disease,
  transmission-; severe-acute-respiratory-syndrome-coronavirus: SARS-CoV,
  respiratory-system-disease, viral-disease, transmission-
MQ: respiratory-therapy: therapeutic-and-prophylactic-techniques, clinical
  -techniques; aerosolization-: aerosol-therapy, therapeutic-and-prophylactic
  -techniques, clinical-techniques
MI: healthcare-workers; respiratory-protection; personal-protective-equipment;
  airborne-transmission
CC: 16006- (Respiratory-system-Pathology)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510179139
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0195
  -6701&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0195
  -6701&isbn=&volume=60&issue=3&spage=&pages=293&date=2005&title=Journal%20of%20Ho
  spital%20Infection&atitle=SARS%2c%20emerging%20diseases%2c%20healthcare%20worker
  s%20and%20respirators&aulast=Lange&pid=%3Cauthor%3ELange%2c%20J%20H%3C%2Fauthor%
  3E%3CAN%3E200510179139%3C%2FAN%3E%3CDT%3ELetter%3C%2FDT%3E

Record 102 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: ABO blood group and susceptibility to severe acute respiratory syndrome (vol
  293, pg 1450, 2005)
AU: Cheng,-Yunfeng [Author]
SO: JAMA-(Journal-of-the-American-Medical-Association). 2005; 294(7): 794
PY: 2005
DT: Errata; Article
IS: 0098-7484
LA: English
MC: Infection-; Hematology-: Human-Medicine, Medical-Sciences; Pulmonary
  -Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: blood-: blood-and-lymphatics
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MI: ABO-blood-group; infection-susceptibility
CC: 15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
15006- (Blood-Blood-lymphatic-and-reticuloendothelial
  -pathologies)
16006- (Respiratory-system-Pathology)
33502- (Virology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510178092
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0098
  -7484&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0098
  -7484&isbn=&volume=294&issue=7&spage=&pages=794&date=2005&title=JAMA%20%28Journa
  l%20of%20the%20American%20Medical%20Association%29&atitle=ABO%20blood%20group%20
  and%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20%28vol%202
  93%2c%20pg%201450%2c%202005%29&aulast=Cheng&pid=%3Cauthor%3ECheng%2c%20Yunfeng%3
  C%2Fauthor%3E%3CAN%3E200510178092%3C%2FAN%3E%3CDT%3EErrata%3bArticle%3C%2FDT%3E

Record 103 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: The impact of the global SARS epidemic on the local public health system in
  Hamburg
AU: Schlaich,-C [Author,-Reprint-Author]; Hamburger-Arbeitskreis
  -Infektionsepidemiologie [Reprint-Author,-Author]
SO: Infection-. 2005; 33(3): 206
PY: 2005
DT: Meeting-Abstract; Meeting
IS: 0300-8126
MT: 8th Congress of Infectious Diseases and Tropical Medicine, Hamburg, GERMANY;
  June 09 -11, 2005 
LA: English
MC: Infection-; Epidemiology-: Population-Studies; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
GE: Hamburg-: Germany-, Europe-, Palearctic-region
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease, epidemiology-
MI: public-health-system
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
16006-
  (Respiratory-system-Pathology)
36006- (Medical-and-clinical-microbiology
  -Virology)
37052- (Public-health-epidemiology-Communicable-diseases)
37054-
  (Public-health-epidemiology-Organic-diseases-and-neoplasms)
37056- (Public
  -health-epidemiology-Miscellaneous)
AN: 200510177748
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0300
  -8126&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0300
  -8126&isbn=&volume=33&issue=3&spage=&pages=206&date=2005&title=Infection%20&atit
  le=The%20impact%20of%20the%20global%20SARS%20epidemic%20on%20the%20local%20publi
  c%20health%20system%20in%20Hamburg&aulast=Schlaich&pid=%3Cauthor%3ESchlaich%2c%2
  0C%3bHamburger%20Arbeitskreis%20Infektionsepidemiologie%3C%2Fauthor%3E%3CAN%3E20
  0510177748%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 104 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Human monoclonal antibodies for the control of emerging viral infections
AU: Ter-Meulen,-J [Author]; de-Kruif,-J [Author]; Torsby,-M [Author]; Bakker,-A
  [Author]; Goudsmith,-J [Author]
SO: Infection-. 2005; 33(3): 185
PY: 2005
DT: Meeting-Abstract; Meeting
IS: 0300-8126
MT: 8th Congress of Infectious Diseases and Tropical Medicine, Hamburg, GERMANY;
  June 09 -11, 2005 
LA: English
MC: Infection-; Immune-System: Chemical-Coordination-and-Homeostasis
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: IgG-antibody: immunoglobulin-G-antibody; monoclonal-antibody: human-
DS: viral-infection: (Virus-Diseases-(MeSH)), viral-disease; SARS-: severe-acute
  -respiratory-syndrome, respiratory-system-disease, viral-disease
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
16006-
  (Respiratory-system-Pathology)
33502- (Virology-General-and-methods)
34502-
  (Immunology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510177687
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0300
  -8126&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0300
  -8126&isbn=&volume=33&issue=3&spage=&pages=185&date=2005&title=Infection%20&atit
  le=Human%20monoclonal%20antibodies%20for%20the%20control%20of%20emerging%20viral
  %20infections&aulast=Ter
  -Meulen&pid=%3Cauthor%3ETer%20Meulen%2c%20J%3bde%20Kruif%2c%20J%3bTorsby%2c%20M%
  3bBakker%2c%20A%3bGoudsmith%2c%20J%3C%2Fauthor%3E%3CAN%3E200510177687%3C%2FAN%3E
  %3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 105 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Combating viral infections: from smallpox to polio, SARS and avian influenza
AU: Heymann,-D [Author,-Reprint-Author]
SO: Infection-. 2005; 33(3): 184-185
PY: 2005
DT: Meeting-Abstract; Meeting
IS: 0300-8126
MT: 8th Congress of Infectious Diseases and Tropical Medicine, Hamburg, GERMANY;
  June 09 -11, 2005 
LA: English
MC: Pharmacology-; Infection-; Immune-System: Chemical-Coordination-and
  -Homeostasis
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-; -[03603-] Picornaviridae-, -Positive-Sense
  -ssRNA-Viruses, Viruses-, Microorganisms-; -[03110-] Poxviridae-, -dsDNA
  -Viruses, Viruses-, Microorganisms-; -[03305-] Retroviridae-, -DNA-and-RNA
  -Reverse-Transcribing-Viruses, Viruses-, Microorganisms-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-; Avian
  -influenza-virus (Orthomyxoviridae-): common-, pathogen-; influenza-virus
  (Orthomyxoviridae-): common-, pathogen-, strain-H5N1; poliovirus-
  (Picornaviridae-): common-, pathogen-; Smallpox-virus (Poxviridae-): common-,
  Variola-virus, species-, pathogen-; Acquired-immunodeficiency-syndrome
  -retrovirus (Retroviridae-): common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Orthomyxoviridae-: Microorganisms-, Negative-Sense-Single
  -Stranded-RNA-Viruses, Viruses-; Picornaviridae-: Microorganisms-, Positive
  -Sense-Single-Stranded-RNA-Viruses, Viruses-; Poxviridae-: Double-Stranded-DNA
  -Viruses, Microorganisms-, Viruses-; Retroviridae-: DNA-and-RNA-Reverse
  -Transcribing-Viruses, Microorganisms-, Viruses-
CB: oral-polio-vaccine: immunologic-drug, immunostimulant-drug, vaccine-
GE: Thailand-: Asia-, Oriental-region; Vietnam-: Asia-, Oriental-region;
  Cambodia-: Asia-, Oriental-region
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease; smallpox-: (Smallpox-(MeSH)), viral-disease; polio-: (Poliomyelitis
  -(MeSH)), nervous-system-disease, viral-disease, transmission-; avian
  -influenza: (Influenza-(MeSH)), viral-disease
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
12512-
  (Pathology-Therapy)
16006- (Respiratory-system-Pathology)
20506- (Nervous
  -system-Pathology)
22002- (Pharmacology-General)
22005- (Pharmacology
  -Clinical-pharmacology)
22018- (Pharmacology-Immunological-processes-and
  -allergy)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510177685
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0300
  -8126&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0300
  -8126&isbn=&volume=33&issue=3&spage=184&pages=184
  -185&date=2005&title=Infection%20&atitle=Combating%20viral%20infections%3a%20fro
  m%20smallpox%20to%20polio%2c%20SARS%20and%20avian%20influenza&aulast=Heymann&pid
  =%3Cauthor%3EHeymann%2c%20D%3C%2Fauthor%3E%3CAN%3E200510177685%3C%2FAN%3E%3CDT%3
  EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 106 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Molecular detection of rare and emerging viruses
AU: Drosten,-C [Author,-Reprint-Author]
SO: Infection-. 2005; 33(3): 177
PY: 2005
DT: Meeting-Abstract; Meeting
IS: 0300-8126
MT: 8th Congress of Infectious Diseases and Tropical Medicine, Hamburg, GERMANY;
  June 09 -11, 2005 
LA: English
MC: Epidemiology-: Population-Studies; Infection-; Molecular-Genetics:
  Biochemistry-and-Molecular-Biophysics; Pulmonary-Medicine: Human-Medicine,
  Medical-Sciences
ST: -[03507-] Arenaviridae-, -Negative-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03506-] Bunyaviridae-, -Negative-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-; -[03502-] Filoviridae-, -Negative-Sense
  -ssRNA-Viruses, Viruses-, Microorganisms-; -[86215-] Hominidae-, -Primates,
  Mammalia-, Vertebrata-, Chordata-, Animalia-; -[03505-] Orthomyxoviridae-, 
  -Negative-Sense-ssRNA-Viruses, Viruses-, Microorganisms-
OR: Lassa-virus (Arenaviridae-): species-, pathogen-; Crimean-Congo-hemorrhagic
  -fever-virus (Bunyaviridae-): species-, pathogen-; Severe-Acute-Respiratory
  -Syndrome-virus (Coronaviridae-): common-, SARS-virus, common-, pathogen-;
  Marburg-virus (Filoviridae-): species-, pathogen-; Ebola-virus (Filoviridae-):
  common-, pathogen-; human- (Hominidae-): common-, adult-, host-; Influenza-A
  -virus (Orthomyxoviridae-): species-
TN: Arenaviridae-: Microorganisms-, Negative-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Bunyaviridae-: Microorganisms-, Negative-Sense-Single-Stranded-RNA
  -Viruses, Viruses-; Coronaviridae-: Microorganisms-, Positive-Sense-Single
  -Stranded-RNA-Viruses, Viruses-; Filoviridae-: Microorganisms-, Negative-Sense
  -Single-Stranded-RNA-Viruses, Viruses-; Hominidae-: Animals-, Chordates-,
  Humans-, Mammals-, Primates-, Vertebrates-; Orthomyxoviridae-: Microorganisms-,
  Negative-Sense-Single-Stranded-RNA-Viruses, Viruses-
PS: respiratory-system: respiratory-system
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, infectious-disease, viral-disease,
  transmission-, mortality-, diagnosis-; hemorrhagic-fever: viral-disease,
  infectious-disease, transmission-, genetics-, diagnosis-, etiology-; nosocomial
  -infection: (Cross-Infection-(MeSH)), infectious-disease, transmission-,
  diagnosis-; influenza-: (Influenza-(MeSH)), respiratory-system-disease,
  infectious-disease, viral-disease, transmission-, diagnosis-
MQ: PCR-: polymerase-chain-reaction, laboratory-techniques, genetic-techniques
MI: quality-assurance-program; genetic-variability
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
03502-
  (Genetics-General)
03508- (Genetics-Human)
10062- (Biochemistry-studies
  -Nucleic-acids-purines-and-pyrimidines)
12504- (Pathology-Diagnostic)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
31500- (Genetics-of-bacteria-and-viruses)
33502- (Virology
  -General-and-methods)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37052- (Public
  -health-epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510177661
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0300
  -8126&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0300
  -8126&isbn=&volume=33&issue=3&spage=&pages=177&date=2005&title=Infection%20&atit
  le=Molecular%20detection%20of%20rare%20and%20emerging%20viruses&aulast=Drosten&p
  id=%3Cauthor%3EDrosten%2c%20C%3C%2Fauthor%3E%3CAN%3E200510177661%3C%2FAN%3E%3CDT
  %3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 107 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Aspects of the reliability of virus diagnostics
AU: Zeichhardt,-H [Author,-Reprint-Author]; Grunert,-H-P [Author]; Lindig,-V
  [Author]; Habermehl,-K-O [Author]
SO: Infection-. 2005; 33(3): 169
PY: 2005
DT: Meeting-Abstract; Meeting
IS: 0300-8126
MT: 8th Congress of Infectious Diseases and Tropical Medicine, Hamburg, GERMANY;
  June 09 -11, 2005 
LA: English
MC: Infection-; Gastroenterology-: Human-Medicine, Medical-Sciences; Clinical
  -Immunology: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03615-] Flaviviridae-, -Positive-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-; -[03301-] Hepadnaviridae-, -DNA-and-RNA-Reverse
  -Transcribing-Viruses, Viruses-, Microorganisms-; -[86215-] Hominidae-, 
  -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-; -[03505-]
  Orthomyxoviridae-, -Negative-Sense-ssRNA-Viruses, Viruses-, Microorganisms-; 
  -[03603-] Picornaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03305-] Retroviridae-, -DNA-and-RNA-Reverse-Transcribing
  -Viruses, Viruses-, Microorganisms-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; Hepatitis-C-virus (Flaviviridae-): species-,
  pathogen-; Hepatitis-B-virus (Hepadnaviridae-): species-, pathogen-; human-
  (Hominidae-): common-, host-; Influenza-virus (Orthomyxoviridae-): common-,
  pathogen-; Hepatitis-A-virus (Picornaviridae-): species-, pathogen-;
  Enterovirus- (Picornaviridae-): species-, pathogen-; Human-immunodeficiency
  -virus (Retroviridae-): common-, HIV-, common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Flaviviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA
  -Viruses, Viruses-; Hepadnaviridae-: DNA-and-RNA-Reverse-Transcribing-Viruses,
  Microorganisms-, Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-,
  Primates-, Vertebrates-; Orthomyxoviridae-: Microorganisms-, Negative-Sense
  -Single-Stranded-RNA-Viruses, Viruses-; Picornaviridae-: Microorganisms-,
  Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-; Retroviridae-: DNA-and
  -RNA-Reverse-Transcribing-Viruses, Microorganisms-, Viruses-
DS: human-immunodeficiency-virus-infection: HIV-infection, (HIV-Infections
  -(MeSH)), viral-disease, immune-system-disease, etiology-; hepatitis-B-virus
  -infection: digestive-system-disease, viral-disease, etiology-; hepatitis-C
  -virus-infection: digestive-system-disease, viral-disease, etiology-; hepatitis
  -A-virus-infection: digestive-system-disease, viral-disease, etiology-
MQ: PCR-: polymerase-chain-reaction, laboratory-techniques, genetic-techniques;
  cell-culture: laboratory-techniques, culturing-techniques; serological-testing:
  clinical-techniques, diagnostic-techniques
MI: quality-control; WHO-
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10062-
  (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
14006- (Digestive
  -system-Pathology)
32500- (Tissue-culture-apparatus-methods-and-media)
33502-
  (Virology-General-and-methods)
34508- (Immunology-Immunopathology-tissue
  -immunology)
36006- (Medical-and-clinical-microbiology-Virology)
36504-
  (Medical-and-clinical-microbiology-Serodiagnosis)
AN: 200510177636
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0300
  -8126&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0300
  -8126&isbn=&volume=33&issue=3&spage=&pages=169&date=2005&title=Infection%20&atit
  le=Aspects%20of%20the%20reliability%20of%20virus%20diagnostics&aulast=Zeichhardt
  &pid=%3Cauthor%3EZeichhardt%2c%20H%3bGrunert%2c%20H%20P%3bLindig%2c%20V%3bHaberm
  ehl%2c%20K%20O%3C%2Fauthor%3E%3CAN%3E200510177636%3C%2FAN%3E%3CDT%3EMeeting%20Ab
  stract%3bMeeting%3C%2FDT%3E

Record 108 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Asymptomatic SARS coronavirus infection among healthcare workers, Singapore
AU: Wilder-Smith,-Annelies [Author,-Reprint-Author]; Teleman,-Monica-D [Author];
  Heng,-Bee-H [Author]; Earnest,-Arul [Author]; Ling,-Ali-E [Author]; Leo,-Yee-S
  [Author]
AD: Tan Tock Seng Hosp, Singapore, Singapore
EMA: epvws@pacific.net.sg
SO: Emerging-Infectious-Diseases. 2005; 11(7): 1142-1145
PY: 2005
DT: Article
IS: 1080-6040
LA: English
AB: We conducted a study among healthcare workers (HCWs) exposed to patients
  with severe acute respiratory syndrome (SARS) before infection control measures
  were instituted. Of all exposed HCWs, 7.5% had asymptomatic SARS-positive
  cases. Asymptomatic SARS was associated with lower SARS antibody titers and
  higher use of masks when compared to pneumonic SARS.
AI: Y
MC: Epidemiology-: Population-Studies; Infection-; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-acute-respiratory-syndrome-virus (Coronaviridae-): species-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, adult-, host-, female
  -, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: severe-acute-respiratory-syndrome-antibody: SARS-antibody
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-, etiology-
MI: healthcare-worker; asymptomatic-infection; infection-control-measures
CC: 16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37052- (Public
  -health-epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510176144
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1080
  -6040&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1080
  -6040&isbn=&volume=11&issue=7&spage=1142&pages=1142
  -1145&date=2005&title=Emerging%20Infectious%20Diseases&atitle=Asymptomatic%20SAR
  S%20coronavirus%20infection%20among%20healthcare%20workers%2c%20Singapore&aulast
  =Wilder-Smith&pid=%3Cauthor%3EWilder%20Smith%2c%20Annelies%3bTeleman%2c%20Monica
  %20D%3bHeng%2c%20Bee%20H%3bEarnest%2c%20Arul%3bLing%2c%20Ali%20E%3bLeo%2c%20Yee%
  20S%3C%2Fauthor%3E%3CAN%3E200510176144%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 109 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: SARS coronavirus detection methods
AU: Lau,-Susanna-K-P [Author]; Che,-Xiao-Yan [Author]; Woo,-Patrick-C-Y
  [Author]; Wong,-Beatrice-H-L [Author]; Cheng,-Vincent-C-C [Author]; Woo,-Gibson
  -K-S [Author]; Hung,-Ivan-F-N [Author]; Poon,-Rosana-W-S [Author]; Chan,-Kwok
  -Hung [Author]; Peiris,-J-S-Malik [Author]; Yuen,-Kwok-Yung [Author,-Reprint
  -Author]
AD: Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Univ Pathol Bldg, Hong
  Kong, Hong Kong, Peoples R China
EMA: hkumicro@hkucc.hku.hk
SO: Emerging-Infectious-Diseases. 2005; 11(7): 1108-1111
PY: 2005
DT: Article
IS: 1080-6040
LA: English
AB: Using clinical samples from patients with severe acute respiratory syndrome,
  we showed that the sensitivities of a quantitative reverse transcription
  -polymerase chain reaction (80% for fecal samples and 25% for urine samples)
  were higher than those of the polyclonal (50% and 5%) and monoclonal (35% and
  8%) antibody-based nucleocapsid antigen capture enzyme-linked immunosorbent
  assays.
AI: Y
MC: Methods-and-Techniques; Digestive-System: Ingestion-and-Assimilation;
  Respiratory-System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: urine-: excretory-system; feces-: digestive-system
CB: monoclonal-antibody; polyclonal-antibody; nucleocapsid-antigen
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, diagnosis-
MQ: quantitative-reverse-transcriptase-polymerase-chain-reaction: laboratory
  -techniques, genetic-techniques; enzyme-linked-immunosorbent-assay: laboratory
  -techniques, immunologic-techniques
CC: 12504- (Pathology-Diagnostic)
14004- (Digestive-system-Physiology-and
  -biochemistry)
15504- (Urinary-system-Physiology-and-biochemistry)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510176134
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1080
  -6040&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1080
  -6040&isbn=&volume=11&issue=7&spage=1108&pages=1108
  -1111&date=2005&title=Emerging%20Infectious%20Diseases&atitle=SARS%20coronavirus
  %20detection%20methods&aulast=Lau&pid=%3Cauthor%3ELau%2c%20Susanna%20K%20P%3bChe
  %2c%20Xiao%20Yan%3bWoo%2c%20Patrick%20C%20Y%3bWong%2c%20Beatrice%20H%20L%3bCheng
  %2c%20Vincent%20C%20C%3bWoo%2c%20Gibson%20K%20S%3bHung%2c%20Ivan%20F%20N%3bPoon%
  2c%20Rosana%20W%20S%3bChan%2c%20Kwok%20Hung%3bPeiris%2c%20J%20S%20Malik%3bYuen%2
  c%20Kwok%20Yung%3C%2Fauthor%3E%3CAN%3E200510176134%3C%2FAN%3E%3CDT%3EArticle%3C%
  2FDT%3E

Record 110 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Emergency department response to SARS, Taiwan
AU: Chen,-Wei-Kung [Author,-Reprint-Author]; Wu,-Hong-Dar-Isaac [Author]; Lin,
  -Cheng-Chieh [Author]; Cheng,-Yi-Chang [Author]
AD: China Med Univ Hosp, Dept Emergency Med, 2 Yuh Der Rd, Taichung 404, Taiwan
EMA: ercwk@www.cmuh.org.tw
SO: Emerging-Infectious-Diseases. 2005; 11(7): 1067-1073
PY: 2005
DT: Article
IS: 1080-6040
LA: English
AB: How emergency departments of different levels and types cope with a large
  -scale contagious infectious disease is unclear. We retrospectively analyzed
  the response of 100 emergency departments regarding use of personal protective
  equipment (PPE) and implementation of infection control measures (ICMs) during
  the severe acute respiratory syndrome outbreak in Taiwan. Emergency department
  workers in large hospitals were more severely affected by the epidemic. Large
  hospitals or public hospitals were more likely to use respirators. Small
  hospitals implemented more restrictive ICMs. Most emergency departments
  provided PPE (80%) and implemented ICMs (66%) at late stages of the outbreak.
  Instructions to use PPE or ICMs more frequently originated by emergency
  department administrators. The difficulty of implementing ICMs was
  significantly negatively correlated with their effectiveness. Because ability
  to prepare for and respond to emerging infectious diseases varies among
  hospitals, grouping infectious patients in a centralized location in an early
  stage of infection may reduce the extent of epidemics.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences; Hospital-Administration: Allied-Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
GE: Taiwan-: Asia-, Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: personal-protective-equipment: field-equipment
MI: infection-control-measure; emergency-department-response
CC: 16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37010- (Public
  -health-Public-health-administration-and-statistics)
37052- (Public-health
  -epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510176125
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1080
  -6040&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1080
  -6040&isbn=&volume=11&issue=7&spage=1067&pages=1067
  -1073&date=2005&title=Emerging%20Infectious%20Diseases&atitle=Emergency%20depart
  ment%20response%20to%20SARS%2c%20Taiwan&aulast=Chen&pid=%3Cauthor%3EChen%2c%20We
  i%20Kung%3bWu%2c%20Hong%20Dar%20Isaac%3bLin%2c%20Cheng%20Chieh%3bCheng%2c%20Yi%2
  0Chang%3C%2Fauthor%3E%3CAN%3E200510176125%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 111 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: SARS vaccine development
AU: Jiang,-Shibo [Author,-Reprint-Author]; He,-Yuxian [Author]; Liu,-Shuwen
  [Author]
AD: New York Blood Ctr, Lindsley F Kimball Res Inst, 310 E 67th St, New York, NY
  10021 USA
EMA: SJiang@NYBloodcenter.org
SO: Emerging-Infectious-Diseases. 2005; 11(7): 1016-1020
PY: 2005
DT: Article
IS: 1080-6040
LA: English
AB: Developing effective and safe vaccines is urgently needed to prevent
  infection by severe acute respiratory syndrome (SARS)-associated coronavirus
  (SARS-CoV). The inactivated SARS-CoV vaccine may be the first one available for
  clinical use because it is easy to generate; however, safety is the main
  concern. The spike (S) protein of SARS-CoV is the major inducer of neutralizing
  antibodies, and the receptor-binding domain (RBD) in the S1 subunit of S
  protein contains multiple conformational neutralizing epitopes. This suggests
  that recombinant proteins containing RBD and vectors encoding the RBD sequence
  can be used to develop safe and effective SARS vaccines.
AI: Y
MC: Pharmacology-; Clinical-Immunology: Human-Medicine, Medical-Sciences;
  Infection-; Pulmonary-Medicine: Human-Medicine, Medical-Sciences; Serology-:
  Allied-Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: spike-protein; neutralizing-antibody; severe-acute-respiratory-syndrome
  -vaccine: SARS-vaccine, immunologic-drug, immunostimulant-drug, vaccine-,
  efficacy-, safety-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy, immunology-,
  prevention-and-control, etiology-, transmission-
CC: 12512- (Pathology-Therapy)
16006- (Respiratory-system-Pathology)
22002-
  (Pharmacology-General)
22005- (Pharmacology-Clinical-pharmacology)
22018-
  (Pharmacology-Immunological-processes-and-allergy)
33502- (Virology-General
  -and-methods)
34502- (Immunology-General-and-methods)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36006- (Medical-and-clinical-microbiology
  -Virology)
36504- (Medical-and-clinical-microbiology-Serodiagnosis)
AN: 200510176117
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1080
  -6040&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1080
  -6040&isbn=&volume=11&issue=7&spage=1016&pages=1016
  -1020&date=2005&title=Emerging%20Infectious%20Diseases&atitle=SARS%20vaccine%20d
  evelopment&aulast=Jiang&pid=%3Cauthor%3EJiang%2c%20Shibo%3bHe%2c%20Yuxian%3bLiu%
  2c%20Shuwen%3C%2Fauthor%3E%3CAN%3E200510176117%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT
  %3E

Record 112 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Occupational deaths among healthcare workers
AU: Sepkowitz,-Kent-A [Author,-Reprint-Author]; Eisenberg,-Leon [Author]
AD: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
EMA: sepkowik@mskcc.org
SO: Emerging-Infectious-Diseases. 2005; 11(7): 1003-1008
PY: 2005
DT: Article
IS: 1080-6040
LA: English
AB: Recent experiences with severe acute respiratory syndrome and the US
  smallpox vaccination program have demonstrated the vulnerability of healthcare
  workers to occupationally acquired infectious diseases. However, despite
  acknowledgment of risk, the occupational death rate for healthcare workers is
  unknown. In contrast, the death rate for other professions with occupational
  risk, such as police officer or firefighter, has been well defined. With
  available information from federal sources and calculating the additional
  number of deaths from infection by using data on prevalence and natural
  history, we estimate the annual death rate for healthcare workers from
  occupational events, including infection, is 17-57 per 1 million workers.
  However, a much more accurate estimate of risk is needed. Such information
  could inform future interventions, as was seen with the introduction of safer
  needle products. This information would also heighten public awareness of this
  often minimized but essential aspect of patient care.
AI: Y
MC: Occupational-Health: Allied-Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, healthcare-worker
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; smallpox-: (Smallpox
  -(MeSH)), viral-disease
MQ: vaccination-: clinical-techniques
CC: 16006- (Respiratory-system-Pathology)
36006- (Medical-and-clinical
  -microbiology-Virology)
37013- (Public-health-Occupational-health)
AN: 200510176115
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1080
  -6040&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1080
  -6040&isbn=&volume=11&issue=7&spage=1003&pages=1003
  -1008&date=2005&title=Emerging%20Infectious%20Diseases&atitle=Occupational%20dea
  ths%20among%20healthcare%20workers&aulast=Sepkowitz&pid=%3Cauthor%3ESepkowitz%2c
  %20Kent%20A%3bEisenberg%2c%20Leon%3C%2Fauthor%3E%3CAN%3E200510176115%3C%2FAN%3E%
  3CDT%3EArticle%3C%2FDT%3E

Record 113 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: The activities of infection control nurse in our hospital
AU: ICN-Team-Koshigaya-Hosp-Dokkyo-Univ-Sch-Med [Reprint-Author,-Author]
SO: Dokkyo-Journal-of-Medical-Sciences. 2004; 31(3): 301-305
PY: 2004
DT: Article
IS: 0385-5023
LA: Japanese
MC: Pharmacology-; Infection-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[07702-] Micrococcaceae-, -Gram-Positive-Cocci,
  Eubacteria-, Bacteria-, Microorganisms-; -[03305-] Retroviridae-, -DNA-and-RNA
  -Reverse-Transcribing-Viruses, Viruses-, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-; Staphylococcus
  -aureus (Micrococcaceae-): species-, pathogen-; Human-immunodeficiency-virus
  (Retroviridae-): common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Micrococcaceae-: Bacteria-, Eubacteria-, Microorganisms-;
  Retroviridae-: DNA-and-RNA-Reverse-Transcribing-Viruses, Microorganisms-,
  Viruses-
CB: methicillin-: 61-32-5, antibacterial-drug, antiinfective-drug
DS: human-immunodeficiency-virus-infection: HIV-infection, (HIV-Infections
  -(MeSH)), viral-disease, immune-system-disease; staphylococcal-infection:
  (Staphylococcal-Infections-(MeSH)), bacterial-disease; severe-combined
  -immunodeficiency-disease: immune-system-disease
RN: 61-32-5
MI: drug-resistance; infection-control
CC: 10060- (Biochemistry-studies-General)
12512- (Pathology-Therapy)
22002-
  (Pharmacology-General)
22005- (Pharmacology-Clinical-pharmacology)
31000-
  (Physiology-and-biochemistry-of-bacteria)
33502- (Virology-General-and
  -methods)
34508- (Immunology-Immunopathology-tissue-immunology)
36002-
  (Medical-and-clinical-microbiology-Bacteriology)
36006- (Medical-and-clinical
  -microbiology-Virology)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38504- (Chemotherapy-Antibacterial-agents)
AN: 200510176033
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0385
  -5023&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0385
  -5023&isbn=&volume=31&issue=3&spage=301&pages=301
  -305&date=2004&title=Dokkyo%20Journal%20of%20Medical%20Sciences&atitle=The%20act
  ivities%20of%20infection%20control%20nurse%20in%20our%20hospital&aulast=&pid=%3C
  author%3EICN%20Team%20Koshigaya%20Hosp%20Dokkyo%20Univ%20Sch%20Med%3C%2Fauthor%3
  E%3CAN%3E200510176033%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 114 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Biosafety level 3 laboratory for autopsies of patients with severe acute
  respiratory syndrome: Principles, practices, and prospects
AU: Li,-Ling [Author]; Gu,-Jiang [Author]; Shi,-Xicheng [Author]; Gong,-Encong
  [Author,-Reprint-Author]; Li,-Xingwang [Author]; Shao,-Hongquan [Author]; Shi,
  -Xueying [Author]; Jiang,-Huijun [Author]; Gao,-Xiaoqiang [Author]; Cheng,
  -Daiyun [Author]; Guo,-Lizhu [Author]; Wang,-Hao [Author]; Shi,-Xiaohong
  [Author]; Wang,-Peizhi [Author]; Zhang,-Qianying [Author]; Shen,-Bing [Author]
AD: Peking Univ, Sch Basic Med Sci, Dept Pathol, Hlth Sci Ctr, 38 Xueyuan Rd,
  Beijing 100083, Peoples R China
EMA: pathcon@bjmu.edu.cn
SO: Clinical-Infectious-Diseases. 2005; 41(6): 815-821
PY: 2005
DT: Article
IS: 1058-4838
LA: English
AB: Background. During the outbreak of the emergent severe acute respiratory
  syndrome (SARS) infection, > 30% of the similar to 8000 infected persons were
  health care workers. The highly infectious nature of SARS coronavirus (SARS
  -CoV) compelled our pathologists to consider biosafety issues in the autopsy
  room and for tissue processing procedures.Methods. A specially designed
  biosafety level 3 (BSL-3) autopsy laboratory was constructed and divided into a
  clean area, a semicontaminated area, a contaminated area, and 2 buffer zones.
  High-efficiency particulate air filters were placed in the air supply and
  exhaust systems. Laminar air flow was from the clean areas to the less clean
  areas. The negative pressures of the contaminated, semicontaminated, and clean
  areas were approximately -50 pa, -25 pa, and -5 pa, respectively. Personal
  protective equipment, including gas mask, impermeable protective clothing, and
  3 layers of gloves worn during autopsies; the equipment was decontaminated
  before it was allowed to exit the facility. Strict BSL-3 practices were
  followed.Results. When a given concentration of particulate sarin simulant was
  introduced into the contaminated area, it could not be detected in either the
  semicontaminated area or clean area, and particles > 0.3 mu m in size were not
  detected in the exhaust air. A total of 16 complete postmortem examinations for
  probable and suspected SARS were performed during a 2-month period. Of these, 7
  reported confirmed cases of SARS. None of the 23 pathologists and technicians
  who participated in these autopsies was infected with SARS-CoV.Conclusions. Our
  experience suggests that BSL-3 laboratory operating principles should be among
  the special requirements for performing autopsies of contaminated bodies and
  that they can safeguard the clinicians and the environment involved in these
  procedures.
AI: Y
MC: Infection-; Occupational-Health: Allied-Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-; human- (Hominidae-): common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: autopsy-: clinical-techniques, diagnostic-techniques
MI: health-care-workers; biosafety-level-autopsy-laboratory; tissue-processing
  -procedures
CC: 16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37013- (Public
  -health-Occupational-health)
AN: 200510175274
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1058
  -4838&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1058
  -4838&isbn=&volume=41&issue=6&spage=815&pages=815
  -821&date=2005&title=Clinical%20Infectious%20Diseases&atitle=Biosafety%20level%2
  03%20laboratory%20for%20autopsies%20of%20patients%20with%20severe%20acute%20resp
  iratory%20syndrome%3a%20Principles%2c%20practices%2c%20and%20prospects&aulast=Li
  &pid=%3Cauthor%3ELi%2c%20Ling%3bGu%2c%20Jiang%3bShi%2c%20Xicheng%3bGong%2c%20Enc
  ong%3bLi%2c%20Xingwang%3bShao%2c%20Hongquan%3bShi%2c%20Xueying%3bJiang%2c%20Huij
  un%3bGao%2c%20Xiaoqiang%3bCheng%2c%20Daiyun%3bGuo%2c%20Lizhu%3bWang%2c%20Hao%3bS
  hi%2c%20Xiaohong%3bWang%2c%20Peizhi%3bZhang%2c%20Qianying%3bShen%2c%20Bing%3C%2F
  author%3E%3CAN%3E200510175274%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 115 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Interference of SARS-CoV replication by small interfering RNAs
AU: Zhao-Hui [Author]; Chen-Shui-Ping [Author]; Duan-Hong-Yuan [Author]; Deng
  -Yong-Qiang [Author]; Jiang-Tao [Author]; Zhao-Zhuo [Author]; Yu-Man [Author];
  Kang-Xiao-Ping [Author]; Yang-Bao-An [Author]; Li-Xiao-Yu [Author]; Qin-Cheng
  -Feng [Author]; Qin-E-De [Author,-Reprint-Author]
AD: Acad Mil Med Sci, Inst Microbiol and Epidemiol, State Key Lab Pathogen and
  Biosecur, Beijing 100071, Peoples R China
EMA: qinede@sohu.com
SO: Zhongguo-Shengwu-Huaxue-yu-Fenzi-Shengwu-Xuebao. 2005; 21(3): 397-402
PY: 2005
DT: Article
IS: 1007-7626
LA: Chinese
AB: To investigate interference of SARS-CoV replication in mammalian cells by
  small interfering RNAs (siRNAs), siRNA expression plasmids targeting the
  polymerase gene and the S gene of SARS-CoV were constructed. Vero cells were
  stably transfected with these plasmids. Clonal cell lines, psOa, psOe, psSk and
  psNe were selected by growth in hygromycin B-containing media and characterized
  further by PCR analysis to determine the organization of plasmid DNA in the
  clonal cell lines. Cell lines in which the plasmid DNA was correctly integrated
  into the genome were challenged with SARS-CoV BJ01 strain at a multiplicity of
  infection (MOI) of 0.05. Cytopathic effect (CPE) of cells infected by SARS-CoV
  was observed every day. At 3rd day, postchallenged cells which was no CPE were
  fixed in the slides and immunofluorescence assays (IFA) were performed. One of
  the clonal cell lines, psOe were resistant to SARS-CoV infection. In addition,
  SARS-CoV RNA failed to accumulate in psOe by real-time quantitive PCR analysis.
  Observations have showed that siRNA (psOe) targeting polymerase gene could
  inhibit SARS-CoV RNA replication and protein expression in Vero cells. These
  results suggested a feasibility of using RNAi to elucidate pathogenesis of SARS
  -CoV and that RNAi might represent a new approach for the treatment of SARS
  infection.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Vero-cell-line (Cercopithecidae-): cell_line-; SARS-virus (Coronaviridae-):
  common-, Severe-Acute-Respiratory-Syndrome-virus, common-, pathogen-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
CB: RNA-; plasmid-DNA; hygromycin-B: 31282-04-9; small-interfering-RNA:
  expression-
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease, pathology-
RN: 31282-04-9
MI: SARS-CoV-replication
CC: 02506- (Cytology-Animal)
03502- (Genetics-General)
03506- (Genetics
  -Animal)
10062- (Biochemistry-studies-Nucleic-acids-purines-and
  -pyrimidines)
12502- (Pathology-General)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
31500-
  (Genetics-of-bacteria-and-viruses)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510175002
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1007
  -7626&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1007
  -7626&isbn=&volume=21&issue=3&spage=397&pages=397
  -402&date=2005&title=Zhongguo%20Shengwu%20Huaxue%20yu%20Fenzi%20Shengwu%20Xuebao
  &atitle=Interference%20of%20SARS
  -CoV%20replication%20by%20small%20interfering%20RNAs&aulast=&pid=%3Cauthor%3EZha
  o%20Hui%3bChen%20Shui%20Ping%3bDuan%20Hong%20Yuan%3bDeng%20Yong%20Qiang%3bJiang%
  20Tao%3bZhao%20Zhuo%3bYu%20Man%3bKang%20Xiao%20Ping%3bYang%20Bao%20An%3bLi%20Xia
  o%20Yu%3bQin%20Cheng%20Feng%3bQin%20E%20De%3C%2Fauthor%3E%3CAN%3E200510175002%3C
  %2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 116 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL
  protease
AU: Liu,-Yu-Chih [Author]; Huang,-Vicky [Author]; Chao,-Ti-Chun [Author]; Hsiao,
  -Chwan-Deng [Author]; Lin,-Atsui [Author]; Chang,-Ming-Fu [Author]; Chow,-Lu
  -Ping [Author,-Reprint-Author]
AD: Natl Taiwan Univ, Coll Med, Grad Inst Biochem and Mol Biol, Taipei 106,
  Taiwan
EMA: lupin@ha.mc.ntu.edu.tw
SO: Biochemical-and-Biophysical-Research-Communications. 2005; 333(1): 194-199
PY: 2005
DT: Article
IS: 0006-291X
LA: English
AB: SARS-CoV 3CL protease is essential for viral protein processing and is
  regarded as a good drug target to prevent SARS-CoV replication. In the present
  study, we established a high-throughput FRET technique for screening for anti
  -SARS-CoV 3CL protease drugs. Of a thousand existing drugs examined,
  hexachlorophene was identified as the most potent in inhibiting SARS-CoV 3CL
  protease. Further characterization showed that it was effective at micromolar
  concentrations (K-i = 4 mu M). The binding mode was competitive, and the
  inhibitory effect was dependent on preincubation time. Two other drugs,
  triclosan and nelfinavir, were about 10 times less potent. The structure-based
  search and biological evaluation of various hexachlorophene analogues were
  described. These analogues gave optimal inhibitory activity against SARS-CoV
  3CL protease with IC50 values ranging from 7.6 to 84.5 mu M. Optimization of
  hexachlorophene analogues was shown to provide several active 3CL protease
  inhibitors that function as potential anti-SARS agents. (c) 2005 Elsevier Inc.
  All rights reserved.
AI: Y
MC: Pharmacology-; Infection-; Methods-and-Techniques
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: nelfinavir-: 159989-64-7, enzyme-inhibitor-drug, protease-inhibitor-drug,
  antiviral-drug, antiinfective-drug; 3CL-protease; hexachlorophene-: 70-30-4,
  antiinfective-drug, antiviral-drug; triclosan-: 3380-34-5, antiinfective-drug,
  antiviral-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
RN: 159989-64-7; 70-30-4; 3380-34-5
MQ: fluorescence-resonance-energy-transfer: FRET-, laboratory-techniques,
  spectrum-analysis-techniques
CC: 12512- (Pathology-Therapy)
16006- (Respiratory-system-Pathology)
22002-
  (Pharmacology-General)
33502- (Virology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510173954
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0006
  -291X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0006
  -291X&isbn=&volume=333&issue=1&spage=194&pages=194
  -199&date=2005&title=Biochemical%20and%20Biophysical%20Research%20Communications
  &atitle=Screening%20of%20drugs%20by%20FRET%20analysis%20identifies%20inhibitors%
  20of%20SARS-CoV%203CL%20protease&aulast=Liu&pid=%3Cauthor%3ELiu%2c%20Yu%20Chih%3
  bHuang%2c%20Vicky%3bChao%2c%20Ti%20Chun%3bHsiao%2c%20Chwan%20Deng%3bLin%2c%20Ats
  ui%3bChang%2c%20Ming%20Fu%3bChow%2c%20Lu%20Ping%3C%2Fauthor%3E%3CAN%3E2005101739
  54%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 117 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: A human SARS-CoV neutralizing antibody against epitope on S2 protein
AU: Duan,-Jinzhu [Author]; Yan,-Xiyun [Author,-Reprint-Author]; Guo,-Xueming
  [Author]; Cao,-Wuchun [Author]; Han,-Wei [Author]; Qi,-Cai [Author]; Feng,-Jing
  [Author]; Yang,-Dongling [Author]; Gao,-Guangxia [Author]; Jin,-Gang [Author]
AD: Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China
EMA: yanxy@sun5.ibp.ac.cn
SO: Biochemical-and-Biophysical-Research-Communications. 2005; 333(1): 186-193
PY: 2005
DT: Article
IS: 0006-291X
LA: English
AB: An immune antibody phage-display library was constructed from B cells of
  SARS convalescent patients. More than 80 clones were selected from the library
  by using the whole inactivated SARS-CoV virions as target. One human scFv, B1,
  was characterized extensively. The B1 recognized SARS pseudovirus in vivo and
  competed with SARS sera for binding to SARS-CoV with high affinity (equilibrium
  dissociation constant, K-d = 105 nM). The B1 also has potent neutralizing
  activities against infection by pseudovirus expressing SARS-CoV S protein in
  vitro. Finally, we found that the B1 recognized an epitope on S2 protein,
  especially within amino acids 1023-1189 of S2 protein. This study not only
  first made a human neutralizing antibody, which recognized an epitope on S2
  protein like natural antibody in sera, but also may help us to better
  understand the immunological characteristics of SARS protein and SARS vaccine
  design. (c) 2005 Elsevier Inc. All rights reserved.
AI: Y
MC: Clinical-Immunology: Human-Medicine, Medical-Sciences; Infection-; Molecular
  -Genetics: Biochemistry-and-Molecular-Biophysics; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-; -[86215-] Hominidae-, 
  -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-; Severe-Acute-Respiratory
  -Syndrome-virus (Coronaviridae-): common-, SARS-virus, common-, pathogen-;
  Escherichia-coli (Enterobacteriaceae-): species-; human- (Hominidae-): common-,
  host-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-; Hominidae-:
  Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: serum-: blood-and-lymphatics; B-cell: immune-system, blood-and-lymphatics
CB: S2-protein
GN: human-B1-gene [Hominidae-]
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: immune-antibody-phage-display-library-construction: laboratory-techniques,
  genetic-techniques
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
03502- (Genetics
  -General)
03506- (Genetics-Animal)
03508- (Genetics-Human)
15002- (Blood
  -Blood-and-lymph-studies)
15004- (Blood-Blood-cell-studies)
16006-
  (Respiratory-system-Pathology)
31000- (Physiology-and-biochemistry-of
  -bacteria)
31500- (Genetics-of-bacteria-and-viruses)
33502- (Virology-General
  -and-methods)
34502- (Immunology-General-and-methods)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36002- (Medical-and-clinical-microbiology
  -Bacteriology)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510173953
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0006
  -291X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0006
  -291X&isbn=&volume=333&issue=1&spage=186&pages=186
  -193&date=2005&title=Biochemical%20and%20Biophysical%20Research%20Communications
  &atitle=A%20human%20SARS
  -CoV%20neutralizing%20antibody%20against%20epitope%20on%20S2%20protein&aulast=Du
  an&pid=%3Cauthor%3EDuan%2c%20Jinzhu%3bYan%2c%20Xiyun%3bGuo%2c%20Xueming%3bCao%2c
  %20Wuchun%3bHan%2c%20Wei%3bQi%2c%20Cai%3bFeng%2c%20Jing%3bYang%2c%20Dongling%3bG
  ao%2c%20Guangxia%3bJin%2c%20Gang%3C%2Fauthor%3E%3CAN%3E200510173953%3C%2FAN%3E%3
  CDT%3EArticle%3C%2FDT%3E

Record 118 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Intelligent testing strategies for chemicals testing - A case of more haste,
  less speed?
AU: Combes,-Robert [Author,-Reprint-Author]; Balls,-Michael [Author]
AD: FRAME, Nottingham, UK
EMA: bob@frame.org.uk
SO: ATLA-Alternatives-to-Laboratory-Animals. 2005; 33(3): 289-297
PY: 2005
DT: Editorial; Article
IS: 0261-1929
LA: English
AB: The prospects for using (Q)SAR modelling, read-across (chemical) and other
  non-animal approaches as part of integrated testing strategies for chemical
  risk assessment, within the framework of the EU REACH legislation, are
  considered. The potential advantages and limitations of (Q)SAR modelling and
  read-across methods for chemical regulatory risk assessment are reviewed. It is
  concluded that it would be premature to base a testing strategy on chemical
  -based computational modelling approaches, until such time as criteria to
  validate them for their reliability and relevance by using independent and
  transparent procedures, have been agreed. This is mainly because of inherent
  problems in validating and accepting (Q)SARs for regulatory use in ways that
  are analogous to those that have been developed and applied for in vitro tests.
  Until this issue has been resolved, it is recommended that testing strategies
  should be developed which comprise the integrated use of computational and read
  -across approaches. These should be applied in a cautious and judicious way, in
  association with available tissue culture methods, and in conjunction with
  metabolism and biokinetic studies. Such strategies should be intelligently
  applied by being driven by exposure information (based on bioavailability, not
  merely on production volume) and hazard information needs, in preference to a
  tick-box approach. In the meantime, there should be increased efforts to
  develop improved (Q)SARs, expert systems and new in vitro methods, and, in
  particular, ways to expedite their validation and acceptance must be found and
  prospectively agreed with all major stakeholders.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Methods-and-Techniques
ST: -[33000-] Animalia-, -Animalia
OR: animal- (Animalia-): common-
TN: Animalia-: Animals-
CB: chemicals-
MQ: computational-modeling: mathematical-and-computer-techniques; tissue
  -culture: laboratory-techniques, culturing-techniques; quantitative-structure
  -activity-relationship-model: QSAR-model, mathematical-and-computer-techniques
MI: intelligent-testing-strategy; REACH-legislation
CC: 10060- (Biochemistry-studies-General)
32500- (Tissue-culture-apparatus
  -methods-and-media)
AN: 200510173822
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0261
  -1929&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0261
  -1929&isbn=&volume=33&issue=3&spage=289&pages=289
  -297&date=2005&title=ATLA%20Alternatives%20to%20Laboratory%20Animals&atitle=Inte
  lligent%20testing%20strategies%20for%20chemicals%20testing%20
  -%20A%20case%20of%20more%20haste%2c%20less%20speed%3f&aulast=Combes&pid=%3Cautho
  r%3ECombes%2c%20Robert%3bBalls%2c%20Michael%3C%2Fauthor%3E%3CAN%3E200510173822%3
  C%2FAN%3E%3CDT%3EEditorial%3bArticle%3C%2FDT%3E

Record 119 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Identification of an alternative 5'-untranslated exon and new polymorphisms
  of angiotensin-converting enzyme 2 gene: Lack of association with SARS in the
  Vietnamese population
AU: Itoyama,-Satoru [Author]; Keicho,-Naoto [Author,-Reprint-Author]; Hijikata,
  -Minako [Author]; Quy,-Tran [Author]; Phi,-Nguyen-Chi [Author]; Long,-Hoang
  -Thuy [Author]; Ha,-Le-Dang [Author]; Van-Ban,-Vo [Author]; Matsushita,-Ikumi
  [Author]; Yanai,-Hideki [Author]; Kirikae,-Fumiko [Author]; Kirikae,-Teruo
  [Author]; Kuratsuji,-Tadatoshi [Author]; Sasazuki,-Takehiko [Author]
AD: Int Med Ctr Japan, Res Inst, Dept Resp Dis, Shinjuku Ku, 1-21-1 Toyama,
  Tokyo 1628655, Japan
EMA: nkeicho-tky@umin.ac.jp
SO: American-Journal-of-Medical-Genetics. 2005; 136A(1): 52-57
PY: 2005
DT: Article
IS: 1552-48251552-4833
LA: English
AB: We analyzed genetic variations of angiotensin-converting enzyme 2 (ACE2),
  considering that it might influence patients' susceptibility to severe acute
  respiratory syndrome-associated coronavirus (SARS-CoV) or development of SARS
  as a functional receptor. By cloning of the full-length cDNA of the ACE2 gene
  in the lung, where replication occurs on SARS-CoV, it was shown that there are
  different splicing sites. All exons including the new alternative exon, exon
  -intron boundaries, and the corresponding 5'-flanking region of the gene were
  investigated and 19 single nucleotide polymorphisms (SNPs) were found. Out of
  these, 13 SNPs including one non-synonymous substitution and three 3'-UTR
  polymorphisms were newly identified. A case control study involving 44 SARS
  cases, 16 anti-SARS-CoV antibody-positive contacts, 87 antibody-negative
  contacts, and 50 non-contacts in Vietnam, failed to obtain any evidence that
  the ACE2 gene polymorphisms are involved in the disease process in the
  population. Nevertheless, identification of new 5'-untranslated exon and new
  SNPs is considered helpful in investigating regulation of ACE2 gene expression
  in the future. (c) 2005 Wiley-Liss, Inc.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, adolescent-, aged-, middle-age, adult-, pathogen-, female-,
  male-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: single-nucleotide-polymorphism: SNP-; cDNA-: complementary-DNA; 5'
  -untranslated-exon; anti-severe-acute-respiratory-syndrome-virus-antibody: anti
  -SARS-antibody
GE: Vietnam-: Asia-, Oriental-region
GN: human-ACE2-gene [Hominidae-]: human-angiotensin-converting-enzyme-2-gene,
  polymorphism-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, genetics-
CC: 03502- (Genetics-General)
03508- (Genetics-Human)
10062- (Biochemistry
  -studies-Nucleic-acids-purines-and-pyrimidines)
16006- (Respiratory-system
  -Pathology)
24500- (Gerontology-)
25000- (Pediatrics-)
31500- (Genetics-of
  -bacteria-and-viruses)
33502- (Virology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
AN: 200510173222
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1552
  -48251552-4833&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1552
  -48251552-4833&isbn=&volume=136A&issue=1&spage=52&pages=52
  -57&date=2005&title=American%20Journal%20of%20Medical%20Genetics&atitle=Identifi
  cation%20of%20an%20alternative%205%27
  -untranslated%20exon%20and%20new%20polymorphisms%20of%20angiotensin
  -converting%20enzyme%202%20gene%3a%20Lack%20of%20association%20with%20SARS%20in%
  20the%20Vietnamese%20population&aulast=Itoyama&pid=%3Cauthor%3EItoyama%2c%20Sato
  ru%3bKeicho%2c%20Naoto%3bHijikata%2c%20Minako%3bQuy%2c%20Tran%3bPhi%2c%20Nguyen%
  20Chi%3bLong%2c%20Hoang%20Thuy%3bHa%2c%20Le%20Dang%3bVan%20Ban%2c%20Vo%3bMatsush
  ita%2c%20Ikumi%3bYanai%2c%20Hideki%3bKirikae%2c%20Fumiko%3bKirikae%2c%20Teruo%3b
  Kuratsuji%2c%20Tadatoshi%3bSasazuki%2c%20Takehiko%3C%2Fauthor%3E%3CAN%3E20051017
  3222%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 120 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Contact patterns during the 2003 Greater Toronto Area SARS outbreak
AU: SARS-Quarantine-Evaluation-&-Commu [Reprint-Author,-Author]
AD: Univ Toronto, Toronto, ON, Canada
SO: American-Journal-of-Epidemiology. 2005; 161(11, Suppl. S): S98
PY: 2005
DT: Meeting-Abstract; Meeting
IS: 0002-9262
MT: Joint Meeting of the Society-for-Epidemiologic-Research/Canadian-Society-for
  -Epidemiology-and-Biostatistics, Toronto, CANADA; June 27 -30, 2005 
SP: Soc Epidemiol ResCanadian Soc Epidemiol & Biostat
LA: English
MC: Epidemiology-: Population-Studies; Pulmonary-Medicine: Human-Medicine,
  Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, adult-, infant-, elderly-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
GE: Toronto-: Ontario-, Canada-, North-America, Nearctic-region
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease
MI: household-setting; contact-pattern; school-setting; work-setting; clinical
  -office
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
16006-
  (Respiratory-system-Pathology)
24500- (Gerontology-)
25000- (Pediatrics
  -)
37054- (Public-health-epidemiology-Organic-diseases-and-neoplasms)
37056-
  (Public-health-epidemiology-Miscellaneous)
AN: 200510172980
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0002
  -9262&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0002
  -9262&isbn=&volume=161&issue=11%2c%20Suppl.%20S&spage=&pages=S98&date=2005&title
  =American%20Journal%20of%20Epidemiology&atitle=Contact%20patterns%20during%20the
  %202003%20Greater%20Toronto%20Area%20SARS%20outbreak&aulast=&pid=%3Cauthor%3ESAR
  S%20Quarantine%20Evaluation%20%26%20Commu%3C%2Fauthor%3E%3CAN%3E200510172980%3C%
  2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 121 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Access to an educational colorectal cancer website and subject participation
  in the Ontario Familial Colorectal Cancer Registry
AU: Tucker,-A [Author,-Reprint-Author]; Cotterchio,-M [Author]; Gallinger,-S
  [Author]; Kreiger,-N [Author]; Mclaughlin,-J [Author]; Koo,-M [Author]
AD: Univ Toronto, Toronto, ON, Canada
SO: American-Journal-of-Epidemiology. 2005; 161(11, Suppl. S): S66
PY: 2005
DT: Meeting-Abstract; Meeting
IS: 0002-9262
MT: Joint Meeting of the Society-for-Epidemiologic-Research/Canadian-Society-for
  -Epidemiology-and-Biostatistics, Toronto, CANADA; June 27 -30, 2005 
SP: Soc Epidemiol ResCanadian Soc Epidemiol & Biostat
LA: English
MC: Computer-Applications: Computational-Biology; Digestive-System: Ingestion
  -and-Assimilation; Tumor-Biology
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
GE: Ontario-: Canada-, North-America, Nearctic-region
DS: colorectal-cancer: (Colorectal-Neoplasms-(MeSH)), digestive-system-disease,
  neoplastic-disease; SARS-: severe-acute-respiratory-syndrome, respiratory
  -system-disease
MQ: website-: computer-software
MI: cost-effectiveness; response-rate; reliable-information; Ontario-Familial
  -Colorectal-Cancer-Registry
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
00530-
  (General-biology-Information-documentation-retrieval-and-computer
  -applications)
14004- (Digestive-system-Physiology-and-biochemistry)
14006-
  (Digestive-system-Pathology)
16006- (Respiratory-system-Pathology)
24004-
  (Neoplasms-Pathology-clinical-aspects-and-systemic-effects)
AN: 200510172854
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0002
  -9262&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0002
  -9262&isbn=&volume=161&issue=11%2c%20Suppl.%20S&spage=&pages=S66&date=2005&title
  =American%20Journal%20of%20Epidemiology&atitle=Access%20to%20an%20educational%20
  colorectal%20cancer%20website%20and%20subject%20participation%20in%20the%20Ontar
  io%20Familial%20Colorectal%20Cancer%20Registry&aulast=Tucker&pid=%3Cauthor%3ETuc
  ker%2c%20A%3bCotterchio%2c%20M%3bGallinger%2c%20S%3bKreiger%2c%20N%3bMclaughlin%
  2c%20J%3bKoo%2c%20M%3C%2Fauthor%3E%3CAN%3E200510172854%3C%2FAN%3E%3CDT%3EMeeting
  %20Abstract%3bMeeting%3C%2FDT%3E

Record 122 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Effectiveness of quarantine: Did it prevent transmission of SARS in the 2003
  Toronto area outbreak?
AU: Rea,-E [Author,-Reprint-Author]; Lafleche,-J [Author]; SARS-Quarantine
  -Evaluation-Communi [Reprint-Author,-Author]
AD: Univ Toronto, Toronto Publ Hlth, Toronto, ON M5S 1W8, Canada
SO: American-Journal-of-Epidemiology. 2005; 161(11, Suppl. S): S39
PY: 2005
DT: Meeting-Abstract; Meeting
IS: 0002-9262
MT: Joint Meeting of the Society-for-Epidemiologic-Research/Canadian-Society-for
  -Epidemiology-and-Biostatistics, Toronto, CANADA; June 27 -30, 2005 
SP: Soc Epidemiol ResCanadian Soc Epidemiol & Biostat
LA: English
MC: Epidemiology-: Population-Studies; Pulmonary-Medicine: Human-Medicine,
  Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
GE: Toronto-: Ontario-, Canada-, North-America, Nearctic-region
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease,
  transmission-
MQ: quarantine-: clinical-techniques
MI: method-effectiveness
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
16006-
  (Respiratory-system-Pathology)
37054- (Public-health-epidemiology-Organic
  -diseases-and-neoplasms)
37056- (Public-health-epidemiology-Miscellaneous)
AN: 200510172746
UD: 20050927
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0002
  -9262&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0002
  -9262&isbn=&volume=161&issue=11%2c%20Suppl.%20S&spage=&pages=S39&date=2005&title
  =American%20Journal%20of%20Epidemiology&atitle=Effectiveness%20of%20quarantine%3
  a%20Did%20it%20prevent%20transmission%20of%20SARS%20in%20the%202003%20Toronto%20
  area%20outbreak%3f&aulast=Rea&pid=%3Cauthor%3ERea%2c%20E%3bLafleche%2c%20J%3bSAR
  S%20Quarantine%20Evaluation%20Communi%3C%2Fauthor%3E%3CAN%3E200510172746%3C%2FAN
  %3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 123 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Responsible science
AU: Trevors,-J-T [Author,-Reprint-Author]
AD: Univ Guelph, Dept Environm Biol, Rm 3220 Bovey Bldg, Guelph, ON N1G 2W1,
  Canada
EMA: jtrevors@uoguelph.ca
SO: Water-Air-and-Soil-Pollution. 2005; 163(1-4): 1-2
PY: 2005
DT: Editorial; Article
IS: 0049-6979
LA: English
MC: Infection-; Pollution-Assessment-Control-and-Management; Soil-Science;
  Agriculture-; Waste-Management: Sanitation-; Climatology-: Environmental
  -Sciences
CB: biological-pollutants: pollutant-; chemical-pollutants: pollutant-
DS: tuberculosis-: (Tuberculosis-(MeSH)), bacterial-disease, transmission-,
  prevention-and-control, etiology-; AIDS-: acquired-immunodeficiency-syndrome,
  viral-disease, immune-system-disease, transmission-, prevention-and-control,
  etiology-; influenza-: (Influenza-(MeSH)), respiratory-system-disease, viral
  -disease, transmission-, prevention-and-control, etiology-; SARS-: severe-acute
  -respiratory-syndrome, respiratory-system-disease, viral-disease, transmission
  -, prevention-and-control, etiology-; avian-flu: respiratory-system-disease,
  viral-disease, transmission-, prevention-and-control, etiology-; malaria-:
  (Malaria-(MeSH)), blood-and-lymphatic-disease, parasitic-disease, transmission
  -, prevention-and-control, etiology-
MQ: water-treatment: applied-and-field-techniques; immunization-: clinical
  -techniques; environmental-remediation: applied-and-field-techniques; public
  -health-education: applied-and-field-techniques
MI: energy-conservation; climate-change; renewable-energy-production
CC: 07504- (Ecology-environmental-biology-Bioclimatology-and
  -biometeorology)
15006- (Blood-Blood-lymphatic-and-reticuloendothelial
  -pathologies)
16006- (Respiratory-system-Pathology)
34508- (Immunology
  -Immunopathology-tissue-immunology)
37014- (Public-health-Sewage-disposal-and
  -sanitary-measures)
37015- (Public-health-Air-water-and-soil-pollution)
52502
  - (Agronomy-Miscellaneous-and-mixed-crops)
52801- (Soil-science-General-and
  -methods)
AN: 200510172192
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0049
  -6979&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0049
  -6979&isbn=&volume=163&issue=1-4&spage=1&pages=1
  -2&date=2005&title=Water%20Air%20and%20Soil%20Pollution&atitle=Responsible%20sci
  ence&aulast=Trevors&pid=%3Cauthor%3ETrevors%2c%20J%20T%3C%2Fauthor%3E%3CAN%3E200
  510172192%3C%2FAN%3E%3CDT%3EEditorial%3bArticle%3C%2FDT%3E

Record 124 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Expression of SARS coronavirus membrane protein and its DNA vaccine
  construction
AU: Li-Jian-na [Author]; Xiang-Kai-jun [Author]; Zhou-Rong [Author]; Ding-Yong
  -qiang [Author]; Bai-Pei-sheng [Author]; Zhang-Yu-ping [Author]; Zhu-Bing
  [Author]; Zeng-Qi-yi [Author,-Reprint-Author]
AD: Guangzhou Pediat Inst, Cent Lab, Guangzhou Childrens Hosp, Guangzhou 510120,
  Peoples R China
EMA: zhou3218@yahoo.com
SO: Virologica-Sinica. 2005; 20(2): 113-116
PY: 2005
DT: Article
IS: 1003-5125
LA: Chinese
AB: To study the immunological speciality of M protein of SARS-CoV and analyze
  the feasibility and necessity of M protein as the component of the SARS
  vaccine. M protein of SARS-CoV was expressed in E. coli by pET-15b and pET-22b
  and purified by affinity resin as antigen. M gene was cloned into the
  eukaryotic secretory expression plasmid pSecTagB and named recombinant plasmid
  pSecM as DNA vaccine which will be used to immunize BALB/c mice to obtain the
  antiserum of M protein. The immune effect of the M-DNA vaccine was studied by
  the ELISA technique established with purified M protein. Both of the
  recombinant M proteins can be expressed in soluble form. When compared with the
  SARS-CoV ELISA kit produced by Huada Co. Ltd, the prokaryotic reconbinant M
  proteins could react specifically with the sera from immunized M-DNA mice and
  SARS correct diagnosis patients. The recombinant M protein could be used as an
  antigen to detect SARS and the SARS-CoV M gene vaccine could induce
  specifically antibody. M protein could be considered as SARS-CoV vaccine,
  especially as the vaccine component, which redounds to the development of a
  potential DNA vaccine.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics
ST: -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram-Negative-Rods,
  Eubacteria-, Bacteria-, Microorganisms-
OR: E.-coli (Enterobacteriaceae-): common-, Escherichia-coli, species-,
  expression-system
TN: Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-
CB: DNA-vaccine; membrane-protein: expression-
DS: severe-actue-respiratory-syndrome-coronovirus: SARS-CoV, respiratory-system
  -disease, viral-disease
MQ: ELISA-: laboratory-techniques, immunologic-techniques
CC: 03502- (Genetics-General)
16006- (Respiratory-system-Pathology)
31000-
  (Physiology-and-biochemistry-of-bacteria)
31500- (Genetics-of-bacteria-and
  -viruses)
AN: 200510172144
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1003
  -5125&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1003
  -5125&isbn=&volume=20&issue=2&spage=113&pages=113
  -116&date=2005&title=Virologica%20Sinica&atitle=Expression%20of%20SARS%20coronav
  irus%20membrane%20protein%20and%20its%20DNA%20vaccine%20construction&aulast=&pid
  =%3Cauthor%3ELi%20Jian%20na%3bXiang%20Kai%20jun%3bZhou%20Rong%3bDing%20Yong%20qi
  ang%3bBai%20Pei%20sheng%3bZhang%20Yu%20ping%3bZhu%20Bing%3bZeng%20Qi%20yi%3C%2Fa
  uthor%3E%3CAN%3E200510172144%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 125 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Morphological evidence of SARS associated reovirus
AU: Yang-Yi [Author,-Reprint-Author]; Chen-De-hui [Author]; Duan-Qing [Author];
  Zhu-Hong [Author]; Lang-Zhen-wei [Author]; Meng-Xin [Author]; Zhang-De-tian
  [Author]; Zhang-Sa [Author]
AD: Natl Ctr Biomed Anal, Beijing 100850, Peoples R China
EMA: yangyi@proteomics.com.cn
SO: Virologica-Sinica. 2005; 20(2): 105-107
PY: 2005
DT: Article
IS: 1003-5125
LA: Chinese
AB: To identify the pathogen isolated from lung tissue of a patient died from
  SARS by using electron microscope. Sample of lung tissue taken from autopsy of
  the SARS patient was inoculated onto Hep2 cultured cells. Any cultured cells
  exhibiting cytopathic effect were processed by routine techniques for ultrathin
  sections. Electron microscopic examination revealed the characteristic
  morphological features of reovirus. The virus particles showed in different
  mature stages, the matured particles with dense core and the incompletely
  assembled virus particles with lucent core. Both of them have capsid about
  1.4nm in thickness with a size of virions about 60-80nm in diameter. Most of
  the virions were found in large clusters arranged in crystalline array and
  associated with the viral plasm and microtubular-like structure to form
  cytoplasmic inclusion bodies of different size and shape. In this study! we
  have provided further morphological evidence that reovirus may be associated
  with SARS. However, the correlation of the reovirus infection with SARS
  outbreak needs to be further investigated.
AI: Y
MC: Infection-; Respiratory-System: Respiration-
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia
  -; -[03402-] Reoviridae-, -dsRNA-Viruses, Viruses-, Microorganisms-
OR: Hep2-cell-line (Hominidae-): cell_line-; Reovirus- (Reoviridae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates
  -; Reoviridae-: Double-Stranded-RNA-Viruses, Microorganisms-, Viruses-
PS: lung-tissue: respiratory-system
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease; reovirus-infection: (Reoviridae-Infections-(MeSH)), infectious-disease
MQ: electron-microscopy: laboratory-techniques, imaging-and-microscopy-techniques
CC: 02508- (Cytology-Human)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
33502- (Virology-General
  -and-methods)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510172142
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1003
  -5125&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1003
  -5125&isbn=&volume=20&issue=2&spage=105&pages=105
  -107&date=2005&title=Virologica%20Sinica&atitle=Morphological%20evidence%20of%20
  SARS%20associated%20reovirus&aulast=&pid=%3Cauthor%3EYang%20Yi%3bChen%20De%20hui
  %3bDuan%20Qing%3bZhu%20Hong%3bLang%20Zhen%20wei%3bMeng%20Xin%3bZhang%20De%20tian
  %3bZhang%20Sa%3C%2Fauthor%3E%3CAN%3E200510172142%3C%2FAN%3E%3CDT%3EArticle%3C%2F
  DT%3E

Record 126 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Real-time quantitative RT-PCR assay for quick detection of SARS-associated
  coronavirus RNA
AU: Feng-Yan [Author,-Reprint-Author]; Lu-Yi-yu [Author]; Yan-Ju-ying [Author];
  Shi-Wen [Author]; Li-Min-hong [Author]; Gong-Li-ming [Author]; Ge-Qiong
  [Author]; Zhou-Min [Author]
AD: Ctr Dis Control and Prevent, Hangzhou 310009, Peoples R China
EMA: elsa0502@163.com
SO: Virologica-Sinica. 2005; 20(3): 228-231
PY: 2005
DT: Article
IS: 1003-5125
LA: Chinese
AB: A real-time TaqMan-based RT-PCR assay was developed to rapidly detect the
  Severe acute respiratory syndrome-associate coronavirus(SARS-CoV). Primers and
  probes specific to the conserved region of the SARS-CoV genome were
  selected,and the reactive system and conditions were optimized to improve the
  sensitivity, specificity and repetition of the assay. The results showed that
  the real-time RT-PCR assay was specific and there were no cross reactions with
  influenza A(1), A(3), B and H5N1 virus, measles virus and other common
  respiratory viruses. The sensitivity of the assay was 0.1TCID(50). It took only
  three hours from viral RNA extraction to complete the real-time PCR, and the
  assay was simple and had good repeats. This real-time RT-PCR TaqMan-based assay
  was a specific, sensitive and quick tool suitable for early and quick detection
  of SARS-CoV in clinical labs.
AI: Y
MC: Infection-; Clinical-Chemistry: Allied-Medical-Sciences; Methods-and
  -Techniques
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-; -[03503-] Paramyxoviridae-, -Negative
  -Sense-ssRNA-Viruses, Viruses-, Microorganisms-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-; Influenza-A
  -virus (Orthomyxoviridae-): species-; Influenza-B-virus (Orthomyxoviridae-):
  species-; Influenza-A-1-virus (Orthomyxoviridae-): species-; Influenza-A3-virus
  (Orthomyxoviridae-): species-; Influenza-H5N1-virus (Orthomyxoviridae-):
  species-; Measles-virus (Paramyxoviridae-): species-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Orthomyxoviridae-: Microorganisms-, Negative-Sense-Single
  -Stranded-RNA-Viruses, Viruses-; Paramyxoviridae-: Microorganisms-, Negative
  -Sense-Single-Stranded-RNA-Viruses, Viruses-
CB: SARS-associated-coronavirus-RNA
MQ: real-time-quantitative-RT-PCR: real-time-quantitative-reverse-transcriptase
  -polymerase-chain-reaction, laboratory-techniques, genetic-techniques
MI: cross-reaction
CC: 10006- (Clinical-biochemistry-General-methods-and-applications)
33502-
  (Virology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510172117
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1003
  -5125&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1003
  -5125&isbn=&volume=20&issue=3&spage=228&pages=228
  -231&date=2005&title=Virologica%20Sinica&atitle=Real-time%20quantitative%20RT
  -PCR%20assay%20for%20quick%20detection%20of%20SARS
  -associated%20coronavirus%20RNA&aulast=&pid=%3Cauthor%3EFeng%20Yan%3bLu%20Yi%20y
  u%3bYan%20Ju%20ying%3bShi%20Wen%3bLi%20Min%20hong%3bGong%20Li%20ming%3bGe%20Qion
  g%3bZhou%20Min%3C%2Fauthor%3E%3CAN%3E200510172117%3C%2FAN%3E%3CDT%3EArticle%3C%2
  FDT%3E

Record 127 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Detection of TGF-beta in the autopsy lung tissue from SARS patients
AU: Zhou-Jing-jiao [Author]; Lin-Han-liang [Author]; Fang-Dan-yun [Author]; Wu
  -Hui-xi [Author]; Yan-Hui-jun [Author]; Zhao-Wei [Author]; Long-Bei-guo
  [Author]; Jiang-Li-fang [Author,-Reprint-Author]
AD: Natl Sun Yat Sen Univ, Zhongshan Med Sch, Dept Microbiol, Guangzhou, Peoples
  R China
EMA: jianglf909@yahoo.com.cn
SO: Virologica-Sinica. 2005; 20(3): 225-227
PY: 2005
DT: Article
IS: 1003-5125
LA: Chinese
AB: The expression of TGF and its role in the autopsy lung tissue of patients
  with Severe acute respiratory syndrome (SARS)was investigated. Pathological
  features of 2 autopsy lung tissues of SARS cases were studied by light
  microscope. TGF-beta(1) expression in autopsy lung tissues from patients of
  SARS and control lung tissues was analyzed by semiquantitative method using
  immunohistochemistry staining. In one case, the major pathological changes of
  autopsy lung tissue were diffuse alveolar damage hyaline membrane formed and
  alveolar exudative inflammation. In the other case, early pulmonary fibrosis
  and alveolar organization were presented except degeneration and exudation. The
  mean greym of TGF-beta(1) in autopsy lung tissues of SARS was 103.43 +/- 0.62,
  131.47 +/- 2.64 in lung tissue of lobular pneumonia, 144.24 +/- 0.09 in normal
  lung tissue. There were significantly differences among three groups(P < 0.05).
  The SARS-coronavirus can lead to acute pulmonary interstitial and alveolar
  exudative inflammation. In addition, the alveolar cell proliferation and early
  pulmonary fibrosis were presented during the middle and later stages of SARS.
  The pulmonary lesion and fibrosis in the patients of SARS appear to be
  associated with the overexpression of TGF-beta(1). It means that anti-TGF
  -beta(1) therapy may have a certain clinical siginficance on the prevention and
  treatment of pulmonary fibrosis of SARS.
AI: Y
MC: Infection-; Clinical-Chemistry: Allied-Medical-Sciences; Pulmonary-Medicine:
  Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: lung-: respiratory-system
CB: TGF-beta-1: transforming-growth-factor-beta-1, expression-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, pathology-
MQ: light-microscopy: laboratory-techniques, imaging-and-microscopy-techniques;
  autopsy-: clinical-techniques, diagnostic-techniques; immunohistochemical
  -staining: laboratory-techniques, histology-and-cytology-techniques,
  immunologic-techniques
CC: 10006- (Clinical-biochemistry-General-methods-and-applications)
10064-
  (Biochemistry-studies-Proteins-peptides-and-amino-acids)
12502- (Pathology
  -General)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
17002- (Endocrine-General)
33502- (Virology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510172116
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1003
  -5125&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1003
  -5125&isbn=&volume=20&issue=3&spage=225&pages=225
  -227&date=2005&title=Virologica%20Sinica&atitle=Detection%20of%20TGF
  -beta%20in%20the%20autopsy%20lung%20tissue%20from%20SARS%20patients&aulast=&pid=
  %3Cauthor%3EZhou%20Jing%20jiao%3bLin%20Han%20liang%3bFang%20Dan%20yun%3bWu%20Hui
  %20xi%3bYan%20Hui%20jun%3bZhao%20Wei%3bLong%20Bei%20guo%3bJiang%20Li%20fang%3C%2
  Fauthor%3E%3CAN%3E200510172116%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 128 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Purification of glutathione S-transferase fusion proteins of SARS
  coronavirus spike protein fragment 2 and preparation of anti-GST-S2 polyclonal
  antibody
AU: Qin-Li [Author]; Wu-Shao-ting [Author,-Reprint-Author]; Wang-Xi-ming
  [Author]; Yuan-Shi-shan [Author]; Lei-Ming-jun [Author]; Pan-Hui-rong [Author];
  Huang-Da-na [Author]; Gao-Shi-tong [Author]; Zhang-Ren-li [Author]; Qu-shen
  [Author]
AD: Huazhong Univ Sci and Technol, Tongji Med Coll, Dept Biochem and Mol Biol,
  Wuhan 430030, Peoples R China
EMA: wshaoting@263.net
SO: Virologica-Sinica. 2005; 20(3): 217-220
PY: 2005
DT: Article
IS: 1003-5125
LA: Chinese
AB: To study the immunogenicity of spike protein of SARS coronavirus, an
  expressional plasmid was constructed encoding partial sequence of SARS
  Coronavirus spike protein from 2170 bp to 2814bp, named fragment-2(S2). The
  gene sequence encoding S2 was amplified by RT-PCR from SARS Coronavirus genome
  RNA, cloned to pMD18-T vector and subcloned to pGEX-4T-2. E. coli JM109 that
  contained recombinant expression vector pGEX-S2 was amplified and fusion
  protein expression was induced by 1mmol/L IPTG at 37 degrees C. Protein was
  extracted and purified by GSH-Sepharose affinity chromatography. After
  identified by the serum of SARS patient by Western-blot, the purified protein
  GST-S2 was used to immunize NIH mice three times at two weeks interval, the
  immunized mice produced high titer anti-GST-S2 polyclonal antibody. It lies a
  basis for the future study of subunit vaccine of SARS coronavirus.
AI: Y
MC: Infection-; Immune-System: Chemical-Coordination-and-Homeostasis;
  Biochemistry-and-Molecular-Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-; -[86215-] Hominidae-, 
  -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-; -[86375-] Muridae-, 
  -Rodentia, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; Escherichia-coli (Enterobacteriaceae-): species-,
  expression-system; human- (Hominidae-): common-, host-; mouse- (Muridae-):
  common-, strain-NIH
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-;
  Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-
PS: serum-: blood-and-lymphatics
CB: fusion-protein; plasmid-; glutathione-S-transferase: 50812-37-8, EC
  -2.5.1.18; pMD18-T-vector; genomic-RNA; IPTG-; spike-protein: immunogenicity-,
  fragment-2; pGEX-4T-2; anti-GST-S2-polyclonal-antibody: production-
RN: 50812-37-8
MQ: Western-blotting: electrophoretic-techniques, immunologic-techniques,
  laboratory-techniques; RT-PCR: reverse-transcriptase-polymerase-chain-reaction,
  laboratory-techniques, genetic-techniques; gene-cloning: laboratory-techniques,
  genetic-techniques; GSH-Sepharose-affinity-chromatography: laboratory
  -techniques, chromatographic-techniques
CC: 10060- (Biochemistry-studies-General)
10062- (Biochemistry-studies-Nucleic
  -acids-purines-and-pyrimidines)
10064- (Biochemistry-studies-Proteins-peptides
  -and-amino-acids)
10802- (Enzymes-General-and-comparative-studies
  -coenzymes)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
31000- (Physiology-and-biochemistry-of-bacteria)
33502- (Virology
  -General-and-methods)
34502- (Immunology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
AN: 200510172114
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1003
  -5125&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1003
  -5125&isbn=&volume=20&issue=3&spage=217&pages=217
  -220&date=2005&title=Virologica%20Sinica&atitle=Purification%20of%20glutathione%
  20S-transferase%20fusion%20proteins%20of%20SARS%20coronavirus%20spike%20protein%
  20fragment%202%20and%20preparation%20of%20anti-GST
  -S2%20polyclonal%20antibody&aulast=&pid=%3Cauthor%3EQin%20Li%3bWu%20Shao%20ting%
  3bWang%20Xi%20ming%3bYuan%20Shi%20shan%3bLei%20Ming%20jun%3bPan%20Hui%20rong%3bH
  uang%20Da%20na%3bGao%20Shi%20tong%3bZhang%20Ren%20li%3bQu%20shen%3C%2Fauthor%3E%
  3CAN%3E200510172114%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 129 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Aportaciones del analisis poblacional de ostracodos: la evolucion
  paleoambiental del sector sudoccidental del Parque Nacional de Donana Durante
  el Holoceno Superior
Contributions of the ostracode population analysis:
  paleoenvironmental evolution of the southwestern sector of the Donana National
  Park (SW Spain) during the Late Holocene.
AU: Ruiz,-F [Author,-Reprint-Author]; Abad,-M [Author]; Rodriguez-Ramirez,-A
  [Author]
AD: Univ Huelva, Dept Geodinam and Paleontol, Avda Fuerzas Armadas S-N, E-21071
  Huelva, Spain
EMA: ruizmu@uhu.es
SO: REVISTA-ESPANOLA-DE-MICROPALEONTOLOGIA. 2004; 36(3): 485-492
PY: 2004
DT: Article
IS: 0556-655X
LA: Spanish
AB: The ostracode analysis of two cores collected in the southwestern area of
  the Donana National Park permits to deduce its evolution during the Late
  Holocene. In the last 2,400-2,300 years BP, there was a transition from a
  lagoon, inhabited mainly by Cyprideis torosa (Jones), Loxoconcha elliptica
  (Brady) and Leptocythere castanea (Sars), to the present-day fresh-water pond,
  with numerous individuals of Cyprinotus salinus (Brady) and Herpetocypris
  chevreuxi (Sars). In this period, different energetic events (storms?,
  tsunamis?) have been deduced from both the higher adult proportions of
  Cyprideis torosa and the introduction of marine species.
AI: Y
MC: Biogeography-: Population-Studies; Paleobiology-; Systematics-and-Taxonomy
ST: -[75114-] Ostracoda-, -Crustacea, Arthropoda-, Invertebrata-, Animalia-
OR: Cyprideis-torosa (Ostracoda-): species-, Fossil-; Loxoconcha-elliptica
  (Ostracoda-): species-, Fossil-; Leptocythere-castanea (Ostracoda-): species-,
  Fossil-; Cyprinotus-salinus (Ostracoda-): species-, Fossil-; Herpetocypris
  -chevreuxi (Ostracoda-): species-, Fossil-
TN: Ostracoda-: Animals-, Arthropods-, Crustaceans-, Invertebrates-
GE: Donana-National-Park: Spain-, Europe-, Palearctic-region
TM: Holocene-: Quaternary-
MI: environmental-change; lagoon-; paleoenvironmental-evolution
CC: 00504- (General-biology-Taxonomy-nomenclature-and-terminology)
07502-
  (Ecology-environmental-biology-General-and-methods)
07508- (Ecology
  -environmental-biology-Animal)
62800- (Animal-distribution)
63000-
  (Paleozoology-)
63554- (Invertebrata-general-and-systematic-Arthropoda
  -Crustacea)
64054- (Invertebratacomparative-experimental-morphology-physiology
  -and-pathology-Arthropoda-crustacea)
64500- (Paleobiology-)
64728-
  (Geological-periods-Recent)
AN: 200510169989
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0556
  -655X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0556
  -655X&isbn=&volume=36&issue=3&spage=485&pages=485
  -492&date=2004&title=REVISTA%20ESPANOLA%20DE%20MICROPALEONTOLOGIA&atitle=Aportac
  iones%20del%20analisis%20poblacional%20de%20ostracodos%3a%20la%20evolucion%20pal
  eoambiental%20del%20sector%20sudoccidental%20del%20Parque%20Nacional%20de%20Dona
  na%20Durante%20el%20Holoceno%20Superior&aulast=Ruiz&pid=%3Cauthor%3ERuiz%2c%20F%
  3bAbad%2c%20M%3bRodriguez%20Ramirez%2c%20A%3C%2Fauthor%3E%3CAN%3E200510169989%3C
  %2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 130 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Quaternary structure of the SARS coronavirus main protease
AU: Chou,-C [Author,-Reprint-Author]; Chang,-H [Author]; Hsu,-W [Author]; Chang,
  -G [Author]
AD: Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan
SO: Protein-Science. 2004; 13(Suppl. 1): 176-177
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0961-8368
MT: 18th Symposium of the Protein-Society, San Diego, CA, USA; August 14 -18,
  2004 
SP: Protein SocAbbott Lab FundAmer Peptide SocAmgenBiogen IdecDARPAEli Lilly &
  CoEli Lilly Res Labs, Biotechnol Discovery ResGenencor IntGenentech IncMerck
  Res LabsNatl Sci FdnNIHNew England BioLabsNovartis Inst Biomed ResPfizer
  IncProtein Soc Educ CommProtein Soc Young Protein Sci CommRoche
  PharmaceutSunesis Pharmaceut Inc
LA: English
MC: Infection-; Biochemistry-and-Molecular-Biophysics; Respiratory-System:
  Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Coronavirus- (Coronaviridae-): genus-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: sodium-chloride: 7647-14-5; coronavirus-main-protease; arginine-4; glutamic
  -acid-290
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease
RN: 7647-14-5
MQ: analytical-ultracentrifugation: laboratory-techniques
MI: pH-value
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10060-
  (Biochemistry-studies-General)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
33502- (Virology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510169646
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0961
  -8368&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0961
  -8368&isbn=&volume=13&issue=Suppl.%201&spage=176&pages=176
  -177&date=2004&title=Protein%20Science&atitle=Quaternary%20structure%20of%20the%
  20SARS%20coronavirus%20main%20protease&aulast=Chou&pid=%3Cauthor%3EChou%2c%20C%3
  bChang%2c%20H%3bHsu%2c%20W%3bChang%2c%20G%3C%2Fauthor%3E%3CAN%3E200510169646%3C%
  2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 131 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Computational modeling of SARS coronavirus main proteinase-inhibitor
  complexes
AU: Rao,-M-S [Author,-Reprint-Author]; Andrea,-T-A [Author]
AD: Transtech Pharma, Computat Chem, High Point, NC USA
SO: Protein-Science. 2004; 13(Suppl. 1): 119-120
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0961-8368
MT: 18th Symposium of the Protein-Society, San Diego, CA, USA; August 14 -18,
  2004 
SP: Protein SocAbbott Lab FundAmer Peptide SocAmgenBiogen IdecDARPAEli Lilly &
  CoEli Lilly Res Labs, Biotechnol Discovery ResGenencor IntGenentech IncMerck
  Res LabsNatl Sci FdnNIHNew England BioLabsNovartis Inst Biomed ResPfizer
  IncProtein Soc Educ CommProtein Soc Young Protein Sci CommRoche
  PharmaceutSunesis Pharmaceut Inc
LA: English
MC: Enzymology-: Biochemistry-and-Molecular-Biophysics; Models-and-Simulations:
  Computational-Biology
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Coronavirus- (Coronaviridae-): genus-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: main-proteinase-inhibitor-complex
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, infectious-disease, viral-disease
MQ: computational-modeling: mathematical-and-computer-techniques; TransTech's
  -Translational-technology: pharmaceutical-manufacturing-equipment; TTProbe-:
  pharmaceutical-manufacturing-equipment; TTPredict-: computer-software
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
04500-
  (Mathematical-biology-and-statistical-methods)
10515- (Biophysics
  -Biocybernetics)
10802- (Enzymes-General-and-comparative-studies
  -coenzymes)
16006- (Respiratory-system-Pathology)
33502- (Virology-General
  -and-methods)
36001- (Medical-and-clinical-microbiology-General-and-methods)
AN: 200510169473
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0961
  -8368&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0961
  -8368&isbn=&volume=13&issue=Suppl.%201&spage=119&pages=119
  -120&date=2004&title=Protein%20Science&atitle=Computational%20modeling%20of%20SA
  RS%20coronavirus%20main%20proteinase
  -inhibitor%20complexes&aulast=Rao&pid=%3Cauthor%3ERao%2c%20M%20S%3bAndrea%2c%20T
  %20A%3C%2Fauthor%3E%3CAN%3E200510169473%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bM
  eeting%3C%2FDT%3E

Record 132 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Assessment of putative protein targets derived from the SARS genome
AU: Yan,-L [Author,-Reprint-Author]; Velikanov,-M [Author]; Flook,-P [Author];
  Zheng,-W [Author]; Szalma,-S [Author]; Kahn,-S [Author]
AD: Accelrys, Life Sci R and D, San Diego, CA USA
SO: Protein-Science. 2004; 13(Suppl. 1): 116
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0961-8368
MT: 18th Symposium of the Protein-Society, San Diego, CA, USA; August 14 -18,
  2004 
SP: Protein SocAbbott Lab FundAmer Peptide SocAmgenBiogen IdecDARPAEli Lilly &
  CoEli Lilly Res Labs, Biotechnol Discovery ResGenencor IntGenentech IncMerck
  Res LabsNatl Sci FdnNIHNew England BioLabsNovartis Inst Biomed ResPfizer
  IncProtein Soc Educ CommProtein Soc Young Protein Sci CommRoche
  PharmaceutSunesis Pharmaceut Inc
LA: English
MC: Biochemistry-and-Molecular-Biophysics
CB: protein-; SARS-genome
DS: Severe-Aute-Respiratory-Syndrome: respiratory-system-disease, infectious
  -disease, viral-disease
MQ: systematic-analysis: laboratory-techniques; comprehensive-analysis:
  laboratory-techniques; DS-GeneAtlas-pipeline: laboratory-techniques
MI: method-reliability
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10060-
  (Biochemistry-studies-General)
10064- (Biochemistry-studies-Proteins-peptides
  -and-amino-acids)
16006- (Respiratory-system-Pathology)
36001- (Medical-and
  -clinical-microbiology-General-and-methods)
AN: 200510169461
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0961
  -8368&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0961
  -8368&isbn=&volume=13&issue=Suppl.%201&spage=&pages=116&date=2004&title=Protein%
  20Science&atitle=Assessment%20of%20putative%20protein%20targets%20derived%20from
  %20the%20SARS%20genome&aulast=Yan&pid=%3Cauthor%3EYan%2c%20L%3bVelikanov%2c%20M%
  3bFlook%2c%20P%3bZheng%2c%20W%3bSzalma%2c%20S%3bKahn%2c%20S%3C%2Fauthor%3E%3CAN%
  3E200510169461%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 133 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Structural stability and enzymatic activity of the SARS coronavirus main
  protease 3CL(pro)
AU: Barrila,-J-A [Author,-Reprint-Author]; Bacha,-U-M [Author]; Freire,-E
  [Author]
AD: Johns Hopkins Univ, Baltimore, MD USA
SO: Protein-Science. 2004; 13(Suppl. 1): 83
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0961-8368
MT: 18th Symposium of the Protein-Society, San Diego, CA, USA; August 14 -18,
  2004 
SP: Protein SocAbbott Lab FundAmer Peptide SocAmgenBiogen IdecDARPAEli Lilly &
  CoEli Lilly Res Labs, Biotechnol Discovery ResGenencor IntGenentech IncMerck
  Res LabsNatl Sci FdnNIHNew England BioLabsNovartis Inst Biomed ResPfizer
  IncProtein Soc Educ CommProtein Soc Young Protein Sci CommRoche
  PharmaceutSunesis Pharmaceut Inc
LA: English
MC: Biochemistry-and-Molecular-Biophysics; Respiratory-System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Coronavirus- (Coronaviridae-): genus-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: protease-3CL-pro; protease-: 9001-92-7, full-length
DS: severe-acute-respiratory-syndrome: (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease
RN: 9001-92-7
MI: structural-stability; substrate-recognition; oligomerization-state
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10060-
  (Biochemistry-studies-General)
10802- (Enzymes-General-and-comparative-studies
  -coenzymes)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
33502- (Virology-General-and-methods)
AN: 200510169361
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0961
  -8368&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0961
  -8368&isbn=&volume=13&issue=Suppl.%201&spage=&pages=83&date=2004&title=Protein%2
  0Science&atitle=Structural%20stability%20and%20enzymatic%20activity%20of%20the%2
  0SARS%20coronavirus%20main%20protease%203CL%28pro%29&aulast=Barrila&pid=%3Cautho
  r%3EBarrila%2c%20J%20A%3bBacha%2c%20U%20M%3bFreire%2c%20E%3C%2Fauthor%3E%3CAN%3E
  200510169361%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 134 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Identification of novel inhibitors of the SARS coronavirus main protease
  3CL(pro)
AU: Bacha,-U-M [Author,-Reprint-Author]; Barrila,-J-A [Author]; Freire,-E-I
  [Author]
AD: Johns Hopkins Univ, Baltimore, MD USA
SO: Protein-Science. 2004; 13(Suppl. 1): 79
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0961-8368
MT: 18th Symposium of the Protein-Society, San Diego, CA, USA; August 14 -18,
  2004 
SP: Protein SocAbbott Lab FundAmer Peptide SocAmgenBiogen IdecDARPAEli Lilly &
  CoEli Lilly Res Labs, Biotechnol Discovery ResGenencor IntGenentech IncMerck
  Res LabsNatl Sci FdnNIHNew England BioLabsNovartis Inst Biomed ResPfizer
  IncProtein Soc Educ CommProtein Soc Young Protein Sci CommRoche
  PharmaceutSunesis Pharmaceut Inc
LA: English
MC: Biochemistry-and-Molecular-Biophysics; Respiratory-System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-
OR: Coronavirus- (Coronaviridae-): genus-; Escherichia-coli (Enterobacteriaceae
  -): species-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-
CB: boronic-acid: 13780-71-7; SARS-CoV; protease-: 9001-92-7; serine-139; serine
  -144; serine-147
DS: severe-acute-respiratory-syndrome: (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease
RN: 13780-71-7; 9001-92-7
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10060-
  (Biochemistry-studies-General)
10802- (Enzymes-General-and-comparative-studies
  -coenzymes)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
31000- (Physiology-and-biochemistry-of
  -bacteria)
33502- (Virology-General-and-methods)
AN: 200510169348
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0961
  -8368&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0961
  -8368&isbn=&volume=13&issue=Suppl.%201&spage=&pages=79&date=2004&title=Protein%2
  0Science&atitle=Identification%20of%20novel%20inhibitors%20of%20the%20SARS%20cor
  onavirus%20main%20protease%203CL%28pro%29&aulast=Bacha&pid=%3Cauthor%3EBacha%2c%
  20U%20M%3bBarrila%2c%20J%20A%3bFreire%2c%20E%20I%3C%2Fauthor%3E%3CAN%3E200510169
  348%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 135 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Expression and purification of SARS coronavirus proteins using SUMO-fusions
AU: Zuo,-Xun [Author]; Mattern,-Michael-R [Author]; Tan,-Robin [Author]; Li,
  -Shuisen [Author]; Hall,-John [Author]; Sterner,-David-E [Author]; Shoo,-Joshua
  [Author]; Tran,-Hiep [Author]; Lim,-Peter [Author]; Sarafianos,-Stefan-G
  [Author]; Kazi,-Lubna [Author]; Navas-Martin,-Sonia [Author]; Weiss,-Susan-R
  [Author]; Butt,-Tauseef-R [Author,-Reprint-Author]
AD: LifeSensors Inc, 271 Great Valley Pkwy, Malvern, PA 19355 USA
EMA: butt@lifesensors.com
SO: Protein-Expression-and-Purification. 2005; 42(1): 100-110
PY: 2005
DT: Article
IS: 1046-5928
LA: English
AB: Severe acute respiratory syndrome coronavirus (SARS-CoV) proteins belong to
  it large group of proteins that is difficult to express in traditional
  expression systems. The ability to express and purify SARS-CoV proteins in
  large quantities is critical for basic research and for development of
  pharmaceutical agents. The work reported here demonstrates: (1) fusion of SUMO
  (small ubiquitin-related modifier), a 100 amino acid polypeptide, to the N
  -termini of SARS-CoV proteins dramatically enhances expression in Escherichia
  coli cells and (2) 6x His-tagged SUMO-fusions facilitate rapid purification of
  the viral proteins on it large scale. We have exploited the natural chaperoning
  properties of SUMO to develop an expression system suitable Cor proteins that
  cannot be expressed by traditional methodologies. A unique feature of the
  system is the SUMO tag, which enhances expression. facilitates purification,
  and can be efficiently cleaved by a SUMO-specific protease to generate native
  protein with a desired N-terminus. We have purified various SARS-CoV proteins
  under either native or denaturing conditions. These purified proteins have been
  used to generate highly specific polyclonal antibodies. Our study suggests that
  the SUMO-fusion technology will be useful for enhancing expression and
  purification of the viral proteins for structural and functional studies its
  well as Cor therapeutic uses, (c) 2005 Elsevier Inc. All rights reserved.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Respiratory-System:
  Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; Escherichia-coli (Enterobacteriaceae-): species-,
  expression-system
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-
CB: viral-protein; SUMO-protein: small-ubiquitin-related-modifier-protein
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, etiology-
CC: 10060- (Biochemistry-studies-General)
16004- (Respiratory-system-Physiology
  -and-biochemistry)
16006- (Respiratory-system-Pathology)
31000- (Physiology
  -and-biochemistry-of-bacteria)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510169244
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1046
  -5928&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1046
  -5928&isbn=&volume=42&issue=1&spage=100&pages=100
  -110&date=2005&title=Protein%20Expression%20and%20Purification&atitle=Expression
  %20and%20purification%20of%20SARS%20coronavirus%20proteins%20using%20SUMO
  -fusions&aulast=Zuo&pid=%3Cauthor%3EZuo%2c%20Xun%3bMattern%2c%20Michael%20R%3bTa
  n%2c%20Robin%3bLi%2c%20Shuisen%3bHall%2c%20John%3bSterner%2c%20David%20E%3bShoo%
  2c%20Joshua%3bTran%2c%20Hiep%3bLim%2c%20Peter%3bSarafianos%2c%20Stefan%20G%3bKaz
  i%2c%20Lubna%3bNavas%20Martin%2c%20Sonia%3bWeiss%2c%20Susan%20R%3bButt%2c%20Taus
  eef%20R%3C%2Fauthor%3E%3CAN%3E200510169244%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 136 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Severe acute respiratory syndrome coronavirus infection in children
AU: Ng,-Daniel-K [Author,-Reprint-Author]; Lau,-Wing-Fai [Author]; Chan,-Keung
  -Kit [Author]; Pau,-Benjamin-C [Author]; Lam,-Yuen-Yu [Author]; Chan,-Eric-Y
  [Author]; Ho,-Jackson-C [Author]
AD: Kwong Wah Hosp, Dept Pediat, Waterloo Rd, Kowloon, Hong Kong, Peoples R China
EMA: dkkng@ha.org.hk
SO: Pediatrics-International. 2005; 47(4): 452-455
PY: 2005
DT: Article
IS: 1328-8067
LA: English
MC: Infection-; Pulmonary-Medicine: Human-Medicine, Medical-Sciences; Pediatrics
  -: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, adolescent-, infant-,
  host-, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: serum-: blood-and-lymphatics
CB: ribavirin-: 36791-04-5, antiinfective-drug, antiviral-drug; corticosteroid-:
  antiinfective-drug, glucocorticoid-drug, antiviral-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, pathology-, symptom-,
  diagnosis-, complications-
RN: 36791-04-5
MQ: reverse-transcriptase-polymerase-chain-reaction: RT-PCR, laboratory
  -techniques, genetic-techniques
CC: 10062- (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
10067-
  (Biochemistry-studies-Sterols-and-steroids)
12502- (Pathology-General)
12504-
  (Pathology-Diagnostic)
12512- (Pathology-Therapy)
15002- (Blood-Blood-and
  -lymph-studies)
15004- (Blood-Blood-cell-studies)
16006- (Respiratory-system
  -Pathology)
22005- (Pharmacology-Clinical-pharmacology)
22016- (Pharmacology
  -Endocrine)
25000- (Pediatrics-)
33502- (Virology-General-and-methods)
36006
  - (Medical-and-clinical-microbiology-Virology)
38502- (Chemotherapy-General
  -methods-and-metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510168583
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1328
  -8067&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1328
  -8067&isbn=&volume=47&issue=4&spage=452&pages=452
  -455&date=2005&title=Pediatrics%20International&atitle=Severe%20acute%20respirat
  ory%20syndrome%20coronavirus%20infection%20in%20children&aulast=Ng&pid=%3Cauthor
  %3ENg%2c%20Daniel%20K%3bLau%2c%20Wing%20Fai%3bChan%2c%20Keung%20Kit%3bPau%2c%20B
  enjamin%20C%3bLam%2c%20Yuen%20Yu%3bChan%2c%20Eric%20Y%3bHo%2c%20Jackson%20C%3C%2
  Fauthor%3E%3CAN%3E200510168583%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 137 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: In vitro antitumor structure-activity relationships of
  threo/trans/threo/trans/erythro bis-tetrahydrofuranic acetogenins: Correlations
  with their inhibition of mitochondrial complex I
AU: Tormo,-Jose-R [Author,-Reprint-Author]; DePedro,-Nuria [Author]; Royo,
  -Inmaculada [Author]; Barrachina,-Isabel [Author]; Zafra-Polo,-M-Carmen
  [Author]; Cuadrillero,-Cristina [Author]; Hernandez,-Pilar [Author]; Cortes,
  -Diego [Author]; Pelaez,-Fernando [Author]
AD: ESPANA, MERCK, SHARP and DOHME, CIBE Merck Res Labs, C Josefa Valcarcel,38,
  Madrid 28027, Spain
EMA: jose_tormo@merck.com
SO: Oncology-Research. 2005; 15(3): 129-138
PY: 2005
DT: Article
IS: 0965-0407
LA: English
AB: Annonaceous acetogenins are known to be cytotoxic against tumor cell lines
  by virtue of their inhibition of mitochondrial complex I. We decided to
  conclude part of our recent revisions of the different structure-activity
  relationships (SARs) found within these compounds with a detailed description
  of the cytotoxic activity, and correlations with the inhibition of the target
  enzyme, of the broadest subclass of this family of natural products, the bis
  -tetrahydrofuranic acetogenins (bis-THF ACGs) of
  threo/tranv/threo/trans/erythro relative configuration. Five naturally
  occurring ACGs and more than 10 semisynthetic analogs were tested against the
  MCF-7 (breast), A-549 (lung), HepG2 (liver), HT-29 (colon), MES-SA (ovary), and
  a multidrug-resistant (MDR-MES-SA/Dx5) cell lines using the MTT cytotoxicity
  assay to determine if the mitochondrial complex I inhibition correlated with
  the in vitro antitumor potency of the most common ACGs. Results indicated that
  a previously observed trend for other subclasses of ACGs between the ED50 of
  the cytotoxicity assay and the polarity of compounds was not present in this
  set and that there were several specific interactions that enhanced the
  antitumor activity. For example, some of the guanacone derivatives prepared
  were two orders of magnitude more potent than the parent compound for specific
  cell lines.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Pharmaceuticals-: Pharmacology-;
  Tumor-Biology
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: HepG2-cell-line (Hominidae-): cell_line-, human-liver-cells; HT-29-cell-line
  (Hominidae-): cell_line-, human-colon-cells; MCF-7-cell-line (Hominidae-):
  cell_line-, human-breast-cells; A-549-cell-line (Hominidae-): cell_line-, human
  -lung-cells; MES-SA-cell-line (Hominidae-): cell_line-, human-ovary-cells; MDR
  -MES-SA-Dx5-cell-line (Hominidae-): cell_line-, human-multidrug-resistant-cells
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
CB: mitochondrial-complex-I: 9028-04-0, inhibition-; bis-tetrahydrofuranic
  -acetogenins: antineoplastic-drug, preclinical-trial
RN: 9028-04-0
MQ: MTT-cytotoxicity-assay: laboratory-techniques, bioassay-techniques
MI: structure-activity-relationship
CC: 02508- (Cytology-Human)
10060- (Biochemistry-studies-General)
12512-
  (Pathology-Therapy)
22002- (Pharmacology-General)
24004- (Neoplasms-Pathology
  -clinical-aspects-and-systemic-effects)
24008- (Neoplasms-Therapeutic-agents
  -and-therapy)
AN: 200510168393
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0965
  -0407&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0965
  -0407&isbn=&volume=15&issue=3&spage=129&pages=129
  -138&date=2005&title=Oncology%20Research&atitle=In%20vitro%20antitumor%20structu
  re-activity%20relationships%20of%20threo%2ftrans%2fthreo%2ftrans%2ferythro%20bis
  -tetrahydrofuranic%20acetogenins%3a%20Correlations%20with%20their%20inhibition%2
  0of%20mitochondrial%20complex%20I&aulast=Tormo&pid=%3Cauthor%3ETormo%2c%20Jose%2
  0R%3bDePedro%2c%20Nuria%3bRoyo%2c%20Inmaculada%3bBarrachina%2c%20Isabel%3bZafra%
  20Polo%2c%20M%20Carmen%3bCuadrillero%2c%20Cristina%3bHernandez%2c%20Pilar%3bCort
  es%2c%20Diego%3bPelaez%2c%20Fernando%3C%2Fauthor%3E%3CAN%3E200510168393%3C%2FAN%
  3E%3CDT%3EArticle%3C%2FDT%3E

Record 138 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus
  -induced lung injury
AU: Kuba,-Keiji [Author]; Imai,-Yumiko [Author]; Rao,-Shuan [Author]; Gao,-Hong
  [Author]; Guo,-Feng [Author]; Guan,-Bin [Author]; Huan,-Yi [Author]; Yang,-Peng
  [Author]; Zhang,-Yanli [Author]; Deng,-Wei [Author]; Bao,-Linlin [Author];
  Zhang,-Binlin [Author]; Liu,-Guang [Author]; Wang,-Zhong [Author]; Chappell,
  -Mark [Author]; Liu,-Yanxin [Author]; Zheng,-Dexian [Author]; Leibbrandt,
  -Andreas [Author]; Wada,-Teiji [Author]; Slutsky,-Arthur-S [Author]; Liu,-Depei
  [Author]; Qin,-Chuan [Author]; Jiang,-Chengyu [Author,-Reprint-Author];
  Penninger,-Josef-M [Author]
AD: Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, 5 Dongdan
  Santiao, Beijing 100005, Peoples R China
EMA: jiang@pumc.edu
SO: Nature-Medicine. 2005; 11(8): 875-879
PY: 2005
DT: Article
IS: 1078-8956
LA: English
AB: During several months of 2003, a newly identified illness termed severe
  acute respiratory syndrome (SARS) spread rapidly through the world(1-3). A new
  coronavirus (SARS-CoV) was identified as the SARS pathogen(4-7) which triggered
  severe pneumonia and acute, often lethal, lung failure(8). Moreover, among
  infected individuals influenza such as the Spanish flu(9,10) and the emergence
  of new respiratory disease viruses(11,12) have caused high lethality resulting
  from acute lung failure(13). In cell lines, angiotensin-converting enzyme 2
  (ACE2) has been identified as a potential SARS-CoV receptor(14). The high
  lethality of SARS-CoV infections, its enormous economic and social impact,
  fears of renewed outbreaks as well as the potential misuse of such viruses as
  biologic weapons make it paramount to understand the pathogenesis of SARS-CoV.
  Here we provide the first genetic proof that ACE2 is a crucial SARS-CoV
  receptor in vivo. SARS-CoV infections and the Spike protein of the SARS-CoV
  reduce ACE2 expression. Notably, injection of SARS-CoV Spike into mice worsens
  acute lung failure in vivo that can be attenuated by blocking the renin
  -angiotensin pathway. These results provide a molecular explanation why SARS
  -CoV infections cause severe and often lethal lung failure and suggest a
  rational therapy for SARS and possibly other respiratory disease viruses.
AI: Y
MC: Infection-; Pulmonary-Medicine: Human-Medicine, Medical-Sciences; Enzymology
  -: Biochemistry-and-Molecular-Biophysics
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-; Severe-Acute-Respiratory
  -Syndrome-virus (Coronaviridae-): common-, pathogen-; 293-cell-line (Hominidae
  -): cell_line-; mouse- (Muridae-): common-, host-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-;
  Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-
CB: renin-angiotensin-system; angiotensin-converting-enzyme-2: ACE2-; Spike-
DS: lung-injury: respiratory-system-disease, injury-, pathology-, etiology-;
  severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, pathology-, etiology-,
  complications-
MI: genetic-proof
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10802- (Enzymes-General
  -and-comparative-studies-coenzymes)
12502- (Pathology-General)
16006-
  (Respiratory-system-Pathology)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510167885
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1078
  -8956&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1078
  -8956&isbn=&volume=11&issue=8&spage=875&pages=875
  -879&date=2005&title=Nature%20Medicine&atitle=A%20crucial%20role%20of%20angioten
  sin%20converting%20enzyme%202%20%28ACE2%29%20in%20SARS%20coronavirus
  -induced%20lung%20injury&aulast=Kuba&pid=%3Cauthor%3EKuba%2c%20Keiji%3bImai%2c%2
  0Yumiko%3bRao%2c%20Shuan%3bGao%2c%20Hong%3bGuo%2c%20Feng%3bGuan%2c%20Bin%3bHuan%
  2c%20Yi%3bYang%2c%20Peng%3bZhang%2c%20Yanli%3bDeng%2c%20Wei%3bBao%2c%20Linlin%3b
  Zhang%2c%20Binlin%3bLiu%2c%20Guang%3bWang%2c%20Zhong%3bChappell%2c%20Mark%3bLiu%
  2c%20Yanxin%3bZheng%2c%20Dexian%3bLeibbrandt%2c%20Andreas%3bWada%2c%20Teiji%3bSl
  utsky%2c%20Arthur%20S%3bLiu%2c%20Depei%3bQin%2c%20Chuan%3bJiang%2c%20Chengyu%3bP
  enninger%2c%20Josef%20M%3C%2Fauthor%3E%3CAN%3E200510167885%3C%2FAN%3E%3CDT%3EArt
  icle%3C%2FDT%3E

Record 139 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Recombinant severe acute respiratory syndrome (SARS) coronavirus
  nucleocapsid protein forms a dimer through its c-terminal domain
AU: Yu,-I-Mei [Author]; Gustafson,-Christin-L-T [Author]; Diao,-Jianbo [Author];
  Burgner,-John-W-II [Author]; Li,-Zhihong [Author]; Zhang,-Jingqiang [Author];
  Chen,-Jue [Author,-Reprint-Author]
AD: Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA
EMA: chenjue@purdue.edu
SO: Journal-of-Biological-Chemistry. 2005; 280(24): 23280-23286
PY: 2005
DT: Article
IS: 0021-9258
LA: English
AB: The causative agent of severe acute respiratory syndrome (SARS) is the SARS
  -associated coronavirus, SARS-CoV. The viral nucleocapsid (N) protein plays an
  essential role in viral RNA packaging. In this study, recombinant SARS-CoV N
  protein was shown to be dimeric by analytical ultracentrifugation, size
  exclusion chromatography coupled with light scattering, and chemical cross
  -linking. Dimeric N proteins self-associate into tetramers and higher molecular
  weight oligomers at high concentrations. The dimerization domain of N was
  mapped through studies of the oligomeric states of several truncated mutants.
  Although mutants consisting of residues 1-210 and 1-284 fold as monomers,
  constructs consisting of residues 211-422 and 285-422 efficiently form dimers.
  When in excess, the truncated construct 285-422 inhibits the homodimerization
  of full-length N protein by forming a heterodimer with the full-length N
  protein. These results suggest that the N protein oligomerization involves the
  C-terminal residues 285-422, and this region is a good target for mutagenic
  studies to disrupt N protein self-association and virion assembly.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Virology-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: nucleocapsid-protein: N-protein, recombinant-, dimeric-, oligomerization-
MQ: analytical-ultracentrifugation: laboratory-techniques; size-exclusion
  -chromatography-light-scattering: laboratory-techniques, chromatographic
  -techniques; dimerization-domain-mapping: laboratory-techniques
MI: C-terminal-residue
CC: 10060- (Biochemistry-studies-General)
33502- (Virology-General-and-methods)
AN: 200510165204
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0021
  -9258&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0021
  -9258&isbn=&volume=280&issue=24&spage=23280&pages=23280
  -23286&date=2005&title=Journal%20of%20Biological%20Chemistry&atitle=Recombinant%
  20severe%20acute%20respiratory%20syndrome%20%28SARS%29%20coronavirus%20nucleocap
  sid%20protein%20forms%20a%20dimer%20through%20its%20c
  -terminal%20domain&aulast=Yu&pid=%3Cauthor%3EYu%2c%20I%20Mei%3bGustafson%2c%20Ch
  ristin%20L%20T%3bDiao%2c%20Jianbo%3bBurgner%2c%20John%20W%20II%3bLi%2c%20Zhihong
  %3bZhang%2c%20Jingqiang%3bChen%2c%20Jue%3C%2Fauthor%3E%3CAN%3E200510165204%3C%2F
  AN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 140 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Critical assessment of important regions in the subunit association and
  catalytic action of the severe acute respiratory syndrome coronavirus main
  protease
AU: Hsu,-Wen-Chi [Author]; Chang,-Hui-Chuan [Author]; Chou,-Chi-Yuan [Author];
  Tsai,-Pui-Jen [Author]; Lin,-Pei-In [Author]; Chang,-Gu-Gang [Author,-Reprint
  -Author]
AD: Natl Yang Ming Univ, Fac Life Sci, Inst Biochem, 155 Li Nong St,Sect 2,
  Taipei 112, Taiwan
EMA: ggchang@ym.edu.tw
SO: Journal-of-Biological-Chemistry. 2005; 280(24): 22741-22748
PY: 2005
DT: Article
IS: 0021-9258
LA: English
AB: The severe acute respiratory syndrome (SARS) coronavirus ( CoV) main
  protease represents an attractive target for the development of novel anti-SARS
  agents. The tertiary structure of the protease consists of two distinct folds.
  One is the N-terminal chymotrypsin-like fold that consists of two structural
  domains and constitutes the catalytic machinery; the other is the C-terminal
  helical domain, which has an unclear function and is not found in other RNA
  virus main proteases. To understand the functional roles of the two structural
  parts of the SARS-CoV main protease, we generated the full-length of this
  enzyme as well as several terminally truncated forms, different from each other
  only by the number of amino acid residues at the C- or N-terminal regions. The
  quaternary structure and K-d value of the protease were analyzed by analytical
  ultracentrifugation. The results showed that the N-terminal 1-3 amino acid
  -truncated protease maintains 76% of enzyme activity and that the major form is
  a dimer, as in the wild type. However, the amino acids 1-4-truncated protease
  showed the major form to be a monomer and had little enzyme activity. As a
  result, the fourth amino acid seemed to have a powerful effect on the
  quaternary structure and activity of this protease. The last C- terminal
  helically truncated protease also exhibited a greater tendency to form monomer
  and showed little activity. We concluded that both the C- and the N-terminal
  regions influence the dimerization and enzyme activity of the SARS-CoV main
  protease.
AI: Y
MC: Infection-; Enzymology-: Biochemistry-and-Molecular-Biophysics; Respiratory
  -System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; Coronavirus- (Coronaviridae-): genus-, pathogen-; Escherichia-coli
  (Enterobacteriaceae-): species-, strain-BL21
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-
CB: RNA-; dimer-; monomer-; protease-: 9001-92-7, dimerization-, EC-3.4.21.7;
  chymotrypsin-: 9004-07-3, EC-3.4.21.1, N-terminus, C-terminal-helical-domain
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; coronavirus-infection:
  viral-disease
RN: 9001-92-7; 9004-07-3
MQ: ultracentrifugation-: laboratory-techniques
MI: enzyme-activity; quaternary-structure; subunit-association; catalytic
  -action; critical-assessment
CC: 10062- (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
10802-
  (Enzymes-General-and-comparative-studies-coenzymes)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
31000-
  (Physiology-and-biochemistry-of-bacteria)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510165142
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0021
  -9258&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0021
  -9258&isbn=&volume=280&issue=24&spage=22741&pages=22741
  -22748&date=2005&title=Journal%20of%20Biological%20Chemistry&atitle=Critical%20a
  ssessment%20of%20important%20regions%20in%20the%20subunit%20association%20and%20
  catalytic%20action%20of%20the%20severe%20acute%20respiratory%20syndrome%20corona
  virus%20main%20protease&aulast=Hsu&pid=%3Cauthor%3EHsu%2c%20Wen%20Chi%3bChang%2c
  %20Hui%20Chuan%3bChou%2c%20Chi%20Yuan%3bTsai%2c%20Pui%20Jen%3bLin%2c%20Pei%20In%
  3bChang%2c%20Gu%20Gang%3C%2Fauthor%3E%3CAN%3E200510165142%3C%2FAN%3E%3CDT%3EArti
  cle%3C%2FDT%3E

Record 141 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Synthesis of novel test compounds for antiviral chemotherapy of severe acute
  respiratory syndrome (SARS)
AU: Kesel,-Andreas-J [Author,-Reprint-Author]
AD: Chammunsterstr 47, D-81827 Munich, Germany
EMA: andreas.kesel@t-online.de
SO: Current-Medicinal-Chemistry. 2005; 12(18): 2095-2162
PY: 2005
DT: Article
IS: 0929-8673
LA: English
AB: This contribution reviews the synthesis of a range of experimental drugs
  designed for and aiming at antiviral chemotherapy of severe acute respiratory
  syndrome (SARS) coronavirus (SARS-CoV)-induced human disease conditions. The
  selection of 25 test materials includes eleven trioxa-adamantane-triols (TATs)
  [BN, IBNCA, ABNCA, VANBA, ethylVANBA, euBN, euVANBA, ansaBN, Ehrlich BN,
  [6]prismaneBN, nitrodiBN], trivially termed bananins, one trioxa-adamantan-ol
  (TAO) THYMOBA, one bis-bananin pi-bananin (piBN), one triazaadamantane delta
  -bananin (deltaBN), seven potential nucleic acid-binding drugs (XBQC, INDO,
  PivINDO, AZTRION, AZADO, AZOCYS, AZOGALL), one potential antiviral interferon
  -inducer and distant nucleoside analog diazon, one potential HIV protein Vif
  antagonist AZODIAZON, one folic acid-diazon condensate DIAZONOFOL, and one
  special nucleoside analog (fructoinosine/fructovir). Four of the eleven
  bananins (BN, IBNCA, VANBA, euBN) were already demonstrated to constitute
  effective inhibitors of SARS-CoV NSP10/nsp13 RNA/DNA helicase/NTPase protein
  ATPase enzymatic function. Bananin (BN) was an effective inhibitor of both SARS
  -CoV RNA/DNA helicase nucleic acid unwinding function and SARS-CoV
  (Coronaviridae, Coronavirus) RNA-viral replication in cell culture. In summary,
  at least one selected compound of the synthesized test materials represents an
  interesting drug candidate for treatment of SARS-CoV-induced human disease
  (SARS). Viewed in aspects of organic chemistry [6]prismaneBN and nitrodiBN are
  the first true hexaprismane derivatives synthesized, and all reported compounds
  are entirely new.
AI: Y
MC: Pharmacology-; Infection-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: antiviral-drugs: antiinfective-drug, antiviral-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy
MQ: chemotherapy-: therapeutic-and-prophylactic-techniques, clinical-techniques
CC: 12512- (Pathology-Therapy)
16006- (Respiratory-system-Pathology)
22002-
  (Pharmacology-General)
22005- (Pharmacology-Clinical-pharmacology)
33502-
  (Virology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
38502- (Chemotherapy-General-methods-and-metabolism)
38506-
  (Chemotherapy-Antiviral-agents)
AN: 200510161317
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0929
  -8673&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0929
  -8673&isbn=&volume=12&issue=18&spage=2095&pages=2095
  -2162&date=2005&title=Current%20Medicinal%20Chemistry&atitle=Synthesis%20of%20no
  vel%20test%20compounds%20for%20antiviral%20chemotherapy%20of%20severe%20acute%20
  respiratory%20syndrome%20%28SARS%29&aulast=Kesel&pid=%3Cauthor%3EKesel%2c%20Andr
  eas%20J%3C%2Fauthor%3E%3CAN%3E200510161317%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 142 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Software for optimization of SNP and PCR-RFLP genotyping to discriminate
  many genomes with the fewest assays
AU: Gardner,-Shea-N [Author,-Reprint-Author]; Wagner,-Mark-C [Author]
AD: Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA
EMA: gardner26@llnl.gov; wagner5@llnl.gov
SO: BMC-Genomics. 2005; 6
PY: 2005
DT: Article
IS: 1471-2164
LA: English
AB: Background: Microbial forensics is important in tracking the source of a
  pathogen, whether the disease is a naturally occurring outbreak or part of a
  criminal investigation.Results: A method and SPR Opt ( SNP and PCR-RFLP
  Optimization) software to perform a comprehensive, whole-genome analysis to
  forensically discriminate multiple sequences is presented. Tools for the
  optimization of forensic typing using Single Nucleotide Polymorphism (SNP) and
  PCR-Restriction Fragment Length Polymorphism (PCR-RFLP) analyses across
  multiple isolate sequences of a species are described. The PCR-RFLP analysis
  includes prediction and selection of optimal primers and restriction enzymes to
  enable maximum isolate discrimination based on sequence information. SPR Opt
  calculates all SNP or PCR-RFLP variations present in the sequences, groups them
  into haplotypes according to their co-segregation across those sequences, and
  performs combinatoric analyses to determine which sets of haplotypes provide
  maximal discrimination among all the input sequences. Those set combinations
  requiring that membership in the fewest haplotypes be queried (i.e. the fewest
  assays be performed) are found. These analyses highlight variable regions based
  on existing sequence data. These markers may be heterogeneous among unsequenced
  isolates as well, and thus may be useful for characterizing the relationships
  among unsequenced as well as sequenced isolates. The predictions are multi
  -locus. Analyses of mumps and SARS viruses are summarized. Phylogenetic trees
  created based on SNPs, PCR-RFLPs, and full genomes are compared for SARS virus,
  illustrating that purported phylogenies based only on SNP or PCR-RFLP
  variations do not match those based on multiple sequence alignment of the full
  genomes.Conclusion: This is the first software to optimize the selection of
  forensic markers to maximize information gained from the fewest assays,
  accepting whole or partial genome sequence data as input. As more sequence data
  becomes available for multiple strains and isolates of a species, automated,
  computational approaches such as those described here will be essential to make
  sense of large amounts of information, and to guide and optimize efforts in the
  laboratory. The software and source code for SPR Opt is publicly available and
  free for non-profit use at http://www. llnl.gov/
  IPandC/technology/software/softwaretitles/spropt.php.
AI: Y
MC: Infection-; Methods-and-Techniques; Computer-Applications: Computational
  -Biology
MQ: PCR-RFLP: polymerase-chain-reaction-restriction-fragment-length
  -polymorphism, laboratory-techniques, genetic-techniques; SNP-genotyping:
  laboratory-techniques, genetic-techniques; SPR-Opt-software: computer-software
MI: genome-; microbial-forensics
CC: 00530- (General-biology-Information-documentation-retrieval-and-computer
  -applications)
10062- (Biochemistry-studies-Nucleic-acids-purines-and
  -pyrimidines)
AN: 200510159531
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1471
  -2164&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1471
  -2164&isbn=&volume=6&issue=&spage=&pages=6&date=2005&title=BMC%20Genomics&atitle
  =Software%20for%20optimization%20of%20SNP%20and%20PCR
  -RFLP%20genotyping%20to%20discriminate%20many%20genomes%20with%20the%20fewest%20
  assays&aulast=Gardner&pid=%3Cauthor%3EGardner%2c%20Shea%20N%3bWagner%2c%20Mark%2
  0C%3C%2Fauthor%3E%3CAN%3E200510159531%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 143 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Efficient and quick inactivation of SARS coronavirus and other microbes
  exposed to the surfaces of some metal catalysts
AU: Han,-Jun [Author]; Chen,-Lan [Author]; Duan,-Shu-Min [Author]; Yang,-Qing
  -Xiang [Author]; Yang,-Min [Author]; Gao,-Chen [Author]; Zhang,-Bao-Yun
  [Author]; He,-Hong [Author]; Dong,-Xiao-Ping [Author,-Reprint-Author]
AD: China Ctr Dis Control and Prevent, Inst Viral Dis Control and Prevent,
  Xingxin Rd 100, Beijing 100052, Peoples R China
EMA: honghe@mail.rcees.ac.cn
SO: Biomedical-and-Environmental-Sciences. 2005; 18(3): 176-180
PY: 2005
DT: Article
IS: 0895-3988
LA: English
AB: Objective To study the two metal catalysts Ag/Al2O3 and CuAl2O3 that
  interdict the transmission pathway for SARS and other respiratory infectious
  diseases. Methods Two metal catalysts Ag/Al2O3 and Cu/Al2O3 were pressed into
  wafers. One hundred mu L 10(6) TCID50/mL SARS-CoV, 100 mu L 10(6) PFU/mL
  recombinant baculovirus expressing hamster's prion protein (haPrP) protein and
  roughly 10(6) E. coli were slowly dropped onto the surfaces of the catalyst
  wafers and exposed for 5 and 20 min, respectively. After eluted from the
  surfaces of wafers, the infectivity of viruses and propagation of bacteria were
  measured. The expression of PrP protein was determined by Western blot. The
  morphological changes of bacteria were observed by electronic microscopy.
  Results After exposure to the catalysts surfaces for 5 and 20 min, the
  infectivity of SARS-COV in Vero cells and baculovirus in Sf9 cells dropped down
  to a very low and undetectable level, and no colony was detected using bacteria
  culture method. The expression of haPrP protein reduced to 21.8% in the
  preparation of Sf9 cells infected with recombinant baculovirus exposed for 5
  min and was undetectable exposed for 20 min. Bacterial membranes seemed to be
  cracked and the cytoplasm seemed to be effluent from cell bodies. Conclusion
  Exposure,; to the surfaces, of Ag/Al2O3 and Cu/Al2O3 destroy the replication
  and propagation abilities of SARS-CoV, baculovirus and E. coli. Inactivation
  ability of metal catalysts needs to interact with air, utilizing oxygen
  molecules in air. Efficiently killing viruses and bacteria on the surfaces of
  the two metal catalysts has a promising potential for air-disinfection in
  hospitals, communities, and household,,,.
AI: Y
MC: Pharmacology-; Infection-; Molecular-Genetics: Biochemistry-and-Molecular
  -Biophysics; Respiratory-System: Respiration-
ST: -[05000-] Bacteria-, -Microorganisms; -[03114-] Baculoviridae-, -dsDNA
  -Viruses, Viruses-, Microorganisms-; -[86205-] Cercopithecidae-, -Primates,
  Mammalia-, Vertebrata-, Chordata-, Animalia-; -[03613-] Coronaviridae-, 
  -Positive-Sense-ssRNA-Viruses, Viruses-, Microorganisms-; -[06702-]
  Enterobacteriaceae-, -Facultatively-Anaerobic-Gram-Negative-Rods, Eubacteria-,
  Bacteria-, Microorganisms-
OR: bacteria- (Bacteria-): common-, pathogen-; Baculovirus- (Baculoviridae-):
  species-, pathogen-; Vero-cell-line (Cercopithecidae-): cell_line-, host-,
  green-monkey-kidney-cells; SARS-virus (Coronaviridae-): common-, Severe-Acute
  -Respiratory-Syndrome-virus, common-; Escherichia-coli (Enterobacteriaceae-):
  species-, pathogen-
TN: Bacteria-: Bacteria-, Eubacteria-, Microorganisms-; Baculoviridae-: Double
  -Stranded-DNA-Viruses, Microorganisms-, Viruses-; Cercopithecidae-: Animals-,
  Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman-Vertebrates, Nonhuman
  -Primates, Primates-, Vertebrates-; Coronaviridae-: Microorganisms-, Positive
  -Sense-Single-Stranded-RNA-Viruses, Viruses-; Enterobacteriaceae-: Bacteria-,
  Eubacteria-, Microorganisms-
CB: metal-catalyst: antiinfective-drug, antiviral-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy, prevention
  -and-control, transmission-
MQ: Western-blot: electrophoretic-techniques, immunologic-techniques, laboratory
  -techniques; electronic-microscopy: laboratory-techniques, imaging-and
  -microscopy-techniques
CC: 02506- (Cytology-Animal)
03502- (Genetics-General)
03506- (Genetics
  -Animal)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
12512- (Pathology-Therapy)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
22002- (Pharmacology
  -General)
31000- (Physiology-and-biochemistry-of-bacteria)
31500- (Genetics
  -of-bacteria-and-viruses)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
38502- (Chemotherapy-General
  -methods-and-metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510159322
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0895
  -3988&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0895
  -3988&isbn=&volume=18&issue=3&spage=176&pages=176
  -180&date=2005&title=Biomedical%20and%20Environmental%20Sciences&atitle=Efficien
  t%20and%20quick%20inactivation%20of%20SARS%20coronavirus%20and%20other%20microbe
  s%20exposed%20to%20the%20surfaces%20of%20some%20metal%20catalysts&aulast=Han&pid
  =%3Cauthor%3EHan%2c%20Jun%3bChen%2c%20Lan%3bDuan%2c%20Shu%20Min%3bYang%2c%20Qing
  %20Xiang%3bYang%2c%20Min%3bGao%2c%20Chen%3bZhang%2c%20Bao%20Yun%3bHe%2c%20Hong%3
  bDong%2c%20Xiao%20Ping%3C%2Fauthor%3E%3CAN%3E200510159322%3C%2FAN%3E%3CDT%3EArti
  cle%3C%2FDT%3E

Record 144 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Assessment of impacts of public health interventions on the SARS epidemic in
  Beijing in terms of the intervals between its symptom onset, hospital
  admission, and notification
AU: Liang,-Wan-Nian [Author,-Reprint-Author]; Liu,-Min [Author]; Chen,-Qi
  [Author]; Liu,-Ze-Jun [Author]; He,-Xiong [Author]; Pan,-Yue [Author]; Xie,-Xue
  -Qin [Author]
AD: Beijing Municipal Hlth Bur, 70 Zao Lin Qian St,Xuanwu Dist, Beijing 100053,
  Peoples R China
EMA: liangwannian@sina.com
SO: Biomedical-and-Environmental-Sciences. 2005; 18(3): 153-158
PY: 2005
DT: Article
IS: 0895-3988
LA: English
AB: Objectives To assess the impacts of public health interventions on the
  outbreak of SARS in Beijing by analyzing the intervals between symptom onset,
  hospital admission and notification of its cases. Methods Data of SARS cases
  reported from the Beijing Municipal Centers for Disease Prevention and Control
  (BCDC) were collected and analyzed by descriptive epidemiology. Results In the
  early epidemic period, the intervals between the disease onset and the hospital
  admission seemed irregular, so was the intervals between the hospital admission
  and the notification. After the middle ten days of April, the intervals turned
  out to be more regular, and the disordered situation in terms of the hospital
  admission and the case notification was gradually brought under control.
  Conclusions Public health interventions against SARS has revealed positive
  impacts on SARS control program in Beijing. The timing and sensitivity of
  epidemic information reporting systems has been greatly improved in Beijing as
  a result of successful fight against this disease.
AI: Y
MC: Infection-; Public-Health: Allied-Medical-Sciences; Epidemiology-:
  Population-Studies; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, adult-, female-, male-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
GE: Beijing-: China-, Asia-, Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, infectious-disease, viral-disease,
  pathology-, prevention-and-control, symptom-, epidemiology-
MI: hospital-admission; public-health-intervention
CC: 12502- (Pathology-General)
16006- (Respiratory-system-Pathology)
36001-
  (Medical-and-clinical-microbiology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
37001- (Public-health-General-and
  -miscellaneous)
37052- (Public-health-epidemiology-Communicable
  -diseases)
37054- (Public-health-epidemiology-Organic-diseases-and
  -neoplasms)
37056- (Public-health-epidemiology-Miscellaneous)
AN: 200510159318
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0895
  -3988&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0895
  -3988&isbn=&volume=18&issue=3&spage=153&pages=153
  -158&date=2005&title=Biomedical%20and%20Environmental%20Sciences&atitle=Assessme
  nt%20of%20impacts%20of%20public%20health%20interventions%20on%20the%20SARS%20epi
  demic%20in%20Beijing%20in%20terms%20of%20the%20intervals%20between%20its%20sympt
  om%20onset%2c%20hospital%20admission%2c%20and%20notification&aulast=Liang&pid=%3
  Cauthor%3ELiang%2c%20Wan%20Nian%3bLiu%2c%20Min%3bChen%2c%20Qi%3bLiu%2c%20Ze%20Ju
  n%3bHe%2c%20Xiong%3bPan%2c%20Yue%3bXie%2c%20Xue%20Qin%3C%2Fauthor%3E%3CAN%3E2005
  10159318%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 145 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Summary of the activity of antiviral agents in a murine SARS-associated
  coronavirus (SARS-CoV) replication model
AU: Barnard,-Dale-L [Author,-Reprint-Author]; Jung,-Kie-Hoon [Author]; Day,
  -Craig-W [Author]; Bailey,-Kevin-W [Author]; Heiner,-Matthew-L [Author];
  Wootton,-Walter-M [Author]; Sidwell,-Robert-W [Author]
AD: Utah State Univ, Inst Antiviral Res, Logan, UT USA
SO: Antiviral-Research. 2005; 65(3): A66
PY: 2005
DT: Meeting-Poster; Meeting
IS: 0166-3542
MT: 18th International Conference on Antiviral Research, Barcelona, SPAIN; April
  11 -14, 2005 
SP: Int Soc Antiviral Res
LA: English
MC: Pharmacology-; Infection-; Respiratory-System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Coronavirus- (Coronaviridae-): genus-, pathogen-; BALB-c-mouse (Muridae-):
  common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-
PS: serum-: blood-and-lymphatics; lung-: respiratory-system, weight-
CB: mycophenolic-acid: 24280-93-1; EICAR-: 118908-07-9; VI-: antiinfective-drug,
  antiviral-drug, pharmacodynamics-, calpain-inhibitor, efficacy-,
  intraperitoneal-administration; nelfinavir-: 159989-64-7, antiinfective-drug,
  antiviral-drug, pharmacodynamics-, calpain-inhibitor, efficacy-,
  intraperitoneal-administration; ribavirin-: 36791-04-5, antiinfective-drug,
  antiviral-drug, pharmacodynamics-, calpain-inhibitor, intranasal
  -administration, efficacy-, intraperitoneal-administration
DS: lung-consolidation: respiratory-system-disease; severe-acute-respiratory
  -syndrome: (Severe-Acute-Respiratory-Syndrome-(MeSH)), respiratory-system
  -disease, infectious-disease, viral-disease, etiology-
RN: 24280-93-1; 118908-07-9; 159989-64-7; 36791-04-5
MI: viral-clearance; virus-replication-; virus-titer
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10062-
  (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
12512- (Pathology
  -Therapy)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
22002- (Pharmacology-General)
33502- (Virology
  -General-and-methods)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
38502-
  (Chemotherapy-General-methods-and-metabolism)
38506- (Chemotherapy-Antiviral
  -agents)
AN: 200510157993
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0166
  -3542&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0166
  -3542&isbn=&volume=65&issue=3&spage=&pages=A66&date=2005&title=Antiviral%20Resea
  rch&atitle=Summary%20of%20the%20activity%20of%20antiviral%20agents%20in%20a%20mu
  rine%20SARS-associated%20coronavirus%20%28SARS
  -CoV%29%20replication%20model&aulast=Barnard&pid=%3Cauthor%3EBarnard%2c%20Dale%2
  0L%3bJung%2c%20Kie%20Hoon%3bDay%2c%20Craig%20W%3bBailey%2c%20Kevin%20W%3bHeiner%
  2c%20Matthew%20L%3bWootton%2c%20Walter%20M%3bSidwell%2c%20Robert%20W%3C%2Fauthor
  %3E%3CAN%3E200510157993%3C%2FAN%3E%3CDT%3EMeeting%20Poster%3bMeeting%3C%2FDT%3E

Record 146 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Inhibition, escape and attenuation of SARS coronavirus treated with
  antisense morpholino oligomers
AU: Neuman,-Benjamin-W [Author,-Reprint-Author]; Stein,-David-A [Author];
  Kroeker,-Andrew-D [Author]; Churchill,-Michael-J [Author]; Kim,-Alice-M
  [Author]; Dawson,-Philip [Author]; Moulton,-Hong-M [Author]; Bestwick,-Richard
  -K [Author]; Iversen,-Patrick-L [Author]; Buchmeier,-Michael-J [Author]
AD: Scripps Res Inst, La Jolla, CA USA
SO: Antiviral-Research. 2005; 65(3): A38
PY: 2005
DT: Meeting-Abstract; Meeting
IS: 0166-3542
MT: 18th International Conference on Antiviral Research, Barcelona, SPAIN; April
  11 -14, 2005 
SP: Int Soc Antiviral Res
LA: English
MC: Pharmacology-; Infection-; Respiratory-System: Respiration-
ST: -[03507-] Arenaviridae-, -Negative-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-
OR: Arenavirus- (Arenaviridae-): genus-; Murine-hepatitis-virus (Coronaviridae
  -): species-, pathogen-; Coronavirus- (Coronaviridae-): genus-, pathogen-,
  strain-Tor2
TN: Arenaviridae-: Microorganisms-, Negative-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA
  -Viruses, Viruses-
CB: RNA-; peptide-conjugated-antisense-morpholino-oligomers: antiinfective-drug,
  antiviral-drug, pharmacodynamics-, efficacy-
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease,
  infectious-disease, viral-disease, drug-therapy, etiology-
MI: viral-growth; viral-synthesis
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10062-
  (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
12512- (Pathology
  -Therapy)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
22002- (Pharmacology-General)
33502- (Virology
  -General-and-methods)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
38502-
  (Chemotherapy-General-methods-and-metabolism)
38506- (Chemotherapy-Antiviral
  -agents)
AN: 200510157929
UD: 20050920
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0166
  -3542&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0166
  -3542&isbn=&volume=65&issue=3&spage=&pages=A38&date=2005&title=Antiviral%20Resea
  rch&atitle=Inhibition%2c%20escape%20and%20attenuation%20of%20SARS%20coronavirus%
  20treated%20with%20antisense%20morpholino%20oligomers&aulast=Neuman&pid=%3Cautho
  r%3ENeuman%2c%20Benjamin%20W%3bStein%2c%20David%20A%3bKroeker%2c%20Andrew%20D%3b
  Churchill%2c%20Michael%20J%3bKim%2c%20Alice%20M%3bDawson%2c%20Philip%3bMoulton%2
  c%20Hong%20M%3bBestwick%2c%20Richard%20K%3bIversen%2c%20Patrick%20L%3bBuchmeier%
  2c%20Michael%20J%3C%2Fauthor%3E%3CAN%3E200510157929%3C%2FAN%3E%3CDT%3EMeeting%20
  Abstract%3bMeeting%3C%2FDT%3E

Record 147 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Immunogenicity and safety of an inactivated SARS-associated coronavirus
  vaccine in rhesus monkeys
AU: Zhong-Qiong [Author]; Yang-Zhan-qiu [Author,-Reprint-Author]; Zhou-Jun
  [Author]; Wang-Wei [Author]; Hou-Wei [Author]; Zhu-Run-qing [Author]; Tang-Zhi
  -jiao [Author]; Wang-Yong [Author]; Xian-Qiao-yang [Author]
AD: Wuhan Univ, Sch Med, Dept Pathol, Inst Virol,State Key Lab Virol, Wuhan
  430071, Peoples R China
EMA: yangzhangqiu@163.com
SO: Zhonghua-Weishengwuxue-He-Mianyixue-Zazhi. 2005; 25(4): 302-306
PY: 2005
DT: Article
IS: 0254-5101
LA: Chinese
AB: Objective An inactivated vaccine for SARS-associated coronavirus (SARS-CoV)
  was evaluated in rhesus monkeys. Methods The monkeys intramuscularly were
  inoculated with 0.5, 5, 50, 5000 mu g of vaccine and PBS as control, then
  boosted at day 7. Me humoral and mucosal immune responses in serum. cytokine
  and clinical signs were monitored following the immunization. Results The 50 mu
  g of vaccine elicited SARS-CoV specific immune responses as compared to the
  partial immunity elicited by 0.5 mu g and 5 mu g doses. No systematic side
  effects were recorded in vaccinated animals, even in those of high dose as 5000
  mu g. Conclusion The results show that the inactivated vaccine can induce
  effective concomitant Immoral and mucosal immunity against SARS-CoV infection
  and is safe in monkeys, so it is a potential candidate of vaccine.
AI: Y
MC: Pharmacology-; Infection-; Immune-System: Chemical-Coordination-and
  -Homeostasis; Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: rhesus-monkey (Cercopithecidae-): common-, host-; SARS-virus (Coronaviridae
  -): common-, Severe-Acute-Respiratory-Syndrome-virus, common-, pathogen-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
PS: serum-: blood-and-lymphatics
CB: cytokine-; SARS-virus-inactivated-vaccine: immunologic-drug, immunostimulant
  -drug, vaccine-, intramuscular-administration
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease, immunology-
CC: 12512- (Pathology-Therapy)
15002- (Blood-Blood-and-lymph-studies)
15004-
  (Blood-Blood-cell-studies)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
17002- (Endocrine
  -General)
22002- (Pharmacology-General)
22018- (Pharmacology-Immunological
  -processes-and-allergy)
33502- (Virology-General-and-methods)
34502-
  (Immunology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510155658
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0254
  -5101&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0254
  -5101&isbn=&volume=25&issue=4&spage=302&pages=302
  -306&date=2005&title=Zhonghua%20Weishengwuxue%20He%20Mianyixue%20Zazhi&atitle=Im
  munogenicity%20and%20safety%20of%20an%20inactivated%20SARS
  -associated%20coronavirus%20vaccine%20in%20rhesus%20monkeys&aulast=&pid=%3Cautho
  r%3EZhong%20Qiong%3bYang%20Zhan%20qiu%3bZhou%20Jun%3bWang%20Wei%3bHou%20Wei%3bZh
  u%20Run%20qing%3bTang%20Zhi%20jiao%3bWang%20Yong%3bXian%20Qiao%20yang%3C%2Fautho
  r%3E%3CAN%3E200510155658%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 148 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Immunogenicity of DNA vaccine that express spike gene fragment of SARS
  coronavirus
AU: Li-Jiang [Author]; Qin-Hai-de [Author]; Liu-Peng [Author]; Zhang-Jing-wei
  [Author]; Feng-Bing-jian [Author]; Feng-Qi-sheng [Author]; Chen-Li-zhen
  [Author]; Pan-Zhi-gang [Author]; Huang-Li-xi [Author]; Zhang-Ru-hua [Author];
  Yu-Xing-juan [Author]; Zeng-Yi-xin [Author,-Reprint-Author]
AD: Natl Sun Yat Sen Univ, Ctr Canc, Res Dept, Guangzhou 510060, Peoples R China
EMA: yxzeng@gzsums.edu.cn
SO: Zhonghua-Weishengwuxue-He-Mianyixue-Zazhi. 2005; 25(4): 297-301
PY: 2005
DT: Article
IS: 0254-5101
LA: Chinese
AB: Objective To construct the SARS coronavirus spike gene DNA vaccines and to
  find the immunogenicity of spike gene. Methods We collected two DNA fragments
  coding the N-terminal(D14, 1-663AA) and C-terminal(D23, 634-1255AA) of the
  Spike protein and the whole spike gene(D12, 1-1255AA) from the SARS virus
  (Beijing 01 strain) cDNA by RT-PCR and recombinated the DNA fragments with
  plasmid pcDNA3. The naked. DNA plasmid containing the S gene and the two
  fragments of the N-terminal and C-terminal of the S gene and the empty vector
  pcDNA3 as control were used to immunize Wistar rats intramuscularly. The
  humoral antibody IgG responsed to S gene was detected in the serum of
  vaccination rats in 3(rd), 5(th), 6(th) and 7(th) weeks after the first dosage
  of immunization. The cell-mediated immune(CMI) response of vaccines was
  detected by the MHC class-I limited CD8(+) virus-specific cytotoxic T
  lymphocytes(CTLs) With Cr-51 release experiments and the cytokine level of IFN
  -gamma with the ELISPOT. Results D23 detected vaccinated animals had antiboby
  at 5(th) week and the titer raised by 1000-fold. Other experiment and control
  groups didn't produce antibody. The group of D23 was found to induce stronger
  specific CTL activity than other groups ( P < 0.05, between D23 and control
  group). No specific CTL was found in the groups of D14, D12 and control group
  and the spleenocytes of group of D23 released more IFN-gamma than that of
  spleenocytes from other groups. Conclusion These results identified that the C
  -terminal of spike gene was with more preferential antigenicity expression for
  vaccine.
AI: Y
MC: Pharmacology-; Immune-System: Chemical-Coordination-and-Homeostasis;
  Molecular-Genetics: Biochemistry-and-Molecular-Biophysics; Respiratory-System:
  Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-; Wistar
  -rat (Muridae-): common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-
PS: serum-: blood-and-lymphatics; cytotoxic-T-lymphocyte: immune-system, blood
  -and-lymphatics
CB: cytokine-; immunoglobulin-G: IgG-; interferon-gamma: IFN-gamma; spike
  -protein; pcDNA3-; SARS-coronavirus-spike-gene-DNA-vaccine: immunologic-drug,
  vaccine-
GN: Severe-Acute-Respiratory-Syndrome-virus-spike-gene [Coronaviridae-]
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, etiology-, immunology-,
  prevention-and-control
MQ: reverse-transcriptase-polymerase-chain-reaction: RT-PCR, laboratory
  -techniques, genetic-techniques; ELISPOT-: laboratory-techniques, immunologic
  -techniques
MI: immunogenicity-; cell-mediated-immune-response
CC: 02506- (Cytology-Animal)
03502- (Genetics-General)
03506- (Genetics
  -Animal)
10062- (Biochemistry-studies-Nucleic-acids-purines-and
  -pyrimidines)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
12512- (Pathology-Therapy)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
17002-
  (Endocrine-General)
22002- (Pharmacology-General)
22018- (Pharmacology
  -Immunological-processes-and-allergy)
31500- (Genetics-of-bacteria-and
  -viruses)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510155657
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0254
  -5101&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0254
  -5101&isbn=&volume=25&issue=4&spage=297&pages=297
  -301&date=2005&title=Zhonghua%20Weishengwuxue%20He%20Mianyixue%20Zazhi&atitle=Im
  munogenicity%20of%20DNA%20vaccine%20that%20express%20spike%20gene%20fragment%20o
  f%20SARS%20coronavirus&aulast=&pid=%3Cauthor%3ELi%20Jiang%3bQin%20Hai%20de%3bLiu
  %20Peng%3bZhang%20Jing%20wei%3bFeng%20Bing%20jian%3bFeng%20Qi%20sheng%3bChen%20L
  i%20zhen%3bPan%20Zhi%20gang%3bHuang%20Li%20xi%3bZhang%20Ru%20hua%3bYu%20Xing%20j
  uan%3bZeng%20Yi%20xin%3C%2Fauthor%3E%3CAN%3E200510155657%3C%2FAN%3E%3CDT%3EArtic
  le%3C%2FDT%3E

Record 149 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: The difference of immunology index between SARS patients of mild type and
  severe type
AU: Cheng-Yong-jing [Author,-Reprint-Author]; Huang-Ci-bo [Author]; Xie-Gao
  -qiang [Author]; Wang-Qian [Author]; Liu-Ai-hua [Author]; Lai-Pei [Author];
  Chen-Ying-juan [Author]; Han-De-min [Author]
AD: Beijing Hosp, Dept Rheumatol and Immunol, Beijing 100730, Peoples R China
EMA: mastercheng99@hotmail.com
SO: Zhonghua-Weishengwuxue-He-Mianyixue-Zazhi. 2005; 25(4): 269-272
PY: 2005
DT: Article
IS: 0254-5101
LA: Chinese
AB: Objective To study the difference of immunology index between severe acute
  respiratory syndrome (SARS) patients of mild type and severe type. Methods
  White blood cell(WBC) count, lymphocyte count, CD3(+), CD4(+) and CD8(+) T
  lymphocyte count, level of C3, C4, ESR and CRP from 1291 patients with SARS in
  each week since onset of illness were recorded, the clinical progression of
  each sign was analyzed and difference between mild type and severe type were
  compared. Results Lymphocyte count and CD8(+) T lymphocyte count declined in
  first and second weeks and recovered from the third week, while CRP and C4
  level rised in the first week and then gradually recovered. In severe type,
  lymphocyte count and CD8(+) T lymphocyte count were much lower than that of
  mild type (P < 0.01), while CRP and C4 level in severe type were much higher
  than that of mild type (P < 0.01). Conclusion Lymphocyte count, CD8(+) T
  lympocyte count, CRP and C4 level are useful information for the diagnosis of
  SARS of severe type and the evaluation of severity.
AI: Y
MC: Infection-; Hematology-: Human-Medicine, Medical-Sciences; Clinical
  -Immunology: Human-Medicine, Medical-Sciences; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: lymphocyte-: immune-system, blood-and-lymphatics; white-blood-cell: immune
  -system, blood-and-lymphatics; CD8-positive-T-lymphocyte: immune-system; CD4
  -positive-T-lymphocyte: immune-system; CD3-positive-T-lymphocyte: immune-system
CB: C-reactive-protein: CRP-; C3-; C4-; ESR-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10064- (Biochemistry
  -studies-Proteins-peptides-and-amino-acids)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
15006- (Blood-Blood-lymphatic-and
  -reticuloendothelial-pathologies)
16006- (Respiratory-system-Pathology)
33502
  - (Virology-General-and-methods)
34502- (Immunology-General-and
  -methods)
34508- (Immunology-Immunopathology-tissue-immunology)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510155651
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0254
  -5101&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0254
  -5101&isbn=&volume=25&issue=4&spage=269&pages=269
  -272&date=2005&title=Zhonghua%20Weishengwuxue%20He%20Mianyixue%20Zazhi&atitle=Th
  e%20difference%20of%20immunology%20index%20between%20SARS%20patients%20of%20mild
  %20type%20and%20severe%20type&aulast=&pid=%3Cauthor%3ECheng%20Yong%20jing%3bHuan
  g%20Ci%20bo%3bXie%20Gao%20qiang%3bWang%20Qian%3bLiu%20Ai%20hua%3bLai%20Pei%3bChe
  n%20Ying%20juan%3bHan%20De%20min%3C%2Fauthor%3E%3CAN%3E200510155651%3C%2FAN%3E%3
  CDT%3EArticle%3C%2FDT%3E

Record 150 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: The heat-shock factor is not activated in mammalian cells exposed to
  cellular phone frequency microwaves
AU: Laszlo,-Andrei [Author,-Reprint-Author]; Moros,-Eduardo-G [Author];
  Davidson,-Teri [Author]; Bradbury,-Matt [Author]; Straube,-William [Author];
  Roti,-Joseph-Roti [Author]
AD: Washington Univ, Sch Med, Dept Radiat Oncol, Div Radiat and Canc Biol, 4511
  Forest Pk,Suite 419, St Louis, MO 63108 USA
EMA: laszlo@wustl.edu
SO: Radiation-Research. 2005; 164(2): 163-172
PY: 2005
DT: Article
IS: 0033-7587
LA: English
AB: There has been considerable interest in the biological effects of exposure
  to radiofrequency electromagnetic radiation, given the explosive growth of
  cellular telephone use, with the possible induction of malignancy being a
  significant concern. Thus the determination of whether nonthermal effects of
  radiofrequency electromagnetic radiation contribute to the process leading to
  malignancy is an important task. One proposed pathway to malignancy involves
  the induction of the stress response by exposures to cell phone frequency
  microwaves. The first step in the induction of the stress response is the
  activation of the DNA-binding activity of the specific transcription factor
  involved in this response, the heat-shock factor (HSF). The DNA-binding
  activity of HSF in hamster, mouse and human cells was determined after acute
  and continuous exposures to frequency domain multiple access (FDMA)- or code
  domain multiple access (CDMA)-modulated microwaves at low (0.6 W/kg) or high
  (similar to 5 W/kg) SARs at frequencies used for mobile communication. The DNA
  -binding activity of HSF was monitored using a gel shift assay; the calibration
  of this assay indicated that an increase of similar to 10% in the activation of
  the DNA-binding activity of HSF after a VC increase in temperature could be
  detected. We failed to detect any increase in the DNA-binding ability of HSF in
  cultured mammalian cells as a consequence of any exposure tested, within the
  sensitivity of our assay. Our results do not support the notion that the stress
  response is activated as a consequence of exposure to microwaves of frequencies
  associated with mobile communication devices. (c) 2005 by Radiation Research
  Society.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Radiation-Biology; Tumor-Biology
ST: -[86310-] Cricetidae-, -Rodentia, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-, Chordata-,
  Animalia-
OR: hamster- (Cricetidae-): common-; human- (Hominidae-): common-; mouse-
  (Muridae-): common-
TN: Cricetidae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-; Hominidae-: Animals-, Chordates-, Humans-,
  Mammals-, Primates-, Vertebrates-; Muridae-: Animals-, Chordates-, Mammals-,
  Nonhuman-Vertebrates, Nonhuman-Mammals, Rodents-, Vertebrates-
CB: DNA-binding-transcription-factors; heat-shock-factor
DS: cancer-: (Neoplasms-(MeSH)), neoplastic-disease, etiology-
MQ: gel-shift-assay: laboratory-techniques, genetic-techniques
MI: cellular-telephone-use; radiofrequency-electromagnetic-radiation; stress
  -response-induction
CC: 06502- (Radiation-biology-General)
10060- (Biochemistry-studies
  -General)
24004- (Neoplasms-Pathology-clinical-aspects-and-systemic-effects)
AN: 200510154987
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0033
  -7587&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0033
  -7587&isbn=&volume=164&issue=2&spage=163&pages=163
  -172&date=2005&title=Radiation%20Research&atitle=The%20heat
  -shock%20factor%20is%20not%20activated%20in%20mammalian%20cells%20exposed%20to%2
  0cellular%20phone%20frequency%20microwaves&aulast=Laszlo&pid=%3Cauthor%3ELaszlo%
  2c%20Andrei%3bMoros%2c%20Eduardo%20G%3bDavidson%2c%20Teri%3bBradbury%2c%20Matt%3
  bStraube%2c%20William%3bRoti%2c%20Joseph%20Roti%3C%2Fauthor%3E%3CAN%3E2005101549
  87%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 151 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Appropriate use of personal protective equipment among healthcare workers in
  public sector hospitals and primary healthcare polyclinics during the SARS
  outbreak in Singapore
AU: Chia,-S-E [Author,-Reprint-Author]; Koh,-D [Author]; Fones,-C [Author];
  Qian,-F [Author]; Ng,-V [Author]; Tan,-B-H [Author]; Wong,-K-S [Author]; Chew,
  -W-M [Author]; Tang,-H-K [Author]; Ng,-W [Author]; Muttakin,-Z [Author];
  Emmanuel,-S [Author]; Fong,-N-P [Author]; Koh,-G [Author]; Lim,-M-K [Author]
AD: Natl Univ Singapore, Dept Community Occupat and Family Med, Fac Med MD3, 16
  Med Dr, Singapore 117597, Singapore
EMA: cofcse@nus.edu.sg
SO: Occupational-and-Environmental-Medicine. 2005; 62(7): 473-477
PY: 2005
DT: Article
IS: 1351-0711
LA: English
AB: Background: Singapore was affected by an outbreak of severe acute
  respiratory syndrome (SARS) from 25 February to 31 May 2003, with 238 probable
  cases and 33 deaths. Aims: To study usage of personal protective equipment
  (PPE) among three groups of healthcare workers (HCWs: doctors, nurses, and
  administrative staff), to determine if the appropriate PPE were used by the
  different groups and to examine the factors that may determine inappropriate
  use.Methods: A self-administered questionnaire survey of 14 554 HCWs in nine
  healthcare settings, which included tertiary care hospitals, community
  hospitals, and polyclinics, was carried out in May-July 2003. Only doctors,
  nurses, and clerical staff were selected for subsequent analysis.Results: A
  total of 10 236 valid questionnaires were returned (70.3% response); 873
  doctors, 4404 nurses, and 921 clerical staff were studied. A total of 32.5% of
  doctors, 48.7% of nurses, and 77.1% of the administrative staff agreed that
  paper and/or surgical masks were "useful in protecting from contracting SARS''.
  Among this group, 23.6% of doctors and 42.3% of nurses reported working with
  SARS patients. The view that a paper and/ or surgical mask was adequate
  protection against SARS was held by 33.3% of doctors and 55.9% of nurses
  working at the A&E unit, 30.5% of doctors and 49.4% of nurses from medical
  wards, and 27.5% of doctors and 37.1% of nurses from intensive care units.
  Factors which predicted for agreement that paper and/ or surgical masks were
  protective against SARS, included HCW's job title, reported contact with SARS
  patients, area of work, and Impact Events Scale scores.Conclusion: A variety of
  factors determine appropriate use of personal protective equipment by HCWs in
  the face of a major SARS outbreak.
AI: Y
MC: Occupational-Health: Allied-Medical-Sciences; Equipment-Apparatus-Devices
  -and-Instrumentation; Respiratory-System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
GE: Singapore-: Asia-, Oriental-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, etiology-, mortality-,
  prevention-and-control
MQ: personal-protective-equipment: protective-clothing
MI: healthcare-worker; public-sector-hospital; primary-healthcare-polyclinic
CC: 16004- (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory
  -system-Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
37013- (Public-health-Occupational-health)
AN: 200510154307
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1351
  -0711&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1351
  -0711&isbn=&volume=62&issue=7&spage=473&pages=473
  -477&date=2005&title=Occupational%20and%20Environmental%20Medicine&atitle=Approp
  riate%20use%20of%20personal%20protective%20equipment%20among%20healthcare%20work
  ers%20in%20public%20sector%20hospitals%20and%20primary%20healthcare%20polyclinic
  s%20during%20the%20SARS%20outbreak%20in%20Singapore&aulast=Chia&pid=%3Cauthor%3E
  Chia%2c%20S%20E%3bKoh%2c%20D%3bFones%2c%20C%3bQian%2c%20F%3bNg%2c%20V%3bTan%2c%2
  0B%20H%3bWong%2c%20K%20S%3bChew%2c%20W%20M%3bTang%2c%20H%20K%3bNg%2c%20W%3bMutta
  kin%2c%20Z%3bEmmanuel%2c%20S%3bFong%2c%20N%20P%3bKoh%2c%20G%3bLim%2c%20M%20K%3C%
  2Fauthor%3E%3CAN%3E200510154307%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 152 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Critical role of nosocomial transmission in the Toronto SARS outbreak
AU: Webb,-Glenn-F [Author,-Reprint-Author]; Blaser,-Martin-J [Author]; Zhu,
  -Humping [Author]; Ardal,-Sten [Author]; Wu,-Jianhong [Author]
AD: Vanderbilt Univ, Dept Math, Stevenson Ctr 1326, Nashville, TN 37240 USA
EMA: glenn.f.webb@vanderbilt.edu; Martin.Blaser@msnyuhealth.org;
  huaiping@mathstat.yorku.ca; Sten@Cehip.org; wujh@mathstat.yorku.ca
SO: Mathematical-Biosciences-and-Engineering. 2004; 1(1): 1-13
PY: 2004
DT: Article
IS: 1547-1063
LA: English
AB: We develop a compartmental mathematical model to address the role of
  hospitals in severe acute respiratory syndrome (SARS) transmission dynamics,
  which partially explains the heterogeneity of the epidemic. Comparison of the
  effects of two major policies, strict hospital infection control procedures and
  community-wide quarantine measures, implemented in Toronto two weeks into the
  initial outbreak, shows that their combination is the key to short-term
  containment and that quarantine is the key to long-term containment.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
GE: Toronto-: Ontario-, Canada-, North-America, Nearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, transmission-, prevention
  -and-control, epidemiology-
MQ: compartmental-mathematical-model: mathematical-and-computer-techniques
MI: hospital-infection-control; nosocomial-transmission; epidemic-disease;
  community-wide-quarantine; short-term-containment
CC: 16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37052- (Public
  -health-epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510152253
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1547
  -1063&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1547
  -1063&isbn=&volume=1&issue=1&spage=1&pages=1
  -13&date=2004&title=Mathematical%20Biosciences%20and%20Engineering&atitle=Critic
  al%20role%20of%20nosocomial%20transmission%20in%20the%20Toronto%20SARS%20outbrea
  k&aulast=Webb&pid=%3Cauthor%3EWebb%2c%20Glenn%20F%3bBlaser%2c%20Martin%20J%3bZhu
  %2c%20Humping%3bArdal%2c%20Sten%3bWu%2c%20Jianhong%3C%2Fauthor%3E%3CAN%3E2005101
  52253%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 153 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Analysis of structure-activity relationships for MT2 selective antagonists
  by melatonin MT1 and MT2 receptor models
AU: Rivara,-Silvia [Author,-Reprint-Author]; Lorenzi,-Simone [Author]; Mor,
  -Marco [Author]; Plazzi,-Pier-Vincenzo [Author]; Spadoni,-Gilberto [Author];
  Bedini,-Annalida [Author]; Tarzia,-Giorgio [Author]
AD: Univ Parma, Dipartimento Farmaceut, Parco Area Sci 27-A, I-43100 Parma, Italy
EMA: silvia.rivara@unipr.it
SO: Journal-of-Medicinal-Chemistry. 2005; 48(12): 4049-4060
PY: 2005
DT: Article
IS: 0022-2623
LA: English
AB: Three-dimensional homology models of human MT1 and MT2 melatonin receptors
  were built with the aim to investigate the structure-activity relationships
  (SARs) of MT2 selective antagonists. A common interaction pattern was proposed
  for a series of structurally different MT2 selective antagonists, which were
  positioned within the binding site by docking and simulated annealing. The
  proposed antagonist binding mode to the MT2 receptor is characterized by the
  accommodation of the out-of-plane substituents in a hydrophobic pocket, which
  resulted as being fundamental for the explanation of the antagonist behavior
  and the MT2 receptor selectivity. Moreover, to assess the ability of the MT2
  receptor model to reproduce the SARs of MT2 antagonists, three new derivatives
  of the MT2 selective antagonist N-[1-(4-chloro-benzyl)-4-methoxy-1H-indol-2
  -ylmethyl]-propionamide (7) were synthesized and tested for their receptor
  affinity and intrinsic activity. These compounds were docked into the MT2
  receptor model and were submitted to molecular dynamics studies, providing
  results in qualitative agreement with the experimental data. These results
  confirm the importance of the out-of-plane group in receptor binding and
  selectivity and provide a partial validation of the proposed G protein-coupled
  receptor model.
AI: Y
MC: Pharmacology-; Biochemistry-and-Molecular-Biophysics
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
CB: G-protein-coupled-receptor: GPCR-; melatonin-MT-1-receptor; melatonin-MT-2
  -receptor; N-[1-(4-chloro-benzyl)-4-methoxy-1H-indol-2-ylmethyl]-propionamide:
  synthesis-; melatonin-MT-2-selective-antagonist: hormone-drug
MI: structure-activity-relationship
CC: 10060- (Biochemistry-studies-General)
12512- (Pathology-Therapy)
22002-
  (Pharmacology-General)
22005- (Pharmacology-Clinical-pharmacology)
22016-
  (Pharmacology-Endocrine)
AN: 200510151333
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -2623&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -2623&isbn=&volume=48&issue=12&spage=4049&pages=4049
  -4060&date=2005&title=Journal%20of%20Medicinal%20Chemistry&atitle=Analysis%20of%
  20structure-activity%20relationships%20for%20MT2%20selective%20antagonists%20by%
  20melatonin%20MT1%20and%20MT2%20receptor%20models&aulast=Rivara&pid=%3Cauthor%3E
  Rivara%2c%20Silvia%3bLorenzi%2c%20Simone%3bMor%2c%20Marco%3bPlazzi%2c%20Pier%20V
  incenzo%3bSpadoni%2c%20Gilberto%3bBedini%2c%20Annalida%3bTarzia%2c%20Giorgio%3C%
  2Fauthor%3E%3CAN%3E200510151333%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 154 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Antibody avidity maturation during severe acute respiratory syndrome
  -associated coronavirus infection
AU: Chan,-Paul-K-S [Author,-Reprint-Author]; Lim,-Pak--Leong [Author]; Liu,
  -Esther-Y-M [Author]; Cheung,-Jo-L-K [Author]; Leung,-Danny-T-M [Author]; Sung,
  -Joseph-J-Y [Author]
AD: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong
  Kong, Peoples R China
EMA: paulkschan@cuhk.edu.hk
SO: Journal-of-Infectious-Diseases. 2005; 192(1): 166-169
PY: 2005
DT: Article
IS: 0022-1899
LA: English
AB: The maturation of virus-specific immunoglobulin G avidity during severe
  acute respiratory syndrome-associated coronavirus infection was examined. The
  avidity indices were low ( mean +/- SD, 30.8% +/- 11.6%) among serum samples
  collected <= 50 days after fever onset, intermediate (mean +/- SD, 52.1% +/-
  14.1%) among samples collected between days 51 and 90, and high ( mean +/- SD,
  78.1% +/- 8.0%) among samples collected after day 90. Avidity indices of 40%
  and 55% could be considered as cutoff values for determination of recent (<= 50
  days) and past (> 65 days) infection, respectively. Measurement of antibody
  avidity can be used to differentiate primary infection from reexposure and to
  assess humoral responses to candidate vaccines.
AI: Y
MC: Infection-; Clinical-Chemistry: Allied-Medical-Sciences; Clinical
  -Immunology: Human-Medicine, Medical-Sciences; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, adult-, aged-, aged
  -80-and-over, middle-age, host-, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: serum-: blood-and-lymphatics
CB: immunoglobulin-G: maturation-, avidity-; antibody-: avidity-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MI: humoral-response; avidity-index
CC: 10006- (Clinical-biochemistry-General-methods-and-applications)
10064-
  (Biochemistry-studies-Proteins-peptides-and-amino-acids)
15002- (Blood-Blood
  -and-lymph-studies)
15004- (Blood-Blood-cell-studies)
16006- (Respiratory
  -system-Pathology)
24500- (Gerontology-)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510151273
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -1899&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -1899&isbn=&volume=192&issue=1&spage=166&pages=166
  -169&date=2005&title=Journal%20of%20Infectious%20Diseases&atitle=Antibody%20avid
  ity%20maturation%20during%20severe%20acute%20respiratory%20syndrome
  -associated%20coronavirus%20infection&aulast=Chan&pid=%3Cauthor%3EChan%2c%20Paul
  %20K%20S%3bLim%2c%20Pak%20%20Leong%3bLiu%2c%20Esther%20Y%20M%3bCheung%2c%20Jo%20
  L%20K%3bLeung%2c%20Danny%20T%20M%3bSung%2c%20Joseph%20J%20Y%3C%2Fauthor%3E%3CAN%
  3E200510151273%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 155 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Severe acute respiratory syndrome and the innate immune responses:
  Modulation of effector cell function without productive infection
AU: Tseng,-Chien-Te-K [Author,-Reprint-Author]; Perrone,-Lucy-A [Author]; Zhu,
  -Hongbing [Author]; Makino,-Shinji [Author]; Peters,-Clarence-J [Author]
AD: Univ Texas, Med Branch, Ctr Biodefense and Emerging Dis, Dept Microbiol and
  Immunol, 301 Univ Blvd, Galveston, TX 77555 USA
EMA: sktseng@utmb.edu
SO: Journal-of-Immunology. 2005; 174(12): 7977-7985,7970
PY: 2005
DT: Article
IS: 0022-1767
LA: English
AB: Severe acute respiratory syndrome (SARS) caused by a novel human coronavirus
  (CoV), designated SARS-CoV, is a highly contagious respiratory disease with the
  lungs as a major target. Although the exact mechanism of SARS-CoV pathogenesis
  remains unknown, an intense, ill-regulated local inflammatory response has been
  suggested as partially responsible for the devastating lung pathology. We
  investigated the interaction of SARS-CoV with human macrophages (MO) and
  dendritic cells (DC), two key innate immune cells of the host immune system, by
  focusing on their susceptibility to viral infection and subsequent responses
  (e.g., phenotypic maturation, T cell-priming activity, phagocytosis, and
  cytokine production). We found neither cell to be permissive for SARS-CoV
  replication. However, incubation of M(P and DC with live, but not gamma
  irradiation-inactivated, viruses appeared to better sustain their viability.
  Also, exposure to infectious SARS-CoV led to the phenotypic and functional
  maturation of DC, with regard to MHC class II and costimulatory molecule
  expression, T cell-stimulatory capacity, and cytokine production, respectively.
  Cytokine production was also observed for M phi, which were refractory to cell
  surface phenotypic changes. Strikingly, live SARS-CoV could further prime cell
  types to respond to a suboptimal dose of bacterial LPS (100 ng/ml), resulting
  in massive release of IL-6 and IL-12. However, the endocytic capacity (e.g., Ag
  capture) of M phi was significantly compromised upon exposure to infectious
  SARS-CoV. This study is the first demonstration that although SARS-CoV does not
  productively infect human M phi) or DC, it appears to exert differential
  effects on M phi and DC maturation and functions, which might contribute to
  SARS pathogenesis.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Blood-and-Lymphatics:
  Transport-and-Circulation; Immune-System: Chemical-Coordination-and
  -Homeostasis; Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-; Severe-Acute-Respiratory
  -Syndrome-virus (Coronaviridae-): common-, SARS-virus, common-, pathogen-;
  human- (Hominidae-): common-, host-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: macrophage-: immune-system, blood-and-lymphatics; lung-: respiratory-system;
  dendritic-cell: immune-system; effector/memory-T-cell: immune-system
CB: cytokine-: production-; IL-6: interleukin-6, release-; IL-12: interleukin
  -12, release-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, etiology-, immunology-
MI: innate-immunity; phagocytosis-
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10060- (Biochemistry
  -studies-General)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
17002- (Endocrine-General)
33502- (Virology
  -General-and-methods)
34502- (Immunology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
AN: 200510150998
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -1767&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -1767&isbn=&volume=174&issue=12&spage=&pages=&date=2005&title=Journal%20of%20Imm
  unology&atitle=Severe%20acute%20respiratory%20syndrome%20and%20the%20innate%20im
  mune%20responses%3a%20Modulation%20of%20effector%20cell%20function%20without%20p
  roductive%20infection&aulast=Tseng&pid=%3Cauthor%3ETseng%2c%20Chien%20Te%20K%3bP
  errone%2c%20Lucy%20A%3bZhu%2c%20Hongbing%3bMakino%2c%20Shinji%3bPeters%2c%20Clar
  ence%20J%3C%2Fauthor%3E%3CAN%3E200510150998%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 156 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Emerging zoonoses and social-economic impact in India - A review
AU: Sherikar,-A-T [Author,-Reprint-Author]; Waskar,-V-S [Author]
AD: Maharashtra Anim and Fishery Sci Univ, Seminary Hills, Nagpur 440006,
  Maharashtra, India
SO: Indian-Journal-of-Animal-Sciences. 2005; 75(6): 700-705
PY: 2005
DT: Literature-Review; Article
IS: 0367-8318
LA: English
AB: Emerging and re-emerging zoonoses are newly recognized diseases or are newly
  evolved, or have occurred previously but have more recently shown an increase
  in incidence or expansion into a new geographic, host or vector range. Many new
  human pathogens that have emerged or reemerged worldwide originated from
  animals or from products of animal origin. The emergence of zoonotic diseases
  is associated with a range of underlying causal factors, represents a global
  threat to human and animal health. They hamper agricultural production,
  decrease availability of food and create barriers to trade. In India, livestock
  are important in supporting the livelihoods of poor farmers, consumers, traders
  and labourers throughout the country. Close association between human
  population groups and animals, consumption of unpasteurized milk and dairy
  products, intensification of animal production and increased trade of animals
  and animal products, the large number of stray dogs, illegal slaughtering and
  inappropriate waste disposal are some of the principle factors perpetuating
  infection in humans. Emergence or re-emergence of these diseases requires long
  -term actions from the veterinary sector to decrease incidence among disease
  hosts and reduce or interrupt transmission with commitment between the health
  sector and veterinary sector to implement common control programmes. A close
  collaboration is needed between animal keepers, farmers, veterinarians and
  other health professionals, including epidemiologists, occupational health
  workers, food technologists, specialists in environmental control and
  laboratory personnel.
AI: Y
MC: Epidemiology-: Population-Studies; Infection-
ST: -[85765-] Canidae-, -Carnivora, Mammalia-, Vertebrata-, Chordata-, Animalia
  -; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03502-] Filoviridae-, -Negative-Sense-ssRNA-Viruses, Viruses
  -, Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[03305-] Retroviridae-, -DNA-and-RNA-Reverse
  -Transcribing-Viruses, Viruses-, Microorganisms-
OR: dog- (Canidae-): common-, host-; Severe-Acute-Respiratory-Syndrome-virus
  (Coronaviridae-): common-, SARS-virus, common-, pathogen-; Ebola-virus
  (Filoviridae-): common-, pathogen-; human- (Hominidae-): common-, host-; Human
  -immunodeficiency-virus (Retroviridae-): species-, HIV-, common-, pathogen-
TN: Canidae-: Animals-, Carnivores-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Vertebrates-; Coronaviridae-: Microorganisms-, Positive-Sense
  -Single-Stranded-RNA-Viruses, Viruses-; Filoviridae-: Microorganisms-, Negative
  -Sense-Single-Stranded-RNA-Viruses, Viruses-; Hominidae-: Animals-, Chordates-,
  Humans-, Mammals-, Primates-, Vertebrates-; Retroviridae-: DNA-and-RNA-Reverse
  -Transcribing-Viruses, Microorganisms-, Viruses-
GE: India-: Asia-, Oriental-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-; zoonosis-:
  viral-disease, transmission-, epidemiology-; human-immunodeficiency-virus
  -disease: viral-disease, immune-system-disease, epidemiology-; Ebola-virus
  -disease: viral-disease, epidemiology-
MI: milk-: beverage-, dairy-product; occupational-health; agricultural
  -production; health-sector; veterinary-sector; social-economic-impact
CC: 16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
34508- (Immunology-Immunopathology-tissue-immunology)
36006-
  (Medical-and-clinical-microbiology-Virology)
37052- (Public-health
  -epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510149407
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0367
  -8318&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0367
  -8318&isbn=&volume=75&issue=6&spage=700&pages=700
  -705&date=2005&title=Indian%20Journal%20of%20Animal%20Sciences&atitle=Emerging%2
  0zoonoses%20and%20social-economic%20impact%20in%20India%20
  -%20A%20review&aulast=Sherikar&pid=%3Cauthor%3ESherikar%2c%20A%20T%3bWaskar%2c%2
  0V%20S%3C%2Fauthor%3E%3CAN%3E200510149407%3C%2FAN%3E%3CDT%3ELiterature%20Review%
  3bArticle%3C%2FDT%3E

Record 157 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Clinical significance of hepatic derangement in severe acute respiratory
  syndrome.
AU: Chan,-Henry-L [Author,-Reprint-Author]; Kwan,-Ambrose-C [Author]; Lai,-Sik
  -To [Author]; Chan,-Paul-K [Author]; Leung,-Wai-K [Author]; Lee,-Nelson
  [Author]; Wu,-Alan [Author]; Sung,-Joseph-J [Author]
AD: Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
SO: Hepatology-. 2004; 40(4, Suppl. 1): 287A
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0270-9139
MT: 55th Annual Meeting of the American-Association-for-the-Study-of-Liver
  -Diseases (AASLD), Boston, MA, USA; October 29 -November 02, 2004
SP: Amer Assoc Study Liver Dis
LA: English
MC: Infection-; Gastroenterology-: Human-Medicine, Medical-Sciences; Pulmonary
  -Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03301-] Hepadnaviridae-, -DNA-and-RNA-Reverse-Transcribing
  -Viruses, Viruses-, Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia
  -, Vertebrata-, Chordata-, Animalia-
OR: Coronavirus- (Coronaviridae-): genus-, pathogen-; Hepatitis-B-virus
  (Hepadnaviridae-): species-, pathogen-; human- (Hominidae-): common-, host-,
  patient-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hepadnaviridae-: DNA-and-RNA-Reverse-Transcribing-Viruses,
  Microorganisms-, Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-,
  Primates-, Vertebrates-
PS: liver-: digestive-system; respiratory-system: respiratory-system; hepatocyte
  -: digestive-system
CB: alanine-aminotransferase: ALT-, 9000-86-6, biomarker-, serum-
DS: hepatocellular-carcinoma: (Carcinoma-, Hepatocellular-(MeSH)), digestive
  -system-disease, neoplastic-disease; chronic-hepatitis-B: digestive-system
  -disease, infectious-disease, viral-disease; coronavirus-infection: viral
  -disease, infectious-disease; severe-acute-respiratory-syndrome: SARS-, (Severe
  -Acute-Respiratory-Syndrome-(MeSH)), respiratory-system-disease, infectious
  -disease, viral-disease, therapy-, mortality-
RN: 9000-86-6
MQ: mechanical-ventilation: therapeutic-and-prophylactic-techniques, clinical
  -techniques; postmortem-examination: clinical-techniques, diagnostic-techniques
MI: intensive-care-unit; oxygen-desaturation
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
02506-
  (Cytology-Animal)
02508- (Cytology-Human)
10802- (Enzymes-General-and
  -comparative-studies-coenzymes)
12512- (Pathology-Therapy)
14004- (Digestive
  -system-Physiology-and-biochemistry)
14006- (Digestive-system
  -Pathology)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
24004- (Neoplasms-Pathology-clinical-aspects
  -and-systemic-effects)
24008- (Neoplasms-Therapeutic-agents-and
  -therapy)
33502- (Virology-General-and-methods)
36001- (Medical-and-clinical
  -microbiology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510148081
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0270
  -9139&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0270
  -9139&isbn=&volume=40&issue=4%2c%20Suppl.%201&spage=&pages=287A&date=2004&title=
  Hepatology%20&atitle=Clinical%20significance%20of%20hepatic%20derangement%20in%2
  0severe%20acute%20respiratory%20syndrome.&aulast=Chan&pid=%3Cauthor%3EChan%2c%20
  Henry%20L%3bKwan%2c%20Ambrose%20C%3bLai%2c%20Sik%20To%3bChan%2c%20Paul%20K%3bLeu
  ng%2c%20Wai%20K%3bLee%2c%20Nelson%3bWu%2c%20Alan%3bSung%2c%20Joseph%20J%3C%2Faut
  hor%3E%3CAN%3E200510148081%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FD
  T%3E

Record 158 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Emerging viral infections in transplant recipients
AU: Kumar,-Deepali [Author]; Humar,-Atul [Author,-Reprint-Author]
AD: Univ Hlth Network, Toronto Gen Hosp, 585 Univ Ave,NCSB 11C-1232, Toronto, ON
  M5G 2N2, Canada
EMA: atul.humar@uhn.on.ca
SO: Current-Opinion-in-Infectious-Diseases. 2005; 18(4): 337-341
PY: 2005
DT: Article
IS: 0951-7375
LA: English
AB: Purpose of review Transplant patients are uniquely predisposed to emerging
  infections for a number of reasons. Two outbreaks; West Nile virus and severe
  acute respiratory syndrome, have recently provided important lessons on how
  transplant patients are affected, and how transplant programmes must adapt and
  evolve in the face of emerging infections. An update of emerging infections in
  transplant patients, using West Nile virus and severe acute respiratory
  syndrome as specific examples, is summarized here.Recent findings Exogenous
  immunosuppression, specific allograft factors, and extensive contact with the
  healthcare system all predispose transplant patients to emerging infections.
  Transplant patients may acquire West Nile virus through blood transfusion,
  donor transmission; or community exposure. Seroprevalence data in transplant
  populations suggest the risk of severe neurological disease is several fold
  higher in transplant recipients who acquire West Nile virus compared with
  immunocompetent individuals. Prevention strategies are critical in this
  population. These include nucleic acid testing of blood products and
  potentially also screening organ donors in a similar manner. During the
  outbreak of severe acute respiratory syndrome, transplant patients with severe
  and rapidly progressive disease were reported. Higher viral burdens appeared to
  be present in transplant patients and may have implications for the increased
  infectivity of these patients. Transplant programmes in severe acute
  respiratory syndrome areas were also adversely affected because of donor
  concerns, recipient issues and resource problems.Summary Transplant patients
  are uniquely predisposed to emerging infections. Lessons learned from West Nile
  virus and severe acute respiratory syndrome in transplantation should be
  applicable to future outbreaks of other emerging infectious diseases.
AI: Y
MC: Nervous-System: Neural-Coordination; Infection-; Respiratory-System:
  Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03615-] Flaviviridae-, -Positive-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-,
  Vertebrata-, Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; West-Nile-virus (Flaviviridae-): species-, pathogen-; human- (Hominidae-):
  common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Flaviviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA
  -Viruses, Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-,
  Primates-, Vertebrates-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, transmission-; West-Nile
  -fever: nervous-system-disease, viral-disease, transmission-
MQ: organ-transplantation: therapeutic-and-prophylactic-techniques, clinical
  -techniques; immunosuppression-: laboratory-techniques, immunologic-techniques
MI: predisposition-; transplant-recipients
CC: 16004- (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory
  -system-Pathology)
20504- (Nervous-system-Physiology-and-biochemistry)
20506-
  (Nervous-system-Pathology)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510146800
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0951
  -7375&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0951
  -7375&isbn=&volume=18&issue=4&spage=337&pages=337
  -341&date=2005&title=Current%20Opinion%20in%20Infectious%20Diseases&atitle=Emerg
  ing%20viral%20infections%20in%20transplant%20recipients&aulast=Kumar&pid=%3Cauth
  or%3EKumar%2c%20Deepali%3bHumar%2c%20Atul%3C%2Fauthor%3E%3CAN%3E200510146800%3C%
  2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 159 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: A molecular docking model of SARS-CoV S1 protein in complex with its
  receptor, human ACE2
AU: Zhang,-Yuan [Author]; Zheng,-Nan [Author]; Hao,-Pei [Author]; Cao,-Ying
  [Author]; Zhong,-Yang [Author,-Reprint-Author]
AD: Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China
EMA: yangzhong@fudan.edu.cn
SO: Biosis-title-is-Computational-Biology-and-Chemistry. 2005; 29(3): 254-257
PY: 2005
DT: Article
IS: 1476-9271
LA: English
AB: The exact residues within severe acute respiratory syndrome coronavirus
  (SARS-CoV) S1 protein and its receptor, human ACE2, involved in their
  interaction still remain largely undetermined. Identification of exact amino
  acid residues that are crucial for the interaction of S1 with ACE2 could
  provide working hypotheses for experimental studies and might be helpful for
  the development of antiviral inhibitor. In this paper, a molecular docking
  model of SARS-CoV S1 protein in complex with human ACE2 was constructed. The
  interacting residue pairs within this complex model and their contact types
  were also identified. Our model, supported by significant biochemical evidence,
  suggested receptor-binding residues were concentrated in two segments of S I
  protein. In contrast, the interfacial residues in ACE2, though close to each
  other in tertiary structure, were found to be widely scattered in the primary
  sequence. In particular, the S I residue ARG453 and ACE2 residue LYS341 might
  be the key residues in the complex formation. (c) 2005 Elsevier Ltd. All rights
  reserved.
AI: Y
MC: Enzymology-: Biochemistry-and-Molecular-Biophysics; Models-and-Simulations:
  Computational-Biology
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-acute-respiratory-syndrome-virus (Coronaviridae-): species-, SARS
  -virus, common-; human- (Hominidae-): common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: CoV-S1-protein: amino-acid-residues; angiotensin-converting-enzyme-2: ACE2-,
  amino-acid-residue, receptor-; CoV-S1-ACE2-complex
MQ: molecular-docking-model: mathematical-and-computer-techniques
CC: 04500- (Mathematical-biology-and-statistical-methods)
10515- (Biophysics
  -Biocybernetics)
10802- (Enzymes-General-and-comparative-studies
  -coenzymes)
33502- (Virology-General-and-methods)
AN: 200510146719
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1476
  -9271&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1476
  -9271&isbn=&volume=29&issue=3&spage=254&pages=254
  -257&date=2005&title=Biosis%20title%20is%20Computational%20Biology%20and%20Chemi
  stry&atitle=A%20molecular%20docking%20model%20of%20SARS
  -CoV%20S1%20protein%20in%20complex%20with%20its%20receptor%2c%20human%20ACE2&aul
  ast=Zhang&pid=%3Cauthor%3EZhang%2c%20Yuan%3bZheng%2c%20Nan%3bHao%2c%20Pei%3bCao%
  2c%20Ying%3bZhong%2c%20Yang%3C%2Fauthor%3E%3CAN%3E200510146719%3C%2FAN%3E%3CDT%3
  EArticle%3C%2FDT%3E

Record 160 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Structural analysis of inhibition mechanisms of Aurintricarboxylic Acid on
  SARS-CoV polymerase and other proteins
AU: Yap,-YeeLeng [Author]; Zhang,-XueWu [Author]; Andonov,-Anton [Author]; He,
  -RunTao [Author,-Reprint-Author]
AD: Canadian Sci Ctr Human and Anim Hlth, 1015 Arlington St, Winnipeg, MB R3E
  3R2, Canada
EMA: runtao_he@phac-aspc.gc.ca
SO: Biosis-title-is-Computational-Biology-and-Chemistry. 2005; 29(3): 212-219
PY: 2005
DT: Article
IS: 1476-9271
LA: English
AB: We recently published experimental results that indicated Aurintricarboxylic
  Acid (ATA) could selectively inhibit SARS-CoV replication inside host cells by
  greater than 1000 times. This inhibition suggested that ATA could be developed
  as potent anti-viral drug. Here, to extend our experimental observation, we
  have incorporated protein structural studies (with positive/negative controls)
  to investigate the potential binding modes/sites of ATA onto RNA-dependent RNA
  polymerase (RdRp) from SARS-CoV and other pathogenic positive-strand RNA
  -viruses, as well as other proteins in SARS-CoV based on the fact that ATA
  binds to Ca2+-activated neutral protease (m-calpain), the protein tyrosine
  phosphatase (PTP) and HIV integrase which have existing crystal structures.
  Eight regions with homologous 3D-conformation were derived for 10 proteins of
  interest. One of the region, R-binding (754-766 in SARS-CoV's RdRp), located in
  the palm sub-domain mainly constituted of anti-parallel beta-strand-turn-beta
  -strand hairpin structures that covers two of the three RdRp catalytic sites
  (Asp 760, Asp761), was also predicted by molecular docking method (based on
  free energy of binding A G) to be important binding motif recognized by ATA.
  The existence of this strictly conserved region that incorporated catalytic
  residues, coupled with the homologous ATA binding pockets and their consistent
  Delta G values, suggested strongly ATA may be involved in an analogous
  inhibition mechanism of SARS-COV's RdRp in concomitant to the case in m
  -calpain, PTP and HIV integrase. (c) 2005 Elsevier Ltd. All rights reserved.
AI: Y
MC: Pharmacology-; Infection-; Enzymology-: Biochemistry-and-Molecular-Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: m-calpain: EC-3.4.22.53; protein-tyrosine-phosphatase: 79747-53-8, EC
  -3.1.3.48; HIV-integrase: 52350-85-3; RNA-dependent-RNA-polymerase: 9026-28-2,
  EC-2.7.7.48, catalytic-site, anti-parallel-beta-strand-turn-beta-strand-hairpin
  -structure; aurintricarboxylic-acid: 4431-00-9, enzyme-inhibitor-drug,
  antiviral-drug
RN: 79747-53-8; 52350-85-3; 9026-28-2; 4431-00-9
MQ: molecular-docking-method: mathematical-and-computer-techniques
CC: 10802- (Enzymes-General-and-comparative-studies-coenzymes)
12512-
  (Pathology-Therapy)
22002- (Pharmacology-General)
22005- (Pharmacology
  -Clinical-pharmacology)
33502- (Virology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510146715
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1476
  -9271&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1476
  -9271&isbn=&volume=29&issue=3&spage=212&pages=212
  -219&date=2005&title=Biosis%20title%20is%20Computational%20Biology%20and%20Chemi
  stry&atitle=Structural%20analysis%20of%20inhibition%20mechanisms%20of%20Aurintri
  carboxylic%20Acid%20on%20SARS
  -CoV%20polymerase%20and%20other%20proteins&aulast=Yap&pid=%3Cauthor%3EYap%2c%20Y
  eeLeng%3bZhang%2c%20XueWu%3bAndonov%2c%20Anton%3bHe%2c%20RunTao%3C%2Fauthor%3E%3
  CAN%3E200510146715%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 161 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Serum neopterin for early assessment of severity of severe acute respiratory
  syndrome
AU: Zheng,-Bojian [Author]; Cao,-Kai-Yuan [Author]; Chan,-Cangel-P-Y [Author];
  Choi,-Junet-W-Y [Author]; Leung,-Wingman [Author]; Leung,-Manfai [Author];
  Duan,-Zhao-Hui [Author]; Gao,-Yang [Author]; Wang,-Ming [Author]; Di,-Biao
  [Author]; Hollidt,-Joerg-M [Author]; Bergmann,-Andreas [Author]; Lehmann,
  -Matthias [Author]; Renneberg,-Ilka [Author]; Tam,-John-S-L [Author]; Chan,
  -Paul-K-S [Author]; Cautherley,-George-W-H [Author]; Fuchs,-Dietmar [Author];
  Renneberg,-Reinhard [Author,-Reprint-Author]
AD: Hong Kong Univ Sci and Technol, Dept Chem, Hong Kong, Hong Kong, Peoples R
  China
EMA: chrenneb@ust.hk
SO: Clinical-Immunology-(Orlando). 2005; 116(1): 18-26
PY: 2005
DT: Article
IS: 1521-6616
LA: English
AB: Neopterin and C-reactive protein (CRP) concentrations were determined in
  serum samples from 129 severe acute respiratory syndrome (SARS) patients and
  156 healthy blood donors. In the patients with confirmed SARS, an early
  neopterin elevation was detected already at the day of onset of symptoms and
  rose to a maximum level of 45.0 nmol/L 3 days after the onset. All SARS
  patients had elevated neopterin concentrations (> 10 nmol/L) within 9 days
  after the onset. The mean neopterin concentrations were 34.2 nmol/L in acute
  sera of SARS patients, 5.1 nmol/L in convalescent sera, and 6.7 nmol/L in
  healthy controls. In contrast, the mean CRP concentrations in both acute and
  convalescent sera of SARS patients were in the normal range (< 10 mg/L). Serum
  neopterin level in SARS patients was associated with fever period and thus the
  clinical progression of the disease, while there was no significant correlation
  between the CRP level and the fever period. Serum neopterin may allow early
  assessment of the severity of SARS. The decrease of neopterin level was found
  after steroid treatment, which indicates that blood samples should be collected
  before steroid treatment for the neopterin measurement. (c) 2005 Elsevier Inc.
  All rights reserved.
AI: Y
MC: Pharmacology-; Infection-; Clinical-Chemistry: Allied-Medical-Sciences;
  Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, adolescent-, middle
  -age, adult-, host-, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: serum-: blood-and-lymphatics
CB: C-reactive-protein; neopterin-: 2009-64-5; steroid-: hormone-drug,
  pharmacodynamics-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy, symptom-,
  diagnosis-, pathology-
RN: 2009-64-5
CC: 10006- (Clinical-biochemistry-General-methods-and-applications)
10060-
  (Biochemistry-studies-General)
10064- (Biochemistry-studies-Proteins-peptides
  -and-amino-acids)
10067- (Biochemistry-studies-Sterols-and-steroids)
12502-
  (Pathology-General)
12504- (Pathology-Diagnostic)
12512- (Pathology
  -Therapy)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16006- (Respiratory-system-Pathology)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
22016- (Pharmacology
  -Endocrine)
25000- (Pediatrics-)
33502- (Virology-General-and-methods)
36006
  - (Medical-and-clinical-microbiology-Virology)
AN: 200510146634
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1521
  -6616&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1521
  -6616&isbn=&volume=116&issue=1&spage=18&pages=18
  -26&date=2005&title=Clinical%20Immunology%20%28Orlando%29&atitle=Serum%20neopter
  in%20for%20early%20assessment%20of%20severity%20of%20severe%20acute%20respirator
  y%20syndrome&aulast=Zheng&pid=%3Cauthor%3EZheng%2c%20Bojian%3bCao%2c%20Kai%20Yua
  n%3bChan%2c%20Cangel%20P%20Y%3bChoi%2c%20Junet%20W%20Y%3bLeung%2c%20Wingman%3bLe
  ung%2c%20Manfai%3bDuan%2c%20Zhao%20Hui%3bGao%2c%20Yang%3bWang%2c%20Ming%3bDi%2c%
  20Biao%3bHollidt%2c%20Joerg%20M%3bBergmann%2c%20Andreas%3bLehmann%2c%20Matthias%
  3bRenneberg%2c%20Ilka%3bTam%2c%20John%20S%20L%3bChan%2c%20Paul%20K%20S%3bCauther
  ley%2c%20George%20W%20H%3bFuchs%2c%20Dietmar%3bRenneberg%2c%20Reinhard%3C%2Fauth
  or%3E%3CAN%3E200510146634%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 162 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: The emerging utility of neopterin?
AU: Beigel,-John [Author,-Reprint-Author]
AD: Warren G Magnuson Clin Ctr, Dept Crit Care Med, NIH, Bldg 10,7D43 10 Ctr
  Dr,MSC 1662, Bethesda, MD 20892 USA
EMA: jbeigel@mail.nih.gov
SO: Clinical-Immunology-(Orlando). 2005; 116(1): 1-2
PY: 2005
DT: Editorial; Article
IS: 1521-6616
LA: English
MC: Clinical-Immunology: Human-Medicine, Medical-Sciences
PS: serum-: blood-and-lymphatics; urine-: excretory-system; macrophage-: immune
  -system, blood-and-lymphatics; monocyte-: immune-system, blood-and-lymphatics;
  lymphocyte-: immune-system, blood-and-lymphatics; neutrophil-: immune-system,
  blood-and-lymphatics; cerebral-spinal-fluid: nervous-system
CB: C-reactive-protein; lactate-dehydrogenase: LDH-, 9001-60-9, EC-1.1.1.27;
  pteridine-: 91-18-9; neopterin-: 2009-64-5; guanosine-triphosphate: GTP-, 86-01
  -1; corticosteroid-: antiinflammatory-drug, respiratory-stimulant-drug,
  immunologic-drug
DS: sepsis-: (Sepsis-(MeSH)), bacterial-disease; hepatitis-C: digestive-system
  -disease, viral-disease; severe-acute-respiratory-syndrome: SARS-, (Severe
  -Acute-Respiratory-Syndrome-(MeSH)), respiratory-system-disease, viral-disease;
  human-immunodeficiency-virus-infection: HIV-infection, (HIV-Infections-(MeSH)),
  viral-disease, immune-system-disease; neoplasm-: (Neoplasms-(MeSH)), neoplastic
  -disease; tuberculosis-: (Tuberculosis-(MeSH)), bacterial-disease; nosocomial
  -infection: (Cross-Infection-(MeSH)), infectious-disease; pre-term-labor:
  reproductive-system-disease/female; Dengue-: viral-disease; Ebola-: viral
  -disease; auto-immune-disease: immune-system-disease; avascular-necrosis:
  vascular-disease, integumentary-system-disease
RN: 9001-60-9; 91-18-9; 2009-64-5; 86-01-1
MQ: mechanical-ventilation: therapeutic-and-prophylactic-techniques, clinical
  -techniques
MI: immune-response
CC: 02506- (Cytology-Animal)
10060- (Biochemistry-studies-General)
10062-
  (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
10067-
  (Biochemistry-studies-Sterols-and-steroids)
10802- (Enzymes-General-and
  -comparative-studies-coenzymes)
12512- (Pathology-Therapy)
14006- (Digestive
  -system-Pathology)
14508- (Cardiovascular-system-Blood-vessel
  -pathology)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
15504- (Urinary-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
16506- (Reproductive-system-Pathology)
18506-
  (Integumentary-system-Pathology)
20504- (Nervous-system-Physiology-and
  -biochemistry)
22012- (Pharmacology-Connective-tissue-bone-and-collagen-acting
  -drugs)
22018- (Pharmacology-Immunological-processes-and-allergy)
22030-
  (Pharmacology-Respiratory-system)
24004- (Neoplasms-Pathology-clinical-aspects
  -and-systemic-effects)
34502- (Immunology-General-and-methods)
34508-
  (Immunology-Immunopathology-tissue-immunology)
36001- (Medical-and-clinical
  -microbiology-General-and-methods)
AN: 200510146631
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1521
  -6616&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1521
  -6616&isbn=&volume=116&issue=1&spage=1&pages=1
  -2&date=2005&title=Clinical%20Immunology%20%28Orlando%29&atitle=The%20emerging%2
  0utility%20of%20neopterin%3f&aulast=Beigel&pid=%3Cauthor%3EBeigel%2c%20John%3C%2
  Fauthor%3E%3CAN%3E200510146631%3C%2FAN%3E%3CDT%3EEditorial%3bArticle%3C%2FDT%3E

Record 163 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Comprehensive antibody epitope mapping of the nucleocapsid protein of severe
  acute respiratory syndrome (SARS) coronavirus: Insight into the humoral
  immunity of SARS
AU: Liang,-Yunfei [Author]; Wan,-Ying [Author]; Qiu,-Li-Wen [Author]; Zhou,
  -Jingran [Author]; Ni,-Bing [Author]; Guo,-Bo [Author]; Zou,-Qiang [Author];
  Zou,-Liyun [Author]; Zhou,-Wei [Author]; Jia,-Zhengcai [Author]; Che,-Xiao-Yan
  [Author,-Reprint-Author]; Wu,-Yuzhang [Author]
AD: Third Mil Med Univ, Inst Immunol, PLA, Chongqing 400038, Peoples R China
EMA: linche@pub.guangzhou.gd.cn; wuyuzhang@gmail.com
SO: Clinical-Chemistry. 2005; 51(8): 1382-1396
PY: 2005
DT: Article
IS: 0009-9147
LA: English
AB: Background: The epidemic outbreak of severe acute respiratory syndrome
  (SARS) posed a worldwide threat to public health and economic stability.
  Although the pandemic has been contained, concerns over its recurrence remain.
  It is essential to identify specific diagnostic agents and antiviral vaccine
  candidates to fight this highly contagious disease.Methods: We generated 14
  monoclonal antibodies (mAbs) specific to the SARS coronavirus (SARS-CoV)
  nucleocapsid (N) protein and used these to thoroughly map the N protein
  antigenic determinants. We identified the immunodominant antigenic sites
  responsible for the antibodies in sera from SARS patients and antisera from
  small animals and differentiated the linear from the conformational antibody
  -combining sites comprising the natural epitopes by use of yeast surface
  display.Results: We identified 5 conformational and 3 linear epitopes within
  the entire N protein; 3 conformational and 3 linear epitopes were
  immunodominant. The antibody responses to the N protein fragments in mammalian
  sera revealed that 3 regions of the N protein are strong antigenic domains. We
  expanded the specificity of the N protein epitope and identified 4 novel
  conformational epitopes (amino acids 1-69, 68-213, 212-341, and 337
  -422).Conclusion: The antigenic structures identified for the SARS-CoV N
  protein, the epitope-specific mAbs, and the serum antibody profile in SARS
  patients have potential use in the clinical diagnosis and understanding of the
  protective immunity to SARS-CoV. (c) 2005 American Association for Clinical
  Chemistry.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Methods-and-Techniques; Infection-;
  Immune-System: Chemical-Coordination-and-Homeostasis; Respiratory-System:
  Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Vero-cell-line (Cercopithecidae-): cell_line-; BS-C-1-cell-line
  (Cercopithecidae-): cell_line-; Human-coronavirus-OC43 (Coronaviridae-):
  species-, pathogen-; Human-coronavirus-229E (Coronaviridae-): species-,
  pathogen-; Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-,
  pathogen-, strain-GD01; human- (Hominidae-): common-, adult-, host-, female-,
  male-; MRC-5-cell-line (Hominidae-): cell_line-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: sera-: blood-and-lymphatics
CB: monoclonal-antibody; nucleocapsid-protein
SD: AY278489-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, infectious-disease, viral-disease, drug
  -therapy, immunology-, prevention-and-control, diagnosis-, epidemiology-,
  pathology-
MQ: antibody-epitope-mapping: laboratory-techniques, immunologic-techniques
MI: humoral-immunity
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
03506- (Genetics
  -Animal)
10060- (Biochemistry-studies-General)
10062- (Biochemistry-studies
  -Nucleic-acids-purines-and-pyrimidines)
10064- (Biochemistry-studies-Proteins
  -peptides-and-amino-acids)
12502- (Pathology-General)
12504- (Pathology
  -Diagnostic)
12512- (Pathology-Therapy)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
31500-
  (Genetics-of-bacteria-and-viruses)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
36001- (Medical-and
  -clinical-microbiology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510146615
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0009
  -9147&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0009
  -9147&isbn=&volume=51&issue=8&spage=1382&pages=1382
  -1396&date=2005&title=Clinical%20Chemistry&atitle=Comprehensive%20antibody%20epi
  tope%20mapping%20of%20the%20nucleocapsid%20protein%20of%20severe%20acute%20respi
  ratory%20syndrome%20%28SARS%29%20coronavirus%3a%20Insight%20into%20the%20humoral
  %20immunity%20of%20SARS&aulast=Liang&pid=%3Cauthor%3ELiang%2c%20Yunfei%3bWan%2c%
  20Ying%3bQiu%2c%20Li%20Wen%3bZhou%2c%20Jingran%3bNi%2c%20Bing%3bGuo%2c%20Bo%3bZo
  u%2c%20Qiang%3bZou%2c%20Liyun%3bZhou%2c%20Wei%3bJia%2c%20Zhengcai%3bChe%2c%20Xia
  o%20Yan%3bWu%2c%20Yuzhang%3C%2Fauthor%3E%3CAN%3E200510146615%3C%2FAN%3E%3CDT%3EA
  rticle%3C%2FDT%3E

Record 164 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Synthesis and evaluation of isatin derivatives as effective SARS coronavirus
  3CL protease inhibitors
AU: Chen,-Li-Rung [Author]; Wang,-Yu-Chin [Author]; Lin,-Yi-Wen [Author]; Chou,
  -Shan-Yen [Author]; Chen,-Shyh-Fong [Author]; Liu,-Lee-Tai [Author,-Reprint
  -Author]; Wu,-Ying-Ta [Author]; Kuo,-Chih-Jung [Author]; Chen,-Tom-Shieh-Shung
  [Author]; Juang,-Shin-Hun [Author]
AD: Dev Ctr Biotechnol, 102,Lane 169,Kang Ning St,Xi Zhi 221, Taipei, Taiwan
EMA: ltliu@mail.dcb.org.tw; pjuang@mail.dcb.org.tw
SO: Bioorganic-and-Medicinal-Chemistry-Letters. 2005; 15(12): 3058-3062
PY: 2005
DT: Article
IS: 0960-894X
LA: English
AB: N-Substituted isatin derivatives were prepared from the reaction of isatin
  and various bromides via two steps. Bioactivity assay results (in vitro tests)
  demonstrated that some of these compounds are potent and selective inhibitors
  against SARS coronavirus 3CL protease with IC50 values ranging from 0.95 to
  17.50 mu M. Additionally, isatin 4o exhibited more potent inhibition for SARS
  coronavirus protease than for other proteases including papain, chymotrypsin,
  and trypsin. (c) 2005 Elsevier Ltd. All rights reserved.
AI: Y
MC: Enzymology-: Biochemistry-and-Molecular-Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): species-, SARS
  -coronavirus, common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: trypsin-: 9002-07-7, EC-3.4.21.4; isatin-: 91-56-5; chymotrypsin-: 9004-07
  -3, EC-3.4.21.1; papain-: 9001-73-4, EC-3.4.22.2; bromides-; 3CL-protease
  -inhibitors
RN: 9002-07-7; 91-56-5; 9004-07-3; 9001-73-4
CC: 10802- (Enzymes-General-and-comparative-studies-coenzymes)
33502- (Virology
  -General-and-methods)
AN: 200510145209
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0960
  -894X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0960
  -894X&isbn=&volume=15&issue=12&spage=3058&pages=3058
  -3062&date=2005&title=Bioorganic%20and%20Medicinal%20Chemistry%20Letters&atitle=
  Synthesis%20and%20evaluation%20of%20isatin%20derivatives%20as%20effective%20SARS
  %20coronavirus%203CL%20protease%20inhibitors&aulast=Chen&pid=%3Cauthor%3EChen%2c
  %20Li%20Rung%3bWang%2c%20Yu%20Chin%3bLin%2c%20Yi%20Wen%3bChou%2c%20Shan%20Yen%3b
  Chen%2c%20Shyh%20Fong%3bLiu%2c%20Lee%20Tai%3bWu%2c%20Ying%20Ta%3bKuo%2c%20Chih%2
  0Jung%3bChen%2c%20Tom%20Shieh%20Shung%3bJuang%2c%20Shin%20Hun%3C%2Fauthor%3E%3CA
  N%3E200510145209%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 165 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Inhibitory effect of mizoribine and ribavirin on the replication of severe
  acute respiratory syndrome (SARS)-associated coronavirus
AU: Saijo,-Masayuki [Author,-Reprint-Author]; Morikawa,-Shigeru [Author];
  Fukushi,-Shuetsu [Author]; Mizutani,-Tetsuya [Author]; Hasegawa,-Hideki
  [Author]; Nagata,-Noriyo [Author]; Iwata,-Naoko [Author]; Kurane,-Ichiro
  [Author]
AD: Natl Inst Infect Dis, Dept Virol 1, Special Pathogens Lab, Tokyo 2080011,
  Japan
EMA: msaijo@nih.go.jp
SO: Antiviral-Research. 2005; 66(2-3): 159-163
PY: 2005
DT: Article
IS: 0166-3542
LA: English
AB: The activity of inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors,
  mizoribine and ribavirin, against severe acute respiratory syndrome (SARS)
  -associated coronavirus (SARS-CoV) was determined by plaque reduction and yield
  reduction assays. Mizoribine and ribavirin selectively inhibited replication of
  SARS-CoV. The 50% inhibitory concentration (IC50) of mizoribine for SARS-CoV
  Frankfurt-1 and SARS-CoV HKU39849, as determined by plaque reduction was 3.5 mu
  g/ml and 16 mu g/ml, respectively, and the IC50 of ribavirin for SARS-CoV
  Frankfurt- I and SARS-CoV HKU39849 was 20 mu g/ml and 80 mu g/ml, while the 50%
  cytotoxic concentration of mizoribine and ribavirin for Vero E6 cells exceeded
  200 mu g/ml. In a yield reduction assay, mizoribine (10 mu g/ml) and ribavirin
  (40 mu g/ml) inhibited the replication of SARS-CoV and reduced the infectious
  SARS-CoV titers to one-tenth or less. Mizoribine inhibited replication of SARS
  -CoV more strongly than ribavirin. However, neither drug could completely
  inhibit replication of SARS-CoV even at concentrations Lip to 100 mu g/ml. (c)
  2005 Elsevier B.V. All rights reserved.
AI: Y
MC: Pharmacology-; Infection-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-; Severe-Acute-Respiratory
  -Syndrome-virus (Coronaviridae-): common-, SARS-virus, common-, pathogen-,
  strain-Frankfurt-1, strain-HKU39849
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
CB: inosine-5'-monophosphate-dehydrogenase: IMPDH-, 9028-93-7, EC-1.1.1.205;
  mizoribine-: 50924-49-7, enzyme-inhibitor-drug, antiviral-drug, antiinfective
  -drug, efficacy-; ribavirin-: 36791-04-5, enzyme-inhibitor-drug, antiviral
  -drug, antiinfective-drug, efficacy-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy
RN: 9028-93-7; 50924-49-7; 36791-04-5
MI: viral-replication
CC: 02506- (Cytology-Animal)
10062- (Biochemistry-studies-Nucleic-acids-purines
  -and-pyrimidines)
10802- (Enzymes-General-and-comparative-studies
  -coenzymes)
12512- (Pathology-Therapy)
16006- (Respiratory-system
  -Pathology)
22002- (Pharmacology-General)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
38502-
  (Chemotherapy-General-methods-and-metabolism)
38506- (Chemotherapy-Antiviral
  -agents)
AN: 200510144642
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0166
  -3542&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0166
  -3542&isbn=&volume=66&issue=2-3&spage=159&pages=159
  -163&date=2005&title=Antiviral%20Research&atitle=Inhibitory%20effect%20of%20mizo
  ribine%20and%20ribavirin%20on%20the%20replication%20of%20severe%20acute%20respir
  atory%20syndrome%20%28SARS%29
  -associated%20coronavirus&aulast=Saijo&pid=%3Cauthor%3ESaijo%2c%20Masayuki%3bMor
  ikawa%2c%20Shigeru%3bFukushi%2c%20Shuetsu%3bMizutani%2c%20Tetsuya%3bHasegawa%2c%
  20Hideki%3bNagata%2c%20Noriyo%3bIwata%2c%20Naoko%3bKurane%2c%20Ichiro%3C%2Fautho
  r%3E%3CAN%3E200510144642%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 166 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Highly potent anti-HIV-1 activity isolated from fermented Polygonum
  tinctorium Aiton
AU: Zhong,-Yu [Author]; Yoshinaka,-Yoshiyuki [Author]; Takeda,-Tadahiro
  [Author]; Shimizu,-Noriko [Author]; Yoshizaki,-Sayaka [Author]; Inagaki,-Yoshio
  [Author]; Matsuda,-Shinobu [Author]; Honda,-Gisho [Author]; Fujii,-Nobutaka
  [Author]; Yamamoto,-Naoki [Author,-Reprint-Author]
AD: Tokyo Med and Dent Univ, Dept Mol Virol, Grad Sch, Bunkyo Ku, 1-5-45
  Yushima, Tokyo 1138519, Japan
EMA: yamamoto.mmb@tmd.ac.jp
SO: Antiviral-Research. 2005; 66(2-3): 119-128
PY: 2005
DT: Article
IS: 0166-3542
LA: English
AB: A water-soluble extract of fermented Polygonum tinctorium Aiton
  (Polygonaceae) called Sukumo, exhibited a potent inhibitory activity against
  HIV type I in vitro. The extract potently suppressed acute HIV-1 (IIIB)
  infection in MT-4 cells with EC50 values of 0.5 mu g/ml but exhibited low
  cytotoxicity to MT-4 cells even at a high concentration (CC50 > 1000 mu g/ml).
  It also inhibited giant cell formation in co-cultures of HIV-infected cells and
  uninfected Molt-4 cells. Sukumo extract was found to interact with both the
  viral envelope glycoprotein and cellular receptors, thus blocking virus-cell
  binding and virus-induced syncytium formation. There was a good correlation
  between the extract's anti-HIV-1 activity and its inhibitory effects on HIV-1
  binding. It also suppressed replication of herpes simplex virus type I in Vero
  cells with an EC50 of 11.56 mu g/ml. On the other hand, there was no
  appreciable activity against influenza A virus, poliovirus or SARS corona virus
  when tested at concentrations ranging from 3.2-400 mu g/ml as shown by
  microscopic image analysis for cytopathic effect (CPE). Physico-chemical
  studies revealed that the anti-HIV activity in the extract was essentially
  maintained after boiling at 100 degrees C in 1N HCl or 1N NaOH, and after
  treatment with 100 mM NaIO4. The inhibitory activity of the extract was also
  not reduced after pronase digestion. The active factor in the extract is likely
  to be a novel compound(s) having a polyanionic substructure and a molecular
  weight of 10,000-50,000. (c) 2005 Elsevier B.V. All rights reserved.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Immune-System: Chemical
  -Coordination-and-Homeostasis; Respiratory-System: Respiration-; Pharmacognosy
  -: Pharmacology-
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia
  -; -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[26605-] Polygonaceae-, -Dicotyledones, Angiospermae-,
  Spermatophyta-, Plantae-; -[03305-] Retroviridae-, -DNA-and-RNA-Reverse
  -Transcribing-Viruses, Viruses-, Microorganisms-
OR: MT-4-cell-line (Hominidae-): cell_line-; Molt-4-cell-line (Hominidae-):
  cell_line-; Influenza-A-virus (Orthomyxoviridae-): species-; Polygonum
  -tinctorium (Polygonaceae-): species-, medicinal-plant; Human-immunodeficiency
  -virus-1 (Retroviridae-): species-, pathogen-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates
  -; Orthomyxoviridae-: Microorganisms-, Negative-Sense-Single-Stranded-RNA
  -Viruses, Viruses-; Polygonaceae-: Angiosperms-, Dicots-, Plants-,
  Spermatophytes-, Vascular-Plants; Retroviridae-: DNA-and-RNA-Reverse
  -Transcribing-Viruses, Microorganisms-, Viruses-
PS: syncytium-
CB: hydrochloric-acid: 7647-01-0; sodium-oxide: 1313-59-3; Sukumo-:
  antiinfective-drug, antiviral-drug, potency-
DS: influenza-: (Influenza-(MeSH)), respiratory-system-disease, viral-disease;
  human-immunodeficiency-virus-1-infection: (HIV-Infections-(MeSH)), viral
  -disease, immune-system-disease, drug-therapy, etiology-
RN: 7647-01-0; 1313-59-3
MQ: microscopic-image-analysis: laboratory-techniques, imaging-and-microscopy
  -techniques
CC: 02508- (Cytology-Human)
10060- (Biochemistry-studies-General)
12512-
  (Pathology-Therapy)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
33502- (Virology-General
  -and-methods)
34502- (Immunology-General-and-methods)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36006- (Medical-and-clinical-microbiology
  -Virology)
38502- (Chemotherapy-General-methods-and-metabolism)
38506-
  (Chemotherapy-Antiviral-agents)
51508- (Plant-physiology-Respiration
  -fermentation)
51522- (Plant-physiology-Chemical-constituents)
54000-
  (Pharmacognosy-and-pharmaceutical-botany)
AN: 200510144637
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0166
  -3542&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0166
  -3542&isbn=&volume=66&issue=2-3&spage=119&pages=119
  -128&date=2005&title=Antiviral%20Research&atitle=Highly%20potent%20anti-HIV
  -1%20activity%20isolated%20from%20fermented%20Polygonum%20tinctorium%20Aiton&aul
  ast=Zhong&pid=%3Cauthor%3EZhong%2c%20Yu%3bYoshinaka%2c%20Yoshiyuki%3bTakeda%2c%2
  0Tadahiro%3bShimizu%2c%20Noriko%3bYoshizaki%2c%20Sayaka%3bInagaki%2c%20Yoshio%3b
  Matsuda%2c%20Shinobu%3bHonda%2c%20Gisho%3bFujii%2c%20Nobutaka%3bYamamoto%2c%20Na
  oki%3C%2Fauthor%3E%3CAN%3E200510144637%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 167 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models
AU: Paragas,-Jason [Author,-Reprint-Author]; Blatt,-Lawrence-M [Author];
  Hartmann,-Chris [Author]; Huggins,-John-W [Author]; Endy,-Tim-P [Author]
AD: USA, Med Res Inst Infect Dis, Div Virol, 1425 Porter St, Ft Detrick, MD
  21702 USA
EMA: Jason.paragas@det.amedd.army.mil
SO: Antiviral-Research. 2005; 66(2-3): 99-102
PY: 2005
DT: Article
IS: 0166-3542
LA: English
AB: Preliminary data examining interferon alfacon 1 treatment of SARS-CoV
  (severe acute respiratory syndrome-corona virus)-infected patients suggests
  this therapy is well tolerated and of therapeutic benefit. We report herein
  that interferon alfacon 1, has potent in vitro antiviral activity against SARS
  -CoV. In a cytopathic effect protection (CPE) assay, interferon alfacon I
  inhibited the generation of CPE in a dose-dependent manner with an IC50 of
  0.001 mu g/ml, a clinically achievable level. Furthermore, interferon alfacon 1
  also demonstrated significant antiviral activity in yield reduction and plaque
  reduction assays. The in vitro antiviral activity of interferon alfacon 1
  against SARS-CoV suggests continued evaluation of interferon alfacon 1 as a
  therapeutic treatment for patients infected with SARS-CoV. Published by
  Elsevier B.V.
AI: Y
MC: Pharmacology-; Infection-; Respiratory-System: Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Vero-cell-line (Cercopithecidae-): cell_line-, host-; SARS-virus
  (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome-virus, common-,
  pathogen-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
CB: interferon-alfacon-1: Infergen-, antiinfective-drug, antiviral-drug,
  pharmacodynamics-
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease, drug-therapy
MQ: cytopathic-effect-protection-assay: laboratory-techniques
CC: 02506- (Cytology-Animal)
12512- (Pathology-Therapy)
16004- (Respiratory
  -system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
22002- (Pharmacology-General)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
38502-
  (Chemotherapy-General-methods-and-metabolism)
38506- (Chemotherapy-Antiviral
  -agents)
AN: 200510144634
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0166
  -3542&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0166
  -3542&isbn=&volume=66&issue=2-3&spage=99&pages=99
  -102&date=2005&title=Antiviral%20Research&atitle=Interferon%20alfacon1%20is%20an
  %20inhibitor%20of%20SARS-corona%20virus%20in%20cell
  -based%20models&aulast=Paragas&pid=%3Cauthor%3EParagas%2c%20Jason%3bBlatt%2c%20L
  awrence%20M%3bHartmann%2c%20Chris%3bHuggins%2c%20John%20W%3bEndy%2c%20Tim%20P%3C
  %2Fauthor%3E%3CAN%3E200510144634%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 168 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Development of antiviral therapy for severe acute respiratory syndrome
AU: Cinatl,-Jindrich-Jr [Author,-Reprint-Author]; Michaelis,-Martin [Author];
  Hoever,-Gerold [Author]; Preiser,-Wolfgang [Author]; Doerr,-Hans-Wilhelm
  [Author]
AD: Univ Frankfurt Klinikum, Inst Med Virol, Paul Ehrlich Str 40, D-60596
  Frankfurt, Germany
EMA: Cinatl@em.uni-frankfurt.de; H.W.Doerr@em.uni-frankfurt.de
SO: Antiviral-Research. 2005; 66(2-3): 81-97
PY: 2005
DT: Literature-Review; Article
IS: 0166-3542
LA: English
AB: A new disease, the severe acute respiratory distress syndrome (SARS), caused
  by the SARS coronavirus (SARS-CoV), emerged at the beginning of 2003 and
  rapidly spread throughout the world. Although the disease had disappeared in
  June 2003 its re-emergence cannot be excluded. The development of vaccines
  against SARS-CoV may take years. Therefore, the availability of effective
  antiviral drugs against SARS-CoV may be crucial for the control of future SARS
  outbreaks. In this review, experimental and clinical data about potential anti
  -SARS drugs is summarised and discussed. Animal model studies will be needed to
  help to determine which interventions warrant controlled clinical testing. (c)
  2005 Elsevier B.V. All rights reserved.
AI: Y
MC: Pharmacology-; Infection-; Respiratory-System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-; human-
  (Hominidae-): common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: ribavirin-: 36791-04-5, antiinfective-drug, antiviral-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy
RN: 36791-04-5
MQ: antiviral-therapy: therapeutic-and-prophylactic-techniques, clinical
  -techniques
CC: 10062- (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
12512-
  (Pathology-Therapy)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
33502- (Virology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
38502- (Chemotherapy-General-methods-and-metabolism)
38506-
  (Chemotherapy-Antiviral-agents)
AN: 200510144633
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0166
  -3542&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0166
  -3542&isbn=&volume=66&issue=2-3&spage=81&pages=81
  -97&date=2005&title=Antiviral%20Research&atitle=Development%20of%20antiviral%20t
  herapy%20for%20severe%20acute%20respiratory%20syndrome&aulast=Cinatl&pid=%3Cauth
  or%3ECinatl%2c%20Jindrich%20Jr%3bMichaelis%2c%20Martin%3bHoever%2c%20Gerold%3bPr
  eiser%2c%20Wolfgang%3bDoerr%2c%20Hans%20Wilhelm%3C%2Fauthor%3E%3CAN%3E2005101446
  33%3C%2FAN%3E%3CDT%3ELiterature%20Review%3bArticle%3C%2FDT%3E

Record 169 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Using herbal medicine as a means of prevention experience during the SARS
  crisis
AU: Lau,-T-F [Author]; Leung,-P-C [Author,-Reprint-Author]; Wong,-E-L-Y
  [Author]; Fong,-C [Author]; Cheng,-K-F [Author]; Zhang,-S-C [Author]; Lam,-C-W
  -K [Author]; Wong,-V [Author]; Choy,-K-M [Author]; Ko,-W-M [Author]
AD: Chinese Univ Hong Kong, Prince Wales Hosp, Inst Chinese Med, Ctr Clin Trials
  Chinese Med, 5F,Sch Publ Hlth Bldg, Shatin, Hong Kong, Peoples R China
EMA: pingcleung@cuhk.edu.hk
SO: American-Journal-of-Chinese-Medicine. 2005; 33(3): 345-356
PY: 2005
DT: Article
IS: 0192-415X
LA: English
AB: At the peak of the SARS epidemic in Hong Kong, hospital workers were under
  high risks of contraction of the infection. Herbal preparations had been used
  historically in China to treat influenza-like diseases. During the SARS
  outbreak, herbal preparations had been used jointly with standard modem
  treatment in China. As a means to protect the at-risk hospital workers, an
  innovative herbal formula was created and consumed by 3160 of them in two
  weeks. During the two weeks, symptoms and adverse effects were close monitored;
  37 of them had their serum checked for immunological responses.The results
  showed that none of the herb consumers contracted the infection, compared to
  0.4% among the non-consumers. Adverse effects had been infrequent and mild.
  There were hardly any influenza-like symptoms and the quality of life improved.
  In the group who volunteered to have their immunological state checked,
  significant boosting effects were found. It was concluded that there might be a
  good indication for using suitable herbal preparations as a means of preventing
  influenza-like infection. The mode of preventive effect could be treatment of
  the infection at its very early stage instead of producing a period of higher
  immunological ability, as in the case of vaccination.
AI: Y
MC: Clinical-Immunology: Human-Medicine, Medical-Sciences; Infection-;
  Epidemiology-: Population-Studies; Occupational-Health: Allied-Medical
  -Sciences; Pulmonary-Medicine: Human-Medicine, Medical-Sciences; Pharmacognosy
  -: Pharmacology-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, adult-, aged-, middle
  -age, host-, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: serum-: blood-and-lymphatics
CB: SARS-vaccine: immunologic-drug, immunostimulant-drug, vaccine-, efficacy-
GE: China-: Asia-, Palearctic-region
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease, drug-therapy, immunology-, prevention-and-control, symptom-, etiology
  -, epidemiology-
MQ: vaccination-: clinical-techniques; herbal-therapy: therapeutic-and
  -prophylactic-techniques, clinical-techniques
MI: quality-of-life; hospital-worker
CC: 12512- (Pathology-Therapy)
15002- (Blood-Blood-and-lymph-studies)
15004-
  (Blood-Blood-cell-studies)
16006- (Respiratory-system-Pathology)
22005-
  (Pharmacology-Clinical-pharmacology)
22018- (Pharmacology-Immunological
  -processes-and-allergy)
24500- (Gerontology-)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36006- (Medical-and-clinical-microbiology
  -Virology)
37013- (Public-health-Occupational-health)
37052- (Public-health
  -epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
54000- (Pharmacognosy-and-pharmaceutical-botany)
AN: 200510144331
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0192
  -415X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0192
  -415X&isbn=&volume=33&issue=3&spage=345&pages=345
  -356&date=2005&title=American%20Journal%20of%20Chinese%20Medicine&atitle=Using%2
  0herbal%20medicine%20as%20a%20means%20of%20prevention%20experience%20during%20th
  e%20SARS%20crisis&aulast=Lau&pid=%3Cauthor%3ELau%2c%20T%20F%3bLeung%2c%20P%20C%3
  bWong%2c%20E%20L%20Y%3bFong%2c%20C%3bCheng%2c%20K%20F%3bZhang%2c%20S%20C%3bLam%2
  c%20C%20W%20K%3bWong%2c%20V%3bChoy%2c%20K%20M%3bKo%2c%20W%20M%3C%2Fauthor%3E%3CA
  N%3E200510144331%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 170 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Moraria brevipes (Crustacea: Copepoda) in South Bohemian forest soils
AU: Hanel,-Ladislav [Author,-Reprint-Author]; Christian,-Erhard [Author]
AD: Acad Sci Czech Republ, Inst Soil Biol, Na Sadkach 7, CZ-37005 Ceske
  Budejovice, Czech Republic
EMA: hanel@upb.cas.cz; erhard.christian@boku.ac.at
SO: Acta-Societatis-Zoologicae-Bohemicae. 2004; 68(3): 169-171
PY: 2004
DT: Article
IS: 1211-376X
LA: English
AB: Abundance and phenology data are provided for the copepod Moraria brevipes
  (Sars, 1863) (Canthocamptidae) in three types of woodland habitat in the Sumava
  Mountains, Czech Republic: living spruce forests, dead spruce forests after
  bark-beetle attack and clearings. Highest densities (> 200x10(3) indxm(-2))
  were recorded in June at a site one year after clearcutting and in a dead
  spruce stand. Peaks in abundance were associated with large accumulations of
  litter.
AI: Y
MC: Biogeography-: Population-Studies; Terrestrial-Ecology: Ecology-,
  Environmental-Sciences
ST: -[75304-] Coleoptera-, -Insecta, Arthropoda-, Invertebrata-, Animalia-; 
  -[25102-] Coniferopsida-, -Gymnospermae, Spermatophyta-, Plantae-; -[75110-]
  Copepoda-, -Crustacea, Arthropoda-, Invertebrata-, Animalia-
OR: bark-beetle (Coleoptera-): common-, pest-; spruce- (Coniferopsida-): common
  -, host-; Moraria-brevipes (Copepoda-): species-, copepod-, common-
TN: Coleoptera-: Animals-, Arthropods-, Insects-, Invertebrates-; Coniferopsida
  -: Gymnosperms-, Plants-, Spermatophytes-, Vascular-Plants; Copepoda-: Animals
  -, Arthropods-, Crustaceans-, Invertebrates-
GE: Bohemia-: Czech-Republic, Europe-, Palearctic-region
MI: forest-soil; phenology-data; abundance-data
CC: 07502- (Ecology-environmental-biology-General-and-methods)
07506- (Ecology
  -environmental-biology-Plant)
07508- (Ecology-environmental-biology
  -Animal)
50528- (Botany-general-and-systematic-Floristics-and
  -distribution)
62800- (Animal-distribution)
64054- (Invertebratacomparative
  -experimental-morphology-physiology-and-pathology-Arthropoda-crustacea)
64076-
  (Invertebrata-comparative-experimental-morphology-physiology-and-pathology
  -Insecta-physiology)
AN: 200510144239
UD: 20050913
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1211
  -376X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1211
  -376X&isbn=&volume=68&issue=3&spage=169&pages=169
  -171&date=2004&title=Acta%20Societatis%20Zoologicae%20Bohemicae&atitle=Moraria%2
  0brevipes%20%28Crustacea%3a%20Copepoda%29%20in%20South%20Bohemian%20forest%20soi
  ls&aulast=Hanel&pid=%3Cauthor%3EHanel%2c%20Ladislav%3bChristian%2c%20Erhard%3C%2
  Fauthor%3E%3CAN%3E200510144239%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 171 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: A follow-up study of the lung function and the chest CT changes in medical
  staff with severe acute respiratory syndrome in Beijing
AU: He-Zheng-yi [Author,-Reprint-Author]
AD: Beijing Friendship Hosp, Beijing 100050, Peoples R China
SO: Zhonghua-Jiehe-He-Huxi-Zazhi. 2005; 28(1): 10-12
PY: 2005
DT: Article
IS: 1001-0939
LA: Chinese
AB: Objective To analyze the lung function and radiological changes in
  rehabilitating severe acute respiratory syndrome (SARS) patients of medical
  staff in Beijing. Methods Follow-up lung function tests and chest high
  -resolution computerized tomography (HRCT) were performed in medical staff with
  SARS from Dec. 2003 to Feb. 2004. Results Thirty-one (7.64%) of 406 patients
  showed abnormal ventilatory function, while 165 of 404 patients showed
  diffusing abnormality. Of the 434 patients who had received HRCT scans, 151
  (34.79%) showed abnormalities including subpleural and basal ground-glass and
  reticular attenuation, nodular septal thickening and bronchiectasis. Of the 395
  patients who had received both lung function test and HRCT scanning, 55
  (13.92%) had abnormalities both in the lung function and HRCT. The decrease in
  diffusing capacity in patients with HRCT changes was more significant than
  those without HRCT changes. Conclusions Lung function and lung imaging were
  abnormal in some patients with SARS after recovery. It is suggested that the
  lung damage is chronic,and follow-up is needed.
AI: Y
MC: Infection-; Pulmonary-Medicine: Human-Medicine, Medical-Sciences; Radiology
  -: Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, host-, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: lung-: respiratory-system
GE: Beijing-: China-, Asia-, Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, pathology-, symptom-,
  diagnosis-
MQ: lung-function-test: clinical-techniques, diagnostic-techniques; chest-high
  -resolution-computerized-tomography: HRCT-, imaging-and-microscopy-techniques,
  diagnostic-techniques, clinical-techniques
MI: disease-severity; lung-function; medical-staff; radiological-changes;
  pulmonary-diffusing-capacity
CC: 06504- (Radiation-biology-Radiation-and-isotope-techniques)
12502-
  (Pathology-General)
12504- (Pathology-Diagnostic)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
33502-
  (Virology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510144001
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1001
  -0939&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1001
  -0939&isbn=&volume=28&issue=1&spage=10&pages=10
  -12&date=2005&title=Zhonghua%20Jiehe%20He%20Huxi%20Zazhi&atitle=A%20follow
  -up%20study%20of%20the%20lung%20function%20and%20the%20chest%20CT%20changes%20in
  %20medical%20staff%20with%20severe%20acute%20respiratory%20syndrome%20in%20Beiji
  ng&aulast=&pid=%3Cauthor%3EHe%20Zheng%20yi%3C%2Fauthor%3E%3CAN%3E200510144001%3C
  %2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 172 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Epitope mapping and biological function analysis of antibodies produced by
  immunization of mice with an inactivated Chinese isolate of severe acute
  respiratory syndrome-associated coronavirus (SARS-CoV) (vol 334, pg 134, 2005)
AU: Chou,-Te-Hui-W [Author]; Wang,-Shixia [Author]; Sakhatskyy,-Pavlo-V
  [Author]; Mboudjeka,-Innocent [Author]; Lawrence,-John-M [Author]; Huang,-Song
  [Author]; Coley,-Scott [Author]; Yang,-Baoan [Author]; Li,-Jiaming [Author];
  Zhu,-Qingyu [Author,-Reprint-Author]; Lu,-Shan [Author]
AD: Chinese Acad Mil Med Sci, Inst Microbiol and Epidemiol, Beijing 100071,
  Peoples R China
EMA: qingyzh@yahoo.com.cn; shan.lu@umassmed.edu
SO: Virology-. 2005; 337(1): 204
PY: 2005
DT: Errata; Article
IS: 0042-6822
LA: English
MC: Biochemistry-and-Molecular-Biophysics; Pharmacology-; Infection-; Immune
  -System: Chemical-Coordination-and-Homeostasis
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Severe-acute-respiratory-syndrome-associated-coronavirus (Coronaviridae-):
  common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: antibodies-; severe-acute-respiratory-syndrome-associated-coronavirus: SARS
  -CoV, immunologic-drug, vaccine-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, infectious-disease, viral-disease,
  pathology-, immunology-
MQ: epitope-mapping: laboratory-techniques, immunologic-techniques; immunization
  -: laboratory-techniques
CC: 10060- (Biochemistry-studies-General)
12502- (Pathology-General)
12512-
  (Pathology-Therapy)
16006- (Respiratory-system-Pathology)
22002-
  (Pharmacology-General)
22018- (Pharmacology-Immunological-processes-and
  -allergy)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510143831
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0042
  -6822&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0042
  -6822&isbn=&volume=337&issue=1&spage=&pages=204&date=2005&title=Virology%20&atit
  le=Epitope%20mapping%20and%20biological%20function%20analysis%20of%20antibodies%
  20produced%20by%20immunization%20of%20mice%20with%20an%20inactivated%20Chinese%2
  0isolate%20of%20severe%20acute%20respiratory%20syndrome
  -associated%20coronavirus%20%28SARS
  -CoV%29%20%28vol%20334%2c%20pg%20134%2c%202005%29&aulast=Chou&pid=%3Cauthor%3ECh
  ou%2c%20Te%20Hui%20W%3bWang%2c%20Shixia%3bSakhatskyy%2c%20Pavlo%20V%3bMboudjeka%
  2c%20Innocent%3bLawrence%2c%20John%20M%3bHuang%2c%20Song%3bColey%2c%20Scott%3bYa
  ng%2c%20Baoan%3bLi%2c%20Jiaming%3bZhu%2c%20Qingyu%3bLu%2c%20Shan%3C%2Fauthor%3E%
  3CAN%3E200510143831%3C%2FAN%3E%3CDT%3EErrata%3bArticle%3C%2FDT%3E

Record 173 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Meldungen zu unerwunschten wirkungen von tierarzneimitteln im Jahr
  2004
Suspected adverse drug reactions in 2004
AU: Muentener,-C-R [Author,-Reprint-Author]; Gassner,-B [Author]; Demuth,-D-C
  [Author]; Althaus,-F-R [Author]; Zwahlen,-R [Author]
AD: Univ Zurich, Inst Vet Pharmakol and Toxikol, Winterthurerstr 260, CH-8057
  Zurich, Switzerland
EMA: cedric.muentener@vetpharm.unlzh.ch
SO: Schweizer-Archiv-fuer-Tierheilkunde. 2005; 147(7): 304-310
PY: 2005
DT: Article
IS: 0036-7281
LA: German
AB: We received 62 reports of suspected adverse events (SARs) for the year 2004.
  Their number and repartition according to affected animals and active
  substances were comparable with the previous year. The distributors or
  manufacturers submitted most of the declarations, but the proportion submitted
  by practicing veterinarians is slowly growing. 72% of the declarations dealt
  with adverse reactions in small animals (cats and dogs), followed by cattle and
  horses. Antiparasitics, anti-inflammatory drugs and immunologicals were the
  most frequently mentioned therapeutic classes, which are listed here according
  to the international ATCvet classification. A report from abroad about a
  fatality following injection of an antibiotic preparation for cattle prompted
  Swissmedic to review the security of this medication also sold on the Swiss
  market. It was decided to modify the package insert to warn about the danger of
  inadvertent self-injection in humans, to reduce the risk of similar accidents
  in Switzerland. We hope that the pharmacovigilance system will enjoy an
  increasing awareness by the practicing veterinarians.
AI: Y
MC: Pharmacology-; Veterinary-Medicine: Medical-Sciences
ST: -[85715-] Bovidae-, -Artiodactyla, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[85765-] Canidae-, -Carnivora, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[86145-] Equidae-, -Perissodactyla, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[85770-] Felidae-, -Carnivora, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: cattle- (Bovidae-): common-; dog- (Canidae-): common-; horse- (Equidae-):
  common-; cat- (Felidae-): common-
TN: Bovidae-: Animals-, Artiodactyls-, Chordates-, Mammals-, Nonhuman
  -Vertebrates, Nonhuman-Mammals, Vertebrates-; Canidae-: Animals-, Carnivores-,
  Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman-Mammals, Vertebrates-;
  Equidae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Perissodactyls-, Vertebrates-; Felidae-: Animals-, Carnivores-,
  Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman-Mammals, Vertebrates-
CB: antiparasitic-drugs: antiinfective-drug, antiparasitic-drug, toxicity-,
  adverse-effects; antiinflammatory-drugs: antiinflammatory-drug, immunologic
  -drug, toxicity-, adverse-effects; immunologic-drugs: immunologic-drug,
  toxicity-, adverse-effects
GE: Switzerland-: Europe-, Palearctic-region
DS: adverse-drug-reaction: toxicity-
CC: 12512- (Pathology-Therapy)
22002- (Pharmacology-General)
22012-
  (Pharmacology-Connective-tissue-bone-and-collagen-acting-drugs)
22018-
  (Pharmacology-Immunological-processes-and-allergy)
22501- (Toxicology-General
  -and-methods)
22504- (Toxicology-Pharmacology)
38002- (Veterinary-science
  -General-and-methods)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38510- (Chemotherapy-Antiparasitic-agents)
AN: 200510143308
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0036
  -7281&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0036
  -7281&isbn=&volume=147&issue=7&spage=304&pages=304
  -310&date=2005&title=Schweizer%20Archiv%20fuer%20Tierheilkunde&atitle=Meldungen%
  20zu%20unerwunschten%20wirkungen%20von%20tierarzneimitteln%20im%20Jahr%202004&au
  last=Muentener&pid=%3Cauthor%3EMuentener%2c%20C%20R%3bGassner%2c%20B%3bDemuth%2c
  %20D%20C%3bAlthaus%2c%20F%20R%3bZwahlen%2c%20R%3C%2Fauthor%3E%3CAN%3E20051014330
  8%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 174 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Humanized mice develop coronavirus respiratory disease
AU: Baric,-Ralph-S [Author,-Reprint-Author]; Sims,-Amy-C [Author]
AD: Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA
EMA: rbaric@email.unc.edu
SO: Proceedings-of-the-National-Academy-of-Sciences-of-the-United-States-of
  -America. 2005; 102(23): 8073-8074
PY: 2005
DT: Editorial; Article
IS: 0027-8424
LA: English
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Respiratory-System:
  Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[86375-] Muridae-, -Rodentia, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[03503-] Paramyxoviridae-, -Negative-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-; -[03603-] Picornaviridae-, -Positive-Sense
  -ssRNA-Viruses, Viruses-, Microorganisms-; -[03110-] Poxviridae-, -dsDNA
  -Viruses, Viruses-, Microorganisms-
OR: Human-coronavirus-OC43 (Coronaviridae-): species-; Coronavirus-
  (Coronaviridae-): genus-, pathogen-; Severe-Acute-Respiratory-Syndrome-virus
  (Coronaviridae-): common-, SARS-virus, common-, pathogen-; Human-coronavirus
  -229E (Coronaviridae-): species-; human- (Hominidae-): common-, child-, infant
  -, adult-, host-; mouse- (Muridae-): common-, transgenic-; Measles-virus
  (Paramyxoviridae-): species-, pathogen-; Poliovirus- (Picornaviridae-): species
  -, pathogen-; Poxvirus- (Poxviridae-): common-, gene-vector
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-; Paramyxoviridae-: Microorganisms-,
  Negative-Sense-Single-Stranded-RNA-Viruses, Viruses-; Picornaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Poxviridae-: Double-Stranded-DNA-Viruses, Microorganisms-, Viruses-
CB: RNA-; glycoprotein-; open-reading-frame: ORF-; aminopeptidase-N: 9054-63-1,
  EC-3.4.11.2; CD13-; angiotensin-converting-enzyme-2: ACE-2
DS: pneumonia-: (Pneumonia-(MeSH)), respiratory-system-disease; upper
  -respiratory-tract-infection: (Respiratory-Tract-Infections-(MeSH)),
  respiratory-system-disease, infectious-disease; severe-acute-respiratory
  -syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)), respiratory
  -system-disease, viral-disease; human-coronavirus-229E-infection: viral
  -disease, pathology-; human-coronavirus-OC43-infection: viral-disease,
  pathology-
RN: 9054-63-1
MQ: cloning-: laboratory-techniques, genetic-techniques
MI: genome-; animal-model; innate-immune-response
CC: 10060- (Biochemistry-studies-General)
10062- (Biochemistry-studies-Nucleic
  -acids-purines-and-pyrimidines)
10064- (Biochemistry-studies-Proteins-peptides
  -and-amino-acids)
12502- (Pathology-General)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
25000-
  (Pediatrics-)
33502- (Virology-General-and-methods)
36001- (Medical-and
  -clinical-microbiology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510142970
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0027
  -8424&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0027
  -8424&isbn=&volume=102&issue=23&spage=8073&pages=8073
  -8074&date=2005&title=Proceedings%20of%20the%20National%20Academy%20of%20Science
  s%20of%20the%20United%20States%20of%20America&atitle=Humanized%20mice%20develop%
  20coronavirus%20respiratory%20disease&aulast=Baric&pid=%3Cauthor%3EBaric%2c%20Ra
  lph%20S%3bSims%2c%20Amy%20C%3C%2Fauthor%3E%3CAN%3E200510142970%3C%2FAN%3E%3CDT%3
  EEditorial%3bArticle%3C%2FDT%3E

Record 175 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Molecular identification and characterization of novel coronaviruses
  infecting graylag geese (Anser anser), feral pigeons (Columbia livia) and
  mallards (Anas platyrhynchos)
AU: Jonassen,-Christine-Monceyron [Author,-Reprint-Author]; Kofstad,-Tone
  [Author]; Larsen,-Inger-Lise [Author]; Lovland,-Atle [Author]; Handeland,-Kjell
  [Author]; Follestad,-Arne [Author]; Lillehaug,-Atle [Author]
AD: Natl Vet Inst, Sect Virol and Serol, POB 8156 DEP, N-0033 Oslo, Norway
EMA: christine.monceyron-jonassen@vetinst.no
SO: Journal-of-General-Virology. 2005; 86(Part 6): 1597-1607
PY: 2005
DT: Article
IS: 0022-1317
LA: English
AB: In light of the finding of a previously unknown coronavirus as the aetiology
  of the severe acute respiratory syndrome (SARS), it is probable that other
  coronaviruses, than those recognized to date, are circulating in animal
  populations. Here, the results of a screening for coronavirus are presented,
  using a universal coronavirus RT-PCR, of the bird species graylag goose (Anser
  anser), feral pigeon (Columbia livia) and mallard (Anas platyrhynchos).
  Coronaviruses were found in cloacal swab samples from all the three bird
  species. In the graylag goose, 40 of 163 sampled birds were coronavirus
  positive, whereas two of 100 sampled pigeons and one of five sampled mallards
  tested positive. The infected graylag geese showed lower body weights compared
  with virus-negative birds, suggesting clinical significance of the infection.
  Phylogenetic analyses performed on the replicase gene and nucleocapsid protein
  sequences, indicated that the novel coronaviruses described in the present
  study all branch off from group III coronaviruses. All the novel avian
  coronaviruses harboured the conserved s2m RNA structure in their 3'
  untranslated region, like other previously described group III coronaviruses,
  and like the SARS coronavirus. Sequencing of the complete nucleocapsid gene and
  downstream regions of goose and pigeon coronaviruses, evidenced the presence of
  two additional open reading frames for the goose coronavirus with no sequence
  similarity to known proteins, but with predicted transmembrane domains for one
  of the encoded proteins, and one additional open reading frame for the pigeon
  coronavirus, with a predicted transmembrane domain, downstream of the
  nucleocapsid gene.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Respiratory-System: Respiration-
ST: -[85504-] Anseriformes-, -Aves, Vertebrata-, Chordata-, Animalia-; -[45100-]
  Cestoda-, -Platyhelminthes, Helminthes-, Invertebrata-, Animalia-; -[03613-]
  Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-, Microorganisms-
OR: Anser-anser (Anseriformes-): species-, graylag-goose, common-, host-; Anas
  -platyrhynchos (Anseriformes-): species-, mallard-, common-, host-; Columbia
  -livia (Cestoda-): species-, feral-pigeon, common-, host-; SARS-virus
  (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome-virus, common-,
  pathogen-
TN: Anseriformes-: Animals-, Birds-, Chordates-, Nonhuman-Vertebrates,
  Vertebrates-; Cestoda-: Animals-, Helminths-, Invertebrates-, Platyhelminths-;
  Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: proteins-; RNA-; nucleocapsid-protein; replicase-gene
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: RT-PCR: reverse-transcriptase-polymerase-chain-reaction, laboratory
  -techniques, genetic-techniques; phylogenetic-analysis: laboratory-techniques,
  genetic-techniques
MI: molecular-characterization; molecular-identification
CC: 03502- (Genetics-General)
03506- (Genetics-Animal)
10062- (Biochemistry
  -studies-Nucleic-acids-purines-and-pyrimidines)
10064- (Biochemistry-studies
  -Proteins-peptides-and-amino-acids)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
31500- (Genetics-of
  -bacteria-and-viruses)
33502- (Virology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
64010- (Invertebrata-comparative
  -experimental-morphology-physiology-and-pathology-Platyhelminthes)
AN: 200510139220
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -1317&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -1317&isbn=&volume=86&issue=Part%206&spage=1597&pages=1597
  -1607&date=2005&title=Journal%20of%20General%20Virology&atitle=Molecular%20ident
  ification%20and%20characterization%20of%20novel%20coronaviruses%20infecting%20gr
  aylag%20geese%20%28Anser%20anser%29%2c%20feral%20pigeons%20%28Columbia%20livia%2
  9%20and%20mallards%20%28Anas%20platyrhynchos%29&aulast=Jonassen&pid=%3Cauthor%3E
  Jonassen%2c%20Christine%20Monceyron%3bKofstad%2c%20Tone%3bLarsen%2c%20Inger%20Li
  se%3bLovland%2c%20Atle%3bHandeland%2c%20Kjell%3bFollestad%2c%20Arne%3bLillehaug%
  2c%20Atle%3C%2Fauthor%3E%3CAN%3E200510139220%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3
  E

Record 176 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Pathogenesis of severe acute respiratory syndrome
AU: Lau,-Yu-Lung [Author,-Reprint-Author]; Peiris,-J-S-Malik [Author]
AD: Univ Hong Kong, Queen Mary Hosp, Dept Paediat and Adolescent Med, Room 117
  New Clin Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China
EMA: lauylung@hkucc.hku.hk
SO: Current-Opinion-in-Immunology. 2005; 17(4): 404-410
PY: 2005
DT: Literature-Review; Article
IS: 0952-7915
LA: English
AB: Severe acute respiratory syndrome (SARS) is a zoonotic infectious disease
  caused by a novel coronavirus (CoV). The tissue tropism of SARS-CoV includes
  not only the lung, but also the gastrointestinal tract, kidney and liver.
  Angiotensin-converting enzyme 2 (ACE2), the C-type lectin CD209L (also known L
  -SIGN), and DC-SIGN bind SARS-CoV, but ACE2 appears to be the key functional
  receptor for the virus. There is a prominent innate immune response to SARS-CoV
  infection, including acute-phase proteins, chemokines, inflammatory cytokines
  and C-type lectins such as mannose-binding lectin, which plays a protective
  role against SARS. By contrast there may be a lack of type 1 interferon
  response. Moreover, lymphopenia with decreased numbers of CD4(+) and CD8(+) T
  cells is common during the acute phase. Convalescent patients have IgG-class
  neutralizing antibodies that recognize amino acids 441-700 of the spike protein
  (S protein) as the major epitope.
AI: Y
MC: Infection-; Immune-System: Chemical-Coordination-and-Homeostasis
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: liver-: digestive-system; gastrointestinal-tract: digestive-system; lung-:
  respiratory-system; kidney-: excretory-system; CD8-positive-T-cell: immune
  -system; CD4-positive-T-cell: immune-system
CB: chemokines-; DC-SIGN; type-1-interferon; inflammatory-cytokine; angiotensin
  -converting-enzyme-2: ACE2-enzyme; CD209L-: C-type-lectin
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MI: innat-immune-response
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
14004- (Digestive-system
  -Physiology-and-biochemistry)
15504- (Urinary-system-Physiology-and
  -biochemistry)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
17002- (Endocrine-General)
33502- (Virology
  -General-and-methods)
34502- (Immunology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
AN: 200510133784
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0952
  -7915&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0952
  -7915&isbn=&volume=17&issue=4&spage=404&pages=404
  -410&date=2005&title=Current%20Opinion%20in%20Immunology&atitle=Pathogenesis%20o
  f%20severe%20acute%20respiratory%20syndrome&aulast=Lau&pid=%3Cauthor%3ELau%2c%20
  Yu%20Lung%3bPeiris%2c%20J%20S%20Malik%3C%2Fauthor%3E%3CAN%3E200510133784%3C%2FAN
  %3E%3CDT%3ELiterature%20Review%3bArticle%3C%2FDT%3E

Record 177 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Epidemiology and management of infectious diseases in international adoptees
AU: Murray,-Thomas-S [Author]; Groth,-A-Elizabeth [Author]; Weitzman,-Carol
  [Author]; Cappello,-Michael [Author,-Reprint-Author]
AD: Yale Program Int Child Hlth, 464 Congress Ave, New Haven, CT 06520 USA
EMA: michael.cappello@yale.edu
SO: Clinical-Microbiology-Reviews. 2005; 18(3): 510-520,CP3,CP4-509
PY: 2005
DT: Article
IS: 0893-8512
LA: English
AB: International adoptees represent a group of children with unique health care
  needs. Data from published studies, along with the recent experience of the
  Yale International Adoption Clinic, suggest that the risk of serious infections
  in adoptees is low, although infections associated with institutionalization
  still occur commonly. Interpretation of these data must be undertaken with
  caution, however, since many, if not most, international adoptees are not
  evaluated in specialty clinics. Thus, prospective studies designed to minimize
  selection and referral bias are needed in order to accurately define the risk
  of infectious and noninfectious diseases in all international adoptees.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies
ST: -[06210-] Aerobic-Helical-or-Vibrioid-Gram-Negatives, -Eubacteria, Bacteria
  -, Microorganisms-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-; -[03615-] Flaviviridae-, -Positive-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-; -[03301-] Hepadnaviridae-, -DNA-and-RNA
  -Reverse-Transcribing-Viruses, Viruses-, Microorganisms-; -[03115-]
  Herpesviridae-, -dsDNA-Viruses, Viruses-, Microorganisms-; -[86215-] Hominidae
  -, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-; -[75300-] Insecta-,
  -Arthropoda, Invertebrata-, Animalia-; -[08881-] Mycobacteriaceae-, 
  -Mycobacteria, Actinomycetes-and-Related-Organisms, Eubacteria-, Bacteria-,
  Microorganisms-; -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-; -[03305-] Retroviridae-, -DNA-and-RNA-Reverse
  -Transcribing-Viruses, Viruses-, Microorganisms-
OR: Helicobacter-pylori (Aerobic-Helical-or-Vibrioid-Gram-Negatives): species-,
  pathogen-; Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-,
  pathogen-; Hepatitis-C-virus (Flaviviridae-): species-, pathogen-; Hepatitis-B
  -virus (Hepadnaviridae-): species-, pathogen-; Cytomegalovirus- (Herpesviridae
  -): genus-, pathogen-; human- (Hominidae-): common-, host-; louse- (Insecta-):
  common-, parasite-; Mycobacterium-tuberculosis (Mycobacteriaceae-): species-,
  pathogen-; Avian-influenza-virus (Orthomyxoviridae-): common-, pathogen-; Human
  -immunodeficiency-virus (Retroviridae-): common-, pathogen-
TN: Aerobic-Helical-or-Vibrioid-Gram-Negatives: Bacteria-, Eubacteria-,
  Microorganisms-; Coronaviridae-: Microorganisms-, Positive-Sense-Single
  -Stranded-RNA-Viruses, Viruses-; Flaviviridae-: Microorganisms-, Positive-Sense
  -Single-Stranded-RNA-Viruses, Viruses-; Hepadnaviridae-: DNA-and-RNA-Reverse
  -Transcribing-Viruses, Microorganisms-, Viruses-; Herpesviridae-: Double
  -Stranded-DNA-Viruses, Microorganisms-, Viruses-; Hominidae-: Animals-,
  Chordates-, Humans-, Mammals-, Primates-, Vertebrates-; Insecta-: Animals-,
  Arthropods-, Insects-, Invertebrates-; Mycobacteriaceae-: Bacteria-, Eubacteria
  -, Microorganisms-; Orthomyxoviridae-: Microorganisms-, Negative-Sense-Single
  -Stranded-RNA-Viruses, Viruses-; Retroviridae-: DNA-and-RNA-Reverse
  -Transcribing-Viruses, Microorganisms-, Viruses-
DS: Hepatitis-C-virus-infection: digestive-system-disease, viral-disease,
  epidemiology-, therapy-; human-immunodeficiency-virus-infection: HIV-infection,
  (HIV-Infections-(MeSH)), viral-disease, immune-system-disease, epidemiology-,
  therapy-; hepatitis-B-virus-infection: digestive-system-disease, viral-disease,
  epidemiology-, therapy-; syphilis-: (Syphilis-(MeSH)), bacterial-disease,
  epidemiology-, therapy-; mycobacterial-infection: (Mycobacterium-Infections
  -(MeSH)), bacterial-disease, epidemiology-, therapy-; Helicobacter-pylori
  -infection: bacterial-disease, epidemiology-, therapy-; cytomegalovirus
  -infection: (Cytomegalovirus-Infections-(MeSH)), viral-disease, epidemiology-,
  therapy-; measles-: (Measles-(MeSH)), viral-disease, epidemiology-, therapy-;
  severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-, therapy-;
  avian-influenza-virus: viral-disease, epidemiology-, therapy-; bacterial
  -gastroentritis: digestive-system-disease, bacterial-disease, epidemiology-,
  therapy-; scabies-: (Scabies-(MeSH)), integumentary-system-disease, parasitic
  -disease, epidemiology-, therapy-; pediculosis-: (Lice-Infestations-(MeSH)),
  integumentary-system-disease, parasitic-disease, epidemiology-, therapy-
MI: international-adoptee
CC: 12512- (Pathology-Therapy)
14006- (Digestive-system-Pathology)
16006-
  (Respiratory-system-Pathology)
18506- (Integumentary-system-Pathology)
31000-
  (Physiology-and-biochemistry-of-bacteria)
33502- (Virology-General-and
  -methods)
34508- (Immunology-Immunopathology-tissue-immunology)
36002-
  (Medical-and-clinical-microbiology-Bacteriology)
36006- (Medical-and-clinical
  -microbiology-Virology)
37052- (Public-health-epidemiology-Communicable
  -diseases)
37054- (Public-health-epidemiology-Organic-diseases-and
  -neoplasms)
37056- (Public-health-epidemiology-Miscellaneous)
60502-
  (Parasitology-General)
60504- (Parasitology-Medical)
64076- (Invertebrata
  -comparative-experimental-morphology-physiology-and-pathology-Insecta
  -physiology)
AN: 200510133191
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0893
  -8512&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0893
  -8512&isbn=&volume=18&issue=3&spage=&pages=&date=2005&title=Clinical%20Microbiol
  ogy%20Reviews&atitle=Epidemiology%20and%20management%20of%20infectious%20disease
  s%20in%20international%20adoptees&aulast=Murray&pid=%3Cauthor%3EMurray%2c%20Thom
  as%20S%3bGroth%2c%20A%20Elizabeth%3bWeitzman%2c%20Carol%3bCappello%2c%20Michael%
  3C%2Fauthor%3E%3CAN%3E200510133191%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 178 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Adverse effects of ribavirin and outcome in severe acute respiratory
  syndrome - Experience in two medical centers
AU: Chiou,-Hsueh-Erh [Author]; Liu,-Ching-Lung [Author]; Buttrey,-Mary-Jeanne
  [Author]; Kuo,-Han-Pin [Author]; Lin,-Hui-Wen [Author]; Kuo,-Hsu-Tah [Author];
  Lu,-Yen-Ta [Author,-Reprint-Author]
AD: Mackay Mem Hosp, Div Chest Med, Dept Internal Med, 92 Chung Shan N Rd,Sec 2,
  Taipei 10449, Taiwan
EMA: ytlhl@ms2.mmh.org.tw
SO: Chest-. 2005; 128(1): 263-272
PY: 2005
DT: Article
IS: 0012-3692
LA: English
AB: Study objectives: To assess the effect of ribavirin-induced anemia on the
  outcome of severe acute respiratory syndrome (SARS).Design: A retrospective
  observational study. Setting: Two medical centers in Taiwan. Patients: Forty
  -four patients with SARS who received ribavirin and 7 patients with SARS who
  did not receive ribavirin.Measurements and results: The mean peak C-reactive
  protein and lactate dehydrogenase levels were higher in SARS patients who were
  receiving ribavirin therapy than in SARS patients who were not receiving
  ribavirin therapy. The mortality was also higher, but the difference was not
  statistically significant. On multivariate analysis, hemoglobin level was an
  independent prognostic correlate of hypoxemia or mortality (odds ratio, 2.0;
  95% confidence interval, 1.1 to 3.8; p = 0.03). The hemoglobin began decreasing
  in two thirds of SARS patients (32 of 44 patients; 73%) who were receiving
  ribavirin 3 days after therapy with the antiviral drug was started. Patients
  with a drop in hemoglobin level of > 2 g/dL had a significantly higher
  mortality rate than the other patients. Hypoxemia developed in one third of
  SARS patients (17 of 44 patients; 39%) who were receiving ribavirin, all of
  whom were anemic. Of the 17 hypoxemic patients, 11 (65%) had a drop in
  hemoglobin of > 2 g/dL, and 4 patients (24%) required a blood transfusion. The
  mean slope of the hemoglobin decrease was significantly steeper (p = 0.001) in
  hypoxemic patients with SARS who were receiving ribavirin than in the
  nonhypoxemic patients with SARS who were receiving ribavirin. Only one of seven
  SARS patients (14%) who was not receiving ribavirin became anemic, but this
  individual was not hypoxemic. Eventually, 5 of 17 hypoxemic and anemic SARS
  patients (29%) who were receiving ribavirin died. The combination of hypoxia
  with anemia was thus significantly associated with a higher mortality (p <
  0.001).Conclusions: Hypoxia combined with anemia increased the risk for death
  in SARS patients. Unless ribavirin can be shown to be effective against SARS
  -coronavirus, the risk of anemia posed by this drug argues against its use in
  SARS patients.
AI: Y
MC: Pharmacology-; Toxicology-; Infection-; Clinical-Chemistry: Allied-Medical
  -Sciences; Hematology-: Human-Medicine, Medical-Sciences; Pulmonary-Medicine:
  Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, adult-, aged-, middle
  -age, host-, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: hemoglobin-; lactate-dehydrogenase: 9001-60-9, EC-1.1.1.27; C-reactive
  -protein; ribavirin-: 36791-04-5, antiinfective-drug, antiviral-drug,
  pharmacodynamics-, adverse-effects
GE: Taiwan-: Asia-, Palearctic-region
DS: anemia-: (Anemia-(MeSH)), blood-and-lymphatic-disease, drug-induced; severe
  -acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)),
  respiratory-system-disease, viral-disease, drug-therapy, mortality-, etiology-
RN: 9001-60-9; 36791-04-5
MI: hypoxia-; hypoxemia-
CC: 10006- (Clinical-biochemistry-General-methods-and-applications)
10062-
  (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
10064-
  (Biochemistry-studies-Proteins-peptides-and-amino-acids)
10065- (Biochemistry
  -studies-Porphyrins-and-bile-pigments)
10802- (Enzymes-General-and-comparative
  -studies-coenzymes)
12512- (Pathology-Therapy)
15006- (Blood-Blood-lymphatic
  -and-reticuloendothelial-pathologies)
16006- (Respiratory-system
  -Pathology)
22002- (Pharmacology-General)
22005- (Pharmacology-Clinical
  -pharmacology)
22501- (Toxicology-General-and-methods)
22504- (Toxicology
  -Pharmacology)
24500- (Gerontology-)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
38502-
  (Chemotherapy-General-methods-and-metabolism)
38506- (Chemotherapy-Antiviral
  -agents)
AN: 200510133062
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0012
  -3692&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0012
  -3692&isbn=&volume=128&issue=1&spage=263&pages=263
  -272&date=2005&title=Chest%20&atitle=Adverse%20effects%20of%20ribavirin%20and%20
  outcome%20in%20severe%20acute%20respiratory%20syndrome%20
  -%20Experience%20in%20two%20medical%20centers&aulast=Chiou&pid=%3Cauthor%3EChiou
  %2c%20Hsueh%20Erh%3bLiu%2c%20Ching%20Lung%3bButtrey%2c%20Mary%20Jeanne%3bKuo%2c%
  20Han%20Pin%3bLin%2c%20Hui%20Wen%3bKuo%2c%20Hsu%20Tah%3bLu%2c%20Yen%20Ta%3C%2Fau
  thor%3E%3CAN%3E200510133062%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 179 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Morphology of a Neotropical cladoceran Alona dentifera (Sars, 1901), and its
  position within the Chydoridae Stebbing, 1902 (Branchiopoda: Anomopoda)
AU: Sinev,-A-Yu [Author,-Reprint-Author]; Kotov,-A-A [Author]; Van-Damme,-Kay
  [Author]
AD: Moscow MV Lomonosov State Univ, Fac Biol, Dept Invertebrate Zool, Moscow
  119899, Russia
EMA: artem_sinev@mail.ru; golokot2000@mail.ru; Kay.VanDamme@Ugent.be
SO: Arthropoda-Selecta. 2004; 13(3): 99-107
PY: 2004
DT: Article
IS: 0136-006X
LA: English
AB: The morphology of a Neotropical anomopod, Alonella dentifera Sars, 1901, was
  studied in detail. Our investigation of the trunk limb morphology and the head
  pores in this species revealed that it belongs to the subfamily Aloninae
  Dybowski & Grochowski, 1894 emend. Frey, 1967, instead of Chydorinae Stebbing,
  1902, as it was presumed by many previous authors. As a result, we transfer
  this species to the genus Alona Baird, 1843. We also found that another
  Neotropical taxon,Alonella brasiliensis Bergamin, 1935 is a junior synonym of
  A. dentifera. This species has several outstanding characters, i. e., it is a
  sole species of Aloninae lacking both major and lateral head pores. A
  preliminary position of Alona dentifera (Sars, 1901) within the subfamily is
  discussed.
AI: Y
MC: Systematics-and-Taxonomy
ST: -[75102-] Branchiopoda-, -Crustacea, Arthropoda-, Invertebrata-, Animalia-
OR: Alona-dentifera (Branchiopoda-): species-, description-; Alonella
  -brasiliensis (Branchiopoda-): species-, junior-synonym
TN: Branchiopoda-: Animals-, Arthropods-, Crustaceans-, Invertebrates-
PS: head-pore
CC: 00504- (General-biology-Taxonomy-nomenclature-and-terminology)
11102-
  (Anatomy-and-Histology-Gross-anatomy)
63554- (Invertebrata-general-and
  -systematic-Arthropoda-Crustacea)
64054- (Invertebratacomparative-experimental
  -morphology-physiology-and-pathology-Arthropoda-crustacea)
AN: 200510131571
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0136
  -006X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0136
  -006X&isbn=&volume=13&issue=3&spage=99&pages=99
  -107&date=2004&title=Arthropoda%20Selecta&atitle=Morphology%20of%20a%20Neotropic
  al%20cladoceran%20Alona%20dentifera%20%28Sars%2c%201901%29%2c%20and%20its%20posi
  tion%20within%20the%20Chydoridae%20Stebbing%2c%201902%20%28Branchiopoda%3a%20Ano
  mopoda%29&aulast=Sinev&pid=%3Cauthor%3ESinev%2c%20A%20Yu%3bKotov%2c%20A%20A%3bVa
  n%20Damme%2c%20Kay%3C%2Fauthor%3E%3CAN%3E200510131571%3C%2FAN%3E%3CDT%3EArticle%
  3C%2FDT%3E

Record 180 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Notes on Aloninae Dybowski & Grochowski, 1894 emend. Frey, 1967 (Cladocera:
  Anomopoda: Chydoridae): 3. Alona iheringula nom. nov instead of A-iheringi
  Sars, 1901, with comments on this taxon
AU: Kotov,-Alexey-A [Author,-Reprint-Author]; Sinev,-Artem-Yu [Author]
AD: AN Severtsov Inst Ecol and Evolut, Leninsky Prospect 33, Moscow 119071,
  Russia
EMA: golokot2000@mail.ru; artem_sinev@mail.ru
SO: Arthropoda-Selecta. 2004; 13(3): 95-98
PY: 2004
DT: Article
IS: 0136-006X
LA: English
AB: Alona iheringi Sars, 1901 (Cladocera: Anomopoda: Chydoridae: Aloninae),
  being a separate Neotropical taxon from A. costata-group, is a junior homonym
  of A Iona davidi var. iheringi Richard, 1897. We suggested Alona iheringula
  nom. nov. to replace the invalid Sars' name. Differences between mate of this
  species and other species of costata-group are described.
AI: Y
MC: Systematics-and-Taxonomy
ST: -[75102-] Branchiopoda-[new-taxon], Crustacea-, Arthropoda-, Invertebrata-,
  Animalia-
OR: Alona-iheringi (Branchiopoda-): species-, new-name, male-, description-,
  junior-homonym; Alona-costata (Branchiopoda-): species-; Alona-davidi-var.
  -ilieringi (Branchiopoda-): variety-
TN: Branchiopoda-: Animals-, Arthropods-, Crustaceans-, Invertebrates-
CC: 00504- (General-biology-Taxonomy-nomenclature-and-terminology)
11102-
  (Anatomy-and-Histology-Gross-anatomy)
63554- (Invertebrata-general-and
  -systematic-Arthropoda-Crustacea)
64054- (Invertebratacomparative-experimental
  -morphology-physiology-and-pathology-Arthropoda-crustacea)
AN: 200510131570
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0136
  -006X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0136
  -006X&isbn=&volume=13&issue=3&spage=95&pages=95
  -98&date=2004&title=Arthropoda%20Selecta&atitle=Notes%20on%20Aloninae%20Dybowski
  %20%26%20Grochowski%2c%201894%20emend.%20Frey%2c%201967%20%28Cladocera%3a%20Anom
  opoda%3a%20Chydoridae%29%3a%203.%20Alona%20iheringula%20nom.%20nov%20instead%20o
  f%20A-iheringi%20Sars%2c%201901%2c%20with%20comments%20on%20this%20taxon&aulast=
  Kotov&pid=%3Cauthor%3EKotov%2c%20Alexey%20A%3bSinev%2c%20Artem%20Yu%3C%2Fauthor%
  3E%3CAN%3E200510131570%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 181 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Myopathic changes associated with severe acute respiratory syndrome - A
  postmortem case series
AU: Leung,-Thomas-W [Author,-Reprint-Author]; Wong,-Ka-Sing [Author]; Hui,
  -Andrew-C [Author]; To,-Ka-Fai [Author]; Lai,-Sik-To [Author]; Ng,-Wai-Fu
  [Author]; Ng,-Ho-Keung [Author]
AD: Chinese Univ Hong Kong, Prince Wales Childrens Hosp, Dept Med and Therapeut,
  Shatin, Hong Kong, Peoples R China
EMA: drtleung@cuhk.edu.hk
SO: Archives-of-Neurology. 2005; 62(7): 1113-1117
PY: 2005
DT: Article
IS: 0003-9942
LA: English
AB: Background: The March 2003 outbreak of the severe acute respiratory syndrome
  (SARS) resulted in significant morbidity and mortality. Muscle weakness and
  elevated serum creatine, kinase levels are commonly encountered in patients
  with SARS. However, the nature and cause of myopathy associated with a SARS
  infection are unknown because, to our knowledge, there has been no report of
  histological or postmortem examination of the skeletal muscle from SARS
  -infected patients.Objective: To determine the exact nature of the myopathy
  associated with SARS.Method: Postmortem skeletal muscles from 8 consecutive
  patients who died of SARS in March 2003 were studied under light and electron
  microscopy as well as immunohistochemistry.Results: Focal myofiber necrosis was
  identified in 4 of 8 cases. Macrophage infiltration and regenerative fiber were
  scanty. All 4 patients treated with a steroid had significant myofiber atrophy.
  In situ hybridization for coronavirus was negative in all subjects. Viral
  cultures for coronavirus and examination for viral particles under electron
  microscopy were performed in 2 patients. The viral culture yielded no organisms
  and there were no viral particles seen on electron microscopic
  examination.Conclusions: There is a spectrum of myopathic changes associated
  with a SARS infection. Focal myofiber necrosis is common and possibly is immune
  mediated. Critical illness myopathy and superimposed steroid myopathy may also
  play an important role in SARS.
AI: Y
MC: Methods-and-Techniques; Infection-; Orthopedics-: Human-Medicine, Medical
  -Sciences; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, adult-, aged-, aged-80-and-over, middle-age,
  host-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: serum-: blood-and-lymphatics; skeletal-muscle: muscular-system
CB: creatine-kinase: 9001-15-4, EC-2.7.3.2; steroid-: antiinfective-drug,
  antiviral-drug
DS: myopathy-: muscle-disease, etiology-; severe-acute-respiratory-syndrome:
  SARS-, (Severe-Acute-Respiratory-Syndrome-(MeSH)), respiratory-system-disease,
  viral-disease, drug-therapy, symptom-, etiology-; focal-myofiber-necrosis:
  muscle-disease
RN: 9001-15-4
MQ: electron-microscopy: laboratory-techniques, imaging-and-microscopy
  -techniques; postmortem-examination: clinical-techniques, diagnostic-techniques
CC: 10067- (Biochemistry-studies-Sterols-and-steroids)
10802- (Enzymes-General
  -and-comparative-studies-coenzymes)
12512- (Pathology-Therapy)
15002- (Blood
  -Blood-and-lymph-studies)
15004- (Blood-Blood-cell-studies)
16006-
  (Respiratory-system-Pathology)
17504- (Muscle-Physiology-and
  -biochemistry)
17506- (Muscle-Pathology)
18006- (Bones-joints-fasciae
  -connective-and-adipose-tissue-Pathology)
24500- (Gerontology-)
33502-
  (Virology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
38502- (Chemotherapy-General-methods-and-metabolism)
38506-
  (Chemotherapy-Antiviral-agents)
AN: 200510131417
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0003
  -9942&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0003
  -9942&isbn=&volume=62&issue=7&spage=1113&pages=1113
  -1117&date=2005&title=Archives%20of%20Neurology&atitle=Myopathic%20changes%20ass
  ociated%20with%20severe%20acute%20respiratory%20syndrome%20
  -%20A%20postmortem%20case%20series&aulast=Leung&pid=%3Cauthor%3ELeung%2c%20Thoma
  s%20W%3bWong%2c%20Ka%20Sing%3bHui%2c%20Andrew%20C%3bTo%2c%20Ka%20Fai%3bLai%2c%20
  Sik%20To%3bNg%2c%20Wai%20Fu%3bNg%2c%20Ho%20Keung%3C%2Fauthor%3E%3CAN%3E200510131
  417%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 182 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Virus emergents ou menaces a repetition
Emergent viruses and/or repeated
  threats
AU: Lina,-B [Author,-Reprint-Author]
AD: Lab Virol Lyon Est, CNR Enterovirus, UMR 5537, CNRS, Domaine Rockefeller, F
  -69373 Lyon 08, France
EMA: lina@univ-lyon1.fr
SO: Antibiotiques-. 2005; 7(2): 106-110
PY: 2005
DT: Article
IS: 1294-5501
LA: French
AB: Emergent viruses have attracted attention during years 2003 and 2004.
  Ancient fears have reappeared regarding pathogenic agents, capable to result in
  epidemics with high mortality rates. Such events constitute really repeated
  threats. The analysis of mechanisms permitting emergence of these viruses has
  shown that they are not random phenomenons, but they result from accumulated
  factors leading to transmission from animals to men. Several modes of
  transmission of infection include: either direct transmission, or by
  intermediate vectors (mosquitoes, ticks and other (mammals) animals).
  Convergence of ecologic, economic and epidemiologic factors confer to the
  epidemics potential ability do spread widely. With the development of
  surveillance networks and improvement in diagnostic technologies, these "new"
  viruses are better identified. Recent occurrence of SARS and of the avian
  influenza are best examples of such experiences.
AI: Y
MC: Epidemiology-: Population-Studies; Vector-Biology; Infection-; Virology-
ST: -[75403-] Acarina-, -Chelicerata, Arthropoda-, Invertebrata-, Animalia-; 
  -[33000-] Animalia-, -Animalia; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-; -[75314-] Diptera-, -Insecta, Arthropoda-,
  Invertebrata-, Animalia-; -[86215-] Hominidae-, -Primates, Mammalia-,
  Vertebrata-, Chordata-, Animalia-; -[85700-] Mammalia-, -Vertebrata, Chordata-,
  Animalia-; -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA-Viruses, Viruses
  -, Microorganisms-; -[03000-] Viruses-, -Microorganisms
OR: tick- (Acarina-): common-, disease-vector; animal- (Animalia-): common-,
  host-; Severe-acute-respiratory-syndrome-virus (Coronaviridae-): species-,
  pathogen-; mosquito- (Diptera-): common-, disease-vector; human- (Hominidae-):
  common-, host-; mammal- (Mammalia-): common-, disease-vector; Avian-influenza
  -virus (Orthomyxoviridae-): species-, pathogen-; Viruses- (Viruses-):
  higher_taxa-, pathogen-
TN: Acarina-: Animals-, Arthropods-, Chelicerates-, Invertebrates-; Animalia-:
  Animals-; Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA
  -Viruses, Viruses-; Diptera-: Animals-, Arthropods-, Insects-, Invertebrates-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-;
  Mammalia-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Vertebrates-; Orthomyxoviridae-: Microorganisms-, Negative-Sense
  -Single-Stranded-RNA-Viruses, Viruses-; Viruses-: Microorganisms-, Viruses-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; viral-infection: (Virus
  -Diseases-(MeSH)), viral-disease, transmission-; avian-influenza-infection:
  (Influenza-(MeSH)), viral-disease
MI: epidemic-; epidemiologic-factors; economic-factors; repeated-threats;
  ecologic-factors; viral-emergence; surveillance-network
CC: 16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37052- (Public
  -health-epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
37057- (Public-health-disease-vectors-General)
64060-
  (Invertebrata-comparative-experimental-morphology-physiology-and-pathology
  -Arthropoda-chelicerata)
64076- (Invertebrata-comparative-experimental
  -morphology-physiology-and-pathology-Insecta-physiology)
AN: 200510131253
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1294
  -5501&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1294
  -5501&isbn=&volume=7&issue=2&spage=106&pages=106
  -110&date=2005&title=Antibiotiques%20&atitle=Virus%20emergents%20ou%20menaces%20
  a%20repetition&aulast=Lina&pid=%3Cauthor%3ELina%2c%20B%3C%2Fauthor%3E%3CAN%3E200
  510131253%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 183 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: The future of infectious diseases
AU: Geddes,-A [Author,-Reprint-Author]
AD: Univ Birmingham, Sch Med, Birmingham, W Midlands, UK
EMA: A.M.Geddes@bham.ac.uk
SO: Antibiotiques-. 2005; 7(2): 75-76
PY: 2005
DT: Editorial; Article
IS: 1294-5501
LA: English
MC: Infection-
ST: -[85500-] Aves-, -Vertebrata, Chordata-, Animalia-; -[86145-] Equidae-, 
  -Perissodactyla, Mammalia-, Vertebrata-, Chordata-, Animalia-; -[07700-] Gram
  -Positive-Cocci, -Eubacteria, Bacteria-, Microorganisms-; -[07702-]
  Micrococcaceae-, -Gram-Positive-Cocci, Eubacteria-, Bacteria-, Microorganisms-;
  -[08881-] Mycobacteriaceae-, -Mycobacteria, Actinomycetes-and-Related
  -Organisms, Eubacteria-, Bacteria-, Microorganisms-; -[03503-] Paramyxoviridae
  -, -Negative-Sense-ssRNA-Viruses, Viruses-, Microorganisms-; -[85740-] Suidae-,
  -Artiodactyla, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: poultry- (Aves-): common-; horse- (Equidae-): common-; Streptococcus
  -pyogenes (Gram-Positive-Cocci): species-; Streptococcus-pneumoniae (Gram
  -Positive-Cocci): species-; Staphylococcus-aureus (Micrococcaceae-): species-,
  MRSA-, common-, methicillin-resistant; Mycobacterium-tuberculosis
  (Mycobacteriaceae-): species-; Nipah-virus (Paramyxoviridae-): species-; Hendra
  -respiratory-virus (Paramyxoviridae-): common-, Hendravirus-, species-; pig-
  (Suidae-): common-
TN: Aves-: Animals-, Birds-, Chordates-, Nonhuman-Vertebrates, Vertebrates-;
  Equidae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Perissodactyls-, Vertebrates-; Gram-Positive-Cocci: Bacteria-,
  Eubacteria-, Microorganisms-; Micrococcaceae-: Bacteria-, Eubacteria-,
  Microorganisms-; Mycobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-;
  Paramyxoviridae-: Microorganisms-, Negative-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Suidae-: Animals-, Artiodactyls-, Chordates-, Mammals-, Nonhuman
  -Vertebrates, Nonhuman-Mammals, Vertebrates-
CB: benzylpenicillin-: 61-33-6, antibacterial-drug, antiinfective-drug;
  antibiotic-: antibacterial-drug, antiinfective-drug; vaccine-: antiinfective
  -drug
DS: malaria-: (Malaria-(MeSH)), blood-and-lymphatic-disease, parasitic-disease;
  severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; zoonosis-: infectious
  -disease; anthrax-: (Anthrax-(MeSH)), bacterial-disease; avian-influenza:
  (Influenza-(MeSH)), respiratory-system-disease, viral-disease; leishmaniasis-:
  (Leishmaniasis-(MeSH)), integumentary-system-disease, parasitic-disease;
  bacillary-dysentery: (Dysentery-, Bacillary-(MeSH)), digestive-system-disease,
  bacterial-disease; plague-: (Plague-(MeSH)), bacterial-disease; typhoid-fever:
  (Typhoid-Fever-(MeSH)), bacterial-disease; smallpox-: (Smallpox-(MeSH)), viral
  -disease; botulism-: (Botulism-(MeSH)), bacterial-disease, toxicity-; new
  -variant-Creutzfeld-Jacob-disease: nervous-system-disease, prion-disease,
  behavioral-and-mental-disorders
RN: 61-33-6
MI: global-warming; bioterrorism-; microbial-resistance; hospital-acquired
  -infection; xenotransplantation-
CC: 12512- (Pathology-Therapy)
14006- (Digestive-system-Pathology)
15006-
  (Blood-Blood-lymphatic-and-reticuloendothelial-pathologies)
16006-
  (Respiratory-system-Pathology)
18506- (Integumentary-system-Pathology)
20506-
  (Nervous-system-Pathology)
22501- (Toxicology-General-and-methods)
22504-
  (Toxicology-Pharmacology)
31000- (Physiology-and-biochemistry-of
  -bacteria)
33502- (Virology-General-and-methods)
36001- (Medical-and-clinical
  -microbiology-General-and-methods)
36002- (Medical-and-clinical-microbiology
  -Bacteriology)
36006- (Medical-and-clinical-microbiology-Virology)
38502-
  (Chemotherapy-General-methods-and-metabolism)
38504- (Chemotherapy
  -Antibacterial-agents)
60502- (Parasitology-General)
AN: 200510131248
UD: 20050907
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1294
  -5501&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1294
  -5501&isbn=&volume=7&issue=2&spage=75&pages=75
  -76&date=2005&title=Antibiotiques%20&atitle=The%20future%20of%20infectious%20dis
  eases&aulast=Geddes&pid=%3Cauthor%3EGeddes%2c%20A%3C%2Fauthor%3E%3CAN%3E20051013
  1248%3C%2FAN%3E%3CDT%3EEditorial%3bArticle%3C%2FDT%3E

Record 184 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Protecting human and ecological health under viral threats in Asia
AU: Matsui,-S [Author,-Reprint-Author]
AD: Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto, Japan
EMA: matsui@eden.env.kyoto-u.ac.jp
SO: Water-Science-and-Technology. 2005; 51(8): 91-97
PY: 2005
DT: Article
IS: 0273-1223
LA: English
AB: Severe acute respiratory syndrome (SARS) outbroke in 2003, and the avian
  influenza A (H5N1) also outbroke in 2003 and continued to 2004. These pandemic
  viral diseases originated in South East Asia. Many human and animal lives were
  lost. Economic damages due to the pandemics were also very large. The question
  arises of why did the pandemics originate from South East Asian areas. Human
  influenza A consists of many sub-types of coronaviruses including the SARS
  virus and the avian influenza (H5N1) that are all variants of RNA of avian
  coronavirus. Variants are formed during infection of a coronavirus through not
  only birds but also mammals, including human beings. There are hot spots where
  viral infection rates are accelerated among birds, mammals and human beings.
  Suspicious areas are in South East Asia, where living conditions of birds,
  mammals and human beings are so close that there are always risks of viral
  infection. When we see the living conditions of farmers in southern China,
  northern Vietnam, Laos and northern Myanmar, they commonly raise ducks/chickens
  with pigs sharing ponds into which they discharge household wastewater,
  including human excreta, and pig excreta that are significant carriers of
  viruses. Bird faeces are also key carriers of the viruses. In the ponds, they
  raise ducks and conduct fish culture. Other important players ate migrating
  birds from North Asia, which are principal vectors of avian influenza viruses.
  There is an urgent necessity of improving human and ecological health in South
  East Asia to control viral infection among birds, mammals and human beings. We
  can hinder the vicious cycle of virus infection through water contamination in
  ponds by providing good human, pig and chicken sanitation. It is easy to
  provide good sanitation practices for human, pigs and chickens, introducing
  collection and treatment of excreta. Our modern water technology can find good
  solutions for the problem.
AI: Y
MC: Infection-; Public-Health: Allied-Medical-Sciences; Waste-Management:
  Sanitation-
ST: -[85504-] Anseriformes-, -Aves, Vertebrata-, Chordata-, Animalia-; -[85500-]
  Aves-, -Vertebrata, Chordata-, Animalia-; -[03613-] Coronaviridae-, -Positive
  -Sense-ssRNA-Viruses, Viruses-, Microorganisms-; -[85536-] Galliformes-, -Aves,
  Vertebrata-, Chordata-, Animalia-; -[86215-] Hominidae-, -Primates, Mammalia-,
  Vertebrata-, Chordata-, Animalia-; -[85700-] Mammalia-, -Vertebrata, Chordata-,
  Animalia-; -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA-Viruses, Viruses
  -, Microorganisms-; -[85740-] Suidae-, -Artiodactyla, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: duck- (Anseriformes-): common-, host-; bird- (Aves-): common-, host-;
  Coronavirus- (Coronaviridae-): genus-; chicken- (Galliformes-): common-, host-;
  human- (Hominidae-): common-, host-; mammal- (Mammalia-): common-, host-; Avian
  -influenza-A-virus (Orthomyxoviridae-): common-, Influenza-A-virus, species-,
  pathogen-, strain-H5N1; pig- (Suidae-): common-, host-
TN: Anseriformes-: Animals-, Birds-, Chordates-, Nonhuman-Vertebrates,
  Vertebrates-; Aves-: Animals-, Birds-, Chordates-, Nonhuman-Vertebrates,
  Vertebrates-; Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded
  -RNA-Viruses, Viruses-; Galliformes-: Animals-, Birds-, Chordates-, Nonhuman
  -Vertebrates, Vertebrates-; Hominidae-: Animals-, Chordates-, Humans-, Mammals
  -, Primates-, Vertebrates-; Mammalia-: Animals-, Chordates-, Mammals-, Nonhuman
  -Vertebrates, Nonhuman-Mammals, Vertebrates-; Orthomyxoviridae-: Microorganisms
  -, Negative-Sense-Single-Stranded-RNA-Viruses, Viruses-; Suidae-: Animals-,
  Artiodactyls-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman-Mammals,
  Vertebrates-
PS: feces-: digestive-system
GE: Myanmar-: Asia-, Oriental-region; China-: Asia-, Palearctic-region; Asia-:
  Oriental-region, Palearctic-region; Vietnam-: Asia-, Oriental-region; Laos-:
  Asia-, Oriental-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; avian-influenza-A
  -infection: viral-disease
MI: excreta-; sanitation-practices; pandemics-
CC: 14004- (Digestive-system-Physiology-and-biochemistry)
16006- (Respiratory
  -system-Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
37001- (Public-health-General-and
  -miscellaneous)
37014- (Public-health-Sewage-disposal-and-sanitary-measures)
AN: 200510130360
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0273
  -1223&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0273
  -1223&isbn=&volume=51&issue=8&spage=91&pages=91
  -97&date=2005&title=Water%20Science%20and%20Technology&atitle=Protecting%20human
  %20and%20ecological%20health%20under%20viral%20threats%20in%20Asia&aulast=Matsui
  &pid=%3Cauthor%3EMatsui%2c%20S%3C%2Fauthor%3E%3CAN%3E200510130360%3C%2FAN%3E%3CD
  T%3EArticle%3C%2FDT%3E

Record 185 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Workshop 3 (synthesis): recycling and water utilities - shared
  characteristics of well performing and CR 'turnaround' utilities and the reform
  of poorly performing utilities
AU: Rahman,-A [Author,-Reprint-Author]; Otterpohl,-R [Author]
AD: 40733 Laguna Pl, Fremont, CA 94539 USA
EMA: ausafrahman@comcast.net; otterpohl@tuhh.de
SO: Water-Science-and-Technology. 2005; 51(8): 81-82
PY: 2005
DT: Article
IS: 0273-1223
LA: English
AB: New approaches and technologies are required to deal with extremely
  unsatisfactory sanitation conditions, which give rise to serious health
  problems. Nutrient loads reaching recipients also pose threats to ecosystems.
AI: Y
MC: Public-Health: Allied-Medical-Sciences; Conservation-; Sanitation-
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
CB: water-: 7732-18-5
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
RN: 7732-18-5
MQ: recycling-: applied-and-field-techniques
MI: sanitation-; reuse-; health-problems
CC: 00512- (General-biology-Conservation-and-resource-management)
10060-
  (Biochemistry-studies-General)
16006- (Respiratory-system-Pathology)
36006-
  (Medical-and-clinical-microbiology-Virology)
37001- (Public-health-General-and
  -miscellaneous)
37014- (Public-health-Sewage-disposal-and-sanitary-measures)
AN: 200510130358
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0273
  -1223&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0273
  -1223&isbn=&volume=51&issue=8&spage=81&pages=81
  -82&date=2005&title=Water%20Science%20and%20Technology&atitle=Workshop%203%20%28
  synthesis%29%3a%20recycling%20and%20water%20utilities%20
  -%20shared%20characteristics%20of%20well%20performing%20and%20CR%20%27turnaround
  %27%20utilities%20and%20the%20reform%20of%20poorly%20performing%20utilities&aula
  st=Rahman&pid=%3Cauthor%3ERahman%2c%20A%3bOtterpohl%2c%20R%3C%2Fauthor%3E%3CAN%3
  E200510130358%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 186 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Purification of severe acute respiratory syndrome hyperimmune globulins for
  intravenous injection from convalescent plasma
AU: Zhang,-Zhan [Author]; Xie,-Yi-Wu [Author]; Hong,-Jiling [Author]; Zhang,-Xin
  [Author]; Kwok,-Sui-Yi [Author]; Huang,-Xiaowu [Author]; Wong,-Sai-Wah
  [Author]; Wong,-Bing-Lou [Author,-Reprint-Author]; SARIg-Grp [Author]
AD: Advantek Biol HK Ltd, 3-F,HKIB,2 Biotechnol Ave,12 Miles,Tai Po Rd, Shatin,
  Hong Kong, Peoples R China
EMA: blwong@advantekAB.com
SO: Transfusion-(Malden). 2005; 45(7): 1160-1164
PY: 2005
DT: Article
IS: 0041-1132
LA: English
AB: BACKGROUND: Severe acute respiratory syndrome (SARS) is a new infectious
  disease caused by the SARS virus. Current first-line treatments are
  experimental, and their effectiveness remains open to question. For more
  effective treatment and prevention of SARS, human SARS hyperimmune globulins
  for intravenous (IV) injection were purified in this study.STUDY DESIGN AND
  METHODS: A combination of cold ethanol precipitation and ion-exchange
  chromatography was used to process pooled SARS convalescent plasma samples.
  Virus inactivation and removal approaches were taken to ensure safety.RESULTS:
  The purified hyperimmune globulins were formulated as a 5 percent solution,
  with an antibody titer specifically against the SARS virus of 1:83, 1:1600, and
  1:200, as determined by enzyme-linked immunosorbent assay, immunofluorescence
  assay, and neutralizing antibody test, respectively. The purity of the SARS
  hyperimmune globulins was 99.0 percent, and the monomer and dimer content was
  100 percent. Other variables analyzed met the Chinese Requirements of Biologics
  for IV immune globulin. The SARS hyperimmune globulins prepared were
  subsequently approved for clinical evaluation by the Chinese National Institute
  for the Control of Pharmaceutical & Biological Products.CONCLUSION: IV
  -injectable, purified, and concentrated human SARS hyperimmune globulins were
  prepared from pooled convalescent plasma samples, which are ready to be further
  evaluated.
AI: Y
MC: Pharmacology-; Infection-; Hematology-: Human-Medicine, Medical-Sciences;
  Immune-System: Chemical-Coordination-and-Homeostasis; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: plasma-: blood-and-lymphatics
CB: hyperimmune-globulins: antiinfective-drug, antiviral-drug, intravenous
  -administration
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease, drug-therapy, immunology-, prevention-and-control
MQ: immunofluorescence-assay: laboratory-techniques, immunologic-techniques; ion
  -exchange-chromatography: laboratory-techniques, chromatographic-techniques;
  enzyme-linked-immunosorbent-assay: laboratory-techniques, immunologic
  -techniques; cold-ethanol-precipitation: laboratory-techniques; neutralizing
  -antibody-test: laboratory-techniques, immunologic-techniques
MI: virus-inactivation
CC: 12512- (Pathology-Therapy)
15002- (Blood-Blood-and-lymph-studies)
15004-
  (Blood-Blood-cell-studies)
15006- (Blood-Blood-lymphatic-and
  -reticuloendothelial-pathologies)
16006- (Respiratory-system-Pathology)
22002
  - (Pharmacology-General)
22005- (Pharmacology-Clinical-pharmacology)
33502-
  (Virology-General-and-methods)
34502- (Immunology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
38502- (Chemotherapy-General
  -methods-and-metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510130135
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0041
  -1132&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0041
  -1132&isbn=&volume=45&issue=7&spage=1160&pages=1160
  -1164&date=2005&title=Transfusion%20%28Malden%29&atitle=Purification%20of%20seve
  re%20acute%20respiratory%20syndrome%20hyperimmune%20globulins%20for%20intravenou
  s%20injection%20from%20convalescent%20plasma&aulast=Zhang&pid=%3Cauthor%3EZhang%
  2c%20Zhan%3bXie%2c%20Yi%20Wu%3bHong%2c%20Jiling%3bZhang%2c%20Xin%3bKwok%2c%20Sui
  %20Yi%3bHuang%2c%20Xiaowu%3bWong%2c%20Sai%20Wah%3bWong%2c%20Bing%20Lou%3bSARIg%2
  0Grp%3C%2Fauthor%3E%3CAN%3E200510130135%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 187 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Human coronavirus NL63 employs the severe acute respiratory syndrome
  coronavirus receptor for cellular entry
AU: Hofmann,-Heike [Author]; Pyrc,-Krzysztof [Author]; van-der-Hoek,-Lia
  [Author]; Geier,-Martina [Author]; Berkhout,-Ben [Author]; Poehlmann,-Stefan
  [Author,-Reprint-Author]
AD: Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Gluckstr 6, D-91054 Erlangen,
  Germany
EMA: snpoehlm@viro.med.uni-erlangen.de
SO: Proceedings-of-the-National-Academy-of-Sciences-of-the-United-States-of
  -America. 2005; 102(22): 7988-7993
PY: 2005
DT: Article
IS: 0027-8424
LA: English
AB: Coronavirus (CoV) infection of humans is usually not associated with severe
  disease. However, discovery of the severe acute respiratory syndrome (SARS) CoV
  revealed that highly pathogenic human CoVs (HCoVs) can evolve. The
  identification and characterization of new HCoVs is, therefore, an important
  task. Recently, a HCoV termed NL63 was discovered in patients with respiratory
  tract illness. Here, cell tropism and receptor usage of HCoV-NL63 were
  analyzed. The NL63 spike (S) protein mediated infection of different target
  cells compared with the closely related 229E-S protein but facilitated entry
  into cells known to be permissive to SARS-CoV-S-driven infection. An analysis
  of receptor engagement revealed that NL63-S binds angiotensin-converting enzyme
  (ACE) 2, the receptor for SARS-CoV, and HCoV-NL63 uses ACE2 as a receptor for
  infection of target cells. Potent neutralizing activity directed against NL63-
  but not 229E-S protein was detected in virtually all sera from patients 8 years
  of age or older, suggesting that HCoV-NL63 infection of humans is common and
  usually acquired during childhood. Here, we show that SARS-CoV shares its
  receptor ACE2 with HCoV-NL63. Because the two viruses differ dramatically in
  their ability to induce disease, analysis of HCoV-NL63 might unravel
  pathogenicity factors in SARS-CoV. The frequent HCoV-NL63 infection of humans
  suggests that highly pathogenic variants have ample opportunity to evolve,
  underlining the need for vaccines against HCoVs.
AI: Y
MC: Infection-; Biochemistry-and-Molecular-Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Coronavirus- (Coronaviridae-): genus-; Severe-Acute-Respiratory-Syndrome
  -virus (Coronaviridae-): common-, SARS-virus, common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: vaccines-; spike-protein; ACE2-protein: angiotensin-converting-enzyme-2;
  229E-S-protein; severe-acute-respiratory-syndrome-coronavirus-receptor: SARS
  -CoV-receptor
DS: HCoV-NL63-infection: Human-coronavirus-NL63-infection, viral-disease
MI: cellular-entry
CC: 10060- (Biochemistry-studies-General)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510129132
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0027
  -8424&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0027
  -8424&isbn=&volume=102&issue=22&spage=7988&pages=7988
  -7993&date=2005&title=Proceedings%20of%20the%20National%20Academy%20of%20Science
  s%20of%20the%20United%20States%20of%20America&atitle=Human%20coronavirus%20NL63%
  20employs%20the%20severe%20acute%20respiratory%20syndrome%20coronavirus%20recept
  or%20for%20cellular%20entry&aulast=Hofmann&pid=%3Cauthor%3EHofmann%2c%20Heike%3b
  Pyrc%2c%20Krzysztof%3bvan%20der%20Hoek%2c%20Lia%3bGeier%2c%20Martina%3bBerkhout%
  2c%20Ben%3bPoehlmann%2c%20Stefan%3C%2Fauthor%3E%3CAN%3E200510129132%3C%2FAN%3E%3
  CDT%3EArticle%3C%2FDT%3E

Record 188 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: New approaches to quantifying the spread of infection
AU: Matthews,-Louise [Author,-Reprint-Author]; Woolhouse,-Mark [Author]
AD: Univ Edinburgh, Easter Bush Vet Ctr, Ctr Trop Vet Med, Vet Epidemiol Grp,
  Roslin EH25 9RG, Midlothian, UK
EMA: Louise.Matthews@ed.ac.uk
SO: Nature-Reviews-Microbiology. 2005; 3(7): 529-536
PY: 2005
DT: Literature-Review; Article
IS: 1740-1526
LA: English
AB: Recent major disease outbreaks, such as severe acute respiratory syndrome
  and foot-and-mouth disease in the UK, coupled with fears of emergence of human
  -to-human transmissible variants of avian influenza, have highlighted the
  importance of accurate quantification of disease threat when relatively few
  cases have occurred. Traditional approaches to mathematical modelling of
  infectious diseases deal most effectively with large outbreaks in large
  populations. The desire to elucidate the highly variable dynamics of disease
  spread amongst small numbers of individuals has fuelled the development of
  models that depend more directly on surveillance and contact-tracing data. This
  signals a move towards a closer interplay between epidemiological modelling,
  surveillance and disease-management strategies.
AI: Y
MC: Infection-; Methods-and-Techniques; Epidemiology-: Population-Studies
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-; -[03603-] Picornaviridae-, -Positive-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; Avian-influenza-virus (Orthomyxoviridae-): common-, pathogen-; Foot-and
  -mouth-disease-virus (Picornaviridae-): species-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Orthomyxoviridae-: Microorganisms-, Negative-Sense-Single-Stranded
  -RNA-Viruses, Viruses-; Picornaviridae-: Microorganisms-, Positive-Sense-Single
  -Stranded-RNA-Viruses, Viruses-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-; foot-and
  -mouth-disease: (Foot-and-Mouth-Disease-(MeSH)), viral-disease, epidemiology-
MQ: mathematical-modeling: mathematical-and-computer-techniques
CC: 16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37052- (Public
  -health-epidemiology-Communicable-diseases)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510128129
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1740
  -1526&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1740
  -1526&isbn=&volume=3&issue=7&spage=529&pages=529
  -536&date=2005&title=Nature%20Reviews%20Microbiology&atitle=New%20approaches%20t
  o%20quantifying%20the%20spread%20of%20infection&aulast=Matthews&pid=%3Cauthor%3E
  Matthews%2c%20Louise%3bWoolhouse%2c%20Mark%3C%2Fauthor%3E%3CAN%3E200510128129%3C
  %2FAN%3E%3CDT%3ELiterature%20Review%3bArticle%3C%2FDT%3E

Record 189 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Forecasting versus projection models in epidemiology: The case of the SARS
  epidemics
AU: Massad,-Eduardo [Author,-Reprint-Author]; Burattini,-Marcelo-N [Author];
  Lopez,-Luis-F [Author]; Coutinho,-Francisco-A-B [Author]
AD: Univ Sao Paulo, Sch Med, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil
EMA: edmassad@usp.br
SO: Medical-Hypotheses. 2005; 65(1): 17-22
PY: 2005
DT: Article
IS: 0306-9877
LA: English
AB: In this work we propose a simple mathematical model for the analysis of the
  impact of control measures against an emerging infection, namely, the severe
  acute respiratory syndrome (SARS). The model provides a testable hypothesis by
  considering a dynamical equation for the contact parameter, which drops
  exponentially with time, simulating control measures. We discuss the role of
  modelling in public health and we analyse the distinction between forecasting
  and projection models as assessing toots for the estimation of the impact of
  intervention strategies. The model is applied to the communities of Hong Kong
  and Toronto (Canada) and it mimics those epidemics with fairly good accuracy.
  The estimated values for the basic reproduction number, R-0, were 1.2 for Hong
  Kong and 1.32 for Toronto (Canada). The model projects that, in the absence of
  control, the final number of cases would be 320,000 in Hong Kong and 36,900 in
  Toronto (Canada). In contrast, with control measures, which reduce the contact
  rate to about 25 % of its initial value, the expected final number of cases is
  reduced to 1778 in Hong Kong and 226 in Toronto (Canada). Although SARS can be
  a devastating infection, early recognition, prompt isolation, and appropriate
  precaution measures, can be very effective to Limit its spread. (c) 2005
  Elsevier Ltd. ALL rights reserved.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies; Respiratory-System:
  Respiration-; Models-and-Simulations: Computational-Biology
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
GE: Hong-Kong: Asia-, Palearctic-region; Toronto-: Ontario-, Canada-, North
  -America, Nearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-, etiology-
MQ: projection-model: applied-and-field-techniques; forecasting-: mathematical
  -and-computer-techniques
CC: 04500- (Mathematical-biology-and-statistical-methods)
10515- (Biophysics
  -Biocybernetics)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
33502- (Virology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
37052-
  (Public-health-epidemiology-Communicable-diseases)
37054- (Public-health
  -epidemiology-Organic-diseases-and-neoplasms)
37056- (Public-health
  -epidemiology-Miscellaneous)
AN: 200510127599
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0306
  -9877&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0306
  -9877&isbn=&volume=65&issue=1&spage=17&pages=17
  -22&date=2005&title=Medical%20Hypotheses&atitle=Forecasting%20versus%20projectio
  n%20models%20in%20epidemiology%3a%20The%20case%20of%20the%20SARS%20epidemics&aul
  ast=Massad&pid=%3Cauthor%3EMassad%2c%20Eduardo%3bBurattini%2c%20Marcelo%20N%3bLo
  pez%2c%20Luis%20F%3bCoutinho%2c%20Francisco%20A%20B%3C%2Fauthor%3E%3CAN%3E200510
  127599%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 190 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Cytokine responses in severe acute respiratory syndrome coronavirus-infected
  macrophages in vitro: possible relevance to pathogenesis
AU: Cheung,-Chung-Y [Author]; Poon,-Leo-L-M [Author]; Ng,-Iris-H-Y [Author];
  Luk,-Winsie [Author]; Sia,-Sin-Fun [Author]; Wu,-Mavis-H-S [Author]; Chan,-Kwok
  -Hung [Author]; Yuen,-Kwok-Yung [Author]; Gordon,-Siamon [Author]; Guan,-Yi
  [Author]; Peiris,-Joseph-S-M [Author,-Reprint-Author]
AD: Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Univ Pathol Bldg,Pokfulam
  Rd, Hong Kong, Hong Kong, Peoples R China
EMA: malik@hkucc.hku.hk
SO: Journal-of-Virology. 2005; 79(12): 7819-7826
PY: 2005
DT: Article
IS: 0022-538X
LA: English
AB: The pathogenesis of severe acute respiratory syndrome (SARS) remains
  unclear. Macrophages are key sentinel cells in the respiratory system, and it
  is therefore relevant to compare the responses of human macrophages to
  infections with the SARS coronavirus (SARS-CoV) and other respiratory viruses.
  Primary human monocyte-derived macrophages were infected with SARS-CoV in
  vitro. Virus replication was monitored by measuring the levels of positive- and
  negative-strand RNA, by immunofluorescence detection of the SARS-CoV
  nucleoprotein, and by titration of the infectious virus. The gene expression
  profiles of macrophages infected with SARS-CoV, human coronavirus 229E, and
  influenza A (H1N1) virus were compared by using microarrays and real-time
  quantitative reverse transcriptase PCR. Secreted cytokines were measured with
  an enzyme-linked immunosorbent assay. SARS-CoV initiated viral gene
  transcription and protein synthesis in macrophages, but replication was
  abortive and no infectious virus was produced. In contrast to the case with
  human coronavirus 229E and influenza A virus, there was little or no induction
  of beta interferon (IFN-beta) in SARS-CoV-infected macrophages. Furthermore,
  SARS-CoV induced the expression of chemokines such as CXCL10/IFN-gamma
  -inducible protein 10 and CCL2/monocyte chemotactic protein 1. The poor
  induction of IFN-beta, a key component of innate immunity, and the ability of
  the virus to induce chemokines could explain aspects of the pathogenesis of
  SARS.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Immune-System: Chemical
  -Coordination-and-Homeostasis
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-coronavirus (Coronaviridae-): genus-, pathogen-; human- (Hominidae-):
  common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: respiratory-system: respiratory-system; macrophage-: immune-system, blood
  -and-lymphatics, monocyte-derived
CB: cytokine-; beta-interferon; nucleoprotein-; RNA-: negative-strand, positive
  -strand; chemokines-: expression-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: gene-expression-microarray: laboratory-techniques, genetic-techniques;
  immunofluorescence-: laboratory-techniques, immunologic-techniques; enzyme
  -linked-immunosorbent-assay: laboratory-techniques, immunologic-techniques;
  real-time-quantitative-reverse-transcriptase-polymerase-chain-reaction:
  laboratory-techniques, genetic-techniques
MI: pathogenesis-; protein-synthesis; viral-gene-transcription
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10060- (Biochemistry
  -studies-General)
10062- (Biochemistry-studies-Nucleic-acids-purines-and
  -pyrimidines)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
17002- (Endocrine-General)
33502- (Virology
  -General-and-methods)
34502- (Immunology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
AN: 200510127145
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -538X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -538X&isbn=&volume=79&issue=12&spage=7819&pages=7819
  -7826&date=2005&title=Journal%20of%20Virology&atitle=Cytokine%20responses%20in%2
  0severe%20acute%20respiratory%20syndrome%20coronavirus
  -infected%20macrophages%20in%20vitro%3a%20possible%20relevance%20to%20pathogenes
  is&aulast=Cheung&pid=%3Cauthor%3ECheung%2c%20Chung%20Y%3bPoon%2c%20Leo%20L%20M%3
  bNg%2c%20Iris%20H%20Y%3bLuk%2c%20Winsie%3bSia%2c%20Sin%20Fun%3bWu%2c%20Mavis%20H
  %20S%3bChan%2c%20Kwok%20Hung%3bYuen%2c%20Kwok%20Yung%3bGordon%2c%20Siamon%3bGuan
  %2c%20Yi%3bPeiris%2c%20Joseph%20S%20M%3C%2Fauthor%3E%3CAN%3E200510127145%3C%2FAN
  %3E%3CDT%3EArticle%3C%2FDT%3E

Record 191 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Characterization of monoclonal antibody against SARS coronavirus
  nucleocapsid antigen and development of an antigen capture ELISA
AU: He,-Qigai [Author]; Du,-Qingyun [Author]; Lau,-Suelyn [Author]; Manopo,
  -Ivanus [Author]; Lu,-Liqun [Author]; Chan,-Shzu-Wei [Author]; Fenner,-Beau-J
  [Author]; Kwang,-Jimmy [Author,-Reprint-Author]
AD: Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore 117604,
  Singapore
EMA: kwang@tll.org.sg
SO: Journal-of-Virological-Methods. 2005; 127(1): 46-53
PY: 2005
DT: Article
IS: 0166-0934
LA: English
AB: This report describes the production of several MAbs against N195 protein, a
  major immunodomain of SARS CoV nucleocapsid protein [He, Q., Chong, K.H.,
  Chang, H.H., Leung, B., Ling, A.E., Wei, T., Chan, S.W., Ooi, E.E., Kwang, J.,
  2004. Development of a Western blot assay for detection of antibodies against
  coronavirus causing severe acute respiratory syndrome. Clin. Diagn. Lab.
  Immunol. 11 (2) 417-422.]. One representative IgG1 monoclonal antibody (MAb), S
  -A5D5, was selected and characterized. S-A5D5 reacted specifically react with
  both recombinant and native nucleocapsid protein of SARS CoV The reactivity of
  S-A5D5 with purified N195 protein and utilization of the MAb as a detector
  antibody to develop an antigen capture ELISA was assessed. As little as 37.5 pg
  of purified N protein and 50 TCID50 of SARS CoV could be detected by the
  antigen capture ELISA. Specific binding of the MAb S-A5D5 to both purified N195
  and SARS CoV nucleocapsid antigen was effectively inhibited by human SARS
  positive serum and guinea pig anti-N195 serum. The N protein in N195-spike
  recombinant baculovirus-infected Sf-9 cells could also be identified. N protein
  was detected in 18 IEA IgM-positive serum samples collected from SARS confirmed
  patients, but not in nine samples collected from SARS recovery patient. No
  false positive results were given when 60 samples from healthy individuals were
  tested, and no cross-reaction occurred when infectious bronchitis virus (IBV),
  chicken coronavirus, was tested. This monoclonal antibody-based antigen capture
  ELISA is thus a powerful tool for early diagnosis of SARS CoV infection. (c)
  2005 Elsevier B.V. All rights reserved.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Methods-and-Techniques
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[75330-] Lepidoptera-, -Insecta, Arthropoda-,
  Invertebrata-, Animalia-
OR: Coronavirus- (Coronaviridae-): genus-, pathogen-; SARS-virus (Coronaviridae
  -): common-, Severe-Acute-Respiratory-Syndrome-virus, common-, pathogen-;
  Infectious-bronchitis-virus (Coronaviridae-): species-, IBV-, common-, pathogen
  -; human- (Hominidae-): common-, host-; Sf-9-cell-line (Lepidoptera-):
  cell_line-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Lepidoptera-: Animals-, Arthropods-, Insects-, Invertebrates-
PS: serum-: blood-and-lymphatics
CB: monoclonal-antibody; nucleocapsid-antigen; N195-protein; IgG1-monoclonal
  -antibody; S-A5D5
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; coronavirus-infection:
  viral-disease; infectious-bronchitis-virus-disease: viral-disease
MQ: ELISA-: laboratory-techniques, immunologic-techniques; Western-blot:
  electrophoretic-techniques, immunologic-techniques, laboratory-techniques
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10060- (Biochemistry
  -studies-General)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
64076- (Invertebrata-comparative-experimental
  -morphology-physiology-and-pathology-Insecta-physiology)
AN: 200510127084
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0166
  -0934&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0166
  -0934&isbn=&volume=127&issue=1&spage=46&pages=46
  -53&date=2005&title=Journal%20of%20Virological%20Methods&atitle=Characterization
  %20of%20monoclonal%20antibody%20against%20SARS%20coronavirus%20nucleocapsid%20an
  tigen%20and%20development%20of%20an%20antigen%20capture%20ELISA&aulast=He&pid=%3
  Cauthor%3EHe%2c%20Qigai%3bDu%2c%20Qingyun%3bLau%2c%20Suelyn%3bManopo%2c%20Ivanus
  %3bLu%2c%20Liqun%3bChan%2c%20Shzu%20Wei%3bFenner%2c%20Beau%20J%3bKwang%2c%20Jimm
  y%3C%2Fauthor%3E%3CAN%3E200510127084%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 192 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Immunohistochemical study of severeacute respiratory syndrome-associated
  coronavirus in tissue sections of patients
AU: Hsiao,-Cheng-Hsiang [Author,-Reprint-Author]; Chang,-Ming-Fu [Author];
  Hsueh,-Po-Ren [Author]; Su,-Ih-Jen [Author]
AD: Natl Taiwan Univ Hosp, Dept Pathol, 7,Chung Shan S Rd, Taipei 100, Taiwan
SO: Journal-of-the-Formosan-Medical-Association. 2005; 104(3): 150-156
PY: 2005
DT: Article
IS: 0929-6646
LA: English
AB: Background and Purpose: Severe acute respiratory syndrome (SARS) is a life
  -threatening and highly contagious disease caused by the novel SARS coronavirus
  (SARS-CoV). Immunohistochemical staining for SARS-CoV in the tissue sections of
  SARS patients is helpful in investigations of the biologic behavior of this
  virus in human tissue, and to determine the tar-et cells of this virus in
  different organs.Methods: We studied the pathologic specimens from 6 SARS
  patients by immunohistochemical staining using a specific antibody against SARS
  -CoV.Results: Positive viral staining was only found in the lung tissue taken
  from the patients who died in the early stage of the disease, usually less than
  10 days after symptom onset. No positive staining was found in the lung tissue
  specimens collected in the mid-to-late stage of the disease. The SARS-CoV
  -infected cells had a patchy distribution and tended to be present in the
  periphery of the lung. Immunohistochemically, these viral-infected cells were
  located mainly along the alveolar space, had a cuboidal appearance, and were
  reactive to cytokeratin and surfactant protein C. This suggested that type 11
  pneumocytes are the main target cell of SARS-CoV in the lung. Occasional intra
  -alveolar macrophages were also weakly reactive to SARS-CoV antibody. In
  addition to the lung, positive viral staining was also found in the mucosal
  epithelium of the large intestine in another patient who had the clinical
  symptom of diarrhea. No evidence of viral staining was found in other organs
  including kidney, liver, lymph node and spleen. The skeletal muscle specimens
  of 2 patients who had rhabdomyolysis were also negative for SARS
  -CoVConclusions: SARS-CoV is mainly present in the cytoplasm of type 11
  pneumocytes and can only be detected in the lung tissue during the early stage
  of the disease. In the patient who had symptoms of diarrhea, SARS-CoV staining
  was also identified in the mucosal epithelium of the colon.
AI: Y
MC: Methods-and-Techniques; Infection-; Pulmonary-Medicine: Human-Medicine,
  Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, adult-, aged-, middle-age, host-, female-,
  male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: liver-: digestive-system; colon-: digestive-system; lung-: respiratory
  -system; spleen-: immune-system, blood-and-lymphatics; kidney-: excretory
  -system; lymph-node: immune-system, blood-and-lymphatics; skeletal-muscle:
  muscular-system
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, etiology-, symptom-,
  diagnosis-
MQ: immunohistochemical-staining: laboratory-techniques, histology-and-cytology
  -techniques, immunologic-techniques
CC: 12504- (Pathology-Diagnostic)
14004- (Digestive-system-Physiology-and
  -biochemistry)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood
  -cell-studies)
15504- (Urinary-system-Physiology-and-biochemistry)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
17504- (Muscle-Physiology-and-biochemistry)
24500- (Gerontology
  -)
33502- (Virology-General-and-methods)
34502- (Immunology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510126877
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0929
  -6646&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0929
  -6646&isbn=&volume=104&issue=3&spage=150&pages=150
  -156&date=2005&title=Journal%20of%20the%20Formosan%20Medical%20Association&atitl
  e=Immunohistochemical%20study%20of%20severeacute%20respiratory%20syndrome
  -associated%20coronavirus%20in%20tissue%20sections%20of%20patients&aulast=Hsiao&
  pid=%3Cauthor%3EHsiao%2c%20Cheng%20Hsiang%3bChang%2c%20Ming%20Fu%3bHsueh%2c%20Po
  %20Ren%3bSu%2c%20Ih%20Jen%3C%2Fauthor%3E%3CAN%3E200510126877%3C%2FAN%3E%3CDT%3EA
  rticle%3C%2FDT%3E

Record 193 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Structure-activity relationship studies of benzoxazinones and related
  compounds. Phytotoxicity on Echinochloa crus-galli (L.) p. Beauv.
AU: Macias,-Francisco-A [Author,-Reprint-Author]; Chinchilla,-Nuria [Author];
  Varela,-Rosa-M [Author]; Oliveros-Bastidas,-Alberto [Author]; Marin,-David
  [Author]; Molinillo,-Jose-M-G [Author]
AD: CO Republ Saharaui SN, Fac Ciencias, Grp Alelopatia, Dept Quim Organ,Univ
  Cadiz, Cadiz 11510, Spain
EMA: famacias@uca.es
SO: Journal-of-Agricultural-and-Food-Chemistry. 2005; 53(11): 4373-4380
PY: 2005
DT: Article
IS: 0021-8561
LA: English
AB: Echinochloa crus-galli (E. crus-galli, barnyardgrass) is a weed widely
  distributed. It constitutes a serious weed problem in 42 countries and has been
  found in at least 27 more. It is the world's main weed of rice affecting up to
  36 crops worldwide. Several biotypes of this plant, with resistance to
  herbicides with different modes of action have evolved. In our ongoing studies
  regarding the potential application of benzoxazinones and their soil
  degradation products for weed control, a complete structure-activity
  relationships (SARs) study was made by using barnyardgrass as the target plant.
  Compounds used in this study were previously tested on a wide variety of
  standard target species (STS), and they include natural allelochemicals 2-O
  -beta-D-glucopyranosyl-4-hydroxy-(2H)-1,4-benzoxazin-3(4H)-one (DIBOA-Glc), 2,4
  -dihydroxy-7-methoxy-(2H)-1,4-benzoxazin-3(4H)-one (DIMBOA), and 2,4-dihydroxy
  -(2H)-1,4-benzoxazin-3(4H)-one (DIBOA), together with some degradation
  derivatives found in wheat crop soil and some synthetic analogues. Their
  phytotoxicity on E. crus-galli is discussed and compared with the results
  obtained from previous screening. This work constitutes the next step in the
  search for natural herbicide models based on benzoxazinones and their
  degradation products. The most active compounds were the degradation product 2
  -aminophenol (APH) and the synthetic analogue 4-hydroxy-(2H)-1,4-benzoxazin
  -3(4H)-one (D-DIBOA). Their activities confirm the direction proposed in our
  previous SAR study, which establishes D-DIBOA to be the best lead for natural
  herbicide model development with benzoxazinone structure.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Pesticides-
ST: -[25305-] Gramineae-, -Monocotyledones, Angiospermae-, Spermatophyta-,
  Plantae-
OR: wheat- (Gramineae-): common-; rice- (Gramineae-): common-, grain-crop;
  Echinochloa-crus-galli (Gramineae-): species-, barnyardgrass-, common-, weed-
TN: Gramineae-: Angiosperms-, Monocots-, Plants-, Spermatophytes-, Vascular
  -Plants
CB: benzoxazinones-: pesticide-, herbicide-; DIMBOA-: 2,4-dihydroxy-7-methoxy
  -(2H)-1,4-benzoxazin-3(4H)-one, 15893-52-4; DIBOA-: 2,4-dihydroxy-(2H)-1,4
  -benzoxazin-3(4H)-one, 17359-54-5; 4-hydroxy-(2h)-1,4-benzoxazin-3(4-H)-one: D
  -DIBOA; 2-O-beta-D-glUcopyranosyl-4-hydroxy-(2H)1; benzoxazin-3(4H)-one; 2
  -aminophenol: APH-, 95-55-6
RN: 15893-52-4; 17359-54-5; 95-55-6
MQ: bioassay-: laboratory-techniques, bioassay-techniques; structure-activity
  -relationships-study: SARs-study, mathematical-and-computer-techniques
MI: phytotoxicity-
CC: 10060- (Biochemistry-studies-General)
51522- (Plant-physiology-Chemical
  -constituents)
52504- (Agronomy-Grain-crops)
52518- (Agronomy-Weed
  -control)
54600- (Pest-control-general-pesticides-and-herbicides)
AN: 200510124326
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0021
  -8561&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0021
  -8561&isbn=&volume=53&issue=11&spage=4373&pages=4373
  -4380&date=2005&title=Journal%20of%20Agricultural%20and%20Food%20Chemistry&atitl
  e=Structure-activity%20relationship%20studies%20of%20benzoxazinones%20and%20rela
  ted%20compounds.%20Phytotoxicity%20on%20Echinochloa%20crus
  -galli%20%28L.%29%20p.%20Beauv.&aulast=Macias&pid=%3Cauthor%3EMacias%2c%20Franci
  sco%20A%3bChinchilla%2c%20Nuria%3bVarela%2c%20Rosa%20M%3bOliveros%20Bastidas%2c%
  20Alberto%3bMarin%2c%20David%3bMolinillo%2c%20Jose%20M%20G%3C%2Fauthor%3E%3CAN%3
  E200510124326%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 194 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Stem cells: The revolution in current medicine
AU: Jamil,-Kaiser [Author,-Reprint-Author]; Das,-G-Prabhavathy [Author]
AD: Bhagwan Mahavir Med Res Ctr, Dept Genet, Mahavir Marg,AC Guards, Hyderabad
  500004, Andhra Pradesh, India
EMA: kaiser_jamil@yahoo.co.in
SO: Indian-Journal-of-Biotechnology. 2005; 4(2): 173-185
PY: 2005
DT: Literature-Review; Article
IS: 0972-5849
LA: English
AB: Biological science is being bombarded with problems of HIV, cancers,
  thousands of genetic disorders, obesity, diabetes, microbial infections,
  biological warfare, SARS and degenerative organ diseases of the lung, liver,
  kidney and heart. A big question today is the promise of stem cells. Will stem
  cells one day be good enough to save the sinking Noah's Ark of human health?
  This review attempts to give an overview of stem cells and the scientific
  factors revolving around it.
AI: Y
MC: Methods-and-Techniques; Human-Medicine: Medical-Sciences
ST: -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, adult-, embryo-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
PS: hemopoietic-stem-cell: blood-and-lymphatics
DS: liver-disease: (Liver-Diseases-(MeSH)), digestive-system-disease, therapy-;
  cancer-: (Neoplasms-(MeSH)), neoplastic-disease, therapy-; obesity-: (Obesity
  -(MeSH)), nutritional-disease, therapy-; genetic-disease: genetic-disease,
  therapy-; heart-disease: (Heart-Diseases-(MeSH)), heart-disease, therapy-;
  kidney-disease: (Kidney-Diseases-(MeSH)), urologic-disease, therapy-; HIV
  -disease: human-immunodeficiency-virus-disease, viral-disease, immune-system
  -disease, therapy-; microbial-infection: infectious-disease, therapy-; SARS-:
  severe-acute-respiratory-syndrome, respiratory-system-disease, viral-disease,
  therapy-; lung-disease: (Lung-Diseases-(MeSH)), respiratory-system-disease,
  therapy-
MQ: stem-cell-therapy: therapeutic-and-prophylactic-techniques, clinical
  -techniques
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
03508- (Genetics
  -Human)
12502- (Pathology-General)
12512- (Pathology-Therapy)
14006-
  (Digestive-system-Pathology)
14506- (Cardiovascular-system-Heart
  -pathology)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
15506- (Urinary-system-Pathology)
16006- (Respiratory-system
  -Pathology)
24004- (Neoplasms-Pathology-clinical-aspects-and-systemic
  -effects)
24008- (Neoplasms-Therapeutic-agents-and-therapy)
25502-
  (Development-and-Embryology-General-and-descriptive)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36001- (Medical-and-clinical-microbiology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510123779
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0972
  -5849&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0972
  -5849&isbn=&volume=4&issue=2&spage=173&pages=173
  -185&date=2005&title=Indian%20Journal%20of%20Biotechnology&atitle=Stem%20cells%3
  a%20The%20revolution%20in%20current%20medicine&aulast=Jamil&pid=%3Cauthor%3EJami
  l%2c%20Kaiser%3bDas%2c%20G%20Prabhavathy%3C%2Fauthor%3E%3CAN%3E200510123779%3C%2
  FAN%3E%3CDT%3ELiterature%20Review%3bArticle%3C%2FDT%3E

Record 195 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Immune response in Balb/c mice induced by recombinant spike protein of
  severe acute respiratory syndrome coronavirus
AU: Qin,-Li [Author]; Wu,-Shao-ting [Author,-Reprint-Author]; Wang,-Xi-ming
  [Author]; Yuan,-Shi-shan [Author]; Huang,-Da-na [Author]; Lei,-Ming-jun
  [Author]; Pan,-Hui-rong [Author]; Lin,-Qi-ping [Author]; Gao,-Shi-tong
  [Author]; Zhang,-Ren-li [Author]; Qu,-Shen [Author]
AD: Shenzhen Ctr Dis Control and Prevent, Shenzhen 518020, Peoples R China
EMA: wshaoting@263.net
SO: Chinese-Medical-Journal-(English-Edition). 2005; 118(10): 857-860
PY: 2005
DT: Article
IS: 0366-6999
LA: English
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Respiratory-System:
  Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-; -[86375-] Muridae-, 
  -Rodentia, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-coronavirus (Coronaviridae-): common-,
  SARS-coronavirus, common-; Escherichia-coli (Enterobacteriaceae-): species-,
  expression-system; mouse- (Muridae-): common-, strain-Balb-c
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-; Muridae
  -: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman-Mammals,
  Rodents-, Vertebrates-
PS: cellular-membrane; viral-membrane
CB: spike-protein-1: expression-; spike-protein-2: expression-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; coronavirus-infection:
  viral-disease
MQ: epitope-analysis: laboratory-techniques
CC: 10060- (Biochemistry-studies-General)
16004- (Respiratory-system-Physiology
  -and-biochemistry)
16006- (Respiratory-system-Pathology)
31000- (Physiology
  -and-biochemistry-of-bacteria)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510121438
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0366
  -6999&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0366
  -6999&isbn=&volume=118&issue=10&spage=857&pages=857
  -860&date=2005&title=Chinese%20Medical%20Journal%20%28English%20Edition%29&atitl
  e=Immune%20response%20in%20Balb%2fc%20mice%20induced%20by%20recombinant%20spike%
  20protein%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus&aulast=Qi
  n&pid=%3Cauthor%3EQin%2c%20Li%3bWu%2c%20Shao%20ting%3bWang%2c%20Xi%20ming%3bYuan
  %2c%20Shi%20shan%3bHuang%2c%20Da%20na%3bLei%2c%20Ming%20jun%3bPan%2c%20Hui%20ron
  g%3bLin%2c%20Qi%20ping%3bGao%2c%20Shi%20tong%3bZhang%2c%20Ren%20li%3bQu%2c%20She
  n%3C%2Fauthor%3E%3CAN%3E200510121438%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 196 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Using a CO2 detector to confirm endotracheal intubation in SARS patients
AU: Ting,-Chien-Kun [Author,-Reprint-Author]; Liu,-Hsu-Tang [Author]; Chen,-Kung
  -Yen [Author]; Liu,-Chen-Kou [Author]; Tsou,-Mei-Yung [Author]; Chan,-Kwok-Hon
  [Author]; Tsai,-Shen-Kou [Author]
AD: Taipei Vet Gen Hosp, Taipei, Taiwan
EMA: sktsai@vghtpe.gov.tw
SO: Canadian-Journal-of-Anesthesia. 2005; 52(4): 446-447
PY: 2005
DT: Letter
IS: 0832-610X
LA: English
MC: Infection-; Methods-and-Techniques; Pulmonary-Medicine: Human-Medicine,
  Medical-Sciences; Equipment-Apparatus-Devices-and-Instrumentation
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: carbon-dioxide: 124-38-9; propofol-: 2078-54-8, general-anesthetic-drug,
  autonomic-drug; succinylcholine-: 306-40-1, muscle-relaxant-drug
GE: Taiwan-: Asia-, Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
RN: 124-38-9; 2078-54-8; 306-40-1
MQ: endotracheal-intubation: therapeutic-and-prophylactic-techniques, clinical
  -techniques; carbon-dioxide-detector: Nellcor-Easy-Cap-II, medical-equipment;
  powered-air-purifying-respirator: medical-equipment; medical-gown: protective
  -clothing; medical-gloves: protective-clothing; Tyvek-hood: protective
  -clothing; N95/100-mask: protective-clothing; goggles-: protective-clothing;
  face-shield: protective-clothing
CC: 10060- (Biochemistry-studies-General)
12512- (Pathology-Therapy)
16006-
  (Respiratory-system-Pathology)
22005- (Pharmacology-Clinical
  -pharmacology)
22022- (Pharmacology-Muscle-system)
22024- (Pharmacology
  -Neuropharmacology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510121016
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0832
  -610X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0832
  -610X&isbn=&volume=52&issue=4&spage=446&pages=446
  -447&date=2005&title=Canadian%20Journal%20of%20Anesthesia&atitle=Using%20a%20CO2
  %20detector%20to%20confirm%20endotracheal%20intubation%20in%20SARS%20patients&au
  last=Ting&pid=%3Cauthor%3ETing%2c%20Chien%20Kun%3bLiu%2c%20Hsu%20Tang%3bChen%2c%
  20Kung%20Yen%3bLiu%2c%20Chen%20Kou%3bTsou%2c%20Mei%20Yung%3bChan%2c%20Kwok%20Hon
  %3bTsai%2c%20Shen%20Kou%3C%2Fauthor%3E%3CAN%3E200510121016%3C%2FAN%3E%3CDT%3ELet
  ter%3C%2FDT%3E

Record 197 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Mining SARS-CoV protease cleavage data using non-orthogonal decision trees:
  a novel method for decisive template selection
AU: Yang,-Zheng-Rong [Author,-Reprint-Author]
AD: Univ Exeter, Dept Comp Sci, Exeter EX4 4QJ, Devon, UK
EMA: z.r.yang@exeter.ac.uk
SO: Bioinformatics-(Oxford). 2005; 21(11): 2644-2650
PY: 2005
DT: Article
IS: 1367-4803
LA: English
AB: Motivation: Although the outbreak of the severe acute respiratory syndrome
  (SARS) is currently over, it is expected that it will return to attack human
  beings. A critical challenge to scientists from various disciplines worldwide
  is to study the specificity of cleavage activity of SARS-related coronavirus
  (SARS-CoV) and use the knowledge obtained from the study for effective
  inhibitor design to fight the disease. The most commonly used inductive
  programming methods for knowledge discovery from data assume that the elements
  of input patterns are orthogonal to each other. Suppose a sub-sequence is
  denoted as P2P1P1'P2', the conventional inductive programming method may result
  in a rule like 'if P-1 = Q, then the sub-sequence is cleaved, otherwise non
  -cleaved'. If the site P-1 is not orthogonal to the others (for instance, P-2,
  P-1' and P-2'), the prediction power of these kind of rules may be limited.
  Therefore this study is aimed at developing a novel method for constructing non
  -orthogonal decision trees for mining protease data.Result: Eighteen sequences
  of coronavirus polyprotein were downloaded from NCBI
  (http://www.ncbi.nlm.nih.gov). Among these sequences, 252 cleavage sites were
  experimentally determined. These sequences were scanned using a sliding window
  with size k to generate about 50 000 k-mer sub-sequences (for short, k-mers).
  The value of k varies from 4 to 12 with a gap of two. The bio-basis function
  proposed by Thomson et al. is used to transform the k-mers to a high
  -dimensional numerical space on which an inductive programming method is
  applied for the purpose of deriving a decision tree for decision-making. The
  process of this transform is referred to as a bio-mapping. The constructed
  decision trees select about 10 out of 50 000 k-mers. This small set of selected
  k-mers is regarded as a set of decisive templates. By doing so, non-orthogonal
  decision trees are constructed using the selected templates and the prediction
  accuracy is significantly improved.
AI: Y
MC: Information-Studies; Infection-; Biochemistry-and-Molecular-Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: SARS-related-coronavirus (Coronaviridae-): common-, SARS-CoV, common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: protease-: 9001-92-7, EC-3.4.21.7; polyprotein-
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease
RN: 9001-92-7
MI: cleavage-site; inhibitor-design; inductive-programming-method; non
  -orthogonal-decision; cleavage-activity; bio-mapping
CC: 00530- (General-biology-Information-documentation-retrieval-and-computer
  -applications)
10060- (Biochemistry-studies-General)
10802- (Enzymes-General
  -and-comparative-studies-coenzymes)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510120407
UD: 20050830
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1367
  -4803&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1367
  -4803&isbn=&volume=21&issue=11&spage=2644&pages=2644
  -2650&date=2005&title=Bioinformatics%20%28Oxford%29&atitle=Mining%20SARS
  -CoV%20protease%20cleavage%20data%20using%20non
  -orthogonal%20decision%20trees%3a%20a%20novel%20method%20for%20decisive%20templa
  te%20selection&aulast=Yang&pid=%3Cauthor%3EYang%2c%20Zheng%20Rong%3C%2Fauthor%3E
  %3CAN%3E200510120407%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 198 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Detection of severe acute respiratory syndrome probable patients' virus RNA
  in Hangzhou by using a two loci and a modified nested real-time reverse
  transcription polymerase chain reaction
AU: Ye-Rong [Author]; Pan-Jin-cao [Author,-Reprint-Author]; Huang-Zhi-cheng
  [Author]; Wang-Heng [Author]; Wang-Hao-qiu [Author]; Wei-Dong-fang [Author]; Xu
  -Ke [Author]; Wen-Hong-gen [Author]; Chen-Kang-kai [Author]
AD: Hangzhou Ctr Dis Control and Prevent, Dept Microbiol Test, Hangzhou 310006,
  Peoples R China
SO: Zhonghua-Yufang-Yixue-Zazhi. 2005; 39(2): 129-132
PY: 2005
DT: Article
IS: 0253-9624
LA: Chinese
AB: Objective To detect the RNA of severe acute respiratory syndrome virus (SARS
  -CoV) by using reverse transcription polymerase chain reaction (RT-PCR)
  targeted for a two loci and. a modified nested real-time RT-PCR as to improving
  the reliability and sensitivity of tests. Methods A nested RT-PCR was used for
  detecting one fragment of SARS-CoV RNA in oropharyngeal swabs from 3 SARS
  probable patients 4 SARS suspect patients and other 27 patients with fever in
  Hangzhou, and the nested RT-PCR product from one SARS probable patient was
  sequenced. Meanwhile in these 3 SARS probable patients, other three RT-PCR
  methods, including a hemi-nested RT-PCR targeted for another fragment of SARS
  -CoV RNA, a real-time RT-PCR and a modified nested real-time RT-PCR, were
  employed to detect SARS-CoV RNA. Results Two positives were found in the 3 SARS
  probable patients, and none positive in 4 SARS suspect patients and other 27
  patients with fever, using the nested RT-PCR. The sequence of the nested RTPCR
  product from one SARS probable patient was identified with the counterpart of
  SARS-CoV genomes published in public database. The results of the hemi-nested
  RT-PCR, the real-time RT-PCR and the modified nested real-time RT-PCR in the 3
  SARS patients were consistent with the one of the nested RT-PCR. During
  detecting specimen with low copies of RNA, a weak positive signal was produced
  after about 35 cycles in the real-time RT-PCR, but a strong positive signal was
  found only after 10 cycles in the modified nested real-time RT-PCR. Conclusion
  It might improve the reliability of test by employing RT-PCR targeted for two
  or more fragments in SARS-CoV genome. The modified nested real-time RT-PCR
  might have higher sensitivity than the routine real-time RT-PCR.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies; Methods-and-Techniques;
  Molecular-Genetics: Biochemistry-and-Molecular-Biophysics; Pulmonary-Medicine:
  Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-acute-respiratory-syndrome-virus (Coronaviridae-): species-, pathogen
  -; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: RNA-
GE: Hangzhou-: China-, Asia-, Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-, diagnosis-
MQ: nested-RT-PCR: nested-reverse-transcriptase-polymerase-chain-reaction,
  laboratory-techniques, genetic-techniques; nested-real-time-RT-PCR: nested-real
  -time-reverse-transcriptase-polymerase-chain-reaction, laboratory-techniques,
  genetic-techniques
CC: 03502- (Genetics-General)
03508- (Genetics-Human)
10062- (Biochemistry
  -studies-Nucleic-acids-purines-and-pyrimidines)
12504- (Pathology
  -Diagnostic)
16006- (Respiratory-system-Pathology)
31500- (Genetics-of
  -bacteria-and-viruses)
33502- (Virology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
37052- (Public-health-epidemiology
  -Communicable-diseases)
37054- (Public-health-epidemiology-Organic-diseases
  -and-neoplasms)
37056- (Public-health-epidemiology-Miscellaneous)
AN: 200510118384
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0253
  -9624&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0253
  -9624&isbn=&volume=39&issue=2&spage=129&pages=129
  -132&date=2005&title=Zhonghua%20Yufang%20Yixue%20Zazhi&atitle=Detection%20of%20s
  evere%20acute%20respiratory%20syndrome%20probable%20patients%27%20virus%20RNA%20
  in%20Hangzhou%20by%20using%20a%20two%20loci%20and%20a%20modified%20nested%20real
  -time%20reverse%20transcription%20polymerase%20chain%20reaction&aulast=&pid=%3Ca
  uthor%3EYe%20Rong%3bPan%20Jin%20cao%3bHuang%20Zhi%20cheng%3bWang%20Heng%3bWang%2
  0Hao%20qiu%3bWei%20Dong%20fang%3bXu%20Ke%3bWen%20Hong%20gen%3bChen%20Kang%20kai%
  3C%2Fauthor%3E%3CAN%3E200510118384%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 199 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Molecular cloning, expression, and purification of SARS-CoV nsp 13
AU: Fan,-Zheng [Author]; Peng,-Kunpeng [Author]; Tan,-Xinyu [Author]; Yin,-Bin
  [Author]; Dong,-Xiuhua [Author]; Qiu,-Feichan [Author]; Shen,-Yan [Author];
  Wang,-Heng [Author]; Yuan,-Jiangang [Author]; Qiang,-Boqin [Author]; Peng,
  -Xiaozhong [Author,-Reprint-Author]
AD: Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing
  100005, Peoples R China
EMA: pengxiaozhong@pumc.edu.cn
SO: Protein-Expression-and-Purification. 2005; 41(2): 235-240
PY: 2005
DT: Article
IS: 1046-5928
LA: English
AB: The SARS-nsp13 protein was identified as an mRNA cap I methyltransferase. In
  this Study, the nsp 13 gene was cloned front the SARS-CoV PUMC02 strain viral
  RNA by RT-PCR, and inserted into the expression plasmid pET30a(+). The
  recombinant plasmid pET30a(+)-nsp13 was confirmed by restriction enzymes and
  sequencing analysis, and transformed into Eseherichia coli BL21 (DE3). The His
  -tag-fused protein was expressed by induction of 0.5 mM IPTG and purified by a
  single Ni2+ affinity chromatography. The protein was validated by western blot
  and MS analysis. A large quantity of the nsp13 protein obtained with this
  method may be useful for further study of its structure and function. (c) 2005
  Elsevier Inc. All rialits reserved.
AI: Y
MC: Methods-and-Techniques; Molecular-Genetics: Biochemistry-and-Molecular
  -Biophysics
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[06702-] Enterobacteriaceae-, -Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, strain-PUMC02; Escherichia-coli (Enterobacteriaceae-): species
  -, strain-BL21
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-
CB: mRNA-: messenger-RNA; cap1-methyltransferase
GN: Severe-Acute-Respiratory-Syndrome-virus-nsp13-gene [Coronaviridae-]
MQ: Western-blot: electrophoretic-techniques, immunologic-techniques, laboratory
  -techniques; mass-spectrometry: laboratory-techniques, spectrum-analysis
  -techniques; reverse-transcriptase-polymerase-chain-reaction: RT-PCR,
  laboratory-techniques, genetic-techniques; molecular-cloning: laboratory
  -techniques, genetic-techniques; nickel-affinity-chromatography: laboratory
  -techniques, chromatographic-techniques
CC: 03502- (Genetics-General)
10062- (Biochemistry-studies-Nucleic-acids
  -purines-and-pyrimidines)
10064- (Biochemistry-studies-Proteins-peptides-and
  -amino-acids)
31000- (Physiology-and-biochemistry-of-bacteria)
31500-
  (Genetics-of-bacteria-and-viruses)
33502- (Virology-General-and-methods)
AN: 200510117332
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1046
  -5928&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1046
  -5928&isbn=&volume=41&issue=2&spage=235&pages=235
  -240&date=2005&title=Protein%20Expression%20and%20Purification&atitle=Molecular%
  20cloning%2c%20expression%2c%20and%20purification%20of%20SARS
  -CoV%20nsp%2013&aulast=Fan&pid=%3Cauthor%3EFan%2c%20Zheng%3bPeng%2c%20Kunpeng%3b
  Tan%2c%20Xinyu%3bYin%2c%20Bin%3bDong%2c%20Xiuhua%3bQiu%2c%20Feichan%3bShen%2c%20
  Yan%3bWang%2c%20Heng%3bYuan%2c%20Jiangang%3bQiang%2c%20Boqin%3bPeng%2c%20Xiaozho
  ng%3C%2Fauthor%3E%3CAN%3E200510117332%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 200 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Impacts of SARS on health-seeking behaviors in general population in Hong
  Kong
AU: Lau,-Joseph-T-F [Author,-Reprint-Author]; Yang,-Xilin [Author]; Tsui,-H-Y
  [Author]; Kim,-Jean-H [Author]
AD: Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth, Ctr Biostat and Epidemiol,
  Hong Kong, Hong Kong, Peoples R China
EMA: jlau@cuhk.edu.hk
SO: Preventive-Medicine. 2005; 41(2): 454-462
PY: 2005
DT: Article
IS: 0091-7435
LA: English
AB: Background. The severe acute respiratory syndrome (SARS) epidemic that
  occurred in I long Kong in 2003 caused serious public health consequences. Its
  impacts on health-seeking behaviors of the general public have not been
  assessed.Methods. Two cross-sectional, random telephone surveys interviewed
  1603 Hong Kong adult residents in the post-SARS epidemic period, June and
  September 2003 to investigate changes in the post-SARS period.Results.
  Noteworthy percentages of the respondents self-reported increased frequencies
  of practicing favorable health-seeking behaviors in June 2003, as compared with
  the pre-SARS period. Few respondents reported the opposite. This was observed
  in different dimensions: health services seeking, adoption of healthier
  lifestyle, spending more resources on health, adoption of good personal
  hygiene, mask use when ill with influenza, and avoidance of risk behaviors. The
  frequencies of practicing most or these health-seeking behaviors, as measured
  in June and September 2003, were comparable. Further increases in healthy diet
  and weight control, etc.. were observed during that period. Those who worried
  about contracting SARS were more likely to have improved health-seeking
  behaviors.Conclusions. The community in Hong Kong responded to the SARS
  epidemic by practicing more flavorable health-seeking behaviors. Public health
  workers should utilize these opportunities to foster favorable changes. (c)
  2004 Elsevier Inc. All rights reserved.
AI: Y
MC: Behavior-; Epidemiology-: Population-Studies; Infection-; Pulmonary
  -Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, adolescent-, middle
  -age, adult-, host-, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
GE: Hong-Kong: Asia-, Palearctic-region
DS: influenza-: (Influenza-(MeSH)), respiratory-system-disease, viral-disease;
  severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-
MI: lifestyle-; personal-hygiene; health-seeking-behaviors; mask-use
CC: 07002- (Behavioral-biology-General-and-comparative-behavior)
07004-
  (Behavioral-biology-Human-behavior)
16006- (Respiratory-system
  -Pathology)
25000- (Pediatrics-)
33502- (Virology-General-and-methods)
36006
  - (Medical-and-clinical-microbiology-Virology)
37052- (Public-health
  -epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510117213
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0091
  -7435&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0091
  -7435&isbn=&volume=41&issue=2&spage=454&pages=454
  -462&date=2005&title=Preventive%20Medicine&atitle=Impacts%20of%20SARS%20on%20hea
  lth-seeking%20behaviors%20in%20general%20population%20in%20Hong%20Kong&aulast=La
  u&pid=%3Cauthor%3ELau%2c%20Joseph%20T%20F%3bYang%2c%20Xilin%3bTsui%2c%20H%20Y%3b
  Kim%2c%20Jean%20H%3C%2Fauthor%3E%3CAN%3E200510117213%3C%2FAN%3E%3CDT%3EArticle%3
  C%2FDT%3E

Record 201 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Clinical, virologic and immunologic profiles of a young infant with severe
  acute respiratory syndrome
AU: Cheng,-Frankie-W-T [Author,-Reprint-Author]; Ng,-Enders-K-O [Author]; Li,
  -Albert-Martin [Author]; Hon,-Ellis-K-L [Author]; Chiu,-Rossa-W-K [Author]; Lo,
  -Y-M-Dennis [Author]; Ng,-Pak-C [Author]
AD: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Pediat, Shatin, Hong Kong,
  Peoples R China
SO: Pediatric-Infectious-Disease-Journal. 2005; 24(6): 567-568
PY: 2005
DT: Article
IS: 0891-3668
LA: English
AB: The clinical findings, plasma viral load, cytokines and chemokines of a 4
  -month-old infant with severe acute respiratory syndrome (SARS) were assessed
  at different phases of the disease. Ribavirin failed to inhibit SARS
  coronavirus (SARS-CoV) replication. One-step real time reverse transcription
  -polymerase chain reaction for plasma SARS-CoV RNA quantification was useful
  for early diagnosis and monitoring viremia.
AI: Y
MC: Clinical-Immunology: Human-Medicine, Medical-Sciences; Infection-; Pulmonary
  -Medicine: Human-Medicine, Medical-Sciences; Pediatrics-: Human-Medicine,
  Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, infant-, host-,
  female-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: plasma-: blood-and-lymphatics
CB: cytokines-; RNA-; chemokines-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: real-time-reverse-transcriptase-polymerase-chain-reaction: laboratory
  -techniques, genetic-techniques
MI: viral-replication; plasma-viral-load
CC: 10062- (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
15002-
  (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell-studies)
16006-
  (Respiratory-system-Pathology)
17002- (Endocrine-General)
25000- (Pediatrics
  -)
33502- (Virology-General-and-methods)
34508- (Immunology-Immunopathology
  -tissue-immunology)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510116818
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0891
  -3668&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0891
  -3668&isbn=&volume=24&issue=6&spage=567&pages=567
  -568&date=2005&title=Pediatric%20Infectious%20Disease%20Journal&atitle=Clinical%
  2c%20virologic%20and%20immunologic%20profiles%20of%20a%20young%20infant%20with%2
  0severe%20acute%20respiratory%20syndrome&aulast=Cheng&pid=%3Cauthor%3ECheng%2c%2
  0Frankie%20W%20T%3bNg%2c%20Enders%20K%20O%3bLi%2c%20Albert%20Martin%3bHon%2c%20E
  llis%20K%20L%3bChiu%2c%20Rossa%20W%20K%3bLo%2c%20Y%20M%20Dennis%3bNg%2c%20Pak%20
  C%3C%2Fauthor%3E%3CAN%3E200510116818%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 202 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Reducing the impact of viral respiratory infections in children
AU: Meissner,-H-Cody [Author,-Reprint-Author]
AD: Tufts Univ, Sch Med, Div Pediat Infect Dis, Tufts New England Med Ctr, 750
  Washington St 321, Boston, MA 02111 USA
EMA: cmeissner@tufts-nemc.org
SO: Pediatric-Clinics-of-North-America. 2005; 52(3): 695-710,V,VI-694
PY: 2005
DT: Literature-Review; Article
IS: 0031-3955
LA: English
AB: This article reviews the epidemiology and clinical aspects of the major
  viral causes of upper and lower respiratory tract disease in children.
  Particular emphasis is placed on prevention and control of viral disease
  through the use of vaccines and antiviral agents. Evolution of new viral
  pathogens, such as avian influenza virus and the SARS-CoV, are discussed.
AI: Y
MC: Infection-; Methods-and-Techniques; Pediatrics-: Human-Medicine, Medical
  -Sciences
ST: -[03116-] Adenoviridae-, -dsDNA-Viruses, Viruses-, Microorganisms-; -[03613
  -] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-, Microorganisms-; 
  -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-, Chordata-, Animalia-; 
  -[03505-] Orthomyxoviridae-, -Negative-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03503-] Paramyxoviridae-, -Negative-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-; -[03603-] Picornaviridae-, -Positive-Sense-ssRNA
  -Viruses, Viruses-, Microorganisms-
OR: Adenovirus- (Adenoviridae-): species-, pathogen-; Coronavirus-
  (Coronaviridae-): genus-, pathogen-; SARS-virus (Coronaviridae-): common-,
  Severe-Acute-Respiratory-Syndrome-virus, common-, pathogen-; human- (Hominidae
  -): common-, child-, host-; Influenza-virus (Orthomyxoviridae-): common-,
  pathogen-; Respiratory-syncytial-virus (Paramyxoviridae-): common-, RSV-,
  common-, pathogen-; Human-metapneumovirus (Paramyxoviridae-): common-, pathogen
  -; Parainfluenza-virus (Paramyxoviridae-): common-, pathogen-; Rhinovirus-
  (Picornaviridae-): genus-, pathogen-
TN: Adenoviridae-: Double-Stranded-DNA-Viruses, Microorganisms-, Viruses-;
  Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Orthomyxoviridae-: Microorganisms-, Negative-Sense-Single
  -Stranded-RNA-Viruses, Viruses-; Paramyxoviridae-: Microorganisms-, Negative
  -Sense-Single-Stranded-RNA-Viruses, Viruses-; Picornaviridae-: Microorganisms-,
  Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
CB: live-attenuated-vaccine: immunologic-drug, immunostimulant-drug, vaccine-;
  neuraminidase-inhibitors: antiinfective-drug, antiviral-drug; trivalent
  -inactivated-vaccine: immunologic-drug, immunostimulant-drug, vaccine-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-, etiology-;
  adenovirus-infection: (Adenoviridae-Infections-(MeSH)), viral-disease,
  epidemiology-; respiratory-tract-disease: respiratory-system-disease,
  infectious-disease, viral-disease, drug-therapy, prevention-and-control;
  parainfluenza-: (Paramyxoviridae-Infections-(MeSH)), viral-disease,
  epidemiology-; rhinovirus-infection: viral-disease, epidemiology-; coronavirus
  -infection: viral-disease, epidemiology-, etiology-; human-metapneumovirus
  -infection: viral-disease, epidemiology-, etiology-
MQ: immunoprophylaxis-: laboratory-techniques, immunologic-techniques
MI: vaccine-development
CC: 12512- (Pathology-Therapy)
16006- (Respiratory-system-Pathology)
22005-
  (Pharmacology-Clinical-pharmacology)
22018- (Pharmacology-Immunological
  -processes-and-allergy)
25000- (Pediatrics-)
33502- (Virology-General-and
  -methods)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
38502-
  (Chemotherapy-General-methods-and-metabolism)
38506- (Chemotherapy-Antiviral
  -agents)
AN: 200510116789
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0031
  -3955&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0031
  -3955&isbn=&volume=52&issue=3&spage=&pages=&date=2005&title=Pediatric%20Clinics%
  20of%20North%20America&atitle=Reducing%20the%20impact%20of%20viral%20respiratory
  %20infections%20in%20children&aulast=Meissner&pid=%3Cauthor%3EMeissner%2c%20H%20
  Cody%3C%2Fauthor%3E%3CAN%3E200510116789%3C%2FAN%3E%3CDT%3ELiterature%20Review%3b
  Article%3C%2FDT%3E

Record 203 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Evolution of pulmonary pathology in severe acute respiratory syndrome
AU: Cheng-Hsiang-Hsiao [Author,-Reprint-Author]; Mu-Zong-Wu [Author]; Chi-Long
  -Chen [Author]; Po-Ren-Hsueh [Author]; Shun-Wen-Hsieh [Author]; Pan-Chyr-Yang
  [Author]; Ih-Jen-Su [Author]
AD: Natl Taiwan Univ Hosp, Dept Pathol, 7 Chung Shan S Rd, Taipei 100, Taiwan
SO: Journal-of-the-Formosan-Medical-Association. 2005; 104(2): 75-81
PY: 2005
DT: Article
IS: 0929-6646
LA: English
AB: Background and Purpose: Severe acute respirator), syndrome (SARS) is
  characterized by fever with rapid progression to acute respiratory distress and
  it is associated with substantial morbidity and mortality. Transmission
  patterns suggest spread by respiratory droplet or close person-to-person
  contact. To elucidate the correlation of clinical presentation to the
  pathogenesis and course of the disease, we reviewed the pulmonary pathologic
  specimens of SARS patients taken at different stages of the disease.Methods:
  Four "probable" cases of SARS were studied. SARS-associated coronavirus (SARS
  -CoV) infection was demonstrated using reverse transcriptase-polymerase chain
  reaction in all 4 patients. The pulmonary specimens were taken oil day 7 after
  symptom onset in patient 1, day 11 in patient 2, day 17 in patient 3, and day
  21 in patient 4.Results: The autopsy lung tissue from patient 1, who died 7
  days after symptoms onset due to the complication of acute myocardial
  infarction, revealed mild histologic change in the lung. Only focal pulmonary
  edema or hemorrhage was seen. In the second patient, who (tied I I clays after
  symptom onset, severe acute alveolar damage was characterized by patchy or
  diffuse lung edema, hyaline membrane formation, and scarce lymphocytic
  infiltration. The lymphocytes were mostly CD3-positive and CD20-negative. In
  the third patient, biopsy specimen taken 17 days after symptom onset showed
  patches of organizing pneumonia with reactive fibroblastic proliferation, more
  abundant type 11 pneumocytes and clustering of CD68-positive macrophages within
  the alveolar spaces. Few CD68-positive syncytial multinucleated giant cells
  were also seen in the specimens but no viral inclusion body could be identified
  in these cells. The lung biopsy specimen from patient 4 taken 21 days after
  symptom onset showed characteristics of the fibrotic stage, with significant
  myofibroblastic proliferation ill the alveolar space and interstitium resulting
  in loss of pulmonary architecture. The number of CD3-positive lymphocytes and
  of CD68-positive macrophages in this specimen from a patient ill the fibrotic
  phase of diffuse alveolar damage (DAD) whose condition deteriorated was less
  than in the specimen from case 3 who was in the early proliferative phase of
  DAD and eventually recovered.Conclusions: The histologic evolution of SARS
  coincided with the different stages of DAD: acute, proliferative organizing,
  and fibrotic stages. SARS cannot be differentiated from the other etiologies of
  DAD by morphologic examination alone. The absence of DAD does not rule Out the
  possibility of SARS-CoV infection, particularly in the early stage of the
  disease.
AI: Y
MC: Clinical-Immunology: Human-Medicine, Medical-Sciences; Pulmonary-Medicine:
  Human-Medicine, Medical-Sciences; Pathology-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-associated-coronavirus (Coronaviridae-): species-, SARS-CoV, common-,
  pathogen-; human- (Hominidae-): common-, adult-, aged-, middle-age, host-,
  female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: macrophage-: immune-system, blood-and-lymphatics; lymphocyte-: immune
  -system, blood-and-lymphatics; lung-: respiratory-system; alveolar-space:
  respiratory-system; pneumocyte-: respiratory-system; giant-cell: immune-system
CB: CD3-; CD20-; CD68-: 57-74-9
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, pathology-
RN: 57-74-9
MQ: biopsy-: clinical-techniques, diagnostic-techniques; reverse-transcriptase
  -polymerase-chain-reaction: laboratory-techniques, genetic-techniques
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10062- (Biochemistry
  -studies-Nucleic-acids-purines-and-pyrimidines)
10064- (Biochemistry-studies
  -Proteins-peptides-and-amino-acids)
12502- (Pathology-General)
15002- (Blood
  -Blood-and-lymph-studies)
15004- (Blood-Blood-cell-studies)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
24500- (Gerontology-)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510115526
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0929
  -6646&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0929
  -6646&isbn=&volume=104&issue=2&spage=75&pages=75
  -81&date=2005&title=Journal%20of%20the%20Formosan%20Medical%20Association&atitle
  =Evolution%20of%20pulmonary%20pathology%20in%20severe%20acute%20respiratory%20sy
  ndrome&aulast=&pid=%3Cauthor%3ECheng%20Hsiang%20Hsiao%3bMu%20Zong%20Wu%3bChi%20L
  ong%20Chen%3bPo%20Ren%20Hsueh%3bShun%20Wen%20Hsieh%3bPan%20Chyr%20Yang%3bIh%20Je
  n%20Su%3C%2Fauthor%3E%3CAN%3E200510115526%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 204 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Antigenic cross-reactivity between severe acute respiratory syndrome
  -associated coronavirus and human coronaviruses 229E and OC43
AU: Che,-Xiao-yan [Author,-Reprint-Author]; Qiu,-Li-wen [Author]; Liao,-Zhi-yong
  [Author]; Wang,-Ya-di [Author]; Wen,-Kun [Author]; Pan,-Yu-xian [Author]; Hao,
  -Wei [Author]; Mei,-Ya-bo [Author]; Cheng,-Vincent-C-C [Author]; Yuen,-Kwok
  -yung [Author]
AD: So Med Univ, Zhujiang Hosp, Ctr Lab, Guangzhou 510282, Peoples R China
EMA: linche@pub.guangzhou.gd.cn
SO: Journal-of-Infectious-Diseases. 2005; 191(12): 2033-2037
PY: 2005
DT: Article
IS: 0022-1899
LA: English
AB: Cross-reactivity between antibodies to different human coronaviruses (HCoVs)
  has not been systematically studied. By use of Western blot analysis, indirect
  immunofluorescence assay (IFA), and enzyme-linked immunosorbent assay ( ELISA),
  antigenic cross-reactivity between severe acute respiratory syndrome (SARS) -
  associated coronavirus (SARS-CoV) and 2 HCoVs (229E and OC43) was demonstrated
  in immunized animals and human serum. In 5 of 11 and 10 of 11 patients with
  SARS, paired serum samples showed a >= 4-fold increase in antibody titers
  against HCoV-229E and HCoV-OC43, respectively, by IFA. Overall, serum samples
  from convalescent patients who had SARS had a 1-way cross-reactivity with the 2
  known HCoVs. Antigens of SARS- CoV and HCoV-OC43 were more cross-reactive than
  were those of SARS- CoV and HCoV-229E.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Respiratory-System:
  Respiration-
ST: -[86205-] Cercopithecidae-, -Primates, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; -[86040-] Leporidae-, -Lagomorpha, Mammalia-, Vertebrata
  -, Chordata-, Animalia-
OR: BSC-1-cell-line (Cercopithecidae-): cell_line-, African-green-monkey-kidney
  -cell-line, strain-ATCC-CCL-26; Severe-Acute-Respiratory-Syndrome-virus
  (Coronaviridae-): common-, pathogen-, strain-HKU-39849; Human-coronavirus-229E
  (Coronaviridae-): species-, pathogen-, strain-ATCC-VR740; Human-coronavirus
  -OC43 (Coronaviridae-): species-, pathogen-, strain-ATCC-VR759; human-
  (Hominidae-): common-, adult-, middle-age, host-, female-, male-; MRC-5-cell
  -line (Hominidae-): cell_line-, human-fetal-lung-fibroblast-cell-line, strain
  -ATCC-CCL-171; New-Zealand-White-rabbit (Leporidae-): common-, female-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-;
  Leporidae-: Animals-, Chordates-, Lagomorphs-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Vertebrates-
PS: serum-: blood-and-lymphatics
CB: antibody-; antigen-: cross-reactivity
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, infectious-disease, viral-disease,
  pathology-, immunology-, symptom-
MQ: ELISA-: laboratory-techniques, immunologic-techniques; Western-blot:
  electrophoretic-techniques, immunologic-techniques, laboratory-techniques;
  indirect-immunofluorescence: laboratory-techniques, immunologic-techniques
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10060- (Biochemistry
  -studies-General)
10064- (Biochemistry-studies-Proteins-peptides-and-amino
  -acids)
12502- (Pathology-General)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
33502-
  (Virology-General-and-methods)
34502- (Immunology-General-and-methods)
36001-
  (Medical-and-clinical-microbiology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510114353
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -1899&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -1899&isbn=&volume=191&issue=12&spage=2033&pages=2033
  -2037&date=2005&title=Journal%20of%20Infectious%20Diseases&atitle=Antigenic%20cr
  oss-reactivity%20between%20severe%20acute%20respiratory%20syndrome
  -associated%20coronavirus%20and%20human%20coronaviruses%20229E%20and%20OC43&aula
  st=Che&pid=%3Cauthor%3EChe%2c%20Xiao%20yan%3bQiu%2c%20Li%20wen%3bLiao%2c%20Zhi%2
  0yong%3bWang%2c%20Ya%20di%3bWen%2c%20Kun%3bPan%2c%20Yu%20xian%3bHao%2c%20Wei%3bM
  ei%2c%20Ya%20bo%3bCheng%2c%20Vincent%20C%20C%3bYuen%2c%20Kwok%20yung%3C%2Fauthor
  %3E%3CAN%3E200510114353%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 205 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D)
  treated immunoglobulin preparation
AU: Rabenau,-H-F [Author,-Reprint-Author]; Biesert,-L [Author]; Schmidt,-T
  [Author]; Bauer,-G [Author]; Cinatl,-J [Author]; Doerr,-H-W [Author]
AD: Frankfurt Main Univ Hosp, Sch Med, Inst Med Virol, Paul Ehrlich Str 40, D
  -60596 Frankfurt, Germany
EMA: rabenau@em.uni-frankfurt.de
SO: Biologicals-. 2005; 33(2): 95-99
PY: 2005
DT: Article
IS: 1045-1056
LA: English
AB: SARS-coronavirus (SARS-CoV) is a newly emerged, highly pathogenic agent that
  caused over 8000 human infections with nearly 800 deaths between November 2002
  and September 2003. While direct person-to-person transmission via respiratory
  droplets accounted for most cases, other modes have not been ruled out. SARS
  -CoV viraemia does not seem to reach high titres, however, it has to be
  excluded that virus transmission may occur via blood transfusion or application
  of therapeutic plasma products, e.g. fresh-frozen plasma or single components
  derived thereof. Manufacturing processes of all plasma derivatives are required
  to comprise dedicated virus inactivation/removal steps. Treatment with a
  mixture of solvent and detergent (SD) has successfully been applied to
  inactivate the most members of the transfusion-relevant viruses without
  affecting therapeutic properties of the products. The SD treatment irreversibly
  disrupts the lipid envelope of viruses such as HIV, HBV, HCV, HGV and CMV. In
  this study we evaluated the manufacturing process of an immunoglobulin
  preparation (OCTAGAM, manufactured by Octapharma Pharmazeutika
  Produktionsges.m.b.H., Vienna, Austria) for its capacity to inactivate the SARS
  -CoV. Our results demonstrate that SARS-CoV was completely inactivated below
  the limit of detection. This was found to occur within 1 min of SD treatment.
  (c) 2005 The International Association for Biologicals. Published by Elsevier
  Ltd. All rights reserved.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Blood-and-Lymphatics:
  Transport-and-Circulation; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[03615-] Flaviviridae-, -Positive-Sense-ssRNA-Viruses,
  Viruses-, Microorganisms-; -[03301-] Hepadnaviridae-, -DNA-and-RNA-Reverse
  -Transcribing-Viruses, Viruses-, Microorganisms-; -[03115-] Herpesviridae-, 
  -dsDNA-Viruses, Viruses-, Microorganisms-; -[86215-] Hominidae-, -Primates,
  Mammalia-, Vertebrata-, Chordata-, Animalia-; -[03305-] Retroviridae-, -DNA-and
  -RNA-Reverse-Transcribing-Viruses, Viruses-, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; Hepatitis-C-virus (Flaviviridae-): species-, HCV-,
  common-, pathogen-; Hepatitis-G-virus (Flaviviridae-): species-, HGV-, common-,
  pathogen-; Hepatitis-B-virus (Hepadnaviridae-): species-, HBV-, common-,
  pathogen-; Cytomegalovirus- (Herpesviridae-): genus-, CMV-, common-, pathogen-;
  human- (Hominidae-): common-, host-; Human-immunodeficiency-virus (Retroviridae
  -): species-, HIV-, common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Flaviviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA
  -Viruses, Viruses-; Hepadnaviridae-: DNA-and-RNA-Reverse-Transcribing-Viruses,
  Microorganisms-, Viruses-; Herpesviridae-: Double-Stranded-DNA-Viruses,
  Microorganisms-, Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-,
  Primates-, Vertebrates-; Retroviridae-: DNA-and-RNA-Reverse-Transcribing
  -Viruses, Microorganisms-, Viruses-
PS: plasma-: blood-and-lymphatics
CB: detergent-; solvent-; lipid-envelope
GE: Vienna-: Austria-, Europe-, Palearctic-region
DS: cytomegalovirus-infection: (Cytomegalovirus-Infections-(MeSH)), viral
  -disease; hepatitis-B-virus-infection: digestive-system-disease, viral-disease;
  human-immunodeficiency-virus-infection: HIV-infection, (HIV-Infections-(MeSH)),
  viral-disease, immune-system-disease; hepatitis-C-virus-infection: digestive
  -system-disease, viral-disease; severe-acute-respiratory-syndrome: SARS-,
  (Severe-Acute-Respiratory-Syndrome-(MeSH)), respiratory-system-disease, viral
  -disease, transmission-, mortality-; hepatitis-G-virus-infection: digestive
  -system-disease, viral-disease
MQ: blood-transfusion: therapeutic-and-prophylactic-techniques, clinical
  -techniques
CC: 10060- (Biochemistry-studies-General)
14006- (Digestive-system
  -Pathology)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
34508- (Immunology-Immunopathology-tissue-immunology)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510108317
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1045
  -1056&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1045
  -1056&isbn=&volume=33&issue=2&spage=95&pages=95
  -99&date=2005&title=Biologicals%20&atitle=SARS-coronavirus%20%28SARS
  -CoV%29%20and%20the%20safety%20of%20a%20solvent%2fdetergent%20%28S%2fD%29%20trea
  ted%20immunoglobulin%20preparation&aulast=Rabenau&pid=%3Cauthor%3ERabenau%2c%20H
  %20F%3bBiesert%2c%20L%3bSchmidt%2c%20T%3bBauer%2c%20G%3bCinatl%2c%20J%3bDoerr%2c
  %20H%20W%3C%2Fauthor%3E%3CAN%3E200510108317%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 206 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Object-oriented biological system integration: a SARS coronavirus example
AU: Shegogue,-Daniel [Author]; Zheng,-W-Jim [Author,-Reprint-Author]
AD: Med Univ S Carolina, Hollings Canc Ctr, Dept Biostat Bioinformat and
  Epidemiol, 135 Cannon St,POB 250835, Charleston, SC 29425 USA
EMA: zhengw@musc.edu
SO: Bioinformatics-(Oxford). 2005; 21(10): 2502-2509
PY: 2005
DT: Article
IS: 1367-4803
LA: English
AB: Motivation: The importance of studying biology at the system level has been
  well recognized, yet there is no well-defined process or consistent methodology
  to integrate and represent biological information at this level. To overcome
  this hurdle, a blending of disciplines such as computer science and biology is
  necessary.Results: By applying an adapted, sequential software engineering
  process, a complex biological system (severe acquired respiratory syndrome
  -coronavirus viral infection) has been reverse-engineered and represented as an
  object-oriented software system. The scalability of this object-oriented
  software engineering approach indicates that we can apply this technology for
  the integration of large complex biological systems.
AI: Y
MC: Infection-; Computer-Applications: Computational-Biology; Respiratory
  -System: Respiration-
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, etiology-
MQ: object-oriented-biological-system-software: computer-software
MI: systems-biology
CC: 00530- (General-biology-Information-documentation-retrieval-and-computer
  -applications)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510108273
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1367
  -4803&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1367
  -4803&isbn=&volume=21&issue=10&spage=2502&pages=2502
  -2509&date=2005&title=Bioinformatics%20%28Oxford%29&atitle=Object
  -oriented%20biological%20system%20integration%3a%20a%20SARS%20coronavirus%20exam
  ple&aulast=Shegogue&pid=%3Cauthor%3EShegogue%2c%20Daniel%3bZheng%2c%20W%20Jim%3C
  %2Fauthor%3E%3CAN%3E200510108273%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 207 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by
  fluorescence resonance energy transfer-based assays
AU: Kuang,-Wan-Fen [Author]; Chow,-Lu-Ping [Author]; Wu,-Mei-Hua [Author];
  Hwang,-Lih-Hwa [Author,-Reprint-Author]
AD: Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei
  10764, Taiwan
EMA: lihhwa@ha.mc.ntu.edu.tw
SO: Biochemical-and-Biophysical-Research-Communications. 2005; 331(4): 1554-1559
PY: 2005
DT: Article
IS: 0006-291X
LA: English
AB: The 3C-like protease (3CL(pro)) of severe acute respiratory syndrome
  coronavirus (SARS-CoV) plays key roles in viral replication and is an
  attractive target for anti-SARS drug discovery. In this report, a fluorescence
  resonance energy transfer (FRET)-based method was developed to assess the
  proteolytic activity of SARS-CoV 3CL(pro). Two internally quenched fluorogenic
  peptides, 1NC and 2NC, corresponding to the N-terminal and the C-terminal
  autocleavage sites of SARS-CoV 3CL(pro), respectively, were used as substrates.
  SARS-CoV 3CL(pro) seemed to work more efficiently on 1NC than on 2NC in traps
  -cleavage assay. Mutational analysis demonstrated that the His41 residue, the N
  -terminal 7 amino acids, and the domain III of SARS-CoV 3CL(pro) were important
  for the enzymatic activity. Antibodies recognizing domain III could
  significantly inhibit the enzymatic activity of SARS-CoV 3CL(pro). The effects
  of class-specific protease inhibitors on the trans-cleavage activity revealed
  that this enzyme worked more like a serine protease rather than the papain
  protease. (c) 2005 Elsevier Inc. All rights reserved.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Methods-and-Techniques
CB: SARS-coronavirus-3C-like-protease
MQ: mutational-analysis: laboratory-techniques; inhibitive-analysis: laboratory
  -techniques; fluorescence-resonance-energy-transfer-based-assay: FRET-based
  -proteolytic-assay, laboratory-techniques
CC: 10060- (Biochemistry-studies-General)
AN: 200510108028
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0006
  -291X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0006
  -291X&isbn=&volume=331&issue=4&spage=1554&pages=1554
  -1559&date=2005&title=Biochemical%20and%20Biophysical%20Research%20Communication
  s&atitle=Mutational%20and%20inhibitive%20analysis%20of%20SARS%20coronavirus%203C
  -like%20protease%20by%20fluorescence%20resonance%20energy%20transfer
  -based%20assays&aulast=Kuang&pid=%3Cauthor%3EKuang%2c%20Wan%20Fen%3bChow%2c%20Lu
  %20Ping%3bWu%2c%20Mei%20Hua%3bHwang%2c%20Lih%20Hwa%3C%2Fauthor%3E%3CAN%3E2005101
  08028%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 208 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: A case-control study of SARS versus community acquired pneumonia
AU: Cheng,-F-W-T [Author]; Ng,-P-C [Author,-Reprint-Author]; Chiu,-W-K [Author];
  Chu,-W-C-W [Author]; Li,-A-M [Author]; Lo,-K-L [Author]; Hon,-E-K-L [Author];
  Nelson,-E-A-S [Author]; Leung,-T-F [Author]; Ng,-W-H [Author]; Wong,-E
  [Author]; Ip,-P [Author]; Fok,-T-F [Author]
AD: Chinese Univ Hong Kong, Dept Paediat, Prince Wales Hosp, Level 6,Clin Sci
  Bldg, Shatin, Hong Kong, Peoples R China
EMA: pakcheungng@cuhk.edu.hk
SO: Archives-of-Disease-in-Childhood. 2005; 90(7): 747-749
PY: 2005
DT: Article
IS: 0003-9888
LA: English
AB: The clinical, laboratory, and radiological features at presentation of 16
  children (< 12 years) with severe acute respiratory syndrome (SARS) and
  pneumonia were compared with 32 age matched patients with community acquired
  pneumonia for determination of predictive factors that could allow early
  differentiation of the two conditions. A definitive contact history was the
  most important predictor for SARS. Raised serum lactate dehydrogenase
  concentration in the presence of low neutrophil count and serum creatine
  phosphokinase level at presentation also indicated an increased likelihood of
  SARS-coronavirus infection in young children.
AI: Y
MC: Infection-; Pediatrics-: Human-Medicine, Medical-Sciences
ST: -[03613-] Coronaviridae-, -Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; -[86215-] Hominidae-, -Primates, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; human- (Hominidae-): common-, child-, preadolescent-child, infant-,
  adolescent-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: serum-: blood-and-lymphatics; neutrophil-: immune-system, blood-and
  -lymphatics
CB: lactate-dehydrogenase: 9001-60-9, EC-1.1.1.27; creatine-phosphokinase: 9001
  -15-4, EC-2.7.3.2
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease; community-acquired-pneumonia: respiratory-system-disease, infectious
  -disease
RN: 9001-60-9; 9001-15-4
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10802- (Enzymes-General
  -and-comparative-studies-coenzymes)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
16006- (Respiratory-system
  -Pathology)
25000- (Pediatrics-)
33502- (Virology-General-and-methods)
34502
  - (Immunology-General-and-methods)
36001- (Medical-and-clinical-microbiology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510107729
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0003
  -9888&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0003
  -9888&isbn=&volume=90&issue=7&spage=747&pages=747
  -749&date=2005&title=Archives%20of%20Disease%20in%20Childhood&atitle=A%20case
  -control%20study%20of%20SARS%20versus%20community%20acquired%20pneumonia&aulast=
  Cheng&pid=%3Cauthor%3ECheng%2c%20F%20W%20T%3bNg%2c%20P%20C%3bChiu%2c%20W%20K%3bC
  hu%2c%20W%20C%20W%3bLi%2c%20A%20M%3bLo%2c%20K%20L%3bHon%2c%20E%20K%20L%3bNelson%
  2c%20E%20A%20S%3bLeung%2c%20T%20F%3bNg%2c%20W%20H%3bWong%2c%20E%3bIp%2c%20P%3bFo
  k%2c%20T%20F%3C%2Fauthor%3E%3CAN%3E200510107729%3C%2FAN%3E%3CDT%3EArticle%3C%2FD
  T%3E

Record 209 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Commensal bacteria as a novel delivery system for subunit vaccines directed
  against agents of bioterrorism
AU: Wilson,-Rebecca-L [Author]; Hruby,-Dennis-E [Author,-Reprint-Author]
AD: SIGA Technol Inc, 4575 SW Res Way,Suite 230, Corvallis, OR 97333 USA
SO: Advanced-Drug-Delivery-Reviews. 2005; 57(9): 1392-1402
PY: 2005
DT: Article
IS: 0169-409X
LA: English
AB: Following the anthrax attacks of 2001 and the recent SARS outbreak, concerns
  about emerging and re-emerging infectious diseases have catalyzed a renewed
  interest in developing new vaccination strategies that provide rapid and
  flexible response options to future threats. Because the probability of
  encountering one of these exotic agents is unknown, it is essential that new
  vaccine formulations employ methods that provide effective protection and
  extremely good safety profiles if they are to be used by either military or
  civilian populations. One approach, which potentially satisfies these criteria,
  is the use of live recombinant Gram-positive commensal bacteria as expression
  vectors. This review provides an overview of the system, its advantages and
  limitations, and details an example of how Gram-positive commensal bacteria are
  being developed as a fifth generation vaccine against a Class A biowarfare
  pathogen, namely smallpox. (c) 2005 Elsevier B.V. All rights reserved.
AI: Y
MC: Pharmacology-; Immune-System: Chemical-Coordination-and-Homeostasis
ST: -[05000-] Bacteria-, -Microorganisms; -[86215-] Hominidae-, -Primates,
  Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: Gram-positive-bacteria (Bacteria-): common-, gene-vector; human- (Hominidae
  -): common-
TN: Bacteria-: Bacteria-, Eubacteria-, Microorganisms-; Hominidae-: Animals-,
  Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
CB: subunit-vaccine: immunologic-drug, vaccine-
DS: anthrax-: (Anthrax-(MeSH)), bacterial-disease, prevention-and-control;
  smallpox-: (Smallpox-(MeSH)), viral-disease, prevention-and-control; SARS-:
  severe-acute-respiratory-syndrome, respiratory-system-disease, viral-disease,
  prevention-and-control
MQ: vaccination-: clinical-techniques
CC: 12512- (Pathology-Therapy)
16006- (Respiratory-system-Pathology)
22002-
  (Pharmacology-General)
22005- (Pharmacology-Clinical-pharmacology)
22018-
  (Pharmacology-Immunological-processes-and-allergy)
31000- (Physiology-and
  -biochemistry-of-bacteria)
34502- (Immunology-General-and-methods)
36002-
  (Medical-and-clinical-microbiology-Bacteriology)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510106668
UD: 20050824
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0169
  -409X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0169
  -409X&isbn=&volume=57&issue=9&spage=1392&pages=1392
  -1402&date=2005&title=Advanced%20Drug%20Delivery%20Reviews&atitle=Commensal%20ba
  cteria%20as%20a%20novel%20delivery%20system%20for%20subunit%20vaccines%20directe
  d%20against%20agents%20of%20bioterrorism&aulast=Wilson&pid=%3Cauthor%3EWilson%2c
  %20Rebecca%20L%3bHruby%2c%20Dennis%20E%3C%2Fauthor%3E%3CAN%3E200510106668%3C%2FA
  N%3E%3CDT%3EArticle%3C%2FDT%3E

Record 210 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: rOv-ASP-1, a recombinant secreted protein of the helminth Onchocerca
  volvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1
  polypeptide and SARS-CoV peptide antigens
AU: MacDonald,-Angus-J [Author,-Reprint-Author]; Cao,-Long [Author]; He,-Yuxian
  [Author]; Zhao,-Qian [Author]; Jiang,-Shibo [Author]; Lustigman,-Sara [Author]
AD: New York Blood Ctr, Lindsley F Kimball Res Inst, Mol Parasitol Lab, 310 E
  67th St, New York, NY 10021 USA
EMA: angus.macdonald@hepcgen.com
SO: Vaccine-. 2005; 23(26): 3446-3452
PY: 2005
DT: Article
IS: 0264-410X
LA: English
AB: We studied the adjuvanticity of recombinant Onchocerca volvulus activation
  associated protein-1 (rOv-ASP-1) for ovalbumin (OVA) in mice. After a single
  immunization and one boost, rOv-ASP- I exceeded the efficacy of alum or MPL +
  TDM adjuvants in terms of end-point total IgG or IgG1 and IgG2a anti-OVA
  titres. Using the helminth-derived adjuvant, IgG isotype responses to OVA were
  of a mixed Thl/Th2 profile and spleen cell cytokines exclusively Th1-type. The
  potent adjuvanticity of rOv-ASP-1 was confirmed in mice vaccinated with a 37
  -mer peptide from the S protein of SARS-CoV and an HIV-1 gp120-CD4 chimeric
  polypeptide antigen. Unusually for a helminth product, the rOv-ASP-1 adjuvant
  augmented not only Th2 but also Th1 responses, the latter property being of
  potential utility in stimulating anti-viral immune responses. (c) 2005 Elsevier
  Ltd. All rights reserved.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Immune-System: Chemical
  -Coordination-and-Homeostasis
ST: [51300-] Nematoda-, Aschelminthes-, Helminthes-, Invertebrata-, Animalia-
OR: Onchocerca-volvulus (Nematoda-): species-, larva-
TN: Nematoda-: Animals-, Aschelminths-, Helminths-, Invertebrates-
PS: Th1-cell: immune-system, blood-and-lymphatics; Th2-cell: immune-system,
  blood-and-lymphatics; spleen-cell: immune-system, blood-and-lymphatics
CB: IgG-: immunoglobulin-G; ovalbumin-; IgG2a-; gp120-; S-protein; ASP-1
  -protein: adjuvant-; TH-1; IgGl-; CD4-polypeptide-antigen; TH-2
MI: anti-viral-immune-responses
CC: 02506- (Cytology-Animal)
10060- (Biochemistry-studies-General)
10064-
  (Biochemistry-studies-Proteins-peptides-and-amino-acids)
15002- (Blood-Blood
  -and-lymph-studies)
15004- (Blood-Blood-cell-studies)
25502- (Development-and
  -Embryology-General-and-descriptive)
34502- (Immunology-General-and
  -methods)
64016- (Invertebrata-comparative-experimental-morphology-physiology
  -and-pathology-Aschelminthes)
AN: 200510106207
UD: 20050816
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0264
  -410X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0264
  -410X&isbn=&volume=23&issue=26&spage=3446&pages=3446
  -3452&date=2005&title=Vaccine%20&atitle=rOv-ASP
  -1%2c%20a%20recombinant%20secreted%20protein%20of%20the%20helminth%20Onchocerca%
  20volvulus%2c%20is%20a%20potent%20adjuvant%20for%20inducing%20antibodies%20to%20
  ovalbumin%2c%20HIV-1%20polypeptide%20and%20SARS
  -CoV%20peptide%20antigens&aulast=MacDonald&pid=%3Cauthor%3EMacDonald%2c%20Angus%
  20J%3bCao%2c%20Long%3bHe%2c%20Yuxian%3bZhao%2c%20Qian%3bJiang%2c%20Shibo%3bLusti
  gman%2c%20Sara%3C%2Fauthor%3E%3CAN%3E200510106207%3C%2FAN%3E%3CDT%3EArticle%3C%2
  FDT%3E

Record 211 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: 3rd Reunion Conjunta de las Redes de Vigilancia de Enfermedades Infecciosas
  Emergentes y Reemergentes, Atlanta, GA, USA, February 26 -28, 2004
AU: Anonymous [Author]
SO: Revista-de-Patologia-Tropical. 2005; 34(Suppl. 1): 1-128
PY: 2005
DT: Meeting-Report; Meeting
IS: 0301-0406
MT: 3rd Reunion Conjunta de las Redes de Vigilancia de Enfermedades Infecciosas
  Emergentes y Reemergentes, Atlanta, GA, USA; February 26 -28, 2004
LA: Portuguese
AB: This meeting which focuses on the epidemiology and surveillance of emerging
  infectious diseases is written in English and Spanish. Topics discussed include
  WHO proposal's for the International Health Regulations, preparations for a
  potential influenza pandemic, the response to severe acute respiratory syndrome
  (SARS), the status of dengue, and West Nile virus, the implementation of
  syndromic surveillance, the surveillance of antimicrobial resistance and drug
  resistance in Plasmodium falciparum, as well as the degree of compliance with
  recommendations from the previous meeting.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies
ST: [03506-] Bunyaviridae-, Negative-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [03615-] Flaviviridae-, Positive-Sense-ssRNA-Viruses, Viruses
  -, Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; [35400-] Sporozoa-, Protozoa-, Invertebrata-, Animalia-
OR: Hantavirus- (Bunyaviridae-): genus-, pathogen-; West-Nile-virus
  (Flaviviridae-): species-, pathogen-; human- (Hominidae-): common-, host-;
  Plasmodium-falciparum (Sporozoa-): species-, pathogen-
TN: Bunyaviridae-: Microorganisms-, Negative-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Flaviviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA
  -Viruses, Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-,
  Primates-, Vertebrates-; Sporozoa-: Animals-, Invertebrates-, Microorganisms-,
  Protozoans-
GE: Peru-: South-America, Neotropical-region; USA-: North-America, Nearctic
  -region; Brazil-: South-America, Neotropical-region; Canada-: North-America,
  Nearctic-region; Guatemala-: Central-America, Neotropical-region; El-Salvador:
  Central-America, Neotropical-region; Honduras-: Central-America, Neotropical
  -region; Nicaragua-: Central-America, Neotropical-region; Dominican-Republic:
  West-Indies, Neotropical-region
DS: malaria-: (Malaria-(MeSH)), blood-and-lymphatic-disease, parasitic-disease;
  influenza-: (Influenza-(MeSH)), respiratory-system-disease, viral-disease;
  hemolytic-uremic-syndrome: urologic-disease, infectious-disease, blood-and
  -lymphatic-disease; SARS-: severe-acute-respiratory-syndrome, respiratory
  -system-disease, viral-disease; dengue-: (Dengue-(MeSH)), viral-disease;
  hantavirus-pulmonary-syndrome: (Hantavirus-Pulmonary-Syndrome-(MeSH)),
  respiratory-system-disease, viral-disease; West-Nile-fever: nervous-system
  -disease, viral-disease
MI: drug-resistance; antimicrobial-resistance; disease-surveillance; pandemic-;
  emerging-infectious-disease; syndromic-surveillance
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
15006-
  (Blood-Blood-lymphatic-and-reticuloendothelial-pathologies)
15506- (Urinary
  -system-Pathology)
16006- (Respiratory-system-Pathology)
20506- (Nervous
  -system-Pathology)
33502- (Virology-General-and-methods)
36001- (Medical-and
  -clinical-microbiology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
37052- (Public-health-epidemiology-Communicable
  -diseases)
37054- (Public-health-epidemiology-Organic-diseases-and
  -neoplasms)
37056- (Public-health-epidemiology-Miscellaneous)
60502-
  (Parasitology-General)
60504- (Parasitology-Medical)
64002- (Invertebrata
  -comparative-experimental-morphology-physiology-and-pathology-Protozoa)
AN: 200510105684
UD: 20050816
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0301
  -0406&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0301
  -0406&isbn=&volume=34&issue=Suppl.%201&spage=1&pages=1
  -128&date=2005&title=Revista%20de%20Patologia%20Tropical&atitle=3rd%20Reunion%20
  Conjunta%20de%20las%20Redes%20de%20Vigilancia%20de%20Enfermedades%20Infecciosas%
  20Emergentes%20y%20Reemergentes%2c%20Atlanta%2c%20GA%2c%20USA%2c%20February%2026
  %20-28%2c%202004&aulast=&pid=%3Cauthor%3EAnonymous%3C%2Fauthor%3E%3CAN%3E2005101
  05684%3C%2FAN%3E%3CDT%3EMeeting%20Report%3bMeeting%3C%2FDT%3E

Record 212 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: A three-stemmed mRNA pseudoknot in the SARS coronavirus frameshift signal
AU: Plant,-Ewan-P [Author]; Perez-Alvarado,-Gabriela-C [Author]; Jacobs,
  -Jonathan-L [Author]; Mukhopadhyay,-Bani [Author]; Hennig,-Mirko [Author];
  Dinman,-Jonathan-D [Author,-Reprint-Author]
AD: Univ Maryland, Dept Mol Genet and Cell Biol, College Pk, MD 20742 USA
EMA: dinman@umd.edu
SO: PLoS-Biology. 2005; 3(6): 1012-1023
PY: 2005
DT: Article
IS: 1544-9173
LA: English
AB: A wide range of RNA viruses use programmed -1 ribosomal frameshifting for
  the production of viral fusion proteins. Inspection of the overlap regions
  between ORF1a and ORF1b of the SARS-CoV genome revealed that, similar to all
  coronaviruses, a programmed -1 ribosomal frameshift could be used by the virus
  to produce a fusion protein. Computational analyses of the frameshift signal
  predicted the presence of an mRNA pseudoknot containing three double-stranded
  RNA stem structures rather than two. Phylogenetic analyses showed the
  conservation of potential three-stemmed pseudoknots in the frameshift signals
  of all other coronaviruses in the GenBank database. Though the presence of the
  three-stemmed structure is supported by nuclease mapping and two-dimensional
  nuclear magnetic resonance studies, our findings suggest that interactions
  between the stem structures may result in local distortions in the A-form RNA.
  These distortions are particularly evident in the vicinity of predicted A
  -bulges in stems 2 and 3. In vitro and in vivo frameshifting assays showed that
  the SARS-CoV frameshift signal is functionally similar to other viral
  frameshift signals: it promotes efficient frameshifting in all of the standard
  assay systems, and it is sensitive to a drug and a genetic mutation that are
  known to affect frameshifting efficiency of a yeast virus. Mutagenesis studies
  reveal that both the specific sequences and structures of stems 2 and 3 are
  important for efficient frameshifting. We have identified a new RNA structural
  motif that is capable of promoting efficient programmed ribosomal
  frameshifting. The high degree of conservation of three- stemmed mRNA
  pseudoknot structures among the coronaviruses suggests that this presents a
  novel target for antiviral therapeutics.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Respiratory-System: Respiration-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Coronavirus- (Coronaviridae-): genus-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: ORF1a-; ORF1b-
SD: NC001451-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence;
  NC003045-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence;
  NC002645-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence;
  NC006577-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence;
  NC005831-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence;
  NC005147-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence;
  NC001846-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence;
  NC003436-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence;
  NC004718-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence;
  NC002306-: GenBank-, EMBL-, DDJB-, amino-acid-sequence, nucleotide-sequence
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MI: genome-; mRNA-pseudoknot
CC: 03502- (Genetics-General)
10062- (Biochemistry-studies-Nucleic-acids
  -purines-and-pyrimidines)
10064- (Biochemistry-studies-Proteins-peptides-and
  -amino-acids)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
31500- (Genetics-of-bacteria-and
  -viruses)
33502- (Virology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510105430
UD: 20050816
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1544
  -9173&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1544
  -9173&isbn=&volume=3&issue=6&spage=1012&pages=1012
  -1023&date=2005&title=PLoS%20Biology&atitle=A%20three
  -stemmed%20mRNA%20pseudoknot%20in%20the%20SARS%20coronavirus%20frameshift%20sign
  al&aulast=Plant&pid=%3Cauthor%3EPlant%2c%20Ewan%20P%3bPerez%20Alvarado%2c%20Gabr
  iela%20C%3bJacobs%2c%20Jonathan%20L%3bMukhopadhyay%2c%20Bani%3bHennig%2c%20Mirko
  %3bDinman%2c%20Jonathan%20D%3C%2Fauthor%3E%3CAN%3E200510105430%3C%2FAN%3E%3CDT%3
  EArticle%3C%2FDT%3E

Record 213 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Mutations in Sendai virus variant F1-R that correlate with plaque formation
  in the absence of trypsin
AU: Hou,-Xiaogang [Author]; Suquilanda,-Edgar [Author]; Zeledon,-Ana [Author];
  Kacsinta,-Apollo [Author]; Moore,-Akila [Author]; Seto,-Joseph [Author];
  McQueen,-Nancy [Author,-Reprint-Author]
AD: Calif State Univ Los Angeles, Dept Biol Sci, 5151 State Univ Dr, Los
  Angeles, CA 90032 USA
EMA: nmcquee@exchange.calstatela.edu
SO: Medical-Microbiology-and-Immunology. 2005; 194(3): 129-136
PY: 2005
DT: Article
IS: 0300-8584
LA: English
AB: With the emergence of new viruses, such as the SARS virus and the avian
  influenza virus, the importance of investigations on the genetic basis of viral
  infections becomes clear. Sendai virus causes a localized respiratory tract
  infection in rodents, while a mutant, F1-R, causes a systemic infection. It has
  been suggested that two determinants are responsible for the systemic infection
  caused by F1-R [Okada et al (1998) Arch Virol 143:2343-2352]. The primary
  determinant of the pantropism is the enhanced proteolytic cleavability of the
  fusion (F) protein of F1-R, which allows the virus to undergo multiple rounds
  of replication in many different organs, whereas wild-type virus can only
  undergo multiple rounds of replication in the lungs. The enhanced cleavability
  of F1-R F was previously attributed to an amino acid change at F115 that is
  adjacent to the cleavage site at amino acid 116. Secondly, wild-type virus buds
  only from the apical domain of bronchial epithelium. releasing virus into the
  lumen of the respiratory tract, whereas F1-R buds from both apical and
  basolateral domains. Thus, virus is released into the basement membrane where
  it can easily gain access to the bloodstream for dissemination. The microtubule
  disruption is attributed to two amino acid differences in M protein. To confirm
  that the F and M gene mutations described above are solely responsible for the
  phenotypic differences seen in wld-type versus F1-R infections, reverse
  genetics was used to construct recombinant Sendai viruses with various
  combinations of the mutations found in the M and F genes of F1-R. Plaque assays
  were performed with or without trypsin addition. A recombinant virus containing
  all F1-R M and F mutations formed plaques in LLC-MK2 cells and underwent
  multiple cycles of replication without trypsin addition. To clarify which
  mutation(s) are necessary for plaque formation, plaque assays were done using
  other recombinant viruses. A virus with only the F115 change, which was
  previously thought to be the only change important for plaque formation of F1-R
  F, did not confer upon the virus the ability to form plaques without the
  addition of trypsin. Another virus with the F115 and both M changes gave the
  same result. Therefore, more than one mutation in the F gene contributes to the
  ability of F1-R to form plaques without trypsin addition.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Enzymology-: Biochemistry-and-Molecular-Biophysics
ST: [86205-] Cercopithecidae-, Primates-, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; [06702-] Enterobacteriaceae-, Facultatively-Anaerobic-Gram-Negative
  -Rods, Eubacteria-, Bacteria-, Microorganisms-; [03503-] Paramyxoviridae-,
  Negative-Sense-ssRNA-Viruses, Viruses-, Microorganisms-
OR: LLC-MK2-cell-line (Cercopithecidae-): cell_line-, host-; Escherichia-coli
  (Enterobacteriaceae-): species-, expression-system, strain-STBL2; Sendai-virus
  (Paramyxoviridae-): species-, pathogen-, strain-F1-R
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Enterobacteriaceae-:
  Bacteria-, Eubacteria-, Microorganisms-; Paramyxoviridae-: Microorganisms-,
  Negative-Sense-Single-Stranded-RNA-Viruses, Viruses-
CB: trypsin-: 9002-07-7, EC-3.4.21.4; M-protein
GN: Sendai-virus-M-gene [Paramyxoviridae-]: mutation-; Sendai-virus-F-gene
  [Paramyxoviridae-]: mutation-
DS: Sendai-virus-infection: viral-disease, etiology-, genetics-
RN: 9002-07-7
MQ: plaque-assay: laboratory-techniques
MI: proteolytic-cleavage; pantropism-
CC: 02506- (Cytology-Animal)
03502- (Genetics-General)
03506- (Genetics
  -Animal)
10802- (Enzymes-General-and-comparative-studies-coenzymes)
31000-
  (Physiology-and-biochemistry-of-bacteria)
31500- (Genetics-of-bacteria-and
  -viruses)
33502- (Virology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510104159
UD: 20050816
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0300
  -8584&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0300
  -8584&isbn=&volume=194&issue=3&spage=129&pages=129
  -136&date=2005&title=Medical%20Microbiology%20and%20Immunology&atitle=Mutations%
  20in%20Sendai%20virus%20variant%20F1
  -R%20that%20correlate%20with%20plaque%20formation%20in%20the%20absence%20of%20tr
  ypsin&aulast=Hou&pid=%3Cauthor%3EHou%2c%20Xiaogang%3bSuquilanda%2c%20Edgar%3bZel
  edon%2c%20Ana%3bKacsinta%2c%20Apollo%3bMoore%2c%20Akila%3bSeto%2c%20Joseph%3bMcQ
  ueen%2c%20Nancy%3C%2Fauthor%3E%3CAN%3E200510104159%3C%2FAN%3E%3CDT%3EArticle%3C%
  2FDT%3E

Record 214 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Bioterrorism: is it a real threat?
AU: Gottschalk,-Rene [Author,-Reprint-Author]; Preiser,-Wolfgang [Author]
AD: Ctr Competence Highly Infect Dis, Hesse, Germany
EMA: rene.gottschalk@stadt-frankfurt.de
SO: Medical-Microbiology-and-Immunology. 2005; 194(3): 109-114
PY: 2005
DT: Editorial; Article
IS: 0300-8584
LA: English
AB: The Geneva Protocol of 1925 commits the signatory nations to refraining from
  the use of biological weapons. However, the terrorist assaults of September
  2001 and, subsequently, the anthrax-containing letters are cause for great
  concerns: new threats to the security of nations are expected, as terrorist
  organizations seem to increasingly explore novel ways of spreading terror. In
  this context. naturally emerging diseases such as SARS, monkeypox or West Nile
  fever assume new importance because it is difficult to distinguish between
  natural epidemics and possible bioweapon assaults. Great efforts on the part of
  governments and public health authorities are necessary to counteract these
  threats.
AI: Y
MC: Behavior-; Toxicology-; Infection-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [03615-] Flaviviridae-, Positive-Sense-ssRNA-Viruses, Viruses
  -, Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; [03110-] Poxviridae-, dsDNA-Viruses, Viruses-,
  Microorganisms-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; West-Nile-virus (Flaviviridae-): species-, pathogen
  -; human- (Hominidae-): common-, host-; Monkeypox-virus (Poxviridae-): species
  -, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Flaviviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA
  -Viruses, Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-,
  Primates-, Vertebrates-; Poxviridae-: Double-Stranded-DNA-Viruses,
  Microorganisms-, Viruses-
CB: anthrax-toxin
MI: bioterrorism-
CC: 07002- (Behavioral-biology-General-and-comparative-behavior)
07004-
  (Behavioral-biology-Human-behavior)
22501- (Toxicology-General-and
  -methods)
33502- (Virology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510104156
UD: 20050816
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0300
  -8584&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0300
  -8584&isbn=&volume=194&issue=3&spage=109&pages=109
  -114&date=2005&title=Medical%20Microbiology%20and%20Immunology&atitle=Bioterrori
  sm%3a%20is%20it%20a%20real%20threat%3f&aulast=Gottschalk&pid=%3Cauthor%3EGottsch
  alk%2c%20Rene%3bPreiser%2c%20Wolfgang%3C%2Fauthor%3E%3CAN%3E200510104156%3C%2FAN
  %3E%3CDT%3EEditorial%3bArticle%3C%2FDT%3E

Record 215 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Prediction of smallpox outbreak and evaluation of control-measure policy in
  Japan, using a mathematical model
AU: Ohkusa,-Yasushi [Author,-Reprint-Author]; Taniguchi,-Kiyosu [Author]; Okubo,
  -Ichiro [Author]
AD: Natl Inst Infect Dis, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan
EMA: ohkusa@nih.go.jp
SO: Journal-of-Infection-and-Chemotherapy. 2005; 11(2): 71-80
PY: 2005
DT: Article
IS: 1341-321X
LA: English
AB: Since the September 1 terrorist attacks and moreover, since the anthrax
  exposure events in 2001. in the United States, bioterrorism attacks seem to be
  a real threat. Of course, the public health authorities in Japan have started
  to prepare control measures for such events. We report here our attempts, using
  a mathematical model, to estimate outbreak size and to examine the most
  effective measures; comparing ring vaccination (contact tracing, isolation, and
  vaccination among contacts) and mass vaccination of the susceptible population
  in the area. The basic framework of the mathematical model follows a model used
  in previous research. The initial susceptible population is assumed to be 30
  million persons. Concerning the important parameters, such as the number of
  initial-exposure cases, R-0 (infectious power, or natural history) and, the
  starting day of intervention after the initial exposure, we checked the
  robustness of our conclusions by sensitivity analysis. We found that mass
  vaccination is preferable to ring vaccination when the values for the initial
  -exposure cases and R-0 are high and when the start of intervention by public
  health authorities is delayed. In the base-case situation, the mass vaccination
  strategy needs almost 30 million vaccine doses. On the other hand, though ring
  vaccination needs fewer doses, it needs fewer than 50000 doses in the worst
  -case scenario, that with larger first exposure, higher R-0, or later start of
  public health authority intervention. This mathematical model can measure the
  prevalence of an infectious disease and can evaluate control measures for it
  before an outbreak. Especially, it is useful for the planning of the outbreaks
  of emerging diseases such as severe acute respiratory syndrome (SARS) or for
  bioterrorism attacks involving such diseases as smallpox. In further research,
  we will have to take into account the population people vaccinated of for
  smallpox, who account for about 70% of the total population in Japan.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies; Methods-and-Techniques
GE: Japan-: Asia-, Palearctic-region
DS: smallpox-: (Smallpox-(MeSH)), viral-disease
MQ: vaccination-: clinical-techniques; mathematical-model: mathematical-and
  -computer-techniques
MI: control-measure-policy
CC: 37052- (Public-health-epidemiology-Communicable-diseases)
37056- (Public
  -health-epidemiology-Miscellaneous)
AN: 200510103477
UD: 20050816
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1341
  -321X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1341
  -321X&isbn=&volume=11&issue=2&spage=71&pages=71
  -80&date=2005&title=Journal%20of%20Infection%20and%20Chemotherapy&atitle=Predict
  ion%20of%20smallpox%20outbreak%20and%20evaluation%20of%20control
  -measure%20policy%20in%20Japan%2c%20using%20a%20mathematical%20model&aulast=Ohku
  sa&pid=%3Cauthor%3EOhkusa%2c%20Yasushi%3bTaniguchi%2c%20Kiyosu%3bOkubo%2c%20Ichi
  ro%3C%2Fauthor%3E%3CAN%3E200510103477%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 216 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Development of immunoglobulin G enzyme-linked immunosorbent assay for the
  serodiagnosis of severe acute respiratory syndrome
AU: Shao,-Pei-Lan [Author]; Hsueh,-Po-Ren [Author]; Chang,-Luan-Yin [Author];
  Lu,-Chun-Yi [Author]; Kao,-Chuan-Liang [Author]; Chiang,-Yu-Ping [Author];
  Huang,-Hsiang-Yi [Author]; Huang,-Fu-Yuan [Author]; Lee,-Chin-Yun [Author];
  Chang,-Lung-Ji [Author]; Wu,-T-C [Author]; Huang,-Li-Min [Author,-Reprint
  -Author]; SARS-Res-Grp-Natl-Taiwan-Univ-Coll [Author]
AD: Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan
EMA: lmhuang@ha.mc.ntu.edu.tw
SO: Journal-of-Biomedical-Science. 2005; 12(1): 59-64
PY: 2005
DT: Article
IS: 1021-7770
LA: English
AB: Severe acute respiratory syndrome (SARS) is an emerging infectious disease
  caused by a novel SARS-associated coronavirus (SARS-CoV). The clinical
  characteristics are high fever, rapidly progressive diffuse pneumonitis and
  respiratory distress. It is highly infectious through intimate contact or
  direct contact with infectious body fluids. Outbreaks within communities and
  hospitals have been reported. Development of rapid and reliable diagnostic
  tools is urgently needed. We developed an immunoglobulin G (IgG) enzyme-linked
  immunosorbent assay (ELISA), using whole virus antigen of SARS-CoV. Eighty-six
  serum samples collected from patients who were hospitalized for other causes
  were examined to determine the cut-off O.D. value. The cut-off O.D. value was
  defined as 0.175 by calculating the mean O.D. value of the 86 sera plus 3
  standard deviations. To determine the sensitivity and specificity of the ELISA,
  56 positive sera and 204 negative sera were tested. The sensitivity was 96.4%
  and the specificity was 100%. The results suggest that the IgG ELISA using
  whole virus antigen of SARS-CoV has a high sensitivity and specificity in
  detecting SARS IgG antibodies. This IgG ELISA is a powerful tool for
  serodiagnosis of SARS.
AI: Y
MC: Methods-and-Techniques; Infection-; Serology-: Allied-Medical-Sciences;
  Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: [86205-] Cercopithecidae-, Primates-, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Vero-E6-cell-line (Cercopithecidae-): cell_line-, monkey-cells; Severe-Acute
  -Respiratory-Syndrome-virus (Coronaviridae-): species-, SARS-virus, common-,
  pathogen-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
PS: serum-: blood-and-lymphatics
CB: immunoglobulin-G; SARS-CoV-antigen
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, transmission-, symptom-,
  diagnosis-, epidemiology-
MQ: ELISA-: laboratory-techniques, immunologic-techniques; serodiagnosis-:
  laboratory-techniques, immunologic-techniques, diagnostic-techniques, clinical
  -techniques
CC: 02506- (Cytology-Animal)
10064- (Biochemistry-studies-Proteins-peptides-and
  -amino-acids)
12504- (Pathology-Diagnostic)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
36504-
  (Medical-and-clinical-microbiology-Serodiagnosis)
AN: 200510103107
UD: 20050816
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1021
  -7770&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1021
  -7770&isbn=&volume=12&issue=1&spage=59&pages=59
  -64&date=2005&title=Journal%20of%20Biomedical%20Science&atitle=Development%20of%
  20immunoglobulin%20G%20enzyme
  -linked%20immunosorbent%20assay%20for%20the%20serodiagnosis%20of%20severe%20acut
  e%20respiratory%20syndrome&aulast=Shao&pid=%3Cauthor%3EShao%2c%20Pei%20Lan%3bHsu
  eh%2c%20Po%20Ren%3bChang%2c%20Luan%20Yin%3bLu%2c%20Chun%20Yi%3bKao%2c%20Chuan%20
  Liang%3bChiang%2c%20Yu%20Ping%3bHuang%2c%20Hsiang%20Yi%3bHuang%2c%20Fu%20Yuan%3b
  Lee%2c%20Chin%20Yun%3bChang%2c%20Lung%20Ji%3bWu%2c%20T%20C%3bHuang%2c%20Li%20Min
  %3bSARS%20Res%20Grp%20Natl%20Taiwan%20Univ%20Coll%3C%2Fauthor%3E%3CAN%3E20051010
  3107%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 217 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Neue Krankheitsbilder durch pneumotrope Viren
Emerging viral respiratory
  infections
AU: Lange,-C [Author,-Reprint-Author]; Shuett,-M [Author]; Brodt,-H-R [Author]
AD: Forschungszentrum Borstel, Med Klin, Parkallee 35, D-23845 Borstel, Germany
EMA: clange@fz-borstel.de
SO: DMW-Deutsche-Medizinische-Wochenschrift. 2005; 130(22): 1385-1391,1381
PY: 2005
DT: Literature-Review; Article
IS: 0012-0472
LA: German
MC: Infection-; Epidemiology-: Population-Studies
ST: [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
DS: viral-infection: (Virus-Diseases-(MeSH)), viral-disease, epidemiology-;
  severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-; respiratory
  -infections: (Respiratory-Tract-Infections-(MeSH)), respiratory-system-disease,
  infectious-disease, epidemiology-
CC: 16006- (Respiratory-system-Pathology)
36001- (Medical-and-clinical
  -microbiology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
37052- (Public-health-epidemiology-Communicable-diseases)
37054-
  (Public-health-epidemiology-Organic-diseases-and-neoplasms)
37056- (Public
  -health-epidemiology-Miscellaneous)
AN: 200510100856
UD: 20050816
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0012
  -0472&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0012
  -0472&isbn=&volume=130&issue=22&spage=&pages=&date=2005&title=DMW%20Deutsche%20M
  edizinische%20Wochenschrift&atitle=Neue%20Krankheitsbilder%20durch%20pneumotrope
  %20Viren&aulast=Lange&pid=%3Cauthor%3ELange%2c%20C%3bShuett%2c%20M%3bBrodt%2c%20
  H%20R%3C%2Fauthor%3E%3CAN%3E200510100856%3C%2FAN%3E%3CDT%3ELiterature%20Review%3
  bArticle%3C%2FDT%3E

Record 218 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Potent and specific inhibition of SARS-CoV antigen expression by RNA
  interference
AU: Tao-Peng [Author]; Zhang-Jun [Author]; Tang-Ni [Author]; Zhang-Bing-qiang
  [Author]; He-Tong-chuan [Author]; Huang-Ai-long [Author,-Reprint-Author]
AD: Chongqing Univ Med Sci, Inst Viral Hepatitis, 74 Linjiang Rd, Chongqing
  400010, Peoples R China
EMA: ahuang@public.cta.cq.cn
SO: Chinese-Medical-Journal-(English-Edition). 2005; 118(9): 714-719
PY: 2005
DT: Article
IS: 0366-6999
LA: English
AB: Background Severe acute respiratory syndrome (SARS) is an infectious disease
  caused by SARS-CoV. There are no effective antiviral drugs for SARS although
  the epidemic of SARS was controlled. The aim of this study was to develop an
  RNAi (RNA interference) approach that specifically targeted the N gene sequence
  of severe acute respiratory syndrome associated coronavirus (SARS-CoV) by
  synthesizing short hairpin RNA (shRNA) in vivo, and to assess the inhibitory
  effect of this shRNA on SARS-CoV N antigen expression.Methods The eukaryotic
  expression plasmid pEGFP-C1-N, containing SARS-CoV N gene, was co-transfected
  into 293 cells with either the RNAi plasmid pshRNA-N or unrelated control
  plasmid pshRNA-HBV-C4. At 24, 48 and 72 hours post transfection, the green
  fluorescence was observed through a fluorescence microscope. The RNA levels of
  SARS-CoV N were determined by reverse transcription polymerase chain reaction
  (RT-PCR). The expression of Green Fluorescent Protein (GFP) and protein N were
  detected using Western blot.Results The vector, pshRNA-N expressing shRNA which
  targeted the N gene of SARS-CoV, was successfully constructed. The introduction
  of RNAI plasmid efficiently and specifically inhibited the synthesis of protein
  N. RT-PCR showed that RNAs of N gene were clearly reduced when the pEGFP-C1-N
  was cotransfected with pshRNA-N, whereas the control vector did not exhibit
  inhibitory effect on N gene transcription.Conclusions Our results demonstrate
  that RNAi mediated silencing of SARS-CoV gene could effectively inhibit
  expression of SARS-CoV antigen, hence RNAi based strategy should be further
  explored as a more efficacious antiviral therapy of SARS-CoV infection.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Respiratory-System: Respiration-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; 293-cell-line (Hominidae-): cell_line-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: short-hairpin-RNA; green-fluorescent-protein; N-antigen: expression-
GN: Severe-Acute-Respiratory-Syndrome-virus-N-gene [Coronaviridae-]
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, infectious-disease, viral-disease, drug
  -therapy, prevention-and-control, pathology-
MI: RNA-interference
CC: 02508- (Cytology-Human)
03502- (Genetics-General)
03508- (Genetics
  -Human)
10064- (Biochemistry-studies-Proteins-peptides-and-amino-acids)
12502
  - (Pathology-General)
12512- (Pathology-Therapy)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
31500-
  (Genetics-of-bacteria-and-viruses)
33502- (Virology-General-and
  -methods)
36001- (Medical-and-clinical-microbiology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510100409
UD: 20050816
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0366
  -6999&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0366
  -6999&isbn=&volume=118&issue=9&spage=714&pages=714
  -719&date=2005&title=Chinese%20Medical%20Journal%20%28English%20Edition%29&atitl
  e=Potent%20and%20specific%20inhibition%20of%20SARS
  -CoV%20antigen%20expression%20by%20RNA%20interference&aulast=&pid=%3Cauthor%3ETa
  o%20Peng%3bZhang%20Jun%3bTang%20Ni%3bZhang%20Bing%20qiang%3bHe%20Tong%20chuan%3b
  Huang%20Ai%20long%3C%2Fauthor%3E%3CAN%3E200510100409%3C%2FAN%3E%3CDT%3EArticle%3
  C%2FDT%3E

Record 219 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Variation analysis of the severe acute respiratory syndrome coronavirus
  putative non-structural protein 2 gene and construction of three-dimensional
  model
AU: Lu-Jia-hai [Author,-Reprint-Author]; Zhang-Ding-mei [Author]; Wang-Guo-ling
  [Author]; Guo-Zhong-min [Author]; Zhang-Chuan-hai [Author]; Tan-Bing-yan
  [Author]; Ouyang-Li-ping [Author]; Lin-Li [Author]; Liu-Yi-min [Author]; Chen
  -Wei-qing [Author]; Ling-Wen-hua [Author]; Yu-Xin-bing [Author]; Zhong-Nan-shan
  [Author]
AD: Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510080, Peoples R China
EMA: jiahailu@yahoo.com.cn
SO: Chinese-Medical-Journal-(English-Edition). 2005; 118(9): 707-713
PY: 2005
DT: Article
IS: 0366-6999
LA: English
AB: Background The rapid transmission and high mortality rate made severe acute
  respiratory syndrome (SARS) a global threat for which no efficacious therapy is
  available now. Without sufficient knowledge about the SARS coronavirus (SARS
  -CoV), it is impossible to define the candidate for the anti-SARS targets. The
  putative nonstructural protein 2 (nsp2) (3CL(pro), following the nomenclature
  by Gao et al, also known as nsp5 in Snidjer et al) of SARS-CoV plays an
  important role in viral transcription and replication, and is an attractive
  target for anti-SARS drug development, so we carried on this study to have an
  insight into putative polymerase nsp2 of SARS-CoV Guangdong (GD) strain.Methods
  The SARS-CoV strain was isolated from a SARS patient in Guangdong, China, and
  cultured in Vero E6 cells. The nsp2 gene was amplified by reverse transcription
  -polymerase chain reaction (RT-PCR) and cloned into eukaryotic expression
  vector pCI-neo (pCI-neo/nsp2). Then the recombinant eukaryotic expression
  vector pCI-neo/nsp2 was transfected into COS-7 cells using lipofectin reagent
  to express the nsp2 protein. The expressive protein of SARS-CoV nsp2 was
  analyzed by 7% sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS
  -PAGE). The nucleotide sequence and protein sequence of GD nsp2 were compared
  with that of other SARS-CoV strains by nucleotide-nucleotide basic local
  alignment search tool (BLASTN) and protein-protein basic local alignment search
  tool (BLASTP) to investigate its variance trend during the transmission. The
  secondary structure of GD strain and that of other strains were predicted by
  Garnier-Osguthorpe-Robson (GOR) Secondary Structure Prediction. Three
  -dimensional-PSSM Protein Fold Recognition (Threading) Server was employed to
  construct the three-dimensional model of the nsp2 protein.Results The putative
  polymerase nsp2 gene of GD strain was amplified by RT-PCR. The eukaryotic
  expression vector (pCI-neo/nsp2) was constructed and expressed the protein in
  COS-7 cells successfully. The result of sequencing and sequence comparison with
  other SARS-CoV strains showed that nsp2 gene was relatively conservative during
  the transmission and total five base sites mutated in about 100 strains
  investigated, three of which in the early and middle phases caused synonymous
  mutation, and another two base sites variation in the late phase resulted in
  the amino acid substitutions and secondary structure changes. The three
  -dimensional structure of the nsp2 protein was successfully
  constructed.Conclusions The results suggest that polymerase nsp2 is relatively
  stable during the phase of epidemic. The amino acid and secondary structure
  change may be important for viral infection. The fact that majority of single
  nucleotide variations (SNVs) are predicted to cause synonymous, as well as the
  result of low mutation rate of nsp2 gene in the epidemic variations, indicates
  that the nsp2 is conservative and could be a target for anti-SARS drugs. The
  three-dimensional structure result indicates that the nsp2 protein of GD strain
  is high homologous with 3CL(pro) of SARS-CoV urbani strain, 3CL(pro) of
  transmissible gastroenteritis virus and 3CL(pro) of human coronavirus 229E
  strain, which further suggests that nsp2 protein of GD strain possesses the
  activity of 3CL(pro).
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Respiratory-System: Respiration-
ST: [86205-] Cercopithecidae-, Primates-, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: COS-7-cell-line (Cercopithecidae-): cell_line-; Vero-E6-cell-line
  (Cercopithecidae-): cell_line-; Severe-Acute-Respiratory-Syndrome-virus
  (Coronaviridae-): common-, pathogen-, strain-229E, strain-3Cl, strain
  -Guangdong; human- (Hominidae-): common-, host-
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
CB: polymerase-: 344315-57-7; non-structural-protein-2: three-dimensional
  -structure
GN: Severe-Acute-Respiratory-Syndrome-virus-nsp2-gene [Coronaviridae-]: Severe
  -Acute-Respiratory-Syndrome-virus-non-structural-protein-2-gene-gene, mutation
  -, single-nucleotide-variation
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, infectious-disease, viral-disease, drug
  -therapy, mortality-, genetics-, prevention-and-control, therapy-, transmission
  -, pathology-
RN: 344315-57-7
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
03502- (Genetics
  -General)
03506- (Genetics-Animal)
03508- (Genetics-Human)
12502- (Pathology
  -General)
12512- (Pathology-Therapy)
16004- (Respiratory-system-Physiology
  -and-biochemistry)
16006- (Respiratory-system-Pathology)
31500- (Genetics-of
  -bacteria-and-viruses)
33502- (Virology-General-and-methods)
36001- (Medical
  -and-clinical-microbiology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
AN: 200510100408
UD: 20050816
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0366
  -6999&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0366
  -6999&isbn=&volume=118&issue=9&spage=707&pages=707
  -713&date=2005&title=Chinese%20Medical%20Journal%20%28English%20Edition%29&atitl
  e=Variation%20analysis%20of%20the%20severe%20acute%20respiratory%20syndrome%20co
  ronavirus%20putative%20non
  -structural%20protein%202%20gene%20and%20construction%20of%20three
  -dimensional%20model&aulast=&pid=%3Cauthor%3ELu%20Jia%20hai%3bZhang%20Ding%20mei
  %3bWang%20Guo%20ling%3bGuo%20Zhong%20min%3bZhang%20Chuan%20hai%3bTan%20Bing%20ya
  n%3bOuyang%20Li%20ping%3bLin%20Li%3bLiu%20Yi%20min%3bChen%20Wei%20qing%3bLing%20
  Wen%20hua%3bYu%20Xin%20bing%3bZhong%20Nan%20shan%3C%2Fauthor%3E%3CAN%3E200510100
  408%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 220 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Use of quarantine in the control of SARS in Singapore
AU: Ooi,-Peng-Lim [Author,-Reprint-Author]; Lim,-Sonny [Author]; Chew,-Suok-Kai
  [Author]
AD: Minist Hlth, Dis Control Branch, 16 Coll Rd, Singapore 169854, Singapore
EMA: ooi_peng_lim@moh.gov.sg
SO: American-Journal-of-Infection-Control. 2005; 33(5): 252-257
PY: 2005
DT: Article
IS: 0196-6553
LA: English
AB: Background: A total of 238 cases of the severe acute respiratory syndrome
  (SARS) occurred in Singapore between February 25 and May 11, 2003. Control
  relied on empirical methods to detect early and isolate all cases and
  quarantine those who were exposed to prevent spread in the community.Methods:
  On April 28, 2003, the Infectious Diseases Act was amended in Parliament to
  strengthen the legal provisions for serving the Home Quarantine Order (HQO). In
  mounting large-scale quarantine operations, a framework for contact tracing,
  serving quarantine orders, surveillance, enforcement, health education,
  transport, and financial support was developed and urgently put in
  place.Results: A total of 7863 contacts of SARS cases were served with an HQO,
  giving a ratio of 38 contacts per case. Most of those served complied well with
  quarantine: 26 (0.03%) who broke quarantine were penalized.Conclusion:
  Singapore's experience underscored the importance of being prepared to respond
  to challenges with extraordinary measures. With emerging diseases, health
  authorities need to rethink the value of quarantine to reduce opportunities for
  spread from potential reservoirs of infection.
AI: Y
MC: Infection-; Methods-and-Techniques; Pulmonary-Medicine: Human-Medicine,
  Medical-Sciences; Public-Health: Allied-Medical-Sciences
ST: [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
GE: Singapore-: Asia-, Oriental-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, prevention-and-control
MQ: quarantine-: therapeutic-and-prophylactic-techniques, clinical-techniques
MI: home-quarantine-order
CC: 16006- (Respiratory-system-Pathology)
36006- (Medical-and-clinical
  -microbiology-Virology)
37001- (Public-health-General-and-miscellaneous)
AN: 200510099070
UD: 20050816
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0196
  -6553&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0196
  -6553&isbn=&volume=33&issue=5&spage=252&pages=252
  -257&date=2005&title=American%20Journal%20of%20Infection%20Control&atitle=Use%20
  of%20quarantine%20in%20the%20control%20of%20SARS%20in%20Singapore&aulast=Ooi&pid
  =%3Cauthor%3EOoi%2c%20Peng%20Lim%3bLim%2c%20Sonny%3bChew%2c%20Suok%20Kai%3C%2Fau
  thor%3E%3CAN%3E200510099070%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 221 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Characterization of ER retrieval signals in coronavirus spike proteins
AU: McBride,-C-E [Author,-Reprint-Author]; Lontok,-E [Author]; Machamer,-C
  [Author]
AD: Johns Hopkins Univ, Baltimore, MD USA
SO: Molecular-Biology-of-the-Cell. 2004; 15(Suppl. S): 190A
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 1059-1524
MT: 44th Annual Meeting of the American-Society-for-Cell-Biology, Washington,
  DC, USA; December 04 -08, 2004
SP: Amer Soc Cell Biol
LA: English
MC: Infection-; Biochemistry-and-Molecular-Biophysics; Respiratory-System:
  Respiration-
ST: [03000-] Viruses-, Microorganisms-
OR: coronavirus- (Viruses-): common-
TN: Viruses-: Microorganisms-, Viruses-
CB: dilysine-: 13184-13-9; spike-proteins; S-protein; COPI-; ER-membrane
  -protein: endoplasmic-reticulum-membrane-protein; ERGIC-: endoplasmic-reticulum
  -golgi-intermediate-compartment
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease
RN: 13184-13-9
MI: retrieval-signal
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10060-
  (Biochemistry-studies-General)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
33502- (Virology-General
  -and-methods)
AN: 200510094718
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1059
  -1524&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1059
  -1524&isbn=&volume=15&issue=Suppl.%20S&spage=&pages=190A&date=2004&title=Molecul
  ar%20Biology%20of%20the%20Cell&atitle=Characterization%20of%20ER%20retrieval%20s
  ignals%20in%20coronavirus%20spike%20proteins&aulast=McBride&pid=%3Cauthor%3EMcBr
  ide%2c%20C%20E%3bLontok%2c%20E%3bMachamer%2c%20C%3C%2Fauthor%3E%3CAN%3E200510094
  718%3C%2FAN%3E%3CDT%3EMeeting%20Abstract%3bMeeting%3C%2FDT%3E

Record 222 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Th2 predominance and CD8+ memory T cell depletion in patients with severe
  acute respiratory syndrome
AU: Huang,-Jia-Ling [Author]; Huang,-Jian [Author]; Duan,-Zhao-Hui [Author];
  Wei,-Jing [Author]; Min,-Jun [Author]; Luo,-Xiao-Hong [Author]; Li,-Jian-Guo
  [Author]; Tan,-Wei-Ping [Author]; Wu,-Li-Zhi [Author]; Liu,-Ran-Yi [Author];
  Li,-Yan [Author]; Shao,-Jing [Author]; Huang,-Bi-Jun [Author]; Zeng,-Yi-Xin
  [Author]; Huang,-Wenlin [Author,-Reprint-Author]
AD: Natl Sun Yat Sen Univ, Inst Canc, Ctr Canc, 651 Dongfeng Rd E, Guangzhou
  510060, Peoples R China
EMA: wl_huang@hotmail.com
SO: Microbes-and-Infection. 2005; 7(3): 427-436
PY: 2005
DT: Article
IS: 1286-4579
LA: English
AB: The immune spectrum of severe acute respiratory syndrome (SARS) is poorly
  understood.To define the dynamics of the immune spectrum in SARS, serum levels
  of cytokines, chemokines, immunoglobulins, complement and specific antibodies
  against SARS-associated coronavirus (SARS-CoV) were assayed by enzyme-linked
  immunosorbent assay (ELISA), and phenotypes of peripheral lymphocytes were
  analyzed by flow cytometry in 95 SARS-infected patients. Results showed that
  interleukin (IL)-10 and transforming growth factor beta (TGF-beta) were
  continuously up-regulated during the entirety of SARS. Regulated on activation
  normally T cell-expressed and secreted (RANTES) levels were decreased, while
  monocyte chemoattractant protein-1 (MCP-1) was elevated in acute patients.
  Immunoglobulins and complement were elevated during the first month of SARS.
  Both serum-positive rates and titers of specific IgM and IgG antibodies
  responding to SARS-CoV peaked at days 41-60 from the onset of SARS. CD4+ and
  CD8+ T lymphocytes decreased significantly in acute-phase. CD3+CD8+CD45RO+ T
  lymphocytes were decreased by 36.78% in the convalescent patients. Conclusion:
  SARS-CoV seemed to elicit effective humoral immunity but inhibited cellular
  immunity, especially CD8+ memory T lymphocytes over time. Prolonged
  overproduction of IL-10 and TGF-beta may play an important role in the disease.
  (c) 2005 Elsevier SAS. All rights reserved.
AI: Y
MC: Infection-; Clinical-Immunology: Human-Medicine, Medical-Sciences; Pulmonary
  -Medicine: Human-Medicine, Medical-Sciences
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, adult-, host-, female
  -, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: serum-: blood-and-lymphatics; CD4-positive-T-lymphocytes: immune-system,
  blood-and-lymphatics; Th2-cell: immune-system, blood-and-lymphatics; peripheral
  -lymphocytes: immune-system, blood-and-lymphatics; CD8-positive-T-cells: immune
  -system, blood-and-lymphatics; T-lymphocytes: immune-system, blood-and
  -lymphatics
CB: antibodies-; cytokines-; IgG-: immunoglobulin-G; IgM-: immunoglobulin-M; CD3
  -; IL-10: interleukin-10; CD8-; chemokines-; complement-; CD4-; transforming
  -growth-factor-beta: TGF-beta; CD45RO-; immunoglobulins-; RANTES-; monocyte
  -chemoattractant-protein-1: MCP-1
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: ELISA-: laboratory-techniques, immunologic-techniques; flow-cytometry:
  laboratory-techniques, histology-and-cytology-techniques
MI: humoral-immunity; cellular-immunity
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
10064- (Biochemistry
  -studies-Proteins-peptides-and-amino-acids)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
16006- (Respiratory-system
  -Pathology)
17002- (Endocrine-General)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
34508- (Immunology
  -Immunopathology-tissue-immunology)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510093454
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1286
  -4579&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1286
  -4579&isbn=&volume=7&issue=3&spage=427&pages=427
  -436&date=2005&title=Microbes%20and%20Infection&atitle=Th2%20predominance%20and%
  20CD8%2b%20memory%20T%20cell%20depletion%20in%20patients%20with%20severe%20acute
  %20respiratory%20syndrome&aulast=Huang&pid=%3Cauthor%3EHuang%2c%20Jia%20Ling%3bH
  uang%2c%20Jian%3bDuan%2c%20Zhao%20Hui%3bWei%2c%20Jing%3bMin%2c%20Jun%3bLuo%2c%20
  Xiao%20Hong%3bLi%2c%20Jian%20Guo%3bTan%2c%20Wei%20Ping%3bWu%2c%20Li%20Zhi%3bLiu%
  2c%20Ran%20Yi%3bLi%2c%20Yan%3bShao%2c%20Jing%3bHuang%2c%20Bi%20Jun%3bZeng%2c%20Y
  i%20Xin%3bHuang%2c%20Wenlin%3C%2Fauthor%3E%3CAN%3E200510093454%3C%2FAN%3E%3CDT%3
  EArticle%3C%2FDT%3E

Record 223 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Genetic differentiation and local temporal stability of population structure
  in the euphausiid Meganyctiphanes norvegica
AU: Papetti,-Chiara [Author]; Zane,-Lorenzo [Author]; Bortolotto,-Erica
  [Author]; Bucklin,-Ann [Author]; Patarnello,-Tomaso [Author,-Reprint-Author]
AD: Univ Padua, Dept Biol, Via U Bassi 58B, I-35121 Padua, Italy
EMA: tomaso.patarnello@unipd.it
SO: Marine-Ecology-Progress-Series. 2005; 289: 225-235
PY: 2005
DT: Article
IS: 0171-86301616-1599
LA: English
AB: Meganyctiphanes norvegica (M. Sars 1856), the northern krill, is the largest
  and most abundant euphausiid species in the northern hemisphere, where it
  represents a key component of many pelagic communities. Although planktonic,
  krill could be considered a nektonic organism, as it is capable of active
  movements. This behaviour may be adaptive, because it allows these organisms to
  maintain their geographic position, leading to stable population structure,
  despite being continuously exposed to the heterogeneous oceanic conditions. By
  means of single-strand conformation polymorphism and DNA sequencing, we
  analyzed allelic variation of the Subunit 1 of NADH dehydrogenase mtDNA locus
  in 23 populations of the northern krill Meganyctiphanes norvegica, from 15
  locations spanning the distribution range of the species. Analysis of the data
  indicated that the genetic structure, as revealed by analysis of population
  samples collected at the same site in consecutive years, was stable during that
  sampling period. Our results revealed the existence of 4 genetically and
  geographically distinct gene pools of M. norvegica, 2 occurring in the NE
  Atlantic ('northern' NE Atlantic and 'southern' NE Atlantic), 1 in the NW
  Atlantic, and 1 in the Mediterranean (Ligurian) Sea.
AI: Y
MC: Methods-and-Techniques; Enzymology-: Biochemistry-and-Molecular-Biophysics;
  Marine-Ecology: Ecology-, Environmental-Sciences
ST: [75112-] Malacostraca-, Crustacea-, Arthropoda-, Invertebrata-, Animalia-
OR: euphausiid- (Malacostraca-): common-; Meganyctiphanes-norvegica
  (Malacostraca-): species-, northern-krill, common-
TN: Malacostraca-: Animals-, Arthropods-, Crustaceans-, Invertebrates-
CB: mitochondrial-DNA; NADH-dehydrogenase: 9079-67-8, EC-1.6.99.3
RN: 9079-67-8
MQ: DNA-sequencing: laboratory-techniques, genetic-techniques; single-strand
  -conformational-polymorphism-analysis: laboratory-techniques, genetic-techniques
MI: allelic-variation; genetic-differentiation; population-structure; genetic
  -structure; local-temporal-stability
CC: 07508- (Ecology-environmental-biology-Animal)
07512- (Ecology-environmental
  -biology-Oceanography)
10062- (Biochemistry-studies-Nucleic-acids-purines-and
  -pyrimidines)
10802- (Enzymes-General-and-comparative-studies
  -coenzymes)
64054- (Invertebratacomparative-experimental-morphology-physiology
  -and-pathology-Arthropoda-crustacea)
AN: 200510093288
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0171
  -86301616-1599&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0171
  -86301616-1599&isbn=&volume=289&issue=&spage=225&pages=225
  -235&date=2005&title=Marine%20Ecology%20Progress%20Series&atitle=Genetic%20diffe
  rentiation%20and%20local%20temporal%20stability%20of%20population%20structure%20
  in%20the%20euphausiid%20Meganyctiphanes%20norvegica&aulast=Papetti&pid=%3Cauthor
  %3EPapetti%2c%20Chiara%3bZane%2c%20Lorenzo%3bBortolotto%2c%20Erica%3bBucklin%2c%
  20Ann%3bPatarnello%2c%20Tomaso%3C%2Fauthor%3E%3CAN%3E200510093288%3C%2FAN%3E%3CD
  T%3EArticle%3C%2FDT%3E

Record 224 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Variable fatty acid composition of the pelagic appendicularian Oikopleura
  dioica in response to dietary quality and quantity
AU: Troedsson,-Christofer [Author]; Grahl-Nielsen,-Otto [Author]; Thompson,-Eric
  -M [Author,-Reprint-Author]
AD: Sars Int Ctr Marine Mol Biol, Thormohlensgate 55, N-5008 Bergen, Norway
EMA: eric.thompson@sars.uib.no
SO: Marine-Ecology-Progress-Series. 2005; 289: 165-176
PY: 2005
DT: Article
IS: 0171-86301616-1599
LA: English
AB: In marine zooplankton communities, appendicularians are second in abundance
  to copepods, and there is evidence that they are an important dietary component
  for larvae of several fish species. As various algal species upon which the
  appendicularian Oikopleura dioica grazes differ significantly in their fatty
  acid compositions, we have examined how this filter feeder translates diets
  that differ in quality or quantity into its own fatty acid composition. By
  feeding O. dioica diets containing either a single diatom or single flagellate
  species, we demonstrated that the fatty acid composition of O. dioica reflects
  dietary quality. Quantitative differences in the amount of fatty acids in the
  diet also directly led to quantitative differences in fatty acid content of the
  animal, consistent with differences in reproductive output reported earlier.
  Under the same dietary regimes, males differed from females in fatty acid
  composition. Among these differences, females had higher amounts of
  eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), important for
  larval development. Analysis of fatty acid composition of fecal pellets
  revealed selective assimilation of some fatty acids by the animals, including
  EPA and DHA. Overall, consistent with data on other zooplanktonic filter
  feeders, the fatty acid composition of O. dioica reflected dietary composition,
  indicating that the nutritional quality of primary production would be
  transferred to predators of this component of zooplankton without substantial
  intermediary modifications.
AI: Y
MC: Nutrition-; Marine-Ecology: Ecology-, Environmental-Sciences
ST: [85104-] Urochordata-, Protochordata-, Chordata-, Animalia-
OR: Oikopleura-dioica (Urochordata-): species-, larva-, fetus-
TN: Urochordata-: Animals-, Chordates-, Invertebrates-, Protochordates-
CB: eicosapentaenoic-acid: EPA-, 32839-30-8; docosahexaenoic-acid: DHA-, 32839
  -18-2
RN: 32839-30-8; 32839-18-2
MI: reproductive-output; fatty-acid-composition; larval-development; nutritional
  -quality; fecal-pellet; algal-species
CC: 07508- (Ecology-environmental-biology-Animal)
07512- (Ecology-environmental
  -biology-Oceanography)
10066- (Biochemistry-studies-Lipids)
13202- (Nutrition
  -General-studies-nutritional-status-and-methods)
25502- (Development-and
  -Embryology-General-and-descriptive)
AN: 200510093283
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0171
  -86301616-1599&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0171
  -86301616-1599&isbn=&volume=289&issue=&spage=165&pages=165
  -176&date=2005&title=Marine%20Ecology%20Progress%20Series&atitle=Variable%20fatt
  y%20acid%20composition%20of%20the%20pelagic%20appendicularian%20Oikopleura%20dio
  ica%20in%20response%20to%20dietary%20quality%20and%20quantity&aulast=Troedsson&p
  id=%3Cauthor%3ETroedsson%2c%20Christofer%3bGrahl%20Nielsen%2c%20Otto%3bThompson%
  2c%20Eric%20M%3C%2Fauthor%3E%3CAN%3E200510093283%3C%2FAN%3E%3CDT%3EArticle%3C%2F
  DT%3E

Record 225 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Identification and characterization of the putative fusion peptide of the
  severe acute respiratory syndrome-associated coronavirus spike protein
AU: Sainz,-Bruno-Jr [Author]; Rausch,-Joshua-M [Author]; Gallaher,-William-R
  [Author]; Garry,-Robert-F [Author]; Wimley,-William-C [Author,-Reprint-Author]
AD: Tulane Univ, Ctr Hlth Sci, Dept Biochem, 1430 Tulane Ave,SL-43, New Orleans,
  LA 70112 USA
EMA: wwimley@tulane.edu
SO: Journal-of-Virology. 2005; 79(11): 7195-7206
PY: 2005
DT: Article
IS: 0022-538X
LA: English
AB: Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) is a
  newly identified member of the family Coronaviridae and poses a serious public
  health threat. Recent studies indicated that the SARS-CoV viral spike
  glycoprotein is a class I viral fusion protein. A fusion peptide present at the
  N-terminal region of class I viral fusion proteins is believed to initiate
  viral and cell membrane interactions and subsequent fusion. Although the SARS
  -CoV fusion protein heptad repeats have been well characterized, the fusion
  peptide has yet to be identified. Based on the conserved features of known
  viral fusion peptides and using Wimley and White interfacial hydrophobicity
  plots, we have identified two putative fusion peptides (SARS(WW-I) and SARS(WW
  -II)) at the N terminus of the SARS-CoV S2 subunit. Both peptides are
  hydrophobic and rich in alanine, glycine, and/or phenylalanine residues and
  contain a canonical fusion tripeptide along with a central proline residue.
  Only the SARS(WW-I) peptide strongly partitioned into the membranes of large
  unilamellar vesicles (LUV), adopting a P-sheet structure. Likewise, only
  SARS(WW-I) induced the fusion of LUV and caused membrane leakage of vesicle
  contents at peptide/lipid ratios of 1:50 and 1:100, respectively. The activity
  of this synthetic peptide appeared to be dependent on its amino acid (aa)
  sequence, as scrambling the peptide rendered it unable to partition into LUV,
  assume a defined secondary structure, or induce both fusion and leakage of LUV.
  Based on the activity of SARS(WW-I), we propose that the hydrophobic stretch of
  19 aa corresponding to residues 770 to 788 is a fusion peptide of the SARS-CoV
  S2 subunit.
AI: Y
MC: Infection-; Immune-System: Chemical-Coordination-and-Homeostasis; Molecular
  -Genetics: Biochemistry-and-Molecular-Biophysics
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: glycoprotein-; alanine-: 302-72-7; proline-: 609-36-9; glycine-: 56-40-6;
  phenylalanine-: 150-30-1; spike-protein
DS: severe-acute-respiratory-syndrome-associated-coronavirus: respiratory-system
  -disease
RN: 302-72-7; 609-36-9; 56-40-6; 150-30-1
MI: large-unilamellar-vesicle
CC: 03502- (Genetics-General)
10064- (Biochemistry-studies-Proteins-peptides
  -and-amino-acids)
16006- (Respiratory-system-Pathology)
31500- (Genetics-of
  -bacteria-and-viruses)
33502- (Virology-General-and-methods)
34502-
  (Immunology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
AN: 200510093111
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -538X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -538X&isbn=&volume=79&issue=11&spage=7195&pages=7195
  -7206&date=2005&title=Journal%20of%20Virology&atitle=Identification%20and%20char
  acterization%20of%20the%20putative%20fusion%20peptide%20of%20the%20severe%20acut
  e%20respiratory%20syndrome
  -associated%20coronavirus%20spike%20protein&aulast=Sainz&pid=%3Cauthor%3ESainz%2
  c%20Bruno%20Jr%3bRausch%2c%20Joshua%20M%3bGallaher%2c%20William%20R%3bGarry%2c%2
  0Robert%20F%3bWimley%2c%20William%20C%3C%2Fauthor%3E%3CAN%3E200510093111%3C%2FAN
  %3E%3CDT%3EArticle%3C%2FDT%3E

Record 226 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Cinanserin is an inhibitor of the 3C-like proteinase of severe acute
  respiratory syndrome coronavirus and strongly reduces virus replication in vitro
AU: Chen,-Lili [Author]; Gui,-Chunshan [Author]; Luo,-Xiaomin [Author]; Yang,
  -Qingang [Author]; Guenther,-Stephan [Author]; Scandella,-Elke [Author];
  Drosten,-Christian [Author]; Bai,-Donglu [Author]; He,-Xichang [Author];
  Ludewig,-Burkhard [Author]; Chen,-Jing [Author]; Luo,-Haibin [Author]; Yang,
  -Yiming [Author]; Yang,-Yifu [Author]; Zou,-Jianping [Author]; Thiel,-Volker
  [Author]; Chen,-Kaixian [Author]; Shen,-Jianhua [Author]; Shen,-Xu [Author,
  -Reprint-Author]; Jiang,-Hualiang [Author]
AD: Bernhard Nocht Inst Trop Med, Dept Virol, Bernhard Nocht Str 74, D-20359
  Hamburg, Germany
EMA: guenther@bni.uni-hamburg.de; xshen@mail.shcne.ac.cn
SO: Journal-of-Virology. 2005; 79(11): 7095-7103
PY: 2005
DT: Article
IS: 0022-538X
LA: English
AB: The 3C-like proteinase (3CL(pro)) of severe acute respiratory syndrome
  -associated coronavirus (SARS-CoV) is one of the most promising targets for
  anti-SARS-CoV drugs due to its crucial role in the viral life cycle. In this
  study, a database containing structural information of more than 8,000 existing
  drugs was virtually screened by a docking approach to identify potential
  binding molecules of SARS-CoV 3CL(pro). As a target for screening, both a
  homology model and the crystallographic structure of the binding pocket of the
  enzyme were used. Cinanserin (SQ 10,643), a well-characterized serotonin
  antagonist that has undergone preliminary clinical testing in humans in the
  1960s, showed a high score in the screening and was chosen for further
  experimental evaluation. Binding of both cinanserin and its hydrochloride to
  bacterially expressed 3CL(pro) of SARS-CoV and the related human coronavirus
  229E (HCoV-229E) was demonstrated by surface plasmon resonance technology. The
  catalytic activity of both enzymes was inhibited with 50% inhibitory
  concentration (IC50) values of 5 mu M, as tested with a fluorogenic substrate.
  The antiviral activity of cinanserin was further evaluated in tissue culture
  assays, namely, a replicon system based on HCoV-229E and quantitative test
  assays with infectious SARS-CoV and HCoV-229E. All assays revealed a strong
  inhibition of coronavirus replication at nontoxic drug concentrations. The
  level of virus RNA and infectious particles was reduced by up to 4 log units,
  with IC50 values ranging from 19 to 34 mu M. These findings demonstrate that
  the old drug cinanserin is an inhibitor of SARS-CoV replication, acting most
  likely via inhibition of the 3CL proteinase.
AI: Y
MC: Pharmacology-; Infection-; Enzymology-: Biochemistry-and-Molecular
  -Biophysics; Respiratory-System: Respiration-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [06702-] Enterobacteriaceae-, Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; Human-coronavirus-229E (Coronaviridae-): species-, pathogen-; Escherichia
  -coli (Enterobacteriaceae-): species-, strain-BL21
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-
CB: RNA-; 3C-like-proteinase: 218925-73-6; cinanserin-: 1166-34-3, enzyme
  -inhibitor-drug, serotonin-receptor-antagonist-drug, antiviral-drug,
  antiinfective-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy, pathology-
RN: 218925-73-6; 1166-34-3
MQ: surface-plasmon-resonance: laboratory-techniques, spectrum-analysis
  -techniques
CC: 10062- (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
10802-
  (Enzymes-General-and-comparative-studies-coenzymes)
12502- (Pathology
  -General)
12512- (Pathology-Therapy)
16004- (Respiratory-system-Physiology
  -and-biochemistry)
16006- (Respiratory-system-Pathology)
22002- (Pharmacology
  -General)
22024- (Pharmacology-Neuropharmacology)
31000- (Physiology-and
  -biochemistry-of-bacteria)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
38502- (Chemotherapy-General
  -methods-and-metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510093102
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -538X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -538X&isbn=&volume=79&issue=11&spage=7095&pages=7095
  -7103&date=2005&title=Journal%20of%20Virology&atitle=Cinanserin%20is%20an%20inhi
  bitor%20of%20the%203C
  -like%20proteinase%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus%
  20and%20strongly%20reduces%20virus%20replication%20in%20vitro&aulast=Chen&pid=%3
  Cauthor%3EChen%2c%20Lili%3bGui%2c%20Chunshan%3bLuo%2c%20Xiaomin%3bYang%2c%20Qing
  ang%3bGuenther%2c%20Stephan%3bScandella%2c%20Elke%3bDrosten%2c%20Christian%3bBai
  %2c%20Donglu%3bHe%2c%20Xichang%3bLudewig%2c%20Burkhard%3bChen%2c%20Jing%3bLuo%2c
  %20Haibin%3bYang%2c%20Yiming%3bYang%2c%20Yifu%3bZou%2c%20Jianping%3bThiel%2c%20V
  olker%3bChen%2c%20Kaixian%3bShen%2c%20Jianhua%3bShen%2c%20Xu%3bJiang%2c%20Hualia
  ng%3C%2Fauthor%3E%3CAN%3E200510093102%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 227 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Study on the resistance of severe acute respiratory syndrome-associated
  coronavirus
AU: Wang,-Xin-Wei [Author]; Li,-Jin-Song [Author]; Jin,-Min [Author]; Zhen,-Bei
  [Author]; Kong,-Qing-Xin [Author]; Song,-Nong [Author]; Xiao,-Wen-Jun [Author];
  Yin,-Jing [Author]; Wei,-Wei [Author]; Wang,-Gui-Jie [Author]; Si,-Bing-Yin
  [Author]; Guo,-Bao-Zhong [Author]; Liu,-Chao [Author]; Ou,-Guo-Rong [Author];
  Wang,-Min-Nian [Author]; Fang,-Tong-Yu [Author]; Chao,-Fu-Huan [Author]; Li,
  -Jun-Wen [Author,-Reprint-Author]
AD: Tianjin Inst Environm and Hlth, 1 Da Li Rd, Tianjin 300050, Peoples R China
EMA: junwenli@eyou.com
SO: Journal-of-Virological-Methods. 2005; 126(1-2): 171-177
PY: 2005
DT: Article
IS: 0166-0934
LA: English
AB: In this study, the persistence of severe acute respiratory syndrome
  -associated coronavirus (SARS-CoV) was observed in feces, urine and water. In
  addition, the inactivation of SARS-CoV in wastewater with sodium hypochlorite
  and chlorine dioxide was also studied. In vitro experiments demonstrated that
  the virus could only persist for 2 days in hospital wastewater, domestic sewage
  and dechlorinated tap water, while 3 days in feces, 14 days in PBS and 17 days
  in urine at 20 degrees C. However, at 4 degrees C, the SARS-CoV could persist
  for 14 days in wastewater and at least 17 days in feces or urine. SARS-CoV is
  more susceptible to disinfectants than Escherichia coli and 172 phage. Free
  chlorine was found to inactivate SARS-CoV better than chlorine dioxide. Free
  residue chlorine over 0.5 mg/L for chlorine or 2.19 mg/L for chlorine dioxide
  in wastewater ensures complete inactivation of SARS-CoV while it does not
  inactivate completely E. coli and f(2) phage. (c) 2005 Elsevier B.V. All rights
  reserved.
AI: Y
MC: Infection-; Pollution-Assessment-Control-and-Management; Pulmonary-Medicine:
  Human-Medicine, Medical-Sciences
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [06702-] Enterobacteriaceae-, Facultatively-Anaerobic-Gram
  -Negative-Rods, Eubacteria-, Bacteria-, Microorganisms-; [86215-] Hominidae-,
  Primates-, Mammalia-, Vertebrata-, Chordata-, Animalia-; [03201-] Inoviridae-,
  ssDNA-Viruses, Viruses-, Microorganisms-
OR: Coronavirus-infectious-bronchitis-virus (Coronaviridae-): common-,
  Infectious-bronchitis-virus, species-, pathogen-; Escherichia-coli
  (Enterobacteriaceae-): species-, pathogen-; human- (Hominidae-): common-, host
  -; Bacteriophage-f2 (Inoviridae-): common-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Enterobacteriaceae-: Bacteria-, Eubacteria-, Microorganisms-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-;
  Inoviridae-: Single-Stranded-DNA-Viruses, Microorganisms-, Viruses-
PS: urine-: excretory-system; feces-: digestive-system
CB: sodium-hypochlorite: 7681-52-9; water-: 7732-18-5; free-chlorine; tap-water;
  PBS-; chlorine-dioxide: 10049-04-4
DS: acute-respiratory-distress-syndrome: (Respiratory-Distress-Syndrome-(MeSH)),
  respiratory-system-disease; coronavirus-infection: viral-disease
RN: 7681-52-9; 7732-18-5; 10049-04-4
MQ: wastewater-treatment: applied-and-field-techniques
MI: domestic-sewage; hospital-wastewater
CC: 10060- (Biochemistry-studies-General)
14004- (Digestive-system-Physiology
  -and-biochemistry)
15504- (Urinary-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
31000- (Physiology-and-biochemistry-of
  -bacteria)
33502- (Virology-General-and-methods)
36002- (Medical-and-clinical
  -microbiology-Bacteriology)
36006- (Medical-and-clinical-microbiology
  -Virology)
37015- (Public-health-Air-water-and-soil-pollution)
AN: 200510093042
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0166
  -0934&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0166
  -0934&isbn=&volume=126&issue=1-2&spage=171&pages=171
  -177&date=2005&title=Journal%20of%20Virological%20Methods&atitle=Study%20on%20th
  e%20resistance%20of%20severe%20acute%20respiratory%20syndrome
  -associated%20coronavirus&aulast=Wang&pid=%3Cauthor%3EWang%2c%20Xin%20Wei%3bLi%2
  c%20Jin%20Song%3bJin%2c%20Min%3bZhen%2c%20Bei%3bKong%2c%20Qing%20Xin%3bSong%2c%2
  0Nong%3bXiao%2c%20Wen%20Jun%3bYin%2c%20Jing%3bWei%2c%20Wei%3bWang%2c%20Gui%20Jie
  %3bSi%2c%20Bing%20Yin%3bGuo%2c%20Bao%20Zhong%3bLiu%2c%20Chao%3bOu%2c%20Guo%20Ron
  g%3bWang%2c%20Min%20Nian%3bFang%2c%20Tong%20Yu%3bChao%2c%20Fu%20Huan%3bLi%2c%20J
  un%20Wen%3C%2Fauthor%3E%3CAN%3E200510093042%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 228 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: The impact of severe acute respiratory syndrome on medical house staff - A
  qualitative study
AU: Rambaldini,-Gloria [Author]; Wilson,-Kumanan [Author]; Rath,-Darlyne
  [Author]; Lin,-Yulia [Author]; Gold,-Wayne-L [Author]; Kapral,-Moira-K
  [Author]; Straus,-Sharon-E [Author,-Reprint-Author]
AD: Toronto Gen Hosp, Dept Med, 200 Elizabeth St,9ES-407, Toronto, ON M5G 2C4,
  Canada
EMA: sharon.straus@utoronto.ca
SO: Journal-of-General-Internal-Medicine. 2005; 20(5): 381-385
PY: 2005
DT: Article
IS: 0884-8734
LA: English
AB: OBJECTIVE: To explore the impact of severe acute respiratory syndrome (SARS)
  on a medical training program and to develop principles for professional
  training programs to consider in dealing with future, similar crises.DESIGN:
  Qualitative interviews analyzed using grounded theory methodology.SETTING:
  University-affiliated hospitals in Toronto, Canada during the SARS outbreak in
  2003.PARTICIPANTS: Medical house staff who were allocated to a general internal
  medicine clinical teaching unit, infectious diseases consultation service, or
  intensive care unit.RESULTS: Seventeen medical residents participated in this
  study. Participants described their experiences during the outbreak and
  highlighted several themes including concerns about their personal safety and
  about the negative impact of the outbreak on patient care, house staff
  education, and their emotional well-being.CONCLUSION: The ability of residents
  to cope with the stress of the SARS outbreak was enhanced by the communication
  of relevant information and by the leadership of their supervisors and
  infection control officers. It is hoped that training programs for health care
  professionals will be able to implement these tenets of crisis management as
  they develop strategies for dealing with future health threats.
AI: Y
MC: Infection-; Occupational-Health: Allied-Medical-Sciences; Pulmonary
  -Medicine: Human-Medicine, Medical-Sciences; Hospital-Administration: Allied
  -Medical-Sciences; Education-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-acute-respiratory-syndrome-virus (Coronaviridae-): species-, pathogen
  -; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MI: disease-outbreak; patient-care; emotional-well-being; medical-house-staff;
  medical-training-program; personal-safety; house-staff-education
CC: 00514- (General-biology-General-textbooks-and-audio-visual-aids)
16006-
  (Respiratory-system-Pathology)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
37010- (Public-health-Public
  -health-administration-and-statistics)
37013- (Public-health-Occupational
  -health)
AN: 200510091154
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0884
  -8734&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0884
  -8734&isbn=&volume=20&issue=5&spage=381&pages=381
  -385&date=2005&title=Journal%20of%20General%20Internal%20Medicine&atitle=The%20i
  mpact%20of%20severe%20acute%20respiratory%20syndrome%20on%20medical%20house%20st
  aff%20-%20A%20qualitative%20study&aulast=Rambaldini&pid=%3Cauthor%3ERambaldini%2
  c%20Gloria%3bWilson%2c%20Kumanan%3bRath%2c%20Darlyne%3bLin%2c%20Yulia%3bGold%2c%
  20Wayne%20L%3bKapral%2c%20Moira%20K%3bStraus%2c%20Sharon%20E%3C%2Fauthor%3E%3CAN
  %3E200510091154%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 229 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Managing knowledge integration in a national health-care crisis: Lessons
  learned from combating SARS in Singapore
AU: Devadoss,-Paul-Raj [Author,-Reprint-Author]; Pan,-Shan-Ling [Author]; Singh,
  -Shreyan [Author]
AD: Natl Univ Singapore, Dept Informat Syst, Sch Comp, Singapore 17543, Singapore
EMA: paulraj@nus.edu.sg; pansl@comp.nus.edu.sg; shreyansingh@yahoo.com
SO: IEEE-Transactions-On-Information-Technology-In-Biomedicine. 2005; 9(2): 266
  -275
PY: 2005
DT: Article
IS: 1089-7771
LA: English
AB: The outbreak of Severe Acute Respiratory Syndrome is the first severe and
  readily transmissible disease to emerge in the 21st century. Often one, new
  infection meant tracing of several people to monitor their health conditions as
  well. In Singapore, several agencies coordinated their efforts to quickly bring
  the outbreak under control. The current breed of health-care information
  systems (HCIS) was not sufficient to handle new information-sharing needs
  during the crisis. In this paper, we take a look at the measures taken during
  the crisis in Singapore through a knowledge integration perspective. This
  perspective reveals interesting implications for HCIS.
AI: Y
MC: Infection-; Epidemiology-: Population-Studies; Human-Medicine: Medical
  -Sciences
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
GE: Singapore-: Asia-, Oriental-region
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease
MI: health-care-crisis; knowledge-integration
CC: 12502- (Pathology-General)
16006- (Respiratory-system-Pathology)
33502-
  (Virology-General-and-methods)
36006- (Medical-and-clinical-microbiology
  -Virology)
37052- (Public-health-epidemiology-Communicable-diseases)
37054-
  (Public-health-epidemiology-Organic-diseases-and-neoplasms)
37056- (Public
  -health-epidemiology-Miscellaneous)
AN: 200510089532
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1089
  -7771&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1089
  -7771&isbn=&volume=9&issue=2&spage=266&pages=266
  -275&date=2005&title=IEEE%20Transactions%20On%20Information%20Technology%20In%20
  Biomedicine&atitle=Managing%20knowledge%20integration%20in%20a%20national%20heal
  th-care%20crisis%3a%20Lessons%20learned%20from%20combating%20SARS%20in%20Singapo
  re&aulast=Devadoss&pid=%3Cauthor%3EDevadoss%2c%20Paul%20Raj%3bPan%2c%20Shan%20Li
  ng%3bSingh%2c%20Shreyan%3C%2Fauthor%3E%3CAN%3E200510089532%3C%2FAN%3E%3CDT%3EArt
  icle%3C%2FDT%3E

Record 230 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Being the pioneer of life sciences in China - Introduction to Beijing
  Genomics Institute
AU: Anonymous [Author]
SO: Genomics-Proteomics-and-Bioinformatics. 2004; 2(1): 59-63
PY: 2004
DT: Article
IS: 1672-0229
LA: English
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Respiratory-System: Respiration-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [85536-] Galliformes-, Aves-, Vertebrata-, Chordata-, Animalia
  -; [25305-] Gramineae-, Monocotyledones-, Angiospermae-, Spermatophyta-,
  Plantae-; [75330-] Lepidoptera-, Insecta-, Arthropoda-, Invertebrata-, Animalia
  -; [85740-] Suidae-, Artiodactyla-, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; chicken- (Galliformes-): common-, host-; rice-
  (Gramineae-): common-, host-, grain-crop; silkworm- (Lepidoptera-): common-,
  host-; pig- (Suidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Galliformes-: Animals-, Birds-, Chordates-, Nonhuman-Vertebrates,
  Vertebrates-; Gramineae-: Angiosperms-, Monocots-, Plants-, Spermatophytes-,
  Vascular-Plants; Lepidoptera-: Animals-, Arthropods-, Insects-, Invertebrates-;
  Suidae-: Animals-, Artiodactyls-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Vertebrates-
GE: China-: Asia-, Palearctic-region
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease
MI: genome-
CC: 03502- (Genetics-General)
03504- (Genetics-Plant)
03506- (Genetics
  -Animal)
10062- (Biochemistry-studies-Nucleic-acids-purines-and
  -pyrimidines)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
31500- (Genetics-of-bacteria-and
  -viruses)
33502- (Virology-General-and-methods)
36006- (Medical-and-clinical
  -microbiology-Virology)
51508- (Plant-physiology-Respiration
  -fermentation)
52504- (Agronomy-Grain-crops)
64076- (Invertebrata-comparative
  -experimental-morphology-physiology-and-pathology-Insecta-physiology)
AN: 200510089378
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1672
  -0229&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1672
  -0229&isbn=&volume=2&issue=1&spage=59&pages=59
  -63&date=2004&title=Genomics%20Proteomics%20and%20Bioinformatics&atitle=Being%20
  the%20pioneer%20of%20life%20sciences%20in%20China%20
  -%20Introduction%20to%20Beijing%20Genomics%20Institute&aulast=&pid=%3Cauthor%3EA
  nonymous%3C%2Fauthor%3E%3CAN%3E200510089378%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 231 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Preliminary study on detecting the SARS-CoV specific target cDNA fragments
  by multiplex PCR
AU: Chen,-Wenbing [Author,-Reprint-Author]; Li,-Shousong [Author]; Shao,-Biying
  [Author]; Zheng,-Teng [Author]; Jiang,-Shuxun [Author]; Huang,-Xiaorong
  [Author]; Cai,-Kaizhen [Author]; Zhang,-Zhideng [Author]
AD: Fujian Entry Exit Inspect and Quarantine Bur, Fuzhou 350003, Peoples R China
EMA: 621213wbc@163.com
SO: Genomics-Proteomics-and-Bioinformatics. 2004; 2(1): 55-58
PY: 2004
DT: Article
IS: 1672-0229
LA: English
AB: The multiplex polymerase chain reaction (PCR) technique was applied to
  detect the SARS-CoV (severe acute respiratory syndrome-associated coronavirus)
  specific target cDNA fragments in the present study. The target cDNA fragments
  of SARS-CoV were synthesized artificially according to the genome sequence of
  SARS-CoV in GenBank submitted by The Chinese University of Hong Kong, and were
  used as simulated positive samples. Five primers recommended by World Health
  Organization (WHO) were used to amplify the fragments by single PCR and
  multiplex PCR. Three target cDNA fragments (121, 182 and 302 bp), as well as
  the three different combinations of any two of these fragments, were amplified
  by single PCR. The combination of these three fragments was amplified by
  multiplex PCR. The results indicated that the multiplex PCR technique could be
  applied to detect the SARS-CoV specific target cDNA fragments successfully.
AI: Y
MC: Infection-; Methods-and-Techniques; Molecular-Genetics: Biochemistry-and
  -Molecular-Biophysics
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: cDNA-fragments
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: PCR-: polymerase-chain-reaction, laboratory-techniques, genetic-techniques;
  multiplex-PCR: multiplex-polymerase-chain-reaction, laboratory-techniques,
  genetic-techniques
MI: genome-
CC: 03502- (Genetics-General)
10062- (Biochemistry-studies-Nucleic-acids
  -purines-and-pyrimidines)
16006- (Respiratory-system-Pathology)
31500-
  (Genetics-of-bacteria-and-viruses)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510089377
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1672
  -0229&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1672
  -0229&isbn=&volume=2&issue=1&spage=55&pages=55
  -58&date=2004&title=Genomics%20Proteomics%20and%20Bioinformatics&atitle=Prelimin
  ary%20study%20on%20detecting%20the%20SARS
  -CoV%20specific%20target%20cDNA%20fragments%20by%20multiplex%20PCR&aulast=Chen&p
  id=%3Cauthor%3EChen%2c%20Wenbing%3bLi%2c%20Shousong%3bShao%2c%20Biying%3bZheng%2
  c%20Teng%3bJiang%2c%20Shuxun%3bHuang%2c%20Xiaorong%3bCai%2c%20Kaizhen%3bZhang%2c
  %20Zhideng%3C%2Fauthor%3E%3CAN%3E200510089377%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%
  3E

Record 232 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: The nucleocapsid protein of SARS coronavirus has a high binding affinity to
  the human cellular heterogeneous nuclear ribonucleoprotein A1
AU: Luo,-Haibin [Author]; Chen,-Qing [Author]; Chen,-Jing [Author]; Chen,
  -Kaixian [Author]; Shen,-Xu [Author,-Reprint-Author]; Jiang,-Hualiang [Author]
AD: Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci,Drug Discovery and Design
  Ct, Shanghai Inst Mat Med,State Key Lab Drug Res, Shanghai 201203, Peoples R
  China
EMA: xshen@mail.shcnc.ac.cn; hljiang@mail.shcnc.ac.cn
SO: FEBS-Letters. 2005; 579(12): 2623-2628
PY: 2005
DT: Article
IS: 0014-5793
LA: English
AB: The nucleocapsid (N) protein of SARS coronavirus (SARS_CoV) is a major
  structural component of virions, which appears to be a multifunctional protein
  involved in viral RNA replication and translation. Heterogeneous nuclear
  ribonucleoprotein At (hnRNP A1) is related to the pre-mRNA splicing in the
  nucleus and translation regulation in the cytoplasm. In this report, based on
  the relevant biophysical and biochemical assays, the nucleocapsid protein of
  SARS_CoV (SARS_N) was discovered to exhibit high binding affinity to human
  hnRNP A1. GST pull-down results clearly demonstrated that SARS_N protein could
  directly and specifically bind to human hnRNP A I in vitro. Yeast two-hybrid
  assays further indicated in vivo that such binding relates to the fragment (aa
  161-210) of SARS_N and the Gly-rich domain (aa 203-320) of hnRNP A1. Moreover,
  kinetic analyses by surface plasmon resonance (SPR) technology revealed that
  SARS_N protein has a specific binding affinity against human hnRNP At with K-D
  at 0.35 +/- 0.02 mu M (k(on) = 5.83 +/- 0.42 x 10(3) M-1 s(-1) and k(off) =
  2.06 +/- 0.12 x 10(-3) s(-1)). It is suggested that both SARS_N and hnRNP At
  proteins are possibly within the SARS_CoV replication/transcription complex and
  SARS_N/human hnRNP At interaction might function in the regulation of SARS_CoV
  RNA synthesis. In addition, the determined results showed that SARS_N protein
  has only one binding domain for interacting with human hnRNP At, which is
  different from the mouse hepatitis virus (MHV) binding case where the
  nucleocapsid protein of MHV (MHV_N) was found to have two binding domains
  involved in the MHV_N/hnRNP At interaction, thereby suggesting that SARS_N
  protein might carry out a different binding mode to bind to human hnRNP At for
  its further function performance in comparison with MHV_N. (c) 2005 Federal ion
  of European Biochemical Societies. Published by Elsevier B.V. All rights
  reserved.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; Mouse-hepatitis-virus (Coronaviridae-): common-,
  Murine-hepatitis-virus, species-, pathogen-; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: cytoplasm-
CB: nucleocapsid-protein; nuclear-ribonucleoprotein-A1; RNA-: replication-,
  translation-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MQ: surface-plasmon-resonance: laboratory-techniques, spectrum-analysis
  -techniques
CC: 03502- (Genetics-General)
03508- (Genetics-Human)
10062- (Biochemistry
  -studies-Nucleic-acids-purines-and-pyrimidines)
16006- (Respiratory-system
  -Pathology)
31500- (Genetics-of-bacteria-and-viruses)
33502- (Virology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510088966
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0014
  -5793&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0014
  -5793&isbn=&volume=579&issue=12&spage=2623&pages=2623
  -2628&date=2005&title=FEBS%20Letters&atitle=The%20nucleocapsid%20protein%20of%20
  SARS%20coronavirus%20has%20a%20high%20binding%20affinity%20to%20the%20human%20ce
  llular%20heterogeneous%20nuclear%20ribonucleoprotein%20A1&aulast=Luo&pid=%3Cauth
  or%3ELuo%2c%20Haibin%3bChen%2c%20Qing%3bChen%2c%20Jing%3bChen%2c%20Kaixian%3bShe
  n%2c%20Xu%3bJiang%2c%20Hualiang%3C%2Fauthor%3E%3CAN%3E200510088966%3C%2FAN%3E%3C
  DT%3EArticle%3C%2FDT%3E

Record 233 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: The effects of disease severity, use of corticosteroids and social factors
  on neuropsychiatric complaints in severe acute respiratory syndrome (SARS)
  patients at acute and convalescent phases
AU: Sheng,-Bun [Author,-Reprint-Author]; Cheng,-Sammy-Kin-Wing [Author]; Lau,
  -Kwok-Kwong [Author]; Li,-Ho-Lun [Author]; Chan,-Eric-Lok-Yiu [Author]
AD: Princess Margaret Hosp, Dept Med and Geriatr, Kowloon, Hong Kong, Peoples R
  China
EMA: shengbun@hotmail.com
SO: European-Psychiatry. 2005; 20(3): 236-242
PY: 2005
DT: Article
IS: 0924-9338
LA: English
AB: Objective. - To evaluate the effects of disease severity, corticosteroids
  and social factors on neuropsychiatric complaints in severe acute respiratory
  syndrome (SARS) patients, both during acute and convalescent phases.Subjects
  and methods. - Self-administered mail questionnaires survey to 308 SARS
  patients after discharging from hospital. Both patients and their families were
  asked about symptoms related to various neuropsychiatric domains, and the
  questions covered both acute and convalescent phases.Results. - Among the 102
  (33%) valid replies, 65% had strong symptorns in convalescent phase as
  indicated by GHQ28 score >= 5. In multiple linear regression analysis, use of
  pulse steroid and total dosages Of pulse steroid during hospitalisation were
  predictive for anxiety-depression, psychosis and behavioural symptoms in acute
  phase, the effects persisted in convalescent phase. Disease severity had direct
  correlation with symptoms in all neuropsychiatric domains at acute phase and
  anxiety-depression and cognition at convalescent phase. Health care workers had
  more neuropsychiatric complaints in both phases. Severity of symptoms,
  corticosteroids and social factors explained about half of the variances (R-2 =
  52) in anxiety-depression at acute phase and 33% at convalescent
  phase.Conclusion. - Severe disease, high dose corticosteroids and being health
  care workers were independent predictors of neuropsychiatric complaints in both
  acute and convalescent phases. (c) 2004 Elsevier SAS. All rights reserved.
AI: Y
MC: Pharmacology-; Infection-; Pulmonary-Medicine: Human-Medicine, Medical
  -Sciences; Psychiatry-: Human-Medicine, Medical-Sciences
ST: [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
CB: corticosteroids-: hormone-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, symptom-; neuropsychiatric
  -disorders: (Cognition-Disorders-(MeSH)), nervous-system-disease, behavioral
  -and-mental-disorders, symptom-
MI: disease-severity; hospital-discharge; social-factors
CC: 07004- (Behavioral-biology-Human-behavior)
10067- (Biochemistry-studies
  -Sterols-and-steroids)
12512- (Pathology-Therapy)
16006- (Respiratory-system
  -Pathology)
20506- (Nervous-system-Pathology)
21002- (Psychiatry
  -Psychopathology-psychodynamics-and-therapy)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
22016- (Pharmacology
  -Endocrine)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510088837
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0924
  -9338&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0924
  -9338&isbn=&volume=20&issue=3&spage=236&pages=236
  -242&date=2005&title=European%20Psychiatry&atitle=The%20effects%20of%20disease%2
  0severity%2c%20use%20of%20corticosteroids%20and%20social%20factors%20on%20neurop
  sychiatric%20complaints%20in%20severe%20acute%20respiratory%20syndrome%20%28SARS
  %29%20patients%20at%20acute%20and%20convalescent%20phases&aulast=Sheng&pid=%3Cau
  thor%3ESheng%2c%20Bun%3bCheng%2c%20Sammy%20Kin%20Wing%3bLau%2c%20Kwok%20Kwong%3b
  Li%2c%20Ho%20Lun%3bChan%2c%20Eric%20Lok%20Yiu%3C%2Fauthor%3E%3CAN%3E200510088837
  %3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 234 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2
AU: Li,-Wenhui [Author]; Zhang,-Chengsheng [Author]; Sui,-Jianhua [Author];
  Kuhn,-Jens-H [Author]; Moore,-Michael-J [Author]; Luo,-Shiwen [Author]; Wong,
  -Swee--Kee [Author]; Huang,-I-Chueh [Author]; Xu,-Keming [Author]; Vasilieva,
  -Natalya [Author]; Murakami,-Akikazu [Author]; He,-Yaqing [Author]; Marasco,
  -Wayne-A [Author]; Guan,-Yi [Author,-Reprint-Author]; Choe,-Hyeryun [Author];
  Farzan,-Michael [Author]
AD: Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong,
  Peoples R China
EMA: yguan@hkucc.hku.hk; hyeryun.choe@tch.harvard.edu; farzan@hms.harvard.edu
SO: EMBO-(European-Molecular-Biology-Organization)-Journal. 2005; 24(8): 1634
  -1643
PY: 2005
DT: Article
IS: 0261-4189
LA: English
AB: Human angiotensin-converting enzyme 2 (ACE2) is a functional receptor for
  SARS coronavirus (SARS-CoV). Here we identify the SARS-CoV spike (S)-protein
  -binding site on ACE2. We also compare S proteins of SARS-CoV isolated during
  the 2002-2003 SARS outbreak and during the much less severe 2003-2004 outbreak,
  and from palm civets, a possible source of SARS-CoV found in humans. All three
  S proteins bound to and utilized palm-civet ACE2 efficiently, but the latter
  two S proteins utilized human ACE2 markedly less efficiently than did the S
  protein obtained during the earlier human outbreak. The lower affinity of these
  S proteins could be complemented by altering specific residues within the S
  -protein-binding site of human ACE2 to those of civet ACE2, or by altering S
  -protein residues 479 and 487 to residues conserved during the 2002-2003
  outbreak. Collectively, these data describe molecular interactions important to
  the adaptation of SARS-CoV to human cells, and provide insight into the
  severity of the 2002-2003 SARS epidemic.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Pulmonary-Medicine: Human-Medicine, Medical-Sciences; Respiratory-System:
  Respiration-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; [85795-] Viverridae-, Carnivora-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -coronavirus, common-, pathogen-; human- (Hominidae-): common-, host-; palm
  -civet (Viverridae-): common-, host-, disease-vector
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Viverridae-: Animals-, Carnivores-, Chordates-, Mammals-,
  Nonhuman-Vertebrates, Nonhuman-Mammals, Vertebrates-
CB: angiotensin-converting-enzyme-2; spike-protein: binding-site
GN: human-ACE2-gene [Hominidae-]: human-angiotensin-converting-enzyme-2-gene-gene
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, pathology-
MI: SARS-epidemic
CC: 03502- (Genetics-General)
03506- (Genetics-Animal)
03508- (Genetics
  -Human)
12502- (Pathology-General)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
31500- (Genetics-of
  -bacteria-and-viruses)
33502- (Virology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
AN: 200510088514
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0261
  -4189&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0261
  -4189&isbn=&volume=24&issue=8&spage=1634&pages=1634
  -1643&date=2005&title=EMBO%20%28European%20Molecular%20Biology%20Organization%29
  %20Journal&atitle=Receptor%20and%20viral%20determinants%20of%20SARS
  -coronavirus%20adaptation%20to%20human%20ACE2&aulast=Li&pid=%3Cauthor%3ELi%2c%20
  Wenhui%3bZhang%2c%20Chengsheng%3bSui%2c%20Jianhua%3bKuhn%2c%20Jens%20H%3bMoore%2
  c%20Michael%20J%3bLuo%2c%20Shiwen%3bWong%2c%20Swee%20%20Kee%3bHuang%2c%20I%20Chu
  eh%3bXu%2c%20Keming%3bVasilieva%2c%20Natalya%3bMurakami%2c%20Akikazu%3bHe%2c%20Y
  aqing%3bMarasco%2c%20Wayne%20A%3bGuan%2c%20Yi%3bChoe%2c%20Hyeryun%3bFarzan%2c%20
  Michael%3C%2Fauthor%3E%3CAN%3E200510088514%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 235 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: Follow-up study on pulmonary function and lung radiographic changes in
  rehabilitating severe acute respiratory syndrome patients after discharge
AU: Xie,-Lixin [Author]; Liu,-Youning [Author,-Reprint-Author]; Xiao,-Yueyong
  [Author]; Tian,-Qing [Author]; Fan,-Baoxing [Author]; Zhao,-Hong [Author];
  Chen,-Weijun [Author]
AD: Chinese PLA Gen Hosp, Dept Resp Med, 28 Fuxing Rd, Beijing 100853, Peoples R
  China
EMA: liuyn@301hospital.com.cn
SO: Chest-. 2005; 127(6): 2119-2124
PY: 2005
DT: Article
IS: 0012-3692
LA: English
AB: Objectives: To follow-up on the changes in lung function and lung
  radiographic pictures of severe acute respiratory syndrome (SARS) patients
  discharged from Xiaotangshan Hospital in Beijing (by regularly receiving
  examination), and to analyze retrospectively the treatment strategy in these
  patients.Methods: Surviving SARS patients were seen at least twice within 3
  months after discharge and underwent SARS-associated coronavirus (SARS-CoV) IgG
  antibody testing, pulmonary function testing, and chest radiography and/or high
  -resolution CT (HRCT) examinations at Chinese PLA General Hospital. The
  treatments received at Xiaotangshan Hospital were analyzed retrospectively and
  were correlated to later status.Results: Positive SARS-Co virus IgG antibody
  results were seen in 208 of 258 patients, with 21.3 % (55 of 258 patients)
  still having a pulmonary diffusion abnormality (DLCO < 80 % of predicted). By
  comparing the 155 survivors with positive SARS-CoV IgG antibody results and
  DLCO < 80 % predicted with the 50 patients with negative SARS-CoV IgG results,
  we found that 53 patients with positive SARS-CoV IgG results and a lung
  diffusion abnormality had endured a much longer course of fever and received
  larger doses of glucocorticoid, as well as higher ratios of oxygen inhalation
  and noninvasive ventilation treatment. For these patients, 51 of 53 patients
  with positive SARS-CoV IgG results and a lung diffusion abnormality underwent
  pulmonary function testing after approximately 1 month. DLCO improved in 80.4 %
  of patients (41 of 51 patients). Of the patients with a lung diffusion
  abnormality, 40 of 51 patients showed lung fibrotic changes in the lung image
  examination and 22 patients (55 %) showed improvement in lung fibrotic changes
  1 month later.Conclusion: These findings suggest that lung fibrotic changes
  caused by SARS disease occurred mostly in severely sick patients and may be
  self-rehabilitated. DLCO scores might be more sensitive than HRCT when
  evaluating lung fibrotic changes.
AI: Y
MC: Infection-; Pulmonary-Medicine: Human-Medicine, Medical-Sciences
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-, pathogen-; human- (Hominidae-): common-, adult-, aged-, middle
  -age, host-, female-, male-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: lung-: respiratory-system
CB: oxygen-: 7782-44-7; immunoglobulin-G; glucocorticoids-: hormone-drug,
  antiviral-drug, antiinfective-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy,
  complications-
RN: 7782-44-7
MQ: radiography-: laboratory-techniques, diagnostic-techniques, clinical
  -techniques, imaging-and-microscopy-techniques; pulmonary-function-test:
  clinical-techniques, diagnostic-techniques; high-resolution-computed
  -tomography: HRCT-, laboratory-techniques, diagnostic-techniques, clinical
  -techniques, imaging-and-microscopy-techniques
MI: treatment-strategy; lung-function; follow-up-study; lung-radiographic
  -picture; lung-fibrotic-change
CC: 10064- (Biochemistry-studies-Proteins-peptides-and-amino-acids)
10067-
  (Biochemistry-studies-Sterols-and-steroids)
12512- (Pathology-Therapy)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
22005- (Pharmacology-Clinical-pharmacology)
22016- (Pharmacology
  -Endocrine)
24500- (Gerontology-)
33502- (Virology-General-and
  -methods)
34502- (Immunology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510087616
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0012
  -3692&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0012
  -3692&isbn=&volume=127&issue=6&spage=2119&pages=2119
  -2124&date=2005&title=Chest%20&atitle=Follow
  -up%20study%20on%20pulmonary%20function%20and%20lung%20radiographic%20changes%20
  in%20rehabilitating%20severe%20acute%20respiratory%20syndrome%20patients%20after
  %20discharge&aulast=Xie&pid=%3Cauthor%3EXie%2c%20Lixin%3bLiu%2c%20Youning%3bXiao
  %2c%20Yueyong%3bTian%2c%20Qing%3bFan%2c%20Baoxing%3bZhao%2c%20Hong%3bChen%2c%20W
  eijun%3C%2Fauthor%3E%3CAN%3E200510087616%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 236 of 2547 in BIOSIS Previews 2005: 35-43 2005/09-2005/10

TI: 2,3-diaminopyridine as a platform for designing structurally unique
  nonpeptide bradykinin B-1 receptor antagonists
AU: Feng,-Dong-Mel [Author,-Reprint-Author]; Wai,-Jenq-M [Author]; Kuduk,-Scott
  -D [Author]; Ng,-Christina [Author]; Murphy,-Kathy-L [Author]; Ransom,-Richard
  -W [Author]; Reiss,-Duane [Author]; Chang,-Raymond-S-L [Author]; Harrell,
  -Charles-M [Author]; MacNeil,-Tanya [Author]; Tang,-Cuyue [Author];
  Prueksaritanont,-Thomayant [Author]; Freidinger,-Roger-M [Author]; Pettibone,
  -Douglas-J [Author]; Bock,-Mark-G [Author]
AD: Merck Res Labs, Dept Med Chem, W Point, PA 19486 USA
EMA: dongmei_feng@merck.com
SO: Bioorganic-and-Medicinal-Chemistry-Letters. 2005; 15(9): 2385-2388
PY: 2005
DT: Article
IS: 0960-894X
LA: English
AB: A novel class of 2,3-diaminopyridine bradykinin 131 receptor antagonists is
  disclosed. Structure-activity relationship studies (SARs) that led to compounds
  with significantly improved potency and pharmacokinetic properties relative to
  the lead compound are described. (c) 2005 Elsevier Ltd. All rights reserved.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics
CB: bradykinin-B-1-receptor; 2,3-diaminopyridine
MI: structure-activity-relationship; pharmacokinctic-property
CC: 10060- (Biochemistry-studies-General)
AN: 200510086845
UD: 20050809
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0960
  -894X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0960
  -894X&isbn=&volume=15&issue=9&spage=2385&pages=2385
  -2388&date=2005&title=Bioorganic%20and%20Medicinal%20Chemistry%20Letters&atitle=
  2%2c3-diaminopyridine%20as%20a%20platform%20for%20designing%20structurally%20uni
  que%20nonpeptide%20bradykinin%20B
  -1%20receptor%20antagonists&aulast=Feng&pid=%3Cauthor%3EFeng%2c%20Dong%20Mel%3bW
  ai%2c%20Jenq%20M%3bKuduk%2c%20Scott%20D%3bNg%2c%20Christina%3bMurphy%2c%20Kathy%
  20L%3bRansom%2c%20Richard%20W%3bReiss%2c%20Duane%3bChang%2c%20Raymond%20S%20L%3b
  Harrell%2c%20Charles%20M%3bMacNeil%2c%20Tanya%3bTang%2c%20Cuyue%3bPrueksaritanon
  t%2c%20Thomayant%3bFreidinger%2c%20Roger%20M%3bPettibone%2c%20Douglas%20J%3bBock
  %2c%20Mark%20G%3C%2Fauthor%3E%3CAN%3E200510086845%3C%2FAN%3E%3CDT%3EArticle%3C%2
  FDT%3E

Record 237 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Immunogenicity, safety, and protective efficacy of an inactivated SARS
  -associated coronavirus vaccine in rhesus monkeys
AU: Zhou,-Jun [Author]; Wang,-Wei [Author]; Zhong,-Qiong [Author]; Hou,-Wei
  [Author]; Yang,-Zhanqiu [Author,-Reprint-Author]; Xiao,-Shu-Yuan [Author]; Zhu,
  -Runqing [Author]; Tang,-Zhijiao [Author]; Wang,-Yong [Author]; Xian,-Qiaoyang
  [Author]; Tang,-Hongbing [Author]; Wen,-Li [Author]
AD: Wuhan Univ, Inst Virol, Minist Educ, Key Lab Virol, Wuhan 430071, Peoples R
  China
EMA: yangzhanqiu@163.com
SO: Vaccine-. 2005; 23(24): 3202-3209
PY: 2005
DT: Article
IS: 0264-410X
LA: English
AB: An inactivated vaccine for severe acute respiratory syndrome (SARS)
  -associated coronavirus (SARS-CoV) was evaluated in rhesus monkeys. The monkeys
  were inoculated intramuscularly (i.m.) with 0.5, 5, 50, or 5000 mu g of
  vaccine, or PBS as control, and boosted on day 7. After 3 weeks, they were
  challenged with the NS-1 strain of SARS-CoV The humoral and mucosal immune
  responses, clinical signs, chemical indices and viremia were monitored
  following the immunization and challenge. The control animals who received PBS
  developed atypical SAR-CoV infection after viral challenge, according to
  clinical, virological and pathological findings. No systematic side effects
  were observed in vaccinated animals post-immunization, even in at the high dose
  of 5000 mu g. The 50 mu g dosage of vaccine elicited SARS-CoV specific immune
  responses against viral infection as compared to the partial immunity elicited
  by 0.5 and 5 mu g doses. The results show that this inactivated vaccine can
  induce effective concomitant humoral and mucosal immunity against SARS-CoV
  infection, is safe in monkeys, and the vaccine maybe a good candidate for
  clinical trials. (c) 2005 Elsevier Ltd. All rights reserved.
AI: Y
MC: Pharmacology-; Infection-; Immune-System: Chemical-Coordination-and
  -Homeostasis
ST: [86205-] Cercopithecidae-, Primates-, Mammalia-, Vertebrata-, Chordata-,
  Animalia-; [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: rhesus-monkey (Cercopithecidae-): common-, host-; Severe-Acute-Respiratory
  -Syndrome-virus (Coronaviridae-): common-, SARS-virus, common-, pathogen-,
  strain-NS-1
TN: Cercopithecidae-: Animals-, Chordates-, Mammals-, Nonhuman-Mammals, Nonhuman
  -Vertebrates, Nonhuman-Primates, Primates-, Vertebrates-; Coronaviridae-:
  Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses, Viruses-
CB: inactivated-SARS-associated-coronavirus-vaccine: antiinfective-drug,
  antiviral-drug, vaccine-, efficacy-, immunogenicity-, intramuscular
  -administration, safety-
MQ: vaccination-: laboratory-techniques
MI: humoral-immune-response; mucosal-immune-response
CC: 12512- (Pathology-Therapy)
22002- (Pharmacology-General)
33502- (Virology
  -General-and-methods)
34502- (Immunology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510084351
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0264
  -410X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0264
  -410X&isbn=&volume=23&issue=24&spage=3202&pages=3202
  -3209&date=2005&title=Vaccine%20&atitle=Immunogenicity%2c%20safety%2c%20and%20pr
  otective%20efficacy%20of%20an%20inactivated%20SARS
  -associated%20coronavirus%20vaccine%20in%20rhesus%20monkeys&aulast=Zhou&pid=%3Ca
  uthor%3EZhou%2c%20Jun%3bWang%2c%20Wei%3bZhong%2c%20Qiong%3bHou%2c%20Wei%3bYang%2
  c%20Zhanqiu%3bXiao%2c%20Shu%20Yuan%3bZhu%2c%20Runqing%3bTang%2c%20Zhijiao%3bWang
  %2c%20Yong%3bXian%2c%20Qiaoyang%3bTang%2c%20Hongbing%3bWen%2c%20Li%3C%2Fauthor%3
  E%3CAN%3E200510084351%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 238 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated
  vaccine prepared from F69 strain
AU: Zhanga,-Chuan-hai [Author]; Lu,-Jia-hai [Author,-Reprint-Author]; Wang,-Yi
  -fei [Author]; Zheng,-Huan-ying-e [Author]; Xiong,-Sheng [Author]; Zhang,-Mei
  -ying [Author]; Liu,-Xin-jian [Author]; Li,-Jiu-xiang [Author]; Wan,-Zhuo-yue
  [Author]; Yan,-Xin-ge [Author]; Qi,-Shu-Yuan [Author]; Cui,-Zhiyong [Author];
  Zhang,-Biliang [Author]
AD: Chinese Acad Sci, Guangzhou Inst Biomed and Hlth, Guangzhou Int Business
  Incubator, Guangshou Sci Pk, Guangzhou 510663, Peoples R China
EMA: jiahailu@yahoo.com.cn; twangyf@jnu.edu.cn; zhang_biliang@gibh.ac.cn
SO: Vaccine-. 2005; 23(24): 3196-3201
PY: 2005
DT: Article
IS: 0264-410X
LA: English
AB: The immunogenicity of a candidate-inactivated vaccine prepared from SARS-CoV
  F69 strain was evaluated in Balb/c mice. Potent Immoral immune responses were
  induced under the elicitation of three times of immunizations at 2-week
  intervals with this vaccine, combined with three types of adjuvants (Freund's
  adjuvant, Al(OH)(3) adjuvant and CpG adjuvant). Titers of specific IgG
  antibodies in three test groups all peaked in the sixth week after first
  vaccination, but significant differences existed in the kinetics of specific
  IgG antibody levels. The strong neutralizing capacity exhibited in micro
  -cytopathic effect neutralization tests indicated the specific antibodies are
  protective. Western blot assay further demonstrated the specificity of the
  induced serum antibodies. (c) 2005 Elsevier Ltd. All rights reserved.
AI: Y
MC: Pharmacology-; Infection-; Immune-System: Chemical-Coordination-and
  -Homeostasis
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86375-] Muridae-, Rodentia-, Mammalia-, Vertebrata-, Chordata
  -, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, strain-F69; mouse- (Muridae-): common-, strain-Balb-c
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-
CB: SARS-CoV-inactivated-vaccine: antiinfective-drug, antiviral-drug, vaccine-
MQ: vaccination-: laboratory-techniques
MI: immune-response
CC: 12512- (Pathology-Therapy)
22002- (Pharmacology-General)
33502- (Virology
  -General-and-methods)
34502- (Immunology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510084350
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0264
  -410X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0264
  -410X&isbn=&volume=23&issue=24&spage=3196&pages=3196
  -3201&date=2005&title=Vaccine%20&atitle=Immune%20responses%20in%20Balb%2fc%20mic
  e%20induced%20by%20a%20candidate%20SARS
  -CoV%20inactivated%20vaccine%20prepared%20from%20F69%20strain&aulast=Zhanga&pid=
  %3Cauthor%3EZhanga%2c%20Chuan%20hai%3bLu%2c%20Jia%20hai%3bWang%2c%20Yi%20fei%3bZ
  heng%2c%20Huan%20ying%20e%3bXiong%2c%20Sheng%3bZhang%2c%20Mei%20ying%3bLiu%2c%20
  Xin%20jian%3bLi%2c%20Jiu%20xiang%3bWan%2c%20Zhuo%20yue%3bYan%2c%20Xin%20ge%3bQi%
  2c%20Shu%20Yuan%3bCui%2c%20Zhiyong%3bZhang%2c%20Biliang%3C%2Fauthor%3E%3CAN%3E20
  0510084350%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 239 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Negative attitude of highly educated parents and health care workers towards
  future vaccinations in the Dutch childhood vaccination program
AU: Hak,-E [Author,-Reprint-Author]; Schonbeck,-Y [Author]; De-Melker [Author];
  Van-Essen,-G-A [Author]; Sanders,-E-A-M [Author]
AD: Univ Utrecht, Ctr Med, Julius Ctr Hlth Sci and Primary Hlth Care, HP Str 6
  -131, NL-3508 AB Utrecht, Netherlands
EMA: e.hak@umcutrecht.nl
SO: Vaccine-. 2005; 23(24): 3103-3107
PY: 2005
DT: Article
IS: 0264-410X
LA: English
AB: Background: It is unknown whether further expansion of the Dutch childhood
  vaccination program with other vaccines will be accepted and whom should be
  targeted in educational strategies.Aim: To determine attitudes of parents
  towards possible future vaccinations for their children and the behavioural
  determinants associated with a negative attitude.Design: Questionnaire
  study.Methods: Parents of children aged between 3 months and 5 years of day
  -care centres were asked to fill out a questionnaire. Determinants of a
  negative attitude to comply with possible future vaccinations against example
  diseases such as pneumonia or influenza, hepatitis B, TBC, smallpox and SARS
  were assessed using polytomous logistic regression analysis.Results: Of the 283
  respondents, 123 (43%) reported a positive attitude towards all vaccinations,
  129 (46%) reported to have a positive attitude to have their child vaccinated
  against some diseases and 31 (11%) had no intention to comply with any new
  vaccination. Determinants of a fully negative attitude were a high education of
  the parent (odds ratio [OR] 3.3, 95% confidence interval [95% CI]: 1.3-8.6),
  being a health care worker (OR 4.2, 95% CI: 1.4-12.6), absence of religion (OR
  2.6, 95% CI: 1.0-6.7), perception of vaccine ineffectiveness (OR 6.9, 95% CI:
  2.5-18.9) and the perception that vaccinations cause asthma or allergies (OR
  82.4, 95% CI: 8.9-766.8).Conclusion: Modifiable determinants for a negative
  attitude to comply with new vaccinations are mainly based on lack of specific
  knowledge. These barriers to vaccinations might be overcome by improving health
  education in the vaccination program, especially when targeted at educated
  parents and health care workers. (c) 2005 Elsevier Ltd. All rights reserved.
AI: Y
MC: Pharmacology-; Infection-
ST: [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: human- (Hominidae-): common-, child-, infant-, Dutch-
TN: Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-
CB: vaccine-: antiinfective-drug, antiviral-drug, vaccine-
DS: pneumonia-: (Pneumonia-(MeSH)), respiratory-system-disease; infection-:
  (Infection-(MeSH)), infectious-disease, prevention-and-control; hepatitis-B:
  digestive-system-disease, viral-disease; influenza-: (Influenza-(MeSH)),
  respiratory-system-disease, viral-disease; SARS-: severe-acute-respiratory
  -syndrome, respiratory-system-disease, viral-disease; smallpox-: (Smallpox
  -(MeSH)), viral-disease; TBC-: tuberculosis-, bacterial-disease
MQ: vaccination-: clinical-techniques; questionnaire-: clinical-techniques,
  diagnostic-techniques
MI: health-education; dutch-childhood-vaccination-program
CC: 12512- (Pathology-Therapy)
14006- (Digestive-system-Pathology)
16006-
  (Respiratory-system-Pathology)
22002- (Pharmacology-General)
22005-
  (Pharmacology-Clinical-pharmacology)
25000- (Pediatrics-)
36001- (Medical-and
  -clinical-microbiology-General-and-methods)
36002- (Medical-and-clinical
  -microbiology-Bacteriology)
36006- (Medical-and-clinical-microbiology
  -Virology)
38502- (Chemotherapy-General-methods-and-metabolism)
38506-
  (Chemotherapy-Antiviral-agents)
AN: 200510084338
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0264
  -410X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0264
  -410X&isbn=&volume=23&issue=24&spage=3103&pages=3103
  -3107&date=2005&title=Vaccine%20&atitle=Negative%20attitude%20of%20highly%20educ
  ated%20parents%20and%20health%20care%20workers%20towards%20future%20vaccinations
  %20in%20the%20Dutch%20childhood%20vaccination%20program&aulast=Hak&pid=%3Cauthor
  %3EHak%2c%20E%3bSchonbeck%2c%20Y%3bDe%20Melker%3bVan%20Essen%2c%20G%20A%3bSander
  s%2c%20E%20A%20M%3C%2Fauthor%3E%3CAN%3E200510084338%3C%2FAN%3E%3CDT%3EArticle%3C
  %2FDT%3E

Record 240 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: A deficient public health system as a contributing cause of Severe Acute
  Respiratory Syndrome (SARS) epidemic in mainland China
AU: Qin,-Liang [Author]; Jeng,-Hueiwang [Author]; Rakue,-Yasuyuki [Author];
  Mizota,-Tsutomu [Author,-Reprint-Author]
AD: Nagasaki Univ, Dept Social and Environm Hlth, Inst Trop Med, 1-12-4
  Sakamoto, Nagasaki 8528523, Japan
EMA: mizota@net.nagasaki-u.ac.jp
SO: Southeast-Asian-Journal-of-Tropical-Medicine-and-Public-Health. 2005; 36(1):
  213-216
PY: 2005
DT: Article
IS: 0125-1562
LA: English
AB: SARS (Severe Acute Respiratory Syndrome) is a newly emerging infectious
  disease which spread over 32 countries and areas, infected more than 8,000
  people and causing more than 900 deaths from November 2002 to August 2003. More
  than 90% of the SAPS cases and death were reported from China. Nevertheless, we
  still know little about this disease, particularly in etiology. SARS, as an
  emergency of Public Health System (PHS), alarmed health workers throughout the
  world proving there is still the potential for an epidemic of an emerging
  infection both in developed and developing areas. Many reports indicated that
  the insufficiency of the PHS of China was one of the critical factors
  contributing to the outbreak of SAPS. In this study, we attempt to demonstrate
  some of the categories of PHS that contributed to the SARS epidemic. Two of the
  categories studied were the living environment and health resources. In the
  living environment area, the population and population density were examined.
  Health resources include the medical facilities, health workers, and per capita
  public health expenditures. An understanding of these areas is important to
  prevent future epidemic.
AI: Y
MC: Epidemiology-: Population-Studies; Infection-; Pulmonary-Medicine: Human
  -Medicine, Medical-Sciences
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): species-, pathogen
  -; human- (Hominidae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
GE: China-: Asia-, Palearctic-region
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, epidemiology-
MI: public-health-system
CC: 16006- (Respiratory-system-Pathology)
33502- (Virology-General-and
  -methods)
36006- (Medical-and-clinical-microbiology-Virology)
37052- (Public
  -health-epidemiology-Communicable-diseases)
37054- (Public-health-epidemiology
  -Organic-diseases-and-neoplasms)
37056- (Public-health-epidemiology
  -Miscellaneous)
AN: 200510083822
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0125
  -1562&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0125
  -1562&isbn=&volume=36&issue=1&spage=213&pages=213
  -216&date=2005&title=Southeast%20Asian%20Journal%20of%20Tropical%20Medicine%20an
  d%20Public%20Health&atitle=A%20deficient%20public%20health%20system%20as%20a%20c
  ontributing%20cause%20of%20Severe%20Acute%20Respiratory%20Syndrome%20%28SARS%29%
  20epidemic%20in%20mainland%20China&aulast=Qin&pid=%3Cauthor%3EQin%2c%20Liang%3bJ
  eng%2c%20Hueiwang%3bRakue%2c%20Yasuyuki%3bMizota%2c%20Tsutomu%3C%2Fauthor%3E%3CA
  N%3E200510083822%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 241 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Development in lipid drugs
AU: Raulin,-J [Author,-Reprint-Author]
AD: Univ Denis Diderot Paris 7, 22 Rue Poliveau, F-75005 Paris, France
EMA: jeanine.raulin@wanadoo.fr
SO: Mini-Reviews-in-Medicinal-Chemistry. 2005; 5(5): 489-498
PY: 2005
DT: Article
IS: 1389-5575
LA: English
AB: Lipopeptide lipid moieties induce dendritic cell (DC) internalization and
  epitopes are recognized by MHC, the major histocompatibility complex. HIV-1
  (human immunodeficiency virus type 1) lipopeptide vaccine candidate elicits
  immune responses, and sustains HIV control after highly active antiretroviral
  therapy (HAART). Mp- and Dp-MART (anti-melanoma lipopeptides) induce strong CTL
  (cytolytic T lymphocyte) response. New BGTC, BGDA, TGKC lipoplexes mediate gene
  delivery, e.g., into mouse pancreatic tumor nodules. Triterpene glycyrrhizic
  acid (GL) inhibits SARS-CoV (severe acute respiratory syndrome associated
  coronavirus) replication. Compared to CDV (cidofovir), CDV ether lipid esters
  have enhanced activity against vaccinia (VV) and cowpox (CV) viruses in vitro.
  Oral treatment of VV and CV infected mice with CDV ether lipid esters, as
  effective as i.p. CDV, may be useful against orthopoxvirus infections in humans.
AI: Y
MC: Infection-; Pharmaceuticals-: Pharmacology-; Molecular-Genetics:
  Biochemistry-and-Molecular-Biophysics
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; [86375-] Muridae-, Rodentia-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; [03305-] Retroviridae-, DNA-and-RNA-Reverse-Transcribing
  -Viruses, Viruses-, Microorganisms-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-; BxPC-3-cell
  -line (Hominidae-): cell_line-, human-pancreatic-cancer-cells; mouse- (Muridae
  -): common-, host-; Human-immunodeficiency-virus-type1 (Retroviridae-): common
  -, Human-immunodeficiency-virus-1, species-, pathogen-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-; Retroviridae-: DNA-and-RNA-Reverse
  -Transcribing-Viruses, Microorganisms-, Viruses-
PS: dendritic-cell: immune-system; cytolytic-T-lymphocyte: immune-system, blood
  -and-lymphatics
CB: major-histocompatibility-complex: MHC-; glycyrrhizic-acid: 1405-86-3,
  antiinfective-drug, antiviral-drug; Mp-MART: anti-melanoma-lipopeptide; Dp
  -MART: anti-melanoma-lipopeptide; BGTC-; BGDA-; TGKC-; cidofovir-ether-lipid
  -esters: antiinfective-drug, antiviral-drug, oral-administration; human
  -immunodeficiency-virus-type-1-lipopeptide-vaccine: HIV-1-lipopeptide-vaccine,
  immunologic-drug, immunostimulant-drug, vaccine-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; human-immunodeficiency
  -virus-1-infection: (HIV-Infections-(MeSH)), viral-disease, immune-system
  -disease; orthopoxvirus-infection: (Poxviridae-Infections-(MeSH)), viral
  -disease; vaccinia-: (Vaccinia-(MeSH)), viral-disease, drug-therapy; cowpox-:
  (Cowpox-(MeSH)), viral-disease, drug-therapy
RN: 1405-86-3
MQ: gene-delivery: laboratory-techniques, genetic-techniques; gene-transfection:
  laboratory-techniques, genetic-techniques; highly-active-antiretroviral
  -therapy: HAART-, therapeutic-and-prophylactic-techniques, clinical-techniques
MI: immune-response
CC: 02506- (Cytology-Animal)
02508- (Cytology-Human)
03502- (Genetics
  -General)
03506- (Genetics-Animal)
03508- (Genetics-Human)
10064-
  (Biochemistry-studies-Proteins-peptides-and-amino-acids)
12512- (Pathology
  -Therapy)
15002- (Blood-Blood-and-lymph-studies)
15004- (Blood-Blood-cell
  -studies)
16006- (Respiratory-system-Pathology)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
22018- (Pharmacology
  -Immunological-processes-and-allergy)
31500- (Genetics-of-bacteria-and
  -viruses)
33502- (Virology-General-and-methods)
34502- (Immunology-General
  -and-methods)
34508- (Immunology-Immunopathology-tissue-immunology)
36006-
  (Medical-and-clinical-microbiology-Virology)
38502- (Chemotherapy-General
  -methods-and-metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510082309
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1389
  -5575&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1389
  -5575&isbn=&volume=5&issue=5&spage=489&pages=489
  -498&date=2005&title=Mini%20Reviews%20in%20Medicinal%20Chemistry&atitle=Developm
  ent%20in%20lipid%20drugs&aulast=Raulin&pid=%3Cauthor%3ERaulin%2c%20J%3C%2Fauthor
  %3E%3CAN%3E200510082309%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 242 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Comparative host gene transcription by microarray analysis early after
  infection of the Huh7 cell line by severe acute respiratory syndrome
  coronavirus and human coronavirus 229E
AU: Tang,-Bone-S-F [Author]; Chan,-Kwok-hung [Author]; Cheng,-Vincent-C-C
  [Author]; Woo,-Patrick-C-Y [Author]; Lau,-Susanna-K-P [Author]; Lam,-Clarence-C
  -K [Author]; Chan,-Tsun-leung [Author]; Wu,-Alan-K-L [Author]; Hung,-Ivan-F-N
  [Author]; Leung,-Suet-yi [Author]; Yuen,-Kwok-yung [Author,-Reprint-Author]
AD: Univ Hong Kong, Queen Mary Hosp, Ctr Infect and Immunol, Dept
  Microbiol,State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R
  China
EMA: kyyuen@hkucc.hku.hk
SO: Journal-of-Virology. 2005; 79(10): 6180-6193
PY: 2005
DT: Article
IS: 0022-538X
LA: English
AB: The pathogenesis of severe acute respiratory syndrome-associated coronavirus
  (SARS-CoV) at the cellular level is unclear. No human cell line was previously
  known to be susceptible to both SARS-CoV and other human coronaviruses. Huh7
  cells were found to be susceptible to both SARS-CoV, associated with SARS, and
  human coronavirus 229E (HCoV-229E), usually associated with the common cold.
  Highly lytic and productive rates of infections within 48 h of inoculation were
  reproducible with both viruses. The early transcriptional profiles of host cell
  response to both types of infection at 2 and 4 h postinoculation were
  determined by using the Affymetrix HG-U133A microarray (about 22,000 genes).
  Much more perturbation of cellular gene transcription was observed after
  infection by SARS-CoV than after infection by HCoV-229E. Besides the
  upregulation of genes associated with apoptosis, which was exactly opposite to
  the previously reported effect of SARS-CoV in a colonic carcinoma cell line,
  genes related to inflammation, stress response, and procoagulation were also
  upregulated. These findings were confirmed by semiquantitative reverse
  transcription-PCR, reverse transcription-quantitative PCR for mRNA of genes,
  and immunoassays for some encoded proteins. These transcriptomal changes are
  compatible with the histological changes of pulmonary vasculitis and
  microvascular thrombosis in addition to the diffuse alveolar damage involving
  the pneumocytes.
AI: Y
MC: Methods-and-Techniques; Infection-; Cell-Biology; Respiratory-System:
  Respiration-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-Coronavirus (Coronaviridae-): common-,
  pathogen-; Human-coronavirus-229E (Coronaviridae-): species-, pathogen-; Huh7
  -cell-line (Hominidae-): cell_line-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
PS: alveoli-: respiratory-system; pneumocyte-
CB: messenger-RNA: mRNA-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease; common-cold: (Common-Cold
  -(MeSH)), respiratory-system-disease, viral-disease, etiology-; pulmonary
  -vasculitis: vascular-disease, respiratory-system-disease
MQ: microarray-analysis: laboratory-techniques, genetic-techniques; comparative
  -host-gene-transcription: laboratory-techniques, genetic-techniques;
  semiquantitative-reverse-transcription-polymerase-chain-reaction:
  semiquantitative-reverse-transcription-PCR, laboratory-techniques, genetic
  -techniques
MI: cell-line-susceptiblity; host-cell-response
CC: 02502- (Cytology-General)
02506- (Cytology-Animal)
02508- (Cytology
  -Human)
10062- (Biochemistry-studies-Nucleic-acids-purines-and
  -pyrimidines)
14508- (Cardiovascular-system-Blood-vessel-pathology)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510081962
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -538X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -538X&isbn=&volume=79&issue=10&spage=6180&pages=6180
  -6193&date=2005&title=Journal%20of%20Virology&atitle=Comparative%20host%20gene%2
  0transcription%20by%20microarray%20analysis%20early%20after%20infection%20of%20t
  he%20Huh7%20cell%20line%20by%20severe%20acute%20respiratory%20syndrome%20coronav
  irus%20and%20human%20coronavirus%20229E&aulast=Tang&pid=%3Cauthor%3ETang%2c%20Bo
  ne%20S%20F%3bChan%2c%20Kwok%20hung%3bCheng%2c%20Vincent%20C%20C%3bWoo%2c%20Patri
  ck%20C%20Y%3bLau%2c%20Susanna%20K%20P%3bLam%2c%20Clarence%20C%20K%3bChan%2c%20Ts
  un%20leung%3bWu%2c%20Alan%20K%20L%3bHung%2c%20Ivan%20F%20N%3bLeung%2c%20Suet%20y
  i%3bYuen%2c%20Kwok%20yung%3C%2Fauthor%3E%3CAN%3E200510081962%3C%2FAN%3E%3CDT%3EA
  rticle%3C%2FDT%3E

Record 243 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Receptor-independent spread of a highly neurotropic murine coronavirus JHMV
  strain from initially infected microglial cells in mixed neural cultures
AU: Nakagaki,-Keiko [Author]; Nakagaki,-Kazuhide [Author]; Taguchi,-Fumihiro
  [Author,-Reprint-Author]
AD: Natl Inst Infect Dis, Dept Virol 3, Lab Resp Viral Dis and SARS, Murayama
  Branch, 4-7-1 Gakuen, Tokyo 2080011, Japan
EMA: ftaguchi@nih.go.jp
SO: Journal-of-Virology. 2005; 79(10): 6102-6110
PY: 2005
DT: Article
IS: 0022-538X
LA: English
AB: Although neurovirulent mouse hepatitis virus (MHV) strain JHMV multiplies in
  a variety of brain cells, expression of its receptor carcinoembryonic antigen
  cell adhesion molecule 1 (CEACAM 1) (MHVR) is restricted only in microglia. The
  present study was undertaken to clarify the mechanism of an extensive JHMV
  infection in the brain by using neural cells isolated from mouse brain. In
  contrast to wild-type (wt) JHMV, a soluble-receptor-resistant mutant (srr7)
  infects and spreads solely in an MHVR-dependent fashion (F. Taguchi and S.
  Matsuyama, J. Virol. 76:950-958, 2002). In mixed neural cell cultures, srr7
  infected a limited number of cells and infection did not spread, although wt
  JHMV induced syncytia in most of the cells. srr7-infected cells were positive
  for GS-lectin, a microglia marker. Fluorescence-activated cell sorter analysis
  showed that about 80% of the brain cells stained with anti-MHVR antibody (CC1)
  were also positive for GS-lectin. Pretreatment of those cells with CO prevented
  virus attachment to the cell surface and also blocked virus infection. These
  results show that microglia express functional MHVR that mediates JHMV
  infection. As expected, in microglial cell-enriched cultures, both srr7 and wt
  JHMV produced syncytia in a majority of cells. Treatment with CC1 of mixed
  neural cell cultures and microglia cultures previously infected with wt virus
  failed to block the spread of infection, indicating that wt infection spreads
  in an MHVR-independent fashion. Thus, the present study indicates that
  microglial cells are the major population of the initial target for MHV
  infection and that the wt spreads from initially infected microglia to a
  variety of cells in an MHVR-independent fashion.
AI: Y
MC: Nervous-System: Neural-Coordination; Infection-; Immune-System: Chemical
  -Coordination-and-Homeostasis
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86375-] Muridae-, Rodentia-, Mammalia-, Vertebrata-, Chordata
  -, Animalia-
OR: Murine-coronavirus (Coronaviridae-): common-, pathogen-; mouse- (Muridae-):
  common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-
PS: brain-: nervous-system; cerebrum-: nervous-system; microglial-cell: immune
  -system, nervous-system
CB: carcinoembryonic-antigen-related-cell-adhesion-molecule-1: CEACAM-1; GS
  -lectin: microglia-marker; CC1-: anti-mouse-hepatitis-virus-receptor-antibody
DS: coronavirus-infection: viral-disease
MQ: fluorescence-activated-cell-sorting: laboratory-techniques, spectrum
  -analysis-techniques, histology-and-cytology-techniques; mixed-neural-culture:
  laboratory-equipment
MI: cell-surface; srr7-: soluble-receptor-resistant-mutant
CC: 02506- (Cytology-Animal)
20504- (Nervous-system-Physiology-and
  -biochemistry)
33502- (Virology-General-and-methods)
34502- (Immunology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510081954
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -538X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -538X&isbn=&volume=79&issue=10&spage=6102&pages=6102
  -6110&date=2005&title=Journal%20of%20Virology&atitle=Receptor
  -independent%20spread%20of%20a%20highly%20neurotropic%20murine%20coronavirus%20J
  HMV%20strain%20from%20initially%20infected%20microglial%20cells%20in%20mixed%20n
  eural%20cultures&aulast=Nakagaki&pid=%3Cauthor%3ENakagaki%2c%20Keiko%3bNakagaki%
  2c%20Kazuhide%3bTaguchi%2c%20Fumihiro%3C%2Fauthor%3E%3CAN%3E200510081954%3C%2FAN
  %3E%3CDT%3EArticle%3C%2FDT%3E

Record 244 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe
  acute respiratory syndrome by an animal study, epitope mapping, and analysis of
  spike variants
AU: Sui,-Jianhua [Author]; Li,-Wenhui [Author]; Roberts,-Anjeanette [Author];
  Matthews,-Leslie-J [Author]; Murakami,-Akikazu [Author]; Vogel,-Leatrice
  [Author]; Wong,-Swee-Kee [Author]; Subbarao,-Kanta [Author]; Farzan,-Michael
  [Author]; Marasco,-Wayne-A [Author,-Reprint-Author]
AD: Dana Farber Canc Inst, Dept Canc Immunol and AIDS, Dept Med, 44 Binney
  St,JFB 824, Boston, MA 02115 USA
EMA: wayne_marasco@dfci.harvard.edu
SO: Journal-of-Virology. 2005; 79(10): 5900-5906
PY: 2005
DT: Article
IS: 0022-538X
LA: English
AB: In this report, the antiviral activity of 80R immunoglobulin G1 (IgG1), a
  human monoclonal antibody against severe acute respiratory syndrome coronavirus
  (SARS-CoV) spike (S) protein that acts as a viral entry inhibitor in vitro, was
  investigated in vivo in a mouse model. When 80R IgG1 was given prophylactically
  to mice at doses therapeutically achievable in humans, viral replication was
  reduced by more than 4 orders of magnitude to below assay limits. The essential
  core region of S protein required for 80R binding was identified as a
  conformationally sensitive fragment (residues 324 to 503) that overlaps the
  receptor ACE2-binding domain. Amino acids critical for 80R binding were
  identified. In addition, the effects of various 80R-binding domain amino acid
  substitutions which occur in SARS-like-CoV from civet cats, and which evolved
  during the 2002/2003 outbreak and in a 2003/2004 Guangdong index patient, were
  analyzed. The results demonstrated that the vast majority of SARS-CoVs are
  sensitive to 80R. We propose that by establishing the susceptibility and
  resistance profiles of newly emerging SARS-CoVs through early S1 genotyping of
  the core 180-amino-acid neutralizing epitope of 80R, an effective
  immunoprophylaxis strategy with 80R should be possible in an outbreak setting.
  Our study also cautions that for any prophylaxis strategy based on neutralizing
  antibody responses, whether by passive or active immunization, a genotyping
  monitor will be necessary for effective use.
AI: Y
MC: Pharmacology-; Methods-and-Techniques; Infection-; Immune-System: Chemical
  -Coordination-and-Homeostasis; Respiratory-System: Respiration-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; [86375-] Muridae-, Rodentia-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-acute-respiratory-syndrome-coronavirus (Coronaviridae-): common-,
  pathogen-; human- (Hominidae-): common-, host-; mouse- (Muridae-): common-,
  host-, female-, strain-BALB-c
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-
CB: spike-protein; 80R-immunoglobulin-G1: antiinfective-drug, antiviral-drug
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, drug-therapy, prevention
  -and-control
MQ: epitope-mapping: laboratory-techniques, immunologic-techniques
CC: 12512- (Pathology-Therapy)
16004- (Respiratory-system-Physiology-and
  -biochemistry)
16006- (Respiratory-system-Pathology)
22002- (Pharmacology
  -General)
22005- (Pharmacology-Clinical-pharmacology)
33502- (Virology
  -General-and-methods)
34502- (Immunology-General-and-methods)
36006- (Medical
  -and-clinical-microbiology-Virology)
38502- (Chemotherapy-General-methods-and
  -metabolism)
38506- (Chemotherapy-Antiviral-agents)
AN: 200510081934
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -538X&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -538X&isbn=&volume=79&issue=10&spage=5900&pages=5900
  -5906&date=2005&title=Journal%20of%20Virology&atitle=Evaluation%20of%20human%20m
  onoclonal%20antibody%2080R%20for%20immunoprophylaxis%20of%20severe%20acute%20res
  piratory%20syndrome%20by%20an%20animal%20study%2c%20epitope%20mapping%2c%20and%2
  0analysis%20of%20spike%20variants&aulast=Sui&pid=%3Cauthor%3ESui%2c%20Jianhua%3b
  Li%2c%20Wenhui%3bRoberts%2c%20Anjeanette%3bMatthews%2c%20Leslie%20J%3bMurakami%2
  c%20Akikazu%3bVogel%2c%20Leatrice%3bWong%2c%20Swee%20Kee%3bSubbarao%2c%20Kanta%3
  bFarzan%2c%20Michael%3bMarasco%2c%20Wayne%20A%3C%2Fauthor%3E%3CAN%3E200510081934
  %3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 245 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Bisphosphonate inhibitors of Toxoplasma gondi growth: In vitro, QSAR, and in
  vivo investigations
AU: Ling,-Yan [Author]; Sahota,-Gurmukh [Author]; Odeh,-Sarah [Author]; Chan,
  -Julian-M-W [Author]; Araujo,-Fausto-G [Author]; Moreno,-Silvia-N-J [Author];
  Oldfield,-Eric [Author,-Reprint-Author]
AD: Univ Illinois, Mol Parasitol Lab, Dept Pathobiol, 2001 S Lincoln Ave,
  Urbana, IL 61802 USA
EMA: eo@chad.ses.uiuc.edu
SO: Journal-of-Medicinal-Chemistry. 2005; 48(9): 3130-3140
PY: 2005
DT: Article
IS: 0022-2623
LA: English
AB: We have investigated the activity of 60 bisphosphonates against the
  replication of Toxoplasma gondii in vitro and of three of the most active
  compounds, in vivo. The two most active compounds found were n-alkyl
  bisphosphonates containing long (n = 9 or 10) hydrocarbon chains, not the
  nitrogen-containing species used in bone resorption therapy. The target of all
  of the most active bisphosphonates appears to be the isoprene biosynthesis
  pathway enzyme farnesyl pyrophosphate synthase (FPPS), as indicated by the
  correlations between T. gondii growth inhibition and FPPS (human and Leishmania
  major) enzyme inhibition and by the fact that a T. gondii. strain engineered to
  overexpress FPPS required considerably higher levels of bisphosphonates to
  achieve 50% growth inhibition, while the IC50 for atovaquone (which does not
  inhibit FPPS) remained the same in the overexpressing strain. The phosphonate
  inhibitor of the non-mevalonate pathway, fosmidomycin, which inhibits the
  enzyme 1-deoxy-xylulose-5-phosphate reductoisomerase, had no effect on T.
  gondii growth. To investigate structure-activity relationships (SARs) in more
  detail, we used two three-dimensional quantitative SAR methods: comparative
  molecular field analysis (CoMFA) and comparative molecular similarity indices
  analysis (CoMSIA), to investigate all 60 bisphosphonates. Both the CoMFA and
  CoMSIA models indicated a 60-70% contribution from steric interactions and a 30
  -40% contribution from electrostatic interactions and using four N = 55
  training sets for each method, we found on average between a factor of 2 and 3
  error in IC50 prediction. The three most active compounds found in vitro were
  tested in vivo in a Smith-Webster mouse model and the two most active
  bisphosphonates were found to provide up to an 80% protection from death, a
  considerable improvement over that found previously with nitrogen-containing
  bisphosphonates. This effect may originate in the much higher therapeutic
  indices of these alkyl bisphosphonates, as deduced from in vitro assays using
  LD50 values for growth inhibition of a human cell line. Overall, these results
  indicate that alkyl bisphosphonates are promising compounds for further
  development as agents against Toxoplasma gondii growth, in vivo.
AI: Y
MC: Parasitology-; Enzymology-: Biochemistry-and-Molecular-Biophysics
ST: [35200-] Flagellata-, Protozoa-, Invertebrata-, Animalia-; [86215-]
  Hominidae-, Primates-, Mammalia-, Vertebrata-, Chordata-, Animalia-; [86375-]
  Muridae-, Rodentia-, Mammalia-, Vertebrata-, Chordata-, Animalia-; [35400-]
  Sporozoa-, Protozoa-, Invertebrata-, Animalia-
OR: Leishmania-major (Flagellata-): species-; human- (Hominidae-): common-, host
  -; mouse- (Muridae-): common-, host-, breed-Smith-Webster; Toxoplasma-gondi
  (Sporozoa-): species-, parasite-
TN: Flagellata-: Animals-, Invertebrates-, Microorganisms-, Protozoans-;
  Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-, Vertebrates-;
  Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-; Sporozoa-: Animals-, Invertebrates-,
  Microorganisms-, Protozoans-
CB: bisphosphonates-; fosmidomycin-: 66508-37-0; atovaquone-: 95233-18-4;
  farnesyl-pyrophosphate-synthase: 50812-36-7, EC-2.5.1.10; 1-deoxyxylulose-5
  -phospheta-reductoisomerase
DS: toxoplasmosis-: (Toxoplasmosis-(MeSH)), parasitic-disease, therapy-
RN: 66508-37-0; 95233-18-4; 50812-36-7
MQ: comparative-molecular-field-analysis: laboratory-techniques, genetic
  -techniques; bone-resorption-therapy: therapeutic-and-prophylactic-techniques,
  clinical-techniques; comparative-molecular-similarity-indices-analysis:
  laboratory-techniques, genetic-techniques
MI: structure-activity-relationship; electrostatic-interaction; steric
  -interaction
CC: 10802- (Enzymes-General-and-comparative-studies-coenzymes)
12512-
  (Pathology-Therapy)
60502- (Parasitology-General)
60504- (Parasitology
  -Medical)
64002- (Invertebrata-comparative-experimental-morphology-physiology
  -and-pathology-Protozoa)
AN: 200510081220
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0022
  -2623&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0022
  -2623&isbn=&volume=48&issue=9&spage=3130&pages=3130
  -3140&date=2005&title=Journal%20of%20Medicinal%20Chemistry&atitle=Bisphosphonate
  %20inhibitors%20of%20Toxoplasma%20gondi%20growth%3a%20In%20vitro%2c%20QSAR%2c%20
  and%20in%20vivo%20investigations&aulast=Ling&pid=%3Cauthor%3ELing%2c%20Yan%3bSah
  ota%2c%20Gurmukh%3bOdeh%2c%20Sarah%3bChan%2c%20Julian%20M%20W%3bAraujo%2c%20Faus
  to%20G%3bMoreno%2c%20Silvia%20N%20J%3bOldfield%2c%20Eric%3C%2Fauthor%3E%3CAN%3E2
  00510081220%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 246 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Mechanisms of host defense following pulmonary infection of the mouse lung
AU: Glass,-William-G [Author,-Reprint-Author]; Subbarao,-Kanta [Author]; Murphy,
  -Brian-M [Author]; Murphy,-Philip-M [Author]
AD: NIAID, NIH, Bethesda, MD 20892 USA
SO: Journal-of-Leukocyte-Biology. 2004; (Suppl. S): 62
PY: 2004
DT: Meeting-Abstract; Meeting
IS: 0741-5400
MT: 37th Annual Meeting of the Society-for-Leukocyte-Biology, Toronto, CANADA;
  October 21 -23, 2004
SP: Soc Leukocyte Biol
LA: English
MC: Immune-System: Chemical-Coordination-and-Homeostasis; Respiratory-System:
  Respiration-
ST: [86375-] Muridae-, Rodentia-, Mammalia-, Vertebrata-, Chordata-, Animalia-
OR: C57B1-6-mouse (Muridae-): common-, animal-model
TN: Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates, Nonhuman
  -Mammals, Rodents-, Vertebrates-
PS: brain-: nervous-system; lung-: respiratory-system; bronchial-epithelium:
  respiratory-system; bronchiolar-epithelium: respiratory-system
CB: RNA-; mRNA-: messenger-RNA, expression-; CCL5-; CCL3-; CXCR3-; CCL2-; CXCL10
  -; CXCL9-; ACE2-
DS: pulmonary-infection: (Respiratory-Tract-Infections-(MeSH)), respiratory
  -system-disease, infectious-disease; SARS-CoV: severe-acute-respiratory--CoV,
  respiratory-system-disease, infectious-disease, disease-miscellaneous, viral
  -disease
CC: 00520- (General-biology-Symposia-transactions-and-proceedings)
10062-
  (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
20504- (Nervous-system-Physiology-and-biochemistry)
34502-
  (Immunology-General-and-methods)
36001- (Medical-and-clinical-microbiology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510081177
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0741
  -5400&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0741
  -5400&isbn=&volume=&issue=Suppl.%20S&spage=&pages=62&date=2004&title=Journal%20o
  f%20Leukocyte%20Biology&atitle=Mechanisms%20of%20host%20defense%20following%20pu
  lmonary%20infection%20of%20the%20mouse%20lung&aulast=Glass&pid=%3Cauthor%3EGlass
  %2c%20William%20G%3bSubbarao%2c%20Kanta%3bMurphy%2c%20Brian%20M%3bMurphy%2c%20Ph
  ilip%20M%3C%2Fauthor%3E%3CAN%3E200510081177%3C%2FAN%3E%3CDT%3EMeeting%20Abstract
  %3bMeeting%3C%2FDT%3E

Record 247 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Immunological detection of severe acute respiratory syndrome coronavirus by
  monoclonal antibodies
AU: Ohnishi,-Kazuo [Author]; Sakaguchi,-Masahiro [Author]; Kaji,-Tomohiro
  [Author]; Akagawa,-Kiyoko [Author]; Taniyama,-Tadayoshi [Author]; Kasai,
  -Masataka [Author]; Tsunetsugu-Yokota,-Yasuko [Author]; Oshima,-Masamichi
  [Author]; Yamamoto,-Kiichi [Author]; Takasuka,-Naomi [Author]; Hashimoto,-Shu
  -ich [Author]; Ato,-Manabu [Author]; Fujii,-Hideki [Author]; Takahashi,
  -Yoshimasa [Author]; Morikawa,-Shigeru [Author]; Ishii,-Koji [Author]; Sata,
  -Tetsutaro [Author]; Takagi,-Hirotaka [Author]; Itamura,-Shigeyuki [Author];
  Odagiri,-Takato [Author]; Miyamura,-Tatsuo [Author]; Kurane,-Ichiro [Author];
  Tashiro,-Masato [Author]; Kurata,-Takeshi [Author]; Yoshikura,-Hiroshi
  [Author]; Takemori,-Toshitada [Author,-Reprint-Author]
AD: Natl Inst Dis, Dept Immunol, Shinjuku Ku, Toyama 1-23-1, Tokyo 1628640, Japan
EMA: ttoshi@nih.go.jp
SO: Japanese-Journal-of-Infectious-Diseases. 2005; 58(2): 88-94
PY: 2005
DT: Article
IS: 1344-6304
LA: English
AB: In order to establish immunological detection methods for severe acute
  respiratory syndrome coronavirus (SARS-CoV), we established monoclonal
  antibodies directed against structural components of the virus. B cell
  hybridomas were generated from mice that were hyper-immunized with inactivated
  SARS-CoV virion. By screening 2,880 generated hybridomas, we established three
  hybridoma clones that secreted antibodies specific for nucleocapsid protein (N)
  and 27 clones that secreted antibodies specific for spike protein (S). Among
  these, four S-protein specific antibodies had in vitro neutralization activity
  against SARS-CoV infection. These monoclonal antibodies enabled the
  immunological detection of SARS-CoV by immunofluorescence staining, Western
  blot or immunohistology. Furthermore, a combination of monoclonal antibodies
  with different specificities allowed the establishment of a highly sensitive
  antigen-capture sandwich ELISA system. These monoclonal antibodies would be a
  useful tool for rapid and specific diagnosis of SARS and also for possible
  antibody-based treatment of the disease.
AI: Y
MC: Infection-; Methods-and-Techniques; Immune-System: Chemical-Coordination-and
  -Homeostasis; Respiratory-System: Respiration-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86375-] Muridae-, Rodentia-, Mammalia-, Vertebrata-, Chordata
  -, Animalia-
OR: Coronavirus- (Coronaviridae-): genus-, pathogen-; mouse- (Muridae-): common
  -, immature-, host-, female-, strain-BALB-c
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-
PS: B-cell: immune-system, blood-and-lymphatics
CB: monoclonal-antibodies
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease, diagnosis-, immunology-
MQ: Western-blot: electrophoretic-techniques, immunologic-techniques, laboratory
  -techniques; immunohistology-: laboratory-techniques, immunologic-techniques;
  sandwich-ELISA: laboratory-techniques, immunologic-techniques;
  immunofluorescence-staining: laboratory-techniques, histology-and-cytology
  -techniques, immunologic-techniques
CC: 02506- (Cytology-Animal)
10064- (Biochemistry-studies-Proteins-peptides-and
  -amino-acids)
12504- (Pathology-Diagnostic)
15002- (Blood-Blood-and-lymph
  -studies)
15004- (Blood-Blood-cell-studies)
16004- (Respiratory-system
  -Physiology-and-biochemistry)
16006- (Respiratory-system-Pathology)
33502-
  (Virology-General-and-methods)
34502- (Immunology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510079910
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=1344
  -6304&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=1344
  -6304&isbn=&volume=58&issue=2&spage=88&pages=88
  -94&date=2005&title=Japanese%20Journal%20of%20Infectious%20Diseases&atitle=Immun
  ological%20detection%20of%20severe%20acute%20respiratory%20syndrome%20coronaviru
  s%20by%20monoclonal%20antibodies&aulast=Ohnishi&pid=%3Cauthor%3EOhnishi%2c%20Kaz
  uo%3bSakaguchi%2c%20Masahiro%3bKaji%2c%20Tomohiro%3bAkagawa%2c%20Kiyoko%3bTaniya
  ma%2c%20Tadayoshi%3bKasai%2c%20Masataka%3bTsunetsugu%20Yokota%2c%20Yasuko%3bOshi
  ma%2c%20Masamichi%3bYamamoto%2c%20Kiichi%3bTakasuka%2c%20Naomi%3bHashimoto%2c%20
  Shu%20ich%3bAto%2c%20Manabu%3bFujii%2c%20Hideki%3bTakahashi%2c%20Yoshimasa%3bMor
  ikawa%2c%20Shigeru%3bIshii%2c%20Koji%3bSata%2c%20Tetsutaro%3bTakagi%2c%20Hirotak
  a%3bItamura%2c%20Shigeyuki%3bOdagiri%2c%20Takato%3bMiyamura%2c%20Tatsuo%3bKurane
  %2c%20Ichiro%3bTashiro%2c%20Masato%3bKurata%2c%20Takeshi%3bYoshikura%2c%20Hirosh
  i%3bTakemori%2c%20Toshitada%3C%2Fauthor%3E%3CAN%3E200510079910%3C%2FAN%3E%3CDT%3
  EArticle%3C%2FDT%3E

Record 248 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in
  cultured cells and mouse muscles
AU: Zhaa,-Ping [Author]; Qin,-Zhao-Ling [Author]; Ke,-Jin-Shan [Author]; Lu,
  -Yang [Author]; Liu,-Min [Author]; Pan,-Wei [Author]; Zhao,-Lan-Juan [Author];
  Cao,-Jie [Author]; Qi,-Zhong-Tian [Author,-Reprint-Author]
AD: Mil Med Univ 2, Dept Microbiol, Shanghai 200433, Peoples R China
EMA: qizt@smmu.edu.cn
SO: FEBS-Letters. 2005; 579(11): 2404-2410
PY: 2005
DT: Article
IS: 0014-5793
LA: English
AB: SARS-CoV is a newly identified coronavirus that causes severe acute
  respiratory syndrome (SARS). Currently, there is no effective method available
  for prophylaxis and treatment of SARS-CoV infections. In the present study, the
  influence of small interfering RNA (siRNA) on SARS-CoV nucleocapsid (N) protein
  expression was detected in cultured cells and mouse muscles. Four siRNA
  expression cassettes driven by mouse U6 promoter targeting SARS-CoV N gene were
  prepared, and their inhibitory effects on expression of N and enhanced green
  fluorescence protein (EGFP) fusion protein were observed. A candidate siRNA was
  proved to down-regulate N and EGFP expression actively in a sequence-specific
  manner. The expression vector of this siRNA was constructed and confirmed to
  reduce N and EGFP expression efficiently in both cultured cells and adult mouse
  muscles. Our findings suggest that the siRNA should provide the basis for
  prophylaxis and therapy of SARS-CoV infection in human. (c) 2005 Federation of
  European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
AI: Y
MC: Infection-; Molecular-Genetics: Biochemistry-and-Molecular-Biophysics;
  Muscular-System: Movement-and-Support; Respiratory-System: Respiration-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-; [86375-] Muridae-, Rodentia-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, SARS
  -virus, common-, pathogen-; human- (Hominidae-): common-, host-; mouse-
  (Muridae-): common-, host-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-; Muridae-: Animals-, Chordates-, Mammals-, Nonhuman-Vertebrates,
  Nonhuman-Mammals, Rodents-, Vertebrates-
PS: muscle-: muscular-system
CB: enhanced-green-fluorescence-protein: EGFP-; small-interfering-RNA: siRNA-,
  expression-; nucleocapsid-protein: N-protein, expression-
GN: mouse-SARS-CoV-gene [Muridae-]: expression-
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
CC: 03502- (Genetics-General)
03506- (Genetics-Animal)
03508- (Genetics
  -Human)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
17504- (Muscle-Physiology-and
  -biochemistry)
31500- (Genetics-of-bacteria-and-viruses)
33502- (Virology
  -General-and-methods)
36006- (Medical-and-clinical-microbiology-Virology)
AN: 200510079072
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0014
  -5793&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0014
  -5793&isbn=&volume=579&issue=11&spage=2404&pages=2404
  -2410&date=2005&title=FEBS%20Letters&atitle=Small%20interfering%20RNA%20inhibits
  %20SARS-CoV%20nucleocapsid%20gene%20expression%20in%20cultured%20cells%20and%20m
  ouse%20muscles&aulast=Zhaa&pid=%3Cauthor%3EZhaa%2c%20Ping%3bQin%2c%20Zhao%20Ling
  %3bKe%2c%20Jin%20Shan%3bLu%2c%20Yang%3bLiu%2c%20Min%3bPan%2c%20Wei%3bZhao%2c%20L
  an%20Juan%3bCao%2c%20Jie%3bQi%2c%20Zhong%20Tian%3C%2Fauthor%3E%3CAN%3E2005100790
  72%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E

Record 249 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome
  coronavirus
AU: Li,-Frank-Qisheng [Author]; Xiao,-Han [Author]; Tam,-James-P [Author]; Liu,
  -D-X [Author,-Reprint-Author]
AD: Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551,
  Singapore
EMA: dxliu@imcb.a-star.edu.sg
SO: FEBS-Letters. 2005; 579(11): 2387-2396
PY: 2005
DT: Article
IS: 0014-5793
LA: English
AB: Severe acute respiratory syndrome coronavirus (SARS-CoV) encodes a highly
  basic nucleocapsid (N) protein of 422 amino acids. Similar to other coronavirus
  N proteins, SARS-CoV N protein is predicted to be phosphorylated and SARS may
  contain nuclear localization signals, serine/arginine-rich motif, RNA binding
  domain and regions responsible for self-association and homo-oligomerization.
  In this study, we demonstrate that the protein is posttranslationally modified
  by covalent attachment to the small ubiquitin-like modifier. The major
  sumoylation site was mapped to the (62)lysine residue of the N protein. Further
  expression and characterization of wild type N protein and K62A mutant reveal
  that sumoylation of the N protein drastically promotes its homo
  -oligomerization, and plays certain roles in the N protein-mediated
  interference of host cell division. This is the first report showing that a
  coronavirus N protein undergoes posttranslational modification by sumoylation,
  and the functional implication of this modification in the formation of
  coronavirus ribouncleoprotein complex, virion assembly and virus-host
  interactions. (c) 2005 Federation of European Biochemical Societies. Published
  by Elsevier B.V. All rights reserved.
AI: Y
MC: Biochemistry-and-Molecular-Biophysics; Infection-; Respiratory-System:
  Respiration-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-; [86215-] Hominidae-, Primates-, Mammalia-, Vertebrata-,
  Chordata-, Animalia-
OR: Severe-Acute-Respiratory-Syndrome-virus (Coronaviridae-): common-, pathogen
  -; HeLa-cell-line (Hominidae-): cell_line-, human-cervical-carcinoma-cells
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-; Hominidae-: Animals-, Chordates-, Humans-, Mammals-, Primates-,
  Vertebrates-
CB: RNA-; nucleocapsid-protein: N-protein, lysine-62-residue, sumoylation-, RNA
  -binding-domain, nuclear-localization-signals, serine/arginine-rich-motif
DS: severe-acute-respiratory-syndrome: SARS-, (Severe-Acute-Respiratory-Syndrome
  -(MeSH)), respiratory-system-disease, viral-disease
MI: virus-host-interactions
CC: 02508- (Cytology-Human)
10060- (Biochemistry-studies-General)
10062-
  (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
16004-
  (Respiratory-system-Physiology-and-biochemistry)
16006- (Respiratory-system
  -Pathology)
33502- (Virology-General-and-methods)
36006- (Medical-and
  -clinical-microbiology-Virology)
AN: 200510079070
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0014
  -5793&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0014
  -5793&isbn=&volume=579&issue=11&spage=2387&pages=2387
  -2396&date=2005&title=FEBS%20Letters&atitle=Sumoylation%20of%20the%20nucleocapsi
  d%20protein%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus&aulast=
  Li&pid=%3Cauthor%3ELi%2c%20Frank%20Qisheng%3bXiao%2c%20Han%3bTam%2c%20James%20P%
  3bLiu%2c%20D%20X%3C%2Fauthor%3E%3CAN%3E200510079070%3C%2FAN%3E%3CDT%3EArticle%3C
  %2FDT%3E

Record 250 of 2547 in BIOSIS Previews 27-34 2005/07-2005/08

TI: Genosensor on gold films with enzymatic electrochemical detection of a SARS
  virus sequence
AU: Abad-Valle,-Patricia [Author]; Fernandez-Abedul,-M-Teresa [Author]; Costa
  -Garcia,-Agustin [Author,-Reprint-Author]
AD: Univ Oviedo, Dept Quim Fis and Analit, E-33006 Oviedo, Spain
EMA: costa@fq.uniovi.es
SO: Biosensors-and-Bioelectronics. 2005; 20(11): 2251-2260
PY: 2005
DT: Article
IS: 0956-5663
LA: English
AB: A hybridisation-based genosensor was designed on a 100 nm sputtered gold
  film. This material worked as an immobilisation and transduction surface. A 30
  -mer sequence that encodes a short lysine-rich region, unique to SARS (severe
  acute respiratory syndrome) virus, was chosen as target. A complementary strand
  (probe), labelled with a thiol group at the 3'-end, was immobilised on the
  film. After blocking the surface, hybridisation with the biotin-conjugated SARS
  strand (at the 3'-end) took place. Interaction with alkaline phosphatase
  -labelled streptavidin permits amplified indirect electrochemical detection.
  The analytical signal is constituted by an electrochemical process of indigo
  carmine, the soluble product of the enzymatic hydrolysis of 3-indoxyl
  phosphate. The use of a sensitive electrochemical technique such as square wave
  voltammetry allowed a detection limit of 6 pM to be obtained for this DNA
  sequence, lower than any other found in the bibliography. The parameters
  affecting the methodology were studied, with special attention being placed on
  selectivity. Specificity was clearly enhanced when interaction time and
  stringency (in the form of formamide percentage) were increased. With 1 h of
  strand interaction and employing 50% of formamide in the hybridisation buffer,
  a 3-base mismatch strand was perfectly distinguished from the complementary.
  (c) 2004 Elsevier B.V. All rights reserved.
AI: Y
MC: Infection-; Enzymology-: Biochemistry-and-Molecular-Biophysics; Respiratory
  -System: Respiration-
ST: [03613-] Coronaviridae-, Positive-Sense-ssRNA-Viruses, Viruses-,
  Microorganisms-
OR: SARS-virus (Coronaviridae-): common-, Severe-Acute-Respiratory-Syndrome
  -virus, common-
TN: Coronaviridae-: Microorganisms-, Positive-Sense-Single-Stranded-RNA-Viruses,
  Viruses-
CB: lysine-: 70-54-2; alkaline-phosphatase: 9001-78-9, EC-3.1.3.1; biotin-: 58
  -85-5; DNA-: sequence-; streptavidin-: 9013-20-1; formamide-: 75-12-7; indigo
  -carmine: 860-22-0; genosensor-; gold-film; 3-indoxyl-phosphate: 13822-19-0,
  enzymatic-hydrolysis; hybridization-buffer
DS: SARS-: severe-acute-respiratory-syndrome, respiratory-system-disease, viral
  -disease, etiology-
RN: 70-54-2; 9001-78-9; 58-85-5; 9013-20-1; 75-12-7; 860-22-0; 13822-19-0
MQ: square-wave-voltammetry: laboratory-techniques
CC: 10062- (Biochemistry-studies-Nucleic-acids-purines-and-pyrimidines)
10063-
  (Biochemistry-studies-Vitamins)
10064- (Biochemistry-studies-Proteins-peptides
  -and-amino-acids)
10802- (Enzymes-General-and-comparative-studies
  -coenzymes)
16004- (Respiratory-system-Physiology-and-biochemistry)
16006-
  (Respiratory-system-Pathology)
33502- (Virology-General-and-methods)
36006-
  (Medical-and-clinical-microbiology-Virology)
AN: 200510076586
UD: 20050802
WEBLH: Check for Holdings
  http://sladmin.silverplatter.com:4416/lpascripts/holdlink.pl?lpa.holdlink.url=ht
  tp://orbexpress.library.yale.edu/cgi
  -bin/Pwebrecon.cgi?DB%3Dlocal%26BOOL1%3Das%2Ba%2Bphrase%26&lpa.holdlink.issnurl=
  FLD1%3DISSN%2B%28ISSN%29%26CNT%3D50%26SAB1%3D$$LPAISSN&lpa.holdlink.isbnurl=FLD1
  %3DISBN%2B%28ISBN%29%26CNT%3D50%26SAB1%3D$$LPAISBN&lpa.holdlink.issn=0956
  -5663&lpa.holdlink.isbn=
ILINK: <img src=http://www.library.yale.edu/sfx/images/sfx.gif>
  http://sfx.library.yale.edu/sfx_local?sid=SP:PREV&id=pmid:&id=&issn=0956
  -5663&isbn=&volume=20&issue=11&spage=2251&pages=2251
  -2260&date=2005&title=Biosensors%20and%20Bioelectronics&atitle=Genosensor%20on%2
  0gold%20films%20with%20enzymatic%20electrochemical%20detection%20of%20a%20SARS%2
  0virus%20sequence&aulast=Abad
  -Valle&pid=%3Cauthor%3EAbad%20Valle%2c%20Patricia%3bFernandez%20Abedul%2c%20M%20
  Teresa%3bCosta%20Garcia%2c%20Agustin%3C%2Fauthor%3E%3CAN%3E200510076586%3C%2FAN%
  3E%3CDT%3EArticle%3C%2FDT%3E

